2024
Association of hospital-treated infectious diseases and infection burden with cardiovascular diseases and life expectancy. (Journal article)
Zheng, J., Ni, C., Lee, S. W. R., Li, F. -R., Huang, J., Zhou, R., . . . Tang, S. (2024). Association of hospital-treated infectious diseases and infection burden with cardiovascular diseases and life expectancy.. Journal of internal medicine, 295(5), 679-694. doi:10.1111/joim.13780DOI: 10.1111/joim.13780
Prevalence of mental health conditions and brain fog in people with long COVID: A systematic review and meta-analysis. (Journal article)
van der Feltz-Cornelis, C., Turk, F., Sweetman, J., Khunti, K., Gabbay, M., Shepherd, J., . . . Banerjee, A. (2024). Prevalence of mental health conditions and brain fog in people with long COVID: A systematic review and meta-analysis.. General hospital psychiatry, 88, 10-22. doi:10.1016/j.genhosppsych.2024.02.009DOI: 10.1016/j.genhosppsych.2024.02.009
Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation (Journal article)
Gue, Y., Bloomfield, D., Freedholm, D., & Lip, G. Y. H. (n.d.). Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation. Journal of Clinical Medicine, 13(8), 2277. doi:10.3390/jcm13082277DOI: 10.3390/jcm13082277
Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications. (Journal article)
Teppo, K., Airaksinen, K. E. J., Jaakkola, J., Halminen, O., Salmela, B., Kouki, E., . . . Lehto, M. (2024). Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications.. European heart journal, ehae198. doi:10.1093/eurheartj/ehae198DOI: 10.1093/eurheartj/ehae198
Artificial intelligence-enhanced electrocardiogram analysis for identifying cardiac autonomic neuropathy in patients with diabetes. (Journal article)
Irlik, K., Aldosari, H., Hendel, M., Kwiendacz, H., Piaśnik, J., Kulpa, J., . . . Nabrdalik, K. (2024). Artificial intelligence-enhanced electrocardiogram analysis for identifying cardiac autonomic neuropathy in patients with diabetes.. Diabetes, obesity & metabolism. doi:10.1111/dom.15578DOI: 10.1111/dom.15578
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial. (Journal article)
Lip, G. Y. H., Nikorowitsch, J., Sehner, S., Becher, N., Bertaglia, E., Blomstrom-Lundqvist, C., . . . Kirchhof, P. (2024). Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.. European heart journal, ehae225. doi:10.1093/eurheartj/ehae225DOI: 10.1093/eurheartj/ehae225
Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds. (Journal article)
Prats-Sanchez, L., Camps-Renom, P., Nash, P. S., Wilson, D., Ambler, G., Best, J. G., . . . Microbleeds International Collaborative Network (MICON). (2024). Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds.. Neurology, 102(7), e209173. doi:10.1212/wnl.0000000000209173DOI: 10.1212/wnl.0000000000209173
Romiti, G. F., Corica, B., Mei, D. A., Bisson, A., Boriani, G., Olshansky, B., . . . GLORIA-AF Investigators. (2024). Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry.. BMC medicine, 22(1), 151. doi:10.1186/s12916-024-03373-4DOI: 10.1186/s12916-024-03373-4
Eleftheriadou, A., Riley, D., Zhao, S. S., Austin, P., Hernández, G., Lip, G. Y. H., . . . Alam, U. (2024). Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.. Diabetologia. doi:10.1007/s00125-024-06132-5DOI: 10.1007/s00125-024-06132-5
Racial Differences in Ischemic and Hemorrhagic Stroke: An Ecological Epidemiological Study. (Journal article)
Kang, D. -S., Yang, P. -S., Kim, D., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2024). Racial Differences in Ischemic and Hemorrhagic Stroke: An Ecological Epidemiological Study.. Thrombosis and haemostasis. doi:10.1055/a-2278-8769DOI: 10.1055/a-2278-8769
Accelerometer-derived physical activity and the risk of death, heart failure, and stroke in patients with atrial fibrillation: a prospective study from UK Biobank. (Journal article)
Ahn, H. -J., Choi, E. -K., Rhee, T. -M., Choi, J., Lee, K. -Y., Kwon, S., . . . Lip, G. Y. H. (2024). Accelerometer-derived physical activity and the risk of death, heart failure, and stroke in patients with atrial fibrillation: a prospective study from UK Biobank.. British journal of sports medicine, 58(8), 427-434. doi:10.1136/bjsports-2023-106862DOI: 10.1136/bjsports-2023-106862
Cardiovascular Risk in Young Patients Diagnosed With Obstructive Sleep Apnea. (Journal article)
Albertsen, I. E., Bille, J., Piazza, G., Lip, G. Y. H., & Nielsen, P. B. (2024). Cardiovascular Risk in Young Patients Diagnosed With Obstructive Sleep Apnea.. Journal of the American Heart Association, e033506. doi:10.1161/jaha.123.033506DOI: 10.1161/jaha.123.033506
Bucci, T., Romiti, G. F., Shantsila, A., Teo, W. -S., Park, H. -W., Shimizu, W., . . . Asia‐Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. (2024). Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.. Journal of the American Heart Association, 13(7), e032785. doi:10.1161/jaha.123.032785DOI: 10.1161/jaha.123.032785
Sagris, D., Lip, G. Υ. Η., Korompoki, E., Ntaios, G., & Vemmos, K. (2024). Adherence to an integrated care pathway for stroke is associated with lower risk of major cardiovascular events: A report from the Athens Stroke Registry.. European journal of internal medicine, 122, 61-67. doi:10.1016/j.ejim.2023.12.010DOI: 10.1016/j.ejim.2023.12.010
Lai, J. Y. M., Riley, D. R., Anson, M., Henney, A., Cuthbertson, D. J., Hernadez, G., . . . Alam, U. (2024). Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data Analysis.. Diabetes therapy : research, treatment and education of diabetes and related disorders, 15(4), 833-842. doi:10.1007/s13300-024-01544-3DOI: 10.1007/s13300-024-01544-3
Anson, M., Henney, A. E., Zhao, S. S., Ibarburu, G. H., Lip, G. Y. H., Cuthbertson, D. J., . . . Alam, U. (2024). Effect of combination pioglitazone with sodium-glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta-analysis, and real-world study from an international federated database.. Diabetes, obesity & metabolism. doi:10.1111/dom.15576DOI: 10.1111/dom.15576
Buja, A., Rebba, V., Montecchio, L., Renzo, G., Baldo, V., Cocchio, S., . . . Lip, G. Y. H. (2024). The Cost of Atrial Fibrillation: A Systematic Review.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 27(4), 527-541. doi:10.1016/j.jval.2023.12.015DOI: 10.1016/j.jval.2023.12.015
Choi, J., Lee, S. -R., Choi, E. -K., Lee, K. -Y., Ahn, H. -J., Kwon, S., . . . Lip, G. Y. H. (2024). Effect of physical activity on incident atrial fibrillation in individuals with varying duration of diabetes: a nationwide population study.. Cardiovascular diabetology, 23(1), 115. doi:10.1186/s12933-024-02194-2DOI: 10.1186/s12933-024-02194-2
Stroke-heart syndrome: mechanisms, risk factors, and adverse cardiovascular events (Journal article)
Buckley, B. J. R., Harrison, S. L., Lane, D. A., Hill, A., & Lip, G. Y. H. (2023). Stroke-heart syndrome: mechanisms, risk factors, and adverse cardiovascular events. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. doi:10.1093/eurjpc/zwad211DOI: 10.1093/eurjpc/zwad211
Williams, N. H., Collins, B., Comerford, T. J., Dodd, S., Fisher, M., Hardwick, B., . . . Singh, S. J. (2024). Effectiveness and cost-effectiveness of a web-based cardiac rehabilitation programme for people with chronic stable angina: protocol for the ACTIVATE (Angina Controlled Trial Investigating the Value of the 'Activate your heart' Therapeutic E-intervention) randomised controlled trial.. BMJ open, 14(3), e084509. doi:10.1136/bmjopen-2024-084509DOI: 10.1136/bmjopen-2024-084509
Subclinical atrial fibrillation patients, who are the best candidates for oral anticoagulant therapy? (Journal article)
Huang, B., Wright, D. J., & Lip, G. Y. H. (2024). Subclinical atrial fibrillation patients, who are the best candidates for oral anticoagulant therapy?. European journal of internal medicine, S0953-6205(24)00119-5. doi:10.1016/j.ejim.2024.03.015DOI: 10.1016/j.ejim.2024.03.015
Tsai, C. -T., Chan, Y. -H., Liao, J. -N., Chen, T. -J., Lip, G. Y. H., Chen, S. -A., & Chao, T. -F. (2024). The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis-a nationwide cohort study.. BMC medicine, 22(1), 113. doi:10.1186/s12916-024-03338-7DOI: 10.1186/s12916-024-03338-7
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper. (Journal article)
Harenberg, J., Gosselin, R. C., Cuker, A., Becattini, C., Pabinger, I., Poli, S., . . . Weiss, C. (2024). Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.. Thrombosis and haemostasis. doi:10.1055/a-2261-1811DOI: 10.1055/a-2261-1811
Racial Differences in Bleeding Risk: An Ecological Epidemiological Study Comparing Korea and United Kingdom Subjects. (Journal article)
Kang, D. -S., Yang, P. -S., Kim, D., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2024). Racial Differences in Bleeding Risk: An Ecological Epidemiological Study Comparing Korea and United Kingdom Subjects.. Thrombosis and haemostasis. doi:10.1055/a-2269-1123DOI: 10.1055/a-2269-1123
Prokopidis, K., Morwani-Mangnani, J., McDowell, G., Lip, G. Y. H., Venturelli, M., Sankaranarayanan, R., & Isanejad, M. (2024). Sarcopenia is linked to higher levels of B-type natriuretic peptide and its N-terminal fragment in heart failure: a systematic review and meta-analysis.. European geriatric medicine. doi:10.1007/s41999-024-00950-xDOI: 10.1007/s41999-024-00950-x
Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study. (Journal article)
Ahn, H. -J., An, H. Y., Ryu, G., Lim, J., Sun, C., Song, H., . . . Choi, E. -K. (2024). Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.. European heart journal, 45(10), 778-790. doi:10.1093/eurheartj/ehad869DOI: 10.1093/eurheartj/ehad869
Impact of ECG data format on the performance of machine learning models for the prediction of myocardial infarction. (Journal article)
Bellfield, R. A. A., Ortega-Martorell, S., Lip, G. Y. H., Oxborough, D., & Olier, I. (2024). Impact of ECG data format on the performance of machine learning models for the prediction of myocardial infarction.. Journal of electrocardiology, 84, 17-26. doi:10.1016/j.jelectrocard.2024.03.005DOI: 10.1016/j.jelectrocard.2024.03.005
Prokopidis, K., Ishiguchi, H., Jordan, C., Irlik, K., Nabrdalik, K., Formiga, F., . . . Isanejad, M. (2024). Association between natriuretic peptides and C-reactive protein with frailty in heart failure: a systematic review and meta-analysis.. Aging clinical and experimental research, 36(1), 57. doi:10.1007/s40520-024-02713-xDOI: 10.1007/s40520-024-02713-x
Bucci, T., Cardamone, C., Triggiani, M., Ames, P. R. J., & Lip, G. Y. H. (2024). Risk of death, thrombotic and hemorrhagic events in anticoagulated patients with atrial fibrillation and systemic autoimmune diseases: an analysis from a global federated dataset.. Clinical research in cardiology : official journal of the German Cardiac Society. doi:10.1007/s00392-024-02426-1DOI: 10.1007/s00392-024-02426-1
Wafa, H. A., Marshall, I., Wolfe, C. D. A., Xie, W., Johnson, C. O., Veltkamp, R., . . . PRESTIGE-AF consortium. (2024). Burden of intracerebral haemorrhage in Europe: forecasting incidence and mortality between 2019 and 2050.. The Lancet regional health. Europe, 38, 100842. doi:10.1016/j.lanepe.2024.100842DOI: 10.1016/j.lanepe.2024.100842
Frost, F., & Lip, G. Y. H. (2024). Cardiorespiratory Multimorbidity in People Living With Chronic Lung Disease: Challenges, Opportunities, and a Concept for Optimization via an Integrated Care Approach.. Chest, 165(3), 500-502. doi:10.1016/j.chest.2023.11.009DOI: 10.1016/j.chest.2023.11.009
Sagris, D., Ntaios, G., Buckley, B. J. R., Harrison, S. L., Underhill, P., Lane, D. A., & Lip, G. Y. H. (2024). Direct oral anticoagulants are associated with lower risk of dementia in patients with atrial fibrillation.. European journal of internal medicine, 121, 114-120. doi:10.1016/j.ejim.2023.10.033DOI: 10.1016/j.ejim.2023.10.033
Mineralocorticoid receptor antagonist for chronic kidney disease, risk or benefit? (Journal article)
Huang, B., McDowell, G., Rao, A., & Lip, G. Y. H. (2024). Mineralocorticoid receptor antagonist for chronic kidney disease, risk or benefit?. Journal of hypertension, 42(3), 396-398. doi:10.1097/hjh.0000000000003643DOI: 10.1097/hjh.0000000000003643
The Reply. (Journal article)
Gue, Y., & Lip, G. Y. H. (2024). The Reply.. The American journal of medicine, 137(3), e61. doi:10.1016/j.amjmed.2023.11.024DOI: 10.1016/j.amjmed.2023.11.024
Mant, J., Modi, R. N., Charlton, P., Dymond, A., Massou, E., Brimicombe, J., . . . Williams, K. (2024). The feasibility of population screening for paroxysmal atrial fibrillation using hand-held electrocardiogram devices.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26(3), euae056. doi:10.1093/europace/euae056DOI: 10.1093/europace/euae056
Mayer, J., Mbizvo, G. K., Bucci, T., Marson, A., & Lip, G. Y. H. (n.d.). Association of antiseizure medications and adverse cardiovascular events: A global health federated network analysis. Epilepsia. doi:10.1111/epi.17922DOI: 10.1111/epi.17922
Efficacy and safety of oral anticoagulants according to kidney function among patients with atrial fibrillation. (Journal article)
Binding, C., Blanche, P., Lip, G. Y. H., Kamper, A. -L., Lee, C. J. Y., Staerk, L., . . . Bonde, A. N. (2024). Efficacy and safety of oral anticoagulants according to kidney function among patients with atrial fibrillation.. European heart journal. Cardiovascular pharmacotherapy, pvae016. doi:10.1093/ehjcvp/pvae016DOI: 10.1093/ehjcvp/pvae016
Bucci, T., Nabrdalik, K., Shantsila, A., Romiti, G. F., Teo, W. -S., Park, H. -W., . . . Lip, G. Y. H. (n.d.). Adverse Events and Clinical Correlates in Asian Patients with Atrial Fibrillation and Diabetes Mellitus: A Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry. Journal of Clinical Medicine, 13(5), 1274. doi:10.3390/jcm13051274DOI: 10.3390/jcm13051274
Romiti, G. F., Nabrdalik, K., Corica, B., Bucci, T., Proietti, M., Qian, M., . . . WARCEF Investigators. (2024). Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial.. Internal and emergency medicine. doi:10.1007/s11739-024-03544-4DOI: 10.1007/s11739-024-03544-4
New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: a Chinese population-based cohort study. (Journal article)
Gao, X., Zhang, N., Lu, L., Gao, T., Chou, O. H. I., Wong, W. T., . . . Zhou, J. (2024). New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: a Chinese population-based cohort study.. European heart journal. Cardiovascular pharmacotherapy, 10(2), 103-117. doi:10.1093/ehjcvp/pvad086DOI: 10.1093/ehjcvp/pvad086
Jones, I. D., Lane, D. A., Lotto, R. R., Oxborough, D., Neubeck, L., Penson, P. E., . . . Lip, G. Y. H. (2024). Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF) using sensors embedded in the handles of supermarket trolleys: A feasibility study.. American heart journal, S0002-8703(24)00038-3. doi:10.1016/j.ahj.2024.02.011DOI: 10.1016/j.ahj.2024.02.011
Predicting multifaceted risks using machine learning in atrial fibrillation: insights from GLORIA-AF study (Journal article)
Lu, J., Bisson, A., Bennamoun, M., Zheng, Y., Sanfilippo, F. M., Hung, J., . . . Lip, G. Y. H. (n.d.). Predicting multifaceted risks using machine learning in atrial fibrillation: insights from GLORIA-AF study. European Heart Journal - Digital Health. doi:10.1093/ehjdh/ztae010DOI: 10.1093/ehjdh/ztae010
Hematologic Malignancies and Increased Cardiovascular Risk-Can More Be Done to Mitigate? (Journal article)
Gue, Y. X., & Lip, G. Y. H. (2024). Hematologic Malignancies and Increased Cardiovascular Risk-Can More Be Done to Mitigate?. The American journal of cardiology, 213, 182-183. doi:10.1016/j.amjcard.2023.12.039DOI: 10.1016/j.amjcard.2023.12.039
Kwok, C. S., Qureshi, A. I., Will, M., Schwarz, K., Lip, G. Y. H., & Borovac, J. A. (2024). Structural Complications Following ST-Elevation Myocardial Infarction: An Analysis of the National Inpatient Sample 2016 to 2020.. Journal of cardiovascular development and disease, 11(2), 59. doi:10.3390/jcdd11020059DOI: 10.3390/jcdd11020059
Deitelzweig, S., Kang, A., Jiang, J., Gao, C., Luo, X., Atreja, N., . . . Lip, G. Y. H. (2024). Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation.. Journal of clinical medicine, 13(4), 1073. doi:10.3390/jcm13041073DOI: 10.3390/jcm13041073
Chen, Y., Gue, Y., Calvert, P., Gupta, D., McDowell, G., Azariah, J. L., . . . KERALA-AF Registry & APHRS-AF Registry Investigators joint senior authors. (2024). Predicting stroke in Asian patients with atrial fibrillation using machine learning: A report from the KERALA-AF registry, with external validation in the APHRS-AF registry.. Current problems in cardiology, 49(4), 102456. doi:10.1016/j.cpcardiol.2024.102456DOI: 10.1016/j.cpcardiol.2024.102456
The association between time-weighted remnant cholesterol and cardiovascular and non-cardiovascular mortality: A population-based cohort study (Preprint)
DOI: 10.1101/2024.02.08.24302507
High Initial Heart Rate Score is an Independent Predictor of New Atrial High-Rate Episodes in Pacemaker Patients with Sinus Node Dysfunction (Preprint)
DOI: 10.1101/2024.02.07.24302470
Bucci, T., Pastori, D., Pignatelli, P., Ntaios, G., Abdul-Rahim, A. H., Violi, F., & Lip, G. Y. H. (2024). Albumin Levels and Risk of Early Cardiovascular Complications After Ischemic Stroke: A Propensity-Matched Analysis of a Global Federated Health Network.. Stroke. doi:10.1161/strokeaha.123.044248DOI: 10.1161/strokeaha.123.044248
High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. (Journal article)
Zhou, X. -D., Chen, Q. -F., Targher, G., Byrne, C. D., Shapiro, M. D., Tian, N., . . . Zheng, M. -H. (2024). High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography.. Journal of the American Heart Association, 13(3), e032997. doi:10.1161/jaha.123.032997DOI: 10.1161/jaha.123.032997
Wang, R., Liu, Y., Thabane, L., Olier, I., Li, L., Ortega-Martorell, S., . . . Li, G. (2024). Relationship between trajectories of dietary iron intake and risk of type 2 diabetes mellitus: evidence from a prospective cohort study.. Nutrition journal, 23(1), 15. doi:10.1186/s12937-024-00925-5DOI: 10.1186/s12937-024-00925-5
Ritchie, L. A., Harrison, S. L., Penson, P. E., Akbari, A., Torabi, F., Hollinghurst, J., . . . Lane, D. A. (2024). Adherence to the Atrial fibrillation Better Care pathway and the risk of adverse health outcomes in older care home residents with atrial fibrillation: a retrospective data linkage study 2003-18.. Age and ageing, 53(2), afae021. doi:10.1093/ageing/afae021DOI: 10.1093/ageing/afae021
Ahn, H. -J., Lee, S. -R., Choi, J., Lee, K. -Y., Kwon, S., Choi, E. -K., . . . Lip, G. Y. H. (2024). Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26(2), euae033. doi:10.1093/europace/euae033DOI: 10.1093/europace/euae033
Atrial fibrillation first detected after stroke: is timing and detection intensity relevant for stroke risk? (Journal article)
Sposato, L. A., Lip, G. Y. H., & Haeusler, K. G. (2024). Atrial fibrillation first detected after stroke: is timing and detection intensity relevant for stroke risk?. European heart journal, 45(5), 396-398. doi:10.1093/eurheartj/ehad744DOI: 10.1093/eurheartj/ehad744
Shantsila, E., Choi, E. -K., Lane, D. A., Joung, B., & Lip, G. Y. H. (2024). Atrial fibrillation: comorbidities, lifestyle, and patient factors.. The Lancet regional health. Europe, 37, 100784. doi:10.1016/j.lanepe.2023.100784DOI: 10.1016/j.lanepe.2023.100784
Linz, D., Gawalko, M., Betz, K., Hendriks, J. M., Lip, G. Y. H., Vinter, N., . . . Johnsen, S. (2024). Atrial fibrillation: epidemiology, screening and digital health.. The Lancet regional health. Europe, 37, 100786. doi:10.1016/j.lanepe.2023.100786DOI: 10.1016/j.lanepe.2023.100786
Net Clinical Benefit of Oral Anticoagulation Among Frail Patients With Atrial Fibrillation: Nationwide Cohort Study. (Journal article)
Søgaard, M., Jensen, M., Højen, A. A., Larsen, T. B., Lip, G. Y. H., Ording, A. G., & Nielsen, P. B. (2024). Net Clinical Benefit of Oral Anticoagulation Among Frail Patients With Atrial Fibrillation: Nationwide Cohort Study.. Stroke, 55(2), 413-422. doi:10.1161/strokeaha.123.044407DOI: 10.1161/strokeaha.123.044407
Rhee, T. -M., Choi, J., Choi, E. -K., Lee, K. -Y., Ahn, H. -J., Kwon, S., . . . Lip, G. Y. H. (2024). Neuroticism and the Risk of Atrial Fibrillation: An Observational Epidemiologic and Mendelian Randomization Study.. JACC. Asia, 4(2), 138-147. doi:10.1016/j.jacasi.2023.09.010DOI: 10.1016/j.jacasi.2023.09.010
The impact of sodium-glucose co-transporter-2 inhibitors on dementia and cardiovascular events in diabetic patients with atrial fibrillation. (Journal article)
Chen, Y. -Y., Chang, H. -C., Lin, Y. -J., Chien, K. -L., Hsieh, Y. -C., Chung, F. -P., . . . Chen, S. -A. (2024). The impact of sodium-glucose co-transporter-2 inhibitors on dementia and cardiovascular events in diabetic patients with atrial fibrillation.. Diabetes/metabolism research and reviews, 40(2), e3775. doi:10.1002/dmrr.3775DOI: 10.1002/dmrr.3775
Tsai, C. -T., Liao, J. -N., Chan, Y. -H., Kuo, L., Liu, C. -M., Lip, G. Y. H., & Chao, T. -F. (2024). Which dose of apixaban is suitable for Asian patients with atrial fibrillation who have a serum creatinine < 1.5 mg/dL but an estimated glomerular filtration rate < 50 mL/min?. International journal of cardiology. Heart & vasculature, 50, 101333. doi:10.1016/j.ijcha.2023.101333DOI: 10.1016/j.ijcha.2023.101333
Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician. An International Consensus Paper. (Journal article)
Potpara, T., Grygier, M., Haeusler, K. G., Nielsen-Kudsk, J. E., Berti, S., Genovesi, S., . . . Camm, A. J. (2024). Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician. An International Consensus Paper.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, euae035. doi:10.1093/europace/euae035DOI: 10.1093/europace/euae035
Relationship Between Lipoprotein(a), Renal Function Indicators, and Chronic Kidney Disease: Evidence From a Large Prospective Cohort Study. (Journal article)
Liu, Y., Wang, R., Li, S., Zhang, C., Lip, G. Y. H., Thabane, L., & Li, G. (2024). Relationship Between Lipoprotein(a), Renal Function Indicators, and Chronic Kidney Disease: Evidence From a Large Prospective Cohort Study.. JMIR public health and surveillance, 10, e50415. doi:10.2196/50415DOI: 10.2196/50415
Kell, D. B., Khan, M. A., Kane, B., Lip, G. Y. H., & Pretorius, E. (2024). Possible Role of Fibrinaloid Microclots in Postural Orthostatic Tachycardia Syndrome (POTS): Focus on Long COVID.. Journal of personalized medicine, 14(2), 170. doi:10.3390/jpm14020170DOI: 10.3390/jpm14020170
Romiti, G. F., Corica, B., Mei, D. A., Frost, F., Bisson, A., Boriani, G., . . . Lip, G. Y. H. (2024). Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 26(1), euae021. doi:10.1093/europace/euae021DOI: 10.1093/europace/euae021
Relationship between metabolic status, physical activity and cardiovascular disease in participants with obesity. (Journal article)
Liu, Y., Zhao, A., Sun, G., Wang, R., Zhang, J., Lip, G. Y. H., & Li, G. (2024). Relationship between metabolic status, physical activity and cardiovascular disease in participants with obesity.. International journal of obesity (2005). doi:10.1038/s41366-024-01469-8DOI: 10.1038/s41366-024-01469-8
Infective endocarditis: Five key developments. (Journal article)
Mills, M. T., Calvert, P., & Lip, G. Y. H. (2024). Infective endocarditis: Five key developments.. Trends in cardiovascular medicine, S1050-1738(24)00007-0. doi:10.1016/j.tcm.2024.01.007DOI: 10.1016/j.tcm.2024.01.007
Lin, J., Long, D., Jiang, C., Sang, C., Tang, R., Li, S., . . . CCC-AF investigators. (2024). Oral anti-coagulants use in Chinese hospitalized patients with atrial fibrillation.. Chinese medical journal, 137(2), 172-180. doi:10.1097/cm9.0000000000002915DOI: 10.1097/cm9.0000000000002915
When anticoagulation management in atrial fibrillation becomes difficult: Focus on chronic kidney disease, coagulation disorders, and cancer. (Journal article)
Papakonstantinou, P. E., Kalogera, V., Charitos, D., Polyzos, D., Benia, D., Batsouli, A., . . . Lip, G. Y. H. (2024). When anticoagulation management in atrial fibrillation becomes difficult: Focus on chronic kidney disease, coagulation disorders, and cancer.. Blood reviews, 101171. doi:10.1016/j.blre.2024.101171DOI: 10.1016/j.blre.2024.101171
Corica, B., Romiti, G. F., Simoni, A. H., Mei, D. A., Bucci, T., Thompson, J. L. P., . . . WARCEF Investigators. (2024). Educational status affects prognosis of patients with heart failure with reduced ejection fraction: A post-hoc analysis from the WARCEF trial.. European journal of clinical investigation, e14152. doi:10.1111/eci.14152DOI: 10.1111/eci.14152
Best, J. G., Ambler, G., Wilson, D., Du, H., Lee, K. -J., Lim, J. -S., . . . Werring, D. J. (2024). Clinical Associations and Prognostic Value of MRI-Visible Perivascular Spaces in Patients With Ischemic Stroke or TIA: A Pooled Analysis. Neurology, 102(1), e207795. doi:10.1212/wnl.0000000000207795DOI: 10.1212/wnl.0000000000207795
Mayer, J., Fawzy, A. M., Bisson, A., Pasi, M., Bodin, A., Vigny, P., . . . Fauchier, L. (2024). Epilepsy and the risk of adverse cardiovascular events: A nationwide cohort study.. European journal of neurology. doi:10.1111/ene.16116DOI: 10.1111/ene.16116
A Happy New Year 2024 from Thrombosis and Haemostasis! (Journal article)
Lip, G. Y. H., Rigby, A., & Weber, C. (2024). A Happy New Year 2024 from Thrombosis and Haemostasis!. Thrombosis and haemostasis, 124(1), 1-3. doi:10.1055/s-0043-1778033DOI: 10.1055/s-0043-1778033
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients. (Journal article)
Boriani, G., Bonini, N., Vitolo, M., Mei, D. A., Imberti, J. F., Gerra, L., . . . Lip, G. Y. (2024). Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients.. European journal of internal medicine, 119, 53-63. doi:10.1016/j.ejim.2023.09.009DOI: 10.1016/j.ejim.2023.09.009
Cardiac and renal outcomes of direct oral anticoagulants in patients with atrial fibrillation (Journal article)
Wang, Y. -T., Chen, J. -H., Liao, S. -F., Chen, Y. -J., Lip, G. Y. H., & Yeh, J. -S. (2023). Cardiac and renal outcomes of direct oral anticoagulants in patients with atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. doi:10.1111/eci.14086DOI: 10.1111/eci.14086
Ding, W. Y., Fawzy, A. M., Romiti, G. F., Proietti, M., Pastori, D., Huisman, M. V., . . . GLORIA-AF Investigators. (2024). Correction: Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry.. Journal of thrombosis and thrombolysis, 57(1), 178. doi:10.1007/s11239-023-02904-9DOI: 10.1007/s11239-023-02904-9
Liu, S. -T., Li, R., Zheng, J. -P., Lu, F., Sun, H. -N., Hua, L., . . . Bai, Y. (2024). Epidemiology of arrhythmogenic ventricular cardiomyopathy in China.. Clinical cardiology, 47(1), e24160. doi:10.1002/clc.24160DOI: 10.1002/clc.24160
Bucci, T., Shantsila, A., Romiti, G. F., Teo, W. -S., Chao, T. -F., Shimizu, W., . . . Lip, G. Y. H. (2024). External Validation of COOL-AF Scores in the Asian Pacific Heart Rhythm Society Atrial Fibrillation Registry.. JACC. Asia, 4(1), 59-69. doi:10.1016/j.jacasi.2023.09.011DOI: 10.1016/j.jacasi.2023.09.011
Impact of Unhealthy Lifestyles on Patients with Atrial Fibrillation at Low Risk of Stroke: A Nationwide Cohort Study. (Journal article)
Kwon, S., Lee, S. -R., Choi, E. -K., Lee, S. -W., Jung, J. -H., Han, K. -D., . . . Lip, G. Y. H. (2024). Impact of Unhealthy Lifestyles on Patients with Atrial Fibrillation at Low Risk of Stroke: A Nationwide Cohort Study.. The American journal of medicine, 137(1), 37-46.e6. doi:10.1016/j.amjmed.2023.09.012DOI: 10.1016/j.amjmed.2023.09.012
In symptomatic AF, catheter ablation vs. medical therapy reduced depression and anxiety symptoms at 12 mo. (Journal article)
Ishiguchi, H., & Lip, G. Y. H. (2024). In symptomatic AF, catheter ablation vs. medical therapy reduced depression and anxiety symptoms at 12 mo.. Annals of internal medicine, 177(1), JC4. doi:10.7326/j23-0105DOI: 10.7326/j23-0105
Initiation of warfarin is associated with decreased mortality in patients with infective endocarditis: A population-based cohort study. (Journal article)
Lee, T. T. L., Chan, S. C. L., Chou, O. H. I., Lee, S., Chan, J. S. K., Liu, T., . . . Tse, G. (2024). Initiation of warfarin is associated with decreased mortality in patients with infective endocarditis: A population-based cohort study.. Thrombosis research, 233, 1-9. doi:10.1016/j.thromres.2023.11.009DOI: 10.1016/j.thromres.2023.11.009
Non-vitamin K Antagonist Oral Anticoagulant, Warfarin, and ABC Pathway Adherence on Hierarchical Outcomes: Win Ratio Analysis of the COOL-AF Registry. (Journal article)
Treewaree, S., Lip, G. Y. H., & Krittayaphong, R. (2024). Non-vitamin K Antagonist Oral Anticoagulant, Warfarin, and ABC Pathway Adherence on Hierarchical Outcomes: Win Ratio Analysis of the COOL-AF Registry.. Thrombosis and haemostasis, 124(1), 69-79. doi:10.1055/s-0043-1772773DOI: 10.1055/s-0043-1772773
Relationship of Warfarin and Apixaban with Vascular Function in Patients with Atrial Fibrillation. (Journal article)
Junejo, R. T., Gupta, D., Snowdon, R. L., Lip, G. Y. H., & Fisher, J. P. (2024). Relationship of Warfarin and Apixaban with Vascular Function in Patients with Atrial Fibrillation.. Journal of vascular research, 61(2), 59-67. doi:10.1159/000535618DOI: 10.1159/000535618
Lee, S. -R., Lee, J. H., Choi, E. -K., Jung, E. -K., You, S. -J., Oh, S., & Lip, G. Y. (2024). Risk of Atrial Fibrillation and Adverse Outcomes in Patients With Cardiac Implantable Electronic Devices.. Korean circulation journal, 54(1), 13-27. doi:10.4070/kcj.2023.0084DOI: 10.4070/kcj.2023.0084
Sex disparities for patients with atrial fibrillation in the direct oral anticoagulant era. (Journal article)
Ishiguchi, H., Liu, Y., & Lip, G. Y. H. (2024). Sex disparities for patients with atrial fibrillation in the direct oral anticoagulant era.. European journal of clinical investigation, 54(1), e14124. doi:10.1111/eci.14124DOI: 10.1111/eci.14124
Single and 7-day handgrip and squat exercise prevents endothelial ischemia-reperfusion injury in individuals with cardiovascular disease risk factors. (Journal article)
Somani, Y. B., Boidin, M., Peggen, M. A. G., Wanders, I., Proctor, D. N., Low, D. A., . . . Thijssen, D. H. J. (2024). Single and 7-day handgrip and squat exercise prevents endothelial ischemia-reperfusion injury in individuals with cardiovascular disease risk factors.. American journal of physiology. Regulatory, integrative and comparative physiology, 326(1), R79-R87. doi:10.1152/ajpregu.00168.2023DOI: 10.1152/ajpregu.00168.2023
The impact of COVID-19 and the COVID-19 pandemic on hospitalized patients with STEMI in the United States: insights from the National Inpatient Sample. (Journal article)
Kwok, C. S., Qureshi, A. I., Will, M., Schwartz, K., Borovac, J. A., Waters, D., . . . Lip, G. Y. H. (2024). The impact of COVID-19 and the COVID-19 pandemic on hospitalized patients with STEMI in the United States: insights from the National Inpatient Sample.. Coronary artery disease, 35(1), 23-30. doi:10.1097/mca.0000000000001280DOI: 10.1097/mca.0000000000001280
Thrombosis and Haemostasis 2023 Editors' Choice Papers. (Journal article)
Weber, C., Rigby, A., & Lip, G. Y. H. (2024). Thrombosis and Haemostasis 2023 Editors' Choice Papers.. Thrombosis and haemostasis, 124(1), 80-87. doi:10.1055/s-0043-1778032DOI: 10.1055/s-0043-1778032
Grace, A., Lip, G. Y., Lambiase, P. D., Narayan, S. M., Calkins, H., Guo, Y., . . . Katritsis, D. G. (2024). What Cannot be Missed: Important Publications on Electrophysiology in 2023.. Arrhythmia & electrophysiology review, 13, e04. doi:10.15420/aer.2024.03DOI: 10.15420/aer.2024.03
2023
Gooden, T. E., Wang, J., Goulart, A. C., Varella, A. C., Tai, M., Sheron, V. A., . . . Manaseki-Holland, S. (2023). Generalisability of and lessons learned from a mixed-methods study conducted in three low- and middle-income countries to identify care pathways for atrial fibrillation. GLOBAL HEALTH ACTION, 16(1). doi:10.1080/16549716.2023.2231763DOI: 10.1080/16549716.2023.2231763
Uruthirakumar, P., Surenthirakumaran, R., Gooden, T. E., Lip, G. Y. H., Thomas, G. N., Moore, D. J., . . . NIHR Global Health Research Group on Atrial Fibrillation Management. (2023). Correction: The impact of rate and rhythm control strategies on quality of life for patients with atrial fibrillation: a protocol for a systematic review.. Systematic reviews, 12(1), 241. doi:10.1186/s13643-023-02434-8DOI: 10.1186/s13643-023-02434-8
Better blood pressure control in patients with atrial fibrillation: overcoming barriers to improve outcomes (Journal article)
Dzeshka, M. S., Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2023). Better blood pressure control in patients with atrial fibrillation: overcoming barriers to improve outcomes. HEART. doi:10.1136/heartjnl-2023-323028DOI: 10.1136/heartjnl-2023-323028
Metabolic syndrome and ischaemic stroke in non-anticoagulated atrial fibrillation with low CHA<sub>2</sub>DS<sub>2</sub>-VASc scores. (Journal article)
Ahn, H. -J., Lee, S. -R., Choi, E. -K., Lee, S. -W., Han, K. -D., Kwon, S., . . . Lip, G. Y. H. (2023). Metabolic syndrome and ischaemic stroke in non-anticoagulated atrial fibrillation with low CHA<sub>2</sub>DS<sub>2</sub>-VASc scores.. Heart (British Cardiac Society), 110(2), 101-107. doi:10.1136/heartjnl-2022-322143DOI: 10.1136/heartjnl-2022-322143
Singh, H., Shahid, M. Z., Harrison, S. L., Lane, D. A., Lip, G. Y. H., & Logantha, S. J. R. J. (2024). Subclinical thyroid dysfunction and the risk of incident atrial fibrillation: A systematic review and meta-analysis.. PloS one, 19(1), e0296413. doi:10.1371/journal.pone.0296413DOI: 10.1371/journal.pone.0296413
Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study. (Journal article)
Chan, Y. -H., Chao, T. -F., Chen, S. -W., Lee, H. -F., Li, P. -R., Yeh, Y. -H., . . . Lip, G. Y. H. (2023). Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.. European heart journal. Cardiovascular pharmacotherapy, 9(8), 681-691. doi:10.1093/ehjcvp/pvad058DOI: 10.1093/ehjcvp/pvad058
Jones, L., Park, J., Dliso, S., Hawcutt, D., Shantsila, A., Lip, G. Y. H., & Blair, J. C. (2023). Diurnal salivary cortisol and cortisone concentrations in girls with Turner syndrome and healthy controls: a preliminary report.. Archives of disease in childhood, archdischild-2023-326270. doi:10.1136/archdischild-2023-326270DOI: 10.1136/archdischild-2023-326270
Huang, J. -Y., Chan, Y. -H., Tse, Y. -K., Yu, S. -Y., Li, H. -L., Chen, C., . . . Yiu, K. -H. (2023). Statin Therapy Is Associated With a Lower Risk of Heart Failure in Patients With Atrial Fibrillation: A Population-Based Study.. Journal of the American Heart Association, 12(23), e032378. doi:10.1161/jaha.123.032378DOI: 10.1161/jaha.123.032378
Nabrdalik, K., Bisson, A., Irlik, K., Fauchier, G., Ducluzeau, P. H., Lip, G. Y. H., & Fauchier, L. (2023). Metabolically 'extremely unhealthy' obese and non-obese patients with diabetes and the risk of cardiovascular events: a French nationwide cohort study.. Clinical research in cardiology : official journal of the German Cardiac Society. doi:10.1007/s00392-023-02344-8DOI: 10.1007/s00392-023-02344-8
Augmentation of natriuretic peptide (NP) receptor A and B (NPR-A and NPR-B) and cyclic guanosine monophosphate (cGMP) signalling as a therapeutic strategy in heart failure. (Journal article)
Ajay, A., Rasoul, D., Abdullah, A., Lee Wei En, B., Mashida, K., Al-Munaer, M., . . . Sankaranarayanan, R. (2023). Augmentation of natriuretic peptide (NP) receptor A and B (NPR-A and NPR-B) and cyclic guanosine monophosphate (cGMP) signalling as a therapeutic strategy in heart failure.. Expert opinion on investigational drugs, 32(12), 1157-1170. doi:10.1080/13543784.2023.2290064DOI: 10.1080/13543784.2023.2290064
Verma, L. A., Penson, P. E., Akpan, A., Lip, G. Y. H., & Lane, D. A. (2023). Managing older people with atrial fibrillation and preventing stroke: a review of anticoagulation approaches.. Expert review of cardiovascular therapy, 21(12), 963-983. doi:10.1080/14779072.2023.2276892DOI: 10.1080/14779072.2023.2276892
Pharmacokinetics and pharmacodynamics of direct oral anticoagulants. (Journal article)
Hindley, B., Lip, G. Y. H., McCloskey, A. P., & Penson, P. E. (2023). Pharmacokinetics and pharmacodynamics of direct oral anticoagulants.. Expert opinion on drug metabolism & toxicology, 19(12), 911-923. doi:10.1080/17425255.2023.2287472DOI: 10.1080/17425255.2023.2287472
Jones, L., Park, J., Blair, J., Hawcutt, D. B. B., Lip, G. Y. H., & Shantsila, A. (2023). 20 years on - the measurement of blood pressure and detection of hypertension in children and adolescents: a national descriptive survey. JOURNAL OF HUMAN HYPERTENSION. doi:10.1038/s41371-023-00846-6DOI: 10.1038/s41371-023-00846-6
Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19: An American College of Chest Physicians Expert Panel Report. (Journal article)
Potpara, T., Angiolillo, D. J., Bikdeli, B., Capodanno, D., Cole, O., Yataco, A. C., . . . Lip, G. Y. H. (2023). Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19: An American College of Chest Physicians Expert Panel Report.. Chest, 164(6), 1531-1550. doi:10.1016/j.chest.2023.06.032DOI: 10.1016/j.chest.2023.06.032
Association Between Atrial Fibrillation and Diabetes-Related Complications: A Nationwide Cohort Study. (Journal article)
Kwon, S., Lee, S. -R., Choi, E. -K., Ahn, H. -J., Lee, S. -W., Jung, J. -H., . . . Lip, G. Y. H. (2023). Association Between Atrial Fibrillation and Diabetes-Related Complications: A Nationwide Cohort Study.. Diabetes care, 46(12), 2240-2248. doi:10.2337/dc23-0931DOI: 10.2337/dc23-0931
Co-administered oral anticoagulants with nonsteroidal anti-inflammatory drugs and the risk of bleeding: A systematic review and meta-analysis (Journal article)
Zheng, Y., Zhang, N., Tse, G., Li, G., Lip, G. Y. H., & Liu, T. (2023). Co-administered oral anticoagulants with nonsteroidal anti-inflammatory drugs and the risk of bleeding: A systematic review and meta-analysis. Thrombosis Research, 232, 15-26. doi:10.1016/j.thromres.2023.10.011DOI: 10.1016/j.thromres.2023.10.011
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis. (Journal article)
Gorog, D. A., Ferreiro, J. L., Ahrens, I., Ako, J., Geisler, T., Halvorsen, S., . . . Lip, G. Y. H. (2023). De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis.. Nature reviews. Cardiology, 20(12), 830-844. doi:10.1038/s41569-023-00901-2DOI: 10.1038/s41569-023-00901-2
Extracellular vesicles in cardiovascular diseases: From pathophysiology to diagnosis and therapy. (Journal article)
Du, Y., Wu, L., Wang, L., Reiter, R. J., Lip, G. Y. H., & Ren, J. (2023). Extracellular vesicles in cardiovascular diseases: From pathophysiology to diagnosis and therapy.. Cytokine & growth factor reviews, 74, 40-55. doi:10.1016/j.cytogfr.2023.09.006DOI: 10.1016/j.cytogfr.2023.09.006
Frailty predicts incident atrial fibrillation in women but not in men: The Kuopio Ischaemic Heart Disease Risk Factor Study (Journal article)
Tajik, B., Voutilainen, A., Lyytinen, A., Kauhanen, J., Lip, G. Y. H., Tuomainen, T. -P., & Isanejad, M. (2023). Frailty predicts incident atrial fibrillation in women but not in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. CARDIOLOGY. doi:10.1159/000533361DOI: 10.1159/000533361
Increased risk of venous thromboembolism in patients with gastrointestinal disorders (Journal article)
Gue, Y. X., & Lip, G. Y. H. (2023). Increased risk of venous thromboembolism in patients with gastrointestinal disorders. AMERICAN JOURNAL OF HEMATOLOGY. doi:10.1002/ajh.27140DOI: 10.1002/ajh.27140
Metformin and SGLT2i as First-line Combination Therapy in Type 2 Diabetes: A Real-world Study With a Focus on Ethnicity. (Journal article)
Anson, M., Zhao, S. S., Essa, H., Austin, P., Ibarburu, G. H., Lip, G. Y. H., & Alam, U. (2023). Metformin and SGLT2i as First-line Combination Therapy in Type 2 Diabetes: A Real-world Study With a Focus on Ethnicity.. Clinical therapeutics, 45(12), 1259-1265. doi:10.1016/j.clinthera.2023.07.026DOI: 10.1016/j.clinthera.2023.07.026
Turk, F., Sweetman, J., Allsopp, G., Crooks, M., Cuthbertson, D. J., Gabbay, M., . . . STIMULATE-ICP Consortium. (2023). Pathways to care for Long COVID and for long-term conditions from patients' and clinicians' perspective.. Journal of evidence-based medicine, 16(4), 435-437. doi:10.1111/jebm.12563DOI: 10.1111/jebm.12563
Elsheikh, S., Lip, G. Y. H., & Abdul-Rahim, A. H. H. (2023). Potential Embolic Sources in Embolic Stroke of Undetermined Source in Patients with Patent Foramen Ovale: Look Harder. CEREBROVASCULAR DISEASES. doi:10.1159/000529105DOI: 10.1159/000529105
El-Bouri, W. K., Sanders, A., Lip, G. Y. H., & BBC-VTE investigators. (2023). Predicting acute and long-term mortality in a cohort of pulmonary embolism patients using machine learning.. European journal of internal medicine, 118, 42-48. doi:10.1016/j.ejim.2023.07.012DOI: 10.1016/j.ejim.2023.07.012
Gue, Y. X., & Lip, G. Y. H. (2023). Complete revascularization in elderly patients with myocardial infarction-a safe, effective, and necessary strategy?. Cell reports. Medicine, 4(11), 101284. doi:10.1016/j.xcrm.2023.101284DOI: 10.1016/j.xcrm.2023.101284
Concurrent percutaneous left atrial appendage occlusion and catheter ablation for atrial fibrillation: State-of-the-art review. (Journal article)
Mills, M. T., Calvert, P., Velavan, P., Lip, G. Y. H., & Gupta, D. (2023). Concurrent percutaneous left atrial appendage occlusion and catheter ablation for atrial fibrillation: State-of-the-art review.. Trends in cardiovascular medicine, S1050-1738(23)00100-7. doi:10.1016/j.tcm.2023.11.003DOI: 10.1016/j.tcm.2023.11.003
Latt, N. K. Z., Calvert, P., & Lip, G. Y. H. (2023). Balancing the risk of stroke and bleeding in atrial fibrillation patients with a history of falls.. Expert opinion on drug safety, 22(11), 1041-1048. doi:10.1080/14740338.2023.2273333DOI: 10.1080/14740338.2023.2273333
Harrison, S. L., Buckley, B. J. R., Austin, P., Lane, D. A., & Lip, G. Y. H. (2023). Catheter ablation and lower risk of incident dementia and mortality in older adults with atrial fibrillation. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. doi:10.1111/jgs.18538DOI: 10.1111/jgs.18538
Vinter, N., Holst-Hansen, M. Z. B., Johnsen, S. P., Lip, G. Y. H., Frost, L., & Trinquart, L. (2023). Electrical energy by electrode placement for cardioversion of atrial fibrillation: a systematic review and meta-analysis.. Open heart, 10(2), e002456. doi:10.1136/openhrt-2023-002456DOI: 10.1136/openhrt-2023-002456
Gue, Y., Correa, E., Thompson, J. L. P., Homma, S., Qian, M., & Lip, G. Y. H. (2023). Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial.. The American journal of medicine, 136(11), 1099-1108.e2. doi:10.1016/j.amjmed.2023.07.019DOI: 10.1016/j.amjmed.2023.07.019
Doehner, W., Böhm, M., Boriani, G., Christersson, C., Coats, A. J., Haeusler, K. G., . . . Rosano, G. (2023). Interaction of Heart Failure and Stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis.. European journal of heart failure. doi:10.1002/ejhf.3071DOI: 10.1002/ejhf.3071
Yang, W. -Y., Lip, G. Y. H., Sun, Z. -J., Peng, H., Fawzy, A. M., & Li, H. -W. (2023). Implications of new-onset atrial fibrillation on in-hospital and long-term prognosis of patients with acute myocardial infarction: A report from the CBD bank study. Frontiers in Cardiovascular Medicine, 9. doi:10.3389/fcvm.2022.979546DOI: 10.3389/fcvm.2022.979546
Increased cardiovascular events in young patients with mental disorders: a nationwide cohort study. (Journal article)
Park, C. S., Choi, E. -K., Han, K. -D., Ahn, H. -J., Kwon, S., Lee, S. -R., . . . Lip, G. Y. H. (2023). Increased cardiovascular events in young patients with mental disorders: a nationwide cohort study.. European journal of preventive cardiology, 30(15), 1582-1592. doi:10.1093/eurjpc/zwad102DOI: 10.1093/eurjpc/zwad102
Relation of Life's Essential 8 to the genetic predisposition for cardiovascular outcomes and all-cause mortality: results from a national prospective cohort (Journal article)
Zhang, J., Chen, G., Habudele, Z., Wang, X., Cai, M., Li, H., . . . Lin, H. (2023). Relation of Life's Essential 8 to the genetic predisposition for cardiovascular outcomes and all-cause mortality: results from a national prospective cohort. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. doi:10.1093/eurjpc/zwad179DOI: 10.1093/eurjpc/zwad179
Bucci, T., Shantsila, A., Romiti, G. F., Teo, W. -S., Park, H. -W., Shimizu, W., . . . Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. (2023). Sex-related differences in presentation, treatment, and outcomes of Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry.. Scientific reports, 13(1), 18375. doi:10.1038/s41598-023-45345-3DOI: 10.1038/s41598-023-45345-3
The quest to refine atrial fibrillation-related stroke risk stratification: could the answer lie in left atrial appendage angiography? (Journal article)
Lip, G. Y. H., Mills, M. T., & Gupta, D. (2023). The quest to refine atrial fibrillation-related stroke risk stratification: could the answer lie in left atrial appendage angiography?. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 19(8), 625-627. doi:10.4244/eij-e-23-00038DOI: 10.4244/eij-e-23-00038
Wang, Y., Jiang, C., He, L., Du, X., Guo, X., Tang, R., . . . Ma, C. (2023). ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry.. Chinese medical journal, 136(20), 2451-2458. doi:10.1097/cm9.0000000000002833DOI: 10.1097/cm9.0000000000002833
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment. (Journal article)
Ortega-Paz, L., Talasaz, A. H., Sadeghipour, P., Potpara, T. S., Aronow, H. D., Jara-Palomares, L., . . . Bikdeli, B. (2023). COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment.. Seminars in thrombosis and hemostasis, 49(8), 816-832. doi:10.1055/s-0042-1757634DOI: 10.1055/s-0042-1757634
Machine Learning in Cardio-Oncology: New Insights from an Emerging Discipline (Journal article)
Zheng, Y., Chen, Z., Huang, S., Zhang, N., Wang, Y., Hong, S., . . . Liu, T. (2023). Machine Learning in Cardio-Oncology: New Insights from an Emerging Discipline. Reviews in Cardiovascular Medicine, 24(10), 296. doi:10.31083/j.rcm2410296DOI: 10.31083/j.rcm2410296
Kwon, S., Lee, S. -R., Choi, E. -K., Lee, S. -W., Jung, J. -H., Han, K. -D., . . . Lip, G. Y. H. (2023). Impact of components of metabolic syndrome on the risk of adverse renal outcomes in patients with atrial fibrillation: a nationwide cohort study.. Frontiers in cardiovascular medicine, 10, 1208979. doi:10.3389/fcvm.2023.1208979DOI: 10.3389/fcvm.2023.1208979
Romiti, G. F., Proietti, M., Corica, B., Bonini, N., Boriani, G., Huisman, M. V., . . . GLORIA‐AF Investigators. (2023). Implications of Clinical Risk Phenotypes on the Management and Natural History of Atrial Fibrillation: A Report From the GLORIA-AF.. Journal of the American Heart Association, 12(20), e030565. doi:10.1161/jaha.123.030565DOI: 10.1161/jaha.123.030565
Hs-CRP is associated with Heart Failure Hospitalization in Patients with MAFLD and Normal LVEF Undergoing Coronary Angiography (Preprint)
DOI: 10.1101/2023.10.06.23296684
Bucci, T., Ames, P. R. J., Cammisotto, V., Cardamone, C., Ciampa, A., Mangoni, B., . . . ATHERO-APS study group. (2023). Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study.. Thrombosis research, 231, 76-83. doi:10.1016/j.thromres.2023.10.006DOI: 10.1016/j.thromres.2023.10.006
Associations of Life's Essential 8 and fine particulate matter pollution with the incidence of atrial fibrillation (Journal article)
Zhang, J., Chen, G., Xia, H., Wang, X., Wang, C., Cai, M., . . . Lin, H. (2023). Associations of Life's Essential 8 and fine particulate matter pollution with the incidence of atrial fibrillation. JOURNAL OF HAZARDOUS MATERIALS, 459. doi:10.1016/j.jhazmat.2023.132114DOI: 10.1016/j.jhazmat.2023.132114
Lin, J., Wu, X. -Y., Long, D. -Y., Jiang, C. -X., Sang, C. -H., Tang, R. -B., . . . CCC, A. F. I. (2023). Asymptomatic atrial fibrillation among hospitalized patients: clinical correlates and in-hospital outcomes in Improving Care for Cardiovascular Disease in China-Atrial Fibrillation. EUROPACE, 25(10). doi:10.1093/europace/euad272DOI: 10.1093/europace/euad272
Chan, Y. -H., Chan, C. -Y., Chen, S. -W., Chao, T. -F., & Lip, G. Y. H. (2023). Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: a systematic review and meta-analysis of observational studies.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(10), euad288. doi:10.1093/europace/euad288DOI: 10.1093/europace/euad288
Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trial (Journal article)
Wong, K. Y. K., Hughes, D. A., Debski, M., Latt, N., Assaf, O., Abdelrahman, A., . . . Cleland, J. G. F. (2023). Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trial. ACTA CARDIOLOGICA, 78(7), 828-837. doi:10.1080/00015385.2023.2197834DOI: 10.1080/00015385.2023.2197834
Riley, D. R., Essa, H., Austin, P., Preston, F., Kargbo, I., Ibarburu, G. H., . . . Alam, U. (2023). All-cause mortality and cardiovascular outcomes with sodium-glucose Co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and with combination therapy in people with type 2 diabetes. DIABETES OBESITY & METABOLISM, 25(10), 2897-2909. doi:10.1111/dom.15185DOI: 10.1111/dom.15185
Fong, K. Y., Chan, Y. H., Wang, Y., Yeo, C., Rosario, B. H., Lip, G. Y. H., & Tan, V. H. (2023). Dementia Risk of Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation: Systematic Review and Meta-Analysis.. JACC. Asia, 3(5), 776-786. doi:10.1016/j.jacasi.2023.07.012DOI: 10.1016/j.jacasi.2023.07.012
Goulart, A. C., Varella, A. C., Gooden, T. E., Lip, G. Y. H., Jolly, K., Thomas, G. N., . . . NIHR Global Health Research Group on Atrial Fibrillation Management. (2023). Identifying and understanding the care pathway of patients with atrial fibrillation in Brazil and the impact of the COVID-19 pandemic: A mixed-methods study.. PloS one, 18(10), e0292463. doi:10.1371/journal.pone.0292463DOI: 10.1371/journal.pone.0292463
Radiofrequency catheter ablation of atrial fibrillation: A review of techniques. (Journal article)
Calvert, P., Lip, G. Y. H., & Gupta, D. (2023). Radiofrequency catheter ablation of atrial fibrillation: A review of techniques.. Trends in cardiovascular medicine, 33(7), 405-415. doi:10.1016/j.tcm.2022.04.002DOI: 10.1016/j.tcm.2022.04.002
Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Low Stroke Risk. (Journal article)
Fong, K. Y., Chan, Y. H., Yeo, C., Lip, G. Y. H., & Tan, V. H. (2023). Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Low Stroke Risk.. The American journal of cardiology, 204, 366-376. doi:10.1016/j.amjcard.2023.07.108DOI: 10.1016/j.amjcard.2023.07.108
Wang, Y. -F., Jiang, C., He, L., Du, X., Guo, X. -Y., Tang, R. -B., . . . Ma, C. -S. (2023). The ABC-Death Score for Mortality Prediction in Patients With Atrial Fibrillation Undergoing Catheter Ablation.. JACC. Asia, 3(5), 790-801. doi:10.1016/j.jacasi.2023.07.007DOI: 10.1016/j.jacasi.2023.07.007
Use of historical remote monitoring data to determine predictors of CPAP non-compliance in patients with OSA. (Journal article)
Cowen, J., Harrison, S., Thom, L., Thomas, M., Sedano, J., Stephens, P., . . . Craig, S. (2023). Use of historical remote monitoring data to determine predictors of CPAP non-compliance in patients with OSA.. Sleep & breathing = Schlaf & Atmung, 27(5), 1899-1908. doi:10.1007/s11325-023-02806-3DOI: 10.1007/s11325-023-02806-3
Nadarajah, R., Wahab, A., Reynolds, C., Raveendra, K., Askham, D., Dawson, R., . . . Gale, C. P. (2023). Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): pilot study of an electronic health record machine learning algorithm-guided intervention to identify undiagnosed atrial fibrillation. OPEN HEART, 10(2). doi:10.1136/openhrt-2023-002447DOI: 10.1136/openhrt-2023-002447
Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia. (Journal article)
Tsai, C. -T., Chan, Y. -H., Liao, J. -N., Chen, T. -J., Lip, G. Y. H., Chen, S. -A., & Chao, T. -F. (2024). Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia.. Thrombosis and haemostasis, 124(3), 253-262. doi:10.1055/a-2184-7506DOI: 10.1055/a-2184-7506
Prevalence of heart failure stages in the general population and implications for heart failure prevention: reports from the China Hypertension Survey 2012-15. (Journal article)
Cai, A., Zheng, C., Qiu, J., Fonarow, G. C., Lip, G. Y. H., Feng, Y., & Wang, Z. (2023). Prevalence of heart failure stages in the general population and implications for heart failure prevention: reports from the China Hypertension Survey 2012-15.. European journal of preventive cardiology, 30(13), 1391-1400. doi:10.1093/eurjpc/zwad223DOI: 10.1093/eurjpc/zwad223
Associations of renal function with cerebral small vessel disease and functional outcome in acute intracerebral haemorrhage: A hospital-based prospective cohort study. (Journal article)
Nash, P. S., Best, J. G., Ambler, G., Wilson, D., Banerjee, G., Hostettler, I. C., . . . CROMIS-2 collaborators. (2023). Associations of renal function with cerebral small vessel disease and functional outcome in acute intracerebral haemorrhage: A hospital-based prospective cohort study.. Journal of the neurological sciences, 452, 120743. doi:10.1016/j.jns.2023.120743DOI: 10.1016/j.jns.2023.120743
Social determinants of health and recurrence of atrial fibrillation after catheter ablation: a Danish nationwide cohort study (Journal article)
Vinter, N., Calvert, P., Kronborg, M. B., Cosedis-Nielsen, J., Gupta, D., Ding, W. Y., . . . Lip, G. Y. H. (2023). Social determinants of health and recurrence of atrial fibrillation after catheter ablation: a Danish nationwide cohort study. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 9(6), 632-638. doi:10.1093/ehjqcco/qcac071DOI: 10.1093/ehjqcco/qcac071
Temporal trends of stroke severity and the association between antithrombotic drug regimen changes and clinical outcomes after stroke in atrial fibrillation (Preprint)
DOI: 10.1101/2023.09.11.23295390
Camacho, E. M., & Lip, G. Y. H. (2023). Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. doi:10.1093/ehjqcco/qcad055DOI: 10.1093/ehjqcco/qcad055
Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies (Journal article)
Osadnik, K., Osadnik, T., Gierlotka, M., Windak, A., Tomasik, T., Mastej, M., . . . Jozwiak, J. (2023). Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. doi:10.1093/eurjpc/zwad101DOI: 10.1093/eurjpc/zwad101
Lyu, Y., Bennamoun, M., Sharif, N., Lip, G. Y. H., & Dwivedi, G. (2023). Artificial Intelligence in the Image-Guided Care of Atrial Fibrillation. Life, 13(9). doi:10.3390/life13091870DOI: 10.3390/life13091870
Obaid Hassan, A., Moreno Lopez, R., Lane, D. A., Lip, G. Y. H., Harris, R. V., Mughal, A., & Weir, C. (2023). Screening of atrial fibrillation in dental practices: a qualitative feasibility study.. Expert review of cardiovascular therapy. doi:10.1080/14779072.2023.2254679DOI: 10.1080/14779072.2023.2254679
A Commentary on "Low Utility of Short-Term Rhythm Assessment Before Long-Term Rhythm Monitoring in Patients With Cryptogenic Stroke". (Journal article)
Griffin, M., & Lip, G. Y. H. (2023). A Commentary on "Low Utility of Short-Term Rhythm Assessment Before Long-Term Rhythm Monitoring in Patients With Cryptogenic Stroke".. The American journal of cardiology, 202, 239-240. doi:10.1016/j.amjcard.2023.07.015DOI: 10.1016/j.amjcard.2023.07.015
Copper homeostasis and cuproptosis in cardiovascular disease therapeutics. (Journal article)
Yang, L., Yang, P., Lip, G. Y. H., & Ren, J. (2023). Copper homeostasis and cuproptosis in cardiovascular disease therapeutics.. Trends in pharmacological sciences, 44(9), 573-585. doi:10.1016/j.tips.2023.07.004DOI: 10.1016/j.tips.2023.07.004
Long-term risk of cardiovascular implantable electronic device reinterventions following external cardioversion of atrial fibrillation and flutter: A nationwide cohort study. (Journal article)
Elgaard, A. F., Dinesen, P. T., Riahi, S., Hansen, J., Lundbye-Christensen, S., Johansen, J. B., . . . Larsen, J. M. (2023). Long-term risk of cardiovascular implantable electronic device reinterventions following external cardioversion of atrial fibrillation and flutter: A nationwide cohort study.. Heart rhythm, 20(9), 1227-1235. doi:10.1016/j.hrthm.2023.03.024DOI: 10.1016/j.hrthm.2023.03.024
Cameron, A. C. C., Lip, G. Y. H., & Abdul-Rahim, A. H. H. (2023). Machine-learning-derived heart and brain age are independently associated with cognition. EUROPEAN JOURNAL OF NEUROLOGY. doi:10.1111/ene.15953DOI: 10.1111/ene.15953
Guo, Y., Corica, B., Romiti, G. F., Proietti, M., Zhang, H., & Lip, G. Y. H. (n.d.). Mobile health technology integrated care in atrial fibrillation patients with diabetes mellitus in China: A subgroup analysis of the mAFA‐II cluster randomized clinical trial. European Journal of Clinical Investigation. doi:10.1111/eci.14031DOI: 10.1111/eci.14031
Romiti, G. F., Corica, B., Proietti, M., Mei, D. A., Frydenlund, J., Bisson, A., . . . GLORIA-AF Investigators. (2023). Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry.. EClinicalMedicine, 63, 102039. doi:10.1016/j.eclinm.2023.102039DOI: 10.1016/j.eclinm.2023.102039
Biccirè, F. G., Tanzilli, G., Prati, F., Sammartini, E., Gelfusa, M., Celeski, M., . . . Pastori, D. (2023). Prediction of new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention using the C2HEST and mC2HEST scores: A report from the multicenter REALE-ACS registry.. International journal of cardiology, 386, 45-49. doi:10.1016/j.ijcard.2023.05.023DOI: 10.1016/j.ijcard.2023.05.023
Krzemień, P., Kasperczyk, S., Banach, M., Kasperczyk, A., Dobrakowski, M., Tomasik, T., . . . Jóźwiak, J. J. (2023). Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors: analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies.. Archives of medical science : AMS, 19(5), 1214-1227. doi:10.5114/aoms/139313DOI: 10.5114/aoms/139313
Ventricular arrhythmias and cardiac arrest in atrial fibrillation patients with pacemakers and implantable cardioverter-defibrillators. (Journal article)
Fawzy, A. M., Bisson, A., Bentounes, S. A., Bodin, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2023). Ventricular arrhythmias and cardiac arrest in atrial fibrillation patients with pacemakers and implantable cardioverter-defibrillators.. European journal of internal medicine, 115, 70-78. doi:10.1016/j.ejim.2023.05.014DOI: 10.1016/j.ejim.2023.05.014
Visit-to-Visit Heart Rate Variability in the Prediction of Clinical Outcomes of Patients with Atrial Fibrillation. (Journal article)
Krittayaphong, R., Boonyapisit, W., Sairat, P., & Lip, G. Y. H. (2023). Visit-to-Visit Heart Rate Variability in the Prediction of Clinical Outcomes of Patients with Atrial Fibrillation.. Thrombosis and haemostasis, 123(9), 920-929. doi:10.1055/s-0043-1768580DOI: 10.1055/s-0043-1768580
Neuroticism and sudden cardiac death: a prospective cohort study from UK biobank. (Journal article)
Rhee, T. -M., Lee, K. -Y., Choi, J., Choi, E. -K., Ahn, H. -J., Lee, S. -R., . . . Lip, G. Y. H. (2023). Neuroticism and sudden cardiac death: a prospective cohort study from UK biobank.. Clinical research in cardiology : official journal of the German Cardiac Society. doi:10.1007/s00392-023-02289-yDOI: 10.1007/s00392-023-02289-y
Kwiendacz, H., Wijata, A. M., Nalepa, J., Piasnik, J., Kulpa, J., Herba, M., . . . Nabrdalik, K. (2023). Machine learning profiles of cardiovascular risk in patients with diabetes mellitus: the Silesia Diabetes-Heart Project. CARDIOVASCULAR DIABETOLOGY, 22(1). doi:10.1186/s12933-023-01938-wDOI: 10.1186/s12933-023-01938-w
Jeon, W. K., Lee, S. -R., Han, K. -D., Choi, E. -K., Oh, S., & Lip, G. Y. H. (2023). Association between the accumulation of elevated serum γ-glutamyltransferase level and risk of atrial fibrillation: a nationwide cohort study.. Scientific reports, 13(1), 13771. doi:10.1038/s41598-023-40689-2DOI: 10.1038/s41598-023-40689-2
Comparisons of new-onset peripheral arterial disease in Type 2 diabetes mellitus patients exposed to SGLT2I, DPP4I or GLP1a: a population-based cohort study (Preprint)
DOI: 10.1101/2023.08.21.23294389
Bisson, A., Lemrini, Y., Romiti, G. F., Proietti, M., Angoulvant, D., Bentounes, S., . . . Fauchier, L. (2023). Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study.. American heart journal, S0002-8703(23)00203-X. doi:10.1016/j.ahj.2023.08.006DOI: 10.1016/j.ahj.2023.08.006
Pastori, D., Gazzaniga, G., Farcomeni, A., Bucci, T., Menichelli, D., Franchino, G., . . . Lip, G. Y. H. (2023). Venous Thromboembolism in Patients With Atrial Fibrillation. JACC: Advances, 2(7), 100555. doi:10.1016/j.jacadv.2023.100555DOI: 10.1016/j.jacadv.2023.100555
Ding, W. Y., Fawzy, A. M., Romiti, G. F., Proietti, M., Pastori, D., Huisman, M. V., . . . GLORIA-AF Investigators. (2023). Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry.. Journal of thrombosis and thrombolysis. doi:10.1007/s11239-023-02866-yDOI: 10.1007/s11239-023-02866-y
Corica, B., Romiti, G. F., Proietti, M., Mei, D. A., Boriani, G., Chao, T. -F., . . . GLORIA-AF Investigators. (2023). Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry.. Mayo Clinic proceedings, S0025-6196(23)00347-6. doi:10.1016/j.mayocp.2023.07.013DOI: 10.1016/j.mayocp.2023.07.013
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus (Journal article)
Wang, R., Gerstein, H. C., Van Spall, H. G. C., Lip, G. Y. H., Olier, I., Ortega-Martorell, S., . . . Li, G. (2023). Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 9(5), 537-545. doi:10.1093/ehjqcco/qcad030DOI: 10.1093/ehjqcco/qcad030
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply (Journal article)
Wang, R., Gerstein, H. C., Van Spall, H. G. C., Lip, G. Y. H., Olier, I., Ortega-Martorell, S., . . . Li, G. (2023). Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 9(5), 547. doi:10.1093/ehjqcco/qcad038DOI: 10.1093/ehjqcco/qcad038
Lip, G. Y. H., Proietti, M., Potpara, T., Mansour, M., Savelieva, I., Tse, H. F., . . . Boriani, G. (2023). Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal. EUROPACE, 25(9). doi:10.1093/europace/euad226DOI: 10.1093/europace/euad226
Kanagaratnam, P., Francis, D. P., Chamie, D., Coyle, C., Marynina, A., Katritsis, G., . . . Shun-Shin, M. (2023). A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 21(8), 2213-2222. doi:10.1016/j.jtha.2023.04.045DOI: 10.1016/j.jtha.2023.04.045
Zhou, X. -D., Targher, G., Byrne, C. D., Somers, V., Kim, S. U., Chahal, C. A. A., . . . Zheng, M. -H. (2023). An international multidisciplinary consensus statement on MAFLD and the risk of CVD.. Hepatology international, 17(4), 773-791. doi:10.1007/s12072-023-10543-8DOI: 10.1007/s12072-023-10543-8
Association Between Glucosamine Use and the Risk of Incident Heart Failure: The UK Biobank Cohort Study and Mendelian Randomization Analysis. (Journal article)
Zheng, J., Hukportie, D. N., Zhang, Y., Huang, J., Ni, C., Lip, G. Y. H., & Tang, S. (2023). Association Between Glucosamine Use and the Risk of Incident Heart Failure: The UK Biobank Cohort Study and Mendelian Randomization Analysis.. Mayo Clinic proceedings, 98(8), 1177-1191. doi:10.1016/j.mayocp.2023.04.019DOI: 10.1016/j.mayocp.2023.04.019
Lip, G. Y. H., Genaidy, A., & Estes, C. (2023). Cardiovascular disease (CVD) outcomes and associated risk factors in a medicare population without prior CVD history: an analysis using statistical and machine learning algorithms.. Internal and emergency medicine, 18(5), 1373-1383. doi:10.1007/s11739-023-03297-6DOI: 10.1007/s11739-023-03297-6
Cerebral infarction and in-hospital mortality for patients admitted to hospital with intracardiac thrombus: insights from the National Inpatient Sample (Journal article)
Kwok, C. S., Abbas, K. S., Qureshi, A. I., & Lip, G. Y. H. (2023). Cerebral infarction and in-hospital mortality for patients admitted to hospital with intracardiac thrombus: insights from the National Inpatient Sample. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 56(2), 342-350. doi:10.1007/s11239-023-02824-8DOI: 10.1007/s11239-023-02824-8
Comparative validation of HAS-BLED, GARFIELD-AF and ORBIT bleeding risk scores in Asian people with atrial fibrillation treated with oral anticoagulant: A report from the COOL-AF registry. (Journal article)
Chichareon, P., Winijkul, A., Lip, G. Y. H., & Krittayaphong, R. (2023). Comparative validation of HAS-BLED, GARFIELD-AF and ORBIT bleeding risk scores in Asian people with atrial fibrillation treated with oral anticoagulant: A report from the COOL-AF registry.. British journal of clinical pharmacology, 89(8), 2472-2482. doi:10.1111/bcp.15716DOI: 10.1111/bcp.15716
Nabrdalik, K., Kwiendacz, H., Moos, J., Moos, L., Kulpa, J., Brzoza, Z., . . . Lip, G. Y. H. (2023). Diabetic Peripheral Neuropathy is Associated With Diabetic Kidney Disease and Cardiovascular Disease: The Silesia Diabetes-Heart Project. CURRENT PROBLEMS IN CARDIOLOGY, 48(8). doi:10.1016/j.cpcardiol.2023.101726DOI: 10.1016/j.cpcardiol.2023.101726
Poststroke Cardiovascular Management: Current Concepts, Integrated Care, and Future Developments. (Journal article)
Lip, G. Y. H., Lenarczyk, R., Pastori, D., Ntaios, G., Doehner, W., & Schnabel, R. B. (2023). Poststroke Cardiovascular Management: Current Concepts, Integrated Care, and Future Developments.. Current problems in cardiology, 48(8), 101738. doi:10.1016/j.cpcardiol.2023.101738DOI: 10.1016/j.cpcardiol.2023.101738
Liu, X., Feng, G., Marler, S. V., Huisman, M. V., Lip, G. Y. H., & Ma, C. (2023). Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry : Trends in antithrombotic therapy use in China.. Thrombosis journal, 21(1), 83. doi:10.1186/s12959-023-00527-xDOI: 10.1186/s12959-023-00527-x
Shantsila, E., Shantsila, A., & Lip, G. Y. H. (2023). Beyond individual risk factors in atrial fibrillation: The interactions of hypertension and sex.. American journal of hypertension, hpad069. doi:10.1093/ajh/hpad069DOI: 10.1093/ajh/hpad069
Antidiabetic drugs and hypoglycaemia risk in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (Journal article)
Nabrdalik, K., Kwiendacz, H., & Lip, G. Y. H. (2023). Antidiabetic drugs and hypoglycaemia risk in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 9(5), 435-436. doi:10.1093/ehjcvp/pvad042DOI: 10.1093/ehjcvp/pvad042
Ye, X., Huang, C., Yan, V. K. C., Kang, W., Fan, M., Tsang, G. K. C., . . . Chan, E. W. Y. (2023). Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 9(5), 403-412. doi:10.1093/ehjcvp/pvad015DOI: 10.1093/ehjcvp/pvad015
Calvert, P., Gupta, D., & Lip, G. Y. H. (2023). The neurocognitive effects of atrial fibrillation: benefits of the ABC pathway. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 9(5), 413-420. doi:10.1093/ehjcvp/pvad021DOI: 10.1093/ehjcvp/pvad021
Alwan, N., Clutterbuck, D., Pantelic, M., Hayer, J., Fisher, L., Hishmeh, L., . . . STIMULATE-ICP, C. (2023). Long Covid active case finding study protocol: A co-produced community-based pilot within the STIMULATE-ICP study (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways). PLOS ONE, 18(7). doi:10.1371/journal.pone.0284297DOI: 10.1371/journal.pone.0284297
Frost, F., Nazareth, D., Fauchier, L., Wat, D., Shelley, J., Austin, P., . . . Lip, G. Y. H. (2023). Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: A multinational retrospective cohort study.. The European respiratory journal, 2300174. doi:10.1183/13993003.00174-2023DOI: 10.1183/13993003.00174-2023
Harrison, S. L., Johnsen, S. P., & Lip, G. Y. H. (2023). The impact of frailty on the management of atrial fibrillation.. Aging, 15(14), 6622-6624. doi:10.18632/aging.204918DOI: 10.18632/aging.204918
The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes (Journal article)
Nabrdalik-Lesniak, D., Nabrdalik, K., Irlik, K., Janota, O., Kwiendacz, H., Szromek-Bialek, P., . . . Lip, G. Y. H. (2023). The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes. ENDOKRYNOLOGIA POLSKA, 74(4), 349-362. doi:10.5603/EP.a2023.0039DOI: 10.5603/EP.a2023.0039
Shantsila, E., Lip, G. Y. H., Shantsila, A., Kurpas, D., Beevers, G., Gill, P. S., & Williams, N. H. (2023). Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?. Journal of Hypertension, 4(10), 1502-1510. doi:10.1097/hjh.0000000000003495DOI: 10.1097/hjh.0000000000003495
Emanuel, S., Kaba, R. A., Delanerolle, G., Field, B. C. T., Lip, G. Y. H., & de Lusignan, S. (2023). Correct dosing, adherence and persistence of DOACs in atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis.. Open heart, 10(2), e002340. doi:10.1136/openhrt-2023-002340DOI: 10.1136/openhrt-2023-002340
New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: A Chinese population-based cohort study (Preprint)
DOI: 10.1101/2023.07.04.23292207
Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis (Journal article)
Zheng, Y., Li, S., Liu, X., Lip, G. Y. H., Guo, L., & Zhu, W. (2023). Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis. THROMBOSIS AND HAEMOSTASIS. doi:10.1055/s-0043-1770724DOI: 10.1055/s-0043-1770724
Lyrer, F., Zietz, A., Seiffge, D. J., Koga, M., Volbers, B., Wilson, D., . . . NOACISP-LONGTERM, Erlangen Registry, CROMIS-2, SAMURAI-NVAF and Verona Registry collaborators. (2023). Atrial Fibrillation Detected before or after Stroke: Role of Anticoagulation.. Annals of neurology, 94(1), 43-54. doi:10.1002/ana.26654DOI: 10.1002/ana.26654
Early Rhythm Control in Patients With Incident Atrial Fibrillation Who Had a Prior Stroke. (Journal article)
Lee, S. -R., Choi, E. -K., Lee, S. -W., Han, K. -D., Oh, S., & Lip, G. Y. H. (2023). Early Rhythm Control in Patients With Incident Atrial Fibrillation Who Had a Prior Stroke.. JACC. Clinical electrophysiology, 9(7 Pt 2), 1121-1133. doi:10.1016/j.jacep.2022.11.021DOI: 10.1016/j.jacep.2022.11.021
Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitus. (Journal article)
Zhang, J., Van Spall, H. G., Li, L., Khan, M. S., Pandey, A., Thabane, L., . . . Li, G. (2023). Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitus.. Diabetes & metabolic syndrome, 17(7), 102804. doi:10.1016/j.dsx.2023.102804DOI: 10.1016/j.dsx.2023.102804
Soo, Y., Zietz, A., Yiu, B., Mok, V. C. T., Polymeris, A. A., Seiffge, D., . . . Peters, N. (2023). Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation. ANNALS OF NEUROLOGY, 94(1), 61-74. doi:10.1002/ana.26642DOI: 10.1002/ana.26642
Mandaglio-Collados, D., López-Gálvez, R., Ruiz-Alcaraz, A. J., López-García, C., Roldán, V., Lip, G. Y. H., . . . Rivera-Caravaca, J. M. (2023). Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review.. The Science of the total environment, 880, 163352. doi:10.1016/j.scitotenv.2023.163352DOI: 10.1016/j.scitotenv.2023.163352
Nabrdalik, K., Kwiendacz, H., Drozdz, K., Irlik, K., Hendel, M., Wijata, A. M., . . . Lip, G. Y. H. (2023). Machine Learning Predicts Cardiovascular Events in Patients With Diabetes: The Silesia Diabetes-Heart Project. CURRENT PROBLEMS IN CARDIOLOGY, 48(7). doi:10.1016/j.cpcardiol.2023.101694DOI: 10.1016/j.cpcardiol.2023.101694
Using the 4S-AF scheme to characterize new-onset atrial fibrillation after myocardial infarction. (Journal article)
Dunlop, J., Potpara, T., & Lip, G. Y. H. (2023). Using the 4S-AF scheme to characterize new-onset atrial fibrillation after myocardial infarction.. European journal of internal medicine, 113, 20-21. doi:10.1016/j.ejim.2023.05.004DOI: 10.1016/j.ejim.2023.05.004
Bucci, T., Proietti, M., Shantsila, A., Romiti, G. F., Teo, W. -S., Park, H. -W., . . . Chao, T. -F. (2023). Integrated Care for Atrial Fibrillation Using the ABC Pathway in the Prospective APHRS-AF Registry. JACC: Asia, 3(4), 580-591. doi:10.1016/j.jacasi.2023.04.008DOI: 10.1016/j.jacasi.2023.04.008
Bisson, A., M Fawzy, A., Romiti, G. F., Proietti, M., Angoulvant, D., El-Bouri, W., . . . Fauchier, L. (2023). Phenotypes and outcomes in non-anticoagulated patients with atrial fibrillation: An unsupervised cluster analysis.. Archives of cardiovascular diseases, S1875-2136(23)00120-1. doi:10.1016/j.acvd.2023.06.001DOI: 10.1016/j.acvd.2023.06.001
Hypertension and atrial fibrillation: Closing a virtuous circle (Chapter)
Gue, Y. X., & Lip, G. Y. H. (2023). Hypertension and atrial fibrillation: Closing a virtuous circle. In Advances in Surgical and Medical Specialties (pp. 191-195).
Kwiendacz, H., Nabrdalik, K., Wijata, A. M., Bartman, W., Tabor, E., Olejarz, A., . . . Lip, G. Y. H. (2023). Relationship of vitamin D deficiency with cardiovascular disease and glycemic control in patients with type 2 diabetes mellitus: the Silesia Diabetes-Heart Project. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 133(6). doi:10.20452/pamw.16445DOI: 10.20452/pamw.16445
Social determinants of health and catheter ablation after an incident diagnosis of atrial fibrillation: a Danish nationwide cohort study (Journal article)
Vinter, N., Calvert, P., Kronborg, M. B., Cosedis-Nielsen, J., Gupta, D., Ding, W. Y., . . . Lip, G. Y. H. (2023). Social determinants of health and catheter ablation after an incident diagnosis of atrial fibrillation: a Danish nationwide cohort study. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 9(4), 389-396. doi:10.1093/ehjqcco/qcac038DOI: 10.1093/ehjqcco/qcac038
Bucci, T., Mbizvo, G., Rivera-Caravaca, J. M., Mayer, J., Marson, A., Abdul Rahim, A. H., & Lip, G. (2023). Epilepsy-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications in patients with Epilepsy. Current Problems in Cardiology. doi:10.1016/j.cpcardiol.2023.101868DOI: 10.1016/j.cpcardiol.2023.101868
Racial differences in atrial fibrillation-related stroke: A patient-level comparative analysis of UK Biobank and Korean nationwide data (Preprint)
DOI: 10.1101/2023.05.25.23290561
Ntaios, G., Sagris, D., Buckley, B. J. R., Harrison, S. L., Abdul-Rahim, A., Austin, P., & Lip, G. Y. H. (2023). Risk of myocardial infarction and ischemic stroke in individuals with first-diagnosed paroxysmal vs. non-paroxysmal atrial fibrillation under anticoagulation. EUROPACE, 25(6). doi:10.1093/europace/euad143DOI: 10.1093/europace/euad143
Calvert, P., Kollias, G., Puererfellner, H., Narasimhan, C., Osorio, J., Lip, G. Y. H., & Gupta, D. (2023). Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review. EUROPACE, 25(6). doi:10.1093/europace/euad151DOI: 10.1093/europace/euad151
Adherence levels and patterns for multiple cardiac medications prescribed to patients with incident atrial fibrillation events (Journal article)
Lip, G. Y. H., Genaidy, A., Jones, B., Tran, G., Marroquin, P., Estes, C., & Shnaiden, T. (2023). Adherence levels and patterns for multiple cardiac medications prescribed to patients with incident atrial fibrillation events. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 89(6), 1736-1746. doi:10.1111/bcp.15627DOI: 10.1111/bcp.15627
An evidence-based evaluation of left ventricular thrombus treatment, outcomes, and resolution: a systematic review, pooled analysis and meta-analysis (Journal article)
Kwok, C. S., Bennett, S., Borovac, J. A., Will, M., Schwarz, K., & Lip, G. Y. H. (2023). An evidence-based evaluation of left ventricular thrombus treatment, outcomes, and resolution: a systematic review, pooled analysis and meta-analysis. CORONARY ARTERY DISEASE, 34(4), 260-273. doi:10.1097/MCA.0000000000001230DOI: 10.1097/MCA.0000000000001230
Yi, J. K., Rim, T. H., Park, S., Kim, S. S., Kim, H. C., Lee, C. J., . . . Cheng, C. -Y. (2023). Cardiovascular disease risk assessment using a deep-learning-based retinal biomarker: a comparison with existing risk scores.. European heart journal. Digital health, 4(3), 236-244. doi:10.1093/ehjdh/ztad023DOI: 10.1093/ehjdh/ztad023
Proietti, R., Rivera-Caravaca, J. M., Lopez-Galvez, R., Harrison, S. L., Buckley, B. J. R., Marin, F., . . . Lip, G. Y. H. (2023). Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis. CLINICAL CARDIOLOGY, 46(6), 656-662. doi:10.1002/clc.24006DOI: 10.1002/clc.24006
Fawzy, A., Kotalczyk, A., Guo, Y., Wang, Y., Lip, G. Y. H., & ChiOTEAF, R. I. (2023). Effects of the ABC pathway on clinical outcomes in a secondary prevention population of Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. JOURNAL OF ARRHYTHMIA, 39(3), 388-394. doi:10.1002/joa3.12862DOI: 10.1002/joa3.12862
Inflammaging: mechanisms and role in the cardiac and vasculature (Journal article)
Ajoolabady, A., Pratico, D., Vinciguerra, M., Lip, G. Y. H., Franceschi, C., & Ren, J. (2023). Inflammaging: mechanisms and role in the cardiac and vasculature. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 34(6), 373-387. doi:10.1016/j.tem.2023.03.005DOI: 10.1016/j.tem.2023.03.005
Left Atrial Appendage Occlusion-A Choice or a Last Resort? How to Approach the Patient. (Journal article)
Ding, W. Y., Lip, G. Y. H., & Gupta, D. (2023). Left Atrial Appendage Occlusion-A Choice or a Last Resort? How to Approach the Patient.. Cardiac electrophysiology clinics, 15(2), 133-140. doi:10.1016/j.ccep.2023.01.006DOI: 10.1016/j.ccep.2023.01.006
Medication non-adherence patterns and profiles for patients with incident myocardial infarction: Observations from a large multi-morbid US population (Journal article)
Lip, G. Y. H., Genaidy, A., Jones, B., Tran, G., Estes, C., & Sloop, S. (2023). Medication non-adherence patterns and profiles for patients with incident myocardial infarction: Observations from a large multi-morbid US population. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. doi:10.1111/eci.13968DOI: 10.1111/eci.13968
Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea (Journal article)
Lopez-Galvez, R., Rivera-Caravaca, J. M., Mandaglio-Collados, D., Orenes-Pinero, E., Lahoz, A., Hernandez-Romero, D., . . . Marin, F. (2023). Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea. FASEB JOURNAL, 37(6). doi:10.1096/fj.202201965RRDOI: 10.1096/fj.202201965RR
Jung, M., Byeon, K., Kang, K. -W., Lee, W. -S., Kim, S. W., Park, Y. M., . . . Shin, S. Y. (2023). Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS-SPAF). JOURNAL OF ARRHYTHMIA, 39(3), 376-387. doi:10.1002/joa3.12840DOI: 10.1002/joa3.12840
Predictors of left ventricular thrombus after acute myocardial infarction: a systematic review and meta-analysis (Journal article)
Kwok, C. S., Bennett, S., Borovac, J. A., Schwarz, K., & Lip, G. Y. H. (2023). Predictors of left ventricular thrombus after acute myocardial infarction: a systematic review and meta-analysis. CORONARY ARTERY DISEASE, 34(4), 250-259. doi:10.1097/MCA.0000000000001223DOI: 10.1097/MCA.0000000000001223
Associations of high-normal blood pressure and impaired fasting glucose with atrial fibrillation. (Journal article)
Kim, J., Kim, D., Jang, E., Kim, D., You, S. C., Yu, H. T., . . . Joung, B. (2023). Associations of high-normal blood pressure and impaired fasting glucose with atrial fibrillation.. Heart (British Cardiac Society), 109(12), 929-935. doi:10.1136/heartjnl-2022-322094DOI: 10.1136/heartjnl-2022-322094
Pate, A., Sperrin, M., Riley, R. D., Sergeant, J. C., Van Staa, T., Peek, N., . . . Martin, G. P. (2023). Developing prediction models to estimate the risk of two survival outcomes both occurring: A comparison of techniques. STATISTICS IN MEDICINE, 42(18), 3184-3207. doi:10.1002/sim.9771DOI: 10.1002/sim.9771
Roger, A., Cottin, Y., Bentounes, S. A., Bisson, A., Bodin, A., Herbert, J., . . . Fauchier, L. (2023). Incidence of clinical atrial fibrillation and related complications using a screening algorithm at a nationwide level. EUROPACE. doi:10.1093/europace/euad063DOI: 10.1093/europace/euad063
Tajik, B., Voutilainen, A., Sankaranarayanan, R., Lyytinen, A., Kauhanen, J., Lip, G. Y. H., . . . Isanejad, M. (2023). Frailty alone and interactively with obesity predicts heart failure: Kuopio Ischaemic Heart Disease Risk Factor Study. ESC HEART FAILURE. doi:10.1002/ehf2.14392DOI: 10.1002/ehf2.14392
Liu, S. -H., Chao, T. -F., Chan, Y. -H., Liao, J. -N., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2023). Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients without previous oral anticoagulants or stable under warfarin: a nationwide cohort study.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, euad120. doi:10.1093/europace/euad120DOI: 10.1093/europace/euad120
In limb or pelvic fracture, aspirin was noninferior to enoxaparin for reducing all-cause death. (Journal article)
Griffin, M., & Lip, G. Y. H. (2023). In limb or pelvic fracture, aspirin was noninferior to enoxaparin for reducing all-cause death.. Annals of internal medicine, 176(5), JC56. doi:10.7326/j23-0024DOI: 10.7326/j23-0024
Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation. (Journal article)
Barnes, G. D., Ageno, W., Castellucci, L. A., Chiasakul, T., Eslick, R., Ferreiro, J. L., . . . Cuker, A. (2023). Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation.. Journal of thrombosis and haemostasis : JTH, 21(5), 1381-1384. doi:10.1016/j.jtha.2023.02.008DOI: 10.1016/j.jtha.2023.02.008
Ding, W. Y., Romero-Aniorte, A. I., Tello-Montoliu, A., Gil-Perez, P., Lopez-Garcia, C., Veliz-Martinez, A., . . . Marin, F. (2023). Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia. HEART & LUNG, 59, 61-66. doi:10.1016/j.hrtlng.2023.01.010DOI: 10.1016/j.hrtlng.2023.01.010
Bucci, T., Sagris, D., Harrison, S. L., Underhill, P., Pastori, D., Ntaios, G., . . . Lip, G. Y. H. (2023). C-reactive protein levels are associated with early cardiac complications or death in patients with acute ischemic stroke: a propensity-matched analysis of a global federated health from the TriNetX network.. Internal and emergency medicine. doi:10.1007/s11739-023-03280-1DOI: 10.1007/s11739-023-03280-1
Johnston, B., Hill, R. A., Blackwood, B., Lip, G. Y. H., & Welters, I. D. (2023). Development of Core Outcome Sets for trials on the management of Atrial fiBrillAtion in Critically Unwell patientS (COS-ABACUS): a protocol. BMJ open, 13(4), e067257. doi:10.1136/bmjopen-2022-067257DOI: 10.1136/bmjopen-2022-067257
Proietti, M., Romiti, G. F., Corica, B., Mei, D. A., Bonini, N., Vitolo, M., . . . Lip, G. Y. H. (2023). Features of Clinical Complexity in European Patients with Atrial Fibrillation: A Report from a European Observational Prospective AF Registry.. Current problems in cardiology, 101752. doi:10.1016/j.cpcardiol.2023.101752DOI: 10.1016/j.cpcardiol.2023.101752
Savelieva, I., Fumagalli, S., Kenny, R. A., Anker, S., Benetos, A., Boriani, G., . . . Grodzicki, T. (2023). EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). EUROPACE, 25(4), 1249-1276. doi:10.1093/europace/euac123DOI: 10.1093/europace/euac123
Proietti, R., Rivera-Caravaza, J. M., Lopez-Galvez, R., Harrison, S. L., Marin, F., Underhill, P., . . . Lip, G. (n.d.). Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis. Journal of Clinical Medicine, 12(8). doi:10.3390/jcm12082814DOI: 10.3390/jcm12082814
Ng, K. F., Calvert, P., Khalatbari, A., Lip, G. Y. H., Velavan, P., & Gupta, D. (2023). Percutaneous left atrial appendage occlusion following successful treatment of large bi-atrial thrombi in a patient with atrial fibrillation: a case report. EUROPEAN HEART JOURNAL-CASE REPORTS, 7(4). doi:10.1093/ehjcr/ytad165DOI: 10.1093/ehjcr/ytad165
Heightened risks of cardiovascular disease in South Asian populations: causes and consequences (Journal article)
Stefil, M., Bell, J., Calvert, P., & Lip, G. Y. H. (2023). Heightened risks of cardiovascular disease in South Asian populations: causes and consequences. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 21(4), 281-291. doi:10.1080/14779072.2023.2187780DOI: 10.1080/14779072.2023.2187780
Lessons learned from the influence of CYP2C9 genotype on warfarin dosing (Journal article)
Tidbury, N., Preston, J., & Lip, G. Y. H. (2023). Lessons learned from the influence of CYP2C9 genotype on warfarin dosing. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 19(4), 185-188. doi:10.1080/17425255.2023.2220961DOI: 10.1080/17425255.2023.2220961
Artificial intelligence in radiology: trainees want more. (Journal article)
Hashmi, O. -U., Chan, N., de Vries, C. F., Gangi, A., Jehanli, L., & Lip, G. (2023). Artificial intelligence in radiology: trainees want more.. Clinical radiology, 78(4), e336-e341. doi:10.1016/j.crad.2022.12.017DOI: 10.1016/j.crad.2022.12.017
Cardiovascular considerations in management of patients with Turner syndrome (Journal article)
Stefil, M., Kotalczyk, A., Blair, J. C., & Lip, G. Y. H. (2023). Cardiovascular considerations in management of patients with Turner syndrome. TRENDS IN CARDIOVASCULAR MEDICINE, 33(3), 150-158. doi:10.1016/j.tcm.2021.12.002DOI: 10.1016/j.tcm.2021.12.002
Efficacy and safety of vitamin-K antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: An updated systematic review and meta-analysis of randomized clinical trials. (Journal article)
Li, W., Seo, J., Kokkinidis, D. G., Palaiodimos, L., Nagraj, S., Korompoki, E., . . . Ntaios, G. (2023). Efficacy and safety of vitamin-K antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: An updated systematic review and meta-analysis of randomized clinical trials.. International journal of stroke : official journal of the International Stroke Society, 18(4), 392-399. doi:10.1177/17474930221109149DOI: 10.1177/17474930221109149
Exercise-induced release of cardiac troponin is attenuated with repeated bouts of exercise: impact of cardiovascular disease and risk factors. (Journal article)
Somani, Y. B., Uthman, L., Aengevaeren, V. L., Rodwell, L., Lip, G. Y. H., Hopman, M. T. E., . . . Thijssen, D. H. J. (2023). Exercise-induced release of cardiac troponin is attenuated with repeated bouts of exercise: impact of cardiovascular disease and risk factors.. American journal of physiology. Heart and circulatory physiology, 324(4), H519-H524. doi:10.1152/ajpheart.00033.2023DOI: 10.1152/ajpheart.00033.2023
Lopez-Galvez, R., Rivera-Caravaca, J. M., Roldan, V., Orenes-Pinero, E., Esteve-Pastor, M. A., Lopez-Garcia, C., . . . Marin, F. (2023). Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making. AMERICAN HEART JOURNAL, 258, 1-16. doi:10.1016/j.ahj.2022.12.007DOI: 10.1016/j.ahj.2022.12.007
Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation: Application of natural language processing to electronic medical records data. (Journal article)
Reynolds, M. R., Bunch, T. J., Steinberg, B. A., Ronk, C. J., Kim, H., Wieloch, M., & Lip, G. Y. H. (2023). Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation: Application of natural language processing to electronic medical records data.. Journal of cardiovascular electrophysiology, 34(4), 790-799. doi:10.1111/jce.15784DOI: 10.1111/jce.15784
Cameron, A. C. C., Katsas, G., Arnold, M., Docherty, K., Campbell, R. T. T., Murdoch, D., . . . Dawson, J. (2023). Preventing Recurrent Cardioembolic Stroke: Right Approach, Right Patient (PRECISE) Study Protocol. CEREBROVASCULAR DISEASES, 52(2), 123-129. doi:10.1159/000525918DOI: 10.1159/000525918
Heseltine, T., Hughes, E., Mattew, J., Murray, S., Ortega-Martorell, S., Olier, I., . . . Khoo, S. (2023). The association of epicardial adipose tissue volume and density with coronary calcium in HIV-positive and HIV-negative patients. JOURNAL OF INFECTION, 86(4), 376-384. doi:10.1016/j.jinf.2023.02.020DOI: 10.1016/j.jinf.2023.02.020
Bisson, A., Fawzy, A. M., El-Bouri, W., Angoulvant, D., Lip, G. Y. H., Fauchier, L., & Clementy, N. (2023). Clinical Phenotypes and Atrial Fibrillation Recurrences after Catheter Ablation: An Unsupervised Cluster Analysis.. Current problems in cardiology, 101732. doi:10.1016/j.cpcardiol.2023.101732DOI: 10.1016/j.cpcardiol.2023.101732
Farinha, J. M., Gupta, D., & Lip, G. Y. H. (2023). Frequent premature atrial contractions as a signalling marker of atrial cardiomyopathy, incident atrial fibrillation, and stroke. CARDIOVASCULAR RESEARCH, 119(2), 429-439. doi:10.1093/cvr/cvac054DOI: 10.1093/cvr/cvac054
Choi, S. H., Yang, P. -S., Kim, D., Sung, J. -H., Jang, E., Yu, H. T., . . . Joung, B. (2023). Association of obesity with incident atrial fibrillation in Korea and the United Kingdom. SCIENTIFIC REPORTS, 13(1). doi:10.1038/s41598-023-32229-9DOI: 10.1038/s41598-023-32229-9
Ozdemir, H., Sagris, D., Lip, G., & Abdul Rahim, A. H. (2023). Stroke in Atrial Fibrillation and Other Atrial Dysrhythmias. Current Cardiology Reports.
Krittayaphong, R., Pumprueg, S., Kaewkumdee, P., Yindeengam, A., & Lip, G. Y. (2023). Three-year outcomes of patients with non-valvular atrial fibrillation: the COOL-AF registry.. Journal of geriatric cardiology : JGC, 20(3), 163-173. doi:10.26599/1671-5411.2023.03.008DOI: 10.26599/1671-5411.2023.03.008
Initiation of Warfarin is associated with Decreased Mortality in Patients with Infective Endocarditis: A Population-Based Cohort Study (Preprint)
DOI: 10.1101/2023.03.24.23287724
Krittayaphong, R., Winijkul, A., Sairat, P., & Lip, G. Y. H. (2023). Predicting the Absolute Risk of Ischemic Stroke in Asian Patients with Atrial Fibrillation: Comparing the COOL-AF Risk Score with CARS/mCARS Models for Absolute Risk and the CHA2DS2-VASc Score.. Journal of clinical medicine, 12(7), 2449. doi:10.3390/jcm12072449DOI: 10.3390/jcm12072449
Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial Siderosis (Journal article)
Marti-Fabregas, J., Camps-Renom, P. G., Best, J. G., Ramos-Pachon, A., Guasch-Jimenez, M., Martinez-Domeno, A., . . . Prats-Sanchez, L. (2023). Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial Siderosis. NEUROLOGY, 100(12), E1267-E1281. doi:10.1212/WNL.0000000000201723DOI: 10.1212/WNL.0000000000201723
Uruthirakumar, P., Surenthirakumaran, R., Gooden, T., Lip, G. Y. H., Thomas, G. N., Moore, D., . . . Guruparan, M. (2023). The impact of rate and rhythm control strategies on quality of life for patients with atrial fibrillation: a protocol for a systematic review. SYSTEMATIC REVIEWS, 12(1). doi:10.1186/s13643-023-02197-2DOI: 10.1186/s13643-023-02197-2
Guo, Y., Romiti, G. F., Sagris, D., Proietti, M., Bonini, N., Zhang, H., . . . mAF-App II trial investigators. (2023). Mobile health-technology integrated care in secondary prevention atrial fibrillation patients: a post-hoc analysis from the mAFA-II randomized clinical trial.. Internal and emergency medicine. doi:10.1007/s11739-023-03249-0DOI: 10.1007/s11739-023-03249-0
Mobile Health-Technology-Integrated Care for Atrial Fibrillation: A Win Ratio Analysis from the mAFA-II Randomized Clinical Trial (Conference Paper)
Romiti, G. F., Guo, Y., Corica, B., Proietti, M., Zhang, H., & Lip, G. Y. H. (2023). Mobile Health-Technology-Integrated Care for Atrial Fibrillation: A Win Ratio Analysis from the mAFA-II Randomized Clinical Trial. In THROMBOSIS AND HAEMOSTASIS. doi:10.1055/s-0043-1769612DOI: 10.1055/s-0043-1769612
Fields, K. G., Ma, J., Petrinic, T., Alhassan, H., Eze, A., Reddy, A., . . . Muehlschlegel, J. D. (2023). Multivariable prediction models for atrial fibrillation after cardiac surgery: a systematic review protocol. BMJ OPEN, 13(3). doi:10.1136/bmjopen-2022-067260DOI: 10.1136/bmjopen-2022-067260
Zhang, J., Chen, G., Wang, C., Wang, X., Qian, Z. M., Cai, M., . . . Lin, H. (2023). Associations of risk factor burden and genetic predisposition with the 10-year risk of atrial fibrillation: observations from a large prospective study of 348,904 participants. BMC MEDICINE, 21(1). doi:10.1186/s12916-023-02798-7DOI: 10.1186/s12916-023-02798-7
Hydes, T. J., Lip, G. Y. H., & Lane, D. A. (2023). Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease. Circulation, 147(10), 795-797. doi:10.1161/circulationaha.122.063195DOI: 10.1161/circulationaha.122.063195
Single-lead VDD pacing: a literature review on short-term and long-term performance (Journal article)
Mei, D. A., Imberti, J. F., Vitolo, M., Bonini, N., Gerra, L., Romiti, G. F., . . . Boriani, G. (2023). Single-lead VDD pacing: a literature review on short-term and long-term performance. EXPERT REVIEW OF MEDICAL DEVICES, 20(3), 187-197. doi:10.1080/17434440.2023.2178901DOI: 10.1080/17434440.2023.2178901
Corica, B., Bonini, N., Imberti, J. F., Romiti, G. F., Vitolo, M., Attanasio, L., . . . Proietti, M. (2023). Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence.. European heart journal open, 3(2), oead031. doi:10.1093/ehjopen/oead031DOI: 10.1093/ehjopen/oead031
Surma, S., & Lip, G. Y. H. (2023). Alcohol and Atrial Fibrillation. Reviews in Cardiovascular Medicine, 24(3), 73. doi:10.31083/j.rcm2403073DOI: 10.31083/j.rcm2403073
Castleman, J. S., Shantsila, A., Brown, R. A., Shantsila, E., & Lip, G. Y. H. (2023). Altered cardiac and vascular stiffness in pregnancy after a hypertensive pregnancy. JOURNAL OF HUMAN HYPERTENSION, 37(3), 189-196. doi:10.1038/s41371-022-00662-4DOI: 10.1038/s41371-022-00662-4
Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis. (Journal article)
Pastori, D., Menichelli, D., Di Rocco, A., Farcomeni, A., Sciacqua, A., Pignatelli, P., . . . Lip, G. Y. H. (2023). Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis.. Internal and emergency medicine, 18(2), 655-665. doi:10.1007/s11739-022-03156-wDOI: 10.1007/s11739-022-03156-w
Krittayaphong, R., Boonyapiphat, T., Aroonsiriwattana, S., Ngamjanyaporn, P., & Lip, G. Y. H. (2023). Causes of death of patients with non-valvular atrial fibrillation in Asians.. PloS one, 18(3), e0282455. doi:10.1371/journal.pone.0282455DOI: 10.1371/journal.pone.0282455
Increased risk of incident atrial fibrillation in young adults with mental disorders: A nationwide population-based study. (Journal article)
Ahn, H. J., Lee, S. -R., Choi, E. -K., Bae, N. Y., Ahn, H. -J., Kwon, S., . . . Lip, G. Y. H. (2023). Increased risk of incident atrial fibrillation in young adults with mental disorders: A nationwide population-based study.. Heart rhythm, 20(3), 365-373. doi:10.1016/j.hrthm.2022.12.019DOI: 10.1016/j.hrthm.2022.12.019
Choi, S. E., Lip, G. Y. H., & Abdul-Rahim, A. H. (2023). Long-term Management Considerations for Retinal Artery Occlusion and Cardiovascular and Cerebrovascular Mortality. JAMA NETWORK OPEN, 6(3). doi:10.1001/jamanetworkopen.2023.3076DOI: 10.1001/jamanetworkopen.2023.3076
Men who live alone have worse anticoagulation control: A Danish registry study (Journal article)
Bonde, A. N., Bjerre, J., Proietti, M., Lip, G. Y. H., Gislason, G., & Hlatky, M. A. (2023). Men who live alone have worse anticoagulation control: A Danish registry study. AMERICAN HEART JOURNAL, 257, 30-32. doi:10.1016/j.ahj.2022.11.006DOI: 10.1016/j.ahj.2022.11.006
Ward, K., Vail, A., Cameron, A., Katan, M., Lip, G. Y. H., Dawson, J., . . . Kishore, A. K. (2023). Molecular biomarkers predicting newly detected atrial fibrillation after ischaemic stroke or TIA: A systematic review. EUROPEAN STROKE JOURNAL, 8(1), 125-131. doi:10.1177/23969873221136927DOI: 10.1177/23969873221136927
Outcomes for patients hospitalized with acute myocardial infarction and cerebral infarction in the United States: insights from the National Inpatient Sample (Journal article)
Kwok, C. S., Abbas, K. S., Qureshi, A. I., & Lip, G. Y. H. (2023). Outcomes for patients hospitalized with acute myocardial infarction and cerebral infarction in the United States: insights from the National Inpatient Sample. INTERNAL AND EMERGENCY MEDICINE. doi:10.1007/s11739-022-03172-wDOI: 10.1007/s11739-022-03172-w
Racial and Ethnic Disparities in Stroke Prevention for Atrial Fibrillation (Journal article)
Calvert, P., Tamirisa, K., Al-Ahmad, A., Lip, G. Y. H., & Gupta, D. (2023). Racial and Ethnic Disparities in Stroke Prevention for Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 136(3), 225-233. doi:10.1016/j.amjmed.2022.11.009DOI: 10.1016/j.amjmed.2022.11.009
Relationship between obesity severity, metabolic status and cardiovascular disease in obese adults. (Journal article)
Liu, Y., Douglas, P. S., Lip, G. Y. H., Thabane, L., Li, L., Ye, Z., & Li, G. (2023). Relationship between obesity severity, metabolic status and cardiovascular disease in obese adults.. European journal of clinical investigation, 53(3), e13912. doi:10.1111/eci.13912DOI: 10.1111/eci.13912
Response to 'Re. Comparison of open, standard, and complex endovascular aortic repair treatments for juxtarenal/short neck aneurysms: a systematic review and network meta-analysis' (Journal article)
Patel, S. R., Lip, G. Y. H., & Vallabhaneni, S. R. (2023). Response to 'Re. Comparison of open, standard, and complex endovascular aortic repair treatments for juxtarenal/short neck aneurysms: a systematic review and network meta-analysis'. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 65(3). doi:10.1016/j.ejvs.2022.11.018DOI: 10.1016/j.ejvs.2022.11.018
Similarities and differences in systemic risk factors for retinal artery occlusion and retinal vein occlusion: A nationwide case-control study. (Journal article)
Ørskov, M., Vorum, H., Larsen, T. B., Lip, G. Y. H., Bek, T., & Skjøth, F. (2023). Similarities and differences in systemic risk factors for retinal artery occlusion and retinal vein occlusion: A nationwide case-control study.. International ophthalmology, 43(3), 817-824. doi:10.1007/s10792-022-02483-3DOI: 10.1007/s10792-022-02483-3
Khimani, F., Wolf, A. J., Yoon, B., Blancke, A., Gerhart, C., Endsley, D., . . . Sathyamoorthy, M. (2023). Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19. Thrombosis Update, 10, 100126. doi:10.1016/j.tru.2022.100126DOI: 10.1016/j.tru.2022.100126
Proietti, R., Rivera-Caravaca, J. M., Harrison, S. L., Buckley, B. J. R., Lopez-Galvez, R., Marin, F., . . . Lip, G. Y. H. (2023). Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis. INTERNAL AND EMERGENCY MEDICINE. doi:10.1007/s11739-022-03184-6DOI: 10.1007/s11739-022-03184-6
Transient ischemic attack events and incident cardiovascular and non-cardiovascular complications: Observations from a large diversified multimorbid cohort. (Journal article)
Lip, G. Y., Genaidy, A., Estes, C., McKay, D., & Falks, T. (2023). Transient ischemic attack events and incident cardiovascular and non-cardiovascular complications: Observations from a large diversified multimorbid cohort.. European stroke journal, 8(1), 334-343. doi:10.1177/23969873221146044DOI: 10.1177/23969873221146044
Chong, B., Jayabaskaran, J., Kong, G., Chan, Y. H., Chin, Y. H., Goh, R., . . . Chew, N. W. S. (2023). Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019.. EClinicalMedicine, 57, 101850. doi:10.1016/j.eclinm.2023.101850DOI: 10.1016/j.eclinm.2023.101850
Guo, Y., Kotalczyk, A., Imberti, J. F., Wang, Y., Lip, G. Y. H., & ChiOTEAF Registry Investigators. (2023). Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.. European heart journal. Quality of care & clinical outcomes, 9(2), 169-176. doi:10.1093/ehjqcco/qcab054DOI: 10.1093/ehjqcco/qcab054
Fernandez, A. R., Wamil, M., Telford, A., Carapella, V., Borlotti, A., Monteiro, D., . . . Banerjee, A. (2023). Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection. OPEN HEART, 10(1). doi:10.1136/openhrt-2022-002241DOI: 10.1136/openhrt-2022-002241
Ding, W. Y., Blomstrom-Lundqvist, C., Fauchier, L., Marin, F., Potpara, T. S., Boriani, G., & Lip, G. Y. H. (2023). Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry. EUROPACE, 25(2), 277-282. doi:10.1093/europace/euac214DOI: 10.1093/europace/euac214
Shantsila, A., Lip, G. Y. H., & Lane, D. A. (2023). Contemporary management of atrial fibrillation in primary and secondary care in the UK: the prospective long-term AF-GEN-UK Registry. EUROPACE, 25(2), 308-317. doi:10.1093/europace/euac153DOI: 10.1093/europace/euac153
Corrigendum to: How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. (Journal article)
Corrigendum to: How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. (2023). Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(2), 486. doi:10.1093/europace/euac227DOI: 10.1093/europace/euac227
Erratum to: Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants. (Journal article)
Erratum to: Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants. (2023). Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(2), 505. doi:10.1093/europace/euac251DOI: 10.1093/europace/euac251
Chung, S. -C., Lai, A., Lip, G. Y. H., Lambiase, P. D., & Providencia, R. (2023). Impact of anti-arrhythmic drugs and catheter ablation on the survival of patients with atrial fibrillation: a population study based on 199 433 new-onset atrial fibrillation patients in the UK.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(2), 351-359. doi:10.1093/europace/euac155DOI: 10.1093/europace/euac155
Stereolithography 3D printing of Si3N4 cellular ceramics with ultrahigh strength by using highly viscous paste (Journal article)
Huang, Z., Liu, L. Y., Yuan, J., Guo, H., Wang, H., Ye, P., . . . Gan, C. L. (2023). Stereolithography 3D printing of Si3N4 cellular ceramics with ultrahigh strength by using highly viscous paste. Ceramics International, 49(4), 6984-6995. doi:10.1016/j.ceramint.2022.10.137DOI: 10.1016/j.ceramint.2022.10.137
Alobaida, M., Lip, G. Y. H., Lane, D. A., Sagris, D., Hill, A., & Harrison, S. L. (n.d.). Endovascular treatment for ischaemic stroke patients with and without atrial fibrillation, and the effects of adjunctive pharmacotherapy: a narrative review.. Expert Opin Pharmacother. doi:10.1080/14656566.2022.2161362DOI: 10.1080/14656566.2022.2161362
Schnabel, R. B., Marinelli, E. A., Arbelo, E., Boriani, G., Boveda, S., Buckley, C. M., . . . Kirchhof, P. (2023). Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(1), 6-27. doi:10.1093/europace/euac062DOI: 10.1093/europace/euac062
Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper. (Journal article)
Kalarus, Z., Mairesse, G. H., Sokal, A., Boriani, G., Średniawa, B., Casado-Arroyo, R., . . . Eckardt, L. (2023). Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(1), 185-198. doi:10.1093/europace/euac144DOI: 10.1093/europace/euac144
Krittayaphong, R., Winijkul, A., Methavigul, K., & Lip, G. Y. H. (2023). Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway: A Report From the COOL-AF Registry.. Journal of the American Heart Association, 12(3), e028463. doi:10.1161/jaha.122.028463DOI: 10.1161/jaha.122.028463
Talasaz, A. H., Sadeghipour, P., Mehdizadeh, K., Khoshnam Rad, N., Bikdeli, B., Lip, G. Y. H., & Harenberg, J. (2023). Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients with COVID-19: Insights into New SARS-CoV-2 Variants, Vaccination Status, and Emerging Oral Antivirals.. Thrombosis and haemostasis, 123(2), 186-191. doi:10.1055/a-1956-9641DOI: 10.1055/a-1956-9641
Pregnancy-Related Complications and Incidence of Atrial Fibrillation: A Systematic Review. (Journal article)
Al Bahhawi, T., Aqeeli, A., Harrison, S. L., Lane, D. A., Skjøth, F., Buchan, I., . . . Lip, G. Y. H. (2023). Pregnancy-Related Complications and Incidence of Atrial Fibrillation: A Systematic Review.. Journal of clinical medicine, 12(4), 1316. doi:10.3390/jcm12041316DOI: 10.3390/jcm12041316
Krittayaphong, R., Chichareon, P., Komoltri, C., Sairat, P., & Lip, G. Y. H. (2023). Predicting Heart Failure in Patients with Atrial Fibrillation: A Report from the Prospective COOL-AF Registry.. Journal of clinical medicine, 12(4), 1265. doi:10.3390/jcm12041265DOI: 10.3390/jcm12041265
Wang, H., Liu, S., Zhang, X., Zheng, J., Lu, F., Lip, G. Y. H., & Bai, Y. (2023). Prevalence and Impact of Arrhythmia on Outcomes in Restrictive Cardiomyopathy-A Report from the Beijing Municipal Health Commission Information Center (BMHCIC) Database. JOURNAL OF CLINICAL MEDICINE, 12(3). doi:10.3390/jcm12031236DOI: 10.3390/jcm12031236
Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists (Conference Paper)
Zulkifly, H. H., Pastori, D., Lane, D. A., & Lip, G. Y. H. (2023). Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists. In JOURNAL OF CLINICAL MEDICINE Vol. 12. doi:10.3390/jcm12031141DOI: 10.3390/jcm12031141
Zulkifly, H. H., Pastori, D., Lane, D. A., & Lip, G. Y. H. (2023). Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists.. Journal of clinical medicine, 12(3), 1141. doi:10.3390/jcm12031141DOI: 10.3390/jcm12031141
Coronary artery calcium score and its association with stroke: A systematic review and meta-analysis (Journal article)
Kwok, C. S., Bennett, S., & Lip, G. Y. H. (2023). Coronary artery calcium score and its association with stroke: A systematic review and meta-analysis. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 53(2). doi:10.1111/eci.13892DOI: 10.1111/eci.13892
Deitelzweig, S., Keshishian, A., Kang, A., Jenkins, A., Atreja, N., Schuler, P., . . . Lip, G. Y. H. (2023). Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 108, 37-42. doi:10.1016/j.ejim.2022.10.021DOI: 10.1016/j.ejim.2022.10.021
Development and validation of a bleeding risk prediction score for patients with mitral valve stenosis and atrial fibrillation or mechanical heart valves receiving long-term warfarin therapy. (Journal article)
Phetroong, S., Nathisuwan, S., Chindavijak, B., Phrommintikul, A., Sapoo, U., Sookananchai, B., . . . Lip, G. Y. H. (2023). Development and validation of a bleeding risk prediction score for patients with mitral valve stenosis and atrial fibrillation or mechanical heart valves receiving long-term warfarin therapy.. British journal of clinical pharmacology, 89(2), 843-852. doi:10.1111/bcp.15540DOI: 10.1111/bcp.15540
AbuElkhair, A., Boidin, M., Buckley, B. J. R., Lane, D. A., Williams, N. H., Thijssen, D., . . . Barraclough, D. L. (2023). Effects of different exercise types on quality of life for patients with atrial fibrillation: a systematic review and meta-analysis.. Journal of cardiovascular medicine (Hagerstown, Md.), 24(2), 87-95. doi:10.2459/jcm.0000000000001386DOI: 10.2459/jcm.0000000000001386
Budnik, M., Gawałko, M., Lodziński, P., Tymińska, A., Ozierański, K., Grabowski, M., . . . Balsam, P. (2023). Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP-AF general long-term registry.. ESC heart failure, 10(1), 637-649. doi:10.1002/ehf2.14130DOI: 10.1002/ehf2.14130
Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions. (Journal article)
Jones, L., Blair, J., Hawcutt, D. B., Lip, G. Y. H., & Shantsila, A. (2023). Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions.. Journal of hypertension, 41(2), 203-211. doi:10.1097/hjh.0000000000003321DOI: 10.1097/hjh.0000000000003321
Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis (Journal article)
Gent, D. G., Rivera-Caravaca, J. M., Dobson, R., Liverpool, D. J., & Lip, G. Y. H. (2023). Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 108, 117-119. doi:10.1016/j.ejim.2022.09.016DOI: 10.1016/j.ejim.2022.09.016
Improving risk prediction for death, stroke and bleeding in Asian patients with atrial fibrillation. (Journal article)
Krittayaphong, R., Kanjanarutjawiwat, W., Wisaratapong, T., & Lip, G. Y. H. (2023). Improving risk prediction for death, stroke and bleeding in Asian patients with atrial fibrillation.. European journal of clinical investigation, 53(2), e13886. doi:10.1111/eci.13886DOI: 10.1111/eci.13886
Fawzy, A. M., Miguel Rivera-Caravaca, J., Underhill, P., Fauchier, L., & Lip, G. Y. H. (2023). Incident heart failure, arrhythmias and cardiovascular outcomes with sodium-glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database. DIABETES OBESITY & METABOLISM, 25(2), 602-610. doi:10.1111/dom.14854DOI: 10.1111/dom.14854
Vitalis, A., Shantsila, A., Kay, M., Vohra, R. K., & Lip, G. Y. H. (2023). Outcome of Femoral Angioplasty/Stenting Procedures in Different Ethnic Groups in England: A Retrospective Analysis of Hospital Episode Statistics and Review of Literature. JOURNAL OF ENDOVASCULAR THERAPY, 30(1), 132-139. doi:10.1177/15266028211070967DOI: 10.1177/15266028211070967
Alobaida, M., Harrison, S. L., Lane, D. A., Underhill, P., Hill, A., & Lip, G. Y. H. (2023). Outcomes in patients with ischaemic stroke undergoing endovascular thrombectomy: Impact of atrial fibrillation. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 32(2). doi:10.1016/j.jstrokecerebrovasdis.2022.106917DOI: 10.1016/j.jstrokecerebrovasdis.2022.106917
Physical Activity Changes and the Risk of Incident Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: A Nationwide Longitudinal Follow-up Cohort Study of 1.8 Million Subjects. (Journal article)
Park, C. S., Choi, E. -K., Kyung-DoHan., Yoo, J., Ahn, H. -J., Kwon, S., . . . Lip, G. Y. H. (2023). Physical Activity Changes and the Risk of Incident Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: A Nationwide Longitudinal Follow-up Cohort Study of 1.8 Million Subjects.. Diabetes care, 46(2), 434-440. doi:10.2337/dc22-1655DOI: 10.2337/dc22-1655
Martinez-Montesinos, L., Rivera-Caravaca, J. M., Agewall, S., Soler, E., Lip, G. Y. H., Marin, F., & Roldan, V. (2023). Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?. BIOMEDICINE & PHARMACOTHERAPY, 158. doi:10.1016/j.biopha.2022.114064DOI: 10.1016/j.biopha.2022.114064
Pre-admission and In-Hospital Statin Use is Associated With Reduced Short-Term Mortality in Infective Endocarditis (Journal article)
Yu, S. -Y., Li, H. -L., Tse, Y. -K., Li, X., Ren, Q. -W., Wu, M. -Z., . . . Yiu, K. -H. (2023). Pre-admission and In-Hospital Statin Use is Associated With Reduced Short-Term Mortality in Infective Endocarditis. MAYO CLINIC PROCEEDINGS, 98(2), 252-265. doi:10.1016/j.mayocp.2022.06.006DOI: 10.1016/j.mayocp.2022.06.006
Chung, S. -C., O'Brien, B., Lip, G. Y. H., Fields, K. G., Muehlschlegel, J. D., Thakur, A., . . . Providencia, R. (2023). Prognostic model for atrial fibrillation after cardiac surgery: a UK cohort study.. Clinical research in cardiology : official journal of the German Cardiac Society, 112(2), 227-235. doi:10.1007/s00392-022-02068-1DOI: 10.1007/s00392-022-02068-1
Response to letter from Du et al. regarding article 'Sodium-glucose cotransporter-2 inhibitor use was associated with lower risks of stroke and cardiac arrest but not ventricular arrhythmias?' (Journal article)
Fawzy, A. M., Rivera-Caravaca, J. M., Fauchier, L., & Lip, G. Y. H. (2023). Response to letter from Du et al. regarding article 'Sodium-glucose cotransporter-2 inhibitor use was associated with lower risks of stroke and cardiac arrest but not ventricular arrhythmias?'. DIABETES OBESITY & METABOLISM, 25(2), 630-633. doi:10.1111/dom.14913DOI: 10.1111/dom.14913
Miguel Rivera-Caravaca, J., Roldan, V., Martinez-Montesinos, L., Vicente, V., Lip, G. Y. H., & Marin, F. (2023). The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort. JOURNAL OF GENERAL INTERNAL MEDICINE, 38(2), 315-323. doi:10.1007/s11606-022-07567-5DOI: 10.1007/s11606-022-07567-5
Choi, S., Sagris, D., Hill, A., Lip, G., & Abdul Rahim, A. H. (2023). Atrial Fibrillation and Stroke. Expert Review of Cardiovascular Therapy, 21(1), 35-56. doi:10.1080/14779072.2023.2160319DOI: 10.1080/14779072.2023.2160319
Chung, J. -W., Lee, S. -R., Choi, E. -K., Park, S. -H., Lee, H., Choi, J., . . . Lip, G. Y. H. (2023). Cumulative Alcohol Consumption Burden and the Risk of Stroke in Young Adults A Nationwide Population-Based Study. NEUROLOGY, 100(5), E505-E515. doi:10.1212/WNL.0000000000201473DOI: 10.1212/WNL.0000000000201473
Fawzy, A. M. M., Bisson, A., Bodin, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2023). Atrial Fibrillation and the Risk of Ventricular Arrhythmias and Cardiac Arrest: A Nationwide Population-Based Study. JOURNAL OF CLINICAL MEDICINE, 12(3). doi:10.3390/jcm12031075DOI: 10.3390/jcm12031075
Lee, S. -R., Ahn, H. -J., Choi, E. -K., Lee, S. -W., Han, K. -D., Oh, S., & Lip, G. Y. H. (n.d.). Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus: a nationwide cohort study. Cardiovascular Diabetology, 22(1). doi:10.1186/s12933-023-01749-zDOI: 10.1186/s12933-023-01749-z
What acute cardiac care physicians need to know from the latest 2022 ESC Guidelines for ventricular tachycardia and sudden cardiac death. (Journal article)
Goette, A., Lip, G. Y. H., & Gorenek, B. (2023). What acute cardiac care physicians need to know from the latest 2022 ESC Guidelines for ventricular tachycardia and sudden cardiac death.. European heart journal. Acute cardiovascular care, 12(1), 62-68. doi:10.1093/ehjacc/zuac149DOI: 10.1093/ehjacc/zuac149
Harrison, S., Buckley, B., Lane, D., Fazio-Eynullayeva, E., Underhill, P., Hill, A., . . . Lip, G. (n.d.). Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke. Cardiovascular Drugs and Therapy. doi:10.1007/s10557-023-07433-4DOI: 10.1007/s10557-023-07433-4
Tseng, R. M. W. W., Rim, T. H., Shantsila, E., Yi, J. K., Park, S., Kim, S. S., . . . Cheng, C. -Y. (2023). Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank. In BMC MEDICINE Vol. 21. doi:10.1186/s12916-022-02684-8DOI: 10.1186/s12916-022-02684-8
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis (Journal article)
Andreotti, F., Geisler, T., Collet, J. -P., Gigante, B., Gorog, D. A., Halvorsen, S., . . . Vilahur, G. (2023). Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis. European heart journal, 44(4), 262-279. doi:10.1093/eurheartj/ehac515DOI: 10.1093/eurheartj/ehac515
Choi, J., Lee, S. -R., Choi, E. -K., Lee, H., Han, M., Ahn, H. -J., . . . Lip, G. Y. H. (2023). Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: a nationwide population study. CARDIOVASCULAR DIABETOLOGY, 22(1). doi:10.1186/s12933-023-01736-4DOI: 10.1186/s12933-023-01736-4
Vitolo, M., Proietti, M., Imberti, J. F., Bonini, N., Romiti, G. F., Mei, D. A., . . . Boriani, G. (2023). Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients. JOURNAL OF CLINICAL MEDICINE, 12(3). doi:10.3390/jcm12030768DOI: 10.3390/jcm12030768
Qureshi, A., Lip, G. Y. H., Nordsletten, D. A., Williams, S. E., Aslanidi, O., & de Vecchi, A. (2022). Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke.. Frontiers in cardiovascular medicine, 9, 1074562. doi:10.3389/fcvm.2022.1074562DOI: 10.3389/fcvm.2022.1074562
Vinter, N., Gerds, T. A., Cordsen, P., Valentin, J. B., Lip, G. Y. H., Benjamin, E. J. J., . . . Frost, L. (2023). Development and validation of prediction models for incident atrial fibrillation in heart failure.. Open heart, 10(1), e002169. doi:10.1136/openhrt-2022-002169DOI: 10.1136/openhrt-2022-002169
Guo, Y., Corica, B., Romiti, G. F., Proietti, M., Zhang, H., Lip, G. Y. H., & mAFApp, I. I. T. I. (2023). Efficacy of mobile health-technology integrated care based on the 'Atrial fibrillation Better Care' (ABC) pathway in relation to sex: a report from the mAFA-II randomized clinical trial. INTERNAL AND EMERGENCY MEDICINE. doi:10.1007/s11739-022-03188-2DOI: 10.1007/s11739-022-03188-2
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial. (Journal article)
Talasaz, A. H., Sadeghipour, P., Bakhshandeh, H., Sharif-Kashani, B., Rashidi, F., Beigmohammadi, M. T., . . . Bikdeli, B. (2023). Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial.. Thrombosis and haemostasis, 123(7), 723-733. doi:10.1055/a-2059-4844DOI: 10.1055/a-2059-4844
Yu, G. -I., Kim, D., Sung, J. -H., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2023). Impact of frailty on early rhythm control outcomes in older adults with atrial fibrillation: A nationwide cohort study. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.1050744DOI: 10.3389/fcvm.2022.1050744
Nabrdalik, K., Tomasik, A., Irlik, K., Hendel, M., Kwiendacz, H., Radzik, E., . . . Lip, G. Y. H. (2023). Low Quantitative Blush Evaluator score predicts larger infarct size and reduced left ventricular systolic function in patients with STEMI regardless of diabetes status. SCIENTIFIC REPORTS, 13(1). doi:10.1038/s41598-022-24855-6DOI: 10.1038/s41598-022-24855-6
A review of emerging factor XI inhibitors (Journal article)
Elsheikh, S., Tidbury, N., & Lip, G. Y. H. (2023). A review of emerging factor XI inhibitors. EXPERT OPINION ON EMERGING DRUGS, 28(1), 43-53. doi:10.1080/14728214.2023.2192923DOI: 10.1080/14728214.2023.2192923
Boidin, M., Lip, G. Y. H., Shantsila, A., Thijssen, D., & Shantsila, E. (2023). Dynamic changes of monocytes subsets predict major adverse cardiovascular events and left ventricular function after STEMI.. Scientific reports, 13(1), 48. doi:10.1038/s41598-022-26688-9DOI: 10.1038/s41598-022-26688-9
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. (Journal article)
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., . . . ESC/ERS Scientific Document Group. (2023). 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.. The European respiratory journal, 61(1), 2200879. doi:10.1183/13993003.00879-2022DOI: 10.1183/13993003.00879-2022
A Happy New Year 2023 from Thrombosis and Haemostasis. (Journal article)
Lip, G. Y. H., Rigby, A., & Weber, C. (2023). A Happy New Year 2023 from Thrombosis and Haemostasis.. Thrombosis and haemostasis, 123(1), 1-5. doi:10.1055/s-0042-1760264DOI: 10.1055/s-0042-1760264
Romiti, G. F., Proietti, M., Bonini, N., Ding, W. Y., Boriani, G., Huisman, M. V., & Lip, G. Y. H. (2023). Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF Registry. ECLINICALMEDICINE, 55. doi:10.1016/j.eclinm.2022.101757DOI: 10.1016/j.eclinm.2022.101757
Ritchie, L. A., Harrison, S. L., Penson, P. E., Akbari, A., Torabi, F., Hollinghurst, J. P., . . . Lane, D. A. (n.d.). Anticoagulation in older people with atrial fibrillation moving to care homes: a data linkage study. British Journal of General Practice, BJGP.2022.0156. doi:10.3399/bjgp.2022.0156DOI: 10.3399/bjgp.2022.0156
Associations of Life's Essential 8 and Fine Particulate Pollution with Incidence of Atrial Fibrillation: Findings from a Prospective Cohort Study (Preprint)
DOI: 10.2139/ssrn.4442892
Leo, D. G., Ozdemir, H., Lane, D., Lip, G., Keller, S., & Proietti, R. (n.d.). At the heart of the matter: how mental stress and negative emotions affect atrial fibrillation. Frontiers in Cardiovascular Medicine. doi:10.3389/fcvm.2023.1171647DOI: 10.3389/fcvm.2023.1171647
Goulart, A. C., Varella, A. C., Tunes, G., Alencar, A. P., Santos, I. S., Romagnolli, C., . . . Bensenor, I. M. (2023). Cerebrovascular risk factors and their time-dependent effects on stroke survival in the EMMA cohort study.. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 56, e12895. doi:10.1590/1414-431x2023e12895DOI: 10.1590/1414-431x2023e12895
Correction: Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation. (Journal article)
Correction: Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation. (2023). Annals of internal medicine, 176(1), 144. doi:10.7326/l22-0482DOI: 10.7326/l22-0482
Early atrial fibrillation rhythm control after stroke (Journal article)
Calvert, P., Gupta, D., & Lip, G. Y. H. (2022). Early atrial fibrillation rhythm control after stroke. LANCET NEUROLOGY, 22(1), 3-4. Retrieved from https://www.webofscience.com/
Aldosari, H., Coenen, F., Lip, G. Y. H., & Zheng, Y. (2023). Electrocardiogram Two-Dimensional Motifs: A Study Directed at Cardio Vascular Disease Classification. In Communications in Computer and Information Science (pp. 3-27). Springer Nature Switzerland. doi:10.1007/978-3-031-43471-6_1DOI: 10.1007/978-3-031-43471-6_1
Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial (Journal article)
Zhu, W., Cao, Y., Ye, M., Huang, H., Wu, Y., Ma, J., . . . Lip, G. Y. H. (2023). Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial. THROMBOSIS AND HAEMOSTASIS, 123(01), 85-96. doi:10.1055/a-1932-8854DOI: 10.1055/a-1932-8854
Ahn, H. -J., Lee, S. -R., Choi, E. -K., Lee, S. -W., Han, K. -D., Kwon, S., . . . Lip, G. Y. H. (2023). Evaluation of the Paradoxical Association Between Lipid Levels and Incident Atrial Fibrillation According to Statin Usage: A Nationwide Cohort Study.. Journal of lipid and atherosclerosis, 12(1), 73-86. doi:10.12997/jla.2023.12.1.73DOI: 10.12997/jla.2023.12.1.73
Kleinnibbelink, G., Buckley, B. J. R., Harrison, S. L., Williams, N., Fazio-Eynullayeva, E., Underhill, P., . . . Thijssen, D. H. J. (2023). Exercised-based cardiac rehabilitation associates with lower all-cause mortality in patients with primary pulmonary hypertension.. Frontiers in sports and active living, 5, 1247615. doi:10.3389/fspor.2023.1247615DOI: 10.3389/fspor.2023.1247615
Exploring the Technology Acceptance of Wearable Medical Devices Among the Younger Generation in Malaysia: The Role of Cognitive and Social Factors (Conference Paper)
Yap, W. Z., Sia, B. C., Goh, H. L., & Cham, T. H. (2023). Exploring the Technology Acceptance of Wearable Medical Devices Among the Younger Generation in Malaysia: The Role of Cognitive and Social Factors. In Unknown Conference (pp. 667-679). Springer International Publishing. doi:10.1007/978-3-031-20429-6_60DOI: 10.1007/978-3-031-20429-6_60
Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry (Journal article)
Ding, W. Y., Proietti, M., Romiti, G. F., Vitolo, M., Fawzy, A. M., Boriani, G., . . . Lip, G. Y. H. (2023). Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 107, 60-65. doi:10.1016/j.ejim.2022.11.004DOI: 10.1016/j.ejim.2022.11.004
Impact of Pleural Effusion on Clinical Outcomes in Patients with Pulmonary Embolism: Insights from the National Inpatient Sample. (Journal article)
Abbas, K. S., Qureshi, A., Ahmad, S., Lip, G. Y. H., & Kwok, C. S. (2023). Impact of Pleural Effusion on Clinical Outcomes in Patients with Pulmonary Embolism: Insights from the National Inpatient Sample.. Acute medicine, 22(1), 24-32. doi:10.52964/amja.0930DOI: 10.52964/amja.0930
Integrated Care Priorities for Complex, Multi-System, Long-Term Conditions and for Long COVID: Results of the STIMULATE-ICP-Delphi Study Among UK Patients and Healthcare Providers (Preprint)
DOI: 10.2139/ssrn.4498395
Schwarz, G., Banerjee, G., Hostettler, I. C., Ambler, G., Seiffge, D. J., Ozkan, H., . . . Werring, D. J. (2023). MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage.. International journal of stroke : official journal of the International Stroke Society, 18(1), 85-94. doi:10.1177/17474930211062478DOI: 10.1177/17474930211062478
Armentaro, G., D'Arrigo, G., Bo, M., Cassano, V., Miceli, S., Pitino, A., . . . Sciacqua, A. (2023). Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation.. Frontiers in pharmacology, 14, 1210560. doi:10.3389/fphar.2023.1210560DOI: 10.3389/fphar.2023.1210560
Guo, Y., Romiti, G. F., Corica, B., Proietti, M., Bonini, N., Zhang, H., . . . mAF-App, I. I. T. I. (2023). Mobile health-technology integrated care in atrial fibrillation patients with heart failure: A report from the mAFA-II randomized clinical trial. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 107, 46-51. doi:10.1016/j.ejim.2022.11.002DOI: 10.1016/j.ejim.2022.11.002
Prediabetes Is Associated With Increased Risk of Heart Failure Among Patients With Atrial Fibrillation (Journal article)
Huang, J. -Y., Tse, Y. -K., Li, H. -L., Chen, C., Zhao, C. -T., Liu, M. -Y., . . . Yiu, K. -H. (2023). Prediabetes Is Associated With Increased Risk of Heart Failure Among Patients With Atrial Fibrillation. DIABETES CARE, 46(1), 190-196. doi:10.2337/dc22-1188DOI: 10.2337/dc22-1188
Kalarus, Z., Średniawa, B., Mitręga, K., Wierucki, Ł., Sokal, A., Lip, G., . . . Zdrojewski, T. (2023). Prevalence of atrial fibrillation in the 65 or over Polish population. Report of cross-sectional NOMED-AF study.. Kardiologia polska, 81(1), 14-21. doi:10.33963/kp.a2022.0202DOI: 10.33963/kp.a2022.0202
Prevalence of new-onset atrial fibrillation in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis (Journal article)
Corica, B., Tartaglia, F., Oliva, A., Raparelli, V., Cangemi, R., Basili, S., . . . Romiti, G. F. (2023). Prevalence of new-onset atrial fibrillation in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis. INTERNAL AND EMERGENCY MEDICINE, 18(1), 127-135. doi:10.1007/s11739-022-03135-1DOI: 10.1007/s11739-022-03135-1
Relationship between Metabolic Status, Physical Activity and Cardiovascular Disease in Obese Adults (Preprint)
DOI: 10.2139/ssrn.4336164
Lee, S. -R., Choi, E. -K., Park, S. -H., Han, K. -D., Oh, S., Abdelgawwad, K., & Lip, G. Y. H. (2023). Renal outcomes of rivaroxaban compared with warfarin in Asian patients with nonvalvular atrial fibrillation: A nationwide population-based cohort study.. Frontiers in cardiovascular medicine, 10, 1040834. doi:10.3389/fcvm.2023.1040834DOI: 10.3389/fcvm.2023.1040834
Sex differences in pharmacological cardioversion among patients with atrial fibrillation. (Journal article)
Liu, Y., & Lip, G. Y. H. (2023). Sex differences in pharmacological cardioversion among patients with atrial fibrillation.. Kardiologia polska. doi:10.33963/v.kp.98206DOI: 10.33963/v.kp.98206
Zhang, H., Jin, Z., Wang, H., Guo, Y., & Lip, G. Y. H. (2023). Structured Rehabilitation for Patients with Atrial Fibrillation Based on an Integrated Care Approach: Protocol for a Prospective, Observational Cohort Study. VASCULAR HEALTH AND RISK MANAGEMENT, 19, 485-494. doi:10.2147/VHRM.S407974DOI: 10.2147/VHRM.S407974
Temporal Trends of Stroke Severity and the Association between Antithrombotic Drug Regimen Changes and Clinical Outcomes after Stroke in Atrial Fibrillation (Preprint)
DOI: 10.2139/ssrn.4505330
Thrombosis and Haemostasis 2022 Editors' Choice Papers. (Journal article)
Weber, C., Blanchet, X., & Lip, G. Y. H. (2023). Thrombosis and Haemostasis 2022 Editors' Choice Papers.. Thrombosis and haemostasis, 123(1), 123-130. doi:10.1055/s-0042-1760263DOI: 10.1055/s-0042-1760263
What People Post During the Movement Control Order (MCO): A Content Analysis of Intagram’s Top Posts (Conference Paper)
Goh, H. L., Foo, W. H., Cham, T. H., Sia, B. C., & Yap, W. Z. (2023). What People Post During the Movement Control Order (MCO): A Content Analysis of Intagram’s Top Posts. In Unknown Conference (pp. 84-94). Springer International Publishing. doi:10.1007/978-3-031-20429-6_9DOI: 10.1007/978-3-031-20429-6_9
2022
Feilberg Rasmussen, L., Andreasen, J. J., Riahi, S., Lip, G. Y. H., Lundbye-Christensen, S., Melgaard, J., & Graff, C. (2022). Prediction of postoperative atrial fibrillation with postoperative epicardial electrograms.. Scandinavian cardiovascular journal : SCJ, 56(1), 378-386. doi:10.1080/14017431.2022.2130421DOI: 10.1080/14017431.2022.2130421
Paschoal, E., Gooden, T. E., Olmos, R. D., Lotufo, P. A., Benseñor, I. M., Manaseki-Holland, S., . . . Zhong, J. (n.d.). Health care professionals’ perceptions about atrial fibrillation care in the Brazilian public primary care system: a mixed-methods study. BMC Cardiovascular Disorders, 22(1). doi:10.1186/s12872-022-02927-9DOI: 10.1186/s12872-022-02927-9
Carrion-Martinez, A., Buckley, B. J. R., Orenes-Pinero, E., Marin, F., Lip, G. Y. H., & Miguel Rivera-Caravaca, J. (2022). Anthropometric Measures and Risk of Cardiovascular Disease: Is there an Opportunity for Non-Traditional Anthropometric Assessment? A Review. REVIEWS IN CARDIOVASCULAR MEDICINE, 23(12). doi:10.31083/j.rcm2312414DOI: 10.31083/j.rcm2312414
Lee, S. -Y., Lee, S. -R., Choi, E. -K., Han, K. -D., Oh, S., & Lip, G. Y. H. (2022). Impact of Socioeconomic Status on Emergency Department Visits in Patients With Atrial Fibrillation: A Nationwide Population-Based Cohort Study.. Journal of the American Heart Association, 11(24), e027192. doi:10.1161/jaha.122.027192DOI: 10.1161/jaha.122.027192
Vinciguerra, M., Olier, I., Ortega-Martorell, S., & Lip, G. Y. H. (2022). New use for an old drug : Metformin and atrial fibrillation. CELL REPORTS MEDICINE, 3(12). doi:10.1016/j.xcrm.2022.100875DOI: 10.1016/j.xcrm.2022.100875
Bisson, A., Lemrini, Y., El-Bouri, W., Bodin, A., Angoulvant, D., Lip, G. Y. H., & Fauchier, L. (2022). Prediction of incident atrial fibrillation in post-stroke patients using machine learning: a French nationwide study. CLINICAL RESEARCH IN CARDIOLOGY. doi:10.1007/s00392-022-02140-wDOI: 10.1007/s00392-022-02140-w
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry (Journal article)
Esteve-Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Sanmartin Fernandez, M., Arribas, F., Masjuan, J., . . . Marin, F. (2022). Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 9(1), 38-46. doi:10.1093/ehjcvp/pvac060DOI: 10.1093/ehjcvp/pvac060
Chao, T. -F., Chan, Y. -H., Tsai, P. -C., Lee, H. -F., Chang, S. -H., Kuo, C. -T., . . . Yeh, Y. -H. (2022). Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban.. Biomedicines, 10(12), 3210. doi:10.3390/biomedicines10123210DOI: 10.3390/biomedicines10123210
de Vries, C. F., Colosimo, S. J., Boyle, M., Lip, G., Anderson, L. A., Staff, R. T., & iCAIRD Radiology Collaboration. (2022). AI in breast screening mammography: breast screening readers' perspectives.. Insights into imaging, 13(1), 186. doi:10.1186/s13244-022-01322-4DOI: 10.1186/s13244-022-01322-4
Prognosis and treatment of atrial fibrillation in Asian cities: 1-year review of the Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry. (Journal article)
Tse, H. -F., Teo, W. -S., Siu, C. -W., Chao, T. -F., Park, H. -W., Shimizu, W., . . . Lip, G. Y. H. (2022). Prognosis and treatment of atrial fibrillation in Asian cities: 1-year review of the Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 24(12), 1889-1898. doi:10.1093/europace/euab327DOI: 10.1093/europace/euab327
Harrison, S. L., Buckley, B. J. R., Zheng, Y., Hill, A., Hlaing, T., Davies, R., . . . Jones, I. (2022). Evaluation of Huawei Smart Wearables for Detection of Atrial Fibrillation in Patients Following Ischaemic Stroke: The Liverpool-Huawei Stroke Study. American Heart Journal. doi:10.1016/j.ahj.2022.12.004DOI: 10.1016/j.ahj.2022.12.004
Pastori, D., Marang, A., Bisson, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2022). Performance of the HAS-BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 344 Hospitalized Patients With Atrial Fibrillation and Cancer: Data From the French National Hospital Discharge Database. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 11(23). doi:10.1161/JAHA.121.026388DOI: 10.1161/JAHA.121.026388
Ritchie, L. A., Harrison, S. L., Penson, P. E., Akbari, A., Torabi, F., Hollinghurst, J., . . . Lane, D. A. (2022). Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003-2018. AGE AND AGEING, 51(12). doi:10.1093/ageing/afac252DOI: 10.1093/ageing/afac252
Coenen, F., Aldosari, H., Lip, G., & Zheng, Y. (2022). Scanned ECG Arrhythmia Classification Using a Pre-trained Convolutional Neural Network as a Feature Extractor.
Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III (Journal article)
Romiti, G. F., Proietti, M., Bonini, N., Ding, W. Y., Boriani, G., Huisman, M. V., & Lip, G. Y. H. (2022). Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III. THROMBOSIS AND HAEMOSTASIS, 122(12), 2030-2041. doi:10.1055/s-0042-1756355DOI: 10.1055/s-0042-1756355
Ritchie, L. A., Penson, P. E., Akpan, A., Lip, G. Y. H., & Lane, D. A. (2022). Integrated Care for Atrial Fibrillation Management: The Role of the Pharmacist. AMERICAN JOURNAL OF MEDICINE, 135(12), 1410-1426. doi:10.1016/j.amjmed.2022.07.014DOI: 10.1016/j.amjmed.2022.07.014
Microstructure and mechanical properties of electroplated Ni-Sn TLP bonded joints with different bonding and aging times (Journal article)
Yan, G., Gill, V., Gan, C. L., & Chen, Z. (2022). Microstructure and mechanical properties of electroplated Ni-Sn TLP bonded joints with different bonding and aging times. Materials Characterization, 194, 112452. doi:10.1016/j.matchar.2022.112452DOI: 10.1016/j.matchar.2022.112452
Revisiting 'intensive' blood glucose control: A causal directed acyclic graph-guided systematic review of randomized controlled trials (Journal article)
Huang, C. -J., Wang, W. -T., Sung, S. -H., Chen, C. -H., Lip, G. Y. H., Cheng, H. -M., & Chiang, C. -E. (2022). Revisiting 'intensive' blood glucose control: A causal directed acyclic graph-guided systematic review of randomized controlled trials. DIABETES OBESITY & METABOLISM, 24(12), 2341-2352. doi:10.1111/dom.14819DOI: 10.1111/dom.14819
Steiner, D. K., Søgaard, P., Jensen, M., Bjerregaard Larsen, T., Lip, G. Y. H., & Nielsen, P. B. (2022). Risk of stroke or systemic embolism in patients with degenerative mitral stenosis with or without atrial fibrillation: A cohort study.. International journal of cardiology. Heart & vasculature, 43, 101126. doi:10.1016/j.ijcha.2022.101126DOI: 10.1016/j.ijcha.2022.101126
Sinus rhythm restoration and improved outcomes in patients with acute ischemic stroke and in-hospital paroxysmal atrial fibrillation (Journal article)
Sagris, D., Korompoki, E., Ntaios, G., Tzeis, S., Manios, E., Kanakakis, J., . . . Vemmos, K. (2022). Sinus rhythm restoration and improved outcomes in patients with acute ischemic stroke and in-hospital paroxysmal atrial fibrillation. EUROPEAN STROKE JOURNAL, 7(4), 421-430. doi:10.1177/23969873221109405DOI: 10.1177/23969873221109405
Therapeutic<i> vs.</i> prophylactic anticoagulation in COVID-19 patients: a systematic review and meta-analysis of real-world studies (Journal article)
Vio, R., Giordani, A. S., Stefil, M., Alturki, A., Russo, V., China, P., . . . Proietti, R. (2022). Therapeutic<i> vs.</i> prophylactic anticoagulation in COVID-19 patients: a systematic review and meta-analysis of real-world studies. MINERVA CARDIOLOGY AND ANGIOLOGY, 70(6), 652-662. doi:10.23736/S2724-5683.22.06230-5DOI: 10.23736/S2724-5683.22.06230-5
Ultrafast high-temperature sintering of dense and textured alumina (Journal article)
Behera, R. P., Reavley, M. J. -H., Du, Z., Gan, C. L., & Le Ferrand, H. (2022). Ultrafast high-temperature sintering of dense and textured alumina. Journal of the European Ceramic Society, 42(15), 7122-7133. doi:10.1016/j.jeurceramsoc.2022.08.014DOI: 10.1016/j.jeurceramsoc.2022.08.014
The obesity paradox in patients with atrial fibrillation: an insight from the Gulf SAFE registry (Conference Paper)
Li, Y. G., Bai, J., Domek, M., Alsheikh-Ali, A., Almahmeed, W., Shehab, A., . . . Lip, G. Y. H. (2020). The obesity paradox in patients with atrial fibrillation: an insight from the Gulf SAFE registry. In EUROPEAN HEART JOURNAL Vol. 41 (pp. 354). Retrieved from https://www.webofscience.com/
Kang, D. -S., Sung, J. -H., Kim, D., Jin, M. -N., Jang, E., Yu, H. T., . . . Joung, B. (2022). Association between exercise habit changes and mortality following a cardiovascular event. HEART, 108(24), 1945-1951. doi:10.1136/heartjnl-2022-320882DOI: 10.1136/heartjnl-2022-320882
Kanesamoorthy, S., Sheron, V. A., Uruthirakumar, P., Kodippily, C., Kumarendran, B., Gooden, T. E., . . . NIHR Global Health Research Group on Atrial Fibrillation Management. (2022). Prevalence of atrial fibrillation in Northern Sri Lanka: a study protocol for a cross-sectional household survey.. BMJ open, 12(11), e056480. doi:10.1136/bmjopen-2021-056480DOI: 10.1136/bmjopen-2021-056480
Pasi, M., Boulouis, G., Bisson, A., Herbert, J., Bodin, A., Cordonnier, C., . . . Fauchier, L. (2022). Adverse Cardiovascular Events in Non-Traumatic Intracranial Hemorrhage and Ischemic Stroke Survivors. JOURNAL OF CLINICAL MEDICINE, 11(23). doi:10.3390/jcm11236885DOI: 10.3390/jcm11236885
Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial. (Journal article)
Patel, S. M., Palazzolo, M. G., Murphy, S. A., Antman, E. M., Braunwald, E., Lanz, H. -J., . . . Ruff, C. T. (2022). Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 24(11), 1730-1738. doi:10.1093/europace/euac082DOI: 10.1093/europace/euac082
Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. (Journal article)
Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. (2022). European heart journal, 43(44), 4634. doi:10.1093/eurheartj/ehac519DOI: 10.1093/eurheartj/ehac519
Bae, N. Y., Lee, S. -R., Choi, E. -K., Ahn, H. J., Ahn, H. -J., Kwon, S., . . . Lip, G. Y. H. (2022). Impact of mental disorders on the risk of atrial fibrillation in patients with diabetes mellitus: a nationwide population-based study.. Cardiovascular diabetology, 21(1), 251. doi:10.1186/s12933-022-01682-7DOI: 10.1186/s12933-022-01682-7
Safety and efficacy of direct oral anticoagulants in patients with anaemia and atrial fibrillation: an observational nationwide Danish cohort study. (Journal article)
Al-Hussainy, N., Kragholm, K. H., Lundbye-Christensen, S., Torp-Pedersen, C., Pareek, M., Therkelsen, S. K., . . . Riahi, S. (2022). Safety and efficacy of direct oral anticoagulants in patients with anaemia and atrial fibrillation: an observational nationwide Danish cohort study.. European heart journal. Quality of care & clinical outcomes, 8(8), 840-851. doi:10.1093/ehjqcco/qcab095DOI: 10.1093/ehjqcco/qcab095
Burdett, P., & Lip, G. Y. H. (2022). Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom.. European heart journal. Quality of care & clinical outcomes, 8(8), 892-898. doi:10.1093/ehjqcco/qcac005DOI: 10.1093/ehjqcco/qcac005
Han, M., Lee, S. -R., Choi, E. -K., Park, S. -H., Lee, H., Chung, J., . . . Lip, G. Y. H. (2022). The impact of socioeconomic deprivation on the risk of atrial fibrillation in patients with diabetes mellitus: A nationwide population-based study. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.1008340DOI: 10.3389/fcvm.2022.1008340
Drozdz, K., Nabrdalik, K., Kwiendacz, H., Hendel, M., Olejarz, A., Tomasik, A., . . . Lip, G. Y. H. (2022). Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach. CARDIOVASCULAR DIABETOLOGY, 21(1). doi:10.1186/s12933-022-01672-9DOI: 10.1186/s12933-022-01672-9
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry (Journal article)
Boriani, G., Vitolo, M., Malavasi, V. L., Proietti, M., Fantecchi, E., Diemberger, I., . . . Lipand, G. Y. H. (2022). Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 29(15), 1967-1981. doi:10.1093/eurjpc/zwac115DOI: 10.1093/eurjpc/zwac115
Bellfield, R. A. A., Ortega-Martorell, S., Lip, G. Y. H., Oxborough, D., & Olier, I. (2022). The Athlete's Heart and Machine Learning: A Review of Current Implementations and Gaps for Future Research. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 9(11). doi:10.3390/jcdd9110382DOI: 10.3390/jcdd9110382
Gent, D. G., Ali, N., Olsson-Brown, A., Lip, G. Y. H., Wright, D. J., & Dobson, R. (2022). Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights. CASE REPORTS IN ONCOLOGY, 15(3), 950-959. doi:10.1159/000526256DOI: 10.1159/000526256
Brandes, A., Stavrakis, S., Freedman, B., Antoniou, S., Boriani, G., Camm, A. J., . . . Turakhia, M. P. (2022). Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration.. Circulation, 146(19), 1461-1474. doi:10.1161/circulationaha.121.058911DOI: 10.1161/circulationaha.121.058911
Sagris, D., Shantsila, E., & Lip, G. Y. H. (2022). Stroke risk stratification in patients with heart failure and sinus rhythm. EUROPEAN HEART JOURNAL, 43(42), 4480-4482. doi:10.1093/eurheartj/ehac493DOI: 10.1093/eurheartj/ehac493
Stroke and Myocardial Infarction in Patients with Abdominal Aortic Aneurysm and New-Onset Atrial Fibrillation. (Journal article)
Nicolajsen, C. W., Nielsen, P. B., Jensen, M., Eldrup, N., Larsen, T. B., Lip, G. Y. H., . . . Søgaard, M. (2023). Stroke and Myocardial Infarction in Patients with Abdominal Aortic Aneurysm and New-Onset Atrial Fibrillation.. Thrombosis and haemostasis, 123(5), 555-564. doi:10.1055/a-2009-8954DOI: 10.1055/a-2009-8954
Bai, Y., Zheng, J. -P., Lu, F., Zhang, X. -L., Sun, C. -P., Guo, W. -H., . . . Shi, X. -B. (2022). Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China. SCIENTIFIC REPORTS, 12(1). doi:10.1038/s41598-022-20042-9DOI: 10.1038/s41598-022-20042-9
Leo, D. G., Buckley, B. J. R., Chowdhury, M., Harrison, S. L., Isanejad, M., Lip, G. Y. H., . . . Lane, D. A. (2022). Interactive Remote Patient Monitoring Devices for Managing Chronic Health Conditions: Systematic Review and Meta-analysis. JOURNAL OF MEDICAL INTERNET RESEARCH, 24(11). doi:10.2196/35508DOI: 10.2196/35508
Mobile health technology integrated care in older atrial fibrillation patients: a subgroup analysis of the mAFA-II randomised clinical trial (Journal article)
Guo, Y., Romiti, G. F., Proietti, M., Bonini, N., Zhang, H., & Lip, G. Y. H. (2022). Mobile health technology integrated care in older atrial fibrillation patients: a subgroup analysis of the mAFA-II randomised clinical trial. AGE AND AGEING, 51(11). doi:10.1093/ageing/afac245DOI: 10.1093/ageing/afac245
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). (Journal article)
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., . . . ESC Scientific Document Group. (2022). 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).. European heart journal, 43(41), 4229-4361. doi:10.1093/eurheartj/ehac244DOI: 10.1093/eurheartj/ehac244
Adherence to the "Atrial fibrillation Better Care" (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry (Journal article)
Vitolo, M., Proietti, M., Malavasi, V. L., Bonini, N., Romiti, G. F., Imberti, J. F., . . . Boriani, G. (2022). Adherence to the "Atrial fibrillation Better Care" (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 105, 54-62. doi:10.1016/j.ejim.2022.08.004DOI: 10.1016/j.ejim.2022.08.004
Lau, W. C. Y., Torre, C. O., Man, K. K. C., Stewart, H. M., Seager, S., Van Zandt, M., . . . Wong, I. C. K. (2022). Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population-Based Cohort Study. ANNALS OF INTERNAL MEDICINE, 175(11), 1515-+. doi:10.7326/M22-0511DOI: 10.7326/M22-0511
Guo, Y., Zhang, H., Lip, G. Y. H., & mAF-App II Trial investigators. (2022). Consumer-Led Screening for Atrial Fibrillation: A Report From the mAFA-II Trial Long-Term Extension Cohort.. JACC. Asia, 2(6), 737-746. doi:10.1016/j.jacasi.2022.07.006DOI: 10.1016/j.jacasi.2022.07.006
Chan, Y. -H., Chao, T. -F., Chen, S. -W., Lee, H. -F., Chen, W. -M., Li, P. -R., . . . Lip, G. Y. H. (2022). Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan.. JAMA network open, 5(11), e2243307. doi:10.1001/jamanetworkopen.2022.43307DOI: 10.1001/jamanetworkopen.2022.43307
Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta-analysis of 92 studies. (Journal article)
Archontakis-Barakakis, P., Li, W., Kalaitzoglou, D., Tzelves, L., Manolopoulos, A., Giannopoulos, S., . . . Kokkinidis, D. G. (2022). Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta-analysis of 92 studies.. British journal of clinical pharmacology, 88(11), 4663-4675. doi:10.1111/bcp.15464DOI: 10.1111/bcp.15464
External validation of the simple NULL-PLEASE clinical score in predicting outcomes of out-of-hospital cardiac arrest in the Danish population - A nationwide registry-based study. (Journal article)
Byrne, C., Barcella, C. A., Krogager, M. L., Pareek, M., Ringgren, K. B., Andersen, M. P., . . . Lip, G. Y. H. (2022). External validation of the simple NULL-PLEASE clinical score in predicting outcomes of out-of-hospital cardiac arrest in the Danish population - A nationwide registry-based study.. Resuscitation, 180, 128-136. doi:10.1016/j.resuscitation.2022.08.009DOI: 10.1016/j.resuscitation.2022.08.009
Erba, N., Tosetto, A., Langer, M., Abdallah, S. A., Giovanella, E., Lentini, S., . . . Poli, D. (2022). Oral anticoagulant management of patients with mechanical heart valves at the Salam Centre of Khartoum: Observations on quality of anticoagulation and thrombotic risk.. Thrombosis research, 219, 155-161. doi:10.1016/j.thromres.2022.09.018DOI: 10.1016/j.thromres.2022.09.018
Ahn, H. -J., Lee, S. -R., Choi, E. -K., Rhee, T. -M., Kwon, S., Oh, S., & Lip, G. Y. H. (2022). Protective effect of proton-pump inhibitor against gastrointestinal bleeding in patients receiving oral anticoagulants: A systematic review and meta-analysis.. British journal of clinical pharmacology, 88(11), 4676-4687. doi:10.1111/bcp.15478DOI: 10.1111/bcp.15478
van der Feltz-Cornelis, C. M., Sweetman, J., Allsopp, G., Attree, E., Crooks, M. G., Cuthbertson, D. J., . . . STIMULATE-ICP, C. (2022). STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol. PLOS ONE, 17(11). doi:10.1371/journal.pone.0277936DOI: 10.1371/journal.pone.0277936
Vinter, N., Fawzy, A. M., Gent, D., Ding, W. Y., Johnsen, S. P., Frost, L., . . . Lip, G. Y. H. (2022). Social determinants of health and cardiovascular outcomes in patients with heart failure. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 52(11). doi:10.1111/eci.13843DOI: 10.1111/eci.13843
Stroke prevention in atrial fibrillation (Journal article)
Lip, G. Y. H., Gue, Y., Zhang, J., Chao, T. -F., Calkins, H., & Potpara, T. (2022). Stroke prevention in atrial fibrillation. TRENDS IN CARDIOVASCULAR MEDICINE, 32(8), 501-510. doi:10.1016/j.tcm.2021.10.001DOI: 10.1016/j.tcm.2021.10.001
Thromboembolic events and major bleeding with warfarin, non-vitamin K antagonist oral anticoagulants or antiplatelets following mitral valve repair: A systematic review and meta-analysis (Preprint)
DOI: 10.1101/2022.10.29.22281662
Buckley, B. J. R., & Lip, G. Y. H. (2022). Current Concepts: Comprehensive "Cardiovascular Health" Rehabilitation-An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases. THROMBOSIS AND HAEMOSTASIS, 122(12), 1966-1968. doi:10.1055/s-0042-1757403DOI: 10.1055/s-0042-1757403
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry (Journal article)
Proietti, M., Romiti, G. F., Vitolo, M., Potpara, T. S., Boriani, G., & Lip, G. Y. H. (2022). Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 8(7), 778-786. doi:10.1093/ehjqcco/qcab069DOI: 10.1093/ehjqcco/qcab069
Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk (Conference Paper)
Chao, T., Lip, G. Y. H., & Chen, S. A. (2021). Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk. In EUROPEAN HEART JOURNAL Vol. 42 (pp. 552). Retrieved from https://www.webofscience.com/
Habitual fish oil supplementation and the risk of incident atrial fibrillation: findings from a large prospective longitudinal cohort study (Journal article)
Zhang, J., Cai, A., Chen, G., Wang, X., Cai, M., Li, H., . . . Lin, H. (2022). Habitual fish oil supplementation and the risk of incident atrial fibrillation: findings from a large prospective longitudinal cohort study. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 29(14), 1911-1920. doi:10.1093/eurjpc/zwac192DOI: 10.1093/eurjpc/zwac192
Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients? (Journal article)
Gue, Y. X., Gorog, D. A., & Lip, G. Y. H. (2022). Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?. CIRCULATION, 146(16), 1207-1209. doi:10.1161/CIRCULATIONAHA.122.061987DOI: 10.1161/CIRCULATIONAHA.122.061987
Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system (Journal article)
Rivera-Caravaca, J. M., Lip, G. Y. H., Roldan, V., & Marin, F. (2022). Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.1042728DOI: 10.3389/fcvm.2022.1042728
Wang, R., Olier, I., Ortega-Martorell, S., Liu, Y., Ye, Z., Lip, G. Y. H., & Li, G. (2022). Association between metabolically healthy obesity and risk of atrial fibrillation: taking physical activity into consideration. CARDIOVASCULAR DIABETOLOGY, 21(1). doi:10.1186/s12933-022-01644-zDOI: 10.1186/s12933-022-01644-z
Zhu, W., Wu, Z., Dong, Y., Lip, G. Y. H., & Liu, C. (2022). Effectiveness of early rhythm control in improving clinical outcomes in patients with atrial fibrillation: a systematic review and meta-analysis. BMC MEDICINE, 20(1). doi:10.1186/s12916-022-02545-4DOI: 10.1186/s12916-022-02545-4
Zero-burden atrial fibrillation: does stroke risk diminish the longer a person is free from atrial fibrillation? (Journal article)
Junarta, J., Dikdan, S. J., Weitz, H. H., Lip, G. Y. H., & Frisch, D. R. (2022). Zero-burden atrial fibrillation: does stroke risk diminish the longer a person is free from atrial fibrillation?. EUROPACE, 24(9), 1369-1371. doi:10.1093/europace/euac025DOI: 10.1093/europace/euac025
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. (Journal article)
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., . . . ESC/ERS Scientific Document Group. (2022). 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.. European heart journal, 43(38), 3618-3731. doi:10.1093/eurheartj/ehac237DOI: 10.1093/eurheartj/ehac237
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association (Journal article)
Levine, G. N., McEvoy, J. W., Fang, J. C., Ibeh, C., McCarthy, C. P., Misra, A., . . . Lip, G. Y. H. (2022). Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. CIRCULATION, 146(15), E205-E223. doi:10.1161/CIR.0000000000001092DOI: 10.1161/CIR.0000000000001092
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week (Journal article)
De Caterina, R., Agewall, S., Andreotti, F., Angiolillo, D. J., Bhatt, D. L., Byrne, R. A., . . . Potpara, T. (2022). Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. EUROPEAN HEART JOURNAL, 43(37), 3512-3527. doi:10.1093/eurheartj/ehac294DOI: 10.1093/eurheartj/ehac294
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper (Journal article)
Gorog, D. A., Gue, Y. X., Chao, T. -F., Fauchier, L., Ferreiro, J. L., Huber, K., . . . Lip, G. Y. H. (2022). Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper. THROMBOSIS AND HAEMOSTASIS, 122(10), 1625-1652. doi:10.1055/s-0042-1750385DOI: 10.1055/s-0042-1750385
Essa, H., Dobson, R., & Lip, G. Y. H. (2022). Chemotherapy-Induced Arrhythmias. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 80(4), 531-539. doi:10.1097/FJC.0000000000001216DOI: 10.1097/FJC.0000000000001216
Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients A Nationwide Propensity Score-Weighted Study (Journal article)
Kim, D., Yang, P. -S., You, S. C., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2022). Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients A Nationwide Propensity Score-Weighted Study. ANNALS OF INTERNAL MEDICINE, 175(10), 1356-+. doi:10.7326/M21-4798DOI: 10.7326/M21-4798
Ivany, E., Ritchie, L. A., Lip, G. Y. H., Lotto, R. R., Werring, D. J., & Lane, D. A. (2022). Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis. STROKE, 53(10), 3035-3046. doi:10.1161/STROKEAHA.122.038752DOI: 10.1161/STROKEAHA.122.038752
Beier, L., Lu, S., França, L. R., Marler, S., Lip, G. Y. H., Huisman, M. V., . . . Rothman, K. J. (2022). Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.. PloS one, 17(10), e0274237. doi:10.1371/journal.pone.0274237DOI: 10.1371/journal.pone.0274237
Sodium-glucose cotransporter 2 inhibitors: An additional management option for patients with atrial fibrillation? (Journal article)
Proietti, R., & Lip, G. Y. H. (2022). Sodium-glucose cotransporter 2 inhibitors: An additional management option for patients with atrial fibrillation?. DIABETES OBESITY & METABOLISM, 24(10), 1897-1900. doi:10.1111/dom.14818DOI: 10.1111/dom.14818
Chiang, C. -E., Chao, T. -F., Choi, E. -K., Lim, T. W., Krittayaphong, R., Li, M., . . . Lip, G. Y. H. (2022). Stroke Prevention in Atrial Fibrillation: A Scientific Statement of <i>JACC: Asia</i> (Part 2).. JACC. Asia, 2(5), 519-537. doi:10.1016/j.jacasi.2022.06.004DOI: 10.1016/j.jacasi.2022.06.004
Steensig, K., Pareek, M., Krarup, A. L., Sogaard, P., Maeng, M., Tayal, B., . . . Kragholm, K. H. (2022). Thromboembolism and bleeding in patients with atrial fibrillation and liver disease - A nationwide register-based cohort study: Thromboembolism and bleeding in liver disease.. Clinics and research in hepatology and gastroenterology, 46(8), 101952. doi:10.1016/j.clinre.2022.101952DOI: 10.1016/j.clinre.2022.101952
Rasmussen, L. F., Andreasen, J. J., Lundbye-Christensen, S., Riahi, S., Johnsen, S. P., & Lip, G. Y. H. (2022). Using the C<sub>2</sub>HEST Score for Predicting Postoperative Atrial Fibrillation After Cardiac Surgery: A Report From the Western Denmark Heart Registry, the Danish National Patient Registry, and the Danish National Prescription Registry.. Journal of cardiothoracic and vascular anesthesia, 36(10), 3730-3737. doi:10.1053/j.jvca.2022.03.037DOI: 10.1053/j.jvca.2022.03.037
Jung, M., Byeon, K., Kang, K. -W., Park, Y. M., Hwang, Y. M., Lee, S. H., . . . Shin, S. Y. (2022). Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA<sub>2</sub>DS<sub>2</sub>-VASc Score 0-1: A Korean Multi-Center Cohort. YONSEI MEDICAL JOURNAL, 63(10), 892-901. doi:10.3349/ymj.2022.0157DOI: 10.3349/ymj.2022.0157
Hu, Y., Parida, K., Zhang, H., Wang, X., Li, Y., Zhou, X., . . . Fan, H. J. (2022). Bond engineering of molecular ferroelectrics renders soft and high-performance piezoelectric energy harvesting materials.. Nature communications, 13(1), 5607. doi:10.1038/s41467-022-33325-6DOI: 10.1038/s41467-022-33325-6
Copper-Nanoparticle-Coated Fabrics for Rapid and Sustained Antibacterial Activity Applications (Journal article)
Gonçalves, R. A., Ku, J. W. K., Zhang, H., Salim, T., Oo, G., Zinn, A. A., . . . Lam, Y. M. (2022). Copper-Nanoparticle-Coated Fabrics for Rapid and Sustained Antibacterial Activity Applications. ACS Applied Nano Materials, 5(9), 12876-12886. doi:10.1021/acsanm.2c02736DOI: 10.1021/acsanm.2c02736
<i>APOE</i> and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Hemorrhage. (Journal article)
Hostettler, I. C., Seiffge, D., Wong, A., Ambler, G., Wilson, D., Shakeshaft, C., . . . Werring, D. J. (2022). <i>APOE</i> and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Hemorrhage.. Neurology, 99(12), e1290-e1298. doi:10.1212/wnl.0000000000200851DOI: 10.1212/wnl.0000000000200851
Tay, Y. S., Phua, E. J. R., Chen, Z., & Gan, C. L. (2022). Simultaneous Enhancement of Polymerization Kinetics and Properties of Phthalonitrile Using Alumina Fillers.. ACS omega, 7(37), 32996-33003. doi:10.1021/acsomega.2c02667DOI: 10.1021/acsomega.2c02667
Galvain, T., Hill, R., Donegan, S., Lisboa, P., Lip, G. Y. H., & Czanner, G. (2022). Efficacy and Safety of Anticoagulants in Patients with Atrial Fibrillation and History of Falls or Risk of Falls: A Systematic Review and Multilevel Meta-Analysis. DRUG SAFETY, 45(11), 1349-1362. doi:10.1007/s40264-022-01231-xDOI: 10.1007/s40264-022-01231-x
Kwok, C. S., Waters, D., Phan, T., Myint, P. K., & Lip, G. Y. H. (2022). Should Audits Consider the Care Pathway Model? A New Approach to Benchmarking Real-World Activities. HEALTHCARE, 10(9). doi:10.3390/healthcare10091798DOI: 10.3390/healthcare10091798
Anticoagulation in Atrial Fibrillation and Rheumatic Heart Disease. (Journal article)
Lip, G. Y. H. (2022). Anticoagulation in Atrial Fibrillation and Rheumatic Heart Disease.. The New England journal of medicine, 387(11), 1036-1038. doi:10.1056/nejme2210187DOI: 10.1056/nejme2210187
Nabrdalik, K., Skonieczna-Zydecka, K., Irlik, K., Hendel, M., Kwiendacz, H., Loniewski, I., . . . Lip, G. Y. H. (2022). Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials. FRONTIERS IN ENDOCRINOLOGY, 13. doi:10.3389/fendo.2022.975912DOI: 10.3389/fendo.2022.975912
Ding, W. Y., Davies, I. G., Gupta, D., & Lip, G. Y. H. (2022). Relationship between Renal Function, Fibrin Clot Properties and Lipoproteins in Anticoagulated Patients with Atrial Fibrillation. BIOMEDICINES, 10(9). doi:10.3390/biomedicines10092270DOI: 10.3390/biomedicines10092270
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) (Journal article)
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., . . . Srojidinova, N. (2022). 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European Heart Journal - Cardiovascular Imaging, 23(10), e333-e465. doi:10.1093/ehjci/jeac106DOI: 10.1093/ehjci/jeac106
Williams, K., Modi, R. N., Dymond, A., Hoare, S., Powell, A., Burt, J., . . . Mant, J. (2022). Cluster randomised controlled trial of screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the pilot study for the SAFER trial. BMJ OPEN, 12(9). doi:10.1136/bmjopen-2022-065066DOI: 10.1136/bmjopen-2022-065066
Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. (Journal article)
Guo, Y., Kotalczyk, A., Imberti, J. F., Wang, Y., Lip, G. Y. H., & ChiOTEAF Registry Investigators. (2022). Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.. European heart journal. Quality of care & clinical outcomes, 8(6), 651-658. doi:10.1093/ehjqcco/qcab057DOI: 10.1093/ehjqcco/qcab057
A review of risk factors for retinal vein occlusions (Journal article)
Orskov, M., Vorum, H., Larsen, T. B., Vestergaard, N., Lip, G. Y. H., Bek, T., & Skjoth, F. (2022). A review of risk factors for retinal vein occlusions. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 20(9), 761-772. doi:10.1080/14779072.2022.2112667DOI: 10.1080/14779072.2022.2112667
Romiti, G. F., Proietti, M., Vitolo, M., Bonini, N., Fawzy, A. M., Ding, W. Y., . . . Lip, G. Y. H. (2022). Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry. BMC MEDICINE, 20(1). doi:10.1186/s12916-022-02526-7DOI: 10.1186/s12916-022-02526-7
Han, M., Lee, S. -R., Choi, E. -K., Choi, J., Chung, J., Park, S. -H., . . . Lip, G. Y. H. (2022). Habitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea. JAMA NETWORK OPEN, 5(9). doi:10.1001/jamanetworkopen.2022.29799DOI: 10.1001/jamanetworkopen.2022.29799
Vio, R., Giordani, A. S., Stefil, M., Madine, J., Fairbairn, T., Themistoclakis, S., . . . Proietti, R. (2022). Arterial stiffness and atrial fibrillation: shared mechanisms, clinical implications and therapeutic options.. Journal of hypertension, 40(9), 1639-1646. doi:10.1097/hjh.0000000000003223DOI: 10.1097/hjh.0000000000003223
Cardiovascular medications and long-term mortality among stroke survivors in the Brazilian Study of Stroke Mortality and Morbidity (EMMA). (Journal article)
Souza, K. A., Varella, A. C., Olmos, R. D., Romagnolli, C., Gooden, T. E., Thomas, G. N., . . . NIHR Global Health Research Group on Atrial Fibrillation Management. (2022). Cardiovascular medications and long-term mortality among stroke survivors in the Brazilian Study of Stroke Mortality and Morbidity (EMMA).. Geriatrics & gerontology international, 22(9), 715-722. doi:10.1111/ggi.14429DOI: 10.1111/ggi.14429
INSPIRATION INVESTIGATORS. (2022). Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes.. European journal of internal medicine, 103, 76-83. doi:10.1016/j.ejim.2022.06.014DOI: 10.1016/j.ejim.2022.06.014
Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression (Conference Paper)
Proietti, M., Romiti, G. F., Vitolo, M., Borgi, M., Di Rocco, A., Farcomeni, A., . . . Lip, G. Y. H. (2022). Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression. In EUROPEAN JOURNAL OF INTERNAL MEDICINE Vol. 103 (pp. 84-94). doi:10.1016/j.ejim.2022.06.023DOI: 10.1016/j.ejim.2022.06.023
Ding, W. Y., Kotalczyk, A., Boriani, G., Marin, F., Blomstrom-Lundqvist, C., Potpara, T. S., . . . Lip, G. Y. H. (2022). Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 103, 41-49. doi:10.1016/j.ejim.2022.04.026DOI: 10.1016/j.ejim.2022.04.026
Ding, W. Y., Calvert, P., Gupta, D., Huisman, M. V., & Lip, G. Y. H. (2022). Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry. CLINICAL RESEARCH IN CARDIOLOGY, 111(9), 1057-1068. doi:10.1007/s00392-022-02022-1DOI: 10.1007/s00392-022-02022-1
Sagris, D., Harrison, S. L., Buckley, B. J. R., Ntaios, G., & Lip, G. Y. H. (2022). Long-Term Cardiac Monitoring After Embolic Stroke of Undetermined Source: Search Longer, Look Harder. AMERICAN JOURNAL OF MEDICINE, 135(9), E311-E317. doi:10.1016/j.amjmed.2022.04.030DOI: 10.1016/j.amjmed.2022.04.030
Harrison, S. L., Lip, G. Y. H., Akbari, A., Torabi, F., Ritchie, L. A., Akpan, A., . . . Lane, D. A. (2022). Stroke in Older Adults Living in Care Homes: Results From a National Data Linkage Study in Wales. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 23(9), 1548-+. doi:10.1016/j.jamda.2022.05.003DOI: 10.1016/j.jamda.2022.05.003
Tensile behavior of tetragonal zirconia micro/nano‐fibers and beams in situ tested by push‐to‐pull devices (Journal article)
Zeng, X. M., Ye, P., Tan, H. T., Du, Z., & Gan, C. L. (2022). Tensile behavior of tetragonal zirconia micro/nano‐fibers and beams in situ tested by push‐to‐pull devices. Journal of the American Ceramic Society, 105(9), 5911-5920. doi:10.1111/jace.18555DOI: 10.1111/jace.18555
Ultrafast high-temperature sintering of barium titanate ceramics with colossal dielectric constants (Journal article)
Reavley, M. J. -H., Guo, H., Yuan, J., Ng, A. Y. R., Ho, T. Y. K., Tan, H. T., . . . Gan, C. L. (2022). Ultrafast high-temperature sintering of barium titanate ceramics with colossal dielectric constants. Journal of the European Ceramic Society, 42(12), 4934-4943. doi:10.1016/j.jeurceramsoc.2022.04.056DOI: 10.1016/j.jeurceramsoc.2022.04.056
Lip, G. Y. H., Genaidy, A., Tran, G., Marroquin, P., & Estes, C. (2022). Incidence and Complications of Atrial Fibrillation in a Low Socioeconomic and High Disability United States (US) Population: A Combined Statistical and Machine Learning Approach.. International journal of clinical practice, 2022, 8649050. doi:10.1155/2022/8649050DOI: 10.1155/2022/8649050
López-Sendón, J. L., Alonso-Rodríguez, D., Barón-Esquivias, G., Cosin-Sales, J., Marín, F., Galera-Llorca, J., . . . Spanish GLORIA-AF investigators. (2022). Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program.. Medicina clinica, 159(4), 177-182. doi:10.1016/j.medcli.2021.09.016DOI: 10.1016/j.medcli.2021.09.016
Sheron, V. A., Shanmugathas, S., Gooden, T. E., Guruparan, M., Kumarendran, B., Lip, G. Y. H., . . . Beane, A. (2022). Healthcare provider and patient perspectives on access to and management of atrial fibrillation in the Northern Province, Sri Lanka: a rapid evaluation of barriers and facilitators to care. BMC HEALTH SERVICES RESEARCH, 22(1). doi:10.1186/s12913-022-08440-1DOI: 10.1186/s12913-022-08440-1
Lee, S. -R., Jung, J. -H., Choi, E. -K., Lee, S. -W., Kwon, S., Park, J. -S., . . . Lip, G. Y. H. (2022). Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.991293DOI: 10.3389/fcvm.2022.991293
Lip, G. Y. H., Tran, G., Genaidy, A., Marroquin, P., Estes, C., & Landsheft, J. (2022). Improving dynamic stroke risk prediction in non-anticoagulated patients with and without atrial fibrillation: comparing common clinical risk scores and machine learning algorithms.. European heart journal. Quality of care & clinical outcomes, 8(5), 548-556. doi:10.1093/ehjqcco/qcab037DOI: 10.1093/ehjqcco/qcab037
Vinter, N., Cordsen, P., Fenger-Grøn, M., Lip, G. Y. H., Benjamin, E. J., Frost, L., & Johnsen, S. P. (2022). Quality of care and risk of incident atrial fibrillation in patients with newly diagnosed heart failure: a nationwide cohort study.. European heart journal. Quality of care & clinical outcomes, 8(5), 539-547. doi:10.1093/ehjqcco/qcab036DOI: 10.1093/ehjqcco/qcab036
Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study. (Journal article)
Chao, T. -F., Chan, Y. -H., Tuan, T. -C., Liao, J. -N., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2022). Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study.. European heart journal. Quality of care & clinical outcomes, 8(5), 588-595. doi:10.1093/ehjqcco/qcab050DOI: 10.1093/ehjqcco/qcab050
A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium (Journal article)
Johnsen, S. P., Proietti, M., Maggioni, A. P., & Lip, G. Y. H. (2022). A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium. EUROPEAN HEART JOURNAL, 43(31), 2916-2918. doi:10.1093/eurheartj/ehac265DOI: 10.1093/eurheartj/ehac265
A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry (Journal article)
Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Ruiz-Ortiz, M., Muniz, J., Roldan-Rabadan, I., Otero, D., . . . Marin, F. (2022). A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry. EXPERT OPINION ON PHARMACOTHERAPY, 23(12), 1457-1465. doi:10.1080/14656566.2022.2109961DOI: 10.1080/14656566.2022.2109961
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe (Journal article)
Proietti, M., Romiti, G. F., Vitolo, M., Harrison, S. L., Lane, D. A., Fauchier, L., . . . Lip, G. Y. H. (2022). Epidemiology and impact of frailty in patients with atrial fibrillation in Europe. AGE AND AGEING, 51(8). doi:10.1093/ageing/afac192DOI: 10.1093/ageing/afac192
Ding, W. Y., Lane, D. A., Gupta, D., Huisman, M. V., & Lip, G. Y. H. (2022). Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA-AF Registry. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 11(15). doi:10.1161/JAHA.122.026410DOI: 10.1161/JAHA.122.026410
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease Does Less Mean More? (Journal article)
Gue, Y. X., Gorog, D. A., & Lip, G. Y. H. (2022). Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease Does Less Mean More?. JAMA CARDIOLOGY, 7(8), 794-795. doi:10.1001/jamacardio.2022.1572DOI: 10.1001/jamacardio.2022.1572
Ahn, H. -J., Lee, S. -R., Choi, E. -K., Han, K. -D., Rhee, T. -M., Kwon, S., . . . Lip, G. Y. H. (2022). Associations between obesity parameters and the risk of incident atrial fibrillation and ischaemic stroke in the different age groups. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.906844DOI: 10.3389/fcvm.2022.906844
Guo, Y., Imberti, J. F., Kotalczyk, A., Wang, Y., Lip, G. Y. H., & ChiOTEAF Registry Investigators. (2022). Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation.. JACC. Asia, 2(4), 422-429. doi:10.1016/j.jacasi.2022.01.007DOI: 10.1016/j.jacasi.2022.01.007
Atrial fibrillation (Journal article)
Stefil, M., & Lip, G. Y. H. (2022). Atrial fibrillation. Medicine, 50(8), 516-521. doi:10.1016/j.mpmed.2022.05.007DOI: 10.1016/j.mpmed.2022.05.007
Clinical risk factors for retinal artery occlusions: a nationwide case-control study. (Journal article)
Ørskov, M., Vorum, H., Larsen, T. B., Lip, G. Y. H., Bek, T., & Skjøth, F. (2022). Clinical risk factors for retinal artery occlusions: a nationwide case-control study.. International ophthalmology, 42(8), 2483-2491. doi:10.1007/s10792-022-02247-zDOI: 10.1007/s10792-022-02247-z
Højen, A. A., Nielsen, P. B., Riahi, S., Jensen, M., Lip, G. Y. H., Larsen, T. B., & Søgaard, M. (2022). Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.. British journal of clinical pharmacology, 88(8), 3847-3855. doi:10.1111/bcp.15337DOI: 10.1111/bcp.15337
Frailty prevalence and impact on outcomes in patients with atrial fibrillation: A systematic review and meta-analysis of 1,187,000 patients (Journal article)
Proietti, M., Romiti, G. F., Raparelli, V., Diemberger, I., Boriani, G., Vecchia, L. A. D., . . . Cesari, M. (2022). Frailty prevalence and impact on outcomes in patients with atrial fibrillation: A systematic review and meta-analysis of 1,187,000 patients. AGEING RESEARCH REVIEWS, 79. doi:10.1016/j.arr.2022.101652DOI: 10.1016/j.arr.2022.101652
Incident and recurrent myocardial infarction (MI) in relation to comorbidities: Prediction of outcomes using machine-learning algorithms. (Journal article)
Lip, G. Y. H., Genaidy, A., Tran, G., Marroquin, P., Estes, C., Shnaiden, T., & Bayewitz, A. (2022). Incident and recurrent myocardial infarction (MI) in relation to comorbidities: Prediction of outcomes using machine-learning algorithms.. European journal of clinical investigation, 52(8), e13777. doi:10.1111/eci.13777DOI: 10.1111/eci.13777
Sagris, D., Harrison, S. L., & Lip, G. Y. H. (2022). Lipids and atrial fibrillation: New insights into a paradox.. PLoS medicine, 19(8), e1004067. doi:10.1371/journal.pmed.1004067DOI: 10.1371/journal.pmed.1004067
Oral Anticoagulant Use for Patients with Atrial Fibrillation with Concomitant Anemia and/or Thrombocytopenia. (Journal article)
Yeh, Y. -H., Chan, Y. -H., Chen, S. -W., Chang, S. -H., Wang, C. -L., Kuo, C. -T., . . . Chao, T. -F. (2022). Oral Anticoagulant Use for Patients with Atrial Fibrillation with Concomitant Anemia and/or Thrombocytopenia.. The American journal of medicine, 135(8), e248-e256. doi:10.1016/j.amjmed.2022.03.011DOI: 10.1016/j.amjmed.2022.03.011
Kotalczyk, A., Guo, Y., Fawzy, A. M., Wang, Y., & Lip, G. Y. H. (2022). Outcomes in elderly Chinese patients with atrial fibrillation and coronary artery disease. A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. JOURNAL OF ARRHYTHMIA, 38(4), 580-588. doi:10.1002/joa3.12744DOI: 10.1002/joa3.12744
Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding (Journal article)
Lee, S. -R., Kwon, S., Choi, E. -K., Jung, J. -H., Han, K. -D., Oh, S., & Lip, G. Y. H. (2022). Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding. CARDIOVASCULAR DRUGS AND THERAPY, 36(4), 679-689. doi:10.1007/s10557-021-07170-6DOI: 10.1007/s10557-021-07170-6
Lip, G. Y. H., Murphy, R. R., Sahiar, F., Ingall, T. J., Dhamane, A. D., Ferri, M., . . . Deitelzweig, S. (2022). Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.. JAMA network open, 5(8), e2229333. doi:10.1001/jamanetworkopen.2022.29333DOI: 10.1001/jamanetworkopen.2022.29333
Nielsen, P. B., Melgaard, L., Overvad, T. F., Jensen, M., Larsen, T. B., & Lip, G. Y. H. (2022). Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study. STROKE, 53(8), 2559-2568. doi:10.1161/STROKEAHA.121.038331DOI: 10.1161/STROKEAHA.121.038331
Ramasawmy, M., Mu, Y., Clutterbuck, D., Pantelic, M., Lip, G. Y. H., van der Feltz-cornelis, C., . . . Lorgelly, P. (2022). STIMULATE-ICP-CAREINEQUAL (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) study protocol: Defining usual care and examining inequalities in Long Covid support. PLOS ONE, 17(8). doi:10.1371/journal.pone.0271978DOI: 10.1371/journal.pone.0271978
Ørskov, M., Vorum, H., Larsen, T. B., Lip, G. Y. H., Bek, T., & Skjøth, F. (2022). Similarities and Differences in Systemic Risk Factors for Retinal Artery Occlusion and Stroke: A Nationwide Case-Control Study.. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 31(8), 106610. doi:10.1016/j.jstrokecerebrovasdis.2022.106610DOI: 10.1016/j.jstrokecerebrovasdis.2022.106610
Chiang, C. -E., Chao, T. -F., Choi, E. -K., Lim, T. W., Krittayaphong, R., Li, M., . . . Lip, G. Y. H. (2022). Stroke Prevention in Atrial Fibrillation: A Scientific Statement of <i>JACC: Asia</i> (Part 1).. JACC. Asia, 2(4), 395-411. doi:10.1016/j.jacasi.2022.05.005DOI: 10.1016/j.jacasi.2022.05.005
Wolf, A., Khimani, F., Yoon, B., Gerhart, C., Endsley, D., Ray, A. K., . . . Sathyamoorthy, M. (2022). The mechanistic basis linking cytokine storm to thrombosis in COVID-19. Thrombosis Update, 8, 100110. doi:10.1016/j.tru.2022.100110DOI: 10.1016/j.tru.2022.100110
Surma, S., Romańczyk, M., Filipiak, K. J., & Lip, G. Y. H. (2022). Coffee and cardiac arrhythmias: Up-date review of the literature and clinical studies.. Cardiology journal, 30(4), 654-667. doi:10.5603/cj.a2022.0068DOI: 10.5603/cj.a2022.0068
Shantsila, E., Kozieł-Siołkowska, M., & Lip, G. Y. (2022). Antiplatelet agents and anticoagulants for hypertension.. The Cochrane database of systematic reviews, 7, CD003186. doi:10.1002/14651858.cd003186.pub4DOI: 10.1002/14651858.cd003186.pub4
Bensenor, I. M., Goulart, A. C., Thomas, G. N., Lip, G. Y. H., Arasalingam, A., Beane, A., . . . Fi, N. I. H. R. G. H. R. G. A. (2022). Patient and Public Involvement and Engagement (PPIE): first steps in the process of the engagement in research projects in Brazil. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 55(1). doi:10.1590/1414-431X2022e12369DOI: 10.1590/1414-431X2022e12369
Zwart, B., Bor, W. L., de Veer, A. J. W. M., Mahmoodi, B. K., Kelder, J. C., Lip, G. Y. H., . . . Ten Berg, J. M. (2022). A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial.. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 18(4), e292-e302. doi:10.4244/eij-d-21-00165DOI: 10.4244/eij-d-21-00165
Digoxin use and clinical outcomes in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. (Journal article)
Guo, Y., Kotalczyk, A., Wang, Y., & Lip, G. Y. H. (2022). Digoxin use and clinical outcomes in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 24(7), 1076-1083. doi:10.1093/europace/euab319DOI: 10.1093/europace/euab319
Utilizing biomarkers in atrial fibrillation: the pros and cons (Journal article)
Ding, W. Y., McDowell, G., & Lip, G. Y. H. (2022). Utilizing biomarkers in atrial fibrillation: the pros and cons. CARDIOVASCULAR RESEARCH, 118(9), 2035-2036. doi:10.1093/cvr/cvab283DOI: 10.1093/cvr/cvab283
Li, L., Lip, G. Y. H., Li, S., Adachi, J. D., Thabane, L., & Li, G. (2022). Associations between glycated hemoglobin and the risks of incident cardiovascular diseases in patients with gout. CARDIOVASCULAR DIABETOLOGY, 21(1). doi:10.1186/s12933-022-01567-9DOI: 10.1186/s12933-022-01567-9
How to use digital devices to detect and manage arrhythmias: an EHRA practical guide (Journal article)
Svennberg, E., Tjong, F., Goette, A., Akoum, N., Di Biaise, L., Bordachar, P., . . . Sinner, M. (2022). How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. EUROPACE. doi:10.1093/europace/euac038DOI: 10.1093/europace/euac038
Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants (Journal article)
Ritchie, L. A., Lane, D. A., & Lip, G. Y. H. (2022). Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants. EUROPACE, 24(6), 871-873. doi:10.1093/europace/euab313DOI: 10.1093/europace/euab313
Prioritising electrocardiograms for manual review to improve the efficiency of atrial fibrillation screening. (Journal article)
Adeniji, M., Brimicombe, J., Cowie, M. R., Dymond, A., Linden, H. C., Lip, G. Y. H., . . . Charlton, P. H. (2022). Prioritising electrocardiograms for manual review to improve the efficiency of atrial fibrillation screening.. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2022, 3239-3242. doi:10.1109/embc48229.2022.9871092DOI: 10.1109/embc48229.2022.9871092
Apolipoprotein E and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Haemorrhage. (Journal article)
Hostettler, I. C., Seiffge, D., Wong, A., Ambler, G., Wilson, D., Shakeshaft, C., . . . Werring, D. (2022). Apolipoprotein E and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Haemorrhage.. Neurology, 10.1212/WNL.0000000000200851. doi:10.1212/wnl.0000000000200851DOI: 10.1212/wnl.0000000000200851
Proietti, M., Romiti, G. F., Vitolo, M., Borgi, M., Rocco, A. D., Farcomeni, A., . . . Lip, G. Y. H. (2022). Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression. European Journal of Internal Medicine, 103, 84-94. doi:10.1016/j.ejim.2022.06.023DOI: 10.1016/j.ejim.2022.06.023
Lip, G. Y. H., Lane, D. A., Lenarczyk, R., Boriani, G., Doehner, W., Benjamin, L. A., . . . Potpara, T. (2022). Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke. EUROPEAN HEART JOURNAL, 43(26), 2442-2460. doi:10.1093/eurheartj/ehac245DOI: 10.1093/eurheartj/ehac245
Lee, S. -R., Choi, E. -K., Park, S. -H., Lee, S. -W., Han, K. -D., Oh, S., & Lip, G. Y. H. (2022). Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation.. Frontiers in cardiovascular medicine, 9, 885016. doi:10.3389/fcvm.2022.885016DOI: 10.3389/fcvm.2022.885016
Analysis of the ESC/EACTS 2020 Atrial Fibrillation Guidelines With Perioperative Implications (Journal article)
Nelson, J. A., Gue, Y. X., Christensen, J. M., Lip, G. Y. H., & Ramakrishna, H. (2022). Analysis of the ESC/EACTS 2020 Atrial Fibrillation Guidelines With Perioperative Implications. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 36(7), 2177-2195. doi:10.1053/j.jvca.2021.05.011DOI: 10.1053/j.jvca.2021.05.011
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations (Journal article)
Imberti, J. F., Mei, D. A., Vitolo, M., Bonini, N., Proietti, M., Potpara, T., . . . Boriani, G. (2022). Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 101, 1-7. doi:10.1016/j.ejim.2022.04.023DOI: 10.1016/j.ejim.2022.04.023
Editorial commentary: COVID-19 and COVID-19 vaccination: Observations on thrombosis and thrombocytopenia (Journal article)
Elsheikh, S., & Lip, G. Y. H. (2022). Editorial commentary: COVID-19 and COVID-19 vaccination: Observations on thrombosis and thrombocytopenia. TRENDS IN CARDIOVASCULAR MEDICINE, 32(5), 257-258. doi:10.1016/j.tcm.2022.03.002DOI: 10.1016/j.tcm.2022.03.002
Lip, G. Y. H., Keshishian, A., Kang, A., Luo, X., Atreja, N., Zhang, Y., . . . Deitelzweig, S. (2022). Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 54(1), 33-46. doi:10.1007/s11239-022-02660-2DOI: 10.1007/s11239-022-02660-2
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review. (Journal article)
Bikdeli, B., Zahedi Tajrishi, F., Sadeghipour, P., Talasaz, A. H., Fanikos, J., Lippi, G., . . . Lip, G. Y. H. (2022). Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review.. JAMA cardiology, 7(7), 747-759. doi:10.1001/jamacardio.2022.1292DOI: 10.1001/jamacardio.2022.1292
Buckley, B. J. R., Harrison, S. L., Fazio-Eynullayeva, E., Underhill, P., Lane, D. A., Thijssen, D. H. J., & Lip, G. Y. H. (2022). Exercise-Based Cardiac Rehabilitation Associates with Lower Major Adverse Cardiovascular Events in People with Stroke. CEREBROVASCULAR DISEASES, 51(4), 488-492. doi:10.1159/000521025DOI: 10.1159/000521025
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry (Journal article)
Malavasi, V. L., Vitolo, M., Proietti, M., Diemberger, I., Fauchier, L., Marin, F., . . . Boriani, G. (2022). Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 52(7). doi:10.1111/eci.13773DOI: 10.1111/eci.13773
Oral anticoagulation improves survival in very elderly Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry (Journal article)
Guo, Y., Kotalczyk, A., Imberti, J. F., Wang, Y., & Lip, G. Y. H. (2022). Oral anticoagulation improves survival in very elderly Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. INTERNATIONAL JOURNAL OF STROKE, 17(6), 661-668. doi:10.1177/17474930211046743DOI: 10.1177/17474930211046743
Kozieł-Siołkowska, M., Siołkowski, S., Mihajlovic, M., Lip, G. Y. H., Potpara, T. S., & BALKAN-AF Investigators . (2022). Predictors of Adherence to Stroke Prevention in the BALKAN-AF Study: A Machine-Learning Approach.. TH open : companion journal to thrombosis and haemostasis, 6(3), e283-e290. doi:10.1055/s-0042-1755617DOI: 10.1055/s-0042-1755617
Ding, W. Y., Miguel Rivera-Caravaca, J., Marin, F., Roldan, V., & Lip, G. Y. H. (2022). Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 54(1), 1-6. doi:10.1007/s11239-022-02638-0DOI: 10.1007/s11239-022-02638-0
Buckley, B. J. R., Lane, D. A., Calvert, P., Zhang, J., Gent, D., Mullins, C. D., . . . Lip, G. Y. H. (2022). Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis. JOURNAL OF CLINICAL MEDICINE, 11(13). doi:10.3390/jcm11133788DOI: 10.3390/jcm11133788
Antazoline: the Lazarus of antiarrhythmic drugs? (Journal article)
Calvert, P., Gupta, D., & Lip, G. Y. H. (2022). Antazoline: the Lazarus of antiarrhythmic drugs?. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 132(6). doi:10.20452/pamw.16264DOI: 10.20452/pamw.16264
Qin, S., Tian, Z., Boidin, M., Buckley, B. J. R., Thijssen, D. H. J., & Lip, G. Y. H. (2022). Irisin is an Effector Molecule in Exercise Rehabilitation Following Myocardial Infarction (Review). FRONTIERS IN PHYSIOLOGY, 13. doi:10.3389/fphys.2022.935772DOI: 10.3389/fphys.2022.935772
Chan, Y. -H., Chao, T. -F., Chen, S. -W., Lee, H. -F., Li, P. -R., Chen, W. -M., . . . Lip, G. Y. H. (2022). The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study.. Cardiovascular diabetology, 21(1), 118. doi:10.1186/s12933-022-01549-xDOI: 10.1186/s12933-022-01549-x
Antithrombotic dilemmas in stroke medicine: new data, unsolved challenges. (Journal article)
Best, J. G., Cardus, B., Klijn, C. J. M., Lip, G., Seiffge, D. J., Smith, E. E., & Werring, D. J. (2022). Antithrombotic dilemmas in stroke medicine: new data, unsolved challenges.. Journal of neurology, neurosurgery, and psychiatry, jnnp-2020-325249. doi:10.1136/jnnp-2020-325249DOI: 10.1136/jnnp-2020-325249
Yum, Y., Shin, S. Y., Yoo, H., Kim, Y. H., Kim, E. J., Lip, G. Y. H., & Joo, H. J. (2022). Development and Validation of 3-Year Atrial Fibrillation Prediction Models Using Electronic Health Record With or Without Standardized Electrocardiogram Diagnosis and a Performance Comparison Among Models.. Journal of the American Heart Association, 11(12), e024045. doi:10.1161/jaha.121.024045DOI: 10.1161/jaha.121.024045
Castleman, J. S., Lip, G. Y. H., & Shantsila, E. (2022). Monocytes are increased in pregnancy after gestational hypertensive disease. SCIENTIFIC REPORTS, 12(1). doi:10.1038/s41598-022-13606-2DOI: 10.1038/s41598-022-13606-2
Zhang, N., Wang, Y., Chen, Z., Liu, D., Tse, G., Korantzopoulos, P., . . . Liu, T. (2022). Circulating Vitamin D Concentrations and Risk of Atrial Fibrillation: A Mendelian Randomization Study Using Non-deficient Range Summary Statistics. FRONTIERS IN NUTRITION, 9. doi:10.3389/fnut.2022.842392DOI: 10.3389/fnut.2022.842392
Ajoolabady, A., Nattel, S., Lip, G. Y. H., & Ren, J. (2022). Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review.. Journal of the American College of Cardiology, 79(23), 2349-2366. doi:10.1016/j.jacc.2022.03.379DOI: 10.1016/j.jacc.2022.03.379
Efficacy and Safety of Oral Anticoagulants in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis (Conference Paper)
Malhotra, K., Ishfaq, M. F., Goyal, N., Parissis, J., Alexandrov, A., Alexandrov, A., & Tsivgoulis, G. (2019). Efficacy and Safety of Oral Anticoagulants in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis. In STROKE Vol. 50. Retrieved from https://www.webofscience.com/
Discontinuation of direct oral anticoagulants among patients with atrial fibrillation according to gender and cohabitation status: a nationwide cohort study. (Journal article)
Binding, C., Olesen, J. B., Lee, C. J. -Y., Lip, G. Y. H., Sindet-Pedersen, C., Gislason, G., & Bonde, A. N. (2022). Discontinuation of direct oral anticoagulants among patients with atrial fibrillation according to gender and cohabitation status: a nationwide cohort study.. European heart journal. Cardiovascular pharmacotherapy, 8(4), 353-362. doi:10.1093/ehjcvp/pvab065DOI: 10.1093/ehjcvp/pvab065
Vamos, M., Oldgren, J., Nam, G. -B., Lip, G. Y. H., Calkins, H., Zhu, J., . . . Hohnloser, S. H. (2022). Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a <i>post hoc</i> analysis of the ATHENA trial. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 8(4), 363-371. doi:10.1093/ehjcvp/pvab090DOI: 10.1093/ehjcvp/pvab090
Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC-EHRA EORP AF Long-Term General Registry (Journal article)
Ding, W. Y., Boriani, G., Marin, F., Blomstrom-Lundqvist, C., Potpara, T. S., Fauchier, L., & Lip, G. Y. H. (2022). Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC-EHRA EORP AF Long-Term General Registry. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 8(4), 372-382. doi:10.1093/ehjcvp/pvab076DOI: 10.1093/ehjcvp/pvab076
USPSTF found insufficient evidence on the benefits and harms of screening adults ≥50 y for AF. (Journal article)
Choi, S. E., & Lip, G. Y. H. (2022). USPSTF found insufficient evidence on the benefits and harms of screening adults ≥50 y for AF.. Annals of internal medicine, 175(6), JC62. doi:10.7326/j22-0036DOI: 10.7326/j22-0036
Bridge, J., Fu, L., Lin, W., Xue, Y., Lip, G. Y. H., & Zheng, Y. (n.d.). Artificial intelligence to detect abnormal heart rhythm from scanned electrocardiogram tracings. Journal of Arrhythmia. doi:10.1002/joa3.12707DOI: 10.1002/joa3.12707
Hansen, E. R., Sagi, T., Hose, K., Lip, G. Y. H., Larsen, T. B., & Skjøth, F. (2022). Assigning diagnosis codes using medication history.. Artificial intelligence in medicine, 128, 102307. doi:10.1016/j.artmed.2022.102307DOI: 10.1016/j.artmed.2022.102307
Sagris, D., & Lip, G. Y. H. (2022). Atrial fibrillation, a contemporary sign of multimorbidity and irregular social inequity. LANCET REGIONAL HEALTH-EUROPE, 17. doi:10.1016/j.lanepe.2022.100395DOI: 10.1016/j.lanepe.2022.100395
Gue, Y. X., Bisson, A., Bodin, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2022). Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 52(6). doi:10.1111/eci.13754DOI: 10.1111/eci.13754
Nielsen, P. B., Sogaard, M., Jensen, M., Ording, A. G., & Lip, G. Y. H. (2022). Comparative effectiveness and safety of edoxaban versus warfarin in patients with atrial fibrillation: A nationwide cohort study. INTERNATIONAL JOURNAL OF STROKE, 17(5), 536-544. doi:10.1177/17474930211029441DOI: 10.1177/17474930211029441
Drug Interactions Affecting Oral Anticoagulant Use. (Journal article)
Mar, P. L., Gopinathannair, R., Gengler, B. E., Chung, M. K., Perez, A., Dukes, J., . . . from the American Heart Association Electrocardiography & Arrhythmias Committee of the Council of Clinical Cardiology. (2022). Drug Interactions Affecting Oral Anticoagulant Use.. Circulation. Arrhythmia and electrophysiology, 15(6), e007956. doi:10.1161/circep.121.007956DOI: 10.1161/circep.121.007956
Kuroda, M., Tamiya, E., Nose, T., Ogimoto, A., Taura, J., Imamura, Y., . . . Okumura, K. (2022). Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation: A Prespecified Subanalysis of the ELDERCARE-AF Randomized Clinical Trial.. JAMA cardiology, 7(6), 583-590. doi:10.1001/jamacardio.2022.0480DOI: 10.1001/jamacardio.2022.0480
Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation (Journal article)
Kim, D., Yang, P. -S., Sung, J. -H., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2022). Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation. STROKE, 53(6), 1873-1882. doi:10.1161/STROKEAHA.121.036757DOI: 10.1161/STROKEAHA.121.036757
Best, J. G., Arram, L., Ahmed, N., Balogun, M., Bennett, K., Bordea, E., . . . Werring, D. J. (2022). Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial. INTERNATIONAL JOURNAL OF STROKE, 17(5), 583-589. doi:10.1177/17474930211057722DOI: 10.1177/17474930211057722
Chang, P. -Y., Wang, W. -T., Wu, W. -L., Chang, H. -C., Chen, C. -H., Tsai, Y. -W., . . . Chiang, C. -E. (2022). Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation. THROMBOSIS AND HAEMOSTASIS, 122(06), 939-950. doi:10.1055/a-1669-4987DOI: 10.1055/a-1669-4987
Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort (Journal article)
Malavasi, V. L., Vitolo, M., Colella, J., Montagnolo, F., Mantovani, M., Proietti, M., . . . Boriani, G. (2022). Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort. INTERNAL AND EMERGENCY MEDICINE, 17(4), 1001-1012. doi:10.1007/s11739-021-02890-xDOI: 10.1007/s11739-021-02890-x
Lee, H. -J., Lee, S. -R., Choi, E. -K., Park, S. -H., Chung, J. -W., Choi, J. -M., . . . Lip, G. Y. H. (2022). Risk of Dementia After Smoking Cessation in Patients With Newly Diagnosed Atrial Fibrillation.. JAMA network open, 5(6), e2217132. doi:10.1001/jamanetworkopen.2022.17132DOI: 10.1001/jamanetworkopen.2022.17132
Statins to prevent pacing-induced cardiomyopathy: Evidence from the bench applied to clinical studies. (Journal article)
Lin, Y. -S., Lip, G. Y. H., Ho, W. -C., Shi, C. -S., Lin, M. -H., Kuo, T. -Y., . . . Chen, M. -C. (2022). Statins to prevent pacing-induced cardiomyopathy: Evidence from the bench applied to clinical studies.. Heart rhythm, 19(6), 960-968. doi:10.1016/j.hrthm.2022.01.029DOI: 10.1016/j.hrthm.2022.01.029
The Patient Pathway Review for Atrial Fibrillation. (Journal article)
Kwok, C. S., & Lip, G. Y. H. (2022). The Patient Pathway Review for Atrial Fibrillation.. Critical pathways in cardiology, 21(2), 96-102. doi:10.1097/hpc.0000000000000280DOI: 10.1097/hpc.0000000000000280
Rhee, T. -M., Choi, E. -K., Han, K. -D., Ahn, H. -J., Lee, S. -R., Oh, S., & Lip, G. Y. H. (2022). Type and Severity of Migraine Determines Risk of Atrial Fibrillation in Women.. Frontiers in cardiovascular medicine, 9, 910225. doi:10.3389/fcvm.2022.910225DOI: 10.3389/fcvm.2022.910225
Rivera-Caravaca, J. M., Nunez-Gil, I. J., Lip, G. Y. H., Uribarri, A., Viana-Llamas, M. C., Gonzalez, A., . . . Marin, F. (2022). Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022. doi:10.1155/2022/7325060DOI: 10.1155/2022/7325060
Buckley, B. J. R., de Koning, I. A., Harrison, S. L., Fazio-Eynullayeva, E., Underhill, P., Kemps, H. M. C., . . . Thijssen, D. H. J. (2022). Exercise-based cardiac rehabilitation vs. percutaneous coronary intervention for chronic coronary syndrome: impact on morbidity and mortality. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 29(7), 1074-1080. doi:10.1093/eurjpc/zwab191DOI: 10.1093/eurjpc/zwab191
Harrison, S. L., Buckley, B. J. R., Ritchie, L. A., Proietti, R., Underhill, P., Lane, D. A., & Lip, G. Y. H. (2022). Oral anticoagulants and outcomes in adults >= 80 years with atrial fibrillation: A global federated health network analysis. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. doi:10.1111/jgs.17884DOI: 10.1111/jgs.17884
Kwon, S., Lee, S. -R., Choi, E. -K., Ahn, H. -J., Song, H. -S., Lee, Y. -S., . . . Lip, G. Y. H. (2022). Comparison Between the 24-hour Holter Test and 72-hour Single-Lead Electrocardiogram Monitoring With an Adhesive Patch-Type Device for Atrial Fibrillation Detection: Prospective Cohort Study.. Journal of medical Internet research, 24(5), e37970. doi:10.2196/37970DOI: 10.2196/37970
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI. (Journal article)
Costa, F., Valgimigli, M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., Ten Berg, J. M., . . . Cannon, C. P. (2022). Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI.. European heart journal. Cardiovascular pharmacotherapy, 8(3), 216-226. doi:10.1093/ehjcvp/pvaa135DOI: 10.1093/ehjcvp/pvaa135
Calvert, P., Lip, G. Y. H., & Lane, D. A. (2022). Mental health and anticoagulant prescription in atrial fibrillation. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 8(3), 235-237. doi:10.1093/ehjqcco/qcab085DOI: 10.1093/ehjqcco/qcab085
Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry (Journal article)
Ding, W. Y., Proietti, M., Boriani, G., Fauchier, L., Blomstrom-Lundqvist, C., Marin, F., . . . Lip, G. Y. H. (2022). Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry. EUROPACE, 24(5), 721-728. doi:10.1093/europace/euab280DOI: 10.1093/europace/euab280
Esteve-Pastor, M. A., Ruiz-Ortiz, M., Muñiz, J., Roldán-Rabadán, I., Otero, D., Cequier, Á., . . . Marín, F. (2022). Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry.. Frontiers in cardiovascular medicine, 9, 856222. doi:10.3389/fcvm.2022.856222DOI: 10.3389/fcvm.2022.856222
Li, G., Li, L., Adachi, J. D., Wang, R., Ye, Z., Liu, X., . . . Lip, G. Y. H. (2022). Relationship between Serum 25-Hydroxyvitamin D Level and Risk of Recurrent Stroke. NUTRIENTS, 14(9). doi:10.3390/nu14091908DOI: 10.3390/nu14091908
Søgaard, M., Skjøth, F., Nielsen, P. B., Smit, J., Dalager-Pedersen, M., Larsen, T. B., & Lip, G. Y. H. (2022). Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy.. JAMA network open, 5(5), e2213945. doi:10.1001/jamanetworkopen.2022.13945DOI: 10.1001/jamanetworkopen.2022.13945
Age and Outcomes of Early Rhythm Control in Patients With Atrial Fibrillation Nationwide Cohort Study (Journal article)
Kim, D., Yang, P. -S., You, S. C., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2022). Age and Outcomes of Early Rhythm Control in Patients With Atrial Fibrillation Nationwide Cohort Study. JACC-CLINICAL ELECTROPHYSIOLOGY, 8(5), 619-632. doi:10.1016/j.jacep.2022.02.014DOI: 10.1016/j.jacep.2022.02.014
Appropriate dosing of the individual direct oral anticoagulants in atrial fibrillation: Differences in the questions to be answered. (Journal article)
Rubboli, A., Morici, N., & Lip, G. Y. H. (2022). Appropriate dosing of the individual direct oral anticoagulants in atrial fibrillation: Differences in the questions to be answered.. European journal of internal medicine, 99, 116-117. doi:10.1016/j.ejim.2022.01.014DOI: 10.1016/j.ejim.2022.01.014
Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management. (Journal article)
Obeidat, M., Burgess, M., & Lip, G. Y. H. (2022). Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management.. Cardiology clinics, 40(2), 245-258. doi:10.1016/j.ccl.2021.12.012DOI: 10.1016/j.ccl.2021.12.012
Vitolo, M., Malavasi, V. L., Proietti, M., Diemberger, I., Fauchier, L., Marin, F., . . . ESC-EHRA EORP-AF Long-Term General Registry Investigators. (2022). Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry.. European journal of internal medicine, 99, 45-56. doi:10.1016/j.ejim.2022.01.025DOI: 10.1016/j.ejim.2022.01.025
Comparison of Open, Standard, and Complex Endovascular Aortic Repair Treatments for Juxtarenal/Short Neck Aneurysms: A Systematic Review and Network Meta-Analysis (Journal article)
Patel, S. R., Ormesher, D. C., Griffin, R., Jackson, R. J., Lip, G. Y. H., & Vallabhaneni, S. R. (2022). Comparison of Open, Standard, and Complex Endovascular Aortic Repair Treatments for Juxtarenal/Short Neck Aneurysms: A Systematic Review and Network Meta-Analysis. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 63(5), 696-706. doi:10.1016/j.ejvs.2021.12.042DOI: 10.1016/j.ejvs.2021.12.042
Comparison of the HAS-BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct-acting oral anticoagulants (Journal article)
Wattanaruengchai, P., Nathisuwan, S., Karaketklang, K., Wongcharoen, W., Phrommintikul, A., & Lip, G. Y. H. (2022). Comparison of the HAS-BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct-acting oral anticoagulants. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 88(5), 2203-2212. doi:10.1111/bcp.15145DOI: 10.1111/bcp.15145
Lip, G. Y. H., Kotalczyk, A., Teutsch, C., Diener, H. -C., Dubner, S. J., Halperin, J. L., . . . GLORIA-AF Investigators. (2022). Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.. Clinical research in cardiology : official journal of the German Cardiac Society, 111(5), 593. doi:10.1007/s00392-022-02021-2DOI: 10.1007/s00392-022-02021-2
Huisman, M. V., Teutsch, C., Lu, S., Diener, H. -C., Dubner, S. J., Halperin, J. L., . . . GLORIA-AF Investigators. (2022). Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry.. Clinical research in cardiology : official journal of the German Cardiac Society, 111(5), 548-559. doi:10.1007/s00392-021-01957-1DOI: 10.1007/s00392-021-01957-1
Drug Interactions Affecting Antiarrhythmic Drug Use (Journal article)
Mar, P. L., Horbal, P., Chung, M. K., Dukes, J. W., Ezekowitz, M., Lakkireddy, D., . . . Gopinathannair, R. (2022). Drug Interactions Affecting Antiarrhythmic Drug Use. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 15(5). doi:10.1161/CIRCEP.121.007955DOI: 10.1161/CIRCEP.121.007955
Lip, G. Y. H., Genaidy, A., Tran, G., Marroquin, P., Estes, C., & Sloop, S. (2022). Effects of multimorbidity on incident COVID-19 events and its interplay with COVID-19 event status on subsequent incident myocardial infarction (MI).. European journal of clinical investigation, 52(5), e13760. doi:10.1111/eci.13760DOI: 10.1111/eci.13760
Hermans, A. N. L., Gawalko, M., Dohmen, L., van der Velden, R. M. J., Betz, K., Duncker, D., . . . Linz, D. (2022). Mobile health solutions for atrial fibrillation detection and management: a systematic review. CLINICAL RESEARCH IN CARDIOLOGY, 111(5), 479-491. doi:10.1007/s00392-021-01941-9DOI: 10.1007/s00392-021-01941-9
Buckley, B. J. R., Harrison, S. L., Hill, A., Underhill, P., Lane, D. A., & Lip, G. Y. H. (2022). Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke. STROKE, 53(5), 1759-1763. doi:10.1161/STROKEAHA.121.037316DOI: 10.1161/STROKEAHA.121.037316
Tajik, B., Tuomainen, T. -P., Jarroch, R., Kauhanen, J., Lip, G. Y. H., & Isanejad, M. (2022). Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: A report from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD). Journal of Clinical Lipidology. doi:10.1016/j.jacl.2022.04.003DOI: 10.1016/j.jacl.2022.04.003
Bonini, N., Vitolo, M., Imberti, J. F., Proietti, M., Romiti, G. F., Boriani, G., . . . Lip, G. Y. H. (2022). Mobile health technology in atrial fibrillation. EXPERT REVIEW OF MEDICAL DEVICES. doi:10.1080/17434440.2022.2070005DOI: 10.1080/17434440.2022.2070005
Gooden, T. E., Gardner, M., Wang, J., Jolly, K., Lane, D. A., Benjamin, L. A., . . . Thomas, G. N. (2022). Incidence of Cardiometabolic Diseases in People With and Without Human Immunodeficiency Virus in the United Kingdom: A Population-Based Matched Cohort Study. JOURNAL OF INFECTIOUS DISEASES, 225(8), 1348-1356. doi:10.1093/infdis/jiab420DOI: 10.1093/infdis/jiab420
Symptom Status, Clinical Subtypes, and Prognosis in Patients With Atrial Fibrillation from the Middle East Region (from the Gulf-SAFE Registry). (Journal article)
Xie, P. -X., Li, Y. -G., Alsheikh-Ali, A. A., AlMahmeed, W., Shehab, A., Sulaiman, K., . . . Lip, G. Y. H. (2022). Symptom Status, Clinical Subtypes, and Prognosis in Patients With Atrial Fibrillation from the Middle East Region (from the Gulf-SAFE Registry).. The American journal of cardiology, 169, 57-63. doi:10.1016/j.amjcard.2021.12.060DOI: 10.1016/j.amjcard.2021.12.060
Buckley, B. J. R., Risom, S. S., Boidin, M., Lip, G. Y. H., & Thijssen, D. H. J. (2022). Atrial Fibrillation Specific Exercise Rehabilitation: Are We There Yet?. JOURNAL OF PERSONALIZED MEDICINE, 12(4). doi:10.3390/jpm12040610DOI: 10.3390/jpm12040610
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. (Journal article)
Piccini, J. P., Caso, V., Connolly, S. J., Fox, K. A. A., Oldgren, J., Jones, W. S., . . . PACIFIC-AF Investigators. (2022). Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.. Lancet (London, England), 399(10333), 1383-1390. doi:10.1016/s0140-6736(22)00456-1DOI: 10.1016/s0140-6736(22)00456-1
Galvain, T., Hill, R., Donegan, S., Lisboa, P., Lip, G. Y. H., & Czanner, G. (2022). The management of anticoagulants in patients with atrial fibrillation and history of falls or risk of falls: protocol for a systematic review and meta-analysis. SYSTEMATIC REVIEWS, 11(1). doi:10.1186/s13643-022-01937-0DOI: 10.1186/s13643-022-01937-0
Atrial fibrillation. (Journal article)
Brundel, B. J. J. M., Ai, X., Hills, M. T., Kuipers, M. F., Lip, G. Y. H., & de Groot, N. M. S. (2022). Atrial fibrillation.. Nature reviews. Disease primers, 8(1), 21. doi:10.1038/s41572-022-00347-9DOI: 10.1038/s41572-022-00347-9
Kotalczyk, A., Guo, Y., Stefil, M., Wang, Y., & Lip, G. Y. H. (2022). Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy: A Report From the ChiOTEAF Registry. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 11(7). doi:10.1161/JAHA.121.024319DOI: 10.1161/JAHA.121.024319
Park, S. -H., Lee, S. -R., Choi, E. -K., Lee, H., Chung, J., Choi, J., . . . Lip, G. Y. H. (2022). Low Risk of Dementia in Patients With Newly Diagnosed Atrial Fibrillation and a Clustering of Healthy Lifestyle Behaviors: A Nationwide Population-Based Cohort Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 11(7). doi:10.1161/JAHA.121.023739DOI: 10.1161/JAHA.121.023739
Boulestreau, R., van den Born, B. -J. H., Lip, G. Y. H., & Gupta, A. (2022). Malignant Hypertension: Current Perspectives and Challenges. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 11(7). doi:10.1161/JAHA.121.023397DOI: 10.1161/JAHA.121.023397
Jones, I. D., Lane, D. A., Lotto, R. R., Oxborough, D., Neubeck, L., Penson, P. E., . . . Lip, G. Y. H. (2022). Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF): A Mixed Methods Feasibility Study Protocol. JOURNAL OF PERSONALIZED MEDICINE, 12(4). doi:10.3390/jpm12040578DOI: 10.3390/jpm12040578
Russo, V., Ammendola, E., Gasperetti, A., Bottino, R., Schiavone, M., Masarone, D., . . . Proietti, R. (2022). Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 79(4), 472-478. doi:10.1097/FJC.0000000000001202DOI: 10.1097/FJC.0000000000001202
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply (Journal article)
Vitolo, M., Imberti, J. F., Proietti, M., Lip, G. Y. H., & Boriani, G. (2022). Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 98, 115-116. doi:10.1016/j.ejim.2022.01.032DOI: 10.1016/j.ejim.2022.01.032
Shipley, E., Joddrell, M., Lip, G. Y. H., & Zheng, Y. (n.d.). Bridging the Gap Between Artificial Intelligence Research and Clinical Practice in Cardiovascular Science: What the Clinician Needs to Know. Arrhythmia and Electrophysiology Review, 11. doi:10.15420/aer.2022.07DOI: 10.15420/aer.2022.07
CHA<sub>2</sub>DS<sub>2</sub>-VASc impact on risk following percutaneous coronary intervention in atrial fibrillation (Journal article)
Jensen, T., Thrane, P. G., Olesen, K. K. W., Wurtz, M., Nielsen, J. C., Jensen, L. O., . . . Maeng, M. (2022). CHA<sub>2</sub>DS<sub>2</sub>-VASc impact on risk following percutaneous coronary intervention in atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 52(4). doi:10.1111/eci.13717DOI: 10.1111/eci.13717
Left Atrial Appendage Occlusion-A Choice or a Last Resort? How to Approach the Patient. (Journal article)
Ding, W. Y., Lip, G. Y. H., & Gupta, D. (2022). Left Atrial Appendage Occlusion-A Choice or a Last Resort? How to Approach the Patient.. Interventional cardiology clinics, 11(2), 135-142. doi:10.1016/j.iccl.2021.11.006DOI: 10.1016/j.iccl.2021.11.006
Ording, A. G., Søgaard, M., Nielsen, P. B., Lip, G. Y. H., Larsen, T. B., Grove, E. L., & Skjøth, F. (2022). Oral anti-coagulant treatment patterns in atrial fibrillation patients diagnosed with cancer: A Danish nationwide cohort study.. British journal of haematology, 197(2), 223-231. doi:10.1111/bjh.18060DOI: 10.1111/bjh.18060
Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients (Journal article)
Miguel Rivera-Caravaca, J., Ding, W. Y., Marin, F., Roldan, V., Lip, G. Y. H., Lee, C. J. -Y., & Torp-Pedersen, C. (2022). Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 98, 122-124. doi:10.1016/j.ejim.2021.12.014DOI: 10.1016/j.ejim.2021.12.014
Mertz, V., Cottin, Y., Bentounes, S. A., Pastier-Debeaumarché, J., Didier, R., Herbert, J., . . . Fauchier, L. (2022). Prognosis of Atrial Fibrillation with or without Comorbidities: Analysis of Younger Adults from a Nationwide Database.. Journal of clinical medicine, 11(7), 1981. doi:10.3390/jcm11071981DOI: 10.3390/jcm11071981
Vitalis, A., Nirantharakumar, K., Thayakaran, R., Vohra, R. K., Kay, M., Shantsila, A., & Lip, G. Y. H. (2022). The Impact of Atrial Fibrillation on Outcomes of Peripheral Arterial Disease: Analysis of Routinely Collected Primary Care Data. AMERICAN JOURNAL OF MEDICINE, 135(4), 488-492. doi:10.1016/j.amjmed.2021.10.021DOI: 10.1016/j.amjmed.2021.10.021
Narayan, S. M., Calkins, H., Grace, A., Lip, G. Y., Ellenbogen, K., Lambiase, P. D., & Katritsis, D. G. (2022). What Cannot Be Missed: Important Publications on Electrophysiology in 2021.. Arrhythmia & electrophysiology review, 11, e01. doi:10.15420/aer.2022.04DOI: 10.15420/aer.2022.04
Buckley, B. J. R., Harrison, S. L., Underhill, P., Wright, D. J., Thijssen, D. H. J., & Lip, G. Y. H. (2022). Exercise-based cardiac rehabilitation for cardiac implantable electronic device recipients. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 29(4), E153-E155. doi:10.1093/eurjpc/zwab103DOI: 10.1093/eurjpc/zwab103
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes (vol 117, pg 1, 2021) (Journal article)
Boriani, G., Vitolo, M., Diemberger, I., Proietti, M., Valenti, A. C., Malavasi, V. L., & Lip, G. Y. H. (2022). Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes (vol 117, pg 1, 2021). CARDIOVASCULAR RESEARCH, 118(5), 1374. doi:10.1093/cvr/cvab361DOI: 10.1093/cvr/cvab361
Huang, X., Liu, J., Qi, L., Adachi, J. D., Wu, J., Li, Z., . . . Lip, G. Y. H. (2022). Birth Weight and the Risk of Cardiovascular Outcomes: A Report From the Large Population-Based UK Biobank Cohort Study. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.827491DOI: 10.3389/fcvm.2022.827491
Choi, J., Lee, S. -R., Choi, E. -K., Ahn, H. -J., Kwon, S., Park, S. -H., . . . Lip, G. Y. H. (2022). Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study.. Frontiers in cardiovascular medicine, 9, 832023. doi:10.3389/fcvm.2022.832023DOI: 10.3389/fcvm.2022.832023
Gorog, D. A., Gue, Y. X., Chao, T. -F., Fauchier, L., Ferreiro, J. L., Huber, K., . . . Lip, G. Y. H. (2022). Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society. EUROPACE. doi:10.1093/europace/euac020DOI: 10.1093/europace/euac020
Early Rhythm Control and the Risks of Ischemic Stroke, Heart Failure, Mortality, and Adverse Events When Performed Early (<3 Months): A Nationwide Cohort Study of Newly Diagnosed Patients with Atrial Fibrillation. (Journal article)
Chao, T. -F., Chan, Y. -H., Chiang, C. -E., Tuan, T. -C., Liao, J. -N., Chen, T. -J., . . . Chen, S. -A. (2022). Early Rhythm Control and the Risks of Ischemic Stroke, Heart Failure, Mortality, and Adverse Events When Performed Early (<3 Months): A Nationwide Cohort Study of Newly Diagnosed Patients with Atrial Fibrillation.. Thrombosis and haemostasis, 122(11), 1899-1910. doi:10.1055/a-1807-0336DOI: 10.1055/a-1807-0336
Roldan, V., Martinez-Montesinos, L., Lopez-Galvez, R., Garcia-Tomas, L., Lip, G. Y. H., Miguel Rivera-Caravaca, J., & Marin, F. (2022). Relation of the 'Atrial Fibrillation Better Care (ABC) Pathway' to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists. JOURNAL OF PERSONALIZED MEDICINE, 12(3). doi:10.3390/jpm12030487DOI: 10.3390/jpm12030487
Lip, G. Y. H., Kotalczyk, A., Teutsch, C., Diener, H. -C., Dubner, S. J., Halperin, J. L., . . . GLORIA-AF Investigators. (2022). Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.. Clinical research in cardiology : official journal of the German Cardiac Society. doi:10.1007/s00392-022-01996-2DOI: 10.1007/s00392-022-01996-2
Recommendations from the ICM-VTE: General. (Journal article)
ICM-VTE General Delegates. (2022). Recommendations from the ICM-VTE: General.. The Journal of bone and joint surgery. American volume, 104(Suppl 1), 4-162. doi:10.2106/jbjs.21.01531DOI: 10.2106/jbjs.21.01531
Thoracic aortic aneurysms and atrial fibrillation: commonality in pathophysiological pathways (Journal article)
Proietti, R., Lip, G. Y. H., Akhtar, R., & Field, M. (2022). Thoracic aortic aneurysms and atrial fibrillation: commonality in pathophysiological pathways. CARDIOVASCULAR RESEARCH, 118(4), E32-E35. doi:10.1093/cvr/cvac016DOI: 10.1093/cvr/cvac016
Imberti, J. F., Bonini, N., Tosetti, A., Mei, D. A., Gerra, L., Malavasi, V. L., . . . Boriani, G. (2022). Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation. BIOLOGY-BASEL, 11(3). doi:10.3390/biology11030443DOI: 10.3390/biology11030443
Bayer, V., Kotalczyk, A., Kea, B., Teutsch, C., Larsen, P., Button, D., . . . Olshansky, B. (2022). Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry.. Journal of the American Heart Association, 11(6), e023907. doi:10.1161/jaha.121.023907DOI: 10.1161/jaha.121.023907
Schwarz, G., Banerjee, G., Hostettler, I. C., Ambler, G., Seiffge, D. J., Brookes, T. S., . . . CROMIS-2 investigators. (2022). Magnetic resonance imaging-based scores of small vessel diseases: Associations with intracerebral haemorrhage location.. Journal of the neurological sciences, 434, 120165. doi:10.1016/j.jns.2022.120165DOI: 10.1016/j.jns.2022.120165
A comparison of medical therapy and ablation for atrial fibrillation in patients with heart failure (Journal article)
Calvert, P., Farinha, J. M., Gupta, D., Kahn, M., Proietti, R., & Lip, G. Y. H. (2022). A comparison of medical therapy and ablation for atrial fibrillation in patients with heart failure. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 20(3), 169-183. doi:10.1080/14779072.2022.2050695DOI: 10.1080/14779072.2022.2050695
Ivany, E., Lotto, R., Lip, G. Y., & Lane, D. (2022). Managing uncertainty: Physicians' decision-making for stroke prevention for patients with atrial fibrillation and intracerebral haemorrhage.. Thrombosis and haemostasis. doi:10.1055/a-1789-4824DOI: 10.1055/a-1789-4824
Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs. (Journal article)
Burdett, P., & Lip, G. Y. H. (2022). Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs.. European heart journal. Quality of care & clinical outcomes, 8(2), 187-194. doi:10.1093/ehjqcco/qcaa093DOI: 10.1093/ehjqcco/qcaa093
Miyazawa, K., Pastori, D., Martin, D. T., Choucair, W. K., Halperin, J. L., Lip, G. Y. H., & IMPACT Study Investigators. (2022). Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 24(3), 375-383. doi:10.1093/europace/euab186DOI: 10.1093/europace/euab186
Kotalczyk, A., Guo, Y., Wang, Y., & Lip, G. Y. H. (2022). Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation. JOURNAL OF CLINICAL MEDICINE, 11(5). doi:10.3390/jcm11051370DOI: 10.3390/jcm11051370
"Novel Clinical Concepts in Thrombosis": Integrated Care for Stroke Management-Easy as ABC (Journal article)
Lip, G. Y. H., & Ntaios, G. (2022). "Novel Clinical Concepts in Thrombosis": Integrated Care for Stroke Management-Easy as ABC. THROMBOSIS AND HAEMOSTASIS, 122(03), 316-319. doi:10.1055/a-1632-1777DOI: 10.1055/a-1632-1777
Romiti, G. F., Pastori, D., Rivera-Caravaca, J. M., Ding, W. Y., Gue, Y. X., Menichelli, D., . . . Proietti, M. (2022). Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients. THROMBOSIS AND HAEMOSTASIS, 122(03), 406-414. doi:10.1055/a-1515-9630DOI: 10.1055/a-1515-9630
Harrison, S. L., Buckley, B. J. R., Proietti, R., & Lip, G. Y. H. (2022). Atrial Fibrillation Diagnosed following Stroke: Dealing with a New Clinical Entity or Just a Matter of Definition?. CEREBROVASCULAR DISEASES, 51(2), 149-151. doi:10.1159/000520667DOI: 10.1159/000520667
Bikdeli, B., Moustafa, F., Nieto, J. A., Lee, A. I., Ruíz-Giménez, N., Lorenzo, A., . . . RIETE Investigators. (2022). Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism.. Thrombosis research, 211, 10-18. doi:10.1016/j.thromres.2022.01.007DOI: 10.1016/j.thromres.2022.01.007
Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis. (Journal article)
Escobar, C., Barrios, V., Lip, G. Y. H., Amin, A. N., Auladell-Rispau, A., Santero, M., . . . Requeijo, C. (2022). Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis.. Clinical drug investigation, 42(3), 279-280. doi:10.1007/s40261-022-01126-wDOI: 10.1007/s40261-022-01126-w
Hypertension control and end-stage renal disease in atrial fibrillation: a nationwide population-based cohort study (Journal article)
Kwon, S., Lee, S. -R., Choi, E. -K., Jung, J. -H., Han, K. -D., Oh, S., & Lip, G. Y. H. (2022). Hypertension control and end-stage renal disease in atrial fibrillation: a nationwide population-based cohort study. CLINICAL RESEARCH IN CARDIOLOGY, 111(3), 284-293. doi:10.1007/s00392-021-01899-8DOI: 10.1007/s00392-021-01899-8
Campbell, N. G., Wollborn, J., Fields, K. G., Lip, G. Y. H., Ruetzler, K., Muehlschlegel, J. D., & O'Brien, B. (2022). Inconsistent Methodology as a Barrier to Meaningful Research Outputs From Studies of Atrial Fibrillation After Cardiac Surgery.. Journal of cardiothoracic and vascular anesthesia, 36(3), 739-745. doi:10.1053/j.jvca.2021.10.009DOI: 10.1053/j.jvca.2021.10.009
Tajik, B., Voutilainen, A., Kauhanen, J., Mazidi, M., Lip, G. Y. H., Tuomainen, T. -P., & Isanejad, M. (2022). Lipid profile, lipid ratios, apolipoproteins, and risk of cardiometabolic multimorbidity in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. LIPIDS, 57(2), 141-149. doi:10.1002/lipd.12337DOI: 10.1002/lipd.12337
Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study (Journal article)
Li, G., Zhang, X., Liu, Y., Zhang, J., Li, L., Huang, X., . . . Lip, G. Y. H. (2022). Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study. EUROPEAN RESPIRATORY JOURNAL, 59(3). doi:10.1183/13993003.01399-2021DOI: 10.1183/13993003.01399-2021
Sanders, A., El-Bouri, W. K., Lip, G. Y. H., & *BBC-VTE investigators. (2022). The Birmingham and Black Country cohort of Venous Thromboembolism (BBC-VTE) registry: Rationale, design and preliminary results.. European journal of internal medicine, 97, 50-55. doi:10.1016/j.ejim.2022.01.022DOI: 10.1016/j.ejim.2022.01.022
The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B. (Journal article)
Webb, R. J., Mazidi, M., Lip, G. Y. H., Kengne, A. P., Banach, M., & Davies, I. G. (2022). The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B.. Nutrition, metabolism, and cardiovascular diseases : NMCD, 32(3), 605-615. doi:10.1016/j.numecd.2021.12.004DOI: 10.1016/j.numecd.2021.12.004
Zhang, J., Bisson, A., Fauchier, G., Bodin, A., Herbert, J., Ducluzeau, P. H., . . . Fauchier, L. (2022). Yearly Incidence of Stroke and Bleeding in Atrial Fibrillation with Concomitant Hyperthyroidism: A National Discharge Database Study. JOURNAL OF CLINICAL MEDICINE, 11(5). doi:10.3390/jcm11051342DOI: 10.3390/jcm11051342
Ding, W. Y., Protty, M. B., Davies, I. G., & Lip, G. Y. H. (2022). Relationship between lipoproteins, thrombosis, and atrial fibrillation. CARDIOVASCULAR RESEARCH, 118(3), 716-731. doi:10.1093/cvr/cvab017DOI: 10.1093/cvr/cvab017
Buckley, B. J. R., Harrison, S. L., Fazio-Eynullayeva, E., Underhill, P., Jones, I. D., Williams, N., & Lip, G. Y. H. (2022). Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 29(1), E32-E34. doi:10.1093/eurjpc/zwaa135DOI: 10.1093/eurjpc/zwaa135
Farinha, J. M., Jones, I. D., & Lip, G. Y. H. (2022). Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation.. European heart journal supplements : journal of the European Society of Cardiology, 24(Suppl A), A42-A55. doi:10.1093/eurheartj/suab152DOI: 10.1093/eurheartj/suab152
Malavasi, V. L., Valenti, A. C., Ruggerini, S., Manicardi, M., Orlandi, C., Sgreccia, D., . . . Boriani, G. (2022). Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome. JOURNAL OF CLINICAL MEDICINE, 11(3). doi:10.3390/jcm11030891DOI: 10.3390/jcm11030891
Kim, M. -H., Sung, J. -H., Jin, M. -N., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2022). Impact of Physical Activity on All-Cause Mortality According to Specific Cardiovascular Disease. FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. doi:10.3389/fcvm.2022.811058DOI: 10.3389/fcvm.2022.811058
Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis (Journal article)
Zhang, N., Wang, Y., Tse, G., Korantzopoulos, P., Letsas, K. P., Zhang, Q., . . . Liu, T. (2022). Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 28(17), 1961-1973. doi:10.1093/eurjpc/zwab173DOI: 10.1093/eurjpc/zwab173
Role of cardiorespiratory fitness in cancer development: time for an update (Journal article)
Boidin, M., Lip, G. Y. H., & Thijssen, D. (2022). Role of cardiorespiratory fitness in cancer development: time for an update. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 28(17), E14-E16. doi:10.1177/2047487320935228DOI: 10.1177/2047487320935228
Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry (Journal article)
Miguel Rivera-Caravaca, J., Piot, O., Roldan-Rabadan, I., Denis, A., Anguita, M., Mansourati, J., . . . Marin, F. (2022). Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry. EUROPACE, 24(2), 202-210. doi:10.1093/europace/euab202DOI: 10.1093/europace/euab202
Warfarin and increased fracture risk? Answering the big question (Journal article)
Fawzy, A. M., & Lip, G. Y. H. (2022). Warfarin and increased fracture risk? Answering the big question. AGE AND AGEING, 51(2). doi:10.1093/ageing/afab263DOI: 10.1093/ageing/afab263
Krzemien, P., Kasperczyk, S., Banach, M., Kasperczyk, A., Dobrakowski, M., Tomasik, T., . . . Jozwiak, J. J. (2022). Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study. RHEUMATOLOGY INTERNATIONAL, 42(2), 261-271. doi:10.1007/s00296-021-05033-9DOI: 10.1007/s00296-021-05033-9
Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration (Journal article)
Rivard, L., Friberg, L., Conen, D., Healey, J. S., Berge, T., Boriani, G., . . . Freedman, B. (2022). Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. CIRCULATION, 145(5), 392-409. doi:10.1161/CIRCULATIONAHA.121.055018DOI: 10.1161/CIRCULATIONAHA.121.055018
Park, J., Jung, J. -H., Choi, E. -K., Lee, S. -W., Kwon, S., Lee, S. -R., . . . Lip, G. Y. H. (2022). Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. PLOS ONE, 17(2). doi:10.1371/journal.pone.0264538DOI: 10.1371/journal.pone.0264538
Chan, Y. -H., Chao, T. -F., Lee, H. -F., Yeh, Y. -H., Chang, S. -H., Kuo, C. -T., . . . Chen, S. -A. (2022). Different Renal Function Equations and Dosing of Direct Oral Anticoagulants in Atrial Fibrillation.. JACC. Asia, 2(1), 46-58. doi:10.1016/j.jacasi.2021.11.006DOI: 10.1016/j.jacasi.2021.11.006
ER stress in obesity pathogenesis and management. (Journal article)
Ajoolabady, A., Liu, S., Klionsky, D. J., Lip, G. Y. H., Tuomilehto, J., Kavalakatt, S., . . . Ren, J. (2022). ER stress in obesity pathogenesis and management.. Trends in pharmacological sciences, 43(2), 97-109. doi:10.1016/j.tips.2021.11.011DOI: 10.1016/j.tips.2021.11.011
Integrated Care Systems and the Aortovascular Hub (Journal article)
Field, M., Kuduvalli, M., Torella, F., McKay, V., Khalatbari, A., & Lip, G. Y. H. (2022). Integrated Care Systems and the Aortovascular Hub. THROMBOSIS AND HAEMOSTASIS, 122(02), 177-180. doi:10.1055/a-1591-8033DOI: 10.1055/a-1591-8033
Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation (Journal article)
Fauchier, L., Bisson, A., Bodin, A., Herbert, J., Spiesser, P., Pierre, B., . . . Lip, G. Y. H. (2022). Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation. STROKE, 53(2), 497-504. doi:10.1161/STROKEAHA.121.034213DOI: 10.1161/STROKEAHA.121.034213
Melatonin-based therapeutics for atherosclerotic lesions and beyond: Focusing on macrophage mitophagy (Journal article)
Ajoolabady, A., Bi, Y., McClements, D. J., Lip, G. Y. H., Richardson, D. R., Reiter, R. J., . . . Ren, J. (2022). Melatonin-based therapeutics for atherosclerotic lesions and beyond: Focusing on macrophage mitophagy. PHARMACOLOGICAL RESEARCH, 176. doi:10.1016/j.phrs.2022.106072DOI: 10.1016/j.phrs.2022.106072
Not All Constipation is Created Equal Reply (Journal article)
Vitalis, A., Shantsila, A., & Lip, G. Y. H. (2022). Not All Constipation is Created Equal Reply. AMERICAN JOURNAL OF MEDICINE, 135(2), 59-60. doi:10.1016/j.amjmed.2021.09.019DOI: 10.1016/j.amjmed.2021.09.019
Relationship between Chronic Kidney Disease, Time-in-Therapeutic Range, and Adverse Outcomes in Atrial Fibrillation: A post hoc Analysis from the AMADEUS Trial (Journal article)
Ding, W. Y., Lip, G. Y. H., & Shantsila, A. (2022). Relationship between Chronic Kidney Disease, Time-in-Therapeutic Range, and Adverse Outcomes in Atrial Fibrillation: A post hoc Analysis from the AMADEUS Trial. CEREBROVASCULAR DISEASES, 51(1), 29-35. doi:10.1159/000517608DOI: 10.1159/000517608
Kotalczyk, A., Imberti, J. F., Lip, G. Y. H., & Wright, D. J. (2022). Telemedical Monitoring Based on Implantable Devices-the Evolution Beyond the CardioMEMS™ Technology. CURRENT HEART FAILURE REPORTS, 19(1), 7-14. doi:10.1007/s11897-021-00537-8DOI: 10.1007/s11897-021-00537-8
Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2022). Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022. doi:10.1155/2022/5951262DOI: 10.1155/2022/5951262
Guo, Y., Imberti, J. F., Kotalczyk, A., Wang, Y., Lip, G. Y. H., & ChiOTEAF Registry Investigators. (2022). 4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients.. European journal of clinical investigation, e13751. doi:10.1111/eci.13751DOI: 10.1111/eci.13751
Banach, M., Shekoohi, N., Mikhailidis, D. P., Lip, G. Y. H., Hernandez, A. V., & Mazidi, M. (2022). Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (<i>n</i> = 355,591) and randomized controlled trials (<i>n</i> = 165,988).. Archives of medical science : AMS, 18(4), 912-929. doi:10.5114/aoms/145970DOI: 10.5114/aoms/145970
Mazidi, M., Webb, R. J., Lip, G. Y. H., Kengne, A. P., Banach, M., & Davies, I. G. (2022). Discordance between LDL-C and Apolipoprotein B Levels and Its Association with Renal Dysfunction: Insights from a Population-Based Study. JOURNAL OF CLINICAL MEDICINE, 11(2). doi:10.3390/jcm11020313DOI: 10.3390/jcm11020313
Ding, W. Y., Potpara, T. S., Blomstrom-Lundqvist, C., Boriani, G., Marin, F., Fauchier, L., . . . Reg, E. S. C. -E. H. R. A. E. O. R. P. -A. F. L. -T. G. (2022). Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. doi:10.1111/eci.13745DOI: 10.1111/eci.13745
INSPIRATION-S Investigators. (2022). Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial.. BMJ (Clinical research ed.), 376, e068407. doi:10.1136/bmj-2021-068407DOI: 10.1136/bmj-2021-068407
Ding, W. Y., Rivera-Caravaca, J. M., Fazio-Eynullayeva, E., Underhill, P., Gupta, D., Marin, F., & Lip, G. Y. H. (2022). Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation. CLINICAL RESEARCH IN CARDIOLOGY. doi:10.1007/s00392-021-01983-zDOI: 10.1007/s00392-021-01983-z
Association of rhythm control with incident dementia among patients with atrial fibrillation: a nationwide population-based cohort study (Journal article)
Kim, D., Yang, P. -S., You, S. C., Sung, J. -H., Jang, E., Yu, H. T., . . . Joung, B. (2022). Association of rhythm control with incident dementia among patients with atrial fibrillation: a nationwide population-based cohort study. AGE AND AGEING, 51(1). doi:10.1093/ageing/afab248DOI: 10.1093/ageing/afab248
Association between sodium-glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials (Journal article)
Sfairopoulos, D., Zhang, N., Wang, Y., Chen, Z., Letsas, K. P., Tse, G., . . . Korantzopoulos, P. (2022). Association between sodium-glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials. EUROPACE, 24(1), 20-+. doi:10.1093/europace/euab177DOI: 10.1093/europace/euab177
Kozieł-Siołkowska, M., Mihajlovic, M., Nedeljkovic, M., Pavlovic, N., Paparisto, V., Music, L., . . . Potpara, T. S. (2022). Adherence to the 4S-AF Scheme in the Balkan region: Insights from the BALKAN-AF survey.. Kardiologia polska, 80(4), 461-467. doi:10.33963/kp.a2022.0053DOI: 10.33963/kp.a2022.0053
Park, Y. J., Yang, P. -S., Yu, H. T., Kim, T. -H., Jang, E., Uhm, J. -S., . . . Joung, B. (2022). Association of proteinuria and hypertension with incident atrial fibrillation in an elderly population: nationwide data from a community-based elderly cohort. JOURNAL OF HYPERTENSION, 40(1), 128-135. doi:10.1097/HJH.0000000000002987DOI: 10.1097/HJH.0000000000002987
Zhang, Z., Jiang, C., He, L., Bai, Y., Wu, J., Hu, R., . . . Ma, C. (2022). Associations of anemia with death and major bleeding in patients with atrial fibrillation: A report from the Chinese Atrial Fibrillation Registry Study. CLINICAL CARDIOLOGY, 45(1), 91-100. doi:10.1002/clc.23764DOI: 10.1002/clc.23764
Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry (Journal article)
Temporelli, P. L., Arbelo, E., Laroche, C., Blomstrom-Lundqvist, C., Kirchhof, P., Lip, G. Y. H., . . . Tavazzi, L. (2022). Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 346, 19-26. doi:10.1016/j.ijcard.2021.11.010DOI: 10.1016/j.ijcard.2021.11.010
Cardiovascular Disorders (Chapter)
Shantsila, E., Shantsila, A., Dzeshka, M. S., & Lip, G. Y. H. (2022). Cardiovascular Disorders. In Textbook of Occupational Medicine Practice (pp. 463-504). WORLD SCIENTIFIC. doi:10.1142/9789811245657_0012DOI: 10.1142/9789811245657_0012
Bai, Y., Luo, S. -Q., Liu, S. -T., Gong, L., Zhong, P., Wang, Z. -Z., . . . Guo, W. -H. (2022). Clinical Features Associated with 'Normal Range' Fibrin D-Dimer Levels in Atrial Fibrillation Patients with Left Atrial Thrombus. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 28. doi:10.1177/10760296221133380DOI: 10.1177/10760296221133380
Clinical utility and prognostic implications of the 4S-AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry. (Journal article)
Chao, T. -F., Tse, H. -F., Teo, W. -S., Park, H. -W., Shimizu, W., Chen, S. -A., . . . Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. (2022). Clinical utility and prognostic implications of the 4S-AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry.. European journal of clinical investigation, 52(10), e13825. doi:10.1111/eci.13825DOI: 10.1111/eci.13825
Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation (Journal article)
Chao, T. -F., Chan, Y. -H., Chiang, C. -E., Tuan, T. -C., Liao, J. -N., Chen, T. -J., . . . Chen, S. -A. (2022). Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation. CLINICAL RESEARCH IN CARDIOLOGY, 111(1), 23-33. doi:10.1007/s00392-021-01816-zDOI: 10.1007/s00392-021-01816-z
Embedded-EEPROM descrambling via laser-based techniques – A case study on AVR MCU (Conference Paper)
Chef, S., Tah, C. C., Yun Tay, J., Cheah, J., & Gan, C. L. (2022). Embedded-EEPROM descrambling via laser-based techniques – A case study on AVR MCU. In 2022 Workshop on Fault Detection and Tolerance in Cryptography (FDTC). IEEE. doi:10.1109/fdtc57191.2022.00010DOI: 10.1109/fdtc57191.2022.00010
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. (Journal article)
Verma, S., Dhingra, N. K., Butler, J., Anker, S. D., Ferreira, J. P., Filippatos, G., . . . EMPEROR-Reduced trial committees and investigators. (2022). Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.. The lancet. Diabetes & endocrinology, 10(1), 35-45. doi:10.1016/s2213-8587(21)00292-8DOI: 10.1016/s2213-8587(21)00292-8
Ording, A. G., Søgaard, M., Skjøth, F., Grove, E. L., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2022). Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer.. Research and practice in thrombosis and haemostasis, 6(1), e12629. doi:10.1002/rth2.12629DOI: 10.1002/rth2.12629
Wang, Y. -F., Jiang, C., He, L., Du, X., Sang, C. -H., Long, D. -Y., . . . Ma, C. -S. (2021). Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry. FRONTIERS IN CARDIOVASCULAR MEDICINE, 8. doi:10.3389/fcvm.2021.762245DOI: 10.3389/fcvm.2021.762245
Vinter, N., Cordsen, P., Lip, G. Y. H., Benjamin, E. J., Johnsen, S. P., Frost, L., & Trinquart, L. (2022). Life-Years Lost After Newly Diagnosed Atrial Fibrillation in Patients with Heart Failure.. Clinical epidemiology, 14, 711-720. doi:10.2147/clep.s365706DOI: 10.2147/clep.s365706
Management of cardiovascular complications of bruton tyrosine kinase inhibitors (Journal article)
Tang, C. P. S., Lip, G. Y. H., McCormack, T., Lyon, A. R., Hillmen, P., Iyengar, S., . . . Walewska, R. (2022). Management of cardiovascular complications of bruton tyrosine kinase inhibitors. BRITISH JOURNAL OF HAEMATOLOGY, 196(1), 70-78. doi:10.1111/bjh.17788DOI: 10.1111/bjh.17788
Modelling Virchow's Triad to Improve Stroke Risk Assessment in Atrial Fibrillation Patients (Conference Paper)
Qureshi, A., Balmus, M., E. Williams, S., Y. H. Lip, G., A. Nordsletten, D., Aslanidi, O., & de Vecchi", A. (n.d.). Modelling Virchow's Triad to Improve Stroke Risk Assessment in Atrial Fibrillation Patients. In Computing in Cardiology Conference (CinC). Computing in Cardiology. doi:10.22489/cinc.2022.378DOI: 10.22489/cinc.2022.378
Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world <i>vs</i>. clinical-trial evidence (Journal article)
Ding, W. Y., Miguel Rivera-Caravaca, J., Marin, F., Li, G., Roldan, V., & Lip, G. Y. H. (2022). Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world <i>vs</i>. clinical-trial evidence. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 88(1), 282-289. doi:10.1111/bcp.14961DOI: 10.1111/bcp.14961
Polymeris, A. A., Macha, K., Paciaroni, M., Wilson, D., Koga, M., Cappellari, M., . . . Engelter, S. T. (2022). Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation. ANNALS OF NEUROLOGY, 91(1), 78-88. doi:10.1002/ana.26267DOI: 10.1002/ana.26267
Stefil, M., Dixon, M., Bahar, J., Saied, S., Mashida, K., Heron, O., . . . Sankaranarayanan, R. (2022). Polypharmacy in Older People With Heart Failure: Roles of the Geriatrician and Pharmacist.. Cardiac failure review, 8, e34. doi:10.15420/cfr.2022.14DOI: 10.15420/cfr.2022.14
Proietti, M., Vitolo, M., Harrison, S. L., Lane, D. A., Fauchier, L., Marin, F., . . . Lip, G. Y. H. (2022). Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry. CLINICAL RESEARCH IN CARDIOLOGY, 111(1), 70-84. doi:10.1007/s00392-021-01914-yDOI: 10.1007/s00392-021-01914-y
Krzemien, P., Kasperczyk, S., Banach, M., Kasperczyk, A., Dobrakowski, M., Tomasik, T., . . . Jozwiak, J. J. (2022). Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress. BIOMARKER INSIGHTS, 17. doi:10.1177/11772719211066791DOI: 10.1177/11772719211066791
Reply to 'Digoxin and beta-blockers in patients with heart failure'. Letter regarding the article 'Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure' (Journal article)
Fauchier, L., Bisson, A., & Lip, G. Y. H. (2022). Reply to 'Digoxin and beta-blockers in patients with heart failure'. Letter regarding the article 'Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure'. EUROPEAN JOURNAL OF HEART FAILURE, 24(1), 239-241. doi:10.1002/ejhf.2389DOI: 10.1002/ejhf.2389
Li, M., Shi, J., Chu, M., Shen, Y., Zhang, S., Sun, X., . . . Chen, M. (2022). Screening for Atrial Fibrillation by Village Doctors in Rural Areas of China: The Jiangsu Province Rural Community AF Project.. Vascular health and risk management, 18, 757-766. doi:10.2147/vhrm.s379182DOI: 10.2147/vhrm.s379182
Selective Staining on Non-Volatile Memory Cells for Data Retrieval (Journal article)
Zeng, X. M., Liu, Q., Tay, J. Y., & Gan, C. L. (2022). Selective Staining on Non-Volatile Memory Cells for Data Retrieval. IEEE Transactions on Information Forensics and Security, 17, 1884-1892. doi:10.1109/tifs.2022.3172222DOI: 10.1109/tifs.2022.3172222
Harrison, S. L., Lane, D. A., Buckley, B. J. R., Chatterjee, K., Alobaida, M., Shipley, E., & Lip, G. Y. H. (2022). The Liverpool Heart And bRain Project (L-HARP): Protocol for an Observational Cohort Study of Cardiovascular Risk and Outcomes Following Stroke. VASCULAR HEALTH AND RISK MANAGEMENT, 18, 313-318. doi:10.2147/VHRM.S357829DOI: 10.2147/VHRM.S357829
Goulart, A. C., Olmos, R. D., Santos, I. S., Tunes, G., Alencar, A. P., Thomas, N., . . . Bensenor, I. M. (2022). The impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality: A 12-year evaluation of the prospective Brazilian Study of Stroke Mortality and Morbidity. INTERNATIONAL JOURNAL OF STROKE, 17(1), 48-58. doi:10.1177/1747493021995592DOI: 10.1177/1747493021995592
Aldosari, H., Coenen, F., Lip, G., & Zheng, Y. (2022). Two-dimensional Motif Extraction from Images: A Study using an Electrocardiogram. In Proceedings of the 14th International Joint Conference on Knowledge Discovery, Knowledge Engineering and Knowledge Management. SCITEPRESS - Science and Technology Publications. doi:10.5220/0011380500003335DOI: 10.5220/0011380500003335
2021
Drozdz, K., Nabrdalik, K., Hajzler, W., Kwiendacz, H., Gumprecht, J., & Lip, G. Y. H. (2022). Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota. NUTRIENTS, 14(1). doi:10.3390/nu14010103DOI: 10.3390/nu14010103
Kim, D., Yang, P. -S., You, S. C., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2021). Comparative Effectiveness of Early Rhythm Control Versus Rate Control for Cardiovascular Outcomes in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 10(24). doi:10.1161/JAHA.121.023055DOI: 10.1161/JAHA.121.023055
Banerjee, A., Chen, S., Pasea, L., Lai, A. G., Katsoulis, M., Denaxas, S., . . . Hemingway, H. (2021). Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 28(14), 1599-1608. doi:10.1093/eurjpc/zwaa155DOI: 10.1093/eurjpc/zwaa155
Stevens, D., Lane, D. A., Harrison, S. L., Lip, G. Y. H., & Kolamunnage-Dona, R. (2021). Modelling of longitudinal data to predict cardiovascular disease risk: a methodological review. BMC MEDICAL RESEARCH METHODOLOGY, 21(1). doi:10.1186/s12874-021-01472-xDOI: 10.1186/s12874-021-01472-x
Gue, Y. X., Bisson, A., Bodin, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2021). Season of Birth and Cardiovascular Mortality in Atrial Fibrillation: A Population-Based Cohort Study. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 8(12). doi:10.3390/jcdd8120177DOI: 10.3390/jcdd8120177
Buckley, B. J. R., Harrison, S. L., Gupta, D., Fazio-Eynullayeva, E., Underhill, P., & Lip, G. Y. H. (2021). Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real-World Data. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 10(23). doi:10.1161/JAHA.121.021970DOI: 10.1161/JAHA.121.021970
Melgaard, L., Overvad, T. F., Jensen, M., Christensen, T. D., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2021). Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 10(23). doi:10.1161/JAHA.121.022628DOI: 10.1161/JAHA.121.022628
Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study (Journal article)
Lee, S. R., Choi, E. K., Jung, J. H., Han, K. D., Oh, S., & Lip, G. Y. H. (2021). Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study. EUROPEAN HEART JOURNAL, 42, 335. Retrieved from https://www.webofscience.com/
Chao, T. -F., Joung, B., Takahashi, Y., Lim, T. W., Choi, E. -K., Chan, Y. -H., . . . Lip, G. Y. H. (2021). 2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation.. Journal of arrhythmia, 37(6), 1389-1426. doi:10.1002/joa3.12652DOI: 10.1002/joa3.12652
CMOS-Compatible Ti/TiN/Al Refractory Ohmic Contact for GaAs Heterojunction Bipolar Transistors Grown on Ge/Si Substrate (Journal article)
Wang, Y., Loke, W. K., Gao, Y., Lee, K. H., Kian Lee, K. E., Gan, C. L., . . . Yoon, S. F. (2021). CMOS-Compatible Ti/TiN/Al Refractory Ohmic Contact for GaAs Heterojunction Bipolar Transistors Grown on Ge/Si Substrate. IEEE Transactions on Electron Devices, 68(12), 6065-6068. doi:10.1109/ted.2021.3119557DOI: 10.1109/ted.2021.3119557
Cardiovascular disease prevention: Risk factor modification at the heart of the matter (Journal article)
Fawzy, A. M., & Lip, G. Y. H. (2021). Cardiovascular disease prevention: Risk factor modification at the heart of the matter. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 17. doi:10.1016/j.lanwpc.2021.100291DOI: 10.1016/j.lanwpc.2021.100291
Crizanlizumab A CRITICAL Drug During a CRITICAL Time? (Journal article)
Gue, Y. X., Pula, G., & Lip, G. Y. H. (2021). Crizanlizumab A CRITICAL Drug During a CRITICAL Time?. JACC-BASIC TO TRANSLATIONAL SCIENCE, 6(12), 946-947. doi:10.1016/j.jacbts.2021.10.013DOI: 10.1016/j.jacbts.2021.10.013
In ACS, de-escalation of DAPT reduces bleeding and does not increase ischemic events vs. other DAPT strategies (Journal article)
Fawzy, A. M., & Lip, G. Y. H. (2021). In ACS, de-escalation of DAPT reduces bleeding and does not increase ischemic events vs. other DAPT strategies. ANNALS OF INTERNAL MEDICINE, 174(12), JC138. doi:10.7326/ACPJ202112210-138DOI: 10.7326/ACPJ202112210-138
Byrne, C., Pareek, M., Krogager, M. L., Ringgren, K. B., Wissenberg, M., Folke, F., . . . Kragholm, K. (2021). Increased 5-year risk of stroke, atrial fibrillation, acute coronary syndrome, and heart failure in out- of-hospital cardiac arrest survivors compared with population controls: A nationwide registry-based study. RESUSCITATION, 169, 53-59. doi:10.1016/j.resuscitation.2021.10.024DOI: 10.1016/j.resuscitation.2021.10.024
Increased risk of ischemic stroke and systemic embolism in hyperthyroidism-related atrial fibrillation: A nationwide cohort study (Journal article)
Kim, K., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2021). Increased risk of ischemic stroke and systemic embolism in hyperthyroidism-related atrial fibrillation: A nationwide cohort study. AMERICAN HEART JOURNAL, 242, 123-131. doi:10.1016/j.ahj.2021.08.018DOI: 10.1016/j.ahj.2021.08.018
Vinter, N., Cordsen, P., Lip, G. Y. H., Benjamin, E. J., Trinquart, L., Johnsen, S. P., & Frost, L. (2021). Newly diagnosed atrial fibrillation and hospital utilization in heart failure: a nationwide cohort study. ESC HEART FAILURE, 8(6), 4808-4819. doi:10.1002/ehf2.13668DOI: 10.1002/ehf2.13668
Guo, Y., Wang, H., Zhang, H., Liu, T., Li, L., Liu, L., . . . Lip, G. Y. H. (2021). Photoplethysmography-Based Machine Learning Approaches for Atrial Fibrillation Prediction: A Report From the Huawei Heart Study.. JACC. Asia, 1(3), 399-408. doi:10.1016/j.jacasi.2021.09.004DOI: 10.1016/j.jacasi.2021.09.004
Yao, Y., Guo, Y., & Lip, G. Y. H. (2021). The Effects of Implementing a Mobile Health-Technology Supported Pathway on Atrial Fibrillation-Related Adverse Events Among Patients With Multimorbidity The mAFA-II Randomized Clinical Trial. JAMA NETWORK OPEN, 4(12). doi:10.1001/jamanetworkopen.2021.40071DOI: 10.1001/jamanetworkopen.2021.40071
Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials (Journal article)
Talasaz, A. H., Sadeghipour, P., Aghakouchakzadeh, M., Kakavand, H., Ariannejad, H., Connors, J. M., . . . Bikdeli, B. (2021). Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 19(12), 3080-3089. doi:10.1111/jth.15533DOI: 10.1111/jth.15533
Studzinski, K., Tomasik, T., Windak, A., Banach, M., Wojtowicz, E., Mastej, M., . . . Jozwiak, J. J. (2021). The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study. JOURNAL OF CLINICAL MEDICINE, 10(23). doi:10.3390/jcm10235656DOI: 10.3390/jcm10235656
Sagris, D., Georgiopoulos, G., Pateras, K., Perlepe, K., Korompoki, E., Milionis, H., . . . Ntaios, G. (2021). Atrial High-Rate Episode Duration Thresholds and Thromboembolic Risk: A Systematic Review and Meta-Analysis. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 10(22). doi:10.1161/JAHA.121.022487DOI: 10.1161/JAHA.121.022487
Atrial fibrillation and cognitive decline: it takes more than an irregular heart beat, to beat the brain (Journal article)
Sagris, D., & Lip, G. Y. H. (2021). Atrial fibrillation and cognitive decline: it takes more than an irregular heart beat, to beat the brain. AGE AND AGEING, 50(6), 1891-1893. doi:10.1093/ageing/afab158DOI: 10.1093/ageing/afab158
Alsharari, R., Shantsila, E., Lip, G. Y. H., & Shantsila, A. (2021). Revisiting the diagnosis of 'resistant hypertension': what should we do nowadays'. JOURNAL OF HUMAN HYPERTENSION. doi:10.1038/s41371-021-00631-3DOI: 10.1038/s41371-021-00631-3
Biomarkers for Atrial Fibrillation Detection After Stroke Systematic Review and Meta-analysis (Journal article)
Cameron, A., Cheng, H. K., Lee, R. -P., Doherty, D., Hall, M., Khashayar, P., . . . Dawson, J. (2021). Biomarkers for Atrial Fibrillation Detection After Stroke Systematic Review and Meta-analysis. NEUROLOGY, 97(18), E1775-E1789. doi:10.1212/WNL.0000000000012769DOI: 10.1212/WNL.0000000000012769
Calvert, P., Gupta, D., & Lip, G. Y. H. (2021). Antithrombotic therapy in chronic liver disease: to clot or not to clot. LANCET REGIONAL HEALTH-EUROPE, 10. doi:10.1016/j.lanepe.2021.100226DOI: 10.1016/j.lanepe.2021.100226
Atrial fibrillation in the presence of chronic kidney disease: To ablation or not to ablate (Journal article)
Ding, W. Y., Gupta, D., Wong, C. F., & Lip, G. Y. H. (2021). Atrial fibrillation in the presence of chronic kidney disease: To ablation or not to ablate. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 75(11). doi:10.1111/ijcp.14723DOI: 10.1111/ijcp.14723
Beyond atrial fibrillation detection: how digital tools impact the care of patients with atrial fibrillation (Journal article)
Guo, Y., & Lip, G. Y. H. (2021). Beyond atrial fibrillation detection: how digital tools impact the care of patients with atrial fibrillation. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 93, 117-118. doi:10.1016/j.ejim.2021.08.026DOI: 10.1016/j.ejim.2021.08.026
COVID-19 and ischemic stroke (Journal article)
Sagris, D., Papanikolaou, A., Kvernland, A., Korompoki, E., Frontera, J. A., Troxel, A. B., . . . Ntaios, G. (2021). COVID-19 and ischemic stroke. EUROPEAN JOURNAL OF NEUROLOGY, 28(11), 3826-3836. doi:10.1111/ene.15008DOI: 10.1111/ene.15008
Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation (Journal article)
Lee, S. -R., Choi, E. -K., Park, S. -H., Jung, J. -H., Han, K. -D., Oh, S., & Lip, G. Y. H. (2021). Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation. STROKE, 52(11), 3459-3468. doi:10.1161/STROKEAHA.120.033338DOI: 10.1161/STROKEAHA.120.033338
Erkuner, O., van Eck, M., Xhaet, O., Verheij, H., Neefs, J., Duygun, A., . . . Mairesse, G. H. (2021). Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry. NETHERLANDS HEART JOURNAL, 29(11), 584-594. doi:10.1007/s12471-021-01634-yDOI: 10.1007/s12471-021-01634-y
Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis (Journal article)
Escobar, C., Barrios, V., Lip, G. Y. H., Amin, A. N., Auladell-Rispau, A., Santero, M., . . . Requeijo, C. (2021). Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis. CLINICAL DRUG INVESTIGATION, 41(11), 941-953. doi:10.1007/s40261-021-01091-wDOI: 10.1007/s40261-021-01091-w
Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus (Journal article)
Fauchier, G., Bisson, A., Bodin, A., Herbert, J., Angoulvant, D., Ducluzeau, P. H., . . . Fauchier, L. (2021). Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus. DIABETOLOGIA, 64(11), 2602-2605. doi:10.1007/s00125-021-05551-yDOI: 10.1007/s00125-021-05551-y
Metabolically healthy obesity and cardiovascular events: A nationwide cohort study (Journal article)
Fauchier, G., Bisson, A., Bodin, A., Herbert, J., Semaan, C., Angoulvant, D., . . . Fauchier, L. (2021). Metabolically healthy obesity and cardiovascular events: A nationwide cohort study. DIABETES OBESITY & METABOLISM, 23(11), 2492-2501. doi:10.1111/dom.14492DOI: 10.1111/dom.14492
Response to Comment on Choi et al. Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: a Nationwide Population-Based Study. Diabetes Care 2021;44:1393-1401. (Journal article)
Choi, Y. -J., Han, K. -D., Lee, S. -R., Choi, E. -K., Oh, S., & Lip, G. Y. H. (2021). Response to Comment on Choi et al. Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: a Nationwide Population-Based Study. Diabetes Care 2021;44:1393-1401.. Diabetes care, 44(11), e199. doi:10.2337/dci21-0039DOI: 10.2337/dci21-0039
Review new concepts in pharmacotherapy for peripheral arterial disease (Journal article)
Kotalczyk, A., Vallabhaneni, S. R., & Lip, G. Y. H. (2021). Review new concepts in pharmacotherapy for peripheral arterial disease. CURRENT OPINION IN CARDIOLOGY, 36(6), 720-726. doi:10.1097/HCO.0000000000000883DOI: 10.1097/HCO.0000000000000883
Lee, S., Jeevaratnam, K., Liu, T., Chang, D., Chang, C., Wong, W. T., . . . Tse, G. (2021). Risk stratification of cardiac arrhythmias and sudden cardiac death in type 2 diabetes mellitus patients receiving insulin therapy: A population-based cohort study. CLINICAL CARDIOLOGY, 44(11), 1602-1612. doi:10.1002/clc.23728DOI: 10.1002/clc.23728
Cushnan, D., Berka, R., Bertolli, O., Williams, P., Schofield, D., Joshi, I., . . . Collaborative, N. C. C. I. D. (2021). Towards nationally curated data archives for clinical radiology image analysis at scale: Learnings from national data collection in response to a pandemic. DIGITAL HEALTH, 7. doi:10.1177/20552076211048654DOI: 10.1177/20552076211048654
Quantitative Study of Photoelectric Laser Stimulation for Logic State Imaging in Embedded SRAM (Conference Paper)
Chef, S., Chua, C. T., Tay, J. Y., & Gan, C. L. (2021). Quantitative Study of Photoelectric Laser Stimulation for Logic State Imaging in Embedded SRAM. In International Symposium for Testing and Failure Analysis. ASM International. doi:10.31399/asm.cp.istfa2021p0154DOI: 10.31399/asm.cp.istfa2021p0154
Targeted atrial fibrillation detection in COVID-19 vaccination clinics (Journal article)
Ford, G. A., Hargroves, D., Lowe, D., Hicks, N., Lip, G. Y. H., Rooney, G., & Oatley, H. (2021). Targeted atrial fibrillation detection in COVID-19 vaccination clinics. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 7(6), 526-528. doi:10.1093/ehjqcco/qcab061DOI: 10.1093/ehjqcco/qcab061
Kuzma, L., Tomaszuk-Kazberuk, A., Kurasz, A., Dobrzycki, S., Kozinski, M., Sobkowicz, B., & Lip, G. Y. H. (2021). Predicting Mortality in Patients with Atrial Fibrillation and Obstructive Chronic Coronary Syndrome: The Bialystok Coronary Project. JOURNAL OF CLINICAL MEDICINE, 10(21). doi:10.3390/jcm10214949DOI: 10.3390/jcm10214949
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. (Journal article)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., . . . Watkins, C. L. (2021). Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.. European heart journal, 42(40), 4194. doi:10.1093/eurheartj/ehab648DOI: 10.1093/eurheartj/ehab648
Proietti, M., Vitolo, M., Harrison, S. L., Lane, D. A., Fauchier, L., Marin, F., . . . Lip, G. Y. H. (2021). Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry. BMC MEDICINE, 19(1). doi:10.1186/s12916-021-02120-3DOI: 10.1186/s12916-021-02120-3
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19<i> JACC</i> State-of-the-Art Review (Journal article)
Talasaz, A. H., Sadeghipour, P., Aghakouchakzadeh, M., Dreyfus, I., Kakavand, H., Ariannejad, H., . . . Bikdeli, B. (2021). Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19<i> JACC</i> State-of-the-Art Review. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 78(16), 1635-1654. doi:10.1016/j.jacc.2021.08.021DOI: 10.1016/j.jacc.2021.08.021
Are low doses of non-vitamin K antagonists effective in Chinese patients with atrial fibrillation? A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry (Journal article)
Kotalczyk, A., Guo, Y., Wang, Y., & Lip, G. Y. H. (2022). Are low doses of non-vitamin K antagonists effective in Chinese patients with atrial fibrillation? A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. INTERNATIONAL JOURNAL OF STROKE, 17(8), 848-854. doi:10.1177/17474930211053140DOI: 10.1177/17474930211053140
Empagliflozin in Heart Failure with a Preserved Ejection Fraction. (Journal article)
Anker, S. D., Butler, J., Filippatos, G., Ferreira, J. P., Bocchi, E., Böhm, M., . . . EMPEROR-Preserved Trial Investigators. (2021). Empagliflozin in Heart Failure with a Preserved Ejection Fraction.. The New England journal of medicine, 385(16), 1451-1461. doi:10.1056/nejmoa2107038DOI: 10.1056/nejmoa2107038
Low-dose rivaroxaban plus aspirin for elderly patients with symptomatic peripheral artery disease: is it worth the bleeding risk? (Journal article)
Zhang, J., Vallabhaneni, S. R., & Lip, G. Y. H. (2021). Low-dose rivaroxaban plus aspirin for elderly patients with symptomatic peripheral artery disease: is it worth the bleeding risk?. EUROPEAN HEART JOURNAL, 42(39), 4049-4052. doi:10.1093/eurheartj/ehab602DOI: 10.1093/eurheartj/ehab602
Phrommintikul, A., Nathisuwan, S., Gunaparn, S., Krittayaphong, R., Wongcharoen, W., Sehmi, S., . . . Lip, G. Y. H. (2021). Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT<sub>2</sub>R<sub>2</sub> score-guided strategy in anticoagulant-naive Thai patients with atrial fibrillation (TREATS-AF): a study protocol. BMJ OPEN, 11(10). doi:10.1136/bmjopen-2021-051987DOI: 10.1136/bmjopen-2021-051987
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (Journal article)
Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., . . . Field, M. (2021). 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. EUROPACE, 23(10), 1612-1676. doi:10.1093/europace/euab065DOI: 10.1093/europace/euab065
Stevens, D., Harrison, S. L., Kolamunnage-Dona, R., Lip, G. Y. H., & Lane, D. A. (2021). The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review. EUROPACE, 23(10), 1511-1527. doi:10.1093/europace/euab092DOI: 10.1093/europace/euab092
Aortovascular medicine: what is it? (Journal article)
Field, M. L., Kuduvalli, M., Torella, F., & Lip, G. Y. H. (2021). Aortovascular medicine: what is it?. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 114(10), 467-469. doi:10.1177/01410768211013436DOI: 10.1177/01410768211013436
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis (Journal article)
Imberti, J. F., Ding, W. Y., Kotalczyk, A., Zhang, J., Boriani, G., Lip, G., . . . Gupta, D. (2021). Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. HEART, 107(20), 1630-1636. doi:10.1136/heartjnl-2021-319496DOI: 10.1136/heartjnl-2021-319496
Chemotherapy-Induced Arrhythmia - Underrecognized and Undertreated (Journal article)
Essa, H., Wright, D. J., Dobson, R., & Lip, G. Y. H. (2021). Chemotherapy-Induced Arrhythmia - Underrecognized and Undertreated. AMERICAN JOURNAL OF MEDICINE, 134(10), 1224-+. doi:10.1016/j.amjmed.2021.05.026DOI: 10.1016/j.amjmed.2021.05.026
Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non-Vitamin K Antagonist Oral Anticoagulants A Nationwide Cohort Study (Journal article)
Chan, Y. -H., Chao, T. -F., Lee, H. -F., Chen, S. -W., Li, P. -R., Liu, J. -R., . . . Lip, G. Y. H. (2021). Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non-Vitamin K Antagonist Oral Anticoagulants A Nationwide Cohort Study. STROKE, 52(10), 3132-3141. doi:10.1161/STROKEAHA.120.033470DOI: 10.1161/STROKEAHA.120.033470
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis (Journal article)
Vitolo, M., Imberti, J. F., Maisano, A., Albini, A., Bonini, N., Valenti, A. C., . . . Boriani, G. (2021). Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 92, 100-106. doi:10.1016/j.ejim.2021.05.038DOI: 10.1016/j.ejim.2021.05.038
Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis (Journal article)
See, L. -C., Lee, H. -F., Chao, T. -F., Li, P. -R., Liu, J. -R., Wu, L. -S., . . . Lip, G. Y. H. (2021). Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis. CARDIOVASCULAR DRUGS AND THERAPY, 35(5), 975-986. doi:10.1007/s10557-020-07108-4DOI: 10.1007/s10557-020-07108-4
SoSTART Collaboration. (2021). Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial.. The Lancet. Neurology, 20(10), 842-853. doi:10.1016/s1474-4422(21)00264-7DOI: 10.1016/s1474-4422(21)00264-7
Exploring the influence of rural residence on uptake of organized cancer screening - A systematic review of international literature. (Journal article)
Walji, L. T., Murchie, P., Lip, G., Speirs, V., & Iversen, L. (2021). Exploring the influence of rural residence on uptake of organized cancer screening - A systematic review of international literature.. Cancer epidemiology, 74, 101995. doi:10.1016/j.canep.2021.101995DOI: 10.1016/j.canep.2021.101995
McCullough, D., Kirwan, R., Butler, T., Perez de Heredia, F., Thijssen, D., Lip, G. Y. H., . . . Davies, I. G. (2021). Feasibility of a high-PRotein Mediterranean-style diet and resistance Exercise in cardiac Rehabilitation patients with sarcopenic obesity (PRiMER): Study protocol for a randomised control trial.. Clinical nutrition ESPEN, 45, 492-498. doi:10.1016/j.clnesp.2021.08.001DOI: 10.1016/j.clnesp.2021.08.001
Ding, W. Y., Yang, P. -S., Jang, E., Gupta, D., Sung, J. -H., Joung, B., & Lip, G. Y. H. (2021). Impact of abdominal obesity on outcomes of catheter ablation in Korean patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. doi:10.1111/ijcp.14696DOI: 10.1111/ijcp.14696
Lin, Y. -S., Kuan, F. -C., Chao, T. -F., Wu, M., Chen, S. -W., Chen, M. -C., . . . Wu, V. C. -C. (2021). Mortality associated with the use of non-vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban. CANCER MEDICINE, 10(20), 7079-7088. doi:10.1002/cam4.4241DOI: 10.1002/cam4.4241
Guo, Y., Wang, H., Kotalczyk, A., Wang, Y., & Lip, G. Y. H. (2021). One-year Follow-up Results of the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. JOURNAL OF ARRHYTHMIA, 37(5), 1227-1239. doi:10.1002/joa3.12608DOI: 10.1002/joa3.12608
Vitalis, A., Shantsila, A., Kay, M., Vohra, R. K., & Lip, G. Y. H. (2021). Outcome of Femoral-popliteal Bypass Procedures in Different Ethnic Groups in England: A Retrospective Analysis of Hospital Episode Statistics. ANNALS OF VASCULAR SURGERY, 76, 351-356. doi:10.1016/j.avsg.2021.04.018DOI: 10.1016/j.avsg.2021.04.018
Relationship between multimorbidity and outcomes in atrial fibrillation (Journal article)
Proietti, M., Esteve-Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Rabadan, I. R., Muniz, J., . . . Marin, F. (2021). Relationship between multimorbidity and outcomes in atrial fibrillation. EXPERIMENTAL GERONTOLOGY, 153. doi:10.1016/j.exger.2021.111482DOI: 10.1016/j.exger.2021.111482
Gue, Y. X., El-Bouri, W. K., & Lip, G. Y. H. (2021). Photoplethysmography rhythm interpretation: an essential skill in an era of novel technologies.. European heart journal. Digital health, 2(3), 361-362. doi:10.1093/ehjdh/ztab068DOI: 10.1093/ehjdh/ztab068
Labuz-Roszak, B., Banach, M., Skrzypek, M., Windak, A., Tomasik, T., Mastej, M., . . . Jozwiak, J. J. (2021). Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study. JOURNAL OF CLINICAL MEDICINE, 10(19). doi:10.3390/jcm10194472DOI: 10.3390/jcm10194472
How effective is pharmacotherapy for stroke and what more is needed? A focus on atrial fibrillation (Journal article)
Kotalczyk, A., Potpara, T. S., & Lip, G. Y. H. (2021). How effective is pharmacotherapy for stroke and what more is needed? A focus on atrial fibrillation. EXPERT OPINION ON PHARMACOTHERAPY, 22(14), 1807-1810. doi:10.1080/14656566.2021.1921738DOI: 10.1080/14656566.2021.1921738
Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy (Journal article)
Lip, G. Y. H., Keshishian, A., Kang, A., Dhamane, A. D., Luo, X., Klem, C., . . . Deitelzweig, S. (2021). Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(5), 405-414. doi:10.1093/ehjcvp/pvaa117DOI: 10.1093/ehjcvp/pvaa117
Off-label underdosed apixaban use in Asian patients with non-valvular atrial fibrillation (Journal article)
Lee, S. -R., Choi, E. -K., Park, S. -H., Jung, J. -H., Han, K. -D., Oh, S., & Lip, G. Y. H. (2021). Off-label underdosed apixaban use in Asian patients with non-valvular atrial fibrillation. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(5), 415-423. doi:10.1093/ehjcvp/pvab004DOI: 10.1093/ehjcvp/pvab004
Lee, S. -R., Han, K. -D., Choi, E. -K., Ahn, H. -J., Oh, S., & Lip, G. Y. H. (2021). Risk of Atrial Fibrillation in Young Adults With Isolated Diastolic, Isolated Systolic, and Systolic-Diastolic Hypertension. HYPERTENSION, 78(5), 1248-1258. doi:10.1161/HYPERTENSIONAHA.121.17399DOI: 10.1161/HYPERTENSIONAHA.121.17399
Procedural complications in patients undergoing catheter ablation for atrial fibrillation: let's talk about sex (Journal article)
Imberti, J. F., Boriani, G., Gupta, D., & Lip, G. Y. H. (2021). Procedural complications in patients undergoing catheter ablation for atrial fibrillation: let's talk about sex. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 7(5), 427-428. doi:10.1093/ehjqcco/qcab046DOI: 10.1093/ehjqcco/qcab046
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients (Journal article)
Romiti, G. F., Corica, B., Pipitone, E., Vitolo, M., Raparelli, V., Basili, S., . . . Group, A. F. -C. O. M. E. T. I. C. (2021). Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. EUROPEAN HEART JOURNAL, 42(35), 3541-+. doi:10.1093/eurheartj/ehab453DOI: 10.1093/eurheartj/ehab453
Left Atrial Appendage Morphology Impacts Thrombus Formation Risks in Multi-Physics Atrial Models (Conference Paper)
Qureshi, A., Balmus, M., Nechipurenko, D., Ataullakhanov, F., Williams, S., Lip, G., . . . de Vecchi, A. (2021). Left Atrial Appendage Morphology Impacts Thrombus Formation Risks in Multi-Physics Atrial Models. In 2021 Computing in Cardiology (CinC). IEEE. doi:10.23919/cinc53138.2021.9662901DOI: 10.23919/cinc53138.2021.9662901
Buckley, B., Harrison, S., Fazio-Eynullayeva, E., Underhill, P., Lane, D., & Lip, G. (2021). Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. European Journal of Clinical Investigation.
Characteristics and clinical outcomes in atrial fibrillation patients classified using cluster analysis: the Fushimi AF Registry (Journal article)
Ogawa, H., An, Y., Nishi, H., Fukuda, S., Ishigami, K., Ikeda, S., . . . Akao, M. (2021). Characteristics and clinical outcomes in atrial fibrillation patients classified using cluster analysis: the Fushimi AF Registry. EUROPACE, 23(9), 1369-1379. doi:10.1093/europace/euab079DOI: 10.1093/europace/euab079
Bikdeli, B., Jimenez, D., del Toro, J., Piazza, G., Rivas, A., Fernandez-Reyes, J. L., . . . Monreal, M. (2021). Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 10(17). doi:10.1161/JAHA.121.021467DOI: 10.1161/JAHA.121.021467
High resolution front-side visualization of charge stored in EEPROM with scanning nonlinear dielectric microscopy (SNDM). (Journal article)
Zeng, X. M., Liu, Q., Tay, J. Y., Chew, K. Y., Cheah, J., & Gan, C. L. (2021). High resolution front-side visualization of charge stored in EEPROM with scanning nonlinear dielectric microscopy (SNDM).. Nanotechnology, 32(48). doi:10.1088/1361-6528/ac1ebdDOI: 10.1088/1361-6528/ac1ebd
Rivera-Caravaca, J. M., Harrison, S. L., Buckley, B. J. R., Fazio-Eynullayeva, E., Underhill, P., Marin, F., & Lip, G. Y. H. (2021). Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases. CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01368-6DOI: 10.1186/s12933-021-01368-6
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis (vol 20, 100, 2021) (Journal article)
Li, H. -L., Lip, G. Y. H., Feng, Q., Fei, Y., Tse, Y. -K., Wu, M. -Z., . . . Yiu, K. -H. (2021). Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis (vol 20, 100, 2021). CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01371-xDOI: 10.1186/s12933-021-01371-x
Sgreccia, D., Manicardi, M., Malavasi, V. L., Vitolo, M., Valenti, A. C., Proietti, M., . . . Boriani, G. (2021). Comparing Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation: A Systematic Review and Meta-Analysis of 81,462 Patients. JOURNAL OF CLINICAL MEDICINE, 10(17). doi:10.3390/jcm10173979DOI: 10.3390/jcm10173979
Zhang, J., Bisson, A., Boumhidi, J., Herbert, J., Saint Etienne, C., Bernard, A., . . . Fauchier, L. (2021). The Prognosis of Baseline Mitral Regurgitation in Patients with Transcatheter Aortic Valve Implantation. JOURNAL OF CLINICAL MEDICINE, 10(17). doi:10.3390/jcm10173974DOI: 10.3390/jcm10173974
Age-Dependent Anticoagulant Therapy for Atrial Fibrillation Patients with Intermediate Risk of Ischemic Stroke: A Nationwide Population-Based Study (Journal article)
Choi, S. Y., Kim, M. H., Lee, K. M., Cho, Y. -R., Park, J. S., Yun, S. -C., & Lip, G. Y. H. (2021). Age-Dependent Anticoagulant Therapy for Atrial Fibrillation Patients with Intermediate Risk of Ischemic Stroke: A Nationwide Population-Based Study. THROMBOSIS AND HAEMOSTASIS, 121(09), 1151-1160. doi:10.1055/a-1336-0476DOI: 10.1055/a-1336-0476
Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure (Journal article)
Bisson, A., Ding, W. Y., Bodin, A., Lip, G. Y. H., & Fauchier, L. (2021). Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure. EUROPEAN JOURNAL OF HEART FAILURE, 23(9), 1563-1565. doi:10.1002/ejhf.2292DOI: 10.1002/ejhf.2292
Watanabe, E., Noyama, S., Kiyono, K., Inoue, H., Atarashi, H., Okumura, K., . . . Origasa, H. (2021). Comparison among random forest, logistic regression, and existing clinical risk scores for predicting outcomes in patients with atrial fibrillation: A report from the J-RHYTHM registry. CLINICAL CARDIOLOGY, 44(9), 1305-1315. doi:10.1002/clc.23688DOI: 10.1002/clc.23688
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes (Journal article)
Rivera-Caravaca, J. M., Buckley, B. J. R., Harrison, S. L., Fazio-Eynullayeva, E., Underhill, P., Marin, F., & Lip, G. Y. H. (2021). Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes. THROMBOSIS RESEARCH, 205, 1-7. doi:10.1016/j.thromres.2021.06.014DOI: 10.1016/j.thromres.2021.06.014
Deitelzweig, S., V. Keshishian, A., Zhang, Y., Kang, A., Dhamane, A. D., Luo, X., . . . Lip, G. Y. H. (2021). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer. JACC: CARDIOONCOLOGY, 3(3), 411-424. doi:10.1016/j.jaccao.2021.06.004DOI: 10.1016/j.jaccao.2021.06.004
Improvements in the modulus and strength of multi-dimensional hybrid composites through synergistic reinforcement between 1D fiber and 0D particle fillers (Journal article)
Markandan, K., Kanaujia, P. K., Abhineet, J. P., Yap, X. Y., Gan, C. L., & Lai, C. Q. (2021). Improvements in the modulus and strength of multi-dimensional hybrid composites through synergistic reinforcement between 1D fiber and 0D particle fillers. Journal of Materials Science, 56(27), 15162-15179. doi:10.1007/s10853-021-06277-3DOI: 10.1007/s10853-021-06277-3
Incident atrial fibrillation and its risk prediction in patients developing COVID-19: A machine learning based algorithm approach (Journal article)
Lip, G. Y. H., Genaidy, A., Tran, G., Marroquin, P., & Estes, C. (2021). Incident atrial fibrillation and its risk prediction in patients developing COVID-19: A machine learning based algorithm approach. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 91, 53-58. doi:10.1016/j.ejim.2021.04.023DOI: 10.1016/j.ejim.2021.04.023
Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study (Journal article)
van der Wall, S. J., Lip, G. Y. H., Teutsch, C., Kalejs, O., Lyrer, P., Hall, C., . . . Huisman, M. V. (2021). Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 91, 75-80. doi:10.1016/j.ejim.2021.05.020DOI: 10.1016/j.ejim.2021.05.020
Screening participants' attitudes to the introduction of artificial intelligence in breast screening. (Journal article)
de Vries, C. F., Morrissey, B. E., Duggan, D., Staff, R. T., & Lip, G. (2021). Screening participants' attitudes to the introduction of artificial intelligence in breast screening.. Journal of medical screening, 28(3), 221-222. doi:10.1177/09691413211001405DOI: 10.1177/09691413211001405
Kim, J., Yang, P. -S., Park, B. -E., Kang, T. S., Lim, S. -H., Cho, S., . . . Joung, B. (2021). Association of proteinuria and incident atrial fibrillation in patients with diabetes mellitus: a population-based senior cohort study (vol 11, 17013, 2021). SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-97510-1DOI: 10.1038/s41598-021-97510-1
Zeymer, U., Leiva, O., Hohnloser, S. H., Steg, P. G., Oldgren, J., Nickenig, G., . . . Cannon, C. P. (2021). Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial. EUROINTERVENTION, 17(6), 474-+. doi:10.4244/EIJ-D-20-00799DOI: 10.4244/EIJ-D-20-00799
Zhang, J., Zhou, C., Ihsan, M., Tsangarides, A., Ahmed, S., Fernando, R., . . . Sankaranarayanan, R. (2021). Continuous infusion versus bolus injection of loop diuretics for congestive heart failure. The Cochrane database of systematic reviews, 2021(8).
Buckley, B. J. R., Lip, G. Y. H., & Thijssen, D. H. J. (2021). Effect of Training on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 326(8), 770-771. doi:10.1001/jama.2021.10055DOI: 10.1001/jama.2021.10055
Kim, J., Yang, P. -S., Park, B. -E., Kang, T. S., Lim, S. -H., Cho, S., . . . Joung, B. (2021). Association of proteinuria and incident atrial fibrillation in patients with diabetes mellitus: a population-based senior cohort study. SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-96483-5DOI: 10.1038/s41598-021-96483-5
McEvoy, J. W., Jennings, C., Kotseva, K., De Backer, G., De Bacquer, D., Erlund, I., . . . Wood, D. A. (2021). INTERASPIRE: an International Survey of Coronary Patients; Their Cardiometabolic, Renal and Biomarker Status; and the Quality of Preventive Care Delivered in All WHO Regions In Partnership with the World Heart Federation, European Society of Cardiology, Asia Pacific Society of Cardiology, InterAmerican Society of Cardiology, and PanAfrican Society of Cardiology.. CURRENT CARDIOLOGY REPORTS, 23(10). doi:10.1007/s11886-021-01568-2DOI: 10.1007/s11886-021-01568-2
Lee, S. -Y., Lee, S. -R., Choi, E. -K., Kwon, S., Yang, S., Park, J., . . . Lip, G. Y. H. (2021). Association Between Change in Metabolic Syndrome Status and Risk of Incident Atrial Fibrillation: A Nationwide Population-Based Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 10(16). doi:10.1161/JAHA.121.020901DOI: 10.1161/JAHA.121.020901
Heseltine, T., Murray, S., Ortega-Martorell, S., Olier, I., Lip, G. Y. H., & Khoo, S. (2021). Associations of Hepatosteatosis With Cardiovascular Disease in HIV-Positive and HIV-Negative Patients: The Liverpool HIV-Heart Project. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 87(5), 1221-1227. doi:10.1097/QAI.0000000000002721DOI: 10.1097/QAI.0000000000002721
Schwartz, G. G., Szarek, M., Bittner, V. A., Diaz, R., Goodman, S. G., Jukema, J. W., . . . ODYSSEY Outcomes Committees and Investigators. (2021). Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.. Journal of the American College of Cardiology, 78(5), 421-433. doi:10.1016/j.jacc.2021.04.102DOI: 10.1016/j.jacc.2021.04.102
Lip, G. Y. H., Keshishian, A. V., Zhang, Y., Kang, A., Dhamane, A. D., Luo, X., . . . Deitelzweig, S. (2021). Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding. JAMA NETWORK OPEN, 4(8). doi:10.1001/jamanetworkopen.2021.20064DOI: 10.1001/jamanetworkopen.2021.20064
Khan, A. A., Junejo, R. T., Alsharari, R., Thomas, G. N., Fisher, J. P., & Lip, G. Y. H. (n.d.). A greater burden of atrial fibrillation is associated with worse endothelial dysfunction in hypertension. Journal of Human Hypertension. doi:10.1038/s41371-020-0383-8DOI: 10.1038/s41371-020-0383-8
Violi, F., Ceccarelli, G., Cangemi, R., Cipollone, F., D'Ardes, D., Oliva, A., . . . Mastroianni, C. M. (2021). Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality. INTERNAL AND EMERGENCY MEDICINE, 16(5), 1231-1237. doi:10.1007/s11739-020-02621-8DOI: 10.1007/s11739-020-02621-8
Atrial Fibrillation in Patients with Chronic Kidney Disease (Journal article)
Kotalczyk, A., Ding, W. Y., Wong, C. F., Rao, A., Gupta, D., & Lip, G. Y. H. (2021). Atrial Fibrillation in Patients with Chronic Kidney Disease. CARDIOLOGY CLINICS, 39(3), 435-446. doi:10.1016/j.ccl.2021.04.005DOI: 10.1016/j.ccl.2021.04.005
Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation (Journal article)
Malavasi, V. L., Fantecchi, E., Tordoni, V., Melara, L., Barbieri, A., Vitolo, M., . . . Boriani, G. (2021). Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation. INTERNAL AND EMERGENCY MEDICINE, 16(5), 1131-1140. doi:10.1007/s11739-020-02551-5DOI: 10.1007/s11739-020-02551-5
Kozieł, M., Teutsch, C., Bayer, V., Lu, S., Gurusamy, V. K., Halperin, J. L., . . . GLORIA‐AF Investigators. (2021). Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world.. Journal of arrhythmia, 37(4), 990-1006. doi:10.1002/joa3.12588DOI: 10.1002/joa3.12588
Clinical prediction of genotypes in hypertrophic cardiomyopathy: A systematic review (Journal article)
Aziz, A., Musiol, S. K., Moody, W. E., Pickup, L., Cooper, R., & Lip, G. Y. H. (2021). Clinical prediction of genotypes in hypertrophic cardiomyopathy: A systematic review. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 51(8). doi:10.1111/eci.13593DOI: 10.1111/eci.13593
Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis (Journal article)
Zhang, J., Wang, X., Liu, X., Larsen, T. B., Witt, D. M., Ye, Z., . . . Lip, G. Y. H. (2021). Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 36(8), 793-812. doi:10.1007/s10654-021-00751-7DOI: 10.1007/s10654-021-00751-7
Kotalczyk, A., & Lip, G. Y. H. (2021). Disparities in atrial fibrillation: a call for holistic care.. The Lancet regional health. Europe, 7, 100160. doi:10.1016/j.lanepe.2021.100160DOI: 10.1016/j.lanepe.2021.100160
Heart Failure With Sinus Rhythm: Does Anticoagulation Reduce Stroke at All? (Journal article)
Zhang, J., Shantsila, E., & Lip, G. Y. H. (2021). Heart Failure With Sinus Rhythm: Does Anticoagulation Reduce Stroke at All?. JOURNAL OF CARDIAC FAILURE, 27(8), 865-868. doi:10.1016/j.cardfail.2021.03.008DOI: 10.1016/j.cardfail.2021.03.008
Strickland, J., Elsberger, B., Lip, G., Fuller, M., & Masannat, Y. (n.d.). Impalpable Breast Cancer and Service Delivery During the COVID-19 Pandemic – the Role of Radiofrequency Tag localization. Archives of Breast Cancer, 247-250. doi:10.32768/abc.202183247-250DOI: 10.32768/abc.202183247-250
Zhao, J., Wang, H., Li, X., Hu, Y., Yan, V. K. C., Wong, C. K. H., . . . Chan, E. W. (2021). Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment. PLOS MEDICINE, 18(8). doi:10.1371/journal.pmed.1003730DOI: 10.1371/journal.pmed.1003730
Machine learning for time-resolved emission: Image resolution enhancement (Journal article)
Chef, S., Chua, C. T., & Gan, C. L. (2021). Machine learning for time-resolved emission: Image resolution enhancement. Electronic Device Failure Analysis, 23(3), 24-31.
Lip, G. Y. H., Tran, G., Genaidy, A., Marroquin, P., & Estes, C. (2021). Revisiting the dynamic risk profile of cardiovascular/non-cardiovascular multimorbidity in incident atrial fibrillation patients and five cardiovascular/non-cardiovascular outcomes: A machine-learning approach.. Journal of arrhythmia, 37(4), 931-941. doi:10.1002/joa3.12555DOI: 10.1002/joa3.12555
Elalamy, I., Gerotziafas, G., Alamowitch, S., Laroche, J. -P., Van Dreden, P., Ageno, W., . . . Scientific Reviewer Committee. (2021). SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia.. Thrombosis and haemostasis, 121(8), 982-991. doi:10.1055/a-1499-0119DOI: 10.1055/a-1499-0119
Proietti, M., Rivera-Caravaca, J. M., Asuncion Esteve-Pastor, M., Marin, F., & Lip, G. Y. H. (2021). Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA <sub>2</sub> DS <sub>2</sub> -VASc and GARFIELD-AF Risk Scores. THROMBOSIS AND HAEMOSTASIS, 121(08), 1107-1114. doi:10.1055/a-1333-4448DOI: 10.1055/a-1333-4448
Gerotziafas, G. T., Catalano, M., Theodorou, Y., Dreden, P. V., Marechal, V., Spyropoulos, A. C., . . . Scientific Reviewer Committee. (2021). The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper.. Thrombosis and haemostasis, 121(8), 992-1007. doi:10.1055/a-1535-8807DOI: 10.1055/a-1535-8807
Updating a simple clinical score predicting incident atrial fibrillation: The C<sub>2</sub>HEST score or more (mC<sub>2</sub>HEST)? (Journal article)
Imberti, J. F., Boriani, G., & Lip, G. Y. H. (2021). Updating a simple clinical score predicting incident atrial fibrillation: The C<sub>2</sub>HEST score or more (mC<sub>2</sub>HEST)?. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 90, 27-29. doi:10.1016/j.ejim.2021.06.014DOI: 10.1016/j.ejim.2021.06.014
Rashidi, A., Whitehead, L., Newson, L., Astin, F., Gill, P., Lane, D. A., . . . Jones, I. D. (2021). The Role of Acceptance and Commitment Therapy in Cardiovascular and Diabetes Healthcare: A Scoping Review. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 18(15). doi:10.3390/ijerph18158126DOI: 10.3390/ijerph18158126
Faust, O., Koh, J. E. W., Jahmunah, V., Sabut, S., Ciaccio, E. J., Majid, A., . . . Acharya, U. R. (2021). Fusion of Higher Order Spectra and Texture Extraction Methods for Automated Stroke Severity Classification with MRI Images. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 18(15). doi:10.3390/ijerph18158059DOI: 10.3390/ijerph18158059
Ding, W. Y., Rivera-Caravaca, J. M., Marin, F., Torp-Pedersen, C., Roldan, V., & Lip, G. Y. H. (2021). Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS. JOURNAL OF CLINICAL MEDICINE, 10(15). doi:10.3390/jcm10153357DOI: 10.3390/jcm10153357
Next-generation Packaging Enabled by an Engineered Copper Nanomaterial (Conference Paper)
Stoltenberg, R. M., Capanzana, A., Vega, A., Ngo, N., Joven, R., Zhenggang, L., . . . Zinn, A. A. (2021). Next-generation Packaging Enabled by an Engineered Copper Nanomaterial. In 2021 IEEE 21st International Conference on Nanotechnology (NANO). IEEE. doi:10.1109/nano51122.2021.9514346DOI: 10.1109/nano51122.2021.9514346
Vitolo, M., Proietti, M., Shantsila, A., Boriani, G., & Lip, G. Y. H. (2021). Clinical Phenotype Classification of Atrial Fibrillation Patients Using Cluster Analysis and Associations with Trial-Adjudicated Outcomes. BIOMEDICINES, 9(7). doi:10.3390/biomedicines9070843DOI: 10.3390/biomedicines9070843
El-Bouri, W. K., Gue, Y., & Lip, G. Y. H. (2021). 'Rise of the machines': the next frontier in individualized medicine.. Cardiovascular research. doi:10.1093/cvr/cvab220DOI: 10.1093/cvr/cvab220
Lim, J., Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Ahn, H. -J., . . . Lip, G. Y. H. (2021). Exercise and the Risk of Dementia in Patients with Newly Diagnosed Atrial Fibrillation: A Nationwide Population-Based Study. JOURNAL OF CLINICAL MEDICINE, 10(14). doi:10.3390/jcm10143126DOI: 10.3390/jcm10143126
A new index to predict quality of anticoagulation control in patients on vitamin K antagonists: the DAFNE score. (Journal article)
Barrios, V., Escobar, C., Prieto, L., Polo, J., Muñiz, J., Anguita, M., & H Lip, G. Y. (2021). A new index to predict quality of anticoagulation control in patients on vitamin K antagonists: the DAFNE score.. Future cardiology, 17(4), 685-692. doi:10.2217/fca-2020-0122DOI: 10.2217/fca-2020-0122
Kiviniemi, T., Bustamante-Munguira, J., Olsson, C., Jeppsson, A., Halfwerk, F. R., Hartikainen, J., . . . van Putte, B. (2021). A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery--LAA-CLOSURE trial protocol. AMERICAN HEART JOURNAL, 237, 127-134. doi:10.1016/j.ahj.2021.03.014DOI: 10.1016/j.ahj.2021.03.014
Ording, A. G., Sogaard, M., Skjoth, F., Grove, E. L., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2021). Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants. CANCER MEDICINE, 10(13), 4405-4414. doi:10.1002/cam4.4012DOI: 10.1002/cam4.4012
Johansen, K. L., Garimella, P. S., Hicks, C. W., Kalra, P. A., Kelly, D. M., Martens, S., . . . Conference Participants. (2021). Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.. In Kidney international Vol. 100 (pp. 35-48). doi:10.1016/j.kint.2021.04.029DOI: 10.1016/j.kint.2021.04.029
Chronic Kidney Disease and Cerebrovascular Disease Consensus and Guidance From a KDIGO Controversies Conference (Journal article)
Kelly, D. M., Ademi, Z., Doehner, W., Lip, G. Y. H., Mark, P., Toyoda, K., . . . Sood, M. M. (2021). Chronic Kidney Disease and Cerebrovascular Disease Consensus and Guidance From a KDIGO Controversies Conference. STROKE, 52(7), E328-E346. doi:10.1161/STROKEAHA.120.029680DOI: 10.1161/STROKEAHA.120.029680
Ferritinophagy and ferroptosis in the management of metabolic diseases (Journal article)
Ajoolabady, A., Aslkhodapasandhokmabad, H., Libby, P., Tuomeilehto, J., Lip, G. Y. H., Penninger, J. M., . . . Ren, J. (2021). Ferritinophagy and ferroptosis in the management of metabolic diseases. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 32(7), 444-462. doi:10.1016/j.tem.2021.04.010DOI: 10.1016/j.tem.2021.04.010
Harrison, S. L., Akpan, A., & Lip, G. Y. H. (2021). Frailty and cognitive impairment are not reasons to withhold anticoagulation in people with atrial fibrillation but screening could guide management. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 69(7), 1807-1810. doi:10.1111/jgs.17142DOI: 10.1111/jgs.17142
Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants (Journal article)
Lip, G. Y. H., & Deitelzweig, S. B. (2021). Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants. JOURNAL OF INTERNAL MEDICINE, 290(1), 221-222. doi:10.1111/joim.13296DOI: 10.1111/joim.13296
Kotalczyk, A., Lip, G. Y., & Calkins, H. (2021). The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation.. Arrhythmia & electrophysiology review, 10(2), 65-67. doi:10.15420/aer.2021.07DOI: 10.15420/aer.2021.07
Eccleston, D. S., Kim, J. M., ten Berg, J. M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., . . . Cannon, C. P. (2021). The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials). CLINICAL CARDIOLOGY, 44(7), 1002-1010. doi:10.1002/clc.23649DOI: 10.1002/clc.23649
Hassan, A. O., Lip, G. Y. H., Bisson, A., Herbert, J., Bodin, A., Fauchier, L., & Harris, R. V. (2021). Acute Dental Periapical Abscess and New-Onset Atrial Fibrillation: A Nationwide, Population-Based Cohort Study. JOURNAL OF CLINICAL MEDICINE, 10(13). doi:10.3390/jcm10132927DOI: 10.3390/jcm10132927
Gumprecht, J., Lip, G. Y. H., Sokal, A., Sredniawa, B., Mitrega, K., Stokwiszewski, J., . . . Kalarus, Z. (2021). Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study. CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01318-2DOI: 10.1186/s12933-021-01318-2
Awad, K., Mohammed, M., Zaki, M. M., Abushouk, A. I., Lip, G. Y. H., Blaha, M. J., . . . Banach, M. (2021). Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies. BMC MEDICINE, 19(1). doi:10.1186/s12916-021-02009-1DOI: 10.1186/s12916-021-02009-1
Challenges and opportunities in improving the management of atrial fibrillation: recent research advances and their clinical translation (Journal article)
Nattel, S., Lip, G. Y. H., Filgueiras-Rama, D., & Dobrev, D. (2021). Challenges and opportunities in improving the management of atrial fibrillation: recent research advances and their clinical translation. CARDIOVASCULAR RESEARCH, 117(7), 1609-1611. doi:10.1093/cvr/cvab170DOI: 10.1093/cvr/cvab170
Olier, I., Ortega-Martorell, S., Pieroni, M., & Lip, G. Y. H. (2021). How machine learning is impacting research in atrial fibrillation: implications for risk prediction and future management. CARDIOVASCULAR RESEARCH, 117(7), 1700-1717. doi:10.1093/cvr/cvab169DOI: 10.1093/cvr/cvab169
Boriani, G., Vitolo, M., Diemberger, I., Proietti, M., Valenti, A. C., Malavasi, V. L., & Lip, G. Y. H. (2021). Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atria fibrillation severity, risk and outcomes. CARDIOVASCULAR RESEARCH, 117(7), 1-21. doi:10.1093/cvr/cvab147DOI: 10.1093/cvr/cvab147
Quality indicators in the management of atrial fibrillation: the BALKAN-AF survey (Journal article)
Koziel, M., Mihajlovic, M., Nedeljkovic, M., Pavlovic, N., Paparisto, V., Music, L., . . . Potpara, T. S. (2021). Quality indicators in the management of atrial fibrillation: the BALKAN-AF survey. INTERNATIONAL JOURNAL OF CARDIOLOGY, 333, 105-109. doi:10.1016/j.ijcard.2021.02.041DOI: 10.1016/j.ijcard.2021.02.041
Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study (Journal article)
Pastori, D., Marang, A., Bisson, A., Menichelli, D., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2021). Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study. CANCER, 127(12), 2122-2129. doi:10.1002/cncr.33470DOI: 10.1002/cncr.33470
Jung, H., Yang, P. -S., Kim, D., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2021). Associations of hypertension burden on subsequent dementia: a population-based cohort study. SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-91923-8DOI: 10.1038/s41598-021-91923-8
Harrison, S., Buckley, B., Rivera-Caravaca, J. M., Zhang, J., & Lip, G. (2021). Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. European Heart Journal - Quality of Care and Clinical Outcomes. doi:10.1093/ehjqcco/qcab029DOI: 10.1093/ehjqcco/qcab029
Prediction of thromboembolic events and mortality by the CHADS<sub>2</sub> and the CHA<sub>2</sub>DS<sub>2</sub>-VASc in COVID-19 (Journal article)
Caro-Codon, J., Lip, G. Y. H., Rey, J. R., Iniesta, A. M., Rosillo, S. O., Castrejon-Castrejon, S., . . . Merino, J. L. (2021). Prediction of thromboembolic events and mortality by the CHADS<sub>2</sub> and the CHA<sub>2</sub>DS<sub>2</sub>-VASc in COVID-19. EUROPACE, 23(6), 937-947. doi:10.1093/europace/euab015DOI: 10.1093/europace/euab015
Should we make the risk stratification process more complex in patients with atrial fibrillation? (Journal article)
Miguel Rivera-Caravaca, J., Nielsen, P. B., & Lip, G. Y. H. (2021). Should we make the risk stratification process more complex in patients with atrial fibrillation?. EUROPACE, 23(6), 978. doi:10.1093/europace/euab007DOI: 10.1093/europace/euab007
Romiti, G. F., Corica, B., Lip, G. Y. H., & Proietti, M. (2021). Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. JOURNAL OF CLINICAL MEDICINE, 10(11). doi:10.3390/jcm10112490DOI: 10.3390/jcm10112490
Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide Population-Based Study (Journal article)
Choi, Y. -J., Han, K. -D., Choi, E. -K., Jung, J. -H., Lee, S. -R., Oh, S., & Lip, G. Y. H. (2021). Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide Population-Based Study. DIABETES CARE, 44(6), 1393-1401. doi:10.2337/dc20-2607DOI: 10.2337/dc20-2607
Azar, R. R., Ragy, H. I., Kozan, O., El Khuri, M., Bazergani, N., Marler, S., . . . Huisman, M. V. (2021). Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program.. International journal of cardiology. Heart & vasculature, 34, 100763. doi:10.1016/j.ijcha.2021.100763DOI: 10.1016/j.ijcha.2021.100763
Ahn, H. -J., Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Lim, J. -H., . . . Lip, G. Y. H. (2021). Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study. PLOS MEDICINE, 18(6). doi:10.1371/journal.pmed.1003659DOI: 10.1371/journal.pmed.1003659
Hypertension and atrial fibrillation: Closing a virtuous circle (Journal article)
Gue, Y. X., & Lip, G. Y. H. (2021). Hypertension and atrial fibrillation: Closing a virtuous circle. PLOS MEDICINE, 18(6). doi:10.1371/journal.pmed.1003598DOI: 10.1371/journal.pmed.1003598
Bunting, K. V., Gill, S. K., Sitch, A., Mehta, S., O'Connor, K., Lip, G. Y. H., . . . Kotecha, D. (2021). Improving the diagnosis of heart failure in patients with atrial fibrillation. HEART, 107(11), 902-908. doi:10.1136/heartjnl-2020-318557DOI: 10.1136/heartjnl-2020-318557
Integrated care and outcomes in patients with atrial fibrillation and comorbidities (Journal article)
Proietti, M., Vitolo, M., & Lip, G. Y. H. (2021). Integrated care and outcomes in patients with atrial fibrillation and comorbidities. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 51(6). doi:10.1111/eci.13498DOI: 10.1111/eci.13498
Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation (Conference Paper)
Chao, T. -F., Chiang, C. -E., Chan, Y. -H., Liao, J. -N., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2021). Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation. In HEART RHYTHM Vol. 18 (pp. 871-877). doi:10.1016/j.hrthm.2021.02.018DOI: 10.1016/j.hrthm.2021.02.018
Milling, T. J. J., Warach, S., Johnston, S. C., Gajewski, B., Costantini, T., Price, M., . . . Lip, G. Y. H. (2021). Restart TICrH: An Adaptive Randomized Trial of Time Intervals to Restart Direct Oral Anticoagulants after Traumatic Intracranial Hemorrhage. JOURNAL OF NEUROTRAUMA, 38(13), 1791-1798. doi:10.1089/neu.2020.7535DOI: 10.1089/neu.2020.7535
Symptom management strategies: Rhythm vs rate control in patients with atrial fibrillation in the Balkan region: Data from the BALKAN-AF survey (Journal article)
Koziel, M., Mihajlovic, M., Nedeljkovic, M., Pavlovic, N., Paparisto, V., Music, L., . . . Potpara, T. S. (2021). Symptom management strategies: Rhythm vs rate control in patients with atrial fibrillation in the Balkan region: Data from the BALKAN-AF survey. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 75(6). doi:10.1111/ijcp.14080DOI: 10.1111/ijcp.14080
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity (Journal article)
Deitelzweig, S., Keshishian, A., Kang, A., Dhamane, A. D., Luo, X., Klem, C., . . . Lip, G. Y. H. (2021). Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity. ADVANCES IN THERAPY, 38(6), 3166-3184. doi:10.1007/s12325-021-01724-8DOI: 10.1007/s12325-021-01724-8
Lunde, E. D., Joensen, A. M., Fonager, K., Lundbye-Christensen, S., Johnsen, S. P., Larsen, M. L., . . . Riahi, S. (2021). Socioeconomic inequality in oral anticoagulation therapy initiation in patients with atrial fibrillation with high risk of stroke: a register-based observational study. BMJ OPEN, 11(5). doi:10.1136/bmjopen-2021-048839DOI: 10.1136/bmjopen-2021-048839
Cryoablation as Initial Therapy for Atrial Fibrillation (Journal article)
Proietti, R., Vio, R., & Lip, G. Y. H. (2021). Cryoablation as Initial Therapy for Atrial Fibrillation. NEW ENGLAND JOURNAL OF MEDICINE, 384(21). doi:10.1056/NEJMc2103408DOI: 10.1056/NEJMc2103408
Mitrega, K., Lip, G. Y. H., Sredniawa, B., Sokal, A., Streb, W., Przyludzki, K., . . . Kalarus, Z. (2021). Predicting Silent Atrial Fibrillation in the Elderly: A Report from the NOMED-AF Cross-Sectional Study. JOURNAL OF CLINICAL MEDICINE, 10(11). doi:10.3390/jcm10112321DOI: 10.3390/jcm10112321
Understanding the global burden of atrial fibrillation and regional variations: we need improvement (Journal article)
Vitolo, M., & Lip, G. Y. H. (2021). Understanding the global burden of atrial fibrillation and regional variations: we need improvement. CARDIOVASCULAR RESEARCH, 117(6), 1420-1422. doi:10.1093/cvr/cvaa330DOI: 10.1093/cvr/cvaa330
Current trends in the use of anticoagulant pharmacotherapy in the United Kingdom are changes on the horizon? (Journal article)
Kotalczyk, A., Gue, Y. X., Potpara, T. S., & Lip, G. Y. H. (2021). Current trends in the use of anticoagulant pharmacotherapy in the United Kingdom are changes on the horizon?. EXPERT OPINION ON PHARMACOTHERAPY, 22(8), 1061-1070. doi:10.1080/14656566.2021.1879050DOI: 10.1080/14656566.2021.1879050
Lee, S. -R., Choi, E. -K., Jung, J. -H., Han, K. -D., Oh, S., & Lip, G. Y. H. (2021). Smoking Cessation after Diagnosis of New-Onset Atrial Fibrillation and the Risk of Stroke and Death. JOURNAL OF CLINICAL MEDICINE, 10(11). doi:10.3390/jcm10112238DOI: 10.3390/jcm10112238
Shantsila, E., Koziel, M., & Lip, G. Y. H. (2021). Anticoagulation versus placebo for heart failure in sinus rhythm. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD003336.pub4DOI: 10.1002/14651858.CD003336.pub4
Disparities in atrial fibrillation management: Is race to blame? (Journal article)
Olshansky, B., & Lip, G. Y. H. (2021). Disparities in atrial fibrillation management: Is race to blame?. INTERNATIONAL JOURNAL OF CARDIOLOGY, 331, 118-119. doi:10.1016/j.ijcard.2021.01.020DOI: 10.1016/j.ijcard.2021.01.020
Buckley, B., Harrison, S., Fazio-Eynullayeva, E., Underhill, P., Sankaranarayanan, R., Wright, D., . . . Lip, G. (2021). Cardiac rehabilitation and all-cause mortality in patients with heart failure: A retrospective cohort study. European Journal of Preventive Cardiology. doi:10.1093/eurjpc/zwab061.328DOI: 10.1093/eurjpc/zwab061.328
Kim, D., Yang, P. -S., You, S. C., Sung, J. -H., Jang, E., Yu, H. T., . . . Joung, B. (2021). Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study. BMJ-BRITISH MEDICAL JOURNAL, 373. doi:10.1136/bmj.n991DOI: 10.1136/bmj.n991
Li, H. -L., Lip, G. -Y. H., Feng, Q., Fei, Y., Tse, Y. -K., Wu, M. -Z., . . . Yiu, K. -H. (2021). Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis. CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01293-8DOI: 10.1186/s12933-021-01293-8
Heidarali, M., Bakhshandeh, H., Golpira, R., Fazelifar, A., Alizadeh-Diz, A., Emkanjoo, Z., . . . Haghjoo, M. (2021). A prospective survey of atrial fibrillation management in Iran: Baseline results of the Iranian Registry of Atrial Fibrillation (IRAF). INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 75(8). doi:10.1111/ijcp.14313DOI: 10.1111/ijcp.14313
Alsharari, R., Oxborough, D., Lip, G. Y. H., & Shantsila, A. (2021). Myocardial Strain Imaging in Resistant Hypertension. CURRENT HYPERTENSION REPORTS, 23(5). doi:10.1007/s11906-021-01148-3DOI: 10.1007/s11906-021-01148-3
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials. (Journal article)
Talasaz, A. H., Sadeghipour, P., Aghakouchakzadeh, M., Dreyfus, I., Kakavand, H., Ariannejad, H., . . . Bikdeli, B. (2021). Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials.. medRxiv. doi:10.1101/2021.05.03.21256468DOI: 10.1101/2021.05.03.21256468
Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry (Journal article)
Potpara, T. S., Lip, G. Y. H., Dagres, N., Crijns, H. J. M. G., Boriani, G., Kirchhof, P., . . . Gale, C. P. (2021). Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 7(3), 229-237. doi:10.1093/ehjqcco/qcaa050DOI: 10.1093/ehjqcco/qcaa050
Intracerebral Hemorrhage and Exposure to Antithrombotic Drugs (Journal article)
Nielsen, P. B., Milling, T. J., & Lip, G. Y. H. (2021). Intracerebral Hemorrhage and Exposure to Antithrombotic Drugs. JAMA NETWORK OPEN, 4(5). doi:10.1001/jamanetworkopen.2021.9175DOI: 10.1001/jamanetworkopen.2021.9175
Alterations in atrial electrogram amplitude as steady sinus rhythm transitions to paroxysmal atrial fibrillation during continuous monitoring in patients with implantable cardiac devices: Insights from the IMPACT study (Journal article)
Kantharia, B. K., Lip, G. Y. H., & Martin, D. T. (2021). Alterations in atrial electrogram amplitude as steady sinus rhythm transitions to paroxysmal atrial fibrillation during continuous monitoring in patients with implantable cardiac devices: Insights from the IMPACT study. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 32(5), 1357-1363. doi:10.1111/jce.14997DOI: 10.1111/jce.14997
Gue, Y. X., Ding, W. Y., Lip, G. Y. H., & Gorog, D. A. (2021). Assessment of endogenous fibrinolysis in clinical practice using novel tests: ready for clinical roll-out?. SN APPLIED SCIENCES, 3(5). doi:10.1007/s42452-021-04517-4DOI: 10.1007/s42452-021-04517-4
Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications (Journal article)
Harrison, S. L., Buckley, B. J. R., Lane, D. A., Underhill, P., & Lip, G. Y. H. (2021). Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications. PHARMACOLOGICAL RESEARCH, 167. doi:10.1016/j.phrs.2021.105534DOI: 10.1016/j.phrs.2021.105534
Atrial fibrillation and cardiac arrhythmia associated with acute dental infection: A systematic literature review and case report (Journal article)
Hassan, A., Lip, G. Y. H., & Harris, R. V. (2021). Atrial fibrillation and cardiac arrhythmia associated with acute dental infection: A systematic literature review and case report. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 75(5). doi:10.1111/ijcp.13875DOI: 10.1111/ijcp.13875
Clinical Practice Guide Guide ESC 2020 on the diagnosis and treatment of atrial fibrillation, developed in collaboration with the <i>European Association for Cardio-Thoracic Surgery (EACTS)</i> (Journal article)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomstrom-Lundqvist, C., . . . Watkins, C. L. (2021). Clinical Practice Guide Guide ESC 2020 on the diagnosis and treatment of atrial fibrillation, developed in collaboration with the <i>European Association for Cardio-Thoracic Surgery (EACTS)</i>. REVISTA ESPANOLA DE CARDIOLOGIA, 74(5). doi:10.1016/j.recesp.2020.10.022DOI: 10.1016/j.recesp.2020.10.022
Comments on the Pathophysiological Basis and Rationale for Early Treatment of COVID-19 Reply (Journal article)
Vitalis, A., Shantsila, A., & Lip, G. Y. H. (2021). Comments on the Pathophysiological Basis and Rationale for Early Treatment of COVID-19 Reply. AMERICAN JOURNAL OF MEDICINE, 134(5), E354-E355. doi:10.1016/j.amjmed.2020.11.033DOI: 10.1016/j.amjmed.2020.11.033
Qin, S., Boidin, M., Buckley, B. J. R., Lip, G. Y. H., & Thijssen, D. H. J. (2021). Endothelial dysfunction and vascular maladaptation in atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 51(5). doi:10.1111/eci.13477DOI: 10.1111/eci.13477
Harrison, S. L., Fazio-Eynullayeva, E., Lane, D. A., Underhill, P., & Lip, G. Y. H. (2021). Higher Mortality of Ischaemic Stroke Patients Hospitalized with COVID-19 Compared to Historical Controls. CEREBROVASCULAR DISEASES, 50(3), 326-331. doi:10.1159/000514137DOI: 10.1159/000514137
Kwon, S., Jung, J. H., Choi, E. K., Lee, S. W., Park, J., Lee, S. R., . . . Lip, G. Y. H. (2021). Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. KOREAN CIRCULATION JOURNAL, 51(5), 409-422. doi:10.4070/kcj.2020.0407DOI: 10.4070/kcj.2020.0407
Long-term outcomes of left atrial appendage occlusion in high-risk atrial fibrillation patients: 4-year follow up data (Journal article)
Ding, W. Y., Lip, G. Y. H., Bartoletti, S., Morrison, L., Khalatbari, A., Aggarwal, S., . . . Gupta, D. (2021). Long-term outcomes of left atrial appendage occlusion in high-risk atrial fibrillation patients: 4-year follow up data. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 51(4), 1090-1093. doi:10.1007/s11239-020-02333-yDOI: 10.1007/s11239-020-02333-y
Predictors of ischemic stroke for low-risk patients with atrial fibrillation: A matched case-control study (Journal article)
Kwon, S., Kim, T. J., Choi, E. -K., Ahn, H. -J., Lee, E., Lee, S. -R., . . . Lip, G. Y. H. (2021). Predictors of ischemic stroke for low-risk patients with atrial fibrillation: A matched case-control study. HEART RHYTHM, 18(5), 702-708. doi:10.1016/j.hrthm.2021.01.016DOI: 10.1016/j.hrthm.2021.01.016
Prevalence/incidence of atrial fibrillation based on integrated medical/pharmacy claims, and association with co-morbidity profiles/multi-morbidity in a large US adult cohort (Journal article)
Lip, G. Y. H., Tran, G., Genaidy, A., Marroquin, P., Estes, C., & Harrelll, T. (2021). Prevalence/incidence of atrial fibrillation based on integrated medical/pharmacy claims, and association with co-morbidity profiles/multi-morbidity in a large US adult cohort. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 75(5). doi:10.1111/ijcp.14042DOI: 10.1111/ijcp.14042
Real-World Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in a Developing Country (Journal article)
Mitsuntisuk, P., Nathisuwan, S., Junpanichjaroen, A., Wongcharoen, W., Phrommintikul, A., Wattanaruengchai, P., . . . Lip, G. Y. H. (2021). Real-World Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in a Developing Country. CLINICAL PHARMACOLOGY & THERAPEUTICS, 109(5), 1282-1292. doi:10.1002/cpt.2090DOI: 10.1002/cpt.2090
Stroke Care during the COVID-19 Pandemic: International Expert Panel Review (Journal article)
Venketasubramanian, N., Anderson, C., Ay, H., Aybek, S., Brinjikji, W., de Freitas, G. R., . . . Hennerici, M. G. (2021). Stroke Care during the COVID-19 Pandemic: International Expert Panel Review. CEREBROVASCULAR DISEASES, 50(3), 245-261. doi:10.1159/000514155DOI: 10.1159/000514155
The heart in hypertension (Journal article)
Nadar, S. K., & Lip, G. Y. H. (2021). The heart in hypertension. JOURNAL OF HUMAN HYPERTENSION, 35(5), 383-386. doi:10.1038/s41371-020-00427-xDOI: 10.1038/s41371-020-00427-x
Kostopoulos, G., Doundoulakis, I., Antza, C., Bouras, E., Nirantharakumar, K., Tsiachris, D., . . . Toulis, K. A. (2021). Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis. ENDOCRINE-RELATED CANCER, 28(5), 325-335. doi:10.1530/ERC-20-0496DOI: 10.1530/ERC-20-0496
Catheter ablation for atrial fibrillation in heart failure: untying the Gordian knot (Journal article)
Javed, S., Koniari, I., Fox, D., Skene, C., Lip, G. Y. H., & Gupta, D. (2021). Catheter ablation for atrial fibrillation in heart failure: untying the Gordian knot. JOURNAL OF GERIATRIC CARDIOLOGY, 18(4), 297-306. doi:10.11909/j.issn.1671-5411.2021.04.002DOI: 10.11909/j.issn.1671-5411.2021.04.002
Almarzouki, A., Wilson, D., Ambler, G., Shakeshaft, C., Cohen, H., Yousry, T., . . . Werring, D. J. (2021). Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage (vol 10, 15529, 2020). SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-88890-5DOI: 10.1038/s41598-021-88890-5
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial (Journal article)
Sadeghipour, P., Talasaz, A. H., Rashidi, F., Sharif-Kashani, B., Beigmohammadi, M. T., Farrokhpour, M., . . . Bikdeli, B. (2021). Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 325(16), 1620-1630. doi:10.1001/jama.2021.4152DOI: 10.1001/jama.2021.4152
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19 (Journal article)
Talasaz, A. H., Sadeghipour, P., Kakavand, H., Aghakouchakzadeh, M., Kordzadeh-Kermani, E., Van Tassell, B. W., . . . Bikdeli, B. (2021). Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 77(15), 1903-1921. doi:10.1016/j.jacc.2021.02.035DOI: 10.1016/j.jacc.2021.02.035
Mechanical properties and failure behaviour of architected alumina microlattices fabricated by stereolithography 3D printing (Journal article)
Yap, X. Y., Seetoh, I., Goh, W. L., Ye, P., Zhao, Y., Du, Z., . . . Gan, C. L. (2021). Mechanical properties and failure behaviour of architected alumina microlattices fabricated by stereolithography 3D printing. International Journal of Mechanical Sciences, 196, 106285. doi:10.1016/j.ijmecsci.2021.106285DOI: 10.1016/j.ijmecsci.2021.106285
Cerebral Small Vessel Disease and Functional Outcome Prediction After Intracerebral Hemorrhage (Journal article)
Hostettler, I. C., Schwarz, G., Ambler, G., Wilson, D., Banerjee, G., Seiffge, D. J., . . . Werring, D. J. (2021). Cerebral Small Vessel Disease and Functional Outcome Prediction After Intracerebral Hemorrhage. NEUROLOGY, 96(15), E1954-E1965. doi:10.1212/WNL.0000000000011746DOI: 10.1212/WNL.0000000000011746
Hassan, A., Lip, G. Y. H., Fauchier, L., & Harris, R. V. (2021). Atrial Fibrillation and Oral Health. ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 10(1), 7-9. doi:10.15420/aer.2021.09DOI: 10.15420/aer.2021.09
Peterson, B. E., Bhatt, D. L., Steg, P. G., Oldgren, J., Maeng, M., Zeymer, U., . . . Cannon, C. P. (2021). Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial. JACC-CARDIOVASCULAR INTERVENTIONS, 14(7), 768-780. doi:10.1016/j.jcin.2021.02.022DOI: 10.1016/j.jcin.2021.02.022
Narayan, S. M., Calkins, H., Grace, A., Ellenbogen, K., Lip, G. Y., Lambiase, P. D., & Katritsis, D. G. (2021). What Cannot Be Missed: Important Publications on Electrophysiology in 2020.. Arrhythmia & electrophysiology review, 10(1), 5-6. doi:10.15420/aer.2021.02DOI: 10.15420/aer.2021.02
Lee, C. J. -Y., Toft-Petersen, A. P., Ozenne, B., Phelps, M., Olesen, J. B., Ellinor, P. T., . . . Gerds, T. A. (2021). Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor-based approach. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(F11), F3-F10. doi:10.1093/ehjcvp/pvaa063DOI: 10.1093/ehjcvp/pvaa063
Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study (Journal article)
Proietti, M., Marzona, I., Vannini, T., Colacioppo, P., Tettamanti, M., Foresta, A., . . . Roncaglioni, M. C. (2021). Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(F11), F84-F92. doi:10.1093/ehjcvp/pvaa015DOI: 10.1093/ehjcvp/pvaa015
Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients (Journal article)
Menichelli, D., Del Sole, F., Di Rocco, A., Farcomeni, A., Vestri, A., Violi, F., . . . Pastori, D. (2021). Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(F11), F11-F19. doi:10.1093/ehjcvp/pvab002DOI: 10.1093/ehjcvp/pvab002
Vitolo, M., Lane, D. A., Boriani, G., & Lip, G. Y. H. (2021). The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(F11), F81-F83. doi:10.1093/ehjcvp/pvaa020DOI: 10.1093/ehjcvp/pvaa020
Melgaard, L., Overvad, T. F., Jensen, M., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2021). Thromboembolism and bleeding complications in anticoagulated patients with atrial fibrillation and native aortic or mitral valvular heart disease: a descriptive nationwide cohort study. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(F11), F101-F110. doi:10.1093/ehjcvp/pvaa008DOI: 10.1093/ehjcvp/pvaa008
Park, J., Jung, J. -H., Choi, E. -K., Lee, S. -W., Kwon, S., Lee, S. -R., . . . Lip, G. Y. H. (2021). Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study. JOURNAL OF CLINICAL MEDICINE, 10(7). doi:10.3390/jcm10071505DOI: 10.3390/jcm10071505
Kotalczyk, A., Ding, W. Y., Gupta, D., Wright, D. J., & Lip, G. Y. H. (2021). Clinical outcomes following rhythm control for atrial fibrillation: is early better?. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 19(4), 277-287. doi:10.1080/14779072.2021.1902307DOI: 10.1080/14779072.2021.1902307
3D Printing of Transparent Spinel Ceramics with Transmittance Approaching the Theoretical Limit. (Journal article)
Wang, H., Liu, L. Y., Ye, P., Huang, Z., Ng, A. Y. R., Du, Z., . . . Gan, C. L. (2021). 3D Printing of Transparent Spinel Ceramics with Transmittance Approaching the Theoretical Limit.. Advanced materials (Deerfield Beach, Fla.), 33(15), e2007072. doi:10.1002/adma.202007072DOI: 10.1002/adma.202007072
Koziel, M., Teutsch, C., Halperin, J. L., Rothman, K. J., Diener, H. -C., Ma, C. -S., . . . Lip, G. Y. H. (2021). Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF. PLOS ONE, 16(4). doi:10.1371/journal.pone.0249524DOI: 10.1371/journal.pone.0249524
Li, J. -Y., Wang, H. -F., Yin, P., Li, D., Wang, D. -L., Peng, P., . . . Lip, G. Y. H. (2021). Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 19(4), 1038-1048. doi:10.1111/jth.15261DOI: 10.1111/jth.15261
Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients (Journal article)
Zhu, W., Ye, Z., Chen, S., Wu, D., He, J., Dong, Y., . . . Liu, C. (2021). Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients. STROKE, 52(4), 1225-1233. doi:10.1161/STROKEAHA.120.031007DOI: 10.1161/STROKEAHA.120.031007
Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies (Journal article)
Best, J. G., Ambler, G., Wilson, D., Lee, K. -J., Lim, J. -S., Shiozawa, M., . . . Werring, D. J. (2021). Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies. LANCET NEUROLOGY, 20(4), 294-303. doi:10.1016/S1474-4422(21)00024-7DOI: 10.1016/S1474-4422(21)00024-7
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2021). Effects of antithrombotic drugs on the prothrombotic state in patients with atrial fibrillation: The west Birmingham atrial fibrillation project. THROMBOSIS RESEARCH, 200, 149-155. doi:10.1016/j.thromres.2021.02.005DOI: 10.1016/j.thromres.2021.02.005
Hypertension and sleep health: a multidimensional puzzle (Journal article)
Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2021). Hypertension and sleep health: a multidimensional puzzle. JOURNAL OF HYPERTENSION, 39(4), 600-601. doi:10.1097/HJH.0000000000002743DOI: 10.1097/HJH.0000000000002743
In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events (Journal article)
Gue, Y. X., & Lip, G. Y. H. (2021). In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events. ANNALS OF INTERNAL MEDICINE, 174(4), JC43. doi:10.7326/ACPJ202104200-043DOI: 10.7326/ACPJ202104200-043
GUE, Y. X., ADATIA, K., KANJI, R., POTPARA, T., LIP, G. Y. H., & GOROG, D. A. (2021). Out-of-hospital cardiac arrest: A systematic review of current risk scores to predict survival. AMERICAN HEART JOURNAL, 234, 31-41. doi:10.1016/j.ahj.2020.12.011DOI: 10.1016/j.ahj.2020.12.011
Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs 'real-world' (Journal article)
Ding, W. Y., Rivera-Caravaca, J. M., Shantsila, A., Marin, F., Gupta, D., Roldan, V., & Lip, G. Y. H. (2021). Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs 'real-world'. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 75(4). doi:10.1111/ijcp.13888DOI: 10.1111/ijcp.13888
Vitalis, A., Shantsila, A., Proietti, M., Vohra, R. K., Kay, M., Olshansky, B., & Lip, G. Y. H. (2021). Peripheral Arterial Disease in Patients with Atrial Fibrillation: The AFFIRM Study. AMERICAN JOURNAL OF MEDICINE, 134(4), 514-518. doi:10.1016/j.amjmed.2020.08.026DOI: 10.1016/j.amjmed.2020.08.026
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry (Journal article)
Bertomeu-Gonzalez, V., Moreno-Arribas, J., Esteve-Pastor, M. A., Roldan-Rabadan, I., Muniz, J., Otero Garcia, D., . . . Marin, F. (2021). Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 51(4). doi:10.1111/eci.13431DOI: 10.1111/eci.13431
Stroke prevention strategies in high-risk patients with atrial fibrillation (Journal article)
Kotalczyk, A., Mazurek, M., Kalarus, Z., Potpara, T. S., & Lip, G. Y. H. (2021). Stroke prevention strategies in high-risk patients with atrial fibrillation. NATURE REVIEWS CARDIOLOGY, 18(4), 276-290. doi:10.1038/s41569-020-00459-3DOI: 10.1038/s41569-020-00459-3
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease (Journal article)
Kim, H. K., Tantry, U. S., Smith, S. C. J., Jeong, M. H., Park, S. -J., Kim, M. H., . . . Jeong, Y. -H. (2021). The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease. THROMBOSIS AND HAEMOSTASIS, 121(04), 422-432. doi:10.1055/s-0040-1718729DOI: 10.1055/s-0040-1718729
Cheung, C. -L., Sing, C. -W., Lau, W. C. Y., Li, G. H. Y., Lip, G. Y. H., Tan, K. C. B., . . . Wong, I. C. K. (2021). Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population-based cohort study. CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01263-0DOI: 10.1186/s12933-021-01263-0
Pathophysiology of atrial fibrillation and chronic kidney disease (Journal article)
Ding, W. Y., Gupta, D., Wong, C. F., & Lip, G. Y. H. (2021). Pathophysiology of atrial fibrillation and chronic kidney disease. CARDIOVASCULAR RESEARCH, 117(4), 1046-1059. doi:10.1093/cvr/cvaa258DOI: 10.1093/cvr/cvaa258
Seiffge, D. J., Wilson, D., Ambler, G., Banerjee, G., Hostettler, I. C., Houlden, H., . . . Werring, D. J. (2021). Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 92 (pp. 805-814). doi:10.1136/jnnp-2020-325299DOI: 10.1136/jnnp-2020-325299
Li, Y. -G., Pastori, D., Miyazawa, K., Shahid, F., & Lip, G. Y. H. (2021). Identifying At-Risk Patients for Sustained Atrial High-Rate Episodes Using the C<sub>2</sub>HEST Score: The West Birmingham Atrial Fibrillation Project. In JOURNAL OF THE AMERICAN HEART ASSOCIATION Vol. 10. doi:10.1161/JAHA.120.017519DOI: 10.1161/JAHA.120.017519
Bentley, R., Hardy, L. J., Scott, L. J., Sharma, P., Philippou, H., & Lip, G. Y. H. (2021). Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation. Expert Opinion on Investigational Drugs. doi:10.1080/13543784.2021.1897786DOI: 10.1080/13543784.2021.1897786
Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the Fushimi AF registry (Journal article)
Ogawa, H., An, Y., Ishigami, K., Ikeda, S., Doi, K., Hamatani, Y., . . . Akao, M. (2021). Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the Fushimi AF registry. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 7(2), 163-171. doi:10.1093/ehjqcco/qcaa082DOI: 10.1093/ehjqcco/qcaa082
Ritchie, L. A., Lip, G. Y. H., & Lane, D. A. (2021). Optimization of atrial fibrillation care: management strategies and quality measures. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 7(2), 121-133. doi:10.1093/ehjqcco/qcaa063DOI: 10.1093/ehjqcco/qcaa063
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference (Journal article)
Fabritz, L., Crijns, H. J. G. M., Guasch, E., Goette, A., Hausler, K. G., Kotecha, D., . . . Kirchhof, P. (2021). Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. EUROPACE, 23(3), 329-344. doi:10.1093/europace/euaa279DOI: 10.1093/europace/euaa279
Hypertension Burden and the Risk of New-Onset Atrial Fibrillation A Nationwide Population-Based Study (Journal article)
Lee, S. -R., Park, C. S., Choi, E. -K., Ahn, H. -J., Han, K. -D., Oh, S., & Lip, G. Y. H. (2021). Hypertension Burden and the Risk of New-Onset Atrial Fibrillation A Nationwide Population-Based Study. HYPERTENSION, 77(3), 919-928. doi:10.1161/HYPERTENSIONAHA.120.16659DOI: 10.1161/HYPERTENSIONAHA.120.16659
Anticoagulant selection in relation to the SAMe-TT<sub>2</sub>R<sub>2</sub> score in patients with atrial fibrillation: The GLORIA-AF registry (Journal article)
Ntaios, G., Huisman, M. V., Diener, H. -C., Halperin, J. L., Teutsch, C., Marler, S., . . . Olshansky, B. (2021). Anticoagulant selection in relation to the SAMe-TT<sub>2</sub>R<sub>2</sub> score in patients with atrial fibrillation: The GLORIA-AF registry. HELLENIC JOURNAL OF CARDIOLOGY, 62(2), 152-157. doi:10.1016/j.hjc.2020.11.009DOI: 10.1016/j.hjc.2020.11.009
Atrial Fibrillation and Stroke. (Journal article)
Essa, H., Hill, A. M., & Lip, G. Y. H. (2021). Atrial Fibrillation and Stroke.. Cardiac electrophysiology clinics, 13(1), 243-255. doi:10.1016/j.ccep.2020.11.003DOI: 10.1016/j.ccep.2020.11.003
Atrial fibrillation and vascular disease: Coronary artery disease and/or peripheral artery disease? (Journal article)
Essa, H., & Lip, G. Y. H. (2021). Atrial fibrillation and vascular disease: Coronary artery disease and/or peripheral artery disease?. ARCHIVES OF CARDIOVASCULAR DISEASES, 114(3), 173-175. doi:10.1016/j.acvd.2021.02.002DOI: 10.1016/j.acvd.2021.02.002
Lip, G. (n.d.). Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry. European Journal of Clinical Investigation. doi:10.1111/eci.13385DOI: 10.1111/eci.13385
Guo, Y., Zhang, J., & Lip, G. Y. H. (2021). Embolic Stroke of Undetermined Source: The Need for an Integrated and Holistic Approach to Care. THROMBOSIS AND HAEMOSTASIS, 121(03), 251-254. doi:10.1055/a-1336-0576DOI: 10.1055/a-1336-0576
Zhang, J., Johnsen, S. P., Guo, Y., & Lip, G. Y. H. (2021). Epidemiology of Atrial Fibrillation: Geographic/Ecological Risk Factors, Age, Sex, Genetics.. Cardiac Electrophysiology Clinics, 13(1), 1-23. doi:10.1016/j.ccep.2020.10.010DOI: 10.1016/j.ccep.2020.10.010
Essa, H., Lodhi, T., Dobson, R., Wright, D., & Lip, G. Y. H. (2021). How to Manage Atrial Fibrillation Secondary to Ibrutinib. JACC: CARDIOONCOLOGY, 3(1), 140-144. doi:10.1016/j.jaccao.2020.11.016DOI: 10.1016/j.jaccao.2020.11.016
Dam-Vervloet, A. J., van Erk, M. D., Doorn, N., Lip, S. G. J., Timmermans, N. A., Vanwinsen, L., . . . Bosschaart, N. (2021). Inter-device reproducibility of transcutaneous bilirubin meters.. Pediatric research, 89(4), 770-775. doi:10.1038/s41390-020-01118-6DOI: 10.1038/s41390-020-01118-6
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis (Journal article)
Albini, A., Malavasi, V. L., Vitolo, M., Imberti, J. F., Marietta, M., Lip, G. Y. H., & Boriani, G. (2021). Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 85, 27-33. doi:10.1016/j.ejim.2020.12.018DOI: 10.1016/j.ejim.2020.12.018
Nonatrial Fibrillation Patients With Complete P Wave Disappearance An Overlooked Population With High Stroke Risk (Journal article)
Liu, H., Li, M., Li, C., Wang, Z., Lu, Q., Gu, Z., . . . Chen, M. (2021). Nonatrial Fibrillation Patients With Complete P Wave Disappearance An Overlooked Population With High Stroke Risk. STROKE, 52(3), 1074-1078. doi:10.1161/STROKEAHA.120.031666DOI: 10.1161/STROKEAHA.120.031666
Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand (Journal article)
Wattanaruengchai, P., Nathisuwan, S., Rattanavipanon, W., Chulavatnatol, S., Kongwatcharapong, J., Mitsuntisuk, P., . . . Lip, G. Y. H. (2021). Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 87(3), 1390-1400. doi:10.1111/bcp.14535DOI: 10.1111/bcp.14535
Renal Disease and Atrial Fibrillation. (Journal article)
Stefil, M., Nabrdalik, K., & Lip, G. Y. H. (2021). Renal Disease and Atrial Fibrillation.. Cardiac electrophysiology clinics, 13(1), 95-112. doi:10.1016/j.ccep.2020.11.001DOI: 10.1016/j.ccep.2020.11.001
Statin use and mortality in atrial fibrillation: A systematic review and meta-analysis of 100,287 patients (Journal article)
Pastori, D., Baratta, F., Di Rocco, A., Farcomeni, A., Del Ben, M., Angelico, F., . . . Lip, G. Y. H. (2021). Statin use and mortality in atrial fibrillation: A systematic review and meta-analysis of 100,287 patients. PHARMACOLOGICAL RESEARCH, 165. doi:10.1016/j.phrs.2021.105418DOI: 10.1016/j.phrs.2021.105418
The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study (Journal article)
Pastori, D., Menichelli, D., Violi, F., Pignatelli, P., & Lip, G. Y. H. (2021). The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 85, 80-85. doi:10.1016/j.ejim.2020.12.011DOI: 10.1016/j.ejim.2020.12.011
Senoo, K., Nakata, M., Teramukai, S., Kumagai, M., Yamamoto, T., Nishimura, H., . . . Matoba, S. (2021). Relationship Between Body Mass Index and Incidence of Atrial Fibrillation in Young Japanese Men -The Nishimura Health Survey-. CIRCULATION JOURNAL, 85(3), 243-+. doi:10.1253/circj.CJ-20-0864DOI: 10.1253/circj.CJ-20-0864
Bentley, R., Logantha, S. J. R. J., Sharma, P., Rainbow, R. R., & Lip, G. Y. H. (2021). Pathophysiological insights into atrial fibrillation: revisiting the electrophysiological substrate, anatomical substrate, and possible insights from proteomics. CARDIOVASCULAR RESEARCH, 117(3), E41-E45. doi:10.1093/cvr/cvaa276DOI: 10.1093/cvr/cvaa276
Liang, W., Wu, Y., Xue, R., Wu, Z., Wu, D., He, J., . . . Liu, C. (2021). C<sub>2</sub>HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial. BMC MEDICINE, 19(1). doi:10.1186/s12916-021-01921-wDOI: 10.1186/s12916-021-01921-w
Nabrdalik, K., Krzyzak, K., Hajzler, W., Drozdz, K., Kwiendacz, H., Gumprecht, J., & Lip, G. Y. H. (2021). Fat, Sugar or Gut Microbiota in Reducing Cardiometabolic Risk: Does Diet Type Really Matter?. NUTRIENTS, 13(2). doi:10.3390/nu13020639DOI: 10.3390/nu13020639
Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention (Journal article)
Pastori, D., Biccire, F. G., Lip, G. Y. H., Menichelli, D., Pignatelli, P., Barilla, F., . . . Tanzilli, G. (2021). Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention. AMERICAN JOURNAL OF CARDIOLOGY, 141, 1-6. doi:10.1016/j.amjcard.2020.11.006DOI: 10.1016/j.amjcard.2020.11.006
Lee, S. -R., Han, K. -D., Choi, E. -K., Oh, S., & Lip, G. Y. H. (2021). Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study. SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-83367-xDOI: 10.1038/s41598-021-83367-x
Camelo-Castillo, A., Rivera-Caravaca, J. M., Orenes-Pinero, E., Ramirez-Macias, I., Roldan, V., Lip, G. Y. H., & Marin, F. (2021). Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications. JOURNAL OF CLINICAL MEDICINE, 10(4). doi:10.3390/jcm10040715DOI: 10.3390/jcm10040715
Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation (Journal article)
Kim, D., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2021). Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation. EUROPACE, 23(2), 184-195. doi:10.1093/europace/euaa192DOI: 10.1093/europace/euaa192
Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis fromthe ESC-EHRA EORPAtrial Fibrillation General Long-Term (AFGen LT) Registry (Journal article)
Proietti, M., Lip, G. Y. H., Laroche, C., Fauchier, L., Marin, F., Nabauer, M., . . . Boriani, G. (2021). Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis fromthe ESC-EHRA EORPAtrial Fibrillation General Long-Term (AFGen LT) Registry. EUROPACE, 23(2), 174-183. doi:10.1093/europace/euaa274DOI: 10.1093/europace/euaa274
The interpretation of CHA<sub>2</sub>DS<sub>2</sub>-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke (Journal article)
Zhang, J., Lenarczyk, R., Marin, F., Malaczynska-Rajpold, K., Kosiuk, J., Doehner, W., . . . Potpara, T. S. (2021). The interpretation of CHA<sub>2</sub>DS<sub>2</sub>-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke. EUROPACE, 23(2), 314-322. doi:10.1093/europace/euaa358DOI: 10.1093/europace/euaa358
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC (vol 42, pg 373, 2021) (Journal article)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomstroem-Lundqvist, C., . . . Watkins, C. L. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC (vol 42, pg 373, 2021). EUROPEAN HEART JOURNAL, 42(40), 4194. doi:10.1093/eurheartj/ehab648DOI: 10.1093/eurheartj/ehab648
Associations of atrial fibrillation progression with clinical risk factors and clinical prognosis: A report from the Chinese Atrial Fibrillation Registry study (Journal article)
Yang, W. -Y., Du, X., Fawzy, A. M., He, L., Li, H. -W., Dong, J. -Z., . . . Ma, C. -S. (2021). Associations of atrial fibrillation progression with clinical risk factors and clinical prognosis: A report from the Chinese Atrial Fibrillation Registry study. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 32(2), 333-341. doi:10.1111/jce.14826DOI: 10.1111/jce.14826
Effect of Diabetes Mellitus and Left Ventricular Perfusion on Frequency of Development of Heart Failure and/or All-cause Mortality Late After Acute Myocardial Infarction (Journal article)
Tomasik, A., Nabrdalik, K., Kwiendacz, H., Radzik, E., Pigon, K., Mlynczak, T., . . . Lip, G. Y. H. (2021). Effect of Diabetes Mellitus and Left Ventricular Perfusion on Frequency of Development of Heart Failure and/or All-cause Mortality Late After Acute Myocardial Infarction. AMERICAN JOURNAL OF CARDIOLOGY, 140, 25-32. doi:10.1016/j.amjcard.2020.10.051DOI: 10.1016/j.amjcard.2020.10.051
From the CHA<sub>2</sub>DS<sub>2</sub>-VASc score to inflammation: a path leading to frailty? An update of the PURE-Rhythm Trial (Journal article)
Fumagalli, S., Di Serio, C., Ricciardi, G., Lip, G. Y. H., & Marchionni, N. (2021). From the CHA<sub>2</sub>DS<sub>2</sub>-VASc score to inflammation: a path leading to frailty? An update of the PURE-Rhythm Trial. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 84, 118-120. doi:10.1016/j.ejim.2020.12.001DOI: 10.1016/j.ejim.2020.12.001
Boriani, G., Vitolo, M., Lane, D. A., Potpara, T. S., & Lip, G. Y. H. (2021). Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 86, 1-11. doi:10.1016/j.ejim.2021.01.006DOI: 10.1016/j.ejim.2021.01.006
Buckley, B. J. R., Harrison, S. L., Fazio-Eynullayeva, E., Underhill, P., Lane, D. A., Thijssen, D. H. J., & Lip, G. Y. H. (2021). Association of Exercise-Based Cardiac Rehabilitation with Progression of Paroxysmal to Sustained Atrial Fibrillation. JOURNAL OF CLINICAL MEDICINE, 10(3). doi:10.3390/jcm10030435DOI: 10.3390/jcm10030435
Bisson, A., Bodin, A., Fauchier, G., Herbert, J., Angoulvant, D., Ducluzeau, P. H., . . . Fauchier, L. (2021). Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis. CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01216-7DOI: 10.1186/s12933-021-01216-7
Ahn, H. -J., Han, K. -D., Choi, E. -K., Jung, J. -H., Kwon, S., Lee, S. -R., . . . Lip, G. Y. H. (2021). Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study. CARDIOVASCULAR DIABETOLOGY, 20(1). doi:10.1186/s12933-021-01215-8DOI: 10.1186/s12933-021-01215-8
Rubboli, A., Valgimigli, M., Capodanno, D., & Lip, G. Y. H. (2021). Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequence. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(1), 68-73. doi:10.1093/ehjcvp/pvaa047DOI: 10.1093/ehjcvp/pvaa047
Effectiveness and safety of edoxaban in patients with atrial fibrillation:data from the Danish Nationwide Cohort (Journal article)
Nielsen, P. B., Larsen, T. B., Skjoth, F., Sogaard, M., & Lip, G. Y. H. (2021). Effectiveness and safety of edoxaban in patients with atrial fibrillation:data from the Danish Nationwide Cohort. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(1), 31-39. doi:10.1093/ehjcvp/pvz070DOI: 10.1093/ehjcvp/pvz070
Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease (Journal article)
Lee, H. -F., See, L. -C., Li, P. -R., Liu, J. -R., Chao, T. -F., Chang, S. -H., . . . Lip, G. Y. H. (2021). Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(1), 50-58. doi:10.1093/ehjcvp/pvz072DOI: 10.1093/ehjcvp/pvz072
Javed, S., Gupta, D., & Lip, G. Y. H. (2021). Obesity and atrial fibrillation: making inroads through fat. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 7(1), 59-67. doi:10.1093/ehjcvp/pvaa013DOI: 10.1093/ehjcvp/pvaa013
Lee, S. -R., Choi, E. -K., Jung, J. -H., Park, S. -H., Han, K. -D., Oh, S., & Lip, G. Y. H. (2021). Body Mass Index and Clinical Outcomes in Asian Patients With Atrial Fibrillation Receiving Oral Anticoagulation.. Stroke, 52(2), 521-530. doi:10.1161/strokeaha.120.030356DOI: 10.1161/strokeaha.120.030356
Kwon, S., Lee, S. -R., Choi, E. -K., Lee, E., Jung, J. -H., Han, K. -D., . . . Lip, G. Y. H. (2021). Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding.. Stroke, 52(2), 511-520. doi:10.1161/strokeaha.120.030761DOI: 10.1161/strokeaha.120.030761
Acute ischemic stroke management: concepts and controversies.A narrative review (Journal article)
Li, K. H. C., Jesuthasan, A., Kui, C., Davies, R., Tse, G., & Lip, G. Y. H. (2021). Acute ischemic stroke management: concepts and controversies.A narrative review. EXPERT REVIEW OF NEUROTHERAPEUTICS, 21(1), 65-79. doi:10.1080/14737175.2021.1836963DOI: 10.1080/14737175.2021.1836963
<i>Thrombosis and Haemostasis</i> 2020 Editors' Choice Papers (Journal article)
Weber, C., Rigby, A., & Lip, G. Y. H. (2021). <i>Thrombosis and Haemostasis</i> 2020 Editors' Choice Papers. THROMBOSIS AND HAEMOSTASIS, 121(01), 109-114. doi:10.1055/s-0040-1722171DOI: 10.1055/s-0040-1722171
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomstrӧm-Lundqvist, C., . . . Watkins, C. L. (n.d.). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Russian Journal of Cardiology, 26(9), 4701. doi:10.15829/1560-4071-2021-4701DOI: 10.15829/1560-4071-2021-4701
Chao, T. -F., Joung, B., Takahashi, Y., Lim, T. W., Choi, E. -K., Chan, Y. -H., . . . Lip, G. Y. H. (2022). 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary *. THROMBOSIS AND HAEMOSTASIS, 122(01), 20-47. doi:10.1055/s-0041-1739411DOI: 10.1055/s-0041-1739411
A Rollercoaster Plunge into 2022. (Journal article)
Lip, G. Y. H., Rigby, A., & Weber, C. (2022). A Rollercoaster Plunge into 2022.. Thrombosis and haemostasis, 122(1), 1-4. doi:10.1055/s-0041-1741073DOI: 10.1055/s-0041-1741073
Aldosari, H., Coenen, F., Lip, G. Y. H., & Zheng, Y. (2021). Addressing the Challenge of Data Heterogeneity Using a Homogeneous Feature Vector Representation: A Study Using Time Series and Cardiovascular Disease Classification. In ARTIFICIAL INTELLIGENCE XXXVIII Vol. 13101 (pp. 254-266). doi:10.1007/978-3-030-91100-3_21DOI: 10.1007/978-3-030-91100-3_21
van der Wall, S. J., Teutsch, C., Dubner, S. J., Diener, H. -C., Halperin, J. L., Ma, C. S., . . . GLORIA-AF Investigators . (2021). Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF.. TH open : companion journal to thrombosis and haemostasis, 5(1), e35-e42. doi:10.1055/s-0040-1722706DOI: 10.1055/s-0040-1722706
Santos, I. S., Lotufo, P. A., Brant, L., Pinto, M. M., Pereira, A. D. C., Barreto, S. M., . . . Bensenor, I. M. (2021). Atrial Fibrillation Diagnosis using ECG Records and Self-Report in the Community: Cross-Sectional Analysis from ELSA-Brasil. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 117(3), 426-434. doi:10.36660/abc.20190873DOI: 10.36660/abc.20190873
Krittayaphong, R., Pumprueg, S., Ratanasumawong, K., Sairat, P., & Lip, G. Y. H. (2021). Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry. CLINICAL INTERVENTIONS IN AGING, 16, 1835-1846. doi:10.2147/CIA.S335321DOI: 10.2147/CIA.S335321
Blood pressure measurement in atrial fibrillation: goodbye mercury? (vol 29, pg 638, 2020) (Journal article)
Watson, T., & Lip, G. Y. H. (2021). Blood pressure measurement in atrial fibrillation: goodbye mercury? (vol 29, pg 638, 2020). JOURNAL OF HUMAN HYPERTENSION, 35(1), 107. doi:10.1038/s41371-020-0315-7DOI: 10.1038/s41371-020-0315-7
Deitelzweig, S., Keshishian, A., Kang, A., Dhamane, A. D., Luo, X., Balachander, N., . . . Lip, G. Y. H. (2021). Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 14. doi:10.1177/1756284821997352DOI: 10.1177/1756284821997352
Diabetes mellitus and atrial fibrillation—Untying the Gordian Knot (Chapter)
Domek, M., Javed, S., Gumprecht, J., & Lip, G. Y. H. (2021). Diabetes mellitus and atrial fibrillation—Untying the Gordian Knot. In Diabetes and Cardiovascular Disease (pp. 95-121). Elsevier. doi:10.1016/b978-0-12-817428-9.00004-8DOI: 10.1016/b978-0-12-817428-9.00004-8
Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients (Journal article)
Lin, Y. -S., Lin, M. -S., Wu, V. C. -C., Chen, Y. -L., Chang, J. -J., Chu, P. -H., . . . Chen, M. -C. (2021). Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients. FRONTIERS IN CARDIOVASCULAR MEDICINE, 8. doi:10.3389/fcvm.2021.775564DOI: 10.3389/fcvm.2021.775564
FIRST-TIME HOMEBUYERS’ INTERESTS IN USING PROPERTY CROWDFUNDING AS AN ALTERNATIVE FINANCING OPTION (Journal article)
Hon, C. C., Sivanathan, S., Goh, H. L., & Low, C. W. (n.d.). FIRST-TIME HOMEBUYERS’ INTERESTS IN USING PROPERTY CROWDFUNDING AS AN ALTERNATIVE FINANCING OPTION. PLANNING MALAYSIA, 19. doi:10.21837/pm.v19i17.989DOI: 10.21837/pm.v19i17.989
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomstrom-Lundqvist, C., . . . Watkins, C. L. (2021). Grupul de lucru pentru diagnosticul şi tratamentul fi brilaţiei atriale al societăţii europene de cardiologie (Esc). Revista Romana de Cardiologie, 31(3), 641-791.
Khan, A. A., Junejo, R. T., Thomas, G. N., Fisher, J. P., & Lip, G. Y. H. (2021). Heart rate variability in patients with atrial fibrillation and hypertension. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 51(1). doi:10.1111/eci.13361DOI: 10.1111/eci.13361
Koziel, M., Simovic, S., Pavlovic, N., Kocijancic, A., Paparisto, V., Music, L., . . . Investigators, B. A. L. K. A. N. -A. F. (n.d.). Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey. ANNALS OF MEDICINE. doi:10.1080/07853890.2020.1799241DOI: 10.1080/07853890.2020.1799241
Improving Stroke Risk Prediction in the General Population: A Comparative Assessment of Common Clinical Rules, a New Multimorbid Index, and Machine-Learning-Based Algorithms (Journal article)
Lip, G. Y. H., Genaidy, A., Tran, G., Marroquin, P., Estes, C., & Sloop, S. (2022). Improving Stroke Risk Prediction in the General Population: A Comparative Assessment of Common Clinical Rules, a New Multimorbid Index, and Machine-Learning-Based Algorithms. THROMBOSIS AND HAEMOSTASIS, 122(01), 142-150. doi:10.1055/a-1467-2993DOI: 10.1055/a-1467-2993
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial (Journal article)
Bikdeli, B., Talasaz, A. H., Rashidi, F., Bakhshandeh, H., Rafiee, F., Rezaeifar, P., . . . Sadeghipour, P. (2022). Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial. THROMBOSIS AND HAEMOSTASIS, 122(01), 131-141. doi:10.1055/a-1485-2372DOI: 10.1055/a-1485-2372
Looking Back on 2020, Looking Forward to 2021 (Journal article)
Lip, G. Y. H., Rigby, A., & Weber, C. (2021). Looking Back on 2020, Looking Forward to 2021. THROMBOSIS AND HAEMOSTASIS, 121(01), 1-3. doi:10.1055/s-0040-1722198DOI: 10.1055/s-0040-1722198
Aldosari, H., Coenen, F., Lip, G. Y. H., & Zheng, Y. (2021). Motif Based Feature Vectors: Towards a Homogeneous Data Representation for Cardiovascular Diseases Classification. In BIG DATA ANALYTICS AND KNOWLEDGE DISCOVERY (DAWAK 2021) Vol. 12925 (pp. 235-241). doi:10.1007/978-3-030-86534-4_22DOI: 10.1007/978-3-030-86534-4_22
Cheng, W. -H., Chiang, C. -E., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chao, T. -F. (2021). Non-Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation: Changing Clinical Practice and Outcomes for Stroke Prevention in a Nationwide Cohort Study. MAYO CLINIC PROCEEDINGS, 96(1), 52-65. doi:10.1016/j.mayocp.2020.08.042DOI: 10.1016/j.mayocp.2020.08.042
Khan, A. A., Hardy, L. J., Shantsila, E., Lau, Y. C., Philippou, H., & Lip, G. Y. H. (2021). Observations on clot properties in atrial fibrillation: Relation to renal function and choice of anticoagulant. THROMBOSIS RESEARCH, 197, 69-76. doi:10.1016/j.thromres.2020.10.039DOI: 10.1016/j.thromres.2020.10.039
Bahuleyan, C. G., Namboodiri, N., Jabir, A., Lip, G. Y. H., Koshy, G., Shifas, B. M., . . . Lordson, A. J. (2021). One-year clinical outcome of patients with nonvalvular atrial fibrillation: Insights from KERALA-AF registry. INDIAN HEART JOURNAL, 73(1), 56-62. doi:10.1016/j.ihj.2020.11.152DOI: 10.1016/j.ihj.2020.11.152
Lip, G. Y. H., Keshishian, A. V., Kang, A. L., Dhamane, A. D., Luo, X., Li, X., . . . Deitelzweig, S. (n.d.). Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study. Journal of Internal Medicine. doi:10.1111/joim.13140DOI: 10.1111/joim.13140
Essa, H., & Lip, G. Y. H. (2021). Palpitations in the Cancer Patient. EUROPEAN CARDIOLOGY REVIEW, 16. doi:10.15420/ecr.2021.44DOI: 10.15420/ecr.2021.44
Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia (Journal article)
Du, H., Wilson, D., Ambler, G., Banerjee, G., Shakeshaft, C., Cohen, H., . . . Werring, D. J. (2021). Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia. STROKE, 52(1), 91-99. doi:10.1161/STROKEAHA.120.029474DOI: 10.1161/STROKEAHA.120.029474
Thrombosis and Haemostasis 2021 Editors' Choice Papers. (Journal article)
Weber, C., Rigby, A., & Lip, G. Y. H. (2022). Thrombosis and Haemostasis 2021 Editors' Choice Papers.. Thrombosis and haemostasis, 122(1), 163-170. doi:10.1055/s-0041-1741072DOI: 10.1055/s-0041-1741072
Deng, K., Meng, Y., Gao, D., Bridge, J., Shen, Y., Lip, G., . . . Zheng, Y. (2021). TransBridge: A Lightweight Transformer for Left Ventricle Segmentation in Echocardiography. In SIMPLIFYING MEDICAL ULTRASOUND Vol. 12967 (pp. 63-72). doi:10.1007/978-3-030-87583-1_7DOI: 10.1007/978-3-030-87583-1_7
2020
Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review. (Journal article)
Ritchie, L. A., Oke, O. B., Harrison, S. L., Rodgers, S. E., Lip, G. Y. H., & Lane, D. A. (2021). Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review.. Age and Ageing, 50(3), 744-757. doi:10.1093/ageing/afaa268DOI: 10.1093/ageing/afaa268
Why Is Atrial Fibrillation So Frequent in Hypertensive Patients? (Journal article)
Vitolo, M., Lip, G. Y. H., & Shantsila, A. (2020). Why Is Atrial Fibrillation So Frequent in Hypertensive Patients?. AMERICAN JOURNAL OF HYPERTENSION, 33(12), 1067-1070. doi:10.1093/ajh/hpaa157DOI: 10.1093/ajh/hpaa157
Santos, I. S., Goulart, A. C., Olmos, R. D., Thomas, G. N., Lip, G. Y. H., Lotufo, P. A., & Bensenor, I. M. (2020). Atrial fibrillation in low- and middle-income countries: a narrative review. EUROPEAN HEART JOURNAL SUPPLEMENTS, 22(O), 61-77. doi:10.1093/eurheartj/suaa181DOI: 10.1093/eurheartj/suaa181
Atrial fibrillation is more frequently associated with nonobstructive coronary lesions: the Bialystok Coronary Project (Journal article)
Tomaszuk-Kazberuk, A., Kozinski, M., Kuzma, L., Bujno, E., Lopatowska, P., Rogalska, E., . . . Lip, G. Y. H. (2020). Atrial fibrillation is more frequently associated with nonobstructive coronary lesions: the Bialystok Coronary Project. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 130(12), 1029-1036. doi:10.20452/pamw.15635DOI: 10.20452/pamw.15635
Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial (Journal article)
Kotecha, D., Bunting, K. V., Gill, S. K., Mehta, S., Stanbury, M., Jones, J. C., . . . Kirchhof, P. (2020). Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 324(24), 2497-2508. doi:10.1001/jama.2020.23138DOI: 10.1001/jama.2020.23138
Relationship between coronary artery disease and atrial fibrillation still unclear Reply (Journal article)
Kuzma, L., Tomaszuk-Kazberuk, A., Kozinski, M., & Lip, G. Y. H. (2020). Relationship between coronary artery disease and atrial fibrillation still unclear Reply. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 130(12), 1123. doi:10.20452/pamw.15726DOI: 10.20452/pamw.15726
Lane, D. A., & Lip, G. Y. H. (2020). Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal. EUROPEAN HEART JOURNAL SUPPLEMENTS, 22(O), 14-27. doi:10.1093/eurheartj/suaa178DOI: 10.1093/eurheartj/suaa178
What do we do about atrial high rate episodes? (Journal article)
Boriani, G., Vitolo, M., Imberti, J. F., Potpara, T. S., & Lip, G. Y. H. (2020). What do we do about atrial high rate episodes?. EUROPEAN HEART JOURNAL SUPPLEMENTS, 22(O), 42-52. doi:10.1093/eurheartj/suaa179DOI: 10.1093/eurheartj/suaa179
Kim, D., Yang, P. -S., Sung, J. -H., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2020). Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study. EUROPEAN HEART JOURNAL, 41(47), 4483-4493. doi:10.1093/eurheartj/ehaa726DOI: 10.1093/eurheartj/ehaa726
Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease (Journal article)
Melgaard, L., Overvad, T. F., Jensen, M., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2020). Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease. JACC-CLINICAL ELECTROPHYSIOLOGY, 6(13), 1672-1682. doi:10.1016/j.jacep.2020.07.005DOI: 10.1016/j.jacep.2020.07.005
Harrison, S., Fazio-Eynullayeva, E., Lane, D., Underhill, P., & Lip, G. (2020). Atrial fibrillation and the risk of 30-day incident thromboembolic events and mortality in adults ≥50 years with COVID-19. Journal of Arrhythmia.
Miguel Rivera-Caravaca, J., Gil-Perez, P., Lopez-Garcia, C., Veliz-Martinez, A., Quintana-Giner, M., Isabel Romero-Aniorte, A., . . . Marin, F. (2020). A nurse-led atrial fibrillation clinic: Impact on anticoagulation therapy and clinical outcomes. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 74(12). doi:10.1111/ijcp.13634DOI: 10.1111/ijcp.13634
Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: A multicentre cohort study (Journal article)
Pastori, D., Ettorre, E., Lip, G. Y. H., Sciacqua, A., Perticone, F., Melillo, F., . . . Pignatelli, P. (2020). Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: A multicentre cohort study. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 86(12), 2455-2463. doi:10.1111/bcp.14350DOI: 10.1111/bcp.14350
Buckley, B. J. R., Kleinnibbelink, G., Lip, G. Y. H., Taylor, R. S., & Thijssen, D. H. J. (2020). Cardiac rehabilitation meta-analysis of trials in patients with coronary heart disease using individual participant data (CaReMATCH): Project protocol. IJC Heart & Vasculature, 31, 100616. doi:10.1016/j.ijcha.2020.100616DOI: 10.1016/j.ijcha.2020.100616
Detection of Atrial Fibrillation on Stroke Units: Look Harder, Look Longer, Look in More Sophisticated Ways (Journal article)
Gue, Y. X., Potpara, T. S., & Lip, G. Y. H. (2020). Detection of Atrial Fibrillation on Stroke Units: Look Harder, Look Longer, Look in More Sophisticated Ways. CEREBROVASCULAR DISEASES, 49(6), 656-658. doi:10.1159/000512205DOI: 10.1159/000512205
Dubner, S., Saraiva, J. F. K., Fragoso, J. C. N., Barón-Esquivias, G., Teutsch, C., Gurusamy, V. K., . . . Zeballos, C. (2020). Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registry.. International journal of cardiology. Heart & vasculature, 31, 100666. doi:10.1016/j.ijcha.2020.100666DOI: 10.1016/j.ijcha.2020.100666
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. (Journal article)
Gerotziafas, G. T., Catalano, M., Colgan, M. -P., Pecsvarady, Z., Wautrecht, J. C., Fazeli, B., . . . Scientific Reviewer Committee. (2020). Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine.. Thrombosis and haemostasis, 120(12), 1597-1628. doi:10.1055/s-0040-1715798DOI: 10.1055/s-0040-1715798
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies (Journal article)
Bikdeli, B., Talasaz, A. H., Rashidi, F., Sharif-Kashani, B., Farrokhpour, M., Bakhshandeh, H., . . . Sadeghipour, P. (2020). Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies. THROMBOSIS RESEARCH, 196, 382-394. doi:10.1016/j.thromres.2020.09.027DOI: 10.1016/j.thromres.2020.09.027
Letter by Ding et al Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation" (Journal article)
Ding, W. Y., Rivera-Caravaca, J. M., & Lip, G. Y. H. (2020). Letter by Ding et al Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation". STROKE, 51(12), E361-E362. doi:10.1161/STROKEAHA.120.031780DOI: 10.1161/STROKEAHA.120.031780
Guo, Y., Guo, J., Shi, X., Yao, Y., Sun, Y., Xia, Y., . . . Investigators, M. -A. I. I. T. (2020). Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort. European Journal of Internal Medicine, 82, 105-111. doi:10.1016/j.ejim.2020.09.024DOI: 10.1016/j.ejim.2020.09.024
Chan, Y. -H., Chao, T. -F., Chen, S. -W., Lee, H. -F., Yeh, Y. -H., Huang, Y. -C., . . . Chen, S. -A. (2020). Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation. HEART RHYTHM, 17(12), 2102-2110. doi:10.1016/j.hrthm.2020.07.022DOI: 10.1016/j.hrthm.2020.07.022
Physical activity or fitness as medicine for your arteries? (Journal article)
Buckley, B. J. R., Thijssen, D. H. J., & Lip, G. Y. H. (2020). Physical activity or fitness as medicine for your arteries?. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 74(12). doi:10.1111/ijcp.13688DOI: 10.1111/ijcp.13688
Fumagalli, S., Pelagalli, G., Montorzi, R. F., Marozzi, I., Migliorini, M., D'Andria, M. F., . . . Marchionni, N. (2020). The CHA(2)DS(2)-VASc score and Geriatric Multidimensional Assessment tools in elderly patients with persistent atrial fibrillation undergoing electrical cardioversion. A link with arrhythmia relapse?. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 82, 56-61. doi:10.1016/j.ejim.2020.07.010DOI: 10.1016/j.ejim.2020.07.010
The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study (Journal article)
Jozwiak, J. J., Studzinski, K., Tomasik, T., Windak, A., Mastej, M., Catapano, A. L., . . . Banach, M. (2020). The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study. ATHEROSCLEROSIS SUPPLEMENTS, 42, E15-E24. doi:10.1016/j.atherosclerosissup.2021.01.004DOI: 10.1016/j.atherosclerosissup.2021.01.004
Heart-type fatty acid-binding protein: an overlooked cardiac biomarker (Journal article)
Goel, H., Melot, J., Krinock, M. D., Kumar, A., Nadar, S. K., & Lip, G. Y. H. (n.d.). Heart-type fatty acid-binding protein: an overlooked cardiac biomarker. Annals of Medicine. doi:10.1080/07853890.2020.1800075DOI: 10.1080/07853890.2020.1800075
Mc Lernon, S., Schwarz, G., Wilson, D., Ambler, G., Goodwin, R., Shakeshaft, C., . . . Werring, D. J. (2020). Association between critical care admission and 6-month functional outcome after spontaneous intracerebral haemorrhage. JOURNAL OF THE NEUROLOGICAL SCIENCES, 418. doi:10.1016/j.jns.2020.117141DOI: 10.1016/j.jns.2020.117141
Kim, D., Yang, P. -S., Lip, G. Y. H., & Joung, B. (2020). Atrial Fibrillation Increases the Risk of Early-Onset Dementia in the General Population: Data from a Population-Based Cohort. JOURNAL OF CLINICAL MEDICINE, 9(11). doi:10.3390/jcm9113665DOI: 10.3390/jcm9113665
Harrison, S. L., Buckley, B. J. R., Fazio-Eynullayeva, E., Underhill, P., Lane, D. A., & Lip, G. Y. H. (2020). End-Stage Renal Disease and 30-day Mortality for Adults with and without COVID-19. European Journal of Internal Medicine. doi:10.1016/j.ejim.2020.11.003DOI: 10.1016/j.ejim.2020.11.003
Lee, S. -R., Choi, E. -K., Ahn, H. -J., Han, K. -D., Oh, S., & Lip, G. Y. H. (2020). Association between clustering of unhealthy lifestyle factors and risk of new-onset atrial fibrillation: a nationwide population-based study. SCIENTIFIC REPORTS, 10(1). doi:10.1038/s41598-020-75822-yDOI: 10.1038/s41598-020-75822-y
Atrial fibrillation: Can it be as easy as CC to ABC? (Journal article)
Ding, W. Y., Lip, G. Y. H., & Potpara, T. S. (2020). Atrial fibrillation: Can it be as easy as CC to ABC?. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 50(11). doi:10.1111/eci.13413DOI: 10.1111/eci.13413
Cardiovascular Events and Mortality in Patients With Atrial Fibrillation and Anemia (from the Fushimi AF Registry) (Journal article)
An, Y., Ogawa, H., Esato, M., Ishii, M., Iguchi, M., Masunaga, N., . . . Akao, M. (2020). Cardiovascular Events and Mortality in Patients With Atrial Fibrillation and Anemia (from the Fushimi AF Registry). AMERICAN JOURNAL OF CARDIOLOGY, 134, 74-82. doi:10.1016/j.amjcard.2020.08.009DOI: 10.1016/j.amjcard.2020.08.009
De Caterina, R., Procopio, A., Lopez Sendon, J. -L., Raev, D., Mehta, S. R., Opolski, G., . . . Cannon, C. P. (2020). Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI. AMERICAN JOURNAL OF MEDICINE, 133(11), 1302-1312. doi:10.1016/j.amjmed.2020.03.045DOI: 10.1016/j.amjmed.2020.03.045
Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial (Journal article)
Goette, A., Merino, J. L., De Caterina, R., Huber, K., Heidbuchel, H., Jin, J., & Lip, G. Y. H. (2020). Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial. CLINICAL RESEARCH IN CARDIOLOGY, 109(11), 1374-1380. doi:10.1007/s00392-020-01635-8DOI: 10.1007/s00392-020-01635-8
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit (Journal article)
Falsetti, L., Proietti, M., Zaccone, V., Guerra, F., Nitti, C., Salvi, A., . . . Capucci, A. (2020). Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 50(11). doi:10.1111/eci.13317DOI: 10.1111/eci.13317
Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: A nationwide population-based study (Journal article)
Kwon, S., Lee, S. -R., Choi, E. -K., Choe, W. -S., Lee, E., Jung, J. -H., . . . Lip, G. Y. H. (2020). Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: A nationwide population-based study. AMERICAN HEART JOURNAL, 229, 81-91. doi:10.1016/j.ahj.2020.08.006DOI: 10.1016/j.ahj.2020.08.006
Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation (Journal article)
Rivera-Caravaca, J. M., Roldan, V., Vicente, V., Lip, G. Y. H., & Marin, F. (2020). Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation. MAYO CLINIC PROCEEDINGS, 95(11), 2360-2369. doi:10.1016/j.mayocp.2020.05.046DOI: 10.1016/j.mayocp.2020.05.046
Buckley, B. J. R., Thijssen, D., & Lip, G. Y. H. (2020). Relative skeletal muscle mass and incident hypertension: associations, caveats, and future perspectives. JOURNAL OF HYPERTENSION, 38(11), 2150-2151. doi:10.1097/HJH.0000000000002548DOI: 10.1097/HJH.0000000000002548
Sambola, A., Rello, P., Soriano, T., Bhatt, D. L., Pasupuleti, V., Cannon, C. P., . . . Hernandez, A. V. (2020). Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis.. Thrombosis research, 195, 128-135. doi:10.1016/j.thromres.2020.07.010DOI: 10.1016/j.thromres.2020.07.010
Rowe, F. J., Hepworth, L. R., Howard, C., Cullen, C., Sturgess, B., Griffiths, N., & Lip, G. Y. H. (2020). Stroke-Related Visual Impairment; is There an Association with Atrial Fibrillation?. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 29(11). doi:10.1016/j.jstrokecerebrovasdis.2020.105186DOI: 10.1016/j.jstrokecerebrovasdis.2020.105186
Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest (Journal article)
Gue, Y. X., Sayers, M., Whitby, B. T., Kanji, R., Adatia, K., Smith, R., . . . Gorog, D. A. (2020). Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest. AMERICAN JOURNAL OF MEDICINE, 133(11), 1328-1335. doi:10.1016/j.amjmed.2020.03.046DOI: 10.1016/j.amjmed.2020.03.046
Ritchie, L. A., Qin, S., Penson, P. E., Henney, N. C., & Lip, G. Y. H. (2020). Vernakalant hydrochloride for the treatment of atrial fibrillation: evaluation of its place in clinical practice. FUTURE CARDIOLOGY, 16(6), 585-596. doi:10.2217/fca-2020-0039DOI: 10.2217/fca-2020-0039
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation (Journal article)
Okumura, K., Akao, M., Yoshida, T., Kawata, M., Okazaki, O., Akashi, S., . . . Yamashita, T. (2020). Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation. NEW ENGLAND JOURNAL OF MEDICINE, 383(18), 1735-1745. doi:10.1056/NEJMoa2012883DOI: 10.1056/NEJMoa2012883
Optimal INR level in elderly and non-elderly patients with atrial fibrillation receiving warfarin: a report from the COOL-AF nationwide registry in Thailand (Journal article)
Krittayaphong, R., Kunjara-Na-Ayudhya, R., Ngamjanyaporn, P., Boonyaratavej, S., Komoltri, C., Yindeengam, A., . . . Lip, G. Y. H. (2020). Optimal INR level in elderly and non-elderly patients with atrial fibrillation receiving warfarin: a report from the COOL-AF nationwide registry in Thailand. JOURNAL OF GERIATRIC CARDIOLOGY, 17(10), 612-620. doi:10.11909/j.issn.1671-5411.2020.10.004DOI: 10.11909/j.issn.1671-5411.2020.10.004
ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19 (Journal article)
Wang, Y., Tse, G., Li, G., Lip, G. Y. H., & Liu, T. (2020). ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 76(17), 2041. doi:10.1016/j.jacc.2020.07.068DOI: 10.1016/j.jacc.2020.07.068
Best, J. G., Barbato, C., Ambler, G., Du, H., Banerjee, G., Wilson, D., . . . Werring, D. J. (2020). Association of enlarged perivascular spaces and anticoagulant-related intracranial hemorrhage. NEUROLOGY, 95(16), E2192-E2199. doi:10.1212/WNL.0000000000010788DOI: 10.1212/WNL.0000000000010788
Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes (Journal article)
Chan, Y. -H., Chao, T. -F., Lee, H. -F., Yeh, Y. -H., Yeh, C. -H., Huang, Y. -C., . . . Chen, S. -A. (2020). Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 76(15), 1808-1810. doi:10.1016/j.jacc.2020.08.025DOI: 10.1016/j.jacc.2020.08.025
Rivera-Caravaca, J. M., Esteve-Pastor, M. A., Camelo-Castillo, A., Ramirez-Macias, I., Lip, G. Y. H., Roldan, V., & Marin, F. (n.d.). Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy. Expert Opinion on Pharmacotherapy. doi:10.1080/14656566.2020.1789099DOI: 10.1080/14656566.2020.1789099
Ag–Sn Transient Liquid Phase Bonding for High Temperature Electronic Packaging: Effect of Ag Content (Journal article)
Singh Nobeen, N., Yan, G., Gan, C. L., & Chen, Z. (2020). Ag–Sn Transient Liquid Phase Bonding for High Temperature Electronic Packaging: Effect of Ag Content. IEEE Transactions on Components, Packaging and Manufacturing Technology, 10(10), 1604-1610. doi:10.1109/tcpmt.2020.3009515DOI: 10.1109/tcpmt.2020.3009515
Association of relative wall thickness of left ventricle with incidence of thromboembolism in patients with non-valvular atrial fibrillation: The Fushimi AF Registry (Journal article)
Tezuka, Y., Iguchi, M., Hamatani, Y., Ogawa, H., Esato, M., Tsuji, H., . . . Akao, M. (2020). Association of relative wall thickness of left ventricle with incidence of thromboembolism in patients with non-valvular atrial fibrillation: The Fushimi AF Registry. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 6(4), 273-283. doi:10.1093/ehjqcco/qcaa003DOI: 10.1093/ehjqcco/qcaa003
Ding, W. Y., Gupta, D., & Lip, G. Y. H. (2020). Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020. HEART, 106(19), 1463-1468. doi:10.1136/heartjnl-2020-316977DOI: 10.1136/heartjnl-2020-316977
Atrial fibrillation in obesity: Weighing up the evidence for catheter ablation (Journal article)
Javed, S., Gupta, D., & Lip, G. Y. H. (2020). Atrial fibrillation in obesity: Weighing up the evidence for catheter ablation. CLINICAL CARDIOLOGY, 43(10), 1064-1066. doi:10.1002/clc.23416DOI: 10.1002/clc.23416
Wang, Y., Wang, Z., Tse, G., Zhang, L., Wan, E. Y., Guo, Y., . . . Liu, T. (2020). Cardiac arrhythmias in patients with COVID-19. JOURNAL OF ARRHYTHMIA, 36(5), 827-836. doi:10.1002/joa3.12405DOI: 10.1002/joa3.12405
Dubner, S. J., Teutsch, C., Huisman, M. V., Diener, H. -C., Halperin, J., Rothman, K. J., . . . Lip, G. Y. H. (2020). Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF. ESC HEART FAILURE, 7(5), 2679-2689. doi:10.1002/ehf2.12857DOI: 10.1002/ehf2.12857
Boriani, G., Huisman, M. V., Teutsch, C., Marler, S., Franca, L. R., Lu, S., & Lip, G. Y. H. (2020). Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: The GLORIA-AF Registry Program. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 80, 35-44. doi:10.1016/j.ejim.2020.04.032DOI: 10.1016/j.ejim.2020.04.032
Park, J., Choi, E. -K., Han, K. -D., Kim, B., Choi, Y. -J., Lee, S. -R., . . . Lip, G. Y. H. (2020). Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention. PLOS ONE, 15(10). doi:10.1371/journal.pone.0240161DOI: 10.1371/journal.pone.0240161
Guo, Y., Lane, D. A., Chen, Y., & Lip, G. Y. H. (2020). Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial. AMERICAN JOURNAL OF MEDICINE, 133(10), 1195-+. doi:10.1016/j.amjmed.2020.03.019DOI: 10.1016/j.amjmed.2020.03.019
Chang, T. -Y., Chan, Y. -H., Chiang, C. -E., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chao, T. -F. (2020). Risks and outcomes of gastrointestinal malignancies in anticoagulated atrial fibrillation patients experiencing gastrointestinal bleeding: A nationwide cohort study. Heart Rhythm, 17(10), 1745-1751. doi:10.1016/j.hrthm.2020.05.026DOI: 10.1016/j.hrthm.2020.05.026
Ding, W. Y., Lip, G. Y. H., Fairbairn, T., Binukrishnan, S., Khalatbari, A., Velavan, P., & Gupta, D. (2020). Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion.. TH open : companion journal to thrombosis and haemostasis, 4(4), e351-e353. doi:10.1055/s-0040-1718585DOI: 10.1055/s-0040-1718585
Temporal trends of catheter ablation for patients with atrial fibrillation: A Korean nationwide population-based study (Journal article)
Lee, E., Lee, S. -R., Choi, E. -K., Han, K. -D., Cha, M. -J., Lip, G. Y. H., & Oh, S. (2020). Temporal trends of catheter ablation for patients with atrial fibrillation: A Korean nationwide population-based study. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 31(10), 2616-2625. doi:10.1111/jce.14737DOI: 10.1111/jce.14737
Vitolo, M., Proietti, M., Harrison, S., Lane, D. A., Potpara, T. S., Boriani, G., & Lip, G. Y. H. (2020). The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years. INTERNAL AND EMERGENCY MEDICINE, 15(7), 1183-1192. doi:10.1007/s11739-020-02405-0DOI: 10.1007/s11739-020-02405-0
Melgaard, L., Jensen, M., Overvad, T. F., Larsen, T. B., Lip, G. Y. H., & Nielsen, P. B. (n.d.). Thromboembolic and bleeding outcomes in patients with atrial fibrillation and valvular heart disease: A descriptive nationwide cohort study.. International Journal of Clinical Practice. doi:10.1111/ijcp.13589DOI: 10.1111/ijcp.13589
Kozieł, M., Simovic, S., Pavlovic, N., Nedeljkovic, M., Kocijancic, A., Paparisto, V., . . . Potpara, T. S. (n.d.). Treatment implications of renal disease in patients with atrial fibrillation: The BALKAN‐AF survey. Journal of Arrhythmia. doi:10.1002/joa3.12404DOI: 10.1002/joa3.12404
Wearable cardioverter-defibrillator to reduce the transient risk of sudden cardiac death in coronary artery disease: Authors' reply (Journal article)
Tfelt-Hansen, J., Svendsen, J. H., Kalarus, Z., Capodanno, D., Dan, G. -A., De Maria, E., . . . Lip, G. Y. H. (2020). Wearable cardioverter-defibrillator to reduce the transient risk of sudden cardiac death in coronary artery disease: Authors' reply. EUROPACE, 22(10), 1600-1601. doi:10.1093/europace/euaa052DOI: 10.1093/europace/euaa052
Kotalczyk, A., Kalarus, Z., Wright, D. J., Boriani, G., & Lip, G. Y. H. (2020). Cardiac Electronic Devices: Future Directions and Challenges.. Medical devices (Auckland, N.Z.), 13, 325-338. doi:10.2147/mder.s245625DOI: 10.2147/mder.s245625
Almarzouki, A., Wilson, D., Ambler, G., Shakeshaft, C., Cohen, H., Yousry, T., . . . Werring, D. J. (2020). Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage. SCIENTIFIC REPORTS, 10(1). doi:10.1038/s41598-020-72504-7DOI: 10.1038/s41598-020-72504-7
Gawalko, M., Lodzinski, P., Budnik, M., Tyminska, A., Wancerz, A., Ozieranski, K., . . . Balsam, P. (2020). Vascular disease in patients with atrial fibrillation. A report from Polish participants in the EORP-AF General Long-Term Registry. International Journal of Clinical Practice. doi:10.1111/ijcp.13701DOI: 10.1111/ijcp.13701
Buckley, B., Lip, G., & Thijssen, D. H. J. (2020). The counterintuitive role of exercise in the prevention and cause of atrial fibrillation.. American journal of physiology. Heart and circulatory physiology. doi:10.1152/ajpheart.00509.2020DOI: 10.1152/ajpheart.00509.2020
Park, Y. J., Yang, P. -S., Yu, H. T., Kim, T. -H., Jang, E., Uhm, J. -S., . . . Joung, B. (2020). What Is the Ideal Blood Pressure Threshold for the Prevention of Atrial Fibrillation in Elderly General Population?. JOURNAL OF CLINICAL MEDICINE, 9(9). doi:10.3390/jcm9092988DOI: 10.3390/jcm9092988
A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial Fibrillation (Journal article)
Steensig, K., Olesen, K. K. W., Madsen, M., Thim, T., Jensen, L. O., Wurtz, M., . . . Maeng, M. (2020). A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 131, 40-48. doi:10.1016/j.amjcard.2020.06.031DOI: 10.1016/j.amjcard.2020.06.031
Differences in Thromboembolic Complications Between Paroxysmal and Persistent Atrial Fibrillation Patients Following Electrical Cardioversion (From the ENSURE-AF Study) (Journal article)
Goette, A., Lip, G. Y. H., Jin, J., Heidbuchel, H., Cohen, A. -A., Ezekowitz, M., & Luis Merino, J. (2020). Differences in Thromboembolic Complications Between Paroxysmal and Persistent Atrial Fibrillation Patients Following Electrical Cardioversion (From the ENSURE-AF Study). AMERICAN JOURNAL OF CARDIOLOGY, 131, 27-32. doi:10.1016/j.amjcard.2020.06.046DOI: 10.1016/j.amjcard.2020.06.046
Shantsila, E., Shahid, F., Sun, Y., Deeks, J., Calvert, M., Fisher, J. P., . . . Lip, G. Y. H. (2020). Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS-AF Trial. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 9(18). doi:10.1161/JAHA.119.016239DOI: 10.1161/JAHA.119.016239
Yew Ding, W., Kozhuharov, N., Hao Chin, S., Shaw, M., Snowdon, R., Lip, G. Y. H., & Gupta, D. (2020). Feasibility of weight loss in obese atrial fibrillation patients attending a specialist arrhythmia clinic and its impact on ablation outcomes. Journal of Arrhythmia. doi:10.1002/joa3.12432DOI: 10.1002/joa3.12432
Junejo, R. T., Lip, G. Y. H., & Fisher, J. P. (2020). Cerebrovascular Dysfunction in Atrial Fibrillation. FRONTIERS IN PHYSIOLOGY, 11. doi:10.3389/fphys.2020.01066DOI: 10.3389/fphys.2020.01066
Tidbury, N., Preston, J., Ding, W. Y., Rivera-Caravaca, J. M., Marín, F., & Lip, G. Y. H. (2020). Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine response. Expert Review of Precision Medicine and Drug Development, 5(5), 331-345. doi:10.1080/23808993.2020.1804864DOI: 10.1080/23808993.2020.1804864
Sagris, D., Leventis, I., Georgiopoulos, G., Korompoki, E., Makaritsis, K., Vemmos, K., . . . Ntaios, G. (2020). Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 79, 31-36. doi:10.1016/j.ejim.2020.05.001DOI: 10.1016/j.ejim.2020.05.001
Ntaios, G., Michel, P., Georgiopoulos, G., Guo, Y., Li, W., Xiong, J., . . . Lip, G. Y. H. (2020). Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke The Global COVID-19 Stroke Registry. STROKE, 51(9), E254-E258. doi:10.1161/STROKEAHA.120.031208DOI: 10.1161/STROKEAHA.120.031208
Harrison, S. L., Fazio-Eynullayeva, E., Lane, D. A., Underhill, P., & Lip, G. Y. H. (2020). Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis. PLOS MEDICINE, 17(9). doi:10.1371/journal.pmed.1003321DOI: 10.1371/journal.pmed.1003321
Chan, Y. -H., Wu, L. -S., See, L. -C., Liu, J. -R., Chang, S. -H., Chao, T. -F., . . . Lip, G. Y. H. (2020). Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 105(9), 2893-2904. doi:10.1210/clinem/dgaa050DOI: 10.1210/clinem/dgaa050
Nielsen, J. C., Lin, Y. -J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., . . . Leclercq, C. (2020). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.. Heart Rhythm, 17(9), e269-e316. doi:10.1016/j.hrthm.2020.05.004DOI: 10.1016/j.hrthm.2020.05.004
Pastori, D., Menichelli, D., Lip, G. Y. H., Sciacqua, A., Violi, F., Pignatelli, P., & Grp, A. T. H. E. R. O. A. F. S. (2020). Family History of Atrial Fibrillation and Risk of Cardiovascular Events A Multicenter Prospective Cohort Study. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 13(9). doi:10.1161/CIRCEP.120.008477DOI: 10.1161/CIRCEP.120.008477
Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation (Journal article)
Diener, H. -C., Hankey, G. J., Easton, J. D., Lip, G. Y. H., Hart, R. G., & Caso, V. (2020). Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation. EUROPEAN HEART JOURNAL SUPPLEMENTS, 22(I), I13-I21. doi:10.1093/eurheartj/suaa104DOI: 10.1093/eurheartj/suaa104
Domek, M., Gumprecht, J., Ding, W. Y., Lip, G. Y. H., & Lane, D. A. (2020). Practice-derived data on non-vitamin K antagonist oral anticoagulant therapy to complement observations from randomized trials. EUROPEAN HEART JOURNAL SUPPLEMENTS, 22(I), I1-I12. doi:10.1093/eurheartj/suaa100DOI: 10.1093/eurheartj/suaa100
Zhang, J., Potpara, T., & Lip, G. Y. H. (2020). Stroke risk stratification in hypertrophic cardiomyopathy. HELLENIC JOURNAL OF CARDIOLOGY, 61(5), 318-320. doi:10.1016/j.hjc.2020.11.003DOI: 10.1016/j.hjc.2020.11.003
Li, G., Lip, G. Y. H., Marcucci, M., Thabane, L., Tian, J., & Levine, M. A. H. (2020). The number needed to treat for net effect (NNTnet) as a metric for measuring combined benefits and harms. Journal of Clinical Epidemiology, 125, 100-107. doi:10.1016/j.jclinepi.2020.05.031DOI: 10.1016/j.jclinepi.2020.05.031
Wearable cardioverter-defibrillator in patients at risk of sudden cardiac death: consensus document from Kalarus et al. contradicts current guideline recommendations-Authors' reply (Journal article)
Tfelt-Hansen, J., Svendsen, J. H., Kalarus, Z., Capodanno, D., Dan, G. -A., De Maria, E., . . . Lip, G. Y. H. (2020). Wearable cardioverter-defibrillator in patients at risk of sudden cardiac death: consensus document from Kalarus et al. contradicts current guideline recommendations-Authors' reply. EUROPACE, 22(9), 1442-1443. doi:10.1093/europace/euaa053DOI: 10.1093/europace/euaa053
Arbelo, E., Aktaa, S., Bollmann, A., D'Avila, A., Drossart, I., Dwight, J., . . . ESC Scientific Document Group. (2020). Quality indicators for the care and outcomes of adults with atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. doi:10.1093/europace/euaa253DOI: 10.1093/europace/euaa253
Potpara, T. S., Lip, G. Y. H., Blomstrom-Lundqvist, C., Boriani, G., Van Gelder, I. C., Heidbuchel, H., . . . Camm, A. J. (2020). The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation. Thrombosis and Haemostasis. doi:10.1055/s-0040-1716408DOI: 10.1055/s-0040-1716408
Krittayaphong, R., Chichareon, P., Komoltri, C., Kornbongkotmas, S., Yindeengam, A., & Lip, G. Y. H. (2020). Low Body Weight Increases the Risk of Ischemic Stroke and Major Bleeding in Atrial Fibrillation: The COOL-AF Registry. JOURNAL OF CLINICAL MEDICINE, 9(9). doi:10.3390/jcm9092713DOI: 10.3390/jcm9092713
Choi, S. Y., Kim, M. H., Lee, K. M., Cho, Y. -R., Park, J. S., Kim, S. W., . . . Lip, G. Y. H. (2020). Anticoagulant Therapy in Initially Low-Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 9(16). doi:10.1161/JAHA.120.016271DOI: 10.1161/JAHA.120.016271
Vitolo, M., Javed, S., Capodanno, D., Rubboli, A., Boriani, G., & Lip, G. Y. H. (2020). Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis.. Expert Review of Cardiovascular Therapy, 1-14. doi:10.1080/14779072.2020.1808463DOI: 10.1080/14779072.2020.1808463
García-Fernández, A., Esteve-Pastor, M. A., Rabadán, I. R., Muñiz, J., Ruiz Ortiz, M., Cequier, Á., . . . Marín, F. (n.d.). Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: Real-world data from the FANTASIIA registry.. Annals of medicine. doi:10.1080/07853890.2020.1778176DOI: 10.1080/07853890.2020.1778176
Essa, H., Pettitt, A. R., & Lip, G. Y. H. (2020). Hypertension and cardiovascular risk factors when treating cancer patients: underrecognised and undertreated. JOURNAL OF HUMAN HYPERTENSION. doi:10.1038/s41371-020-00400-8DOI: 10.1038/s41371-020-00400-8
Blood pressure targets in atrial fibrillation. (Journal article)
Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2020). Blood pressure targets in atrial fibrillation.. European heart journal, 41(30), 2860-2862. doi:10.1093/eurheartj/ehaa319DOI: 10.1093/eurheartj/ehaa319
Nielsen, J. C., Lin, Y. -J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., . . . Leclercq, C. (2020). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.. Journal of Arrhythmia, 36(4), 553-607. doi:10.1002/joa3.12338DOI: 10.1002/joa3.12338
Essa, H., Dobson, R., Wright, D., & Lip, G. Y. H. (2020). Hypertension management in cardio-oncology. Journal of Human Hypertension. doi:10.1038/s41371-020-0391-8DOI: 10.1038/s41371-020-0391-8
Zulkifly, H., Cheli, P., Lutchman, I., Bai, Y., Lip, G. Y. H., & Lane, D. A. (2020). Anticoagulation control in different ethnic groups receiving vitamin K antagonist therapy for stroke prevention in atrial fibrillation. Thrombosis Research. doi:10.1016/j.thromres.2020.04.001DOI: 10.1016/j.thromres.2020.04.001
Yang, P. -S., Sung, J. -H., Jang, E., Yu, H. T., Kim, T. -H., Lip, G. Y. H., & Joung, B. (2020). Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: A nationwide cohort study.. Journal of arrhythmia, 36(4), 668-677. doi:10.1002/joa3.12364DOI: 10.1002/joa3.12364
Defibrillators for prevention from sudden cardiac death: is it that easy?-Authors' reply (Journal article)
Tfelt-Hansen, J., Svendsen, J. H., Kalarus, Z., Capodanno, D., Dan, G. -A., De Maria, E., . . . Lip, G. Y. H. (2020). Defibrillators for prevention from sudden cardiac death: is it that easy?-Authors' reply. EUROPACE, 22(8), 1298-1299. doi:10.1093/europace/euaa058DOI: 10.1093/europace/euaa058
Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study (Journal article)
Pastori, D., Lip, G. Y. H., Poli, D., Antonucci, E., Rubino, L., Menichelli, D., . . . Pignatelli, P. (2020). Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study. BRITISH JOURNAL OF HAEMATOLOGY, 190(4), 588-593. doi:10.1111/bjh.16528DOI: 10.1111/bjh.16528
Koziel, M., Al-Saady, N., Hjortshoj, S. P., Goudev, A., Huber, K., Cohen, A., . . . Lip, G. Y. H. (2020). Edoxaban versus warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial. CLINICAL RESEARCH IN CARDIOLOGY, 109(8), 1018-1024. doi:10.1007/s00392-019-01594-9DOI: 10.1007/s00392-019-01594-9
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. (Journal article)
Nielsen, J. C., Lin, Y. -J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., . . . Leclercq, C. (2020). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 22(8), 1147-1148. doi:10.1093/europace/euaa065DOI: 10.1093/europace/euaa065
Guo, Y., Lip, G. Y. H., & Lane, D. A. (2020). Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: we could do more.. Trends in cardiovascular medicine. doi:10.1016/j.tcm.2020.03.007DOI: 10.1016/j.tcm.2020.03.007
Banerjee, G., Wilson, D., Ambler, G., Hostettler, I. C., Shakeshaft, C., Cohen, H., . . . Collaborators, C. (2020). Longer term stroke risk in intracerebral haemorrhage survivors. Journal of Neurology, Neurosurgery and Psychiatry, 91(8), 840-845. doi:10.1136/jnnp-2020-323079DOI: 10.1136/jnnp-2020-323079
Junejo, R. T., Braz, I. D., Lucas, S. J. E., van Lieshout, J. J., Phillips, A. A., Lip, G. Y. H., & Fisher, J. P. (2020). Neurovascular coupling and cerebral autoregulation in atrial fibrillation. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 40(8), 1647-1657. doi:10.1177/0271678X19870770DOI: 10.1177/0271678X19870770
Camelo-Castillo, A., Miguel Rivera-Caravaca, J., Marin, F., Vicente, V., Lip, G. Y. H., & Roldan, V. (2020). Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project. THROMBOSIS AND HAEMOSTASIS, 120(08), 1200-1207. doi:10.1055/s-0040-1712914DOI: 10.1055/s-0040-1712914
Sample Preparation for Deprocessing of 3D Multi-Die Stacked Package (Conference Paper)
Kor, H. B., Liu, Q., & Gan, C. L. (2020). Sample Preparation for Deprocessing of 3D Multi-Die Stacked Package. In 2020 IEEE International Symposium on the Physical and Failure Analysis of Integrated Circuits (IPFA). IEEE. doi:10.1109/ipfa49335.2020.9260707DOI: 10.1109/ipfa49335.2020.9260707
Ding, W. Y., Lip, G. Y. H., Pastori, D., & Shantsila, A. (2020). Effects of Atrial Fibrillation and Chronic Kidney Disease on Major Adverse Cardiovascular Events.. The American journal of cardiology. doi:10.1016/j.amjcard.2020.07.004DOI: 10.1016/j.amjcard.2020.07.004
Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation A Population-Based Cohort Study (Journal article)
Lau, W. C. Y., Cheung, C. -L., Man, K. K. C., Chan, E. W., Sing, C. W., Lip, G. Y. H., . . . Wong, I. C. K. (2020). Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation A Population-Based Cohort Study. ANNALS OF INTERNAL MEDICINE, 173(1), 1-+. doi:10.7326/M19-3671DOI: 10.7326/M19-3671
Overvad, T., Skjoth, F., Albertsen, I. E., Larsen, T. B., Sogaard, M., & Lip, G. (2020). Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation?. American Journal of Medicine. doi:10.1016/j.amjmed.2020.05.042DOI: 10.1016/j.amjmed.2020.05.042
An interview with Professor Gregory Lip (Journal article)
Lip, G. Y. H., & Grech, D. (2020). An interview with Professor Gregory Lip. EXPERT OPINION ON PHARMACOTHERAPY, 21(10), 1131-1132. doi:10.1080/14656566.2020.1755192DOI: 10.1080/14656566.2020.1755192
Ni, B., Wang, Z., Gu, W., Li, M., Chen, M., Lip, G. Y. H., & Shao, Y. (2020). Thoracoscopic Left Atrial Appendage Excision Plus Ablation for Atrial Fibrillation to Prevent Stroke. Seminars in Thoracic and Cardiovascular Surgery. doi:10.1053/j.semtcvs.2020.06.041DOI: 10.1053/j.semtcvs.2020.06.041
What is the impact of the latest ACC/AHA and ESC/ESH guidelines on the management of hypertension in the UK? (Journal article)
Akhmimi, A., Lip, G. Y. H., & Shantsila, A. (2020). What is the impact of the latest ACC/AHA and ESC/ESH guidelines on the management of hypertension in the UK?. EXPERT OPINION ON PHARMACOTHERAPY, 21(10), 1123-1125. doi:10.1080/14656566.2019.1707183DOI: 10.1080/14656566.2019.1707183
Acute Kidney Injury and Postoperative Atrial Fibrillation In Patients Undergoing Cardiac Surgery (Journal article)
Cole, O. M., Tosif, S., Shaw, M., & Lip, G. Y. H. (2020). Acute Kidney Injury and Postoperative Atrial Fibrillation In Patients Undergoing Cardiac Surgery. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 34(7), 1783-1790. doi:10.1053/j.jvca.2019.12.048DOI: 10.1053/j.jvca.2019.12.048
Rubboli, A., & Lip, G. Y. H. (2020). Algorithm for the management of antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: an updated proposal based on efficacy considerations. European Heart Journal - Cardiovascular Pharmacotherapy, 6(3), 197-198. doi:10.1093/ehjcvp/pvaa003DOI: 10.1093/ehjcvp/pvaa003
Banerjee, G., Ambler, G., Wilson, D., Hostettler, I. C., Shakeshaft, C., Lunawat, S., . . . Werring, D. J. (2020). Baseline factors associated with early and late death in intracerebral haemorrhage survivors. EUROPEAN JOURNAL OF NEUROLOGY, 27(7), 1257-1263. doi:10.1111/ene.14238DOI: 10.1111/ene.14238
Brown, J., Cicali, B., Pham, P., Schmidt, S., & Lip, G. Y. H. (2020). Breaking the rules for studies using real-world observational data: the case of direct-acting anticoagulants and antiepileptic drugs. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 6(3), 155-156. doi:10.1093/ehjcvp/pvz053DOI: 10.1093/ehjcvp/pvz053
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial (Journal article)
Nicolau, J. C., Bhatt, D. L., Hohnloser, S. H., Kimura, T., Lip, G. Y. H., Miede, C., . . . Cannon, C. P. (2020). Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial. DRUGS, 80(10), 995-1005. doi:10.1007/s40265-020-01323-xDOI: 10.1007/s40265-020-01323-x
Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study (Journal article)
Overvad, T. F., Andersen, S. D., Larsen, T. B., Lip, G. Y. H., Sogaard, M., Skjoth, F., & Nielsen, P. B. (2020). Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study. THROMBOSIS RESEARCH, 191, 1-8. doi:10.1016/j.thromres.2020.03.024DOI: 10.1016/j.thromres.2020.03.024
Bikdeli, B., Madhavan, M. V., Gupta, A., Jimenez, D., Burton, J. R., Nigoghossian, C. D., . . . Collabo, G. C. T. (2020). Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thrombosis and Haemostasis, 120(07), 1004-1024. doi:10.1055/s-0040-1713152DOI: 10.1055/s-0040-1713152
Huppertz, N., Lip, G. Y. H., & Lane, D. A. (2020). Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation. CLINICAL RESEARCH IN CARDIOLOGY, 109(7), 802-809. doi:10.1007/s00392-019-01567-yDOI: 10.1007/s00392-019-01567-y
Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention (Journal article)
Mihajlovic, M., Marinkovic, M., Koziel, M., Mujovic, N., Lip, G. Y. H., & Potpara, T. S. (2020). Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention. KARDIOLOGIA POLSKA, 78(6), 512-519. doi:10.33963/KP.15428DOI: 10.33963/KP.15428
Koziel, M., Mazurek, M., Teutsch, C., Diener, H. -C., Dubner, S. J., Halperin, J. L., . . . Lip, G. Y. H. (2020). Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up. JOURNAL OF CLINICAL MEDICINE, 9(6). doi:10.3390/jcm9061969DOI: 10.3390/jcm9061969
Vinter, N., Frederiksen, A. S., Albertsen, A. E., Lip, G. Y. H., Fenger-Grøn, M., Trinquart, L., . . . Møller, D. S. (2020). Role for machine learning in sex-specific prediction of successful electrical cardioversion in atrial fibrillation?. Open heart, 7(1), e001297. doi:10.1136/openhrt-2020-001297DOI: 10.1136/openhrt-2020-001297
Essa, H., Torella, F., & Lip, G. Y. H. (2020). Current and emerging drug treatment strategies for peripheral arterial disease. Expert Opinion on Pharmacotherapy. doi:10.1080/14656566.2020.1774556DOI: 10.1080/14656566.2020.1774556
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow (Journal article)
Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., . . . Lip, G. Y. H. (2020). COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 75(23), 2950-2973. doi:10.1016/j.jacc.2020.04.031DOI: 10.1016/j.jacc.2020.04.031
Yu, H. T., Yang, P. -S., Jang, E., Kim, T. -H., Uhm, J. -S., Kim, J. -Y., . . . Joung, B. (2020). Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation. Journal of the American Heart Association, 9(12). doi:10.1161/JAHA.119.014177DOI: 10.1161/JAHA.119.014177
Lee, H. -J., Choi, E. -K., Han, K. -D., Kim, D. H., Lee, E., Lee, S. -R., . . . Lip, G. Y. H. (2020). High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study. CARDIOVASCULAR DIABETOLOGY, 19(1). doi:10.1186/s12933-020-01059-8DOI: 10.1186/s12933-020-01059-8
Combining Anticoagulant and Antiplatelet Therapies for Chronic Atherosclerotic Disease A Focus on Diabetes Mellitus as a High-Risk Patient Group (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2020). Combining Anticoagulant and Antiplatelet Therapies for Chronic Atherosclerotic Disease A Focus on Diabetes Mellitus as a High-Risk Patient Group. Circulation, 141(23), 1855-1858. doi:10.1161/CIRCULATIONAHA.120.046905DOI: 10.1161/CIRCULATIONAHA.120.046905
Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies (Journal article)
Jozwiak, J., Kasperczyk, S., Tomasik, T., Osadnik, T., Windak, A., Studzinski, K., . . . Banach, M. (2020). Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies. ARCHIVES OF MEDICAL SCIENCE, 18(3), 604-616. doi:10.5114/aoms.2020.96052DOI: 10.5114/aoms.2020.96052
Guo, Y., & Lip, G. Y. (2020). Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial.. Arrhythmia & electrophysiology review, 9(1), 5-7. doi:10.15420/aer.2020.12DOI: 10.15420/aer.2020.12
Grace, A., Calkins, H., Ellenbogen, K., Lambiase, P. D., Lip, G. Y., Narayan, S. M., & Katritsis, D. G. (2020). What Cannot Be Missed: Important Publications on Electrophysiology in 2019.. Arrhythmia & electrophysiology review, 9(1), 4. doi:10.15420/aer.2020.06DOI: 10.15420/aer.2020.06
Krittayaphong, R., Chantrarat, T., Rojjarekampai, R., Jittham, P., Sairat, P., & Lip, G. Y. H. (2020). Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry. JOURNAL OF CLINICAL MEDICINE, 9(6). doi:10.3390/jcm9061698DOI: 10.3390/jcm9061698
Yang, P. -S., Sung, J. -H., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2020). The Effect of Integrated Care Management on Dementia in Atrial Fibrillation. Journal of Clinical Medicine, 9(6). doi:10.3390/jcm9061696DOI: 10.3390/jcm9061696
Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population The COOL-AF Registry (Journal article)
Krittayaphong, R., Winijkul, A., Kunjara-Na-Ayudhya, R., Apiyasawat, S., Siriwattana, K., Kanjanarutjawiwat, W., . . . Lip, G. Y. H. (2020). Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population The COOL-AF Registry. STROKE, 51(6), 1772-1780. doi:10.1161/STROKEAHA.120.029295DOI: 10.1161/STROKEAHA.120.029295
Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes Without Cardiovascular Disease: A Danish Cohort Study (Journal article)
Fangel, M. V., Nielsen, P. B., Kristensen, J. K., Larsen, T. B., Overvad, T. F., Lip, G. Y. H., & Jensen, M. B. (2020). Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes Without Cardiovascular Disease: A Danish Cohort Study. AMERICAN JOURNAL OF MEDICINE, 133(6), E269-E279. doi:10.1016/j.amjmed.2019.10.042DOI: 10.1016/j.amjmed.2019.10.042
Tsai, C. -T., Liao, J. -N., Chiang, C. -E., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2020). Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage. JAMA NETWORK OPEN, 3(6). doi:10.1001/jamanetworkopen.2020.6424DOI: 10.1001/jamanetworkopen.2020.6424
Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology (Journal article)
Gorenek, B., Halvorsen, S., Kudaiberdieva, G., Bueno, H., Van Gelder, I. C., Lettino, M., . . . Lip, G. Y. H. (2020). Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 9(4), 348-357. doi:10.1177/2048872619894255DOI: 10.1177/2048872619894255
Lip, G. Y. H., Merino, J. L., Banach, M., Al-Saady, N., Jin, J., Melino, M., . . . Goette, A. (2020). Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) randomized trial.. Journal of arrhythmia, 36(3), 430-438. doi:10.1002/joa3.12341DOI: 10.1002/joa3.12341
Documenting Sex and Sex Differences in Animal Studies (Journal article)
Rigby, A., Lip, G. Y. H., & Weber, C. (2020). Documenting Sex and Sex Differences in Animal Studies. THROMBOSIS AND HAEMOSTASIS, 120(6), 879-882. doi:10.1055/s-0040-1710017DOI: 10.1055/s-0040-1710017
Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions (Journal article)
Bodin, A., Bisson, A., Gaborit, C., Herbert, J., Clementy, N., Babuty, D., . . . Fauchier, L. (2020). Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions. STROKE, 51(6), 1674-1681. doi:10.1161/STROKEAHA.120.029048DOI: 10.1161/STROKEAHA.120.029048
Ma, C., Riou Franca, L., Lu, S., Diener, H. -C., Dubner, S. J., Halperin, J. L., . . . Rothman, K. J. (2020). Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registry. JOURNAL OF ARRHYTHMIA, 36(3), 408-416. doi:10.1002/joa3.12321DOI: 10.1002/joa3.12321
Fogacci, S., Fogacci, F., Banach, M., Michos, E. D., Hernandez, A. V., Lip, G. Y. H., . . . Cicero, A. F. G. (2020). Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials. CLINICAL NUTRITION, 39(6), 1742-1752. doi:10.1016/j.clnu.2019.08.015DOI: 10.1016/j.clnu.2019.08.015
Deitelzweig, S., Keshishian, A., Kang, A., Dhamane, A. D., Luo, X., Li, X., . . . Lip, G. Y. H. (n.d.). Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study. Journal of Clinical Medicine, 9(6). doi:10.3390/jcm9061633DOI: 10.3390/jcm9061633
Excessive Supraventricular Ectopic Activity and Adverse Cardiovascular Outcomes: a Systematic Review and Meta-analysis (Journal article)
Meng, L., Tsiaousis, G., He, J., Tse, G., Antoniadis, A. P., Korantzopoulos, P., . . . Liu, T. (2020). Excessive Supraventricular Ectopic Activity and Adverse Cardiovascular Outcomes: a Systematic Review and Meta-analysis. CURRENT ATHEROSCLEROSIS REPORTS, 22(4). doi:10.1007/s11883-020-0832-4DOI: 10.1007/s11883-020-0832-4
Proietti, M., Romiti, G. F., Olshansky, B., Lane, D. A., & Lip, G. Y. H. (2020). Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial. Journal of the American Heart Association, e014932. doi:10.1161/jaha.119.014932DOI: 10.1161/jaha.119.014932
Guo, Y., Wang, H., Zhang, H., Chen, Y., & Lip, G. Y. H. (2020). Population-Based Screening or Targeted Screening Based on Initial Clinical Risk Assessment for Atrial Fibrillation: A Report from the Huawei Heart Study. JOURNAL OF CLINICAL MEDICINE, 9(5). doi:10.3390/jcm9051493DOI: 10.3390/jcm9051493
Lee, S. -R., Choi, E. -K., Lee, S. -Y., Lee, E., Han, K. -D., Cha, M. -J., . . . Lip, G. Y. H. (2020). Temporal Trends of Emergency Department Visits of Patients with Atrial Fibrillation: A Nationwide Population-Based Study. JOURNAL OF CLINICAL MEDICINE, 9(5). doi:10.3390/jcm9051485DOI: 10.3390/jcm9051485
Chan, Y. -H., Lee, H. -F., Li, P. -R., Liu, J. -R., Chao, T. -F., Wu, L. -S., . . . Lip, G. Y. H. (2020). Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants. CARDIOVASCULAR DIABETOLOGY, 19(1). doi:10.1186/s12933-020-01043-2DOI: 10.1186/s12933-020-01043-2
Torp-Pedersen, C., Goette, A., Nielsen, P. B., Potpara, T., Fauchier, L., Camm, A. J., . . . Al-Khatib, S. M. (2020). 'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS). EUROPACE, 22(5), 831-+. doi:10.1093/europace/euz210DOI: 10.1093/europace/euz210
Avoiding Stroke: A Continuous Monitoring Challenge (Journal article)
Gumprecht, J., Domek, M., Hill, A. M., & Lip, G. Y. H. (2020). Avoiding Stroke: A Continuous Monitoring Challenge. CEREBROVASCULAR DISEASES, 49(2), 121-123. doi:10.1159/000506680DOI: 10.1159/000506680
Blood Pressure Control and Dementia Risk in Midlife Patients With Atrial Fibrillation (Journal article)
Kim, D., Yang, P. -S., Jang, E., Yu, H., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2020). Blood Pressure Control and Dementia Risk in Midlife Patients With Atrial Fibrillation. HYPERTENSION, 75(5), 1296-1304. doi:10.1161/HYPERTENSIONAHA.119.14388DOI: 10.1161/HYPERTENSIONAHA.119.14388
CaseReport: Aldosterone-secreting adrenal carcinoma complicating longstanding hypertension (Journal article)
Shantsila, A., Lip, G. Y. H., & Beevers, D. G. (2020). CaseReport: Aldosterone-secreting adrenal carcinoma complicating longstanding hypertension. JOURNAL OF HUMAN HYPERTENSION, 34(5), 411-412. doi:10.1038/s41371-019-0209-8DOI: 10.1038/s41371-019-0209-8
Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial (Journal article)
Koziel, M., Merino, J. L., De Caterina, R., Huber, K., Jin, J., Melino, M., . . . Lip, G. Y. H. (2020). Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 50(5). doi:10.1111/eci.13221DOI: 10.1111/eci.13221
Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation A Nationwide Cohort Study (Journal article)
Chao, T. -F., Chiang, C. -E., Liao, J. -N., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2020). Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation A Nationwide Cohort Study. CHEST, 157(5), 1266-1277. doi:10.1016/j.chest.2019.11.025DOI: 10.1016/j.chest.2019.11.025
Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus (Journal article)
Lip, G. Y. H., Keshishian, A. V., Kang, A. L., Li, X., Dhamane, A. D., Luo, X., . . . Deitelzweig, S. B. (2020). Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus. MAYO CLINIC PROCEEDINGS, 95(5), 929-943. doi:10.1016/j.mayocp.2019.05.032DOI: 10.1016/j.mayocp.2019.05.032
Generating Hypotheses Is Great, but at Some Point We Just Need to Do the Trials and Get the Answers (Journal article)
O'Brien, B., & Lip, G. Y. H. (2020). Generating Hypotheses Is Great, but at Some Point We Just Need to Do the Trials and Get the Answers. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 34(5), 1162-1164. doi:10.1053/j.jvca.2019.12.035DOI: 10.1053/j.jvca.2019.12.035
Guo, Y., Lane, D. A., Chen, Y., & Lip, G. Y. H. (2020). Letter by Guo et al Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation". CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 13(5), 273-274. doi:10.1161/CIRCOUTCOMES.120.006635DOI: 10.1161/CIRCOUTCOMES.120.006635
Guo, Y., Lane, D. A., Chen, Y., & Lip, G. Y. H. (2020). Mobile health technology facilitates population screening and integrated care management in patients with atrial fibrillation. EUROPEAN HEART JOURNAL, 41(17), 1617-1619. doi:10.1093/eurheartj/ehaa161DOI: 10.1093/eurheartj/ehaa161
Gumprecht, J., Domek, M., Proietti, M., Li, Y. -G., Asaad, N., Rashed, W., . . . Lip, G. Y. H. (2020). Compliance of Atrial Fibrillation Treatment with the Atrial Fibrillation Better Care (ABC) Pathway Improves the Clinical Outcomes in the Middle East Population: A Report from the Gulf Survey of Atrial Fibrillation Events (SAFE) Registry. JOURNAL OF CLINICAL MEDICINE, 9(5). doi:10.3390/jcm9051286DOI: 10.3390/jcm9051286
Fauchier, L., Bodin, A., Bisson, A., Herbert, J., Spiesser, P., Clementy, N., . . . Lip, G. Y. H. (2020). Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis. JOURNAL OF CLINICAL MEDICINE, 9(4). doi:10.3390/jcm9041234DOI: 10.3390/jcm9041234
In patients with SBP ≥ 130 mm Hg and CV risk, intensive vs standard BP control did not increase fear of falling (Journal article)
Shantsila, A., & Lip, G. Y. H. (2020). In patients with SBP ≥ 130 mm Hg and CV risk, intensive vs standard BP control did not increase fear of falling. ANNALS OF INTERNAL MEDICINE, 172(8), JC42. doi:10.7326/ACPJ202004210-042DOI: 10.7326/ACPJ202004210-042
In patients with no indication for anticoagulation after TAVR, rivaroxaban increased adverse events vs antiplatelets (Journal article)
Ding, W. Y., Field, M., & Lip, G. Y. H. (2020). In patients with no indication for anticoagulation after TAVR, rivaroxaban increased adverse events vs antiplatelets. ANNALS OF INTERNAL MEDICINE, 172(8), JC40. doi:10.7326/ACPJ202004210-040DOI: 10.7326/ACPJ202004210-040
Usefulness of P Wave Duration in Embolic Stroke of Undetermined Source (Journal article)
Jung, M., Kim, J. -S., Song, J. H., Kim, J. -M., Park, K. -Y., Lee, W. -S., . . . Shin, S. Y. (2020). Usefulness of P Wave Duration in Embolic Stroke of Undetermined Source. JOURNAL OF CLINICAL MEDICINE, 9(4). doi:10.3390/jcm9041134DOI: 10.3390/jcm9041134
McMahon, N. E., Bangee, M., Benedetto, V., Bray, E. P., Georgiou, R. F., Gibson, J. M. E., . . . Watkins, C. L. (2020). Etiologic Workup in Cases of Cryptogenic Stroke: A Systematic Review of International Clinical Practice Guidelines.. Stroke, STROKEAHA119027123. doi:10.1161/strokeaha.119.027123DOI: 10.1161/strokeaha.119.027123
Guo, Y., Lane, D. A., Wang, L., Zhang, H., Wang, H., Zhang, W., . . . Fulin, G. (2020). Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 75(13), 1523-1534. doi:10.1016/j.jacc.2020.01.052DOI: 10.1016/j.jacc.2020.01.052
Harrison, S. L., Lane, D. A., Guo, Y., & Lip, G. Y. H. (2020). The potential for photoplethysmographic (PPG)-based smart devices in atrial fibrillation detection. EXPERT REVIEW OF MEDICAL DEVICES, 17(4), 253-255. doi:10.1080/17434440.2020.1740085DOI: 10.1080/17434440.2020.1740085
Khan, A. A., Boriani, G., & Lip, G. Y. H. (2020). Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?. CLINICAL RESEARCH IN CARDIOLOGY, 109(4), 409-416. doi:10.1007/s00392-019-01545-4DOI: 10.1007/s00392-019-01545-4
Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients (Journal article)
Proietti, M., Farcomeni, A., Romiti, G. F., Di Rocco, A., Placentino, F., Diemberger, I., . . . Boriani, G. (2020). Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 27(6), 633-644. doi:10.1177/2047487318817662DOI: 10.1177/2047487318817662
Pham, P., Schmidt, S., Lesko, L., Lip, G. Y. H., & Brown, J. D. (2020). Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function. JAMA NETWORK OPEN, 3(4). doi:10.1001/jamanetworkopen.2020.3593DOI: 10.1001/jamanetworkopen.2020.3593
Bai, Y., Shantsila, A., & Lip, G. Y. H. (2020). Clinical outcomes associated with kidney function changes in anticoagulated atrial fibrillation patients: An ancillary analysis from the BOREALIS trial. JOURNAL OF ARRHYTHMIA, 36(2), 282-288. doi:10.1002/joa3.12306DOI: 10.1002/joa3.12306
Ding, W. Y., Harrison, S. L., Lane, D. A., & Lip, G. Y. H. (2020). Considerations when choosing an appropriate bleeding risk assessment tool for patients with atrial fibrillation. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 18(4), 788-790. doi:10.1111/jth.14738DOI: 10.1111/jth.14738
Device-Pocket Hematoma After Cardiac Implantable Electronic Devices (Journal article)
Notaristefano, F., Angeli, F., Verdecchia, P., Zingarini, G., Spighi, L., Annunziata, R., . . . Cavallini, C. (2020). Device-Pocket Hematoma After Cardiac Implantable Electronic Devices. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 13(4). doi:10.1161/CIRCEP.120.008372DOI: 10.1161/CIRCEP.120.008372
Berry, N. C., Mauri, L., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., . . . Cannon, C. P. (2020). Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention A Subgroup Analysis From the REDUAL PCI Trial. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 13(4). doi:10.1161/CIRCINTERVENTIONS.119.008349DOI: 10.1161/CIRCINTERVENTIONS.119.008349
Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation An Instrumental Variable Analysis of a Nationwide Cohort (Journal article)
Bonde, A. N., Martinussen, T., Lee, C. J. -Y., Lip, G. Y. H., Staerk, L., Bang, C. N., . . . Hlatky, M. A. (2020). Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation An Instrumental Variable Analysis of a Nationwide Cohort. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 13(4). doi:10.1161/CIRCOUTCOMES.119.006058DOI: 10.1161/CIRCOUTCOMES.119.006058
The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients. (Journal article)
Kim, D., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2020). The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients.. EP-Europace, 22(4), 547-557. doi:10.1093/europace/euz273DOI: 10.1093/europace/euz273
Koziel, M., Simovic, S., Pavlovic, N., Kocijancic, A., Paparisto, V., Music, L., . . . Potpara, T. S. (2020). Adherence to the ABC (Atrial fibrillation Better Care) pathway in the Balkan region: the BALKAN-AF survey. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 130(3), 187-195. doi:10.20452/pamw.15146DOI: 10.20452/pamw.15146
Shape-Memory Actuation in Aligned Zirconia Nanofibers for Artificial Muscle Applications at Elevated Temperatures (Journal article)
Du, Z., Zhou, X., Ye, P., Zeng, X., & Gan, C. L. (2020). Shape-Memory Actuation in Aligned Zirconia Nanofibers for Artificial Muscle Applications at Elevated Temperatures. ACS Applied Nano Materials, 3(3), 2156-2166. doi:10.1021/acsanm.9b02073DOI: 10.1021/acsanm.9b02073
Trends in antithrombotic management of patients with atrial fibrillation A report from the Polish part of the EURObservational Research Programme - Atrial Fibrillation General Long-Term Registry (Journal article)
Lodzinski, P., Gawalko, M., Budnik, M., Tyminska, A., Ozieranski, K., Grabowski, M., . . . Balsam, P. (2020). Trends in antithrombotic management of patients with atrial fibrillation A report from the Polish part of the EURObservational Research Programme - Atrial Fibrillation General Long-Term Registry. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 130(3), 196-205. doi:10.20452/pamw.15157DOI: 10.20452/pamw.15157
Heart rate variability changes following catheter ablation for atrial fibrillation (Journal article)
Shantsila, A., Gupta, D., & Lip, G. Y. H. (2020). Heart rate variability changes following catheter ablation for atrial fibrillation. KARDIOLOGIA POLSKA, 78(3), 179-180. doi:10.33963/KP.15249DOI: 10.33963/KP.15249
REPLY: Observations From the Huawei Heart Study Using Photoplethysmography-Based Smart Devices for Atrial Fibrillation Screening (Journal article)
Guo, Y., Liu, T., Chen, Y., & Lip, G. Y. H. (2020). REPLY: Observations From the Huawei Heart Study Using Photoplethysmography-Based Smart Devices for Atrial Fibrillation Screening. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 75(11), 1366-1367. doi:10.1016/j.jacc.2020.01.021DOI: 10.1016/j.jacc.2020.01.021
Lee, H. -J., Choi, E. -K., Han, K. -D., Lee, E., Moon, I., Lee, S. -R., . . . Lip, G. Y. H. (2020). Bodyweight fluctuation is associated with increased risk of incident atrial fibrillation. HEART RHYTHM, 17(3), 365-371. doi:10.1016/j.hrthm.2019.09.029DOI: 10.1016/j.hrthm.2019.09.029
ten Berg, J. M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., de Veer, A., Nordaby, M., . . . Cannon, C. P. (2020). Comparison of the Effect of Age (< 75 Versus ≥75) on the Efficacy and Safety of Dual Therapy (Dabigatran plus Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin plus Aspirin plus Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial). AMERICAN JOURNAL OF CARDIOLOGY, 125(5), 735-743. doi:10.1016/j.amjcard.2019.11.029DOI: 10.1016/j.amjcard.2019.11.029
Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use (Journal article)
Lee, S. -R., Choi, E. -K., Kwon, S., Jung, J. -H., Han, K. -D., Cha, M. -J., . . . Lip, G. Y. H. (2020). Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 13(3). doi:10.1161/CIRCOUTCOMES.119.005894DOI: 10.1161/CIRCOUTCOMES.119.005894
Galectin-3 and risk of atrial fibrillation: A systematic review and meta-analysis (Journal article)
Gong, M., Cheung, A., Wang, Q. -S., Li, G., Goudis, C. A., Bazoukis, G., . . . Liu, T. (2020). Galectin-3 and risk of atrial fibrillation: A systematic review and meta-analysis. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 34(3). doi:10.1002/jcla.23104DOI: 10.1002/jcla.23104
Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage (Journal article)
Hostettler, I. C., Morton, M. J., Ambler, G., Kazmi, N., Gaunt, T., Wilson, D., . . . Werring, D. J. (2020). Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 91(3), 298-304. doi:10.1136/jnnp-2019-321774DOI: 10.1136/jnnp-2019-321774
Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based survey (Journal article)
Potpara, T. S., Ferro, C., Lip, G. Y. H., Dan, G. A., Lenarczyk, R., Mallamaci, F., . . . Dagres, N. (2020). Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based survey. EUROPACE, 22(3), 496-505. doi:10.1093/europace/euz358DOI: 10.1093/europace/euz358
One-year all-cause mortality risk among atrial fibrillation patients in Middle East with and without diabetes: The Gulf SAFE registry (Journal article)
Domek, M., Li, Y. -G., Gumprecht, J., Asaad, N., Rashed, W., Alsheikh-Ali, A., . . . Lip, G. Y. H. (2020). One-year all-cause mortality risk among atrial fibrillation patients in Middle East with and without diabetes: The Gulf SAFE registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 302, 47-52. doi:10.1016/j.ijcard.2019.12.061DOI: 10.1016/j.ijcard.2019.12.061
Stroke prevention in elderly patients with non-valvular atrial fibrillation in the BALKAN-AF survey (Journal article)
Potpara, T. S., Simovic, S., Pavlovic, N., Nedeljkovic, M., Paparisto, V., Music, L., . . . Lip, G. Y. H. (2020). Stroke prevention in elderly patients with non-valvular atrial fibrillation in the BALKAN-AF survey. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 50(3). doi:10.1111/eci.13200DOI: 10.1111/eci.13200
Kozieł, M., Potpara, T. S., & Lip, G. Y. H. (2020). Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting.. Research and practice in thrombosis and haemostasis, 4(3), 357-365. doi:10.1002/rth2.12319DOI: 10.1002/rth2.12319
Alsharari, R., Lip, G. Y. H., & Shantsila, A. (2020). Assessment of Arterial Stiffness in Patients With Resistant Hypertension: Additional Insights Into the Pathophysiology of This Condition?. AMERICAN JOURNAL OF HYPERTENSION, 33(2), 107-115. doi:10.1093/ajh/hpz169DOI: 10.1093/ajh/hpz169
Ding, W. Y., Harrison, S., Gupta, D., Lip, G. Y. H., & Lane, D. A. (2020). Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies. FRONTIERS IN MEDICINE, 7. doi:10.3389/fmed.2020.00054DOI: 10.3389/fmed.2020.00054
Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia: A Nationwide Cohort Study. (Journal article)
Lee, H. -F., Chan, Y. -H., Li, P. -R., Liu, J. -R., Chao, T. -F., Wu, L. -S., . . . Lip, G. Y. H. (2020). Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia: A Nationwide Cohort Study.. The Canadian Journal of Cardiology. doi:10.1016/j.cjca.2020.02.071DOI: 10.1016/j.cjca.2020.02.071
Endothelial function in patients with atrial fibrillation (Journal article)
Khan, A. A., Thomas, G. N., Lip, G. Y. H., & Shantsila, A. (2020). Endothelial function in patients with atrial fibrillation. ANNALS OF MEDICINE, 52(1-2), 1-11. doi:10.1080/07853890.2019.1711158DOI: 10.1080/07853890.2019.1711158
Evolution of the Editorial Board Underpins a Commitment to Change and Innovation (Journal article)
Katritsis, D. G. (2020). Evolution of the Editorial Board Underpins a Commitment to Change and Innovation. Arrhythmia & Electrophysiology Review, 8(4), 238-239. doi:10.15420/aer.8.4.fo1DOI: 10.15420/aer.8.4.fo1
Begg, G. A., Swoboda, P. P., Karim, R., Oesterlein, T., Rhode, K., Holden, A. V., . . . Tayebjee, M. H. (2020). Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 22(1). doi:10.1186/s12968-020-0603-yDOI: 10.1186/s12968-020-0603-y
Blood Pressure Variability and Incidence of New-Onset Atrial Fibrillation A Nationwide Population-Based Study (Journal article)
Lee, S. -R., Choi, Y. -J., Choi, E. -K., Han, K. -D., Lee, E., Cha, M. -J., . . . Lip, G. Y. H. (2020). Blood Pressure Variability and Incidence of New-Onset Atrial Fibrillation A Nationwide Population-Based Study. HYPERTENSION, 75(2), 309-315. doi:10.1161/HYPERTENSIONAHA.119.13708DOI: 10.1161/HYPERTENSIONAHA.119.13708
Challenges in stroke prevention among very elderly patients with atrial fibrillation: discerning facts from prejudices (Journal article)
Potpara, T. S., Mujovic, N., & Lip, G. Y. H. (2020). Challenges in stroke prevention among very elderly patients with atrial fibrillation: discerning facts from prejudices. EUROPACE, 22(2), 173-176. doi:10.1093/europace/euz344DOI: 10.1093/europace/euz344
Paquette, M., Franca, L. R., Teutsch, C., Diener, H. -C., Lu, S., Dubner, S. J., . . . Nieuwlaat, R. (2020). Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry. AMERICAN JOURNAL OF CARDIOLOGY, 125(3), 383-391. doi:10.1016/j.amjcard.2019.10.047DOI: 10.1016/j.amjcard.2019.10.047
Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association (Journal article)
Stepinska, J., Lettino, M., Ahrens, I., Bueno, H., Garcia-Castrillo, L., Khoury, A., . . . Huber, K. (2020). Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 9(1), 76-89. doi:10.1177/2048872619885346DOI: 10.1177/2048872619885346
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update (Journal article)
Glikson, M., Wolff, R., Hindricks, G., Mandrola, J., Camm, A. J., Lip, G. Y. H., . . . Meier, B. (2020). EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. EUROPACE, 22(2). doi:10.1093/europace/euz258DOI: 10.1093/europace/euz258
Editorial commentary: Reversal agents in the era of non-vitamin k antagonists oral anticoagulants: Necessity or psychological crutch? (Journal article)
Dzeshka, M. S., & Lip, G. Y. H. (2020). Editorial commentary: Reversal agents in the era of non-vitamin k antagonists oral anticoagulants: Necessity or psychological crutch?. TRENDS IN CARDIOVASCULAR MEDICINE, 30(2), 91-92. doi:10.1016/j.tcm.2019.04.007DOI: 10.1016/j.tcm.2019.04.007
Kozieł, M., Simovic, S., Pavlovic, N., Nedeljkovic, M., Paparisto, V., Music, L., . . . BALKAN-AF investigators. (2020). Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey.. International journal of cardiology. Heart & vasculature, 26, 100461. doi:10.1016/j.ijcha.2019.100461DOI: 10.1016/j.ijcha.2019.100461
Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage (Journal article)
Lee, S. -R., Choi, E. -K., Kwon, S., Jung, J. -H., Han, K. -D., Cha, M. -J., . . . Lip, G. Y. H. (2020). Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage. STROKE, 51(2), 416-423. doi:10.1161/STROKEAHA.119.028030DOI: 10.1161/STROKEAHA.119.028030
Gumprecht, J., Lip, G. Y. H., & Potpara, T. S. (2020). Regional registries on the management of atrial fibrillation: Essential pieces in the global puzzle.. International journal of cardiology. Heart & vasculature, 26, 100473. doi:10.1016/j.ijcha.2020.100473DOI: 10.1016/j.ijcha.2020.100473
Harrison, S. L., O'Flaherty, M., & Lip, G. Y. H. (2020). Revisiting the dynamic risks of incident atrial fibrillation: does the use of nonsteroidal anti-inflammatory drugs contribute to risk?. QJM : monthly journal of the Association of Physicians, 113(2), 77-78. doi:10.1093/qjmed/hcz310DOI: 10.1093/qjmed/hcz310
The year in cardiology: arrhythmias and pacing: The year in cardiology 2019 (Journal article)
Camm, A. J., Lip, G. Y. H., Schilling, R., Calkins, H., & Steffel, J. (2020). The year in cardiology: arrhythmias and pacing: The year in cardiology 2019. EUROPEAN HEART JOURNAL, 41(5), 619-+. doi:10.1093/eurheartj/ehz931DOI: 10.1093/eurheartj/ehz931
Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EORP Atrial Fibrillation Ablation Long-Term and Atrial Fibrillation General Pilot Registries (Journal article)
Tilz, R. R., Dagres, N., Arbelo, E., Blomstroem-Lundqvist, C., Crijns, H. J., Kirchhof, P., . . . Tavazzi, L. (2020). Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EORP Atrial Fibrillation Ablation Long-Term and Atrial Fibrillation General Pilot Registries. EUROPACE, 22(2), 250-258. doi:10.1093/europace/euz291DOI: 10.1093/europace/euz291
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation (Journal article)
Steg, P. G., Ducrocq, G., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., Miede, C., . . . Cannon, C. P. (2020). Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 75(2), 238-240. doi:10.1016/j.jacc.2019.09.072DOI: 10.1016/j.jacc.2019.09.072
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update (Journal article)
Glikson, M., Wolff, R., Hindricks, G., Mandrola, J., Camm, A. J., Lip, G. Y. H., . . . Meier, B. (2020). EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. EUROINTERVENTION, 15(13), 1133-+. doi:10.4244/EIJY19M08_01DOI: 10.4244/EIJY19M08_01
Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry (Journal article)
Bertomeu-Gonzalez, V., Moreno-Arribas, J., Esteve-Pastor, M. A., Roldan-Rabadan, I., Muniz, J., Rana-Miguez, P., . . . Marin, F. (2020). Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 9(1). doi:10.1161/JAHA.119.013789DOI: 10.1161/JAHA.119.013789
Banerjee, G., Chan, E., Ambler, G., Wilson, D., Cipolotti, L., Shakeshaft, C., . . . Werring, D. J. (2020). Cognitive Impairment Before Atrial Fibrillation-Related Ischemic Events: Neuroimaging and Prognostic Associations. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 9(1). doi:10.1161/JAHA.119.014537DOI: 10.1161/JAHA.119.014537
A Toast to the Last Decade and a Very Happy 2020 from Thrombosis and Haemostasis! (Journal article)
Lip, G. Y. H., Rigby, A., & Weber, C. (2020). A Toast to the Last Decade and a Very Happy 2020 from Thrombosis and Haemostasis!. THROMBOSIS AND HAEMOSTASIS, 120(1), 1-4. doi:10.1055/s-0039-3402054DOI: 10.1055/s-0039-3402054
Mazurek, M., Halperin, J. L., Huisman, M. V., Diener, H. -C., Dubner, S. J., Ma, C. S., . . . Lip, G. Y. H. (2020). Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme. EUROPACE, 22(1), 47-57. doi:10.1093/europace/euz278DOI: 10.1093/europace/euz278
Atrial Fibrillation in Heart Failure Focus on Antithrombotic Management (Journal article)
Obeidat, M., Burgess, M., & Lip, G. Y. H. (2020). Atrial Fibrillation in Heart Failure Focus on Antithrombotic Management. HEART FAILURE CLINICS, 16(1), 107-+. doi:10.1016/j.hfc.2019.08.007DOI: 10.1016/j.hfc.2019.08.007
Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices (Journal article)
Pastori, D., Miyazawa, K., Li, Y., Szekely, O., Shahid, F., Farcomeni, A., & Lip, G. Y. H. (2020). Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices. CLINICAL RESEARCH IN CARDIOLOGY, 109(1), 96-102. doi:10.1007/s00392-019-01493-zDOI: 10.1007/s00392-019-01493-z
Clinical performance of the atrial fibrillation in the russian population depending on the antithrombotic therapy: Findings from the gloria-af registry phase 2 (Journal article)
Shlyakhto, E. V., Villevalde, S. V., Ezhov, A. V., Zenin, S. A., Koziolova, N. A., Korennova, O. Y., . . . Huisman, M. V. (2020). Clinical performance of the atrial fibrillation in the russian population depending on the antithrombotic therapy: Findings from the gloria-af registry phase 2. Russian Journal of Cardiology, 25(11), 73-84. doi:10.15829/1560-4071-2020-4179DOI: 10.15829/1560-4071-2020-4179
Evaluation of the C<sub>2</sub>HEST Risk Score as a Possible Opportunistic Screening Tool for Incident Atrial Fibrillation in a Healthy Population (From a Nationwide Danish Cohort Study) (Journal article)
Lip, G. Y. H., Skjoth, F., Nielsen, P. B., & Larsen, T. B. (2020). Evaluation of the C<sub>2</sub>HEST Risk Score as a Possible Opportunistic Screening Tool for Incident Atrial Fibrillation in a Healthy Population (From a Nationwide Danish Cohort Study). AMERICAN JOURNAL OF CARDIOLOGY, 125(1), 48-54. doi:10.1016/j.amjcard.2019.09.034DOI: 10.1016/j.amjcard.2019.09.034
Frailty and Anticoagulant Therapy in Patients Aged 65 Years or Older with Atrial Fibrillation (Journal article)
Liu, J., Du, X., Li, M., Jia, Z., Lu, S., Chang, S., . . . Ma, C. (2020). Frailty and Anticoagulant Therapy in Patients Aged 65 Years or Older with Atrial Fibrillation. Cardiovascular Innovations and Applications, 4(3). doi:10.15212/cvia.2019.0562DOI: 10.15212/cvia.2019.0562
Malignant hypertension: does this still exist? (Journal article)
Domek, M., Gumprecht, J., Lip, G. Y. H., & Shantsila, A. (2020). Malignant hypertension: does this still exist?. JOURNAL OF HUMAN HYPERTENSION, 34(1), 1-4. doi:10.1038/s41371-019-0267-yDOI: 10.1038/s41371-019-0267-y
Harrison, S. L., Lane, D. A., & Lip, G. Y. H. (2020). Reducing risk of adverse cardiovascular and renal outcomes for patients with atrial fibrillation and type 2 diabetes. EUROPEAN JOURNAL OF HEART FAILURE, 22(1), 136-138. doi:10.1002/ejhf.1685DOI: 10.1002/ejhf.1685
Response by Lee et al to Letter Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage" (Journal article)
Lee, S. -R., Choi, E. -K., & Lip, G. Y. H. (2020). Response by Lee et al to Letter Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage". STROKE, 51(6), E112. doi:10.1161/STROKEAHA.120.029551DOI: 10.1161/STROKEAHA.120.029551
Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials (Journal article)
Potpara, T. S., Mujovic, N., Proietti, M., Dagres, N., Hindricks, G., Collet, J. -P., . . . Lip, G. Y. H. (2020). Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials. EUROPACE, 22(1), 33-46. doi:10.1093/europace/euz259DOI: 10.1093/europace/euz259
Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study (Journal article)
Nielsen, P. B., Overvad, T. F., Andersen, S. D., Larsen, T. B., Skjoth, F., Sogaard, M., & Lip, G. Y. H. (2019). Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study. CEREBROVASCULAR DISEASES, 48(3-6), 236-243. doi:10.1159/000504926DOI: 10.1159/000504926
Pandiaraja, M., Brimicombe, J., Cowie, M., Dymond, A., Lindén, H. C., Lip, G. Y. H., . . . Charlton, P. H. (2020). Screening for Atrial Fibrillation: Improving Efficiency of Manual Review of Handheld Electrocardiograms <sup>†</sup>.. Engineering proceedings, 2(1), 78. doi:10.3390/ecsa-7-08195DOI: 10.3390/ecsa-7-08195
Social Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial Fibrillation (Journal article)
Yu, H. T., Yang, P. -S., Hwang, J., Ryu, S., Jang, E., Kim, T. -H., . . . Joung, B. (2020). Social Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial Fibrillation. KOREAN CIRCULATION JOURNAL, 50(3), 267-277. doi:10.4070/kcj.2019.0207DOI: 10.4070/kcj.2019.0207
Shantsila, E., Shahid, F., Sun, Y., Deeks, J. J., Haynes, R., Calvert, M., . . . Lip, G. Y. H. (2020). Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT.
Stroke in Heart Failure (Journal article)
Essa, H., Sankaranarayanan, R., & Lip, G. Y. H. (2020). Stroke in Heart Failure. CLINICAL EPIDEMIOLOGY, 12, 1245-1247. doi:10.2147/CLEP.S270702DOI: 10.2147/CLEP.S270702
The Continuum of Stroke Prevention in Patients with Atrial Fibrillation in Clinical Practice: “Learning Curves”, New Challenges and Unmet Needs Across the Globe (Journal article)
Miroslav, M., & Tatjana, P. (2020). The Continuum of Stroke Prevention in Patients with Atrial Fibrillation in Clinical Practice: “Learning Curves”, New Challenges and Unmet Needs Across the Globe. Revista Argentina de Cardiologia, 88(4), 279-281. doi:10.7775/rac.v88.i4.18624DOI: 10.7775/rac.v88.i4.18624
The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study (Journal article)
Yang, W. -Y., Du, X., Jiang, C., He, L., Fawzy, A. M., Wang, L., . . . Ma, C. -S. (2020). The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study. EUROPACE, 22(1), 90-99. doi:10.1093/europace/euz235DOI: 10.1093/europace/euz235
Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study (Journal article)
Lau, W. C. Y., Douglas, I. J., Wong, I. C. K., Smeeth, L., Lip, G. Y. H., Leung, W. K., . . . Chan, E. W. (2020). Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study. HEART RHYTHM, 17(1), 33-40. doi:10.1016/j.hrthm.2019.07.034DOI: 10.1016/j.hrthm.2019.07.034
Thrombosis and Haemostasis 2019 Editor's Choice Papers (Journal article)
Weber, C., Rigby, A., & Lip, G. Y. H. (2020). Thrombosis and Haemostasis 2019 Editor's Choice Papers. THROMBOSIS AND HAEMOSTASIS, 120(1), 184-189. doi:10.1055/s-0039-3402055DOI: 10.1055/s-0039-3402055
Towards Assigning Diagnosis Codes Using Medication History (Conference Paper)
Sagi, T., Hansen, E. R., Hose, K., Lip, G. Y. H., Bjerregaard Larsen, T., & Skjøth, F. (2020). Towards Assigning Diagnosis Codes Using Medication History. In Unknown Conference (pp. 203-213). Springer International Publishing. doi:10.1007/978-3-030-59137-3_19DOI: 10.1007/978-3-030-59137-3_19
2019
Park, J., Lee, S. -R., Choi, E. -K., Kwon, S., Jung, J. -H., Do-Han, K., . . . Lip, G. Y. H. (2019). Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation. JOURNAL OF CLINICAL MEDICINE, 8(12). doi:10.3390/jcm8122228DOI: 10.3390/jcm8122228
Bray, E. P., McMahon, N. E., Bangee, M., Al-Khalidi, A. H., Benedetto, V., Chauhan, U., . . . Watkins, C. L. (2019). Etiologic workup in cases of cryptogenic stroke: protocol for a systematic review and comparison of international clinical practice guidelines. SYSTEMATIC REVIEWS, 8(1). doi:10.1186/s13643-019-1247-6DOI: 10.1186/s13643-019-1247-6
In older patients with AF, antiarrhythmic drugs were linked to fall-related injuries and syncope vs rate-lowering drugs (Journal article)
Gumprecht, J., & Lip, G. Y. H. (2019). In older patients with AF, antiarrhythmic drugs were linked to fall-related injuries and syncope vs rate-lowering drugs. ANNALS OF INTERNAL MEDICINE, 171(12), JC71. doi:10.7326/ACPJ201912170-071DOI: 10.7326/ACPJ201912170-071
Miguel Rivera-Caravaca, J., Marin, F., Asuncion Esteve-Pastor, M., Galvez, J., Lip, G. Y. H., Vicente, V., & Roldan, V. (2019). Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation. BMJ OPEN, 9(12). doi:10.1136/bmjopen-2019-033712DOI: 10.1136/bmjopen-2019-033712
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes (Journal article)
Maeng, M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., Miede, C., . . . Cannon, C. P. (2019). Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes. JACC-CARDIOVASCULAR INTERVENTIONS, 12(23), 2346-2355. doi:10.1016/j.jcin.2019.07.059DOI: 10.1016/j.jcin.2019.07.059
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation The RE-DUAL PCI Trial Subanalysis (Journal article)
ten Berg, J. M., de Veer, A., Oldgren, J., Steg, P. G., Zateyshchikov, D. A., Jansky, P., . . . Cannon, C. P. (2019). Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation The RE-DUAL PCI Trial Subanalysis. JACC-CARDIOVASCULAR INTERVENTIONS, 12(23), 2331-2341. doi:10.1016/j.jcin.2019.08.039DOI: 10.1016/j.jcin.2019.08.039
Estimating individual lifetime benefit and bleeding risk of adding oral anticoagulation to aspirin for patients with stable cardiovascular disease: directions from COMPASS? (Journal article)
Koziel, M., & Lip, G. Y. H. (2019). Estimating individual lifetime benefit and bleeding risk of adding oral anticoagulation to aspirin for patients with stable cardiovascular disease: directions from COMPASS?. EUROPEAN HEART JOURNAL, 40(46), 3779-3781. doi:10.1093/eurheartj/ehz517DOI: 10.1093/eurheartj/ehz517
Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF? (Journal article)
Khan, A. A., & Lip, G. Y. H. (2019). Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?. EUROPEAN HEART JOURNAL, 40(46), 3754-3756. doi:10.1093/eurheartj/ehz005DOI: 10.1093/eurheartj/ehz005
Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study (Journal article)
Bonde, A. N., Blanche, P., Staerk, L., Gerds, T. A., Gundlund, A., Gislason, G., . . . Olesen, J. B. (2019). Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study. EUROPEAN HEART JOURNAL, 40(46), 3782-3790. doi:10.1093/eurheartj/ehz155DOI: 10.1093/eurheartj/ehz155
Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group (Journal article)
Barkun, A. N., Almadi, M., Kuipers, E. J., Laine, L., Sung, J., Tse, F., . . . Bardou, M. (2019). Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group. ANNALS OF INTERNAL MEDICINE, 171(11), 805-+. doi:10.7326/M19-1795DOI: 10.7326/M19-1795
Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation (Journal article)
Gue, Y. X., Inoue, N., Spinthakis, N., Takei, A., Takahara, H., Otsui, K., . . . Gorog, D. A. (2019). Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(22), 2822-2824. doi:10.1016/j.jacc.2019.01.079DOI: 10.1016/j.jacc.2019.01.079
Kwon, S., Lee, S. -R., Choi, E. -K., Han, K. -D., Yang, S., Lee, S. -Y., . . . Lip, G. Y. H. (2019). Fluctuating renal function and the risk of incident atrial fibrillation: a nationwide population-based study. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-54528-wDOI: 10.1038/s41598-019-54528-w
Mazurek, M., Teutsch, C., Diener, H. -C., Dubner, S. J., Halperin, J. L., Ma, C. -S., . . . GLORIA-AF Investigators. (2019). Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.. American heart journal, 218, 123-127. doi:10.1016/j.ahj.2019.08.012DOI: 10.1016/j.ahj.2019.08.012
<i>C9orf72</i> and intracerebral hemorrhage (Journal article)
Hostettler, I. C., Bernal-Quiros, M., Wong, A., Sharma, N., Wilson, D., Seiffge, D. J., . . . Houlden, H. (2019). <i>C9orf72</i> and intracerebral hemorrhage. NEUROBIOLOGY OF AGING, 84. doi:10.1016/j.neurobiolaging.2019.07.007DOI: 10.1016/j.neurobiolaging.2019.07.007
Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry (Journal article)
Gao, Y., Chang, S., Du, X., Dong, J., Xu, X., Zhou, Y., . . . Ma, C. (2019). Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 19(6), 579-587. doi:10.1007/s40256-019-00350-8DOI: 10.1007/s40256-019-00350-8
Behavior of Resorcinol based Phthalonitrile as High Temperature Encapsulant (Conference Paper)
Tay, Y. S., Phua, J. R. E., & Gan, C. L. (2019). Behavior of Resorcinol based Phthalonitrile as High Temperature Encapsulant. In 2019 IEEE 21st Electronics Packaging Technology Conference (EPTC). IEEE. doi:10.1109/eptc47984.2019.9026569DOI: 10.1109/eptc47984.2019.9026569
Cognitive Decline Over Time in Patients With Systolic Heart Failure Insights From WARCEF (Journal article)
Lee, T. C., Qian, M., Liu, Y., Graham, S., Mann, D. L., Nakanishi, K., . . . Di Tullio, M. R. (2019). Cognitive Decline Over Time in Patients With Systolic Heart Failure Insights From WARCEF. JACC-HEART FAILURE, 7(12), 1042-1053. doi:10.1016/j.jchf.2019.09.003DOI: 10.1016/j.jchf.2019.09.003
Georgiopoulos, G., Ntaios, G., Stamatelopoulos, K., Manios, E., Korompoki, E., Vemmou, E., . . . Vemmos, K. (2019). Comparison of Risk Scores for the Prediction of the Overall Cardiovascular Risk in Patients with Ischemic Stroke: The Athens Stroke Registry. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 28(12). doi:10.1016/j.jstrokecerebrovasdis.2019.104415DOI: 10.1016/j.jstrokecerebrovasdis.2019.104415
Bai, Y., Shantsila, A., & Lip, G. Y. H. (2019). Differences in outcomes between oral anticoagulation "new starters" and "switchers" in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials. JOURNAL OF ARRHYTHMIA, 35(6), 815-820. doi:10.1002/joa3.12255DOI: 10.1002/joa3.12255
Lane, D. A., & Lip, G. Y. H. (2019). Integrated care for the management of atrial fibrillation: what are the key components and important outcomes?. EUROPACE, 21(12), 1759-1761. doi:10.1093/europace/euz211DOI: 10.1093/europace/euz211
Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management (Journal article)
Gumprecht, J., Domek, M., Lip, G. Y. H., & Shantsila, A. (2019). Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management. JOURNAL OF HUMAN HYPERTENSION, 33(12), 824-836. doi:10.1038/s41371-019-0279-7DOI: 10.1038/s41371-019-0279-7
Proietti, M., Marzona, I., Vannini, T., Tettamanti, M., Fortino, I., Merlino, L., . . . Nobili, A. (2019). Long-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use. MAYO CLINIC PROCEEDINGS, 94(12), 2427-2436. doi:10.1016/j.mayocp.2019.06.012DOI: 10.1016/j.mayocp.2019.06.012
Mechanical response of lightweight hollow truss metal oxide lattices (Journal article)
Kanaujia, P. K., bin Ramezan, M. A., Yap, X. Y., Song, Y., Du, Z., Gan, C. L., . . . Lai, C. Q. (2019). Mechanical response of lightweight hollow truss metal oxide lattices. Materialia, 8, 100439. doi:10.1016/j.mtla.2019.100439DOI: 10.1016/j.mtla.2019.100439
Gumprecht, J., Szulik, M., Domek, M., Mazurek, M., Shantsila, A., Oxborough, D., & Lip, G. Y. H. (2019). Novel Echocardiographic Biomarkers in the Management of Atrial Fibrillation. CURRENT CARDIOVASCULAR IMAGING REPORTS, 12(12). doi:10.1007/s12410-019-9520-6DOI: 10.1007/s12410-019-9520-6
Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: Systematic review and meta-analysis of randomized controlled trials (Journal article)
Ntaios, G., Vemmos, K., & Lip, G. Y. H. (2019). Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: Systematic review and meta-analysis of randomized controlled trials. INTERNATIONAL JOURNAL OF STROKE, 14(9), 856-861. doi:10.1177/1747493019877296DOI: 10.1177/1747493019877296
Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: A report from the China atrial fibrillation registry study (Journal article)
Jiang, C., Lan, D. -H., Du, X., Geng, Y. -P., Chang, S. -S., Zheng, D., . . . Ma, C. -S. (2019). Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: A report from the China atrial fibrillation registry study. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 30(12), 2759-2767. doi:10.1111/jce.14231DOI: 10.1111/jce.14231
Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis (Journal article)
Chan, Y. -H., Lee, H. -F., Chao, T. -F., Wu, C. -T., Chang, S. -H., Yeh, Y. -H., . . . Lip, G. Y. H. (2019). Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis. CARDIOVASCULAR DRUGS AND THERAPY, 33(6), 701-710. doi:10.1007/s10557-019-06910-zDOI: 10.1007/s10557-019-06910-z
Wang, Y., Ma, C. -S., Du, X., He, L., Li, J., Wang, G. -H., . . . Lip, G. Y. H. (2019). Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry. BMC CARDIOVASCULAR DISORDERS, 19(1). doi:10.1186/s12872-019-1260-7DOI: 10.1186/s12872-019-1260-7
Searching for Atrial Fibrillation Poststroke A White Paper of the AF-SCREEN International Collaboration (Journal article)
Schnabel, R. B., Haeusler, K. G., Healey, J. S., Freedman, B., Boriani, G., Brachmann, J., . . . Yan, B. (2019). Searching for Atrial Fibrillation Poststroke A White Paper of the AF-SCREEN International Collaboration. CIRCULATION, 140(22), 1834-1850. doi:10.1161/CIRCULATIONAHA.119.040267DOI: 10.1161/CIRCULATIONAHA.119.040267
Jung, H., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2019). Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation - A Nationwide Cohort Study.. Circulation journal : official journal of the Japanese Circulation Society, 83(12), 2547-2554. doi:10.1253/circj.cj-19-0527DOI: 10.1253/circj.cj-19-0527
Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation (Journal article)
Malavasi, V. L., Proietti, M., Spagni, S., Valenti, A. C., Battista, A., Pettorelli, D., . . . Boriani, G. (2019). Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 124(10), 1561-1567. doi:10.1016/j.amjcard.2019.08.008DOI: 10.1016/j.amjcard.2019.08.008
Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI (Journal article)
Lip, G. Y. H., Bhatt, D. L., Hohnloser, S. H., Kimura, T., Miede, C., Nordaby, M., . . . Cannon, C. P. (2019). Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(19), 2431-2433. doi:10.1016/j.jacc.2019.09.009DOI: 10.1016/j.jacc.2019.09.009
Guo, Y., Wang, H., Zhang, H., Liu, T., Liang, Z., Xia, Y., . . . Investigators, M. A. F. A. I. I. (2019). Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(19), 2365-2375. doi:10.1016/j.jacc.2019.08.019DOI: 10.1016/j.jacc.2019.08.019
Miyazawa, K., Ogawa, H., Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., . . . Lip, G. Y. H. (2019). Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries.. Circulation journal : official journal of the Japanese Circulation Society, 83(12), 2434-2442. doi:10.1253/circj.cj-19-0546DOI: 10.1253/circj.cj-19-0546
A Time to Stop and Think Before the Shock (Journal article)
Mandrola, J., Lip, G. Y. H., & Foy, A. (2019). A Time to Stop and Think Before the Shock. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(18), 2275-2777. doi:10.1016/j.jacc.2019.08.1044DOI: 10.1016/j.jacc.2019.08.1044
Shin, S. Y., Han, S. -J., Kim, J. -S., Im, S. I., Shim, J., Ahn, J., . . . Lim, H. E. (2019). Identification of Markers Associated With Development of Stroke in "Clinically Low-Risk" Atrial Fibrillation Patients. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 8(21). doi:10.1161/JAHA.119.012697DOI: 10.1161/JAHA.119.012697
REPLY: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease (Journal article)
Choi, E. -K., Lee, S. -R., Oh, S., & Lip, G. Y. H. (2019). REPLY: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(18), 2330-2331. doi:10.1016/j.jacc.2019.09.003DOI: 10.1016/j.jacc.2019.09.003
Age-Dependent Prognostic Impact of Paroxysmal Versus Sustained Atrial Fibrillation on the Incidence of Cardiac Death and Heart Failure Hospitalization (the Fushimi AF Registry) (Journal article)
An, Y., Ogawa, H., Esato, M., Ishii, M., Iguchi, M., Masunaga, N., . . . Akao, M. (2019). Age-Dependent Prognostic Impact of Paroxysmal Versus Sustained Atrial Fibrillation on the Incidence of Cardiac Death and Heart Failure Hospitalization (the Fushimi AF Registry). AMERICAN JOURNAL OF CARDIOLOGY, 124(9), 1420-1429. doi:10.1016/j.amjcard.2019.07.048DOI: 10.1016/j.amjcard.2019.07.048
Association between epicardial adipose tissue and embolic stroke after catheter ablation of atrial fibrillation (Journal article)
Ahn, J., Shin, S. Y., Shim, J., Kim, Y. -H., Han, S. -J., Choi, E. -K., . . . Lim, H. E. (2019). Association between epicardial adipose tissue and embolic stroke after catheter ablation of atrial fibrillation. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 30(11), 2209-2216. doi:10.1111/jce.14154DOI: 10.1111/jce.14154
Merino, J. L., Lip, G. Y. H., Heidbuchel, H., Cohen, A. -A., De Caterina, R., de Groot, J. R., . . . Goette, A. (2019). Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis. EUROPACE, 21(11), 1633-1638. doi:10.1093/europace/euz213DOI: 10.1093/europace/euz213
Heart rate variability in atrial fibrillation: The balance between sympathetic and parasympathetic nervous system (Journal article)
Khan, A. A., Lip, G. Y. H., & Shantsila, A. (2019). Heart rate variability in atrial fibrillation: The balance between sympathetic and parasympathetic nervous system. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 49(11). doi:10.1111/eci.13174DOI: 10.1111/eci.13174
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation Insights From the PIONEER AF-PCI Trial (Journal article)
Kerneis, M., Yee, M. K., Mehran, R., Nafee, T., Bode, C., Halperin, J. L., . . . Gibson, M. (2019). Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation Insights From the PIONEER AF-PCI Trial. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 12(11). doi:10.1161/CIRCINTERVENTIONS.119.008160DOI: 10.1161/CIRCINTERVENTIONS.119.008160
Triple or dual antithrombotic therapy post-percutaneous coronary intervention: Which one is better? (Journal article)
Ding, W. Y., Potpara, T. S., Stables, R. H., & Lip, G. Y. H. (2019). Triple or dual antithrombotic therapy post-percutaneous coronary intervention: Which one is better?. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 30(11), 2473-2474. doi:10.1111/jce.14130DOI: 10.1111/jce.14130
Very late arrhythmia recurrences in patients with sinus rhythm within the first year after catheter ablation: The Leipzig Heart Center AF Ablation Registry (Journal article)
Kornej, J., Schumacher, K., Sommer, P., Potpara, T., Arya, A., Dagres, N., . . . Hindricks, G. (2019). Very late arrhythmia recurrences in patients with sinus rhythm within the first year after catheter ablation: The Leipzig Heart Center AF Ablation Registry. EUROPACE, 21(11), 1646-1652. doi:10.1093/europace/euz233DOI: 10.1093/europace/euz233
Li, Y. -M., Jiang, C., He, L., Li, X. -X., Hou, X. -X., Chang, S. -S., . . . Ma, C. -S. (2019). Sex Differences in Presentation, Quality of Life, and Treatment in Chinese Atrial Fibrillation Patients: Insights from the China Atrial Fibrillation Registry Study. MEDICAL SCIENCE MONITOR, 25, 8011-8018. doi:10.12659/MSM.919366DOI: 10.12659/MSM.919366
A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention (Journal article)
Gumprecht, J., Domek, M., & Lip, G. Y. H. (2019). A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention. EXPERT OPINION ON DRUG SAFETY. doi:10.1080/14740338.2019.1676723DOI: 10.1080/14740338.2019.1676723
Analysis of housing prices in Petaling district, Malaysia using functional relationship model (Journal article)
Chang, Y. F., Choong, W. C., Looi, S. Y., Pan, W. Y., & Goh, H. L. (2019). Analysis of housing prices in Petaling district, Malaysia using functional relationship model. International Journal of Housing Markets and Analysis, 12(5), 884-905. doi:10.1108/ijhma-12-2018-0099DOI: 10.1108/ijhma-12-2018-0099
Prevalence of Hypertension in the Middle Belt of Ghana: A Community-Based Screening Study (Journal article)
Dosoo, D. K., Nyame, S., Enuameh, Y., Ayetey, H., Danwonno, H., Twumasi, M., . . . Asante, K. P. (2019). Prevalence of Hypertension in the Middle Belt of Ghana: A Community-Based Screening Study. INTERNATIONAL JOURNAL OF HYPERTENSION, 2019. doi:10.1155/2019/1089578DOI: 10.1155/2019/1089578
Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease (Journal article)
Moon, I., Lee, S. -R., Choi, E. -K., Lee, E., Jung, J. -H., Han, K. -D., . . . Lip, G. Y. H. (2019). Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease. JOURNAL OF CLINICAL MEDICINE, 8(10). doi:10.3390/jcm8101624DOI: 10.3390/jcm8101624
Considerations when restarting anticoagulants in patients with atrial fibrillation after bleeding (Journal article)
Koziel, M., Ding, W. Y., Kalarus, Z., & Lip, G. Y. H. (2019). Considerations when restarting anticoagulants in patients with atrial fibrillation after bleeding. EXPERT REVIEW OF HEMATOLOGY, 12(10), 845-855. doi:10.1080/17474086.2019.1647779DOI: 10.1080/17474086.2019.1647779
Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: The West Birmingham Atrial Fibrillation Project (Journal article)
Li, Y. -G., Miyazawa, K., Pastori, D., Szekely, O., Shahid, F., & Lip, G. Y. H. (2019). Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: The West Birmingham Atrial Fibrillation Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 292, 126-130. doi:10.1016/j.ijcard.2019.04.055DOI: 10.1016/j.ijcard.2019.04.055
Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA) (Journal article)
Kalarus, Z., Svendsen, J. H., Capodanno, D., Dan, G. -A., De Maria, E., Gorenek, B., . . . Berti, S. (2019). Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA). EUROPACE, 21(10), 1603-+. doi:10.1093/europace/euz163DOI: 10.1093/europace/euz163
Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial (Journal article)
Packer, M., Butler, J., Filippatos, G. S., Jamal, W., Salsali, A., Schnee, J., . . . Palmer, M. (2019). Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial. EUROPEAN JOURNAL OF HEART FAILURE, 21(10), 1270-1278. doi:10.1002/ejhf.1536DOI: 10.1002/ejhf.1536
Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial. (Journal article)
Anker, S. D., Butler, J., Filippatos, G. S., Jamal, W., Salsali, A., Schnee, J., . . . EMPEROR-Preserved Trial Committees and Investigators. (2019). Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial.. European journal of heart failure, 21(10), 1279-1287. doi:10.1002/ejhf.1596DOI: 10.1002/ejhf.1596
Recommendations on stroke prevention for patients having a CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines (Journal article)
Chao, T. -F., Chen, S. -A., & Lip, G. Y. H. (2019). Recommendations on stroke prevention for patients having a CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines. TRENDS IN CARDIOVASCULAR MEDICINE, 29(7), 427-428. doi:10.1016/j.tcm.2019.02.008DOI: 10.1016/j.tcm.2019.02.008
Venous thromboembolism prophylaxis strategies for patients undergoing elective total knee replacement (Journal article)
Koziel, M., & Lip, G. Y. H. (2019). Venous thromboembolism prophylaxis strategies for patients undergoing elective total knee replacement. LANCET HAEMATOLOGY, 6(10), E496-E497. doi:10.1016/S2352-3026(19)30164-4DOI: 10.1016/S2352-3026(19)30164-4
Meeting the unmet needs to improve management and outcomes of patients with atrial fibrillation: fitting global solutions to local settings (Journal article)
Potpara, T. S., Mujovic, N., & Lip, G. Y. H. (2019). Meeting the unmet needs to improve management and outcomes of patients with atrial fibrillation: fitting global solutions to local settings. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 129(9), 574-576. doi:10.20452/pamw.14996DOI: 10.20452/pamw.14996
Lip, G. Y. H., Guo, Y., Lotufo, P., Surenthirakumaran, R., Humphreys, L., Thomas, G. N., . . . Thomas, G. N. (2019). The National Institute for Health Research (NIHR) Global Health Research Group on Atrial Fibrillation management. EUROPEAN HEART JOURNAL, 40(36), 3005-3007. doi:10.1093/eurheartj/ehz648DOI: 10.1093/eurheartj/ehz648
Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation (Journal article)
Lee, S. -R., Rhee, T. -M., Kang, D. -Y., Choi, E. -K., Oh, S., & Lip, G. Y. H. (2019). Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 124(6), 879-885. doi:10.1016/j.amjcard.2019.05.072DOI: 10.1016/j.amjcard.2019.05.072
Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor? <i>JACC</i> Review Topic of the Week (Journal article)
Gorog, D. A., & Lip, G. Y. H. (2019). Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor? <i>JACC</i> Review Topic of the Week. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(10), 1366-1375. doi:10.1016/j.jacc.2019.07.030DOI: 10.1016/j.jacc.2019.07.030
Spinthakis, N., Gue, Y., Farag, M., Srinivasan, M., Wellsted, D., Arachchillage, D. R. J., . . . Gorog, D. A. (2019). Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation. EUROPACE, 21(9), 1297-1306. doi:10.1093/europace/euz176DOI: 10.1093/europace/euz176
Miyazawa, K., Pastori, D., Li, Y. -G., Szekely, O., Shahid, F., Boriani, G., & Lip, G. Y. H. (2019). Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes. CLINICAL RESEARCH IN CARDIOLOGY, 108(9), 1034-1041. doi:10.1007/s00392-019-01432-yDOI: 10.1007/s00392-019-01432-y
Clinical factors and imaging leading to risk of incident atrial fibrillation (Journal article)
Shantsila, A., Oxborough, D., Fairbairn, T. A., & Lip, G. Y. H. (2019). Clinical factors and imaging leading to risk of incident atrial fibrillation. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 20(9), 988-989. doi:10.1093/ehjci/jez199DOI: 10.1093/ehjci/jez199
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation (Journal article)
Chan, Y. -H., Lee, H. -F., See, L. -C., Tu, H. -T., Chao, T. -F., Yeh, Y. -H., . . . Lip, G. Y. H. (2019). Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation. CHEST, 156(3), 529-543. doi:10.1016/j.chest.2019.04.108DOI: 10.1016/j.chest.2019.04.108
Effects of forward gate bias stressing on the leakage current of AlGaN/GaN high electron mobility transistors (Journal article)
Gao, Y., Sasangka, W. A., Thompson, C. V., & Gan, C. L. (2019). Effects of forward gate bias stressing on the leakage current of AlGaN/GaN high electron mobility transistors. Microelectronics Reliability, 100-101, 113432. doi:10.1016/j.microrel.2019.113432DOI: 10.1016/j.microrel.2019.113432
Iron-facilitated dynamic active-site generation on spinel CoAl2O4 with self-termination of surface reconstruction for water oxidation (Journal article)
Wu, T., Sun, S., Song, J., Xi, S., Du, Y., Chen, B., . . . Xu, Z. J. (n.d.). Iron-facilitated dynamic active-site generation on spinel CoAl2O4 with self-termination of surface reconstruction for water oxidation. Nature Catalysis, 2(9), 763-772. doi:10.1038/s41929-019-0325-4DOI: 10.1038/s41929-019-0325-4
Long-Term Impact of Newly Diagnosed Atrial Fibrillation During Critical Care A South Korean Nationwide Cohort Study (Journal article)
Kim, K., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -N., Uhm, J. -S., . . . Joung, B. (2019). Long-Term Impact of Newly Diagnosed Atrial Fibrillation During Critical Care A South Korean Nationwide Cohort Study. CHEST, 156(3), 518-528. doi:10.1016/j.chest.2019.04.011DOI: 10.1016/j.chest.2019.04.011
Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation (Journal article)
Cheng, W. -H., Chao, T. -F., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2019). Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation. STROKE, 50(9), 2574-2577. doi:10.1161/STROKEAHA.119.025623DOI: 10.1161/STROKEAHA.119.025623
Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI (Journal article)
Hohnloser, S. H., Steg, P. G., Oldgren, J., Nickenig, G., Kiss, R. G., Ongen, Z., . . . Cannon, C. P. (2019). Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI. JACC-CARDIOVASCULAR INTERVENTIONS, 12(16), 1553-1561. doi:10.1016/j.jcin.2019.05.050DOI: 10.1016/j.jcin.2019.05.050
Atrial Fibrillation in Older People: Concepts and Controversies (Journal article)
Zathar, Z., Karunatilleke, A., Fawzy, A. M., & Lip, G. Y. H. (2019). Atrial Fibrillation in Older People: Concepts and Controversies. FRONTIERS IN MEDICINE, 6. doi:10.3389/fmed.2019.00175DOI: 10.3389/fmed.2019.00175
Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation (Journal article)
Lee, S. -R., Choi, E. -K., Kwon, S., Han, K. -D., Jung, J. -H., Cha, M. -J., . . . Lip, G. Y. H. (2019). Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation. STROKE, 50(8), 2245-2249. doi:10.1161/STROKEAHA.119.025536DOI: 10.1161/STROKEAHA.119.025536
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial (Journal article)
Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., . . . Zobouyan, I. (2019). Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. LANCET DIABETES & ENDOCRINOLOGY, 7(8), 618-628. doi:10.1016/S2213-8587(19)30158-5DOI: 10.1016/S2213-8587(19)30158-5
To the Editor-Patients with atrial fibrillation with hypertrophic cardiomyopathy: Do we need new stroke risk stratification? (Journal article)
Joung, B., & Lip, G. Y. H. (2019). To the Editor-Patients with atrial fibrillation with hypertrophic cardiomyopathy: Do we need new stroke risk stratification?. HEART RHYTHM, 16(8), E56. doi:10.1016/j.hrthm.2019.04.006DOI: 10.1016/j.hrthm.2019.04.006
Using Blood Biomarkers to Identify Atrial Fibrillation-Related Stroke: Balancing Simplicity and Practicality (Journal article)
Koziel, M., Potpara, T. S., & Lip, G. Y. H. (2019). Using Blood Biomarkers to Identify Atrial Fibrillation-Related Stroke: Balancing Simplicity and Practicality. STROKE, 50(8), 1956-1957. doi:10.1161/STROKEAHA.119.026185DOI: 10.1161/STROKEAHA.119.026185
Kerala Atrial Fibrillation Registry: a prospective observational study on clinical characteristics, treatment pattern and outcome of atrial fibrillation in Kerala, India, cohort profile (Journal article)
Gopalan, B. C., Namboodiri, N., Abdullakutty, J., Lip, G. Y. H., Koshy, A. G., Nair, V. K., . . . Felix, V. (2019). Kerala Atrial Fibrillation Registry: a prospective observational study on clinical characteristics, treatment pattern and outcome of atrial fibrillation in Kerala, India, cohort profile. BMJ OPEN, 9(7). doi:10.1136/bmjopen-2018-025901DOI: 10.1136/bmjopen-2018-025901
Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA (Journal article)
Wilson, D., Ambler, G., Shakeshaft, C., Banerjee, G., Charidimou, A., Seiffge, D., . . . Vahidassr, D. (2019). Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA. BMJ OPEN, 9(7). doi:10.1136/bmjopen-2018-028387DOI: 10.1136/bmjopen-2018-028387
Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort (Journal article)
Kim, D., Yang, P. -S., Yu, H. T., Kim, T. -H., Jang, E., Sung, J. -H., . . . Joung, B. (2019). Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort. EUROPEAN HEART JOURNAL, 40(28), 2313-2323. doi:10.1093/eurheartj/ehz386DOI: 10.1093/eurheartj/ehz386
Stroke prevention in atrial fibrillation: State of the art (Journal article)
Li, Y. -G., & Lip, G. Y. H. (2019). Stroke prevention in atrial fibrillation: State of the art. INTERNATIONAL JOURNAL OF CARDIOLOGY, 287, 201-209. doi:10.1016/j.ijcard.2018.09.057DOI: 10.1016/j.ijcard.2018.09.057
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI <i>JACC</i> State-of-the-Art Review (Journal article)
Capodanno, D., Huber, K., Mehran, R., Lip, G. Y. H., Faxon, D. P., Granger, C. B., . . . Angiolillo, D. J. (2019). Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI <i>JACC</i> State-of-the-Art Review. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(1), 83-99. doi:10.1016/j.jacc.2019.05.016DOI: 10.1016/j.jacc.2019.05.016
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease (Journal article)
Lee, S. -R., Lee, H. -J., Choi, E. -K., Han, K. -D., Jung, J. -H., Cha, M. -J., . . . Lip, G. Y. H. (2019). Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(25), 3295-3308. doi:10.1016/j.jacc.2019.04.052DOI: 10.1016/j.jacc.2019.04.052
ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study (Journal article)
Pastori, D., Farcomeni, A., Pignatelli, P., Violi, F., & Lip, G. Y. H. (2019). ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study. AMERICAN JOURNAL OF MEDICINE, 132(7), 856-861. doi:10.1016/j.amjmed.2019.01.003DOI: 10.1016/j.amjmed.2019.01.003
Lane, D. A., Dagres, N., Dan, G. -A., Garcia Seara, J., Iliodromitis, K., Lenarczyk, R., . . . Potpara, T. S. (2019). Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey. EUROPACE, 21(7), 1116-1125. doi:10.1093/europace/euz033DOI: 10.1093/europace/euz033
Boriani, G., Proietti, M., Laroche, C., Fauchier, L., Marin, F., Nabauer, M., . . . Lip, G. Y. H. (2019). Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry. EUROPACE, 21(7), 1013-1022. doi:10.1093/europace/euz032DOI: 10.1093/europace/euz032
Wilson, D., Ambler, G., Lee, K. -J., Lim, J. -S., Shiozawa, M., Koga, M., . . . Werring, D. J. (2019). Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies. LANCET NEUROLOGY, 18(7), 653-665. doi:10.1016/S1474-4422(19)30197-8DOI: 10.1016/S1474-4422(19)30197-8
EHRA White Paper: knowledge gaps in arrhythmia management-status 2019 (Journal article)
Goette, A., Auricchio, A., Boriani, G., Braunschweig, F., Brugada Terradellas, J., Burri, H., . . . Heinzel, F. R. (2019). EHRA White Paper: knowledge gaps in arrhythmia management-status 2019. EUROPACE, 21(7), 993-+. doi:10.1093/europace/euz055DOI: 10.1093/europace/euz055
Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort (Journal article)
Pastori, D., Pignatelli, P., Menichelli, D., Violi, F., & Lip, G. Y. H. (2019). Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort. MAYO CLINIC PROCEEDINGS, 94(7), 1261-1267. doi:10.1016/j.mayocp.2018.10.022DOI: 10.1016/j.mayocp.2018.10.022
Guo, Y., Lane, D. A., Wang, L., Chen, Y., Lip, G. Y. H., Wang, L., . . . Ge, F. (2019). Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 73(7). doi:10.1111/ijcp.13352DOI: 10.1111/ijcp.13352
Study of Front-Side Approach to Retrieve Stored Data in Non-Volatile Memory Devices Using Scanning Capacitance Microscopy (Conference Paper)
Tay, J. Y., Cheah, J., Liu, Q., & Gan, C. L. (2019). Study of Front-Side Approach to Retrieve Stored Data in Non-Volatile Memory Devices Using Scanning Capacitance Microscopy. In 2019 IEEE 26th International Symposium on Physical and Failure Analysis of Integrated Circuits (IPFA). IEEE. doi:10.1109/ipfa47161.2019.8984802DOI: 10.1109/ipfa47161.2019.8984802
Lim, J. S. K., Gan, C. L., Hu, X. M., & Hu, X. M. (2019). Unraveling the Mechanistic Origins of Epoxy Degradation in Acids.. ACS omega, 4(6), 10799-10808. doi:10.1021/acsomega.9b00859DOI: 10.1021/acsomega.9b00859
Li, Y. -G., Bisson, A., Bodin, A., Herbert, J., Grammatico-Guillon, L., Joung, B., . . . Fauchier, L. (2019). C2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study.. Journal of the American Heart Association, 8(13), e012546. doi:10.1161/jaha.119.012546DOI: 10.1161/jaha.119.012546
Liang, H. -F., Du, X., Zhou, Y. -C., Yang, X. -Y., Xia, S. -J., Dong, J. -Z., . . . Ma, C. -S. (2019). Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry. MEDICAL SCIENCE MONITOR, 25, 4691-4698. doi:10.12659/MSM.917131DOI: 10.12659/MSM.917131
β-Blocker Use in Pregnancy and the Risk for Congenital Malformations (Journal article)
Shantsila, A., Beevers, D. G., & Lip, G. Y. H. (2019). β-Blocker Use in Pregnancy and the Risk for Congenital Malformations. ANNALS OF INTERNAL MEDICINE, 170(12), 909. doi:10.7326/L19-0156DOI: 10.7326/L19-0156
Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study (Journal article)
Park, J., Choi, E. -K., Han, K. -D., Choi, Y. -J., Lee, S. -R., Cha, M. -J., . . . Lip, G. Y. H. (2019). Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study. AMERICAN JOURNAL OF CARDIOLOGY, 123(12), 1921-1926. doi:10.1016/j.amjcard.2019.03.024DOI: 10.1016/j.amjcard.2019.03.024
Letter by Guo et al Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial" (Journal article)
Guo, Y., Lip, G. Y. H., & Potpara, T. (2019). Letter by Guo et al Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial". CIRCULATION, 139(24), E1037-E1038. doi:10.1161/CIRCULATIONAHA.118.038961DOI: 10.1161/CIRCULATIONAHA.118.038961
Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study (Journal article)
Sogaard, M., Skjoth, F., Jensen, M., Kjaeldgaard, J. N., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2019). Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 8(11). doi:10.1161/JAHA.118.011358DOI: 10.1161/JAHA.118.011358
Proietti, M., Farcomeni, A., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Mairesse, G. H. (2019). Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 26(9), 964-972. doi:10.1177/2047487319839184DOI: 10.1177/2047487319839184
Etiological Research Using Observational Data, and Net Clinical Benefit. Simplicity and Practicality Matter (Journal article)
Nielsen, P. B., Buchan, I., & Lip, G. Y. H. (2019). Etiological Research Using Observational Data, and Net Clinical Benefit. Simplicity and Practicality Matter. AMERICAN JOURNAL OF MEDICINE, 132(6), 671-672. doi:10.1016/j.amjmed.2019.01.038DOI: 10.1016/j.amjmed.2019.01.038
Predicting stroke in patients without atrial fibrillation (Journal article)
Steensig, K., Olesen, K. K. W., Thim, T., Nielsen, J. C., Madsen, M., Jensen, S. E., . . . Maeng, M. (2019). Predicting stroke in patients without atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 49(6). doi:10.1111/eci.13103DOI: 10.1111/eci.13103
Prothrombin Complex Concentrate or Coagulation Factor Xa (Recombinant), Inactivated-zhzo Response (Journal article)
Lip, G. Y. H., Ruff, C. T., & Moores, L. (2019). Prothrombin Complex Concentrate or Coagulation Factor Xa (Recombinant), Inactivated-zhzo Response. CHEST, 155(6), 1309. doi:10.1016/j.chest.2019.03.001DOI: 10.1016/j.chest.2019.03.001
Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction (Journal article)
Shah, N., Qian, M., Di Tullio, M. R., Graham, S., Mann, D. L., Sacco, R. L., . . . Freudenberger, R. S. (2019). Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 49(6). doi:10.1111/eci.13092DOI: 10.1111/eci.13092
Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial (Journal article)
Lip, G. Y. H., Mauri, L., Montalescot, G., Ozkor, M., Vardas, P., Steg, P. G., . . . Cannon, C. P. (2019). Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial. AMERICAN HEART JOURNAL, 212, 13-22. doi:10.1016/j.ahj.2019.02.006DOI: 10.1016/j.ahj.2019.02.006
Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry (Journal article)
Deng, H., Shantsila, A., Xue, Y., Bai, Y., Guo, P., Potpara, T. S., . . . Lip, G. Y. H. (2019). Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry. ARCHIVES OF CARDIOVASCULAR DISEASES, 112(6-7), 420-429. doi:10.1016/j.acvd.2019.02.006DOI: 10.1016/j.acvd.2019.02.006
The New <i>CHEST</i> Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban Response (Journal article)
Lip, G. Y. H., Ruff, C. T., & Moores, L. (2019). The New <i>CHEST</i> Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban Response. CHEST, 155(6), 1311-1312. doi:10.1016/j.chest.2019.03.037DOI: 10.1016/j.chest.2019.03.037
The Use of Rivaroxaban in Patients With Atrial Fibrillation Receiving Hemodialysis-Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report Response (Journal article)
Lip, G. Y. H., Ruff, C. T., & Moores, L. (2019). The Use of Rivaroxaban in Patients With Atrial Fibrillation Receiving Hemodialysis-Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report Response. CHEST, 155(6), 1307. doi:10.1016/j.chest.2019.02.329DOI: 10.1016/j.chest.2019.02.329
Revisiting the risks of incident atrial fibrillation: a narrative review. Part 2 (Journal article)
Panchal, G., Mahmood, M., & Lip, G. Y. H. (2019). Revisiting the risks of incident atrial fibrillation: a narrative review. Part 2. KARDIOLOGIA POLSKA, 77(5), 515-524. doi:10.33963/KP.14846DOI: 10.33963/KP.14846
Microparticles and cardiovascular diseases (Journal article)
Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2019). Microparticles and cardiovascular diseases. ANNALS OF MEDICINE, 51(3-4), 193-223. doi:10.1080/07853890.2019.1609076DOI: 10.1080/07853890.2019.1609076
Chao, T. -F., Lip, G. Y. H., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2019). Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities. European heart journal, 40(19), 1504-1514. doi:10.1093/eurheartj/ehy837DOI: 10.1093/eurheartj/ehy837
Oldgren, J., Steg, P. G., Hohnloser, S. H., Lip, G. Y. H., Kimura, T., Nordaby, M., . . . Cannon, C. P. (2019). Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial. EUROPEAN HEART JOURNAL, 40(19), 1553-+. doi:10.1093/eurheartj/ehz059DOI: 10.1093/eurheartj/ehz059
Short-Term Outcomes of Apixaban Versus Warfarin in Patients With Atrial Fibrillation Is Body Weight an Important Consideration? (Journal article)
Lip, G. Y. H., Khan, A. A., & Olshansky, B. (2019). Short-Term Outcomes of Apixaban Versus Warfarin in Patients With Atrial Fibrillation Is Body Weight an Important Consideration?. CIRCULATION, 139(20), 2301-2303. doi:10.1161/CIRCULATIONAHA.119.040021DOI: 10.1161/CIRCULATIONAHA.119.040021
Kornej, J., Schumacher, K., Zeynalova, S., Sommer, P., Arya, A., Weiss, M., . . . Hindricks, G. (2019). Time-dependent prediction of arrhythmia recurrences during long-term follow-up in patients undergoing catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-43644-2DOI: 10.1038/s41598-019-43644-2
Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation (Journal article)
Chao, T. -F., Chiang, C. -E., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2019). Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation. ANNALS OF INTERNAL MEDICINE, 170(9), 663-+. doi:10.7326/M18-1177DOI: 10.7326/M18-1177
Pharmacokinetics and pharmacodynamics of oral anticoagulants used in atrial fibrillation (Journal article)
Fawzy, A. M., & Lip, G. Y. H. (2019). Pharmacokinetics and pharmacodynamics of oral anticoagulants used in atrial fibrillation. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 15(5), 381-398. doi:10.1080/17425255.2019.1604686DOI: 10.1080/17425255.2019.1604686
Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review (Journal article)
Deitelzweig, S., & Lip, G. Y. H. (2019). Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 19(3), 243-244. doi:10.1080/14737167.2019.1592834DOI: 10.1080/14737167.2019.1592834
Atrial Fibrillation and End-Stage COPD A Close Association Revisited (Journal article)
Shin, S. Y., Manuel, A. R. G., & Lip, G. Y. H. (2019). Atrial Fibrillation and End-Stage COPD A Close Association Revisited. CHEST, 155(5), 888-889. doi:10.1016/j.chest.2019.01.027DOI: 10.1016/j.chest.2019.01.027
Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association (Journal article)
Temporelli, P. L., Tilz, R. R., Arbelo, E., Dagres, N., Laroche, C., Crijns, H. J., . . . Tavazzi, L. (2019). Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association. EUROPEAN JOURNAL OF HEART FAILURE, 21(5), 690-+. doi:10.1002/ejhf.1458DOI: 10.1002/ejhf.1458
Banerjee, G., Chan, E., Ambler, G., Wilson, D., Cipolotti, L., Shakeshaft, C., . . . Vahidassr, D. (2019). Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA. In JOURNAL OF NEUROLOGY Vol. 266 (pp. 1250-1259). doi:10.1007/s00415-019-09256-6DOI: 10.1007/s00415-019-09256-6
Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus A Danish Cohort Study (Journal article)
Fangel, M. V., Nielsen, P. B., Kristensen, J. K., Larsen, T. B., Overvad, T. F., Lip, G. Y. H., & Jensen, M. B. (2019). Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus A Danish Cohort Study. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 12(5). doi:10.1161/CIRCEP.118.007030DOI: 10.1161/CIRCEP.118.007030
Guideline Implications of Prothrombotic State Assessment in Low-Risk Atrial Fibrillation Patients: Consistency With CHA<sub>2</sub>DS<sub>2</sub>-VASc and Support for CHADS-65 (Journal article)
Nattel, S., & Lip, G. Y. H. (2019). Guideline Implications of Prothrombotic State Assessment in Low-Risk Atrial Fibrillation Patients: Consistency With CHA<sub>2</sub>DS<sub>2</sub>-VASc and Support for CHADS-65. CANADIAN JOURNAL OF CARDIOLOGY, 35(5), 547-549. doi:10.1016/j.cjca.2019.03.001DOI: 10.1016/j.cjca.2019.03.001
Importance of Risk Reassessment in Patients With Atrial Fibrillation in Guidelines: Assessing Risk as a Dynamic Process (Journal article)
Chang, T. -Y., Lip, G. Y. H., Chen, S. -A., & Chao, T. -F. (2019). Importance of Risk Reassessment in Patients With Atrial Fibrillation in Guidelines: Assessing Risk as a Dynamic Process. CANADIAN JOURNAL OF CARDIOLOGY, 35(5), 611-618. doi:10.1016/j.cjca.2019.01.018DOI: 10.1016/j.cjca.2019.01.018
Safety of drug-eluting stents compared to bare metal stents in patients with an indication for long-term oral anticoagulation: A propensity score matched analysis (Journal article)
Limeres, J., Lip, G. Y. H., Garcia del Blanco, B., Ferreira-Gonzalez, I., Mutuberria, M., Alfonso, F., . . . Sambola, A. (2019). Safety of drug-eluting stents compared to bare metal stents in patients with an indication for long-term oral anticoagulation: A propensity score matched analysis. THROMBOSIS RESEARCH, 177, 180-186. doi:10.1016/j.thromres.2019.02.021DOI: 10.1016/j.thromres.2019.02.021
Proietti, M., Lane, D. A., Boriani, G., & Lip, G. Y. H. (2019). Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines. CANADIAN JOURNAL OF CARDIOLOGY, 35(5), 619-633. doi:10.1016/j.cjca.2019.02.009DOI: 10.1016/j.cjca.2019.02.009
Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Oh, S., & Lip, G. Y. H. (2019). Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-43224-4DOI: 10.1038/s41598-019-43224-4
Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function. (Journal article)
Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Oh, S., & Lip, G. Y. H. (2019). Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function.. Stroke, 50(5), 1140-1148. doi:10.1161/strokeaha.118.024210DOI: 10.1161/strokeaha.118.024210
Chua, W., Purmah, Y., Cardoso, V. R., Gkoutos, G. V., Tull, S. P., Neculau, G., . . . Fabritz, L. (2019). Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation. EUROPEAN HEART JOURNAL, 40(16), 1268-+. doi:10.1093/eurheartj/ehy815DOI: 10.1093/eurheartj/ehy815
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation. (Journal article)
Lopes, R. D., Heizer, G., Aronson, R., Vora, A. N., Massaro, T., Mehran, R., . . . AUGUSTUS Investigators. (2019). Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.. The New England journal of medicine, 380(16), 1509-1524. doi:10.1056/nejmoa1817083DOI: 10.1056/nejmoa1817083
Revisiting the risks of incident atrial fibrillation: a narrative review. Part 1 (Journal article)
Panchal, G., Mahmood, M., & Lip, G. Y. H. (2019). Revisiting the risks of incident atrial fibrillation: a narrative review. Part 1. KARDIOLOGIA POLSKA, 77(4), 430-436. doi:10.33963/KP.14806DOI: 10.33963/KP.14806
Hernandez-Romero, D., Sanchez-Quinones, J., Antonio Vilchez, J., Miguel Rivera-Caravaca, J., de la Morena, G., Lip, G. Y. H., . . . Marin, F. (2019). Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-42727-4DOI: 10.1038/s41598-019-42727-4
Corrigendum to “Crystal orientation dependence of the stress-induced martensitic transformation in zirconia-based shape memory ceramics” [Acta Mater. 116 (2016) 124–135] (Journal article)
Zeng, X. M., Lai, A., Gan, C. L., & Schuh, C. A. (2019). Corrigendum to “Crystal orientation dependence of the stress-induced martensitic transformation in zirconia-based shape memory ceramics” [Acta Mater. 116 (2016) 124–135]. Acta Materialia, 168, 511-512. doi:10.1016/j.actamat.2019.02.027DOI: 10.1016/j.actamat.2019.02.027
Liu, C., Du, X., Jiang, C., He, L., Chang, S. -S., Guo, X. -Y., . . . Ma, C. -S. (2019). Long-Term Persistence with Newly-Initiated Warfarin or Non-VKA Oral Anticoagulant (NOAC) in Patients with Non-Valvular Atrial Fibrillation: Insights from the Prospective China-AF Registry. MEDICAL SCIENCE MONITOR, 25, 2649-2657. doi:10.12659/MSM.915875DOI: 10.12659/MSM.915875
Congenital absence of the deep inferior epigastric system: a case report (Journal article)
Harris, T. G. W., Wohlgemut, H. S., Lip, G., & Curnier, A. P. R. (2019). Congenital absence of the deep inferior epigastric system: a case report. European Journal of Plastic Surgery, 42(2), 197-200. doi:10.1007/s00238-018-1463-7DOI: 10.1007/s00238-018-1463-7
Lee, T. C., Qian, M., Mu, L., Di Tullio, M. R., Graham, S., Mann, D. L., . . . Ye, S. (2019). Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial. ESC HEART FAILURE, 6(2), 297-307. doi:10.1002/ehf2.12407DOI: 10.1002/ehf2.12407
Cancer and atrial fibrillation. Author's reply (Journal article)
Malavasi, V. L., Marietta, M., Lip, G. Y. H., & Boriani, G. (2019). Cancer and atrial fibrillation. Author's reply. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 62, E24-E25. doi:10.1016/j.ejim.2019.01.002DOI: 10.1016/j.ejim.2019.01.002
Community screening for atrial fibrillation in the era of smart devices (Journal article)
Shin, S. Y., & Lip, G. Y. H. (2019). Community screening for atrial fibrillation in the era of smart devices. INTERNATIONAL JOURNAL OF CARDIOLOGY, 280, 95-96. doi:10.1016/j.ijcard.2019.01.001DOI: 10.1016/j.ijcard.2019.01.001
Economic evaluation of the use of non-vitamin Koral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands (Journal article)
Bennaghmouch, N., de Veer, A. J. W. M., Mahmoodi, B. K., Jofre-Bonet, M., Lip, G. Y. H., Bode, K., & ten Berg, J. M. (2019). Economic evaluation of the use of non-vitamin Koral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 5(2), 127-135. doi:10.1093/ehjqcco/qcy030DOI: 10.1093/ehjqcco/qcy030
Nielsen, P. B., Skjoth, F., Sogaard, M., Kjaeldgaard, J. N., Lip, G. Y. H., & Larsen, T. B. (2019). Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage. STROKE, 50(4), 939-946. doi:10.1161/STROKEAHA.118.023797DOI: 10.1161/STROKEAHA.118.023797
Stroke risk in female patients with atrial fibrillation: Relationship to current guideline recommendations (Journal article)
Nielsen, P. B., Potpara, T. S., & Lip, G. Y. H. (2019). Stroke risk in female patients with atrial fibrillation: Relationship to current guideline recommendations. TRENDS IN CARDIOVASCULAR MEDICINE, 29(3), 150-152. doi:10.1016/j.tcm.2018.07.003DOI: 10.1016/j.tcm.2018.07.003
The Liverpool Centre for Cardiovascular Science: The Centre was established to advance cardiovascular and stroke research and innovation locally, nationally and internationally (Journal article)
Lip, G. Y. H., & Lane, D. A. (2019). The Liverpool Centre for Cardiovascular Science: The Centre was established to advance cardiovascular and stroke research and innovation locally, nationally and internationally. EUROPEAN HEART JOURNAL, 40(12), 957-958. doi:10.1093/eurheartj/ehz107DOI: 10.1093/eurheartj/ehz107
Junejo, R. T., Braz, I. D., Lucas, S. J. E., van Lieshout, J. J., Lip, G. Y. H., & Fisher, J. P. (2019). Impaired Cerebrovascular Reactivity in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(10), 1230-+. doi:10.1016/j.jacc.2019.01.009DOI: 10.1016/j.jacc.2019.01.009
Factor XI inhibition fulfilling the optimal expectations for ideal anticoagulation (Journal article)
Szekely, O., Borgi, M., & Lip, G. Y. H. (2019). Factor XI inhibition fulfilling the optimal expectations for ideal anticoagulation. EXPERT OPINION ON EMERGING DRUGS, 24(1), 55-61. doi:10.1080/14728214.2019.1591368DOI: 10.1080/14728214.2019.1591368
Arnar, D. O., Mairesse, G. H., Boriani, G., Calkins, H., Chin, A., Coats, A., . . . EHRA Scientific Documents Committee. (2019). Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS).. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. doi:10.1093/europace/euz046DOI: 10.1093/europace/euz046
WORLDWIDE ORAL ANTICOAGULANT PRESCRIPTION PREVALENCE AND TRENDS IN PATIENTS WITH ATRIAL FIBRILLATION FROM A MULTI-NATIONAL COHORT: INSIGHTS FROM THE INTERNATIONAL COLLABORATIVE PARTNERSHIP FOR THE STUDY OF ATRIAL FIBRILLATION (INTERAF) COLLABORATIVE (Conference Paper)
Hsu, J. C., Akao, M., Avezum Junior, A., Bloomfield, G., Kohsaka, S., Lane, D., . . . Maddox, T. (2019). WORLDWIDE ORAL ANTICOAGULANT PRESCRIPTION PREVALENCE AND TRENDS IN PATIENTS WITH ATRIAL FIBRILLATION FROM A MULTI-NATIONAL COHORT: INSIGHTS FROM THE INTERNATIONAL COLLABORATIVE PARTNERSHIP FOR THE STUDY OF ATRIAL FIBRILLATION (INTERAF) COLLABORATIVE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 376). doi:10.1016/S0735-1097(19)30984-2DOI: 10.1016/S0735-1097(19)30984-2
Kim, T. -H., Yang, P. -S., Yu, H. T., Jang, E., Shin, H., Kim, H. Y., . . . Lip, G. Y. H. (2019). Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population. European Heart Journal, 40(10), 809-819. doi:10.1093/eurheartj/ehy877DOI: 10.1093/eurheartj/ehy877
Lee, S. -R., Choi, E. -K., Park, C. S., Han, K. -D., Jung, J. -H., Oh, S., & Lip, G. Y. H. (2019). Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(8), 919-931. doi:10.1016/j.jacc.2018.11.051DOI: 10.1016/j.jacc.2018.11.051
Safety of direct oral anticoagulants in real-world clinical practice: translating the trials to everyday clinical management (Journal article)
Fawzy, A. M., Yang, W. -Y., & Lip, G. Y. H. (2019). Safety of direct oral anticoagulants in real-world clinical practice: translating the trials to everyday clinical management. EXPERT OPINION ON DRUG SAFETY, 18(3), 187-209. doi:10.1080/14740338.2019.1578344DOI: 10.1080/14740338.2019.1578344
Li, Y. -G., Pastori, D., Farcomeni, A., Yang, P. -S., Jang, E., Joung, B., . . . Lip, G. Y. H. (2019). A Simple Clinical Risk Score (C<sub>2</sub>HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects. CHEST, 155(3), 510-518. doi:10.1016/j.chest.2018.09.011DOI: 10.1016/j.chest.2018.09.011
Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy (Journal article)
Pastori, D., Mezzaroma, I., Pignatelli, P., Violi, F., & Lip, G. Y. H. (2019). Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 85(3), 508-515. doi:10.1111/bcp.13837DOI: 10.1111/bcp.13837
COMPARATIVE EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS (Conference Paper)
Lip, G. Y. H., Keshishian, A., Kang, A., Dhamane, A., Luo, X., Li, X., . . . Deitelzweig, S. (2019). COMPARATIVE EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 320). doi:10.1016/S0735-1097(19)30928-3DOI: 10.1016/S0735-1097(19)30928-3
EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS (Conference Paper)
Deitelzweig, S., Keshishian, A., Kang, A., Dhamane, A., Luo, X., Li, X., . . . Lip, G. Y. H. (2019). EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 435). doi:10.1016/S0735-1097(19)31043-5DOI: 10.1016/S0735-1097(19)31043-5
EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS COMPARED TO WARFARIN AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS (Conference Paper)
Lip, G. Y. H., Keshishian, A., Kang, A., Dhamane, A., Luo, X., Li, X., . . . Deitelzweig, S. (2019). EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS COMPARED TO WARFARIN AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 432). doi:10.1016/S0735-1097(19)31040-XDOI: 10.1016/S0735-1097(19)31040-X
EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN OBESE NONVALVULAR ATRIAL FIBRILLATION PATIENTS: A POOLED CLAIMS DATABASE ANALYSIS (Conference Paper)
Deitelzweig, S., Keshishian, A., Kang, A., Dhamane, A., Luo, X., Li, X., . . . Lip, G. Y. H. (2019). EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN OBESE NONVALVULAR ATRIAL FIBRILLATION PATIENTS: A POOLED CLAIMS DATABASE ANALYSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 434). doi:10.1016/S0735-1097(19)31042-3DOI: 10.1016/S0735-1097(19)31042-3
Petryszyn, P., Niewinski, P., Staniak, A., Piotrowski, P., Well, A., Well, M., . . . Ponikowski, P. (2019). Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis. PLOS ONE, 14(3). doi:10.1371/journal.pone.0213198DOI: 10.1371/journal.pone.0213198
Electrochemical Oxidation in AlGaN/GaN-on-Si High Electron Mobility Transistors (Conference Paper)
Gan, C. L., Sasangka, W. A., & Thompson, C. V. (2019). Electrochemical Oxidation in AlGaN/GaN-on-Si High Electron Mobility Transistors. In 2019 Electron Devices Technology and Manufacturing Conference (EDTM). IEEE. doi:10.1109/edtm.2019.8731316DOI: 10.1109/edtm.2019.8731316
Epidemiology of out-of-hospital cardiac arrest: A French national incidence and mid-term survival rate study (Journal article)
Luc, G., Baert, V., Escutnaire, J., Genin, M., Vilhelm, C., Di Pompeo, C., . . . Hubert, H. (2019). Epidemiology of out-of-hospital cardiac arrest: A French national incidence and mid-term survival rate study. ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 38(2), 131-135. doi:10.1016/j.accpm.2018.04.006DOI: 10.1016/j.accpm.2018.04.006
Mon2 predicts poor outcome in ST-elevation myocardial infarction (Journal article)
Shantsila, E., Ghattas, A., Griffiths, H. R., & Lip, G. Y. H. (2019). Mon2 predicts poor outcome in ST-elevation myocardial infarction. JOURNAL OF INTERNAL MEDICINE, 285(3), 301-316. doi:10.1111/joim.12847DOI: 10.1111/joim.12847
Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry (Journal article)
Deng, H., Shantsila, A., Guo, P., Potpara, T. S., Zhan, X., Fang, X., . . . Lip, G. Y. H. (2019). Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry. ARCHIVES OF CARDIOVASCULAR DISEASES, 112(3), 171-179. doi:10.1016/j.acvd.2018.10.006DOI: 10.1016/j.acvd.2018.10.006
Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation (Conference Paper)
Bisson, A., Bernard, A., Bodin, A., Clementy, N., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2019). Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation. In CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY Vol. 12. doi:10.1161/CIRCEP.118.006990DOI: 10.1161/CIRCEP.118.006990
USING THE CHA2DS2-VASC SCORE TO PREDICT ISCHEMIC STROKE IN PATIENTS WITH INTRACEREBRAL HEMORRHAGE: A NATIONWIDE COHORT STUDY (Conference Paper)
Nielsen, P. B., Overvad, T. F., Skjoth, F., Andersen, S. D., Sogaard, M., Larsen, T. B., & Lip, G. Y. H. (2019). USING THE CHA2DS2-VASC SCORE TO PREDICT ISCHEMIC STROKE IN PATIENTS WITH INTRACEREBRAL HEMORRHAGE: A NATIONWIDE COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 503). doi:10.1016/S0735-1097(19)31111-8DOI: 10.1016/S0735-1097(19)31111-8
VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER CIRRHOSIS: FINDINGS FROM THE RIETE REGISTRY (Conference Paper)
Bikdeli, B., Jimenez, D., Garcia-Tsao, G., Barba, R., Font, C., Diaz-Pedroche, M. D. C., . . . Monreal, M. (2019). VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER CIRRHOSIS: FINDINGS FROM THE RIETE REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 2043). doi:10.1016/S0735-1097(19)32649-XDOI: 10.1016/S0735-1097(19)32649-X
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies (Journal article)
Li, G., Lip, G. Y. H., Holbrook, A., Chang, Y., Larsen, T. B., Sun, X., . . . Levine, M. A. H. (2019). Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 34(2), 173-190. doi:10.1007/s10654-018-0415-7DOI: 10.1007/s10654-018-0415-7
Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF) (Journal article)
Lip, G. Y. H., Merino, J. L., Banach, M., de Groot, J. R., Maier, L. S., Themistoclakis, S., . . . Goette, A. (2019). Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF). AMERICAN JOURNAL OF CARDIOLOGY, 123(4), 592-597. doi:10.1016/j.amjcard.2018.11.019DOI: 10.1016/j.amjcard.2018.11.019
Diener, H. -C., Hart, R. G., Koudstaal, P. J., Lane, D. A., & Lip, G. Y. H. (2019). Atrial Fibrillation and Cognitive Function <i>JACC</i> Review Topic of the Week. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(5), 612-619. doi:10.1016/j.jacc.2018.10.077DOI: 10.1016/j.jacc.2018.10.077
Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials (Journal article)
Fu, L., Zhu, W., Huang, L., Hu, J., Ma, J., Lip, G. Y. H., & Hong, K. (2019). Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 19(1), 37-47. doi:10.1007/s40256-018-0299-7DOI: 10.1007/s40256-018-0299-7
Ding, W. Y., Khan, A. A., Gupta, D., & Lip, G. Y. H. (2019). Short-Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity?. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 8(3). doi:10.1161/JAHA.119.011953DOI: 10.1161/JAHA.119.011953
2018 ESC/ESH Guidelines for the management of arterial hypertension (vol 39, pg 3021, 2018) (Journal article)
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2019). 2018 ESC/ESH Guidelines for the management of arterial hypertension (vol 39, pg 3021, 2018). EUROPEAN HEART JOURNAL, 40(5), 475. doi:10.1093/eurheartj/ehy686DOI: 10.1093/eurheartj/ehy686
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) (Journal article)
Lip, G. Y. H., Collet, J. -P., Haude, M., Byrne, R., Chung, E. H., Fauchier, L., . . . Jardine, R. (2019). 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). EUROPACE, 21(2), 192-+. doi:10.1093/europace/euy174DOI: 10.1093/europace/euy174
Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention Insights From the PIONEER AF-PCI Trial (Journal article)
Kerneis, M., Yee, M. K., Mehran, R., Nafee, T., Bode, C., Halperin, J. L., . . . Gibson, C. M. (2019). Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention Insights From the PIONEER AF-PCI Trial. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 12(2). doi:10.1161/CIRCINTERVENTIONS.118.007124DOI: 10.1161/CIRCINTERVENTIONS.118.007124
Body Mass Index Variability and Long-term Risk of New-Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study (Journal article)
Lim, Y. -M., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2019). Body Mass Index Variability and Long-term Risk of New-Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study. MAYO CLINIC PROCEEDINGS, 94(2), 225-235. doi:10.1016/j.mayocp.2018.10.019DOI: 10.1016/j.mayocp.2018.10.019
Kosich, F., Schumacher, K., Potpara, T., Lip, G. Y., Hindricks, G., & Kornej, J. (2019). Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation. CLINICAL CARDIOLOGY, 42(2), 320-329. doi:10.1002/clc.23139DOI: 10.1002/clc.23139
Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis) (Journal article)
Korjian, S., Daaboul, Y., Laliberte, F., Zhao, Q., Mehran, R., Bode, C., . . . Pinto, D. S. (2019). Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis). AMERICAN JOURNAL OF CARDIOLOGY, 123(3), 355-360. doi:10.1016/j.amjcard.2018.10.033DOI: 10.1016/j.amjcard.2018.10.033
ESC/ESH 2018 Guide on the diagnosis and treatment of arterial hypertension (Journal article)
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2019). ESC/ESH 2018 Guide on the diagnosis and treatment of arterial hypertension. REVISTA ESPANOLA DE CARDIOLOGIA, 72(2). doi:10.1016/j.recesp.2018.12.005DOI: 10.1016/j.recesp.2018.12.005
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy A Nationwide Cohort Study (Journal article)
Jung, H., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2019). Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy A Nationwide Cohort Study. CHEST, 155(2), 354-363. doi:10.1016/j.chest.2018.11.009DOI: 10.1016/j.chest.2018.11.009
Frailty and multi-morbidities should not govern oral anticoagulation therapy prescribing for patients with atrial fibrillation (Journal article)
Fawzy, A. M., Olshansky, B., & Lip, G. Y. H. (2019). Frailty and multi-morbidities should not govern oral anticoagulation therapy prescribing for patients with atrial fibrillation. AMERICAN HEART JOURNAL, 208, 120-122. doi:10.1016/j.ahj.2018.10.003DOI: 10.1016/j.ahj.2018.10.003
Malignant hypertension: not quite an obsolete diagnosis yet (Journal article)
Shantsila, A., & Lip, G. Y. H. (2019). Malignant hypertension: not quite an obsolete diagnosis yet. JOURNAL OF HYPERTENSION, 37(2), 282-283. doi:10.1097/HJH.0000000000001974DOI: 10.1097/HJH.0000000000001974
Management of atrial fibrillation: easy as ABC (Journal article)
Mahmood, M., & Lip, G. Y. (2019). Management of atrial fibrillation: easy as ABC. MINERVA MEDICA, 110(1), 27-34. doi:10.23736/S0026-4806.18.05824-XDOI: 10.23736/S0026-4806.18.05824-X
Physician Estimation of Thrombotic and Bleeding Risks in Atrial Fibrillation: Let's Talk About Sex (Journal article)
Ding, W. Y., Gupta, D., & Lip, G. Y. H. (2019). Physician Estimation of Thrombotic and Bleeding Risks in Atrial Fibrillation: Let's Talk About Sex. CANADIAN JOURNAL OF CARDIOLOGY, 35(2), 145-146. doi:10.1016/j.cjca.2018.12.011DOI: 10.1016/j.cjca.2018.12.011
Relation of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study) (Journal article)
Koene, R. J., Alraies, M. C., Norby, F. L., Soliman, E. Z., Maheshwari, A., Lip, G. Y. H., . . . Chen, L. Y. (2019). Relation of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study). AMERICAN JOURNAL OF CARDIOLOGY, 123(3), 402-408. doi:10.1016/j.amjcard.2018.10.037DOI: 10.1016/j.amjcard.2018.10.037
Tackling anti-coagulation under-prescription in the elderly (Journal article)
Fawzy, A. M., Chao, T. -F., & Lip, G. Y. H. (2019). Tackling anti-coagulation under-prescription in the elderly. AGING-US, 11(4), 1070-1072. doi:10.18632/aging.101809DOI: 10.18632/aging.101809
Lip, G. Y. H. (2019). The safety of NOACs in atrial fibrillation patient subgroups: A narrative review. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 73(2). doi:10.1111/ijcp.13285DOI: 10.1111/ijcp.13285
Habboushe, J., Altman, C., & Lip, G. Y. H. (2019). Time trends in use of the CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc scores, and the geographical and specialty uptake of these scores from a popular online clinical decision tool and medical reference. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 73(2). doi:10.1111/ijcp.13280DOI: 10.1111/ijcp.13280
Validation of the MB-LATER score for prediction of late recurrence after catheter-ablation of atrial fibrillation (Journal article)
Potpara, T. S., Mujovic, N., Sivasambu, B., Shantsila, A., Marinkovic, M., Calkins, H., . . . Lip, G. Y. H. (2019). Validation of the MB-LATER score for prediction of late recurrence after catheter-ablation of atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 276, 130-135. doi:10.1016/j.ijcard.2018.08.018DOI: 10.1016/j.ijcard.2018.08.018
Sex differences in risk of incident venous thromboembolism in heart failure patients (Journal article)
Melgaard, L., Nielsen, P. B., Overvad, T. F., Skjoth, F., Lip, G. Y. H., & Larsen, T. B. (2019). Sex differences in risk of incident venous thromboembolism in heart failure patients. CLINICAL RESEARCH IN CARDIOLOGY, 108(1), 101-109. doi:10.1007/s00392-018-1329-9DOI: 10.1007/s00392-018-1329-9
2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) (vol 27, pg 314, 2018) (Journal article)
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormai, I. (2019). 2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) (vol 27, pg 314, 2018). BLOOD PRESSURE, 28(1), 74. doi:10.1080/08037051.2018.1557365DOI: 10.1080/08037051.2018.1557365
Response by Chao et al to Letter Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study" (Journal article)
Chao, T. -F., Lip, G. Y. H., & Chen, S. -A. (2019). Response by Chao et al to Letter Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study". CIRCULATION, 139(1), 146-147. doi:10.1161/CIRCULATIONAHA.118.037670DOI: 10.1161/CIRCULATIONAHA.118.037670
2018 ESC/ESH Guidelines for the management of arterial hypertension (Journal article)
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Lovic, D. (2019). 2018 ESC/ESH Guidelines for the management of arterial hypertension. KARDIOLOGIA POLSKA, 77(2), 71-159. doi:10.5603/KP.2019.0018DOI: 10.5603/KP.2019.0018
A study of clustering for the enhancement of image resolution in dynamic photon emission (Conference Paper)
Chef, S., Chua, C. T., & Gan, C. L. (2019). A study of clustering for the enhancement of image resolution in dynamic photon emission. In Conference Proceedings from the International Symposium for Testing and Failure Analysis (pp. 68-78).
Anticoagulation in elderly patients with nonvalvular atrial fibrillation: A balancing act (Journal article)
Fawzy, A. M., & Lip, G. Y. H. (2019). Anticoagulation in elderly patients with nonvalvular atrial fibrillation: A balancing act. HEART RHYTHM, 16(1), 38-40. doi:10.1016/j.hrthm.2018.09.011DOI: 10.1016/j.hrthm.2018.09.011
Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality (Journal article)
Malavasi, V. L., Fantecchi, E., Gianolio, L., Pesce, F., Longo, G., Marietta, M., . . . Boriani, G. (2019). Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 59, 27-33. doi:10.1016/j.ejim.2018.10.012DOI: 10.1016/j.ejim.2018.10.012
Automated Profiling Method for Laser Fault Injection in FPGAs (Chapter)
Breier, J., He, W., Bhasin, S., Jap, D., Chef, S., Ong, H. G., & Gan, C. L. (2019). Automated Profiling Method for Laser Fault Injection in FPGAs. In Automated Methods in Cryptographic Fault Analysis (pp. 301-325). doi:10.1007/978-3-030-11333-9-14DOI: 10.1007/978-3-030-11333-9-14
Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry (Journal article)
An, Y., Ogawa, H., Yamashita, Y., Ishii, M., Iguchi, M., Masunaga, N., . . . Akao, M. (2019). Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 5(1), 35-42. doi:10.1093/ehjqcco/qcy033DOI: 10.1093/ehjqcco/qcy033
Deitelzweig, S., Keshishian, A., Li, X., Kang, A., Dhamane, A. D., Luo, X., . . . Lip, G. Y. H. (2019). Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 67(8), 1662-1671. doi:10.1111/jgs.15956DOI: 10.1111/jgs.15956
ESC Council on hypertension position document on themanagement of hypertensive emergencies (Journal article)
van den Born, B. -J. H., Lip, G. Y. H., Brguljan-Hitij, J., Cremer, A., Segura, J., Morales, E., . . . Williams, B. (2019). ESC Council on hypertension position document on themanagement of hypertensive emergencies. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 5(1), 37-46. doi:10.1093/ehjcvp/pvy032DOI: 10.1093/ehjcvp/pvy032
Wilson, D., Ambler, G., Banerjee, G., Shakeshaft, C., Cohen, H., Yousry, T. A., . . . Werring, D. J. (2019). Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90(3), 320-325. doi:10.1136/jnnp-2018-318890DOI: 10.1136/jnnp-2018-318890
Zeng, J., Zhang, X., Lip, G. Y. H., Shu, X., Thabane, L., Tian, J., & Li, G. (2019). Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 25. doi:10.1177/1076029619853629DOI: 10.1177/1076029619853629
Xiong, Q., Wang, C., Liu, H., Tan, Z., Chen, C., Li, J., . . . Hong, K. (2019). Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asians With Nonvalvular Atrial Fibrillation: A Network Meta-Analysis. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 25. doi:10.1177/1076029619885188DOI: 10.1177/1076029619885188
Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation (Journal article)
Mork, M., Andreasen, J. J., Rasmussen, L. H., Lip, G. Y. H., Pedersen, S., Baek, R., . . . Kristensen, S. R. (2019). Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation. THROMBOSIS RESEARCH, 173, 141-150. doi:10.1016/j.thromres.2018.11.026DOI: 10.1016/j.thromres.2018.11.026
Lowres, N., Olivier, J., Chao, T. -F., Chen, S. -A., Chen, Y., Diederichsen, A., . . . Freedman, B. (2019). Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals. PLOS MEDICINE, 16(9). doi:10.1371/journal.pmed.1002903DOI: 10.1371/journal.pmed.1002903
European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS) (Journal article)
Boriani, G., Fauchier, L., Aguinaga, L., Beattie, J. M., Lundqvist, C. B., Cohen, A., . . . Chin, A. (2019). European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). EUROPACE, 21(1), 7-+. doi:10.1093/europace/euy110DOI: 10.1093/europace/euy110
Ghidul ESC/ESH 2018 pentru managementul hipertensiunii arteriale (Journal article)
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2019). Ghidul ESC/ESH 2018 pentru managementul hipertensiunii arteriale. Revista Romana de Cardiologie, 29(1), 69-177.
Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study (Journal article)
Jung, H., Yang, P. -S., Sung, J. -H., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2019). Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study. THROMBOSIS AND HAEMOSTASIS, 119(2), 285-293. doi:10.1055/s-0038-1676818DOI: 10.1055/s-0038-1676818
Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study (Journal article)
Yoon, M., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2019). Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study. THROMBOSIS AND HAEMOSTASIS, 119(10), 1695-1703. doi:10.1055/s-0039-1693516DOI: 10.1055/s-0039-1693516
Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially 'Low-Risk' Patients (Journal article)
Chao, T. -F., Liao, J. -N., Tuan, T. -C., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2019). Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially 'Low-Risk' Patients. THROMBOSIS AND HAEMOSTASIS, 119(7), 1162-1170. doi:10.1055/s-0039-1683933DOI: 10.1055/s-0039-1683933
Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function (Journal article)
Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Cha, M. -J., Oh, S., & Lip, G. Y. H. (2019). Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function. STROKE, 50(6), 1480-1489. doi:10.1161/STROKEAHA.118.024264DOI: 10.1161/STROKEAHA.118.024264
One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry (Journal article)
Li, Y. -G., Miyazawa, K., Wolff, A., Zubaid, M., Alsheikh-Ali, A. A., Sulaiman, K., & Lip, G. Y. H. (2019). One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 274, 158-162. doi:10.1016/j.ijcard.2018.08.091DOI: 10.1016/j.ijcard.2018.08.091
Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores (Journal article)
Miguel Rivera-Caravaca, J., Marin, F., Antonio Vilchez, J., Galvez, J., Asuncion Esteve-Pastor, M., Vicente, V., . . . Roldan, V. (2019). Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores. STROKE, 50(6), 1372-1379. doi:10.1161/STROKEAHA.118.024305DOI: 10.1161/STROKEAHA.118.024305
Risk assessment and management of atrial fibrillation patients with left atrial thrombus (Journal article)
Miyazawa, K., & Lip, G. Y. H. (2019). Risk assessment and management of atrial fibrillation patients with left atrial thrombus. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 42(1), 1-3. doi:10.1111/pace.13556DOI: 10.1111/pace.13556
Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE) (Journal article)
Miyazawa, K., Li, Y. -G., Rashed, W. A., Al Mahmeed, W., Shehab, A., Zubaid, M., & Lip, G. Y. H. (2019). Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE). INTERNATIONAL JOURNAL OF CARDIOLOGY, 274, 126-131. doi:10.1016/j.ijcard.2018.07.120DOI: 10.1016/j.ijcard.2018.07.120
Should We Judge Stroke Risk by Static or Dynamic Risk Scores? A Focus on the Dynamic Nature of Stroke and Bleeding Risks in Patients With Atrial Fibrillation (Journal article)
Domek, M., Gumprecht, J., Mazurek, M., Chao, T. -F., & Lip, G. Y. H. (2019). Should We Judge Stroke Risk by Static or Dynamic Risk Scores? A Focus on the Dynamic Nature of Stroke and Bleeding Risks in Patients With Atrial Fibrillation. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 74(6), 491-498. doi:10.1097/FJC.0000000000000750DOI: 10.1097/FJC.0000000000000750
Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study (Journal article)
Lip, G. Y. H., Jensen, M., Melgaard, L., Skjoth, F., Nielsen, P. B., & Larsen, T. B. (2019). Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study. EUROPACE, 21(1), 33-40. doi:10.1093/europace/euy151DOI: 10.1093/europace/euy151
Stroke: Insights into Thromboembolism Treatment and Prevention through the Decades (Journal article)
Ntaios, G., & Lip, G. Y. H. (2019). Stroke: Insights into Thromboembolism Treatment and Prevention through the Decades. THROMBOSIS AND HAEMOSTASIS, 119(5), 685-687. doi:10.1055/s-0039-1685454DOI: 10.1055/s-0039-1685454
Park, J., Choi, E. -K., Han, K. -D., Choi, Y. -J., Lee, E., Choe, W., . . . Lip, G. Y. H. (2019). Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study. PLOS ONE, 14(1). doi:10.1371/journal.pone.0209593DOI: 10.1371/journal.pone.0209593
The CHA<sub>2</sub>DS<sub>2</sub>-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history (Retraction of Vol 36, Pg 2880, 2015) (Journal article)
Lip, G. Y. H. (2019). The CHA<sub>2</sub>DS<sub>2</sub>-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history (Retraction of Vol 36, Pg 2880, 2015). EUROPEAN HEART JOURNAL, 40(7). Retrieved from https://www.webofscience.com/
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations (Journal article)
De Caterina, R., Ageno, W., Agnelli, G., Chan, N. C., Diener, H. -C., Hylek, E., . . . Weitz, J. I. (2019). The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations. THROMBOSIS AND HAEMOSTASIS, 119(1), 14-38. doi:10.1055/s-0038-1675816DOI: 10.1055/s-0038-1675816
The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal (Journal article)
Asuncion Esteve-Pastor, M., Roldan, V., Miguel Rivera-Caravaca, J., Ramirez-Macias, I., Lip, G. Y. H., & Marin, F. (2019). The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal. THROMBOSIS AND HAEMOSTASIS, 119(12), 1901-1919. doi:10.1055/s-0039-1696955DOI: 10.1055/s-0039-1696955
The prothrombotic state in atrial fibrillation: pathophysiological and management implications (Journal article)
Khan, A. A., & Lip, G. Y. H. (2019). The prothrombotic state in atrial fibrillation: pathophysiological and management implications. CARDIOVASCULAR RESEARCH, 115(1), 31-45. doi:10.1093/cvr/cvy272DOI: 10.1093/cvr/cvy272
Thrombosis and Haemostasis 2018 Editor's Choice Papers (Journal article)
Weber, C., & Lip, G. Y. H. (2019). Thrombosis and Haemostasis 2018 Editor's Choice Papers. THROMBOSIS AND HAEMOSTASIS, 119(1), 183-186. doi:10.1055/s-0038-1676653DOI: 10.1055/s-0038-1676653
Thrombosis and Haemostasis Wishes You a Happy New Year Ahead! (Journal article)
Lip, G. Y. H., & Weber, C. (2019). Thrombosis and Haemostasis Wishes You a Happy New Year Ahead!. THROMBOSIS AND HAEMOSTASIS, 119(1), 1-2. doi:10.1055/s-0038-1676651DOI: 10.1055/s-0038-1676651
Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response (Journal article)
Mahmood, M., & Lip, G. Y. H. (2019). Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response. REVISTA ESPANOLA DE CARDIOLOGIA, 72(1), 97-98. doi:10.1016/j.recesp.2018.07.023DOI: 10.1016/j.recesp.2018.07.023
Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response. (Journal article)
Mahmood, M., & Lip, G. Y. H. (2019). Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response.. Revista espanola de cardiologia (English ed.), 72(1), 97-98. doi:10.1016/j.rec.2018.08.002DOI: 10.1016/j.rec.2018.08.002
Bikdeli, B., Jimenez, D., Garcia-Tsao, G., Barba, R., Font, C., del Carmen Diaz-Pedroche, M., . . . Monreal, M. (2019). Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 45(8), 793-801. doi:10.1055/s-0039-1697682DOI: 10.1055/s-0039-1697682
Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EURObservational Research Programme (Conference Paper)
Tilz, R., Dagres, N., Arbelo, E., Lundqvist, C. H. B., Pokushalov, E., Crijns, H. J., . . . Tavazzi, L. (2019). Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EURObservational Research Programme. In EUROPEAN HEART JOURNAL Vol. 40 (pp. 138). Retrieved from https://www.webofscience.com/
2018
Urinary Biomarkers of Oxidative Stress in Atrial Fibrillation (Journal article)
Meng, L., Wong, R., Tsui, M. Y., Tse, G., Li, G., Liu, T., & Lip, G. Y. H. (2018). Urinary Biomarkers of Oxidative Stress in Atrial Fibrillation. The Open Biomarkers Journal, 8(1), 24-33. doi:10.2174/1875318301808010024DOI: 10.2174/1875318301808010024
Usefulness of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score to Predict the Risk of Sudden Cardiac Death and Ventricular Arrhythmias in Patients With Atrial Fibrillation (Conference Paper)
Kuo, L., Chao, T. -F., Liu, C. -J., Chen, S. -J., Tuan, T. -C., Lin, Y. -J., . . . Chen, S. -A. (2018). Usefulness of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score to Predict the Risk of Sudden Cardiac Death and Ventricular Arrhythmias in Patients With Atrial Fibrillation. In AMERICAN JOURNAL OF CARDIOLOGY Vol. 122 (pp. 2049-2054). doi:10.1016/j.amjcard.2018.08.056DOI: 10.1016/j.amjcard.2018.08.056
Single right coronary artery with congenital absence of left coronary system. (Journal article)
Upadhyaya, S. G. N., Mughal, L. H., Connolly, D., & Lip, G. (2018). Single right coronary artery with congenital absence of left coronary system.. BMJ case reports, 11(1), e228296. doi:10.1136/bcr-2018-228296DOI: 10.1136/bcr-2018-228296
Current and emerging pharmacotherapy for ischemic stroke prevention in patients with atrial fibrillation (Journal article)
Szekely, O., Miyazawa, K., & Lip, G. Y. H. (2018). Current and emerging pharmacotherapy for ischemic stroke prevention in patients with atrial fibrillation. EXPERT OPINION ON PHARMACOTHERAPY, 19(18), 1999-2009. doi:10.1080/14656566.2018.1537368DOI: 10.1080/14656566.2018.1537368
Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry (Journal article)
An, Y., Esato, M., Ishii, M., Iguchi, M., Masunaga, N., Tsuji, H., . . . Akao, M. (2018). Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry. HEART AND VESSELS, 33(12), 1534-1546. doi:10.1007/s00380-018-1194-5DOI: 10.1007/s00380-018-1194-5
Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry (vol 33, pg 1534, 2018) (Journal article)
An, Y., Esato, M., Ishii, M., Iguchi, M., Masunaga, N., Tsuji, H., . . . Akao, M. (2018). Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry (vol 33, pg 1534, 2018). HEART AND VESSELS, 33(12), 1547-1548. doi:10.1007/s00380-018-1212-7DOI: 10.1007/s00380-018-1212-7
Does Renal Function Predict Short- and Medium-Term Mortality and Hospital Readmissions in Poststroke Patients? (Journal article)
Ding, W. Y., & Lip, G. Y. H. (2018). Does Renal Function Predict Short- and Medium-Term Mortality and Hospital Readmissions in Poststroke Patients?. STROKE, 49(12), 2812-2813. doi:10.1161/STROKEAHA.118.023723DOI: 10.1161/STROKEAHA.118.023723
Goette, A., Kwong, W. J., Ezekowitz, M. D., Banach, M., Hjortshoj, S. P., Zamoryakhin, D., & Lip, G. Y. H. (2018). Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study. In EUROPACE Vol. 20 (pp. 1936-1943). doi:10.1093/europace/euy141DOI: 10.1093/europace/euy141
Guest Editorial for IRSP 2018 Conference (Journal article)
Budiman, A. S., Gan, C. L., Pey, K. -L., Sukharev, V., & Thomas, O. (2018). Guest Editorial for IRSP 2018 Conference. IEEE Transactions on Device and Materials Reliability, 18(4), 487-489. doi:10.1109/tdmr.2018.2881614DOI: 10.1109/tdmr.2018.2881614
Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015 (Journal article)
Kim, D., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2018). Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015. HEART, 104(24), 2010-2017. doi:10.1136/heartjnl-2017-312930DOI: 10.1136/heartjnl-2017-312930
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (vol 13, pg 651, 2018) (Journal article)
Raparelli, V., Pastori, D., Pignataro, S. F., Vestri, A. R., Pignatelli, P., Cangemi, R., . . . Basili, S. (2018). Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (vol 13, pg 651, 2018). INTERNAL AND EMERGENCY MEDICINE, 13(8), 1349. doi:10.1007/s11739-018-1922-yDOI: 10.1007/s11739-018-1922-y
Deng, H., Shantsila, E., Guo, P., Zhan, X., Fang, X., Liao, H., . . . Lip, G. Y. H. (2018). Multiple biomarkers and arrhythmia outcome following catheter ablation of atrial fibrillation: The Guangzhou Atrial Fibrillation Project. JOURNAL OF ARRHYTHMIA, 34(6), 617-625. doi:10.1002/joa3.12111DOI: 10.1002/joa3.12111
Phthalonitrile-Based Electronic Packages for High Temperature Applications (Conference Paper)
PHUA, E. J. R., LIU, M., LIM, J. S. K., CHO, B., & GAN, C. L. (2018). Phthalonitrile-Based Electronic Packages for High Temperature Applications. In 2018 IEEE 20th Electronics Packaging Technology Conference (EPTC). IEEE. doi:10.1109/eptc.2018.8654340DOI: 10.1109/eptc.2018.8654340
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: comment (Journal article)
Brown, J. D., Goodin, A., & Lip, G. Y. H. (2018). The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: comment. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 16(12), 2537-2539. doi:10.1111/jth.14301DOI: 10.1111/jth.14301
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome (Journal article)
Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., . . . Ball, E. (2018). Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. NEW ENGLAND JOURNAL OF MEDICINE, 379(22), 2097-2107. doi:10.1056/NEJMoa1801174DOI: 10.1056/NEJMoa1801174
Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation - The Fushimi AF Registry - (Journal article)
Masunaga, N., Abe, M., Ogawa, H., Aono, Y., Ikeda, S., Doi, K., . . . Akao, M. (2018). Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation - The Fushimi AF Registry -. CIRCULATION JOURNAL, 82(12), 2983-+. doi:10.1253/circj.CJ-18-0872DOI: 10.1253/circj.CJ-18-0872
Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry (Journal article)
Boriani, G., Proietti, M., Laroche, C., Diemberger, I., Popescu, M. I., Riahi, S., . . . Lip, G. Y. H. (2018). Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 271, 68-74. doi:10.1016/j.ijcard.2018.05.034DOI: 10.1016/j.ijcard.2018.05.034
CAD Is an Independent Risk Factor for Stroke Among Patients With Atrial Fibrillation (Journal article)
Steensig, K., Olesen, K. K. W., Thim, T., Nielsen, J. C., Jensen, S. E., Jensen, L. O., . . . Maeng, M. (2018). CAD Is an Independent Risk Factor for Stroke Among Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(20), 2540-2542. doi:10.1016/j.jacc.2018.08.1046DOI: 10.1016/j.jacc.2018.08.1046
Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy (Journal article)
Jung, H., Sung, J. -H., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., . . . Lip, G. Y. H. (2018). Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(19), 2409-2411. doi:10.1016/j.jacc.2018.07.098DOI: 10.1016/j.jacc.2018.07.098
Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review. (Journal article)
Lunde, E. D., Nielsen, P. B., Riahi, S., Larsen, T. B., Lip, G. Y. H., Fonager, K., . . . Joensen, A. M. (2018). Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review.. Expert review of cardiovascular therapy, 16(11), 857-873. doi:10.1080/14779072.2018.1533118DOI: 10.1080/14779072.2018.1533118
Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report (Journal article)
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., . . . Moores, L. (2018). Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report. Chest, 154(5), 1121-1201. doi:10.1016/j.chest.2018.07.040DOI: 10.1016/j.chest.2018.07.040
Are Alpha-Adrenergic Receptor Antagonists Beneficial to Prevent Heart Failure? Alpha-Adrenergic Receptor Antagonists Revisited (Journal article)
Shin, S. Y., & Lip, G. Y. H. (2018). Are Alpha-Adrenergic Receptor Antagonists Beneficial to Prevent Heart Failure? Alpha-Adrenergic Receptor Antagonists Revisited. JACC-HEART FAILURE, 6(11), 926-927. doi:10.1016/j.jchf.2018.07.013DOI: 10.1016/j.jchf.2018.07.013
Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study (Journal article)
Skjoth, F., Vadmann, H., Hjortshoj, S. P., Riahi, S., Lip, G. Y. H., & Larsen, T. B. (2018). Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(11). doi:10.1111/ijcp.13258DOI: 10.1111/ijcp.13258
Proietti, M., Romiti, G. F., Olshansky, B., Lane, D. A., & Lip, G. Y. H. (2018). Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway. AMERICAN JOURNAL OF MEDICINE, 131(11), 1359-+. doi:10.1016/j.amjmed.2018.06.012DOI: 10.1016/j.amjmed.2018.06.012
Predicting recurrent atrial fibrillation after catheter ablation (Journal article)
Mujovic, N., Marinkovic, M., Lip, G. Y. H., & Potpara, T. S. (2018). Predicting recurrent atrial fibrillation after catheter ablation. EUROPACE, 20, F460. doi:10.1093/europace/euy022DOI: 10.1093/europace/euy022
Real world comparison of major bleeding risk among non-valvular atrial fibrillation patients newly initiated on apixaban, dabigatran, rivaroxaban or warfarin (Conference Paper)
Lip, G. Y. H., Pan, X., Kamble, S., Kawabata, H., Mardekian, J., Masseria, C., . . . Phatak, H. (2015). Real world comparison of major bleeding risk among non-valvular atrial fibrillation patients newly initiated on apixaban, dabigatran, rivaroxaban or warfarin. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1085). Retrieved from https://www.webofscience.com/
Screening for atrial fibrillation: look harder, look longer, and improve stroke outcomes with oral anticoagulation (Journal article)
Miyazawa, K., Mairesse, G. H., & Lip, G. Y. H. (2018). Screening for atrial fibrillation: look harder, look longer, and improve stroke outcomes with oral anticoagulation. EUROPACE, 20, F278-F279. doi:10.1093/europace/euy088DOI: 10.1093/europace/euy088
Seasonal variation in the risk of ischemic stroke in patients with atrial fibrillation: A nationwide cohort study (Journal article)
Liao, J. -N., Chao, T. -F., Liu, C. -J., Chen, S. -J., Hung, C. -L., Lin, Y. -J., . . . Chen, S. -A. (2018). Seasonal variation in the risk of ischemic stroke in patients with atrial fibrillation: A nationwide cohort study. HEART RHYTHM, 15(11), 1611-1616. doi:10.1016/j.hrthm.2018.06.043DOI: 10.1016/j.hrthm.2018.06.043
Shin, S. Y., & Lip, G. Y. H. (2018). The Importance and Future of Population Screening for Atrial Fibrillation. CANADIAN JOURNAL OF CARDIOLOGY, 34(11), 1407-1411. doi:10.1016/j.cjca.2018.08.016DOI: 10.1016/j.cjca.2018.08.016
Using the MB-LATER score for predicting arrhythmia outcome after catheter ablation for atrial fibrillation: The Guangzhou atrial fibrillation project (Journal article)
Deng, H., Shantsila, A., Xue, Y., Potpara, T. S., Bai, Y., Zhan, X., . . . Lip, G. Y. H. (2018). Using the MB-LATER score for predicting arrhythmia outcome after catheter ablation for atrial fibrillation: The Guangzhou atrial fibrillation project. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(11). doi:10.1111/ijcp.13247DOI: 10.1111/ijcp.13247
[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. (Journal article)
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2018). [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)].. Giornale italiano di cardiologia (2006), 19(11 Suppl 1), 3S-73S. doi:10.1714/3026.30245DOI: 10.1714/3026.30245
Atrial fibrillation occurring initially during acute medical illness: the heterogeneous nature of disease, outcomes and management strategies (Journal article)
Li, Y. -G., Borgi, M., & Lip, G. Y. H. (2021). Atrial fibrillation occurring initially during acute medical illness: the heterogeneous nature of disease, outcomes and management strategies. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 10(5), 567-569. doi:10.1177/2048872618801763DOI: 10.1177/2048872618801763
NOninvasive Monitoring for Early Detection of Atrial Fibrillation: rationale and design of the NOMED-AF study (Journal article)
Kalarus, Z., Balsam, P., Bandosz, P., Grodzicki, T., Kazmierczak, J., Kiedrowicz, R., . . . Lip, G. Y. H. (2018). NOninvasive Monitoring for Early Detection of Atrial Fibrillation: rationale and design of the NOMED-AF study. KARDIOLOGIA POLSKA, 76(10), 1482-1485. doi:10.5603/KP.a2018.0193DOI: 10.5603/KP.a2018.0193
Adlan, A. M., van Zanten, J. J. C. S. V., Lip, G. Y. H., Paton, J. F. R., Kitas, G. D., & Fisher, J. P. (2018). Acute hydrocortisone administration reduces cardiovagal baroreflex sensitivity and heart rate variability in young men. JOURNAL OF PHYSIOLOGY-LONDON, 596(20), 4847-4861. doi:10.1113/JP276644DOI: 10.1113/JP276644
Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients (Journal article)
Marzona, I., Proietti, M., Farcomeni, A., Romiti, G. F., Romanazzi, I., Raparelli, V., . . . Roncaglioni, M. C. (2018). Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients. INTERNATIONAL JOURNAL OF CARDIOLOGY, 269, 182-191. doi:10.1016/j.ijcard.2018.07.044DOI: 10.1016/j.ijcard.2018.07.044
Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan (Journal article)
Chao, T. -F., Chiang, C. -E., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2018). Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan. CIRCULATION, 138(14), 1485-1487. doi:10.1161/CIRCULATIONAHA.118.036046DOI: 10.1161/CIRCULATIONAHA.118.036046
Lan, D. -H., Jiang, C., Du, X., He, L., Guo, X. -Y., Zuo, S., . . . Ma, C. -S. (2018). Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China-AF Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(19). doi:10.1161/JAHA.118.009391DOI: 10.1161/JAHA.118.009391
Mukhtar, O., Cheriyan, J., Cockcroft, J. R., Collier, D., Coulson, J. M., Dasgupta, I., . . . Wilkinson, I. B. (2018). A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program-AIM-HY INFORM trial. AMERICAN HEART JOURNAL, 204, 102-108. doi:10.1016/j.ahj.2018.05.006DOI: 10.1016/j.ahj.2018.05.006
Anticoagulantes orales no dependientes de la vitamina K para pacientes con fibrilación auricular e insuficiencia renal grave (Journal article)
Mahmood, M., & Lip, G. Y. H. (2018). Anticoagulantes orales no dependientes de la vitamina K para pacientes con fibrilación auricular e insuficiencia renal grave. Revista Española de Cardiología, 71(10), 847-855. doi:10.1016/j.recesp.2018.03.023DOI: 10.1016/j.recesp.2018.03.023
Atrial fibrillation (Journal article)
Miyazawa, K., & Lip, G. Y. H. (2018). Atrial fibrillation. Medicine, 46(10), 627-631. doi:10.1016/j.mpmed.2018.07.009DOI: 10.1016/j.mpmed.2018.07.009
Schumacher, K., Kornej, J., Shantsila, E., & Lip, G. Y. H. (2018). Heart Failure and Stroke.. Current heart failure reports, 15(5), 287-296. doi:10.1007/s11897-018-0405-9DOI: 10.1007/s11897-018-0405-9
Di Tullio, M. R., Qian, M., Thompson, J. L. P., Labovitz, A. J., Mann, D. L., Sacco, R. L., . . . Homma, S. (2018). Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment. ESC HEART FAILURE, 5(5), 800-808. doi:10.1002/ehf2.12331DOI: 10.1002/ehf2.12331
Modelling projections for the risks related with atrial fibrillation in East Asia: a focus on ischaemic stroke and death (Journal article)
Bai, Y., Guo, S. -D., Shantsila, A., & Lip, G. Y. H. (2018). Modelling projections for the risks related with atrial fibrillation in East Asia: a focus on ischaemic stroke and death. EUROPACE, 20(10), 1584-1590. doi:10.1093/europace/eux328DOI: 10.1093/europace/eux328
Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis (Journal article)
Telles-Garcia, N., Dahal, K., Kocherla, C., Lip, G. Y. H., Reddy, P., & Dominic, P. (2018). Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 268, 143-148. doi:10.1016/j.ijcard.2018.04.034DOI: 10.1016/j.ijcard.2018.04.034
Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction. (Journal article)
Mahmood, M., & Lip, G. Y. H. (2018). Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction.. Revista espanola de cardiologia (English ed.), 71(10), 847-855. doi:10.1016/j.rec.2018.05.015DOI: 10.1016/j.rec.2018.05.015
Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society (Journal article)
Linde, C., Bongiorni, M. G., Birgersdotter-Green, T., Curtis, A. B., Deisenhofer, I., Furokawa, T., . . . Varma, N. (2018). Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society. EUROPACE, 20(10), 1565-+. doi:10.1093/europace/euy067DOI: 10.1093/europace/euy067
Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention (Journal article)
Chi, G., Yee, M. K., Kalayci, A., Kerneis, M., AlKhalfan, F., Mehran, R., . . . Gibson, C. M. (2018). Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 46(3), 346-350. doi:10.1007/s11239-018-1703-5DOI: 10.1007/s11239-018-1703-5
Two-year safety and effectiveness of dabigatran in Asian patients with atrial fibrillation: Phase II results from Asian countries in the GLORIA-AF Registry Program (Conference Paper)
Ma, C., Kim, Y. H., Higashino, Y., Shlyakhto, E. V., Dubner, S. J., Halperin, J. L., . . . Lip, G. Y. H. (2018). Two-year safety and effectiveness of dabigatran in Asian patients with atrial fibrillation: Phase II results from Asian countries in the GLORIA-AF Registry Program. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 72 (pp. C175-C176). doi:10.1016/j.jacc.2018.08.783DOI: 10.1016/j.jacc.2018.08.783
Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study (Journal article)
Fangel, M. V., Nielsen, P. B., Larsen, T. B., Christensen, B., Overvad, T. F., Lip, G. Y. H., . . . Jensen, M. B. (2018). Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 268, 137-142. doi:10.1016/j.ijcard.2018.05.037DOI: 10.1016/j.ijcard.2018.05.037
Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function: Post hoc analysis of a prospective cohort (Journal article)
Malavasi, V. L., Pettorelli, D., Fantecchi, E., Zoccali, C., Laronga, G., Trenti, T., . . . Boriani, G. (2018). Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function: Post hoc analysis of a prospective cohort. INTERNAL AND EMERGENCY MEDICINE, 13(7), 1059-1067. doi:10.1007/s11739-018-1857-3DOI: 10.1007/s11739-018-1857-3
Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control (Journal article)
Bonde, A. N., Staerk, L., Lee, C. J. -Y., Vinding, N. E., Bang, C. N., Torp-Pedersen, C., . . . Olesen, J. B. (2018). Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(12), 1357-1365. doi:10.1016/j.jacc.2018.06.065DOI: 10.1016/j.jacc.2018.06.065
Proietti, M., Miguel Rivera-Caravaca, J., Asuncion Esteve-Pastor, M., Romiti, G. F., Marin, F., & Lip, G. Y. H. (2018). Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(18). doi:10.1161/JAHA.118.009766DOI: 10.1161/JAHA.118.009766
Ideal Blood Pressure in Patients With Atrial Fibrillation (Journal article)
Kim, D., Yang, P. -S., Kim, T. -H., Jang, E., Shin, H., Kim, H. Y., . . . Lip, G. Y. H. (2018). Ideal Blood Pressure in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(11), 1233-1245. doi:10.1016/j.jacc.2018.05.076DOI: 10.1016/j.jacc.2018.05.076
2018 ESC/ESH Guidelines for the management of arterial hypertension (Journal article)
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. EUROPEAN HEART JOURNAL, 39(33), 3021-+. doi:10.1093/eurheartj/ehy339DOI: 10.1093/eurheartj/ehy339
Deng, H., Shantsila, A., Guo, P., Potpara, T. S., Zhan, X., Fang, X., . . . Lip, G. Y. H. (2018). A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: A report from the Guangzhou atrial fibrillation ablation registry. EBIOMEDICINE, 35, 40-45. doi:10.1016/j.ebiom.2018.08.034DOI: 10.1016/j.ebiom.2018.08.034
Blood glucose reduction by diabetic drugs with minimal hypoglycaemia risk for cardiovascular outcomes: Evidence from meta-regression analysis of randomized controlled trials (Journal article)
Huang, C. -J., Wang, W. -T., Sung, S. -H., Chen, C. -H., Lip, G. Y. H., Cheng, H. -M., & Chiang, C. -E. (2018). Blood glucose reduction by diabetic drugs with minimal hypoglycaemia risk for cardiovascular outcomes: Evidence from meta-regression analysis of randomized controlled trials. DIABETES OBESITY & METABOLISM, 20(9), 2131-2139. doi:10.1111/dom.13342DOI: 10.1111/dom.13342
Does ECG have additive benefit for predicting atrial fibrillation in patients with or without hypertension? (Journal article)
Shin, S. Y., Shantsilla, A., & Lip, G. Y. H. (2018). Does ECG have additive benefit for predicting atrial fibrillation in patients with or without hypertension?. JOURNAL OF HYPERTENSION, 36(9), 1793-1794. doi:10.1097/HJH.0000000000001788DOI: 10.1097/HJH.0000000000001788
Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation (Journal article)
Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldan, V., Orenes-Pinero, E., Romiti, G. F., Romanazzi, I., . . . Lip, G. Y. H. (2018). Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 122(5), 785-792. doi:10.1016/j.amjcard.2018.05.012DOI: 10.1016/j.amjcard.2018.05.012
European Heart RhythmAssociation (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? (Journal article)
Dagres, N., Chao, T. -F., Fenelon, G., Aguinaga, L., Benhayon, D., Benjamin, E. J., . . . Shantsila, A. (2018). European Heart RhythmAssociation (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?. EUROPACE, 20(9), 1399-+. doi:10.1093/europace/euy046DOI: 10.1093/europace/euy046
Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials (Journal article)
Tse, G., Gong, M., Li, G., Wong, S. H., Wu, W. K. K., Wong, W. T., . . . Liu, T. (2018). Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 84(9), 1868-1882. doi:10.1111/bcp.13621DOI: 10.1111/bcp.13621
Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial) (Journal article)
Lee, T. C., Qian, M., Lip, G. Y. H., Di Tullio, M. R., Graham, S., Mann, D. L., . . . Ye, S. (2018). Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial). AMERICAN JOURNAL OF CARDIOLOGY, 122(5), 821-827. doi:10.1016/j.amjcard.2018.05.024DOI: 10.1016/j.amjcard.2018.05.024
Impact of carbon impurities on the initial leakage current of AlGaN/GaN high electron mobility transistors (Journal article)
Sasangka, W. A., Gao, Y., Gan, C. L., & Thompson, C. V. (2018). Impact of carbon impurities on the initial leakage current of AlGaN/GaN high electron mobility transistors. Microelectronics Reliability, 88-90, 393-396. doi:10.1016/j.microrel.2018.06.048DOI: 10.1016/j.microrel.2018.06.048
Proietti, M., Laroche, C., Nieuwlaat, R., Crijns, H. J. G. M., Maggioni, A. P., Lane, D. A., . . . Lip, G. Y. H. (2018). Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 55, 28-34. doi:10.1016/j.ejim.2018.05.016DOI: 10.1016/j.ejim.2018.05.016
Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices (Journal article)
Pastori, D., Miyazawa, K., Li, Y., Shahid, F., Hado, H., & Lip, G. Y. H. (2018). Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices. CLINICAL RESEARCH IN CARDIOLOGY, 107(9), 772-777. doi:10.1007/s00392-018-1244-0DOI: 10.1007/s00392-018-1244-0
Letter by Shahid and Lip Regarding Article, "Stroke Risk Factors Unique to Women" (Journal article)
Shahid, F., & Lip, G. Y. H. (2018). Letter by Shahid and Lip Regarding Article, "Stroke Risk Factors Unique to Women". STROKE, 49(9), E290. doi:10.1161/STROKEAHA.118.021933DOI: 10.1161/STROKEAHA.118.021933
Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry (Journal article)
Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldan-Rabadan, I., Roldan, V., Muniz, J., Rana-Miguez, P., . . . Marin, F. (2018). Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry. EUROPACE, 20(9), 1435-1441. doi:10.1093/europace/eux314DOI: 10.1093/europace/eux314
Reply to 'Comment on 'Genotype-guided warfarin dosing <i>vs</i>. conventional dosing strategies: a systematic review and metaanalysis of randomized clinical trials' by Tse <i>et al</i>.' (Journal article)
Tse, G., Roever, L., Wong, M. C. S., Lip, G. Y. H., & Liu, T. (2018). Reply to 'Comment on 'Genotype-guided warfarin dosing <i>vs</i>. conventional dosing strategies: a systematic review and metaanalysis of randomized clinical trials' by Tse <i>et al</i>.'. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 84(9), 2165-2166. doi:10.1111/bcp.13658DOI: 10.1111/bcp.13658
Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial (Journal article)
Chi, G., Kerneis, M., Kalayci, A., Liu, Y., Mehran, R., Bode, C., . . . Gibson, C. M. (2018). Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial. AMERICAN HEART JOURNAL, 203, 17-24. doi:10.1016/j.ahj.2018.06.003DOI: 10.1016/j.ahj.2018.06.003
Descrambling of Embedded SRAM Using a Laser Probe (Conference Paper)
Chef, S., Chua, C. T., Tay, J. Y., Siah, Y. W., Bhasin, S., Breier, J., & Gan, C. L. (2018). Descrambling of Embedded SRAM Using a Laser Probe. In 2018 IEEE International Symposium on the Physical and Failure Analysis of Integrated Circuits (IPFA). IEEE. doi:10.1109/ipfa.2018.8452604DOI: 10.1109/ipfa.2018.8452604
Failure Analysis of Damages on Advanced Technologies Induced by Picosecond Pulsed Laser During Space Radiation SEE Testing (Conference Paper)
Chua, C. T., Liu, Q., Chef, S., Sanchez, K., Pcrdu, P., & Gan, C. L. (2018). Failure Analysis of Damages on Advanced Technologies Induced by Picosecond Pulsed Laser During Space Radiation SEE Testing. In 2018 IEEE International Symposium on the Physical and Failure Analysis of Integrated Circuits (IPFA). IEEE. doi:10.1109/ipfa.2018.8452544DOI: 10.1109/ipfa.2018.8452544
Kornej, J., Schumacher, K., Dinov, B., Kosich, F., Sommer, P., Arya, A., . . . Hindricks, G. (2018). Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation. SCIENTIFIC REPORTS, 8. doi:10.1038/s41598-018-31133-xDOI: 10.1038/s41598-018-31133-x
Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Oh, S., & Lip, G. Y. H. (2018). Edoxaban in Asian Patients With Atrial Fibrillation Effectiveness and Safety. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(8), 838-853. doi:10.1016/j.jacc.2018.05.066DOI: 10.1016/j.jacc.2018.05.066
Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universe (Journal article)
Fanaroff, A. C., Steffel, J., Alexander, J. H., Lip, G. Y. H., Califf, R. M., & Lopes, R. D. (2018). Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universe. EUROPEAN HEART JOURNAL, 39(32), 2932-+. doi:10.1093/eurheartj/ehy236DOI: 10.1093/eurheartj/ehy236
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA) (Journal article)
Miyazawa, K., Pastori, D., Hammerstingl, C., Cappato, R., Meng, I. L., Kramer, F., . . . Marin, F. (2018). Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA). ANNALS OF MEDICINE, 50(6), 511-518. doi:10.1080/07853890.2018.1495337DOI: 10.1080/07853890.2018.1495337
Relationship of troponin to incident atrial fibrillation occurrence, recurrence after radiofrequency ablation and prognosis: a systematic review, meta-analysis and meta-regression (Journal article)
Bai, Y., Guo, S. -D., Liu, Y., Ma, C. -S., & Lip, G. Y. H. (2018). Relationship of troponin to incident atrial fibrillation occurrence, recurrence after radiofrequency ablation and prognosis: a systematic review, meta-analysis and meta-regression. BIOMARKERS, 23(6), 512-517. doi:10.1080/1354750X.2018.1463562DOI: 10.1080/1354750X.2018.1463562
Differences in Heart Rate Response and Recovery After 6-Minute Walk Test Between Patients With Atrial Fibrillation and in Sinus Rhythm (Journal article)
Luo, X., Xiong, Q., Xu, J., Hong, K., Peng, Q., Li, J., . . . Hai, S. (2018). Differences in Heart Rate Response and Recovery After 6-Minute Walk Test Between Patients With Atrial Fibrillation and in Sinus Rhythm. AMERICAN JOURNAL OF CARDIOLOGY, 122(4), 592-596. doi:10.1016/j.amjcard.2018.04.048DOI: 10.1016/j.amjcard.2018.04.048
Erkuner, O., Dudink, E. A. M. P., Nieuwlaat, R., Rienstra, M., Van Gelder, I. C., Camm, A. J., . . . Luermans, J. G. L. M. (2018). Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey). AMERICAN JOURNAL OF CARDIOLOGY, 122(4), 578-583. doi:10.1016/j.amjcard.2018.04.053DOI: 10.1016/j.amjcard.2018.04.053
Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI (Journal article)
Lip, G. Y. H., Collet, J. -P., Haude, M., & Huber, K. (2018). Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI. EUROPEAN HEART JOURNAL, 39(31), 2847-2850. doi:10.1093/eurheartj/ehy396DOI: 10.1093/eurheartj/ehy396
10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population (Journal article)
Kim, D., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2018). 10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population. AMERICAN HEART JOURNAL, 202, 20-26. doi:10.1016/j.ahj.2018.04.017DOI: 10.1016/j.ahj.2018.04.017
A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials (Journal article)
Miguel Rivera-Caravaca, J., Asuncion Esteve-Pastor, M., Marin, F., Valdes, M., Vicente, V., Roldan, V., & Lip, G. Y. H. (2018). A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials. MAYO CLINIC PROCEEDINGS, 93(8), 1065-1073. doi:10.1016/j.mayocp.2018.01.028DOI: 10.1016/j.mayocp.2018.01.028
Ambulatory blood pressure and long-term risk for atrial fibrillation (Journal article)
Tihonoff, V., Kuznetsova, T., Thijs, L., Cauwenberghs, N., Stolarz-Skrzypek, K., Seidlerova, J., . . . Staessen, J. A. (2018). Ambulatory blood pressure and long-term risk for atrial fibrillation. HEART, 104(15), 1263-+. doi:10.1136/heartjnl-2017-312488DOI: 10.1136/heartjnl-2017-312488
Atrial Tachyarrhythmia Prevalence in Patients with Implantable Cardiac Resynchronization Defibrillators (Conference Paper)
Gillett, S., Reyes, C., Martin, D., & Lip, G. (2018). Atrial Tachyarrhythmia Prevalence in Patients with Implantable Cardiac Resynchronization Defibrillators. In JOURNAL OF CARDIAC FAILURE Vol. 24 (pp. S57). doi:10.1016/j.cardfail.2018.07.257DOI: 10.1016/j.cardfail.2018.07.257
Effect of Implantable Cardioverter-Defibrillators by Etiology of Heart Failure: A Propensity-Matched Mortality Analysis of the WARCEF Trial (Conference Paper)
Lee, T. C., Qian, M., Mu, L., Di Tullio, M. R., Graham, S., Mann, D. L., . . . Ye, S. (2018). Effect of Implantable Cardioverter-Defibrillators by Etiology of Heart Failure: A Propensity-Matched Mortality Analysis of the WARCEF Trial. In JOURNAL OF CARDIAC FAILURE Vol. 24 (pp. S75). doi:10.1016/j.cardfail.2018.07.311DOI: 10.1016/j.cardfail.2018.07.311
Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program (Journal article)
Mazurek, M., Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. -C., . . . Lip, G. Y. H. (2018). Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program. AMERICAN JOURNAL OF MEDICINE, 131(8), 945-+. doi:10.1016/j.amjmed.2018.03.024DOI: 10.1016/j.amjmed.2018.03.024
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants (Journal article)
Pastori, D., Lip, G. Y. H., Farcomeni, A., Del Sole, F., Sciacqua, A., Perticone, F., . . . Violi, F. (2018). Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants. INTERNATIONAL JOURNAL OF CARDIOLOGY, 264, 58-63. doi:10.1016/j.ijcard.2018.01.097DOI: 10.1016/j.ijcard.2018.01.097
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Journal article)
Raparelli, V., Pastori, D., Pignataro, S. F., Vestri, A. R., Pignatelli, P., Cangemi, R., . . . Basili, S. (2018). Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study. INTERNAL AND EMERGENCY MEDICINE, 13(5), 651-660. doi:10.1007/s11739-018-1835-9DOI: 10.1007/s11739-018-1835-9
Borgognone, A., Shantsila, E., Worrall, S. M., Prompunt, E., Loka, T., Loudon, B. L., . . . Madhani, M. (2018). Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation. CARDIOVASCULAR RESEARCH, 114(10), 1313-1323. doi:10.1093/cvr/cvy087DOI: 10.1093/cvr/cvy087
Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus (Journal article)
Li, Y. -G., Pastori, D., & Lip, G. Y. H. (2018). Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus. DIABETIC MEDICINE, 35(8), 1134-1135. doi:10.1111/dme.13685DOI: 10.1111/dme.13685
Role of chronic kidney disease and atrial fibrillation in outcomes of patients with ischemic stroke (Journal article)
Khan, A. A., & Lip, G. Y. H. (2018). Role of chronic kidney disease and atrial fibrillation in outcomes of patients with ischemic stroke. EUROPEAN JOURNAL OF NEUROLOGY, 25(8), 1009-1010. doi:10.1111/ene.13664DOI: 10.1111/ene.13664
Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients (Journal article)
Li, Y. -G., Lee, S. -R., Choi, E. -K., & Lip, G. Y. H. (2018). Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients. KOREAN CIRCULATION JOURNAL, 48(8), 665-684. doi:10.4070/kcj.2018.0190DOI: 10.4070/kcj.2018.0190
Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation (Journal article)
Pastori, D., Farcomeni, A., Saliola, M., Del Sole, F., Pignatelli, P., Violi, F., & Lip, G. Y. H. (2018). Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 54, 34-39. doi:10.1016/j.ejim.2018.04.007DOI: 10.1016/j.ejim.2018.04.007
The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis (Conference Paper)
Penson, P. E., Awad, K., Lane, D., Banach, M., & Lip, G. Y. H. (2018). The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 817). Retrieved from https://www.webofscience.com/
Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey (Journal article)
Dan, G. -A., Iliodromitis, K., Scherr, D., Marin, F., Lenarczyk, R., Estner, H. L., . . . Lip, G. Y. H. (2018). Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey. EUROPACE, 20(8), 1382-1387. doi:10.1093/europace/euy094DOI: 10.1093/europace/euy094
Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation (Journal article)
Kea, B., Lin, A. L., Olshansky, B., Malveau, S., Fu, R., Raitt, M., . . . Sun, B. C. (2018). Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(4), 471-472. doi:10.1016/j.jacc.2018.05.022DOI: 10.1016/j.jacc.2018.05.022
Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation (Journal article)
Law, S. W. Y., Lau, W. C. Y., Wong, I. C. K., Lip, G. Y. H., Mok, M. T., Siu, C. -W., & Chan, E. W. (2018). Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(3), 271-282. doi:10.1016/j.jacc.2018.04.066DOI: 10.1016/j.jacc.2018.04.066
Arrhythmias and cognitive function (Journal article)
Dagres, N., Chao, T. -F., Fenelon, G., Lip, G. Y. H., & Chung, M. (2018). Arrhythmias and cognitive function. EUROPEAN HEART JOURNAL, 39(26), 2446-2447. doi:10.1093/eurheartj/ehy317DOI: 10.1093/eurheartj/ehy317
Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study (Journal article)
Chao, T. -F., Liu, C. -J., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2018). Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study. CIRCULATION, 138(1), 37-47. doi:10.1161/CIRCULATIONAHA.117.031658DOI: 10.1161/CIRCULATIONAHA.117.031658
The relationship of systemic markers of haemostasis with retinal blood vessel responses in cardiovascular disease and/or diabetes (Journal article)
Heitmar, R., Nicholl, P., Lee, B., Lau, Y. C., & Lip, G. Y. H. (2018). The relationship of systemic markers of haemostasis with retinal blood vessel responses in cardiovascular disease and/or diabetes. BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 75(3), 116-121. doi:10.1080/09674845.2017.1420130DOI: 10.1080/09674845.2017.1420130
Dynamic Changes of CHA<sub>2</sub>DS<sub>2</sub>-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study (Journal article)
Yoon, M., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2018). Dynamic Changes of CHA<sub>2</sub>DS<sub>2</sub>-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study. THROMBOSIS AND HAEMOSTASIS, 118(7), 1296-1304. doi:10.1055/s-0038-1651482DOI: 10.1055/s-0038-1651482
Guideline-adherent secondary prevention post-acute coronary syndromes: the importance of patient uptake and persistence (Journal article)
Szekely, O., Lane, D. A., & Lip, G. Y. H. (2018). Guideline-adherent secondary prevention post-acute coronary syndromes: the importance of patient uptake and persistence. EUROPEAN HEART JOURNAL, 39(25), 2365-2367. doi:10.1093/eurheartj/ehy308DOI: 10.1093/eurheartj/ehy308
Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report (Journal article)
Fumagalli, S., Said, S. A., Laroche, C., Gabbai, D., Boni, S., Marchionni, N., . . . Lip, G. Y. H. (2018). Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 4(3), 172-179. doi:10.1093/ehjcvp/pvx037DOI: 10.1093/ehjcvp/pvx037
Predictors of diastolic dysfunction in ethnic groups: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES) (Journal article)
Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2018). Predictors of diastolic dysfunction in ethnic groups: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). JOURNAL OF HUMAN HYPERTENSION, 32(7), 477-486. doi:10.1038/s41371-018-0064-zDOI: 10.1038/s41371-018-0064-z
Shahid, F., Rahmat, N. A., Lip, G. Y. H., & Shantsila, E. (2018). Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project. PLOS ONE, 13(7). doi:10.1371/journal.pone.0200373DOI: 10.1371/journal.pone.0200373
Cohen, A. T., Lip, G. Y., De Caterina, R., Heidbuchel, H., Zamorano, J. L., Agnelli, G., . . . Camm, A. J. (2018). State of play and future direction with NOACs: An expert consensus. VASCULAR PHARMACOLOGY, 106, 9-21. doi:10.1016/j.vph.2018.04.001DOI: 10.1016/j.vph.2018.04.001
Mujovic, N., Marinkovic, M., Markovic, N., Vucicevic, V., Lip, G. Y. H., Bunch, T. J., & Potpara, T. S. (2018). The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set. SCIENTIFIC REPORTS, 8. doi:10.1038/s41598-018-28072-yDOI: 10.1038/s41598-018-28072-y
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care (Journal article)
Diemberger, I., Fantecchi, E., Reggiani, M. L. B., Martignani, C., Angeletti, A., Massaro, G., . . . Boriani, G. (2018). Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care. INTERNATIONAL JOURNAL OF CARDIOLOGY, 261, 73-77. doi:10.1016/j.ijcard.2018.03.058DOI: 10.1016/j.ijcard.2018.03.058
Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis (Journal article)
Proietti, M., Romiti, G. F., Romanazzi, I., Farcomeni, A., Staerk, L., Nielsen, P. B., & Lip, G. Y. H. (2018). Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 261, 84-91. doi:10.1016/j.ijcard.2018.03.053DOI: 10.1016/j.ijcard.2018.03.053
Risk factors for new-onset atrial fibrillation: A focus on Asian populations (Journal article)
Li, Y., Pastori, D., Guo, Y., Wang, Y., & Lip, G. Y. H. (2018). Risk factors for new-onset atrial fibrillation: A focus on Asian populations. INTERNATIONAL JOURNAL OF CARDIOLOGY, 261, 92-98. doi:10.1016/j.ijcard.2018.02.051DOI: 10.1016/j.ijcard.2018.02.051
Effect of the size of carbon nanotubes (CNTs) on the microstructure and mechanical strength of CNTs-doped composite Sn0.3Ag0.7Cu-CNTs solder (Journal article)
Zhu, Z., Chan, Y. -C., Chen, Z., Gan, C. -L., & Wu, F. (2018). Effect of the size of carbon nanotubes (CNTs) on the microstructure and mechanical strength of CNTs-doped composite Sn0.3Ag0.7Cu-CNTs solder. Materials Science and Engineering: A, 727, 160-169. doi:10.1016/j.msea.2018.05.002DOI: 10.1016/j.msea.2018.05.002
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2018). Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis. CLINICAL CARDIOLOGY, 41(6), 855-861. doi:10.1002/clc.22971DOI: 10.1002/clc.22971
Wilson, D., Ambler, G., Shakeshaft, C., Brown, M. M., Charidimou, A., Salman, R. A. -S., . . . Werring, D. J. (2018). Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. LANCET NEUROLOGY, 17(6), 539-547. doi:10.1016/S1474-4422(18)30145-5DOI: 10.1016/S1474-4422(18)30145-5
European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS) (Journal article)
Gorenek, B., Boriani, G., Dan, G. -A., Fauchier, L., Fenelon, G., Huang, H., . . . Fuenmayor, A. (2018). European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). EUROPACE, 20(6), 895-+. doi:10.1093/europace/euy051DOI: 10.1093/europace/euy051
Dagres, N., Chao, T. -F., Fenelon, G., Aguinaga, L., Benhayon, D., Benjamin, E. J., . . . Chung, M. K. (2018). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?. HEART RHYTHM, 15(6), E37-E60. doi:10.1016/j.hrthm.2018.03.005DOI: 10.1016/j.hrthm.2018.03.005
HIGH HEART RATE PREDICTS CARDIAC FIBROSIS IN PATIENTS WITH ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION (Conference Paper)
Shahid, F., Lip, G., & Shantsila, E. (2018). HIGH HEART RATE PREDICTS CARDIAC FIBROSIS IN PATIENTS WITH ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION. In HEART Vol. 104 (pp. A76-A77). doi:10.1136/heartjnl-2018-BCS.91DOI: 10.1136/heartjnl-2018-BCS.91
Chang, S. -S., Wu, J. -H., Liu, Y., Zhang, T., Du, X., Dong, J. -Z., . . . Ma, C. -S. (2018). In-hospital direct costs for thromboembolism and bleeding in Chinese patients with atrial fibrillation.. Chronic diseases and translational medicine, 4(2), 127-134. doi:10.1016/j.cdtm.2018.01.001DOI: 10.1016/j.cdtm.2018.01.001
Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation (Journal article)
Jose Serna, M., Miguel Rivera-Caravaca, J., Gonzalez-Conejero, R., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., . . . Marin, F. (2018). Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 48(6). doi:10.1111/eci.12929DOI: 10.1111/eci.12929
Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation (Journal article)
Shahid, F., Pastori, D., Violi, F., & Lip, G. Y. H. (2018). Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation. PHARMACOLOGICAL RESEARCH, 132, 149-159. doi:10.1016/j.phrs.2018.04.019DOI: 10.1016/j.phrs.2018.04.019
Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices (Journal article)
Miyazawa, K., Kondo, Y., Nakano, M., Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Senoo, K., . . . Lip, G. Y. H. (2018). Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 52, 54-59. doi:10.1016/j.ejim.2018.02.019DOI: 10.1016/j.ejim.2018.02.019
Dias, I. H. K., Milic, I., Lip, G. Y. H., Devitt, A., Polidori, M. C., & Griffiths, H. R. (2018). Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia. REDOX BIOLOGY, 16, 139-145. doi:10.1016/j.redox.2018.02.014DOI: 10.1016/j.redox.2018.02.014
Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project (Journal article)
Miguel Rivera-Caravaca, J., Roldan, V., Romera, M., Asuncion Esteve-Pastor, M., Valdes, M., Lip, G. Y. H., . . . Marin, F. (2018). Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project. JOURNAL OF GENERAL INTERNAL MEDICINE, 33(6), 847-854. doi:10.1007/s11606-017-4279-4DOI: 10.1007/s11606-017-4279-4
Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification (Journal article)
Bisson, A., Bodin, A., Clementy, N., Bernard, A., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2018). Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification. INTERNATIONAL JOURNAL OF CARDIOLOGY, 260, 93-98. doi:10.1016/j.ijcard.2018.03.017DOI: 10.1016/j.ijcard.2018.03.017
Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program (Journal article)
McIntyre, W. F., Conen, D., Olshansky, B., Halperin, J. L., Hayek, E., Huisman, M. V., . . . Healey, J. S. (2018). Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program. CLINICAL CARDIOLOGY, 41(6), 744-751. doi:10.1002/clc.22936DOI: 10.1002/clc.22936
TOTAL MONOCYTE COUNT AS PREDICTOR OF EXERCISE CAPACITY IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION - THE WEST BIRMINGHAM AF PROJECT (Conference Paper)
Khan, A., Shahid, F., Lip, G., & Shantsila, E. (2018). TOTAL MONOCYTE COUNT AS PREDICTOR OF EXERCISE CAPACITY IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION - THE WEST BIRMINGHAM AF PROJECT. In HEART Vol. 104 (pp. A79). doi:10.1136/heartjnl-2018-BCS.96DOI: 10.1136/heartjnl-2018-BCS.96
Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation (Journal article)
Pastori, D., Pignatelli, P., Cribari, F., Carnevale, R., Saliola, M., Violi, F., & Lip, G. Y. H. (2018). Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation. AMERICAN HEART JOURNAL, 200, 32-36. doi:10.1016/j.ahj.2018.03.004DOI: 10.1016/j.ahj.2018.03.004
Health care facility type-related challenges in the management of stroke risk in patients with atrial fibrillation: practical implications (Journal article)
Potpara, T. S., Andrei-Dan, G., & Lip, G. Y. H. (2018). Health care facility type-related challenges in the management of stroke risk in patients with atrial fibrillation: practical implications. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 128(5), 271-273. Retrieved from https://www.webofscience.com/
Anticoagulation Resumption After Intracerebral Hemorrhage (Journal article)
Li, Y. -G., & Lip, G. Y. H. (2018). Anticoagulation Resumption After Intracerebral Hemorrhage. CURRENT ATHEROSCLEROSIS REPORTS, 20(7). doi:10.1007/s11883-018-0733-yDOI: 10.1007/s11883-018-0733-y
Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice (Journal article)
Li, Y. -G., Pastori, D., & Lip, G. Y. H. (2018). Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice. ANNALS OF MEDICINE, 50(4), 288-302. doi:10.1080/07853890.2018.1460489DOI: 10.1080/07853890.2018.1460489
Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice (vol 50, pg 288, 2018) (Journal article)
Li, Y. -G., Pastori, D., & Lip, G. Y. H. (2018). Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice (vol 50, pg 288, 2018). ANNALS OF MEDICINE, 50(4), 361. doi:10.1080/07853890.2018.1468134DOI: 10.1080/07853890.2018.1468134
Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study (Journal article)
Staerk, L., Fosbol, E. L., Lamberts, M., Bonde, A. N., Gadsboll, K., Sindet-Pedersen, C., . . . Olesen, J. B. (2018). Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study. EUROPEAN HEART JOURNAL, 39(19), 1698-+. doi:10.1093/eurheartj/ehx598DOI: 10.1093/eurheartj/ehx598
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review andmeta-analysis of randomized clinical trials (Journal article)
Golwala, H. B., Cannon, C. P., Steg, P. G., Doros, G., Qamar, A., Ellis, S. G., . . . Bhatt, D. L. (2018). Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review andmeta-analysis of randomized clinical trials. EUROPEAN HEART JOURNAL, 39(19), 1726-+. doi:10.1093/eurheartj/ehy162DOI: 10.1093/eurheartj/ehy162
Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study (Journal article)
Christiansen, C. B., Torp-Pedersen, C., Olesen, J. B., Gislason, G., Lamberts, M., Carlson, N., . . . Lip, G. Y. H. (2018). Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study. BMC CARDIOVASCULAR DISORDERS, 18. doi:10.1186/s12872-018-0825-1DOI: 10.1186/s12872-018-0825-1
Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study (Journal article)
Guo, Y., Wang, Y., Li, X., Shan, Z., Shi, X., Xi, G., & Lip, G. Y. H. (2018). Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study. BMJ OPEN, 8(5). doi:10.1136/bmjopen-2017-020191DOI: 10.1136/bmjopen-2017-020191
Atrial fibrillation in the Middle East: unmapped, underdiagnosed, undertreated. (Journal article)
Al-Shamkhani, W., Ayetey, H., & Lip, G. Y. H. (2018). Atrial fibrillation in the Middle East: unmapped, underdiagnosed, undertreated.. Expert review of cardiovascular therapy, 16(5), 341-348. doi:10.1080/14779072.2018.1457953DOI: 10.1080/14779072.2018.1457953
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP) (Journal article)
Dan, G. -A., Martinez-Rubio, A., Agewall, S., Boriani, G., Borggrefe, M., Gaita, F., . . . Wolpert, C. (2018). Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). EUROPACE, 20(5), 731-+. doi:10.1093/europace/eux373DOI: 10.1093/europace/eux373
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP) (vol 20, pg 731, 2018) (Journal article)
Dan, G. -A., Martinez-Rubio, A., Agewall, S., Boriani, G., Borggrefe, M., Gaita, F., . . . Wolpert, C. (2018). Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP) (vol 20, pg 731, 2018). EUROPACE, 20(5), 738. doi:10.1093/europace/euy119DOI: 10.1093/europace/euy119
Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis (Journal article)
Garcia Garre, E., Luengo Gil, G., Montoro Garcia, S., Gonzalez Billalabeitia, E., Zafra Poves, M., Garcia Martinez, E., . . . Ayala de la Pena, F. (2018). Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis. BREAST CANCER RESEARCH AND TREATMENT, 169(1), 83-92. doi:10.1007/s10549-017-4656-zDOI: 10.1007/s10549-017-4656-z
Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry (Journal article)
Boriani, G., Proietti, M., Laroche, C., Fauchier, L., Marin, F., Nabauer, M., . . . Lip, G. Y. H. (2018). Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry. EUROPACE, 20(5), 747-757. doi:10.1093/europace/eux301DOI: 10.1093/europace/eux301
Impact of Mon2 monocyte-platelet aggregates on human coronary artery disease (Journal article)
Brown, R. A., Lip, G. Y. H., Varma, C., & Shantsila, E. (2018). Impact of Mon2 monocyte-platelet aggregates on human coronary artery disease. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 48(5). doi:10.1111/eci.12911DOI: 10.1111/eci.12911
Integrating pulsed laser for a galvo mirror based SEE scanning microscope with optical failure analysis capabilities (Conference Paper)
Chua, C. T., Chef, S., Sanchez, K., Bascoul, G., Perdu, P., Tan, S. H., & Gan, C. L. (2018). Integrating pulsed laser for a galvo mirror based SEE scanning microscope with optical failure analysis capabilities. In 2018 International Conference on Radiation Effects of Electronic Devices (ICREED). IEEE. doi:10.1109/icreed.2018.8905093DOI: 10.1109/icreed.2018.8905093
REPLY: The Case of Dynamic CHA<sub>2</sub>DS<sub>2</sub>-VASc Score Beyond Risk Prediction (Journal article)
Chao, T. -F., Lip, G. Y. H., & Chen, S. -A. (2018). REPLY: The Case of Dynamic CHA<sub>2</sub>DS<sub>2</sub>-VASc Score Beyond Risk Prediction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 71(17), 1942-1943. doi:10.1016/j.jacc.2018.03.012DOI: 10.1016/j.jacc.2018.03.012
Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry (Journal article)
Roldan Rabadan, I., Asuncion Esteve-Pastor, M., Anguita-Sanchez, M., Muniz, J., Camacho Siles, J., Angustias Quesada, M., . . . Badimon, L. (2018). Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 48(5). doi:10.1111/eci.12910DOI: 10.1111/eci.12910
The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants (Journal article)
Lip, G. Y. H., Skjoth, F., Nielsen, P. B., Kjaeldgaard, J. N., & Larsen, T. B. (2018). The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants. AMERICAN JOURNAL OF MEDICINE, 131(5). doi:10.1016/j.amjmed.2017.11.046DOI: 10.1016/j.amjmed.2017.11.046
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction (Journal article)
Potpara, T. S., Ferro, C. J., & Lip, G. Y. H. (2018). Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction. NATURE REVIEWS NEPHROLOGY, 14(5), 337-351. doi:10.1038/nrneph.2018.19DOI: 10.1038/nrneph.2018.19
Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches (Journal article)
Yang, P. -S., Ryu, S., Kim, D., Jang, E., Yu, H. T., Kim, T. -H., . . . Lip, G. Y. H. (2018). Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches. SCIENTIFIC REPORTS, 8. doi:10.1038/s41598-018-25111-6DOI: 10.1038/s41598-018-25111-6
Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor (Journal article)
Wang, Z., Stuckey, D. J., Murdoch, C. E., Camelliti, P., Lip, G. Y. H., & Griffin, M. (2018). Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor. CELL DEATH & DISEASE, 9. doi:10.1038/s41419-018-0573-2DOI: 10.1038/s41419-018-0573-2
Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients (Journal article)
Pastori, D., Miguel Rivera-Caravaca, J., Asuncion Esteve-Pastor, M., Roldan, V., Marin, F., Pignatelli, P., . . . Lip, G. Y. H. (2018). Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients. CIRCULATION JOURNAL, 82(5), 1286-+. doi:10.1253/circj.CJ-17-1318DOI: 10.1253/circj.CJ-17-1318
Incidence and Risk Factors of Stroke or Systemic Embolism in Patients With Atrial Fibrillation and Heart Failure - The Fushimi AF Registry (Journal article)
Iguchi, M., Tezuka, Y., Ogawa, H., Hamatani, Y., Takagi, D., An, Y., . . . Akao, M. (2018). Incidence and Risk Factors of Stroke or Systemic Embolism in Patients With Atrial Fibrillation and Heart Failure - The Fushimi AF Registry. CIRCULATION JOURNAL, 82(5), 1327-+. doi:10.1253/circj.CJ-17-1155DOI: 10.1253/circj.CJ-17-1155
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (Journal article)
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jais, P., Josephson, M. E., . . . Blomstrom-Lundqvist, C. (2018). European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). EUROPEAN HEART JOURNAL, 39(16), 1442-1445. doi:10.1093/eurheartj/ehw455DOI: 10.1093/eurheartj/ehw455
Lip, G. Y. H., Lane, D. A., & Potpara, T. S. (2018). Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation. EUROPEAN HEART JOURNAL, 39(16), 1404-1406. doi:10.1093/eurheartj/ehx807DOI: 10.1093/eurheartj/ehx807
Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention Insights From the PIONEER AF-PCI Trial (Journal article)
Kerneis, M., Gibson, C. M., Chi, G., Mehran, R., AlKhalfan, F., Talib, U., . . . Cohen, M. (2018). Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention Insights From the PIONEER AF-PCI Trial. JACC-CARDIOVASCULAR INTERVENTIONS, 11(7), 626-634. doi:10.1016/j.jcin.2017.11.009DOI: 10.1016/j.jcin.2017.11.009
CHA<sub>2</sub>DS<sub>2</sub>-VASc score risk factors as predictors of stroke after acute coronary syndrome: Can we really be sure there is no atrial fibrillation? (Journal article)
Mazurek, M., & Lip, G. Y. H. (2018). CHA<sub>2</sub>DS<sub>2</sub>-VASc score risk factors as predictors of stroke after acute coronary syndrome: Can we really be sure there is no atrial fibrillation?. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 7(3), 275-277. doi:10.1177/2048872616688455DOI: 10.1177/2048872616688455
Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation (Journal article)
Fauchier, L., Bisson, A., Clementy, N., Vourc'h, P., Angoulvant, D., Babuty, D., . . . Lip, G. Y. H. (2018). Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation. AMERICAN HEART JOURNAL, 198, 39-45. doi:10.1016/j.ahj.2017.12.017DOI: 10.1016/j.ahj.2017.12.017
Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non-vitamin K antagonist oral anticoagulants (Journal article)
Miyazawa, K., Pastori, D., & Lip, G. Y. H. (2018). Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non-vitamin K antagonist oral anticoagulants. AMERICAN HEART JOURNAL, 198, 166-168. doi:10.1016/j.ahj.2017.11.015DOI: 10.1016/j.ahj.2017.11.015
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study (Journal article)
Paciullo, F., Proietti, M., Bianconi, V., Nobili, A., Pirro, M., Mannucci, P. M., . . . Lupattelli, G. (2018). Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study. DRUGS & AGING, 35(4), 365-373. doi:10.1007/s40266-018-0532-8DOI: 10.1007/s40266-018-0532-8
Pastori, D., Lip, G. Y. H., Farcomeni, A., Del Sole, F., Sciacqua, A., Perticone, F., . . . ATHERO-AF study group. (2018). Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.. Data in brief, 17, 830-836. doi:10.1016/j.dib.2018.01.109DOI: 10.1016/j.dib.2018.01.109
Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban (Journal article)
Lip, G. Y. H., Pan, X., Kamble, S., Kawabata, H., Mardekian, J., Masseria, C., & Phatak, H. (2018). Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban. PLOS ONE, 13(4). doi:10.1371/journal.pone.0195950DOI: 10.1371/journal.pone.0195950
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice? (Journal article)
Dagres, N., Chao, T. -F., Fenelon, G., Aguinaga, L., Benhayon, D., Benjamin, E. J., . . . Chung, M. K. (2018). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?. JOURNAL OF ARRHYTHMIA, 34(2), 99-123. doi:10.1002/joa3.12050DOI: 10.1002/joa3.12050
Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors (Journal article)
Chao, T. -F., Lip, G. Y. H., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2018). Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors. THROMBOSIS AND HAEMOSTASIS, 118(4), 768-777. doi:10.1055/s-0038-1636534DOI: 10.1055/s-0038-1636534
Novel biomarker-based risk prediction for new onset atrial fibrillation in patients with ST elevation myocardial infarction: Balancing simplicity and practicality (Journal article)
Shin, S. Y., & Lip, G. Y. H. (2018). Novel biomarker-based risk prediction for new onset atrial fibrillation in patients with ST elevation myocardial infarction: Balancing simplicity and practicality. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(4). doi:10.1111/ijcp.13090DOI: 10.1111/ijcp.13090
Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry (Journal article)
Boriani, G., Laroche, C., Diemberger, I., Fantecchi, E., Meeder, J., Kurpesa, M., . . . Lip, G. Y. H. (2018). Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 29(4), 566-572. doi:10.1111/jce.13428DOI: 10.1111/jce.13428
Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study (Journal article)
Melgaard, L., Overvad, T. F., Skjoth, F., Christensen, J. H., Larsen, T. B., & Lip, G. Y. H. (2018). Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study. ESC HEART FAILURE, 5(2), 319-326. doi:10.1002/ehf2.12256DOI: 10.1002/ehf2.12256
Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF) (Journal article)
Sobue, Y., Watanabe, E., Lip, G. Y. H., Koshikawa, M., Ichikawa, T., Kawai, M., . . . Ozaki, Y. (2018). Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF). HEART AND VESSELS, 33(4), 403-412. doi:10.1007/s00380-017-1073-5DOI: 10.1007/s00380-017-1073-5
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry (Journal article)
Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. -C., Dubner, S. J., . . . Lip, G. Y. H. (2018). Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry. AMERICAN HEART JOURNAL, 198, 55-63. doi:10.1016/j.ahj.2017.08.018DOI: 10.1016/j.ahj.2017.08.018
Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2018). Use of the SAMe-TT<sub>2</sub>R<sub>2</sub> score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A review. HEART RHYTHM, 15(4), 615-623. doi:10.1016/j.hrthm.2017.11.026DOI: 10.1016/j.hrthm.2017.11.026
Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation (Journal article)
Pastori, D., Pignatelli, P., Sciacqua, A., Perticone, M., Violi, F., & Lip, G. Y. H. (2018). Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 255, 69-73. doi:10.1016/j.ijcard.2017.12.076DOI: 10.1016/j.ijcard.2017.12.076
Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy A Meta-Analysis of Randomized Trials (Journal article)
Bennaghmouch, N., de Veer, A. J. W. M., Bode, K., Mahmoodi, B. K., Dewilde, W. J. M., Lip, G. Y. H., . . . ten Berg, J. M. (2018). Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy A Meta-Analysis of Randomized Trials. CIRCULATION, 137(11), 1117-1129. doi:10.1161/CIRCULATIONAHA.117.028513DOI: 10.1161/CIRCULATIONAHA.117.028513
Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment (Journal article)
Brown, J. D., Goodin, A. J., Lip, G. Y. H., & Adams, V. R. (2018). Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(6). doi:10.1161/JAHA.117.007901DOI: 10.1161/JAHA.117.007901
Novel high temperature polymeric encapsulation material for extreme environment electronics packaging (Journal article)
Phua, E. J. R., Liu, M., Cho, B., Liu, Q., Amini, S., Hu, X., & Gan, C. L. (2018). Novel high temperature polymeric encapsulation material for extreme environment electronics packaging. Materials & Design, 141, 202-209. doi:10.1016/j.matdes.2017.12.029DOI: 10.1016/j.matdes.2017.12.029
Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality (Journal article)
Miguel Rivera-Caravaca, J., Marin, F., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Roldan, V., & Lip, G. Y. H. (2018). Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(3). doi:10.1111/ijcp.13069DOI: 10.1111/ijcp.13069
Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation (Journal article)
Dan, G. A., Badila, E., Weiss, E., Laroche, C., Boriani, G., Dan, A., . . . Lip, G. Y. H. (2018). Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 254, 136-141. doi:10.1016/j.ijcard.2017.10.092DOI: 10.1016/j.ijcard.2017.10.092
BLEEDING EVENTS AND THEIR CONSEQUENCES ON CARDIOVASCULAR EVENTS, READMISSION AND NET CLINICAL BENEFIT (Conference Paper)
Steg, P., Bhatt, D., Ellis, S., Hohnloser, S., Kleine, E., Nordaby, M., . . . Cannon, C. (2018). BLEEDING EVENTS AND THEIR CONSEQUENCES ON CARDIOVASCULAR EVENTS, READMISSION AND NET CLINICAL BENEFIT. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 1154). doi:10.1016/S0735-1097(18)31695-4DOI: 10.1016/S0735-1097(18)31695-4
COMPARATIVE EFFECTIVENESS AND SAFETY OF NOACS VERSUS WARFARIN FOR SECONDARY STROKE PREVENTION IN ATRIAL FIBRILLATION: A NATIONWIDE DANISH COHORT STUDY (Conference Paper)
Nielsen, P. B., Togersen, F. A., Skjoth, F., Sogaard, M., Larsen, T. B., & Lip, G. (2018). COMPARATIVE EFFECTIVENESS AND SAFETY OF NOACS VERSUS WARFARIN FOR SECONDARY STROKE PREVENTION IN ATRIAL FIBRILLATION: A NATIONWIDE DANISH COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 501). doi:10.1016/S0735-1097(18)31042-8DOI: 10.1016/S0735-1097(18)31042-8
COMPARISON OF EFFECTIVENESS, SAFETY, AND THE NET CLINICAL OUTCOME BETWEEN DIFFERENT DIRECT ORAL ANTICOAGULANTS IN 162,707 NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED IN US CLINICAL PRACTICE (Conference Paper)
Deitelzweig, S., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Gupta, K., . . . Lip, G. Y. H. (2018). COMPARISON OF EFFECTIVENESS, SAFETY, AND THE NET CLINICAL OUTCOME BETWEEN DIFFERENT DIRECT ORAL ANTICOAGULANTS IN 162,707 NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED IN US CLINICAL PRACTICE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 275). doi:10.1016/S0735-1097(18)30816-7DOI: 10.1016/S0735-1097(18)30816-7
DOES RENAL FUNCTION INFLUENCE THE BENEFIT OF DUAL ANTITHROMBOTIC THERAPY WITH DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM RE-DUAL PCI (Conference Paper)
Hohnloser, S., Steg, P., Oldgren, J., Nickenig, G., Kiss, R. G., Ongen, Z., . . . Cannon, C. (2018). DOES RENAL FUNCTION INFLUENCE THE BENEFIT OF DUAL ANTITHROMBOTIC THERAPY WITH DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM RE-DUAL PCI. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 314). doi:10.1016/S0735-1097(18)30855-6DOI: 10.1016/S0735-1097(18)30855-6
EFFECTIVENESS AND SAFETY OF NOAC VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH HEMORRHAGIC STROKE (Conference Paper)
Nielsen, P. B., Skjoth, F., Sogaard, M., Larsen, T. B., & Lip, G. (2018). EFFECTIVENESS AND SAFETY OF NOAC VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH HEMORRHAGIC STROKE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 502). doi:10.1016/S0735-1097(18)31043-XDOI: 10.1016/S0735-1097(18)31043-X
Editor's Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association. (Journal article)
Walker, D. M., Gale, C. P., Lip, G., Martin-Sanchez, F. J., McIntyre, H. F., Mueller, C., . . . Bueno, H. (2018). Editor's Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association.. European heart journal. Acute cardiovascular care, 7(2), 176-193. doi:10.1177/2048872618758931DOI: 10.1177/2048872618758931
Epidemiology of atrial fibrillation (Journal article)
Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2018). Epidemiology of atrial fibrillation. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(3). doi:10.1111/ijcp.13070DOI: 10.1111/ijcp.13070
Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients (Journal article)
Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldan, V., Vicente, V., Romiti, G. F., Romanazzi, I., . . . Lip, G. Y. H. (2018). Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients. INTERNATIONAL JOURNAL OF CARDIOLOGY, 254, 125-131. doi:10.1016/j.ijcard.2017.11.087DOI: 10.1016/j.ijcard.2017.11.087
IMPACT OF BODY MASS INDEX AND OBESITY ON CLINICAL OUTCOMES IN THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) RANDOMIZED TRIAL (Conference Paper)
Lip, G., Merino, J. L., Banach, M., de Groot, J., Maier, L., Themistoclakis, S., . . . Goette, A. (2018). IMPACT OF BODY MASS INDEX AND OBESITY ON CLINICAL OUTCOMES IN THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) RANDOMIZED TRIAL. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 518). doi:10.1016/S0735-1097(18)31059-3DOI: 10.1016/S0735-1097(18)31059-3
IS IT SAFE TO SWITCH OAC IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM A RE-DUAL PCI SUBANALYSIS (Conference Paper)
Ten Berg, J., de Veer, A., Oldgren, J., Steg, P., Zateyshchikov, D. A., Jansky, P., . . . Cannon, C. (2018). IS IT SAFE TO SWITCH OAC IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM A RE-DUAL PCI SUBANALYSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 1206). doi:10.1016/S0735-1097(18)31747-9DOI: 10.1016/S0735-1097(18)31747-9
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference (Journal article)
Kotecha, D., Breithardt, G., Camm, A. J., Lip, G. Y. H., Schotten, U., Ahlsson, A., . . . Kirchhof, P. (2018). Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference. EUROPACE, 20(3), 395-407. doi:10.1093/europace/eux318DOI: 10.1093/europace/eux318
Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study (Journal article)
Chao, T. -F., Lip, G. Y. H., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2018). Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 254, 157-161. doi:10.1016/j.ijcard.2017.11.025DOI: 10.1016/j.ijcard.2017.11.025
ORAL ANTICOAGULATION IN ATRIAL FIBRILLATION AND ANEMIA: A REPORT FROM DANISH NATIONWIDE REGISTRIES (Conference Paper)
Bonde, A. N., Lip, G., Staerk, L., Gundlund, A., Torp-Pedersen, C., Gislason, G., & Olesen, J. (2018). ORAL ANTICOAGULATION IN ATRIAL FIBRILLATION AND ANEMIA: A REPORT FROM DANISH NATIONWIDE REGISTRIES. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 508). doi:10.1016/S0735-1097(18)31049-0DOI: 10.1016/S0735-1097(18)31049-0
Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED (Journal article)
Miguel Rivera-Caravaca, J., Roldan, V., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Marin, F., & Lip, G. Y. H. (2018). Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED. AMERICAN HEART JOURNAL, 197, 27-34. doi:10.1016/j.ahj.2017.11.004DOI: 10.1016/j.ahj.2017.11.004
Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients - Meta - Analysis (Journal article)
Senoo, K., Kondo, Y., Kobayashi, Y., & Lip, G. Y. H. (2018). Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients - Meta - Analysis. CIRCULATION JOURNAL, 82(3), 672-676. doi:10.1253/circj.CJ-17-1164DOI: 10.1253/circj.CJ-17-1164
Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation Should We Use a CHA(2)DS(2)-VA Score Rather Than CHA(2)DS(2)-VASc? (Journal article)
Nielsen, P. B., Skjoth, F., Overvad, T. F., Larsen, T. B., & Lip, G. Y. H. (2018). Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation Should We Use a CHA(2)DS(2)-VA Score Rather Than CHA(2)DS(2)-VASc?. Circulation, 137(8), 832-840. doi:10.1161/CIRCULATIONAHA.117.029081DOI: 10.1161/CIRCULATIONAHA.117.029081
Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort (Journal article)
Bisson, A., Bodin, A., Clementy, N., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2018). Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort. AMERICAN JOURNAL OF CARDIOLOGY, 121(4), 437-444. doi:10.1016/j.amjcard.2017.11.016DOI: 10.1016/j.amjcard.2017.11.016
Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry (Journal article)
Nammas, W., Kiviniemi, T., Schlitt, A., Rubboli, A., Valencia, J., Lip, G. Y. H., . . . Airaksinen, K. E. J. (2018). Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 253, 35-39. doi:10.1016/j.ijcard.2017.07.074DOI: 10.1016/j.ijcard.2017.07.074
Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation (Journal article)
Guo, Y., Zhu, H., Chen, Y., & Lip, G. Y. H. (2018). Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 131(2), 185-192. doi:10.1016/j.amjmed.2017.09.009DOI: 10.1016/j.amjmed.2017.09.009
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study (Journal article)
Verdecchia, P., Reboldi, G., Angeli, F., Mazzotta, G., Lip, G. Y. H., Brueckmann, M., . . . Di Pasquale, G. (2018). Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study. EUROPACE, 20(2), 253-262. doi:10.1093/europace/eux022DOI: 10.1093/europace/eux022
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation REPLY (Journal article)
Cannon, C. P., Lip, G. Y. H., & Oldgren, J. (2018). Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 378(5), 485-486. Retrieved from https://www.webofscience.com/
Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials (Journal article)
Proietti, M., & Lip, G. Y. H. (2018). Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 252, 96-100. doi:10.1016/j.ijcard.2017.10.091DOI: 10.1016/j.ijcard.2017.10.091
Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation A Report From the Taiwan Nationwide AF Cohort Study (Journal article)
Chao, T. -F., Liu, C. -J., Tuan, T. -C., Chen, T. -J., Hsieh, M. -H., Lip, G. Y. H., & Chen, S. -A. (2018). Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation A Report From the Taiwan Nationwide AF Cohort Study. CHEST, 153(2), 453-466. doi:10.1016/j.chest.2017.10.001DOI: 10.1016/j.chest.2017.10.001
Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation (Journal article)
Purmah, Y., Proietti, M., Laroche, C., Mazurek, M., Tahmatzidis, D., Boriani, G., . . . Lip, G. Y. H. (2018). Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation. EUROPACE, 20(2), 243-252. doi:10.1093/europace/euw421DOI: 10.1093/europace/euw421
Shahid, F., Lip, G. Y. H., & Shantsila, E. (2018). Role of Monocytes in Heart Failure and Atrial Fibrillation. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(3). doi:10.1161/JAHA.117.007849DOI: 10.1161/JAHA.117.007849
Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study (Conference Paper)
Khalid, U., Egeberg, A., Ahlehoff, O., Lane, D., Gislason, G. H., Lip, G. Y. H., & Hansen, P. R. (2018). Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study. In JOURNAL OF THE AMERICAN HEART ASSOCIATION Vol. 7. doi:10.1161/JAHA.117.007227DOI: 10.1161/JAHA.117.007227
Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation (Journal article)
Chao, T. -F., Lip, G. Y. H., Liu, C. -J., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2018). Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 71(2), 122-132. doi:10.1016/j.jacc.2017.10.085DOI: 10.1016/j.jacc.2017.10.085
Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of <i>Edoxaban</i> for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study) (Journal article)
Lip, G. Y. H., Merino, J. L., Dan, G. A., Themistoclakis, S., Ellenbogen, K. A., De Caterina, R., . . . Goette, A. (2018). Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of <i>Edoxaban</i> for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study). AMERICAN JOURNAL OF CARDIOLOGY, 121(2), 193-198. doi:10.1016/j.amjcard.2017.10.008DOI: 10.1016/j.amjcard.2017.10.008
Resumption of antiplatelet therapy in patients with primary intracranial haemorrhage: Balancing benefits and risks (Journal article)
Khan, A. A., & Lip, G. Y. H. (2018). Resumption of antiplatelet therapy in patients with primary intracranial haemorrhage: Balancing benefits and risks. JOURNAL OF THE NEUROLOGICAL SCIENCES, 384, 139-140. doi:10.1016/j.jns.2017.11.038DOI: 10.1016/j.jns.2017.11.038
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS (Journal article)
Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J. -P., Costa, F., Jeppsson, A., . . . Aboyans, V. (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. EUROPEAN HEART JOURNAL, 39(3), 213-+. doi:10.1093/eurheartj/ehx419DOI: 10.1093/eurheartj/ehx419
Dementia and Atrial Fibrillation: A Dangerous Combination for Ischemic Stroke and Mortality (Journal article)
Pastori, D., Miyazawa, K., & Lip, G. Y. H. (2018). Dementia and Atrial Fibrillation: A Dangerous Combination for Ischemic Stroke and Mortality. JOURNAL OF ALZHEIMERS DISEASE, 61(3), 1129-1132. doi:10.3233/JAD-170955DOI: 10.3233/JAD-170955
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) (Journal article)
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., . . . Zeymer, U. (2018). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). EUROPEAN HEART JOURNAL, 39(2), 119-177. doi:10.1093/eurheartj/ehx393DOI: 10.1093/eurheartj/ehx393
Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED scores using multiple biomarkers (Journal article)
Roldan, V., Miguel Rivera-Caravaca, J., Shantsila, A., Garcia-Fernandez, A., Asuncion Esteve-Pastor, M., Antonio Vilchez, J., . . . Lip, G. Y. H. (2018). Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED scores using multiple biomarkers. ANNALS OF MEDICINE, 50(1), 26-34. doi:10.1080/07853890.2017.1378429DOI: 10.1080/07853890.2017.1378429
New anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds (Journal article)
Dimitropoulos, G., Rahim, S. M. Z., Moss, A. S., & Lip, G. Y. H. (2018). New anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 27(1), 71-86. doi:10.1080/13543784.2018.1416090DOI: 10.1080/13543784.2018.1416090
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS) (Journal article)
Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J. -P., Costa, F., Jeppsson, A., . . . Aboyans, V. (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 53(1), 34-78. doi:10.1093/ejcts/ezx334DOI: 10.1093/ejcts/ezx334
Calkins, H., Hindricks, G., Cappato, R., Kim, Y. -H., Saad, E. B., Aguinaga, L., . . . Document Reviewers:. (2018). 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 20(1), e1-e160. doi:10.1093/europace/eux274DOI: 10.1093/europace/eux274
2018 ESC/ESH Guidelines for the management of arterial hypertension <i>The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension</i> (Journal article)
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension <i>The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension</i>. JOURNAL OF HYPERTENSION, 36(10), 1953-2041. doi:10.1097/HJH.0000000000001940DOI: 10.1097/HJH.0000000000001940
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology andthe European Society of Hypertension <i>ESC</i>/<i>ESH Task Force for the Management of Arterial Hypertension</i> (Journal article)
Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2018). 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology andthe European Society of Hypertension <i>ESC</i>/<i>ESH Task Force for the Management of Arterial Hypertension</i>. JOURNAL OF HYPERTENSION, 36(12), 2284-2309. doi:10.1097/HJH.0000000000001961DOI: 10.1097/HJH.0000000000001961
A happy new year 2013 for Thrombosis and Haemostasis. (Journal article)
Weber, C., & Lip, G. Y. H. (2013). A happy new year 2013 for Thrombosis and Haemostasis.. Thrombosis and haemostasis, 109(1), 1-2. doi:10.1160/th17-11-0842DOI: 10.1160/th17-11-0842
A novel model for prediction of ischemic stroke in patients without atrial fibrillation (Conference Paper)
Steensig, K., Olesen, K. K. W., Madsen, M., Thim, T., Jensen, L. O., Raungaard, B., . . . Maeng, M. (2018). A novel model for prediction of ischemic stroke in patients without atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1273). Retrieved from https://www.webofscience.com/
A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics (Conference Paper)
Huisman, M. V., Diener, H. -C., Dubner, S. J., Halperin, J. L., Rothman, K. J., Ma, C. -S., . . . Lip, G. Y. H. (2018). A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 825). Retrieved from https://www.webofscience.com/
Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS (Journal article)
Valgimigli, A. M. D. G. D. T. M., Bueno, H., Byrne, R. A., Collet, J. -P., Costa, F., Jeppsson, A., . . . Aboyans, V. (2018). Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS. Revista Española de Cardiología, 71(1), 42.e1-42.e58. doi:10.1016/j.recesp.2017.11.014DOI: 10.1016/j.recesp.2017.11.014
Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation: Cohort Data Covering the Entire Korean Population (Journal article)
Kim, T. -H., Yang, P. -S., Yu, H. T., Jang, E., Uhm, J. -S., Kim, J. -Y., . . . Lip, G. Y. H. (2018). Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation: Cohort Data Covering the Entire Korean Population. STROKE, 49(8), 1872-1879. doi:10.1161/STROKEAHA.118.021047DOI: 10.1161/STROKEAHA.118.021047
Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population (Conference Paper)
Kim, T. -H., Yang, P. -S., Yu, H. -T., Jang, E. S., Uhm, J. -S., Kim, J. -Y., . . . Lip, G. Y. H. (2018). Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 613). Retrieved from https://www.webofscience.com/
Age-dependency in the implementation of guideline-recommended therapy for stroke prevention in patients with non-valvular atrial fibrillation: insights from the BALKAN-AF Survey (Conference Paper)
Potpara, S., Dan, G. A., Kusljugic, Z., Paparisto, V., Goda, A., Trendafilova, E., . . . Lip, G. Y. H. (2018). Age-dependency in the implementation of guideline-recommended therapy for stroke prevention in patients with non-valvular atrial fibrillation: insights from the BALKAN-AF Survey. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 615-616). Retrieved from https://www.webofscience.com/
Anticoagulation control in octogenarian patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west birmingham AF project (Conference Paper)
Zulkifly, H., Cheli, P., Lutchman, I., Bai, Y., Lip, G. Y. H., & Lane, D. (2018). Anticoagulation control in octogenarian patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west birmingham AF project. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1005). Retrieved from https://www.webofscience.com/
Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry (Conference Paper)
Esteve Pastor, M. A., Roldan-Rabadan, I., Rivera-Caravaca, J. M., Roldan, V., Muniz, J., Cequier, A., . . . Marin, F. (2018). Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 613). Retrieved from https://www.webofscience.com/
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of CardiologyWorking Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (vol 19, pg 1757, 2017) (Journal article)
Lip, G. Y. H. (2018). Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of CardiologyWorking Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (vol 19, pg 1757, 2017). EUROPACE, 20(4), 658. Retrieved from https://www.webofscience.com/
Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach (Journal article)
Li, X., Keshishian, A., Hamilton, M., Horblyuk, R., Gupta, K., Luo, X., . . . Deitelzweig, S. (2018). Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach. PLOS ONE, 13(1). doi:10.1371/journal.pone.0191722DOI: 10.1371/journal.pone.0191722
Association of circulating apoptotic (annexin V plus ) microparticles with ventricular fibrosis and diastolic dysfunction in atrial fibrillation patients with heart failure with preserved ejection fraction (Conference Paper)
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Association of circulating apoptotic (annexin V plus ) microparticles with ventricular fibrosis and diastolic dysfunction in atrial fibrillation patients with heart failure with preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 612). Retrieved from https://www.webofscience.com/
Atrial Fibrillation (Chapter)
Kotecha, D., Senoo, K., & Lip, G. Y. H. (2018). Atrial Fibrillation. In Hematology (pp. 2152-2158). Elsevier. doi:10.1016/b978-0-323-35762-3.00147-5DOI: 10.1016/b978-0-323-35762-3.00147-5
Atrial high rate episodes burden improves stroke risk stratification using the CHA2DS2-VASc score: implications for anticoagulating device patients with high atrial arrhythmia burden (Conference Paper)
Miyazawa, K., Kondo, Y., Nakano, M., Senoo, K., Kobayashi, Y., & Lip, G. Y. H. (2018). Atrial high rate episodes burden improves stroke risk stratification using the CHA2DS2-VASc score: implications for anticoagulating device patients with high atrial arrhythmia burden. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 825). Retrieved from https://www.webofscience.com/
Burden of comorbidities, quality of anticoagulation control and outcomes: an analysis from the AFFIRM study (Conference Paper)
Proietti, M., Romiti, G. F., Olshansky, B., & Lip, G. Y. H. (2018). Burden of comorbidities, quality of anticoagulation control and outcomes: an analysis from the AFFIRM study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 193). Retrieved from https://www.webofscience.com/
CHA2DS2VASc score predicts exercise capacity in patients with permanent atrial fibrillation and preserved left ventricular function (Conference Paper)
Khan, A., Shahid, F., Lip, G. Y. H., & Shantsila, E. (2018). CHA2DS2VASc score predicts exercise capacity in patients with permanent atrial fibrillation and preserved left ventricular function. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 402). Retrieved from https://www.webofscience.com/
Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis. (Journal article)
Cheung, A., Gong, M., Bellanti, R., Ali-Hasan-Al-Saegh, S., Li, G., Roig, E., . . . Tse, G. (2018). Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis.. Heart Asia, 10(1), e010970. doi:10.1136/heartasia-2017-010970DOI: 10.1136/heartasia-2017-010970
Change in CHA2DS2-VASc score (delta CHA2DS2-VASc score) and the risk of thromboembolism over 12-years follow-up in initially low-risk patients with first-diagnosed atrial fibrillation (Conference Paper)
Potpara, T. S., Mujovic, N., Marinkovic, J., & Lip, G. Y. H. (2018). Change in CHA2DS2-VASc score (delta CHA2DS2-VASc score) and the risk of thromboembolism over 12-years follow-up in initially low-risk patients with first-diagnosed atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 616). Retrieved from https://www.webofscience.com/
Circulating monocyte-derived (CD14+) and apoptotic (annexin V-binding) microparticles correlate with recurrent atrial fibrillation (Conference Paper)
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Circulating monocyte-derived (CD14+) and apoptotic (annexin V-binding) microparticles correlate with recurrent atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 412-413). Retrieved from https://www.webofscience.com/
Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy (Journal article)
Banerjee, G., Wilson, D., Ambler, G., Appiah, K. O. -B., Shakeshaft, C., Lunawat, S., . . . Werring, D. J. (2018). Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy. STROKE, 49(1), 40-+. doi:10.1161/STROKEAHA.117.019409DOI: 10.1161/STROKEAHA.117.019409
Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study (Conference Paper)
Lip, G. Y. H., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Dhamane, A., . . . Deitelzweig, S. (2018). Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 612-613). Retrieved from https://www.webofscience.com/
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study (Conference Paper)
Deitelzweig, S., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Dhamane, A., . . . Lip, G. Y. H. (2018). Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 610-611). Retrieved from https://www.webofscience.com/
Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants among non-valvular atrial fibrillation patients: the ARISTOPHANES study (Conference Paper)
Deitelzweig, S., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Dhamane, A., . . . Lip, G. Y. H. (2018). Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants among non-valvular atrial fibrillation patients: the ARISTOPHANES study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 505). Retrieved from https://www.webofscience.com/
Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants and warfarin among non-valvular atrial fibrillation patients: the ARISTOPHANES study (Conference Paper)
Lip, G. Y. H., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Dhamane, A., . . . Deitelzweig, S. (2018). Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants and warfarin among non-valvular atrial fibrillation patients: the ARISTOPHANES study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 506). Retrieved from https://www.webofscience.com/
Coronary artery disease is an independent risk factor for ischemic stroke among patients with atrial fibrillation (Conference Paper)
Steensig, K., Olesen, K. K. W., Thim, T., Nielsen, J. C., Madsen, M., Jensen, S. E., . . . Maeng, M. (2018). Coronary artery disease is an independent risk factor for ischemic stroke among patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 432). Retrieved from https://www.webofscience.com/
Development of a risk score for incident atrial fibrillation on 471,446 chinese subjects. The C2HEST score (Conference Paper)
Li, Y. G., Pastori, D., Farcomeni, A., Wang, Y. T., Guo, Y. T., & Lip, G. Y. H. (2018). Development of a risk score for incident atrial fibrillation on 471,446 chinese subjects. The C2HEST score. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 407). Retrieved from https://www.webofscience.com/
Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry (Conference Paper)
Proietti, M., Laroche, C., Fantecchi, E., Zdravkovic, M., Lenarczyk, R., Piot, O., . . . Boriani, G. (2018). Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1265). Retrieved from https://www.webofscience.com/
Dual antithrombotic therapy with dabigatran vs triple therapy with warfarin after PCI in patients with atrial fibrillation and diabetes mellitus (a RE-DUAL PCI subgroup analysis) (Conference Paper)
Maeng, M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., Miede, C., . . . Cannon, C. P. (2018). Dual antithrombotic therapy with dabigatran vs triple therapy with warfarin after PCI in patients with atrial fibrillation and diabetes mellitus (a RE-DUAL PCI subgroup analysis). In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1090-1091). Retrieved from https://www.webofscience.com/
Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future (Journal article)
Weber, C., & Lip, G. Y. H. (2018). Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future. THROMBOSIS AND HAEMOSTASIS, 118(1), 225-227. doi:10.1160/TH17-11-0844DOI: 10.1160/TH17-11-0844
Effect of concomitant antiplatelet agents on clinical outcomes in the Edoxaban versus Warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial (Conference Paper)
Goette, A., Merino, J., De Caterina, R., Huber, K., Heidbuchel, H., Jin, J., . . . Lip, G. Y. H. (2018). Effect of concomitant antiplatelet agents on clinical outcomes in the Edoxaban versus Warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 205-206). Retrieved from https://www.webofscience.com/
Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial (Conference Paper)
Yee, M. K., Kerneis, M., Nafee, T., Travis, R., Chi, G., Mehran, R., . . . Gibson, C. M. (2018). Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 271-272). Retrieved from https://www.webofscience.com/
Lip, G. Y. H., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Gupta, K., . . . Deitelzweig, S. (2018). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study. STROKE, 49(12), 2933-2944. doi:10.1161/STROKEAHA.118.020232DOI: 10.1161/STROKEAHA.118.020232
Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis (Journal article)
Bai, Y., Guo, S. -D., Deng, H., Shantsila, A., Fauchier, L., Ma, C. -S., & Lip, G. Y. H. (2018). Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis. AGE AND AGEING, 47(1), 9-17. doi:10.1093/ageing/afx103DOI: 10.1093/ageing/afx103
Efficacy and safety of non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy with non-valvular atrial fibrillation: a nationwide cohort study (Conference Paper)
Jung, H., Yang, P. S., Jang, E., Yu, H. T., Kim, T. H., Uhm, J. S., . . . Lip, G. Y. H. (2018). Efficacy and safety of non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy with non-valvular atrial fibrillation: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 274-275). Retrieved from https://www.webofscience.com/
Estimated effectiveness and safety of non-vitamin K antagonist oral anticoagulants compared to optimally anticoagulated real-world atrial fibrillation patients taking acenocoumarol (Conference Paper)
Esteve Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Orenes-Pinero, E., Romiti, G. F., Romanazzi, I., . . . Lip, G. Y. H. (2018). Estimated effectiveness and safety of non-vitamin K antagonist oral anticoagulants compared to optimally anticoagulated real-world atrial fibrillation patients taking acenocoumarol. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 873). Retrieved from https://www.webofscience.com/
Galectin 3 as a marker of diastolic dysfunction in patients with atrial fibrillation and heart failure with preserved ejection fraction (Conference Paper)
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Galectin 3 as a marker of diastolic dysfunction in patients with atrial fibrillation and heart failure with preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1387). Retrieved from https://www.webofscience.com/
Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program (Conference Paper)
Beier, L., Franca, L. R., Lip, G. Y. H., Huisman, M. V., Zint, K., Halperin, J. L., . . . Rothman, K. J. (2018). Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1074). Retrieved from https://www.webofscience.com/
High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI (Conference Paper)
De Caterina, R., Lopez Sendon, J. L., Mehta, S., Opolski, G., Oldgren, J., Steg, P. G., . . . Cannon, C. (2018). High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 458). Retrieved from https://www.webofscience.com/
How could non-vitamin K antagonist oral anticoagulants change clinical practice for stroke prevention and improve outcomes in patients with newly-diagnosed atrial fibrillation? (Conference Paper)
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2018). How could non-vitamin K antagonist oral anticoagulants change clinical practice for stroke prevention and improve outcomes in patients with newly-diagnosed atrial fibrillation?. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 457-458). Retrieved from https://www.webofscience.com/
Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial (Conference Paper)
Nafee, T., Yee, M. K., Kerneis, M., Travis, R., Alkhalfan, F., Mehran, R., . . . Gibson, C. M. (2018). Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1073-1074). Retrieved from https://www.webofscience.com/
Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation A Nationwide Cohort Study (Journal article)
Yu, H. T., Yang, P. -S., Kim, T. -H., Jang, E., Kim, D., Uhm, J. -S., . . . Joung, B. (2018). Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation A Nationwide Cohort Study. STROKE, 49(10), 2421-2429. doi:10.1161/STROKEAHA.118.021387DOI: 10.1161/STROKEAHA.118.021387
Impact of comorbidities on major adverse events in atrial fibrillation: 3 years follow-up of the EORP-AF general pilot registry (Conference Paper)
Proietti, M., Laroche, C., Maggioni, A. P., Boriani, G., & Lip, G. Y. H. (2018). Impact of comorbidities on major adverse events in atrial fibrillation: 3 years follow-up of the EORP-AF general pilot registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1292). Retrieved from https://www.webofscience.com/
Incident comorbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): how frequent should we reassess stroke risk in these patients? (Conference Paper)
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2018). Incident comorbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): how frequent should we reassess stroke risk in these patients?. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 264-265). Retrieved from https://www.webofscience.com/
Is there an obesity paradox for adverse outcomes in patients with atrial fibrillation? insights from the FANTASIIA registry (Conference Paper)
Esteve Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Roldan Rabadan, I., Muniz, J., Cequier, A., . . . Marin, F. (2018). Is there an obesity paradox for adverse outcomes in patients with atrial fibrillation? insights from the FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 198-199). Retrieved from https://www.webofscience.com/
Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study (Journal article)
Begg, G. A., Karim, R., Oesterlein, T., Graham, L. N., Hogarth, A. J., Page, S. P., . . . Tayebjeel, M. H. (2018). Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study. PLOS ONE, 13(1). doi:10.1371/journal.pone.0189936DOI: 10.1371/journal.pone.0189936
Long term cardiovascular risk prediction in Real- World atrial fibrillation patients: Validation of the 2MACE score in the FANTASIIA registry (Conference Paper)
Esteve Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Roldan-Rabadan, I., Muniz, J., Cequier, A., . . . Marin, F. (2018). Long term cardiovascular risk prediction in Real- World atrial fibrillation patients: Validation of the 2MACE score in the FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1295). Retrieved from https://www.webofscience.com/
Long-term relationship between atrial fibrillation and charlson comorbidity index in a population-based cohort study (Conference Paper)
Proietti, M., Marzona, I., Vannini, T., Basili, S., Mannucci, P. M., Boriani, G., . . . Nobili, A. (2018). Long-term relationship between atrial fibrillation and charlson comorbidity index in a population-based cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1410-1411). Retrieved from https://www.webofscience.com/
MONOCYTE SUBPOPULATIONS IN PATIENTS FOLLOWING ST-ELEVATION MYOCARDIAL INFARCTION: IMPLICATIONS FOR POST-INFARCTION LEFT VENTRICULAR REMODELLING AND CLINICAL OUTCOMES (Conference Paper)
Ghattas, A., Shantsila, E., Griffiths, H., & Lip, G. (2018). MONOCYTE SUBPOPULATIONS IN PATIENTS FOLLOWING ST-ELEVATION MYOCARDIAL INFARCTION: IMPLICATIONS FOR POST-INFARCTION LEFT VENTRICULAR REMODELLING AND CLINICAL OUTCOMES. In HEART Vol. 104 (pp. A4). doi:10.1136/heartjnl-2018-BCIS.7DOI: 10.1136/heartjnl-2018-BCIS.7
Mechanisms and prognostic significance of pre-existing cognitive impairment in patients with atrial fibrillation related ischaemic stroke or TIA: the CROMIS-2 study (Conference Paper)
Banerjee, G., Wilson, D., Ambler, G., Shakeshaft, C., Chan, E., Cohen, H., . . . Werring, D. J. (2018). Mechanisms and prognostic significance of pre-existing cognitive impairment in patients with atrial fibrillation related ischaemic stroke or TIA: the CROMIS-2 study. In INTERNATIONAL JOURNAL OF STROKE Vol. 13 (pp. 51). Retrieved from https://www.webofscience.com/
NOACs versus warfarin in atrial fibrillation patients and risk of dementia: a nationwide propensity-weighted cohort study (Conference Paper)
Soegaard, M., Skjoth, F., Jensen, M., Kjaeldgaard, J. N., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2018). NOACs versus warfarin in atrial fibrillation patients and risk of dementia: a nationwide propensity-weighted cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1073). Retrieved from https://www.webofscience.com/
Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction (Journal article)
Mahmood, M., & Lip, G. Y. H. (2018). Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction. REVISTA ESPANOLA DE CARDIOLOGIA, 71(10), 847-855. doi:10.1016/j.rec.2018.05.015DOI: 10.1016/j.rec.2018.05.015
Performance of the Cockcroft-Gault, MDRD and CKD-EPI Formulae in Atrial Fibrillation patients. The FANTASIIA Registry (Conference Paper)
Pastor, M. A. E., Rivera-Caravaca, J. M., Roldan, V., Roldan-Rabadan, I., Muniz, J., Cequier, A., . . . Marin, F. (2018). Performance of the Cockcroft-Gault, MDRD and CKD-EPI Formulae in Atrial Fibrillation patients. The FANTASIIA Registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 714). Retrieved from https://www.webofscience.com/
Predicting bleeding events in anticoagulated patients with atrial fibrillation: a comparison between HAS-BLED and GARFIELD-AF bleeding score (Conference Paper)
Proietti, M., Rivera-Caravaca, J. M., Esteve-Pastor, M. A., Romiti, G. F., Marin, F., & Lip, G. Y. H. (2018). Predicting bleeding events in anticoagulated patients with atrial fibrillation: a comparison between HAS-BLED and GARFIELD-AF bleeding score. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 20). Retrieved from https://www.webofscience.com/
Predictors of exercise capacity in the elderly population with permanent atrial fibrillation and preserved left ventricular function (Conference Paper)
Khan, A. A., Shahid, F., Lip, G. Y. H., & Shantsila, E. (2018). Predictors of exercise capacity in the elderly population with permanent atrial fibrillation and preserved left ventricular function. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 95). Retrieved from https://www.webofscience.com/
Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events (Journal article)
Ogawa, H., An, Y., Ikeda, S., Aono, Y., Doi, K., Ishii, M., . . . Akao, M. (2018). Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events. STROKE, 49(10), 2301-2308. doi:10.1161/STROKEAHA.118.021396DOI: 10.1161/STROKEAHA.118.021396
Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation (Journal article)
Miyazawa, K., Pastori, D., & Lip, G. Y. H. (2018). Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation. PROGRESS IN CARDIOVASCULAR DISEASES, 60(4-5), 537-541. doi:10.1016/j.pcad.2017.12.002DOI: 10.1016/j.pcad.2017.12.002
RELATION OF STROKE AND BLEEDING RISK PROFILES TO EFFICACY AND SAFETY OF DABIGATRAN IN ATRIAL FIBRILLATION AFTER PCI: AN ANCILLARY ANALYSIS FROM THE RE-DUAL PCI TRIAL (Conference Paper)
Lip, G., Mauri, L., Montalescot, G., Ozkor, M., Vardas, P., Steg, P. G., . . . Cannon, C. (2018). RELATION OF STROKE AND BLEEDING RISK PROFILES TO EFFICACY AND SAFETY OF DABIGATRAN IN ATRIAL FIBRILLATION AFTER PCI: AN ANCILLARY ANALYSIS FROM THE RE-DUAL PCI TRIAL. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 289). Retrieved from https://www.webofscience.com/
Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation A Systematic Review and Meta-Analysis (Journal article)
Proietti, M., Romanazzi, I., Romiti, G. F., Farcomeni, A., & Lip, G. Y. H. (2018). Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation A Systematic Review and Meta-Analysis. STROKE, 49(1), 98-+. doi:10.1161/STROKEAHA.117.018395DOI: 10.1161/STROKEAHA.117.018395
Tepper, P. G., Mardekian, J., Masseria, C., Phatak, H., Kamble, S., Abdulsattar, Y., . . . Lip, G. Y. H. (2018). Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban. PLOS ONE, 13(11). doi:10.1371/journal.pone.0205989DOI: 10.1371/journal.pone.0205989
Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol (Journal article)
Miguel Rivera-Caravaca, J., Roldar, V., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Marin, F., & Lip, G. Y. H. (2018). Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol. CLINICAL THERAPEUTICS, 40(1), 114-122. doi:10.1016/j.clinthera.2017.11.014DOI: 10.1016/j.clinthera.2017.11.014
Refining stroke and bleeding risk prediction by adding consecutive biomarkers to CHA2DS2-VASc and HAS-BLED scores (Conference Paper)
Rivera Caravaca, J. M., Esteve-Pastor, M. A., Vilchez, J. A., Galvez, J., Vicente, V., Marin, F., . . . Lip, G. Y. H. (2018). Refining stroke and bleeding risk prediction by adding consecutive biomarkers to CHA2DS2-VASc and HAS-BLED scores. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 821-822). Retrieved from https://www.webofscience.com/
Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry (Conference Paper)
Proietti, M., Laroche, C., Popescu, M. I., Tello-Montoliu, A., Garcia-Bolao, I., Lane, D. A., . . . Boriani, G. (2018). Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 694-695). Retrieved from https://www.webofscience.com/
Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry (Journal article)
Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldan-Rabadan, I., Roldan, V., Muniz, J., Rana-Miguez, P., . . . Marin, F. (2018). Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry. THROMBOSIS AND HAEMOSTASIS, 118(2), 279-287. doi:10.1160/TH17-06-0416DOI: 10.1160/TH17-06-0416
Relationship between age and use of oral anticoagulant drugs in european atrial fibrillation patients: the EORP-AF general long-term registry (Conference Paper)
Boriani, G., Proietti, M., Laroche, C., Diemberger, I., Rheinert, C., Serdechnaya, E. V., . . . Lip, G. Y. H. (2018). Relationship between age and use of oral anticoagulant drugs in european atrial fibrillation patients: the EORP-AF general long-term registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 703-704). Retrieved from https://www.webofscience.com/
Relationship between charlson comorbidity index and risk of adverse outcomes in patients with atrial fibrillation: an analysis from the FANTASIIA registry (Conference Paper)
Proietti, M., Esteve-Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Roldan Rabadan, I., Muniz, J., . . . Marin, P. (2018). Relationship between charlson comorbidity index and risk of adverse outcomes in patients with atrial fibrillation: an analysis from the FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1420-1421). Retrieved from https://www.webofscience.com/
Relationship between inflammation and atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices (Conference Paper)
Pastori, D., Miyazawa, K., Li, Y., Shahid, F., Hado, H., & Lip, G. Y. H. (2018). Relationship between inflammation and atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 401). Retrieved from https://www.webofscience.com/
Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source (Journal article)
Ntaios, G., Lip, G. Y. H., Lambrou, D., Michel, P., Perlepe, K., Eskandari, A., . . . Papavasileiou, V. (2018). Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source. STROKE, 49(12), 2904-2909. doi:10.1161/STROKEAHA.118.023281DOI: 10.1161/STROKEAHA.118.023281
Renal function stratification and outcomes following catheter ablation of patients with atrial fibrillation (Conference Paper)
Deng, H., Shantsila, A., Xue, Y. M., Potpapa, T. S., Zhan, X. Z., Liao, H. T., . . . Lip, G. Y. H. (2018). Renal function stratification and outcomes following catheter ablation of patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1221). Retrieved from https://www.webofscience.com/
Risk Stratification in Atrial Fibrillation (Chapter)
Shahid, F., Dzeshka, M., Shantsila, E., & Lip, G. Y. H. (2019). Risk Stratification in Atrial Fibrillation. In Stroke Prevention in Atrial Fibrillation (pp. 47-66). Elsevier. doi:10.1016/b978-0-323-55429-9.00004-2DOI: 10.1016/b978-0-323-55429-9.00004-2
Risk of recurrent intracerebral haemorrhage and ischaemic stroke after intracerebral haemorrhage: a multicentre prospective cohort study (Conference Paper)
Wilson, D., Ambler, G., Hostettler, I. C., Banerjee, G., Shakeshaft, C., Cohen, H., . . . Werring, D. J. (2018). Risk of recurrent intracerebral haemorrhage and ischaemic stroke after intracerebral haemorrhage: a multicentre prospective cohort study. In INTERNATIONAL JOURNAL OF STROKE Vol. 13 (pp. 11). Retrieved from https://www.webofscience.com/
SAFETY AND EFFECTIVENESS OF DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION WITH AND WITHOUT PRIOR STROKE: DATA FROM THE GLORIA-AF REGISTRY PROGRAM (Conference Paper)
Diener, H. C., Teutsch, C., Huisman, M. V., Dubner, S. J., Ma, C. S., Rothman, K. J., . . . Lip, G. Y. H. (2018). SAFETY AND EFFECTIVENESS OF DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION WITH AND WITHOUT PRIOR STROKE: DATA FROM THE GLORIA-AF REGISTRY PROGRAM. In INTERNATIONAL JOURNAL OF STROKE Vol. 13 (pp. 99). Retrieved from https://www.webofscience.com/
Self-reported physical activity is associated with biomarkers of cardiac fibrosis and cell apoptosis in patients with atrial fibrillation (Conference Paper)
Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Self-reported physical activity is associated with biomarkers of cardiac fibrosis and cell apoptosis in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 611). Retrieved from https://www.webofscience.com/
Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: a systematic review and meta-analysis of 993,600 patients (Conference Paper)
Marzona, I., Proietti, M., Farcomeni, A., Romiti, G. F., Romanazzi, I., Raparelli, V., . . . Roncaglioni, M. C. (2018). Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: a systematic review and meta-analysis of 993,600 patients. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 235). Retrieved from https://www.webofscience.com/
Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry (Journal article)
Steensig, K., Olesen, K. K. W., Thim, T., Nielsen, J. C., Jensen, S. E., Jensen, L. O., . . . Maeng, M. (2018). Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry. THROMBOSIS AND HAEMOSTASIS, 118(12), 2162-2170. doi:10.1055/s-0038-1675401DOI: 10.1055/s-0038-1675401
Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study (Journal article)
Staerk, L., Gerds, T. A., Lip, G. Y. H., Ozenne, B., Bonde, A. N., Lamberts, M., . . . Olesen, J. B. (2018). Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study. JOURNAL OF INTERNAL MEDICINE, 283(1), 45-55. doi:10.1111/joim.12683DOI: 10.1111/joim.12683
Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: prospective validation of the EHRA classification in a nationwide cohort study (Conference Paper)
Jensen, M., Skjoeth, F., Nielsen, P. B., Larsen, T. B., Melgaard, L., & Lip, G. Y. H. (2018). Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: prospective validation of the EHRA classification in a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 25). Retrieved from https://www.webofscience.com/
The effect of PCI complexity on the efficacy and safety of dabigatran dual therapy vs warfarin triple therapy in atrial fibrillation: a subgroup analysis from the RE-DUAL PCI trial (Conference Paper)
Mauri, L., Steg, P. S., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., Miede, C., . . . Cannon, C. (2018). The effect of PCI complexity on the efficacy and safety of dabigatran dual therapy vs warfarin triple therapy in atrial fibrillation: a subgroup analysis from the RE-DUAL PCI trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 653). Retrieved from https://www.webofscience.com/
The effect of age on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial (Conference Paper)
Ten Berg, J. M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., De Veer, A. N. N. E., Nordaby, M., . . . Cannon, C. P. (2018). The effect of age on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 439-440). Retrieved from https://www.webofscience.com/
The impact of hypertension on stroke and mortality in patients with atrial fibrillation: the loire valley atrial fibrillation project (Conference Paper)
Shantsila, A., Fauchier, L., Bisson, A., Bodin, A., & Lip, G. Y. H. (2018). The impact of hypertension on stroke and mortality in patients with atrial fibrillation: the loire valley atrial fibrillation project. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1411). Retrieved from https://www.webofscience.com/
The increased risk of stroke, bleeding and mortality with new-onset atrial fibrillation in critically ill patients: a nationwide cohort study (Conference Paper)
Kim, K., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., . . . Lip, G. Y. H. (2018). The increased risk of stroke, bleeding and mortality with new-onset atrial fibrillation in critically ill patients: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1075). Retrieved from https://www.webofscience.com/
Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease: data from GLORIA-AF (Conference Paper)
Halperin, J. L., Teutsch, C., Huisman, M. V., Diener, H. -C., Rothman, K. J., Ma, C. S., . . . Lip, G. Y. H. (2018). Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease: data from GLORIA-AF. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 610). Retrieved from https://www.webofscience.com/
Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry (Conference Paper)
Dubner, S. J., Huisman, M. V., Diener, H. C., Halperin, J. L., Rothman, K. J., Ma, C. S., . . . Lip, G. Y. H. (2018). Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 606-607). Retrieved from https://www.webofscience.com/
Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: a nationwide cohort study (Conference Paper)
Fangel, M. V., Nielsen, P. B., Larsen, T. B., Christensen, B., Overvad, T. F., Lip, G. Y. H., . . . Jensen, M. B. (2018). Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 404). Retrieved from https://www.webofscience.com/
Use of oral anticoagulation and association to outcomes in atrial fibrillation patients who develop chronic kidney disease: a nationwide cohort study (Conference Paper)
Bonde, A. N., Lip, G. Y. H., Kamper, A. L., Gislason, G., Torp-Pedersen, C., Hlatky, M., & Olesen, J. B. (2018). Use of oral anticoagulation and association to outcomes in atrial fibrillation patients who develop chronic kidney disease: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 820). Retrieved from https://www.webofscience.com/
When are atrial fibrillation patients at risk to discontinue anticoagulation treatment? Results from the GLORIA-AF Registry (Conference Paper)
Paquette, M., Huisman, M. V., Lip, G. Y. H., Diener, H. -C., Dubner, S. J., Halperin, J. L., . . . Nieuwlaat, R. (2018). When are atrial fibrillation patients at risk to discontinue anticoagulation treatment? Results from the GLORIA-AF Registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1007). Retrieved from https://www.webofscience.com/
2017
Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation (Journal article)
Miguel Rivera-Caravaca, J., Marin, F., Asuncion Esteve-Pastor, M., Rana-Miguez, P., Anguita, M., Muniz, J., . . . Roldan, V. (2017). Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 120(12), 2176-2181. doi:10.1016/j.amjcard.2017.09.003DOI: 10.1016/j.amjcard.2017.09.003
Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis (Journal article)
Wang, C., Yu, Y., Zhu, W., Yu, J., Lip, G. Y. H., & Hong, K. (2017). Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis. ONCOTARGET, 8(65), 109703-109711. doi:10.18632/oncotarget.19858DOI: 10.18632/oncotarget.19858
Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis (Journal article)
Adlan, A. M., van Zanten, J. J. C. S. V., Lip, G. Y. H., Paton, J. F. R., Kitas, G. D., & Fisher, J. P. (2017). Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 208, 137-145. doi:10.1016/j.autneu.2017.09.003DOI: 10.1016/j.autneu.2017.09.003
Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation The Fushimi AF Registry (Journal article)
Esato, M., Chun, Y. -H., An, Y., Ogawa, H., Wada, H., Hasegawa, K., . . . Akao, M. (2017). Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation The Fushimi AF Registry. CHEST, 152(6), 1266-1275. doi:10.1016/j.chest.2017.08.004DOI: 10.1016/j.chest.2017.08.004
Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis (Journal article)
Tervonen, T., Ustyugova, A., Bhashyam, S. S., Lip, G. Y. H., Verdecchia, P., Kwan, R., . . . Marsh, K. (2017). Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis. VALUE IN HEALTH, 20(10), 1394-1402. doi:10.1016/j.jval.2017.06.006DOI: 10.1016/j.jval.2017.06.006
Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study (Journal article)
Okumura, K., Lip, G. Y. H., Akao, M., Tanizawa, K., Fukuzawae, M., Abe, K., . . . Yamashita, T. (2017). Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study. AMERICAN HEART JOURNAL, 194, 99-106. doi:10.1016/j.ahj.2017.08.017DOI: 10.1016/j.ahj.2017.08.017
Enhanced shape memory and superelasticity in small-volume ceramics: a perspective on the controlling factors (Journal article)
Zeng, X., Du, Z., Schuh, C. A., & Gan, C. L. (2017). Enhanced shape memory and superelasticity in small-volume ceramics: a perspective on the controlling factors. MRS Communications, 7(4), 747-754. doi:10.1557/mrc.2017.99DOI: 10.1557/mrc.2017.99
External Validation of the Simple NULL-PLEASE Clinical Score in Predicting Outcome of Out-of-Hospital Cardiac Arrest (Journal article)
Potpara, T. S., Mihajlovic, M., Stankovic, S., Jozic, T., Jozic, I., Asanin, M. R., . . . Lip, G. Y. H. (2017). External Validation of the Simple NULL-PLEASE Clinical Score in Predicting Outcome of Out-of-Hospital Cardiac Arrest. AMERICAN JOURNAL OF MEDICINE, 130(12). doi:10.1016/j.amjmed.2017.05.035DOI: 10.1016/j.amjmed.2017.05.035
Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST (Journal article)
Ibáñez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., . . . Zeymer, U. (2017). Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST. Revista Española de Cardiología, 70(12), 1082.e1-1082.e61. doi:10.1016/j.recesp.2017.10.048DOI: 10.1016/j.recesp.2017.10.048
Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation (Journal article)
Begg, G. A., Karim, R., Oesterlein, T., Graham, L. N., Hogarth, A. J., Page, S. P., . . . Tayebjee, M. H. (2017). Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation. EUROPACE, 19(12), 1944-1950. doi:10.1093/europace/euw315DOI: 10.1093/europace/euw315
Metal-sulfide-decorated ZnO/Si nano-heterostructure arrays with enhanced photoelectrochemical performance (Journal article)
Yadian, B., Rao, Y., Zhu, B., Liu, Z., Liu, Q., Gan, C. L., . . . Huang, Y. (2017). Metal-sulfide-decorated ZnO/Si nano-heterostructure arrays with enhanced photoelectrochemical performance. Materials Research Bulletin, 96, 503-508. doi:10.1016/j.materresbull.2017.05.017DOI: 10.1016/j.materresbull.2017.05.017
Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial (Journal article)
Guo, Y., Chen, Y., Lane, D. A., Liu, L., Wang, Y., & Lip, G. Y. H. (2017). Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial. AMERICAN JOURNAL OF MEDICINE, 130(12), 1388-1396.e6. doi:10.1016/j.amjmed.2017.07.003DOI: 10.1016/j.amjmed.2017.07.003
Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction (Journal article)
Khan, A. A., & Lip, G. Y. H. (2017). Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction. ANNALS OF TRANSLATIONAL MEDICINE, 5(23). doi:10.21037/atm.2017.09.19DOI: 10.21037/atm.2017.09.19
Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS). (Journal article)
Sarkozy, A., De Potter, T., Heidbuchel, H., Ernst, S., Kosiuk, J., Vano, E., . . . ESC Scientific Document Group. (2017). Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS).. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 19(12), 1909-1922. doi:10.1093/europace/eux252DOI: 10.1093/europace/eux252
Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry (Journal article)
Lahtela, H. M., Bah, A., Kiviniemi, T., Nammas, W., Schlitt, A., Rubboli, A., . . . Airaksinen, K. E. J. (2017). Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry. CLINICAL CARDIOLOGY, 40(12), 1264-1270. doi:10.1002/clc.22821DOI: 10.1002/clc.22821
Persistency of left atrial linear lesions after radiofrequency catheter ablation for atrial fibrillation: Data from an invasive follow-up electrophysiology study (Journal article)
Mujovic, N., Marinkovic, M., Markovic, N., Stankovic, G., Lip, G. Y. H., Blomstrom-Lundqvist, C., . . . Potpara, T. S. (2017). Persistency of left atrial linear lesions after radiofrequency catheter ablation for atrial fibrillation: Data from an invasive follow-up electrophysiology study. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 28(12), 1403-1414. doi:10.1111/jce.13322DOI: 10.1111/jce.13322
Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study (Journal article)
Lee, S. -R., Choi, E. -K., Han, K. -D., Cha, M. -J., Oh, S., & Lip, G. Y. H. (2017). Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study. PLOS ONE, 12(12). doi:10.1371/journal.pone.0189495DOI: 10.1371/journal.pone.0189495
Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase (Journal article)
Proietti, M., Laroche, C., Nyvad, O., Haberka, M., Vassilikos, V. P., Maggioni, A. P., . . . Lip, G. Y. H. (2017). Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase. INTERNATIONAL JOURNAL OF CARDIOLOGY, 248, 166-172. doi:10.1016/j.ijcard.2017.08.055DOI: 10.1016/j.ijcard.2017.08.055
Validation of the Same-TT2R2 Score in a Multiethnic Cohort of Asian Patients with Atrial Fibrillation on Warfarin Therapy - A Multicenter Study (Conference Paper)
Khaw, C. S., Lim, M. S. H., Tiong, L. L., Tan, S. S. N., Ku, M. Y., Tan, C. S. Y., . . . Fong, A. Y. Y. (2017). Validation of the Same-TT2R2 Score in a Multiethnic Cohort of Asian Patients with Atrial Fibrillation on Warfarin Therapy - A Multicenter Study. In INTERNATIONAL JOURNAL OF CARDIOLOGY Vol. 249 (pp. S2). doi:10.1016/j.ijcard.2017.09.115DOI: 10.1016/j.ijcard.2017.09.115
Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity-Weighted Cohort Study (Journal article)
Sogaard, M., Skjoth, F., Kjaeldgaard, J. N., Lip, G. Y. H., & Larsen, T. B. (2017). Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity-Weighted Cohort Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 6(11). doi:10.1161/JAHA.117.007453DOI: 10.1161/JAHA.117.007453
Direct oral anticoagulant reversal: how, when and issues faced (Journal article)
Dzeshka, M. S., Pastori, D., & Lip, G. Y. H. (2017). Direct oral anticoagulant reversal: how, when and issues faced. EXPERT REVIEW OF HEMATOLOGY, 10(11), 1005-1022. doi:10.1080/17474086.2017.1379896DOI: 10.1080/17474086.2017.1379896
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)
Lip, G. Y. H., Collet, J. P., de Caterina, R., Fauchier, L., Lane, D. A., Larsen, T. B., . . . Scott-Millar, R. (2017). Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPACE, 19(11), 1757-+. doi:10.1093/europace/eux240DOI: 10.1093/europace/eux240
Atrial Fibrillation and Hypertension (Journal article)
Dzeshka, M. S., Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2017). Atrial Fibrillation and Hypertension. HYPERTENSION, 70(5), 854-+. doi:10.1161/HYPERTENSIONAHA.117.08934DOI: 10.1161/HYPERTENSIONAHA.117.08934
CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke A Korean Nationwide Cohort Study (Journal article)
Kim, T. -H., Yang, P. -S., Kim, D., Yu, H. T., Uhm, J. -S., Kim, J. -Y., . . . Lip, G. Y. H. (2017). CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke A Korean Nationwide Cohort Study. STROKE, 48(11), 2984-+. doi:10.1161/STROKEAHA.117.018551DOI: 10.1161/STROKEAHA.117.018551
Coronary artery disease and risk of adverse cardiac events and stroke (Journal article)
Olesen, K. K. W., Madsen, M., Lip, G. Y. H., Egholm, G., Thim, T., Jensen, L. O., . . . Maeng, M. (2017). Coronary artery disease and risk of adverse cardiac events and stroke. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 47(11), 819-828. doi:10.1111/eci.12804DOI: 10.1111/eci.12804
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation (Journal article)
Cha, M. -J., Choi, E. -K., Han, K. -D., Lee, S. -R., Lim, W. -H., Oh, S., & Lip, G. Y. H. (2017). Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation. STROKE, 48(11), 3040-+. doi:10.1161/STROKEAHA.117.018773DOI: 10.1161/STROKEAHA.117.018773
Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks (Journal article)
Asuncion Esteve-Pastor, M., Rivera-Caravaca, J. M., & Lip, G. Y. H. (2017). Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks. AMERICAN JOURNAL OF HYPERTENSION, 30(11), 1063-1065. doi:10.1093/ajh/hpx135DOI: 10.1093/ajh/hpx135
Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban (Journal article)
Bai, Y., Shi, X. -B., Ma, C. -S., & Lip, G. Y. H. (2017). Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban. AMERICAN JOURNAL OF CARDIOLOGY, 120(9), 1689-1695. doi:10.1016/j.amjcard.2017.07.072DOI: 10.1016/j.amjcard.2017.07.072
Shantsila, A., Shantsila, E., Beevers, D. G., & Lip, G. Y. H. (2017). Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry. JOURNAL OF HYPERTENSION, 35(11), 2310-2314. doi:10.1097/HJH.0000000000001446DOI: 10.1097/HJH.0000000000001446
Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review (Journal article)
Bikdeli, B., Abou Ziki, M. D., & Lip, G. Y. H. (2017). Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 43(8), 849-863. doi:10.1055/s-0036-1598005DOI: 10.1055/s-0036-1598005
Response to: The Cause of the Arteriolar Injury in Malignant Hypertension (Journal article)
Shantsila, A., & Lip, G. Y. H. (2017). Response to: The Cause of the Arteriolar Injury in Malignant Hypertension. AMERICAN JOURNAL OF HYPERTENSION, 30(11), E15. doi:10.1093/ajh/hpx149DOI: 10.1093/ajh/hpx149
Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management) (Journal article)
Proietti, M., Romiti, G. F., Olshansky, B., & Lip, G. Y. H. (2017). Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). HYPERTENSION, 70(5), 949-958. doi:10.1161/HYPERTENSIONAHA.117.10106DOI: 10.1161/HYPERTENSIONAHA.117.10106
The ABC pathway: an integrated approach to improve AF management (Journal article)
Lip, G. Y. H. (2017). The ABC pathway: an integrated approach to improve AF management. NATURE REVIEWS CARDIOLOGY, 14(11), 627-+. doi:10.1038/nrcardio.2017.153DOI: 10.1038/nrcardio.2017.153
The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden (Journal article)
Boriani, G., Lip, G. Y. H., Ricci, R. P., Proclemer, A., Landolina, M., Lunati, M., . . . Gasparini, M. (2017). The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden. EUROPACE, 19(11), 1767-1775. doi:10.1093/europace/euw333DOI: 10.1093/europace/euw333
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors (Journal article)
Butler, J., Hamo, C. E., Filippatos, G., Pocock, S. J., Bernstein, R. A., Brueckmann, M., . . . Anker, S. D. (2017). The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors. EUROPEAN JOURNAL OF HEART FAILURE, 19(11), 1390-1400. doi:10.1002/ejhf.933DOI: 10.1002/ejhf.933
The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study (Journal article)
Lip, G. Y. H., Al-Saady, N., Ezekowitz, M. D., Banach, M., & Goette, A. (2017). The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. AMERICAN HEART JOURNAL, 193, 16-22. doi:10.1016/j.ahj.2017.07.010DOI: 10.1016/j.ahj.2017.07.010
Streamlining primary and secondary care management pathways for stroke prevention in atrial fibrillation (Journal article)
Lip, G. Y. H., Lane, D. A., & Sarwar, S. (2017). Streamlining primary and secondary care management pathways for stroke prevention in atrial fibrillation. EUROPEAN HEART JOURNAL, 38(40), 2980-2982. doi:10.1093/eurheartj/ehx554DOI: 10.1093/eurheartj/ehx554
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (Journal article)
Cannon, C. P., Bhatt, D. L., Oldgren, J., Lip, G. Y. H., Ellis, S. G., Kimura, T., . . . Hohnloser, S. H. (2017). Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. NEW ENGLAND JOURNAL OF MEDICINE, 377(16), 1513-1524. doi:10.1056/NEJMoa1708454DOI: 10.1056/NEJMoa1708454
The CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores (Journal article)
Tse, G., Lip, G. Y. H., & Liu, T. (2017). The CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores. INTERNATIONAL JOURNAL OF CARDIOLOGY, 245, 181-182. doi:10.1016/j.ijcard.2017.07.109DOI: 10.1016/j.ijcard.2017.07.109
Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis (Journal article)
Zhu, W., Guo, L., Liu, F., Wan, R., Shen, Y., Lip, G. Y. H., & Hong, K. (2017). Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis. ONCOTARGET, 8(46), 81154-81166. doi:10.18632/oncotarget.20870DOI: 10.18632/oncotarget.20870
Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores The Murcia Atrial Fibrillation Project (Journal article)
Asuncion Esteve-Pastort, M., Rivera-Caravaca, J. M., Roldan, V., Vicente, V., Valdes, M., Marin, F., & Lip, G. Y. H. (2017). Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores The Murcia Atrial Fibrillation Project. THROMBOSIS AND HAEMOSTASIS, 117(10), 1848-1858. doi:10.1160/TH17-07-0478DOI: 10.1160/TH17-07-0478
Shibahara, T., Yasaka, M., Wakugawa, Y., Maeda, K., Uwatoko, T., Kuwashiro, T., . . . Okada, Y. (2017). Improvement and Aggravation of Spontaneous Unruptured Vertebral Artery Dissection.. Cerebrovascular diseases extra, 7(3), 153-164. doi:10.1159/000481442DOI: 10.1159/000481442
Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism (Journal article)
Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2017). Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism. AMERICAN JOURNAL OF CARDIOLOGY, 120(7), 1139-1145. doi:10.1016/j.amjcard.2017.06.058DOI: 10.1016/j.amjcard.2017.06.058
Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin (Journal article)
Lau, W. C. Y., Li, X., Wong, I. C. K., Man, K. K. C., Lip, G. Y. H., Leung, W. K., . . . Chan, E. W. (2017). Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 15(10), 1923-1933. doi:10.1111/jth.13780DOI: 10.1111/jth.13780
Brugada syndrome: A general cardiologist's perspective (Journal article)
Polovina, M. M., Vukicevic, M., Banko, B., Lip, G. Y. H., & Potpara, T. S. (2017). Brugada syndrome: A general cardiologist's perspective. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 44, 19-27. doi:10.1016/j.ejim.2017.06.019DOI: 10.1016/j.ejim.2017.06.019
Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review (Journal article)
Deng, H., Bai, Y., Shantsila, A., Fauchier, L., Potpara, T. S., & Lip, G. Y. H. (2017). Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review. CLINICAL RESEARCH IN CARDIOLOGY, 106(10), 813-823. doi:10.1007/s00392-017-1123-0DOI: 10.1007/s00392-017-1123-0
Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta-analysis of controlled trials (Journal article)
Bala, M., Sahebkar, A., Ursoniu, S., Serban, M. -C., Undas, A., Mikhailidis, D. P., . . . Banach, M. (2017). Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta-analysis of controlled trials. PHARMACOLOGICAL RESEARCH, 124, 64-73. doi:10.1016/j.phrs.2017.07.024DOI: 10.1016/j.phrs.2017.07.024
Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation (Journal article)
Orenes-Pinero, E., Esteve-Pastor, M. A., Valdes, M., Lip, G. Y. H., & Marin, F. (2017). Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation. DRUG DISCOVERY TODAY, 22(10), 1565-1571. doi:10.1016/j.drudis.2017.05.010DOI: 10.1016/j.drudis.2017.05.010
Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)
Lip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., . . . Field, M. (2017). Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 3(4), 235-250. doi:10.1093/ehjcvp/pvx019DOI: 10.1093/ehjcvp/pvx019
Is atrial fibrillation another manifestation of organ damage in diabetes? (Journal article)
Miyazawa, K., & Lip, G. Y. H. (2017). Is atrial fibrillation another manifestation of organ damage in diabetes?. LANCET DIABETES & ENDOCRINOLOGY, 5(10), 761-762. doi:10.1016/S2213-8587(17)30282-6DOI: 10.1016/S2213-8587(17)30282-6
Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. (Journal article)
Asunción Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldán, V., Vicente, V., Valdés, M., Marín, F., & Lip, G. Y. H. (2017). Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores.. Thrombosis and haemostasis, 117(10), 1848-1858. doi:10.1160/th17-07-0478DOI: 10.1160/th17-07-0478
Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke (Journal article)
Bisson, A., Clementy, N., Bodin, A., Angoulvant, D., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2017). Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke. STROKE, 48(10), 2878-+. doi:10.1161/STROKEAHA.117.018251DOI: 10.1161/STROKEAHA.117.018251
Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci<remove>n Cardiaca y Electrofisiologia (SOLAECE) (Journal article)
Mairesse, G. H., Moran, P., Van Gelder, I. C., Elsner, C., Rosenqvist, M., Mant, J., . . . Sapp, J. L. (2017). Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci<remove>n Cardiaca y Electrofisiologia (SOLAECE). EUROPACE, 19(10), 1589-1623. doi:10.1093/europace/eux177DOI: 10.1093/europace/eux177
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial (Journal article)
Essebag, V., Proietti, R., Birnie, D. H., Wang, J., Douketis, J., Coutu, B., . . . Healey, J. S. (2017). Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial. EUROPACE, 19(10), 1630-1636. doi:10.1093/europace/euw409DOI: 10.1093/europace/euw409
Bai, Y., Wang, Y. -L., Shantsila, A., & Lip, G. Y. H. (2017). The Global Burden of Atrial Fibrillation and Stroke A Systematic Review of the Clinical Epidemiology of Atrial Fibrillation in Asia. CHEST, 152(4), 810-820. doi:10.1016/j.chest.2017.03.048DOI: 10.1016/j.chest.2017.03.048
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation (Journal article)
Paquette, M., Franca, L. R., Teutsch, C., Diener, H. -C., Lu, S., Dubner, S. J., . . . Nieuwlaat, R. (2017). Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 70(13), 1573-1583. doi:10.1016/j.jacc.2017.07.793DOI: 10.1016/j.jacc.2017.07.793
Sex-Related Differences in the Clinical Events of Patients With Atrial Fibrillation. - The Fushimi AF Registry (Journal article)
Ogawa, H., Hamatani, Y., Doi, K., Tezuka, Y., An, Y., Ishii, M., . . . Akao, M. (2017). Sex-Related Differences in the Clinical Events of Patients With Atrial Fibrillation. - The Fushimi AF Registry. CIRCULATION JOURNAL, 81(10), 1403-1410. doi:10.1253/circj.CJ-17-0071DOI: 10.1253/circj.CJ-17-0071
Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation (Journal article)
Rivera-Caravaca, J. M., Roldan, V., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Lip, G. Y. H., & Marin, F. (2017). Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation. SCIENTIFIC REPORTS, 7. doi:10.1038/s41598-017-11683-2DOI: 10.1038/s41598-017-11683-2
Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction (Journal article)
Sambola, A., Ruiz-Meana, M., Barba, I., Del Blanco, B. G., Barrabes, J. A., Lip, G. Y., . . . Garcia-Dorado, D. (2017). Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction. INTERNATIONAL JOURNAL OF CARDIOLOGY, 243, 9-14. doi:10.1016/j.ijcard.2017.04.089DOI: 10.1016/j.ijcard.2017.04.089
Clinical implications, benefits and pitfalls of using and reversing non-vitamin K antagonist oral anticoagulants (Journal article)
Moss, A. S., Dimitropoulous, G., & Lip, G. Y. H. (2017). Clinical implications, benefits and pitfalls of using and reversing non-vitamin K antagonist oral anticoagulants. EXPERT REVIEW OF HEMATOLOGY, 10(9), 833-845. doi:10.1080/17474086.2017.1358085DOI: 10.1080/17474086.2017.1358085
Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation (Journal article)
Rivera-Caravaca, J. M., Asuncion Esteve-Pastora, M., Roldan, V., Marin, F., & Lip, G. Y. H. (2017). Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation. EXPERT OPINION ON DRUG SAFETY, 16(9), 1051-1062. doi:10.1080/14740338.2017.1351542DOI: 10.1080/14740338.2017.1351542
Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report fromthe EURObservational research programme pilot survey on atrial fibrillation (Journal article)
Proietti, M., Raparelli, V., Laroche, C., Dan, G. -A., Janion, M., Popescu, R., . . . Lip, G. Y. H. (2017). Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report fromthe EURObservational research programme pilot survey on atrial fibrillation. EUROPACE, 19(9), 1439-1448. doi:10.1093/europace/euw169DOI: 10.1093/europace/euw169
All Types of Hemorrhagic Stroke Are Not Created Equally Reply (Journal article)
Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2017). All Types of Hemorrhagic Stroke Are Not Created Equally Reply. JAMA INTERNAL MEDICINE, 177(9), 1399. doi:10.1001/jamainternmed.2017.3240DOI: 10.1001/jamainternmed.2017.3240
Anticoagulation Control in <i>Warfarin</i>-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the <i>Edoxaban</i> Versus <i>Enoxaparin</i>-<i>Warfarin</i> in Patients Undergoing Cardioversion of Atrial Fibrillation Trial) (Journal article)
Lip, G. Y. H., Al-Saady, N., Jin, J., Sun, M., Melino, M., Winters, S. M., . . . Goette, A. (2017). Anticoagulation Control in <i>Warfarin</i>-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the <i>Edoxaban</i> Versus <i>Enoxaparin</i>-<i>Warfarin</i> in Patients Undergoing Cardioversion of Atrial Fibrillation Trial). AMERICAN JOURNAL OF CARDIOLOGY, 120(5), 792-796. doi:10.1016/j.amjcard.2017.06.005DOI: 10.1016/j.amjcard.2017.06.005
Atrial fibrillation and hypertrophic cardiomyopathy: co-existing conditions with additive risks (Journal article)
Miyazawa, K., & Lip, G. Y. H. (2017). Atrial fibrillation and hypertrophic cardiomyopathy: co-existing conditions with additive risks. HELLENIC JOURNAL OF CARDIOLOGY, 58(5), 340-341. doi:10.1016/j.hjc.2017.11.012DOI: 10.1016/j.hjc.2017.11.012
Characterisation of defects generated during constant current InGaN-on-silicon LED operation (Journal article)
Made, R. I., Gao, Y., Syaranamual, G. J., Sasangka, W. A., Zhang, L., Nguyen, X. S., . . . Gan, C. L. (2017). Characterisation of defects generated during constant current InGaN-on-silicon LED operation. Microelectronics Reliability, 76-77, 561-565. doi:10.1016/j.microrel.2017.07.072DOI: 10.1016/j.microrel.2017.07.072
Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart RhythmSociety (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)
Gorenek, B., Bax, J., Boriani, G., Chen, S. -A., Dagres, N., Glotzer, T. V., . . . Savelieva, I. (2017). Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart RhythmSociety (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPACE, 19(9), 1556-1578. doi:10.1093/europace/eux163DOI: 10.1093/europace/eux163
Improved reliability of AlGaN/GaN-on-Si high electron mobility transistors (HEMTs) with high density silicon nitride passivation (Journal article)
Sasangka, W. A., Syaranamual, G. J., Gao, Y., I Made, R., Gan, C. L., & Thompson, C. V. (2017). Improved reliability of AlGaN/GaN-on-Si high electron mobility transistors (HEMTs) with high density silicon nitride passivation. Microelectronics Reliability, 76-77, 287-291. doi:10.1016/j.microrel.2017.06.057DOI: 10.1016/j.microrel.2017.06.057
Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists (Journal article)
Lobos-Bejarano, J. M., Castellanos Rodriguez, A., Barrios, V., Escobar, C., Polo-Garcia, J., Carlos del Castillo-Rodriguez, J., . . . Lip, G. Y. H. (2017). Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 71(9). doi:10.1111/ijcp.12974DOI: 10.1111/ijcp.12974
Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis. (Journal article)
Ntaios, G., Papavasileiou, V., Makaritsis, K., Vemmos, K., Michel, P., & Lip, G. Y. H. (2017). Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.. Stroke, 48(9), 2494-2503. doi:10.1161/strokeaha.117.017549DOI: 10.1161/strokeaha.117.017549
Synthesis of monodisperse CeO<sub>2</sub>–ZrO<sub>2</sub> particles exhibiting cyclic superelasticity over hundreds of cycles (Journal article)
Du, Z., Ye, P., Zeng, X. M., Schuh, C. A., Tamura, N., Zhou, X., & Gan, C. L. (2017). Synthesis of monodisperse CeO<sub>2</sub>–ZrO<sub>2</sub> particles exhibiting cyclic superelasticity over hundreds of cycles. Journal of the American Ceramic Society, 100(9), 4199-4208. doi:10.1111/jace.14972DOI: 10.1111/jace.14972
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation (Journal article)
Korompoki, E., Filippidis, F. T., Nielsen, P. B., Del Giudice, A., Lip, G. Y. H., Kuramatsu, J. B., . . . Veltkamp, R. (2017). Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation. NEUROLOGY, 89(7), 687-696. doi:10.1212/WNL.0000000000004235DOI: 10.1212/WNL.0000000000004235
Age- and sex-specific analysis of patients with embolic stroke of undetermined source (Journal article)
Ntaios, G., Lip, G. Y. H., Vemmos, K., Koroboki, E., Manios, E., Vemmou, A., . . . Papavasileiou, V. (2017). Age- and sex-specific analysis of patients with embolic stroke of undetermined source. NEUROLOGY, 89(6), 532-539. doi:10.1212/WNL.0000000000004199DOI: 10.1212/WNL.0000000000004199
Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation. (Journal article)
Rivera-Caravaca, J. M., & Lip, G. Y. H. (2017). Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation.. Evidence-based medicine, 22(4), 154-155. doi:10.1136/ebmed-2017-110764DOI: 10.1136/ebmed-2017-110764
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients From the WARCEF Trial (Journal article)
Teerlink, J. R., Qian, M., Bello, N. A., Freudenberger, R. S., Levin, B., Di Tullio, M. R., . . . Homma, S. (2017). Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients From the WARCEF Trial. JACC-HEART FAILURE, 5(8), 603-610. doi:10.1016/j.jchf.2017.04.011DOI: 10.1016/j.jchf.2017.04.011
Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor A Nationwide Cohort Study (Journal article)
Lip, G. Y. H., Skjoth, F., Nielsen, P. B., Kjaeldgaard, J. N., & Larsen, T. B. (2017). Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor A Nationwide Cohort Study. JAMA CARDIOLOGY, 2(8), 872-881. doi:10.1001/jamacardio.2017.1883DOI: 10.1001/jamacardio.2017.1883
Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis (Journal article)
Awad, K., Mikhailidis, D. P., Toth, P. P., Jones, S. R., Moriarty, P., Lip, G. Y. H., . . . Banach, M. (2017). Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis. CARDIOVASCULAR DRUGS AND THERAPY, 31(4), 419-431. doi:10.1007/s10557-017-6743-0DOI: 10.1007/s10557-017-6743-0
Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., Proietti, M., & Lip, G. Y. H. (2017). Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry. MAYO CLINIC PROCEEDINGS, 92(8), 1203-1213. doi:10.1016/j.mayocp.2017.05.023DOI: 10.1016/j.mayocp.2017.05.023
Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes (Journal article)
Dzeshka, M. S., Shahid, F., Shantsila, A., & Lip, G. Y. H. (2017). Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes. AMERICAN JOURNAL OF HYPERTENSION, 30(8), 733-755. doi:10.1093/ajh/hpx013DOI: 10.1093/ajh/hpx013
In-situ studies on martensitic transformation and high-temperature shape memory in small volume zirconia (Journal article)
Zeng, X. M., Du, Z., Tamura, N., Liu, Q., Schuh, C. A., & Gan, C. L. (2017). In-situ studies on martensitic transformation and high-temperature shape memory in small volume zirconia. Acta Materialia, 134, 257-266. doi:10.1016/j.actamat.2017.06.006DOI: 10.1016/j.actamat.2017.06.006
Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation (Journal article)
Hellman, T., Kiviniemi, T., Nuotio, I., Vasankari, T., Hartikainen, J., Lip, G. Y. H., & Airaksinen, K. E. J. (2017). Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation. THROMBOSIS RESEARCH, 156, 163-167. doi:10.1016/j.thromres.2017.06.026DOI: 10.1016/j.thromres.2017.06.026
P-Wave Indices and Risk of Ischemic Stroke A Systematic Review and Meta-Analysis (Journal article)
He, J., Tse, G., Korantzopoulos, P., Letsas, K. P., Ali-Hasan-Al-Saegh, S., Kamel, H., . . . Liu, T. (2017). P-Wave Indices and Risk of Ischemic Stroke A Systematic Review and Meta-Analysis. STROKE, 48(8), 2066-+. doi:10.1161/STROKEAHA.117.017293DOI: 10.1161/STROKEAHA.117.017293
Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial (Journal article)
Kirchhoff, P., Blank, B. F., Calvert, M., Camm, A. J., Chlouverakis, G., Diener, H. -C., . . . Vardas, P. (2017). Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. AMERICAN HEART JOURNAL, 190, 12-18. doi:10.1016/j.ahj.2017.04.015DOI: 10.1016/j.ahj.2017.04.015
Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry (Journal article)
Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., Proietti, M., & Lip, G. Y. H. (2017). Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry. STROKE, 48(8), 2198-2205. doi:10.1161/STROKEAHA.116.016146DOI: 10.1161/STROKEAHA.116.016146
The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey (Journal article)
Potpara, T. S., Trendafilova, E., Dan, G. -A., Goda, A., Kusljugic, Z., Manola, S., . . . Lip, G. Y. H. (2017). The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey. ADVANCES IN THERAPY, 34(8), 2043-2057. doi:10.1007/s12325-017-0589-5DOI: 10.1007/s12325-017-0589-5
The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review (Journal article)
De Caterina, R., & Lip, G. Y. H. (2017). The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review. CLINICAL RESEARCH IN CARDIOLOGY, 106(8), 565-572. doi:10.1007/s00392-017-1102-5DOI: 10.1007/s00392-017-1102-5
Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry (Journal article)
Proietti, M., Airaksinen, K. E. J., Rubboli, A., Schlitt, A., Kiviniemi, T., Karjalainen, P. P., & Lip, G. Y. H. (2017). Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry. AMERICAN HEART JOURNAL, 190, 86-93. doi:10.1016/j.ahj.2017.05.016DOI: 10.1016/j.ahj.2017.05.016
Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus (Journal article)
Moss, A. S., Dimitropoulos, G., Connolly, D. L., & Lip, G. Y. H. (2017). Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus. EXPERT OPINION ON PHARMACOTHERAPY, 18(11), 1101-1114. doi:10.1080/14656566.2017.1350647DOI: 10.1080/14656566.2017.1350647
A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial (Journal article)
Kotecha, D., Calvert, M., Deeks, J. J., Griffith, M., Kirchhof, P., Lip, G. Y. H., . . . Townend, J. N. (2017). A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial. BMJ OPEN, 7(7). doi:10.1136/bmjopen-2016-015099DOI: 10.1136/bmjopen-2016-015099
Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores (Journal article)
Rivera-Caravaca, J. M., Roldan, V., Esteve-Pastor, M. A., Valdes, M., Vicente, V., Lip, G. Y. H., & Marin, F. (2017). Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 6(7). doi:10.1161/JAHA.117.006490DOI: 10.1161/JAHA.117.006490
Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary. (Journal article)
Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Diener, H. -C., Hacke, W., . . . ESC Scientific Document Group. (2017). Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.. European heart journal, 38(27), 2137-2149. doi:10.1093/eurheartj/ehw058DOI: 10.1093/eurheartj/ehw058
Copper nanoparticle paste on different metallic substrates for low temperature bonded interconnection (Conference Paper)
Kim, J., Lee, B., Koo, J. -M., & Gan, C. L. (2017). Copper nanoparticle paste on different metallic substrates for low temperature bonded interconnection. In 2017 IEEE 19th Electronics Packaging Technology Conference (EPTC). IEEE. doi:10.1109/eptc.2017.8277556DOI: 10.1109/eptc.2017.8277556
Review on test vehicles for electromigration (EM) study in solder interconnects (Conference Paper)
Zhu, Z., Chan, Y. -C., Wu, F., Gan, C. L., & Chen, Z. (2017). Review on test vehicles for electromigration (EM) study in solder interconnects. In 2017 IEEE 19th Electronics Packaging Technology Conference (EPTC). IEEE. doi:10.1109/eptc.2017.8277478DOI: 10.1109/eptc.2017.8277478
Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis (Journal article)
Awad, K., Serban, M. -C., Penson, P., Mikhailidis, D. P., Toth, P. P., Jones, S. R., . . . Banach, M. (2017). Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis. JOURNAL OF CLINICAL LIPIDOLOGY, 11(4), 972-985. doi:10.1016/j.jacl.2017.06.001DOI: 10.1016/j.jacl.2017.06.001
Microvesicles in vascular homeostasis and diseases. (Journal article)
Ridger, V. C., Boulanger, C. M., Angelillo-Scherrer, A., Badimon, L., Blanc-Brude, O., Bochaton-Piallat, M. -L., . . . Harrison, P. (2017). Microvesicles in vascular homeostasis and diseases.. Thrombosis and haemostasis, 117(7), 1296-1316. doi:10.1160/th16-12-0943DOI: 10.1160/th16-12-0943
Oral anticoagulation for elderly patients with non-valvular atrial fibrillation: recent insights from randomised trials and the 'real world' (Journal article)
Voukalis, C., & Lip, G. Y. H. (2017). Oral anticoagulation for elderly patients with non-valvular atrial fibrillation: recent insights from randomised trials and the 'real world'. HEART, 103(13), 977-978. doi:10.1136/heartjnl-2017-311162DOI: 10.1136/heartjnl-2017-311162
Peripheral arterial disease amongst British ethnic minorities in a community based population: The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES) (Journal article)
Vitalis, A., Shantsila, A., Vohra, R. K., Kay, M., Bennett, P. C., Lip, G. Y. H., & Gill, P. S. (2017). Peripheral arterial disease amongst British ethnic minorities in a community based population: The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 71(7). doi:10.1111/ijcp.12977DOI: 10.1111/ijcp.12977
Renin-angiotensin blockade in atrial fibrillation: where are we now? (Journal article)
Shahid, F., Lip, G. Y. H., & Shantsila, E. (2017). Renin-angiotensin blockade in atrial fibrillation: where are we now?. JOURNAL OF HUMAN HYPERTENSION, 31(7), 425-426. doi:10.1038/jhh.2017.6DOI: 10.1038/jhh.2017.6
Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure (Journal article)
Nakanishi, K., Di Tullio, M. R., Qian, M., Thompson, J. L. P., Labovitz, A. J., Mann, D. L., . . . Homma, S. (2017). Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure. CEREBROVASCULAR DISEASES, 44(1-2), 43-50. doi:10.1159/000474958DOI: 10.1159/000474958
Risk Stratification Models in Atrial Fibrillation (Journal article)
Shahid, F., & Lip, G. Y. H. (2017). Risk Stratification Models in Atrial Fibrillation. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 43(5), 505-513. doi:10.1055/s-0036-1597285DOI: 10.1055/s-0036-1597285
Stroke prevention in atrial fibrillation: Past, present and future. (Journal article)
Lip, G. Y. H., Freedman, B., De Caterina, R., & Potpara, T. S. (2017). Stroke prevention in atrial fibrillation: Past, present and future.. Thrombosis and haemostasis, 117(7), 1230-1239. doi:10.1160/th16-11-0876DOI: 10.1160/th16-11-0876
Viewpoint: Stroke Prevention in Recent Guidelines for the Management of Patients with Atrial Fibrillation: An Appraisal (Journal article)
Potpara, T. S., Lip, G. Y. H., Blomstrom-Lundqvist, C., Chiang, C. -E., & Camm, A. J. (2017). Viewpoint: Stroke Prevention in Recent Guidelines for the Management of Patients with Atrial Fibrillation: An Appraisal. AMERICAN JOURNAL OF MEDICINE, 130(7), 773-779. doi:10.1016/j.amjmed.2017.02.026DOI: 10.1016/j.amjmed.2017.02.026
Ridger, V. C., Boulanger, C. M., Angelillo-Scherrer, A., Badimon, L., Blanc-Brude, O., Bochaton-Piallat, M. -L., . . . Harrison, P. (2017). Microvesicles in vascular homeostasis and diseases Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology. THROMBOSIS AND HAEMOSTASIS, 117(7), 1296-1316. doi:10.1160/TH16-12-0943DOI: 10.1160/TH16-12-0943
Stroke prevention in atrial fibrillation: Past, present and future Comparing the guidelines and practical decision-making (Journal article)
Lip, G. Y. H., Freedman, B., De Caterina, R., & Potpara, T. S. (2017). Stroke prevention in atrial fibrillation: Past, present and future Comparing the guidelines and practical decision-making. THROMBOSIS AND HAEMOSTASIS, 117(7), 1230-1239. doi:10.1160/TH16-11-0876DOI: 10.1160/TH16-11-0876
Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients (Journal article)
Rivera-Caravaca, J. M., Roldan, V., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Lip, G. Y. H., & Marin, F. (2017). Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. THROMBOSIS AND HAEMOSTASIS, 117(7), 1448-1454. doi:10.1160/TH16-12-0961DOI: 10.1160/TH16-12-0961
Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention? (Journal article)
Kuo, L., Chao, T. -F., Liu, C. -J., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2017). Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 6(6). doi:10.1161/JAHA.116.005307DOI: 10.1161/JAHA.116.005307
Granular shape memory ceramic packings (Journal article)
Yu, H. Z., Hassani-Gangaraj, M., Du, Z., Gan, C. L., & Schuh, C. A. (2017). Granular shape memory ceramic packings. Acta Materialia, 132, 455-466. doi:10.1016/j.actamat.2017.04.057DOI: 10.1016/j.actamat.2017.04.057
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis (Journal article)
Niessner, A., Tamargo, J., Morais, J., Koller, L., Wassmann, S., Husted, S. E., . . . Agewall, S. (2017). Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis. EUROPEAN HEART JOURNAL, 38(22), 1710-1U99. doi:10.1093/eurheartj/ehv676DOI: 10.1093/eurheartj/ehv676
Update in General Internal Medicine (vol 131, pg 199, 1999) (Journal article)
Lip, G. Y., Keshishian, A., Kamble, S., Pan, X., Mardekian, J., & Horblyuk, R. (2017). Update in General Internal Medicine (vol 131, pg 199, 1999). ANNALS OF INTERNAL MEDICINE, 166(11), 856. doi:10.7326/M17-0898DOI: 10.7326/M17-0898
Evaluating adherence to non-vitamin-K antagonist oral anticoagulants in post-approval observational studies of patients with atrial fibrillation (Journal article)
Potpara, T. S., Boriani, G., & Lip, G. Y. H. (2017). Evaluating adherence to non-vitamin-K antagonist oral anticoagulants in post-approval observational studies of patients with atrial fibrillation. CURRENT MEDICAL RESEARCH AND OPINION, 33(6), 1175-1177. doi:10.1080/03007995.2017.1313210DOI: 10.1080/03007995.2017.1313210
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice (Journal article)
Li, X., Deitelzweig, S., Keshishian, A., Hamilton, M., Horblyuk, R., Gupta, K., . . . Lip, G. Y. H. (2017). Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. THROMBOSIS AND HAEMOSTASIS, 117(6), 1072-1082. doi:10.1160/TH17-01-0068DOI: 10.1160/TH17-01-0068
Atrial Fibrillation and End Stage Renal Failure in Patients Receiving Dialysis: Balancing the Risks and Benefits of Stroke Prevention (Journal article)
Voukalis, C., & Lip, G. Y. H. (2017). Atrial Fibrillation and End Stage Renal Failure in Patients Receiving Dialysis: Balancing the Risks and Benefits of Stroke Prevention. CANADIAN JOURNAL OF CARDIOLOGY, 33(6), 705-707. doi:10.1016/j.cjca.2017.02.010DOI: 10.1016/j.cjca.2017.02.010
CHA<sub>2</sub>DS<sub>2</sub> - VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation A Korean Nationwide Sample Cohort Study (Journal article)
Kim, T. -H., Yang, P. -S., Uhm, J. -S., Kim, J. -Y., Pak, H. -N., Lee, M. -H., . . . Lip, G. Y. H. (2017). CHA<sub>2</sub>DS<sub>2</sub> - VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation A Korean Nationwide Sample Cohort Study. STROKE, 48(6), 1524-+. doi:10.1161/STROKEAHA.117.016926DOI: 10.1161/STROKEAHA.117.016926
Drug-induced liver injury with oral anticoagulants: a threat or not? (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2017). Drug-induced liver injury with oral anticoagulants: a threat or not?. HEART, 103(11), 809-811. doi:10.1136/heartjnl-2016-310983DOI: 10.1136/heartjnl-2016-310983
Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials (Journal article)
Proietti, M., & Lip, G. Y. H. (2017). Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 236, 244-248. doi:10.1016/j.ijcard.2017.02.127DOI: 10.1016/j.ijcard.2017.02.127
Hypertension and cardiac arrhythmias: a consensus document fromthe European Heart RhythmAssociation (EHRA) and ESC Council on Hypertension, endorsed by the Heart RhythmSociety (HRS), Asia-Pacific Heart RhythmSociety (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)
Lip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., . . . Field, M. (2017). Hypertension and cardiac arrhythmias: a consensus document fromthe European Heart RhythmAssociation (EHRA) and ESC Council on Hypertension, endorsed by the Heart RhythmSociety (HRS), Asia-Pacific Heart RhythmSociety (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPACE, 19(6), 891-911. doi:10.1093/europace/eux091DOI: 10.1093/europace/eux091
Impact of aerobic fitness on cerebral blood flow and cerebral vascular responsiveness to CO<sub>2</sub> in young and older men (Journal article)
Braz, I. D., Fluck, D., Lip, G. Y. H., Lundby, C., & Fisher, J. P. (2017). Impact of aerobic fitness on cerebral blood flow and cerebral vascular responsiveness to CO<sub>2</sub> in young and older men. SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 27(6), 634-642. doi:10.1111/sms.12674DOI: 10.1111/sms.12674
Malignant Hypertension Revisited-Does This Still Exist? (Journal article)
Shantsila, A., & Lip, G. Y. H. (2017). Malignant Hypertension Revisited-Does This Still Exist?. AMERICAN JOURNAL OF HYPERTENSION, 30(6), 543-549. doi:10.1093/ajh/hpx008DOI: 10.1093/ajh/hpx008
RIVAROXABAN VS. DABIGATRAN OR WARFARIN IN REAL-WORLD OBSERVATIONAL STUDIES OF STROKE PREVENTION IN ATRIAL FIBRILLATION: SYSTEMATIC REVIEW AND META-ANALYSIS (Conference Paper)
Bai, Y., Deng, H., Shantsila, A., & Lip, G. Y. H. (2017). RIVAROXABAN VS. DABIGATRAN OR WARFARIN IN REAL-WORLD OBSERVATIONAL STUDIES OF STROKE PREVENTION IN ATRIAL FIBRILLATION: SYSTEMATIC REVIEW AND META-ANALYSIS. In HEART Vol. 103 (pp. A36-A37). doi:10.1136/heartjnl-2017-311726.44DOI: 10.1136/heartjnl-2017-311726.44
Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis" (Journal article)
Bai, Y., Shantsila, A., & Lip, G. Y. H. (2017). Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis". STROKE, 48(6), E149. doi:10.1161/STROKEAHA.117.017460DOI: 10.1161/STROKEAHA.117.017460
Proietti, M., Airaksinen, K. E. J., Rubboli, A., Schlitt, A., Kiviniemi, T., Karjalainen, P. P., & Lip, G. Y. H. (2017). Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry. CLINICAL RESEARCH IN CARDIOLOGY, 106(6), 420-427. doi:10.1007/s00392-016-1071-0DOI: 10.1007/s00392-016-1071-0
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis (Journal article)
Halvorsen, S., Storey, R. F., Rocca, B., Sibbing, D., ten Berg, J., Grove, E. L., . . . Huber, K. (2017). Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. EUROPEAN HEART JOURNAL, 38(19), 1455-1462C. doi:10.1093/eurheartj/ehw454DOI: 10.1093/eurheartj/ehw454
Screening for Atrial Fibrillation A Report of the AF-SCREEN International Collaboration (Journal article)
Freedman, B., Camm, J., Calkins, H., Healey, J. S., Rosenqvist, M., Wang, J., . . . Yan, B. P. (2017). Screening for Atrial Fibrillation A Report of the AF-SCREEN International Collaboration. CIRCULATION, 135(19), 1851-+. doi:10.1161/CIRCULATIONAHA.116.026693DOI: 10.1161/CIRCULATIONAHA.116.026693
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. (Journal article)
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., . . . FOURIER Steering Committee and Investigators. (2017). Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.. The New England journal of medicine, 376(18), 1713-1722. doi:10.1056/nejmoa1615664DOI: 10.1056/nejmoa1615664
'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (Journal article)
Proietti, M., Laroche, C., Opolski, G., Maggioni, A. P., Boriani, G., & Lip, G. Y. H. (2017). 'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase. EUROPACE, 19(5), 722-733. doi:10.1093/europace/euw112DOI: 10.1093/europace/euw112
Death and thrombo-embolic risk after ablation of atrial flutter compared with atrial fibrillation: a nationwide cohort study (Journal article)
Vadmann, H., Gorst-Rasmussen, A., Hjortshoj, S. P., Riahi, S., Lip, G. Y. H., & Larsen, T. B. (2017). Death and thrombo-embolic risk after ablation of atrial flutter compared with atrial fibrillation: a nationwide cohort study. EUROPACE, 19(5), 838-842. doi:10.1093/europace/euw107DOI: 10.1093/europace/euw107
Does Reader Performance with Digital Breast Tomosynthesis Vary according to Experience with Two-dimensional Mammography? (Journal article)
Tucker, L., Gilbert, F. J., Astley, S. M., Dibden, A., Seth, A., Morel, J., . . . Stoner, K. (2017). Does Reader Performance with Digital Breast Tomosynthesis Vary according to Experience with Two-dimensional Mammography?. RADIOLOGY, 283(2), 371-380. doi:10.1148/radiol.2017151936DOI: 10.1148/radiol.2017151936
Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study (Journal article)
Larsen, T. B., Skjoth, F., Kjaeldgaard, J. N., Lip, G. Y. H., Nielsen, P. B., & Sogaard, M. (2017). Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study. LANCET HAEMATOLOGY, 4(5), E237-E244. doi:10.1016/S2352-3026(17)30054-6DOI: 10.1016/S2352-3026(17)30054-6
New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose (Journal article)
Rubboli, A., Agewall, S., Huber, K., & Lip, G. Y. H. (2017). New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 40, E11-E12. doi:10.1016/j.ejim.2017.01.003DOI: 10.1016/j.ejim.2017.01.003
Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study (Journal article)
Clarkesmith, D. E., Lip, G. Y. H., & Lane, D. A. (2017). Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study. THROMBOSIS RESEARCH, 153, 19-27. doi:10.1016/j.thromres.2017.03.002DOI: 10.1016/j.thromres.2017.03.002
Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care (Journal article)
Lane, D. A., Skjoth, F., Lip, G. Y. H., Larsen, T. B., & Kotecha, D. (2017). Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care. Journal of the American Heart Association, 6(5). doi:10.1161/JAHA.116.005155DOI: 10.1161/JAHA.116.005155
Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease (Journal article)
Heitmar, R., Lip, G. Y. H., Ryder, R. E., & Blann, A. D. (2017). Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease. CARDIOVASCULAR DIABETOLOGY, 16. doi:10.1186/s12933-017-0534-6DOI: 10.1186/s12933-017-0534-6
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. (Journal article)
Ridker, P. M., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., . . . SPIRE Cardiovascular Outcome Investigators. (2017). Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.. The New England journal of medicine, 376(16), 1527-1539. doi:10.1056/nejmoa1701488DOI: 10.1056/nejmoa1701488
Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review (vol 43, pg 849, 2017) (Journal article)
Bikdeli, B., Abou Ziki, M. D., & Lip, G. Y. H. (2017). Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review (vol 43, pg 849, 2017). SEMINARS IN THROMBOSIS AND HEMOSTASIS, 43(8), E1. doi:10.1055/s-0037-1602761DOI: 10.1055/s-0037-1602761
Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation - A Nationwide Cohort Study (Journal article)
Chao, T. -F., Liu, C. -J., Tuan, T. -C., Chen, S. -J., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2017). Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation - A Nationwide Cohort Study. SCIENTIFIC REPORTS, 7. doi:10.1038/srep46445DOI: 10.1038/srep46445
Guideline: ACP and AAFP recommend systolic BP targets based on history and risk level in adults ≥ 60 years of age (Journal article)
Shantsila, A., & Lip, G. Y. H. (2017). Guideline: ACP and AAFP recommend systolic BP targets based on history and risk level in adults ≥ 60 years of age. ANNALS OF INTERNAL MEDICINE, 166(8), JC38. doi:10.7326/ACPJC-2017-166-8-038DOI: 10.7326/ACPJC-2017-166-8-038
Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry) (Journal article)
Abe, M., Ogawa, H., Ishii, M., Masunaga, N., Esato, M., Chun, Y. -H., . . . Akao, M. (2017). Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry). AMERICAN JOURNAL OF CARDIOLOGY, 119(8), 1229-1237. doi:10.1016/j.amjcard.2017.01.005DOI: 10.1016/j.amjcard.2017.01.005
Ethnic differences in the prevalence of peripheral arterial disease: a systematic review and meta-analysis (Journal article)
Vitalis, A., Lip, G. Y. H., Kay, M., Vohra, R. K., & Shantsil, A. (2017). Ethnic differences in the prevalence of peripheral arterial disease: a systematic review and meta-analysis. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 15(4), 327-338. doi:10.1080/14779072.2017.1305890DOI: 10.1080/14779072.2017.1305890
'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (vol 19, pg 722, 2017) (Journal article)
Proietti, M., Laroche, C., Opolski, G., Maggioni, A. P., Boriani, G., & Lip, G. Y. H. (2017). 'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (vol 19, pg 722, 2017). EUROPACE, 19(4), 543. doi:10.1093/europace/euw443DOI: 10.1093/europace/euw443
Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2017). Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries. EBIOMEDICINE, 18, 199-203. doi:10.1016/j.ebiom.2017.03.022DOI: 10.1016/j.ebiom.2017.03.022
Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami (Journal article)
Cerasuolo, J. O., Montero-Odasso, M., Ibanez, A., Doocy, S., Lip, G. Y. H., & Sposato, L. A. (2017). Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami. INTERNATIONAL JOURNAL OF STROKE, 12(3), 222-228. doi:10.1177/1747493016687579DOI: 10.1177/1747493016687579
Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project (Journal article)
Li, W. -H., Huang, D., Chiang, C. -E., Lau, C. -P., Tse, H. -F., Chan, E. W., . . . Siu, C. -W. (2017). Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project. CLINICAL CARDIOLOGY, 40(4), 222-229. doi:10.1002/clc.22649DOI: 10.1002/clc.22649
Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the "Real World" (Journal article)
Mazurek, M., & Lip, G. Y. H. (2017). Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the "Real World". GASTROENTEROLOGY, 152(5), 932-934. doi:10.1053/j.gastro.2017.02.027DOI: 10.1053/j.gastro.2017.02.027
Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials (Journal article)
Proietti, M., Guiducci, E., Cheli, P., & Lip, G. Y. H. (2017). Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials. STROKE, 48(4), 857-866. doi:10.1161/STROKEAHA.116.015984DOI: 10.1161/STROKEAHA.116.015984
Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation (Journal article)
Nielsen, P. B., Larsen, T. B., Skjoth, F., & Lip, G. Y. H. (2017). Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation. JAMA INTERNAL MEDICINE, 177(4), 563-570. doi:10.1001/jamainternmed.2016.9369DOI: 10.1001/jamainternmed.2016.9369
Bai, Y., Deng, H., Shantsila, A., & Lip, G. Y. H. (2017). Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation. Stroke, 48(4), 970-976. doi:10.1161/STROKEAHA.116.016275DOI: 10.1161/STROKEAHA.116.016275
Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry (Journal article)
Proietti, M., Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., . . . Lip, G. Y. H. (2017). Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. EUROPACE, 19(4), 535-543. doi:10.1093/europace/euw150DOI: 10.1093/europace/euw150
Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation (Journal article)
Lau, W. C. Y., Chan, E. W., Cheung, C. -L., Sing, C. W., Man, K. K. C., Lip, G. Y. H., . . . Wong, I. C. K. (2017). Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 317(11), 1151-1158. doi:10.1001/jama.2017.1363DOI: 10.1001/jama.2017.1363
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1 (Journal article)
Diener, H. -C., Aisenberg, J., Ansell, J., Atar, D., Breithardt, G., Eikelboom, J., . . . Lip, G. Y. H. (2017). Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. EUROPEAN HEART JOURNAL, 38(12), 852-859B. doi:10.1093/eurheartj/ehv643DOI: 10.1093/eurheartj/ehv643
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2 (Journal article)
Diener, H. -C., Aisenberg, J., Ansell, J., Atar, D., Breithardt, G., Eikelboom, J., . . . Lip, G. Y. H. (2017). Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. EUROPEAN HEART JOURNAL, 38(12), 860-868. doi:10.1093/eurheartj/ehw069DOI: 10.1093/eurheartj/ehw069
Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark (Journal article)
Gadsboll, K., Staerk, L., Fosbol, E. L., Sindet-Pedersen, C., Gundlund, A., Lip, G. Y. H., . . . Olesen, J. B. (2017). Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark. EUROPEAN HEART JOURNAL, 38(12), 899-906. doi:10.1093/eurheartj/ehw658DOI: 10.1093/eurheartj/ehw658
Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study (Journal article)
Staerk, L., Fosbol, E. L., Lip, G. Y. H., Lamberts, M., Bonde, A. N., Torp-Pedersen, C., . . . Olesen, J. B. (2017). Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study. EUROPEAN HEART JOURNAL, 38(12), 907-915. doi:10.1093/eurheartj/ehw496DOI: 10.1093/eurheartj/ehw496
Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2017). Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 317(11), 1115-1116. doi:10.1001/jama.2017.1152DOI: 10.1001/jama.2017.1152
Carotid plaque detection improves the predictive value of CHA<sub>2</sub>DS<sub>2</sub>-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study (Journal article)
Basili, S., Loffredo, L., Pastori, D., Proietti, M., Farcomeni, A., Vestri, A. R., . . . Violi, F. (2017). Carotid plaque detection improves the predictive value of CHA<sub>2</sub>DS<sub>2</sub>-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 231, 143-149. doi:10.1016/j.ijcard.2017.01.001DOI: 10.1016/j.ijcard.2017.01.001
Atrial Fibrillation in the Elderly (Chapter)
Fumagalli, S., Gabbai, D., Padeletti, L., Crijns, H. J., & Lip, G. Y. H. (2017). Atrial Fibrillation in the Elderly. In Cardiac Management in the Frail Elderly Patient and the Oldest Old (pp. 149-163). Springer International Publishing. doi:10.1007/978-3-319-43468-1_12DOI: 10.1007/978-3-319-43468-1_12
REPLY: Apixaban Dosing in Chronic Kidney Disease Differences Between US and EU Labeling (Journal article)
Proietti, M., & Lip, G. Y. H. (2017). REPLY: Apixaban Dosing in Chronic Kidney Disease Differences Between US and EU Labeling. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(9), 1212. doi:10.1016/j.jacc.2016.11.075DOI: 10.1016/j.jacc.2016.11.075
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials (Journal article)
Abdul-Rahim, A. H., Perez, A. -C., MacIsaac, R. L., Jhund, P. S., Claggett, B. L., Carson, P. E., . . . McMurray, J. J. V. (2017). Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials. EUROPEAN HEART JOURNAL, 38(10), 742-750. doi:10.1093/eurheartj/ehw509DOI: 10.1093/eurheartj/ehw509
Applicability of the modified CHA<sub>2</sub>DS<sub>2</sub>-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients (Journal article)
Garcia-Fernandez, A., Roldan, V., Rivera-Caravaca, J. M., Lip, G. Y. H., & Marin, F. (2017). Applicability of the modified CHA<sub>2</sub>DS<sub>2</sub>-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 38, E21-E22. doi:10.1016/j.ejim.2016.11.006DOI: 10.1016/j.ejim.2016.11.006
Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differences (Journal article)
Proietti, M., Cheli, P., Basili, S., Mazureka, M., & Lip, G. Y. H. (2017). Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differences. PHARMACOLOGICAL RESEARCH, 117, 274-282. doi:10.1016/j.phrs.2017.01.004DOI: 10.1016/j.phrs.2017.01.004
Current Understanding of Atherogenesis (Journal article)
Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2017). Current Understanding of Atherogenesis. AMERICAN JOURNAL OF MEDICINE, 130(3), 268-282. doi:10.1016/j.amjmed.2016.10.022DOI: 10.1016/j.amjmed.2016.10.022
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (Journal article)
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jais, P., Josephson, M. E., . . . Rickard, J. (2017). European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). EUROPACE, 19(3), 465-511. doi:10.1093/europace/euw301DOI: 10.1093/europace/euw301
INCIDENT ATRIAL FIBRILLATION ACCORDING TO GENDER IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY (Conference Paper)
Fauchier, L., Bisson, A., Angoulvant, D., Clementy, N., Babuty, D., & Lip, G. (2017). INCIDENT ATRIAL FIBRILLATION ACCORDING TO GENDER IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 367). doi:10.1016/S0735-1097(17)33756-7DOI: 10.1016/S0735-1097(17)33756-7
INCREASED RATE OF PREVIOUS STROKE IN ASYMPTOMATIC/MINIMALLY SYMPTOMATIC VERSUS SYMPTOMATIC PATIENTS WITH NEWLY DETECTED ATRIAL FIBRILLATION WORLDWIDE: RESULTS FROM THE GLORIA-AF REGISTRY (Conference Paper)
Christow, S., Seidl, K., Diener, H. -C., Huisman, M., Lip, G., Rauch-Kroenert, U., . . . Senges, J. (2017). INCREASED RATE OF PREVIOUS STROKE IN ASYMPTOMATIC/MINIMALLY SYMPTOMATIC VERSUS SYMPTOMATIC PATIENTS WITH NEWLY DETECTED ATRIAL FIBRILLATION WORLDWIDE: RESULTS FROM THE GLORIA-AF REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 450). doi:10.1016/S0735-1097(17)33839-1DOI: 10.1016/S0735-1097(17)33839-1
PERSISTENCE WITH THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY (Conference Paper)
Paquette, M., Huisman, M., Lip, G., Diener, H. -C., Dubner, S., Halperin, J., . . . Nieuwlaat, R. (2017). PERSISTENCE WITH THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 374). doi:10.1016/S0735-1097(17)33763-4DOI: 10.1016/S0735-1097(17)33763-4
PREDICTORS OF ANTICOAGULANT PRESCRIPTION IN PATIENTS WITH ATRIAL FIBRILLATION IN NORTH AMERICA: THE GLORIA-AF REGISTRY (Conference Paper)
McIntyre, W. F., Conen, D., Olshansky, B., Halperin, J., Hayek, E., Huisman, M., . . . Healey, J. (2017). PREDICTORS OF ANTICOAGULANT PRESCRIPTION IN PATIENTS WITH ATRIAL FIBRILLATION IN NORTH AMERICA: THE GLORIA-AF REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 413). doi:10.1016/S0735-1097(17)33802-0DOI: 10.1016/S0735-1097(17)33802-0
PREDICTORS OF INCIDENT ATRIAL FIBRILLATION IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY (Conference Paper)
Fauchier, L., Bisson, A., Angoulvant, D., Clementy, N., Babuty, D., & Lip, G. (2017). PREDICTORS OF INCIDENT ATRIAL FIBRILLATION IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 328). doi:10.1016/S0735-1097(17)33717-8DOI: 10.1016/S0735-1097(17)33717-8
Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score) (Journal article)
Jaakkola, S., Lip, G. Y. H., Biancari, F., Nuotio, I., Hartikainen, J. E. K., Ylitalo, A., & Airaksinen, K. E. J. (2017). Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score). AMERICAN JOURNAL OF CARDIOLOGY, 119(5), 749-752. doi:10.1016/j.amjcard.2016.11.026DOI: 10.1016/j.amjcard.2016.11.026
Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study (Journal article)
Fauchier, L., Clementy, N., Bisson, A., Stamboul, K., Ivanes, F., Angoulvant, D., . . . Lip, G. Y. H. (2017). Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study. CLINICAL RESEARCH IN CARDIOLOGY, 106(3), 202-210. doi:10.1007/s00392-016-1040-7DOI: 10.1007/s00392-016-1040-7
RATES OF STROKE AND BLEEDING WITH DABIGATRAN 150 AND 110 MG BID IN CLINICAL PRACTICE: THE GLORIA-AF REGISTRY (Conference Paper)
Lip, G., Huisman, M., Diener, H. -C., Dubner, S., Ma, C., Rothman, K., . . . Halperin, J. (2017). RATES OF STROKE AND BLEEDING WITH DABIGATRAN 150 AND 110 MG BID IN CLINICAL PRACTICE: THE GLORIA-AF REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 541). doi:10.1016/S0735-1097(17)33930-XDOI: 10.1016/S0735-1097(17)33930-X
Renal dysfunction and diastolic impairment among British ethnic minorities with hypertension: the Ethnic-Echocardiographic Heart of England Screening Study (Journal article)
Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2017). Renal dysfunction and diastolic impairment among British ethnic minorities with hypertension: the Ethnic-Echocardiographic Heart of England Screening Study. JOURNAL OF HUMAN HYPERTENSION, 31(3), 206-211. doi:10.1038/jhh.2016.68DOI: 10.1038/jhh.2016.68
The wearable cardioverter-defibrillator: current technology and evolving indications. (Journal article)
Reek, S., Burri, H., Roberts, P. R., Perings, C., Epstein, A. E., Klein, H. U., . . . Savelieva, I. (2017). The wearable cardioverter-defibrillator: current technology and evolving indications.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 19(3), 335-345. doi:10.1093/europace/euw180DOI: 10.1093/europace/euw180
High-Density 3D-Boron Nitride and 3D-Graphene for High-Performance Nano-Thermal Interface Material. (Journal article)
Loeblein, M., Tsang, S. H., Pawlik, M., Phua, E. J. R., Yong, H., Zhang, X. W., . . . Teo, E. H. T. (2017). High-Density 3D-Boron Nitride and 3D-Graphene for High-Performance Nano-Thermal Interface Material.. ACS nano, 11(2), 2033-2044. doi:10.1021/acsnano.6b08218DOI: 10.1021/acsnano.6b08218
Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (vol 6, 30271, 2016) (Journal article)
Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Petrescu, L., . . . Lip, G. Y. H. (2017). Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (vol 6, 30271, 2016). SCIENTIFIC REPORTS, 7. doi:10.1038/srep42379DOI: 10.1038/srep42379
A halogen-free epoxy with intrinsic flame retardance for use in electronic packaging (Conference Paper)
Lim, S. K. J., Phua, J. R. E., Bai, Y., Hu, X., & Gan, C. L. (2016). A halogen-free epoxy with intrinsic flame retardance for use in electronic packaging. In 2016 IEEE 18th Electronics Packaging Technology Conference (EPTC). IEEE. doi:10.1109/eptc.2016.7861500DOI: 10.1109/eptc.2016.7861500
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2 (Journal article)
Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. -C., Dubner, S. J., . . . Investigators, G. L. O. R. I. A. -A. F. (2017). The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(7), 777-785. doi:10.1016/j.jacc.2016.11.061DOI: 10.1016/j.jacc.2016.11.061
Effect of Reduced Renal Function on Time in Therapeutic Range Among Anticoagulated Atrial Fibrillation Patients (Journal article)
Bonde, A. N., Lip, G. Y. H., Kamper, A. -L., Staerk, L., Torp-Pedersen, C., Gislason, G. H., & Olesen, J. B. (2017). Effect of Reduced Renal Function on Time in Therapeutic Range Among Anticoagulated Atrial Fibrillation Patients. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(6), 752-753. doi:10.1016/j.jacc.2016.11.031DOI: 10.1016/j.jacc.2016.11.031
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study (Journal article)
Nielsen, P. B., Skjoth, F., Sogaard, M., Kjaeldgaard, J. N., Lip, G. Y. H., & Larsen, T. B. (2017). Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ-BRITISH MEDICAL JOURNAL, 356. doi:10.1136/bmj.j510DOI: 10.1136/bmj.j510
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. (Journal article)
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., . . . Cooney, M. -T. (2017). 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.. Revista espanola de cardiologia (English ed.), 70(2), 115. doi:10.1016/j.rec.2017.01.002DOI: 10.1016/j.rec.2017.01.002
Atrial high-rate episodes and stroke prevention (Journal article)
Camm, A. J., Simantirakis, E., Goette, A., Lip, G. Y. H., Vardas, P., Calvert, M., . . . Kirchhof, P. (2017). Atrial high-rate episodes and stroke prevention. EUROPACE, 19(2), 169-179. doi:10.1093/europace/euw279DOI: 10.1093/europace/euw279
Cerebrovascular disease, associated risk factors and antithrombotic therapy in a population screening cohort: Insights from the Belgian Heart Rhythm Week programme (Journal article)
Proietti, M., Mairesse, G. H., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Lip, G. Y. H. (2017). Cerebrovascular disease, associated risk factors and antithrombotic therapy in a population screening cohort: Insights from the Belgian Heart Rhythm Week programme. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 24(3), 328-334. doi:10.1177/2047487316682349DOI: 10.1177/2047487316682349
Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor (Journal article)
Potpara, T. S., Dagres, N., Mujovic, N., Vasic, D., Asanin, M., Nedeljkovic, M., . . . Lip, G. Y. H. (2017). Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor. ADVANCES IN THERAPY, 34(2), 357-377. doi:10.1007/s12325-016-0458-7DOI: 10.1007/s12325-016-0458-7
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (Journal article)
Gorenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J., Fogel, R. I., . . . Abreu, A. (2017). European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). EUROPACE, 19(2), 190-225. doi:10.1093/europace/euw242DOI: 10.1093/europace/euw242
Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis (Journal article)
Adlan, A. M., Paton, J. F. R., Lip, G. Y. H., Kitas, G. D., & Fisher, J. P. (2017). Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis. JOURNAL OF PHYSIOLOGY-LONDON, 595(3), 967-981. doi:10.1113/JP272944DOI: 10.1113/JP272944
Ischemic stroke risk in East Asian patients with CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 1: systematic review and meta-analysis (Journal article)
Bai, Y., Shantsila, A., & Lip, G. Y. H. (2017). Ischemic stroke risk in East Asian patients with CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 1: systematic review and meta-analysis. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 15(2), 145-150. doi:10.1080/14779072.2017.1281742DOI: 10.1080/14779072.2017.1281742
Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice (Journal article)
Mazurek, M., Huisman, M. V., & Lip, G. Y. H. (2017). Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice. AMERICAN JOURNAL OF MEDICINE, 130(2), 135-145. doi:10.1016/j.amjmed.2016.09.012DOI: 10.1016/j.amjmed.2016.09.012
White Matter Hyperintensities Improve Ischemic Stroke Recurrence Prediction (Journal article)
Andersen, S. D., Larsen, T. B., Gorst-Rasmussen, A., Yavarian, Y., Lip, G. Y. H., & Bach, F. W. (2017). White Matter Hyperintensities Improve Ischemic Stroke Recurrence Prediction. CEREBROVASCULAR DISEASES, 43(1-2), 17-24. doi:10.1159/000450962DOI: 10.1159/000450962
Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation? (Journal article)
Garcia-Fernandez, A., Roldan, V., Rivera-Caravaca, J. M., Hernandez-Romero, D., Valdes, M., Vicente, V., . . . Marin, F. (2017). Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?. SCIENTIFIC REPORTS, 7. doi:10.1038/srep41565DOI: 10.1038/srep41565
Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants (Journal article)
Raparelli, V., Proietti, M., Cangemi, R., Lip, G. Y. H., Lane, D. A., & Basili, S. (2017). Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants. THROMBOSIS AND HAEMOSTASIS, 117(2), 209-218. doi:10.1160/TH16-10-0757DOI: 10.1160/TH16-10-0757
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy (Journal article)
Gibson, C. M., Pinto, D. S., Chi, G., Arbetter, D., Yee, M., Mehran, R., . . . Fox, K. A. A. (2017). Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy. CIRCULATION, 135(4), 323-+. doi:10.1161/CIRCULATIONAHA.116.025783DOI: 10.1161/CIRCULATIONAHA.116.025783
Hypertension and cardiac arrhythmias (Journal article)
Lip, G. Y. H., & Coca, A. (2017). Hypertension and cardiac arrhythmias. EUROPEAN HEART JOURNAL, 38(4), 223-225. doi:10.1093/eurheartj/ehw664DOI: 10.1093/eurheartj/ehw664
Prediction of very late arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation: The MB-LATER clinical score (Journal article)
Mujovic, N., Marinkovic, M., Markovic, N., Shantsila, A., Lip, G. Y. H., & Potpara, T. S. (2017). Prediction of very late arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation: The MB-LATER clinical score. SCIENTIFIC REPORTS, 7. doi:10.1038/srep40828DOI: 10.1038/srep40828
Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation (Journal article)
Nielsen, P. B., & Lip, G. Y. H. (2017). Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation. CIRCULATION, 135(3), 220-223. doi:10.1161/CIRCULATIONAHA.116.025944DOI: 10.1161/CIRCULATIONAHA.116.025944
Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study (Journal article)
Nayarese, E. P., Kolodziejczak, M., Winter, M. -P., Alimohammadi, A., Lang, I. M., Buffon, A., . . . Siller-Matula, J. M. (2017). Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 227, 644-649. doi:10.1016/j.ijcard.2016.10.084DOI: 10.1016/j.ijcard.2016.10.084
Superelasticity in micro-scale shape memory ceramic particles (Journal article)
Du, Z., Zeng, X. M., Liu, Q., Schuh, C. A., & Gan, C. L. (2017). Superelasticity in micro-scale shape memory ceramic particles. Acta Materialia, 123, 255-263. doi:10.1016/j.actamat.2016.10.047DOI: 10.1016/j.actamat.2016.10.047
To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation (Journal article)
Mazurek, M., & Lip, G. Y. H. (2017). To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation. HEART, 103(2), 93-95. doi:10.1136/heartjnl-2016-310255DOI: 10.1136/heartjnl-2016-310255
Novel Risk Markers and Risk Assessments for Cardiovascular Disease (Journal article)
Thomas, M. R., & Lip, G. Y. H. (2017). Novel Risk Markers and Risk Assessments for Cardiovascular Disease. CIRCULATION RESEARCH, 120(1), 133-149. doi:10.1161/CIRCRESAHA.116.309955DOI: 10.1161/CIRCRESAHA.116.309955
A happy and prosperous New Year 2017 with "Thrombosis and Haemostasis".... and our 60th Anniversary! (Journal article)
Lip, G. Y. H., & Weber, C. (2017). A happy and prosperous New Year 2017 with "Thrombosis and Haemostasis".... and our 60th Anniversary!. THROMBOSIS AND HAEMOSTASIS, 117(1), 1-2. doi:10.1160/TH16-12-0903DOI: 10.1160/TH16-12-0903
Editors' Choice 2016 papers in Thrombosis and Haemostasis (Journal article)
Weber, C., & Lip, G. Y. H. (2017). Editors' Choice 2016 papers in Thrombosis and Haemostasis. THROMBOSIS AND HAEMOSTASIS, 117(1), 204-206. doi:10.1160/TH16-11-0899DOI: 10.1160/TH16-11-0899
2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. (Journal article)
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., . . . Vardas, P. (2017). 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS.. Revista espanola de cardiologia (English ed.), 70(1), 50. doi:10.1016/j.rec.2016.11.033DOI: 10.1016/j.rec.2016.11.033
2016 ESC POSITION PAPER ON CANCER TREATMENTS AND CARDIOVASCULAR TOXICITY DEVELOPED UNDER THE AUSPICES OF THE ESC COMMITTEE FOR PRACTICE GUIDELINES (Journal article)
Article, E. (n.d.). 2016 ESC POSITION PAPER ON CANCER TREATMENTS AND CARDIOVASCULAR TOXICITY DEVELOPED UNDER THE AUSPICES OF THE ESC COMMITTEE FOR PRACTICE GUIDELINES. Russian Journal of Cardiology, (3), 105-139. doi:10.15829/1560-4071-2017-3-105-139DOI: 10.15829/1560-4071-2017-3-105-139
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) (Journal article)
Luis Zamorano, J., Lancellotti, P., Rodriguez Munoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., . . . Ringwald, J. (2017). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). EUROPEAN JOURNAL OF HEART FAILURE, 19(1), 9-42. doi:10.1002/ejhf.654DOI: 10.1002/ejhf.654
Anticoagulation control in different ethnic-minority patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west Birmingham AF Project (Conference Paper)
Zulkifly, H., Cheli, P., Lutchman, I., Bai, Y., Lip, G. Y. H., & Lane, D. A. (2017). Anticoagulation control in different ethnic-minority patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west Birmingham AF Project. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 770-771). Retrieved from https://www.webofscience.com/
Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting. (Journal article)
Dzeshka, M. S., Brown, R. A., Capodanno, D., & Lip, G. Y. H. (2017). Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting.. Interventional cardiology clinics, 6(1), 91-117. doi:10.1016/j.iccl.2016.08.007DOI: 10.1016/j.iccl.2016.08.007
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)
Lip, G. Y. H., Collet, J. P., de Caterina, R., Fauchier, L., Lane, D. A., Larsen, T. B., . . . Rocca, B. (2017). Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). THROMBOSIS AND HAEMOSTASIS, 117(12), 2215-2236. doi:10.1160/TH-17-10-0709DOI: 10.1160/TH-17-10-0709
Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial (Journal article)
Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Shantsila, A., Roldan, V., Lip, G. Y. H., & Marin, F. (2017). Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial. THROMBOSIS AND HAEMOSTASIS, 117(12), 2261-2266. doi:10.1160/TH17-10-0710DOI: 10.1160/TH17-10-0710
Atherothrombotic strokes in NVAF Reply (Journal article)
Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2017). Atherothrombotic strokes in NVAF Reply. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 47(2), 205-206. Retrieved from https://www.webofscience.com/
Atrial Fibrillation (Chapter)
Kotecha, D., Senoo, K., & Lip, G. Y. H. (2017). Atrial Fibrillation. In Hematology: Basic Principles and Practice (pp. 2152-2158). doi:10.1016/B978-0-323-35762-3.00147-5DOI: 10.1016/B978-0-323-35762-3.00147-5
Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke (Journal article)
Lip, G. Y. H., Hunter, T. D., Quiroz, M. E., Ziegler, P. D., & Turakhia, M. P. (2017). Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 10(1). doi:10.1161/CIRCOUTCOMES.116.002864DOI: 10.1161/CIRCOUTCOMES.116.002864
CLINICAL PORTRAIT OF THE ATRIAL FIBRILLATION PATIENT IN Russian FEDERATION. DATA FROM THE GLOBAL REGISTRY Gloria AF (Journal article)
Shlyakhto, E. V., Ezhov, А. V., Zenin, S. А., Koziolova, N. А., Korennova, О. Y., Novikova, Т. N., . . . Rothman, K. J. (n.d.). CLINICAL PORTRAIT OF THE ATRIAL FIBRILLATION PATIENT IN Russian FEDERATION. DATA FROM THE GLOBAL REGISTRY Gloria AF. Russian Journal of Cardiology, (9), 21-27. doi:10.15829/1560-4071-2017-9-21-27DOI: 10.15829/1560-4071-2017-9-21-27
Cerebrovascular Reactivity in Atrial Fibrillation (Conference Paper)
Fisher, J. P., Braz, I. D., Lucas, S. J. E., Edwards, L., Van Lieshout, J. J., & Lip, G. Y. H. (2017). Cerebrovascular Reactivity in Atrial Fibrillation. In FASEB JOURNAL Vol. 31. Retrieved from https://www.webofscience.com/
Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry (Conference Paper)
Proietti, M., Bouvet, P. E., Laroche, C., Nieuwlaat, R., Crijns, H. J. G. M., Maggioni, A. P., . . . Lip, G. Y. H. (2017). Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1220-1221). Retrieved from https://www.webofscience.com/
Characterization of Access vs. Non-Access Site Bleeding Following PCI in Patients With Atrial Fibrillation (Conference Paper)
Nafee, T., Chi, G., Yee, M. K., Arbetter, D., Pinto, D. S., Mehran, R., . . . Gibson, C. M. (2017). Characterization of Access vs. Non-Access Site Bleeding Following PCI in Patients With Atrial Fibrillation. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study (Journal article)
Begg, G. A., Lip, G. Y. H., Plein, S., & Tayebjee, M. H. (2017). Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study. CLINICAL BIOCHEMISTRY, 50(1-2), 11-15. doi:10.1016/j.clinbiochem.2016.09.008DOI: 10.1016/j.clinbiochem.2016.09.008
Clinical predictors of left atrium thrombi in patients scheduled for cardioversion of atrial fibrillation: a subanalysis from the ENSURE-AF study (Conference Paper)
Merino, J. L., Lip, G. Y. H., Heidbuchel, H., Cohen, A. -A., De Caterina, R., De Groot, J. R., . . . Goette, A. (2017). Clinical predictors of left atrium thrombi in patients scheduled for cardioversion of atrial fibrillation: a subanalysis from the ENSURE-AF study. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1367-1368). Retrieved from https://www.webofscience.com/
Cost-effectiveness analysis of a handheld ECG machine used for a population-wide screening programme: the Belgian Heart Rhythm Week Screening programme (Conference Paper)
Proietti, M., Farcomeni, A., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Lip, G. Y. H. (2017). Cost-effectiveness analysis of a handheld ECG machine used for a population-wide screening programme: the Belgian Heart Rhythm Week Screening programme. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 973-974). Retrieved from https://www.webofscience.com/
Dynamic CHA2DS2-VASc score and risk of ischemic stroke in patients with atrial fibrillation (Conference Paper)
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2017). Dynamic CHA2DS2-VASc score and risk of ischemic stroke in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 774). Retrieved from https://www.webofscience.com/
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication (Journal article)
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Angel Cabrera, J., Chen, S. A., . . . Nattel, S. (2017). EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. HEART RHYTHM, 14(1), E3-E40. doi:10.1016/j.hrthm.2016.05.028DOI: 10.1016/j.hrthm.2016.05.028
Effect of procedure and lesion characteristics on bleeding and ischemic outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: results from the PIONEER AF-PCI trial (Conference Paper)
Chi, G., Korjian, S., Daaboul, Y., Nafee, T., Mehran, R., Bode, C., . . . Gibson, C. M. (2017). Effect of procedure and lesion characteristics on bleeding and ischemic outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: results from the PIONEER AF-PCI trial. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1290). Retrieved from https://www.webofscience.com/
Effectiveness and Safety of Apixaban Compared to Other Oral Anticoagulants Among Non-Valvular Atrial Fibrillation Patients With Coronary Artery Disease or Peripheral Arterial Disease: A Propensity Score Matched Analysis of Four Large Databases (Conference Paper)
Lip, G. Y., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Gupta, K., . . . Deitelzweig, S. (2017). Effectiveness and Safety of Apixaban Compared to Other Oral Anticoagulants Among Non-Valvular Atrial Fibrillation Patients With Coronary Artery Disease or Peripheral Arterial Disease: A Propensity Score Matched Analysis of Four Large Databases. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Among Non-Valvular Atrial Fibrillation Patients: A Propensity Score Matched Analysis of Four Large Databases (Conference Paper)
Deitelzweig, S., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Gupta, K., . . . Lip, G. Y. (2017). Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Among Non-Valvular Atrial Fibrillation Patients: A Propensity Score Matched Analysis of Four Large Databases. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Effectiveness and safety of apixaban versus warfarin among high-risk subgroups of non-valvular atrial fibrillation patients: a propensity score matched analysis (Conference Paper)
Li, X., Deitelzweig, S., Keshishian, A., Hamilton, M., Horblyuk, R., Gupta, K., . . . Lip, G. Y. H. (2017). Effectiveness and safety of apixaban versus warfarin among high-risk subgroups of non-valvular atrial fibrillation patients: a propensity score matched analysis. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 767). Retrieved from https://www.webofscience.com/
Effectiveness and safety of standard and lower dose apixaban compared to warfarin in non-valvular atrial fibrillation patients: a propensity score matched analysis (Conference Paper)
Li, X., Lip, G. Y. H., Keshishian, A., Hamilton, M., Horblyuk, R., Gupta, K., . . . Deitelzweig, S. (2017). Effectiveness and safety of standard and lower dose apixaban compared to warfarin in non-valvular atrial fibrillation patients: a propensity score matched analysis. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 772). Retrieved from https://www.webofscience.com/
Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis (Conference Paper)
Awad, K., Serban, M. G., Penson, P., Mikhailidis, D. P., Toth, P. P., Jones, S. R., . . . Banach, M. (2017). Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 642-643). Retrieved from https://www.webofscience.com/
Efficacy and safety of alternate-day versus daily dosing of statins: a systematic review and meta-analysis (Conference Paper)
Awad, K., Mikhailidis, D. P., Toth, P. P., Jones, S. R., Moriarty, P., Lip, G. Y. H., . . . Banach, M. (2017). Efficacy and safety of alternate-day versus daily dosing of statins: a systematic review and meta-analysis. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 12). Retrieved from https://www.webofscience.com/
Epidemiological Trends in Atrial Fibrillation in Europe: The EURObservational Research Programme in Atrial Fibrillation Pilot and Long-Term Registries and Euro Heart Survey on Atrial Fibrillation (Conference Paper)
Proietti, M., Laroche, C., Nieuwlaat, R., Crijns, H. J., Maggioni, A., Lane, D. A., . . . Lip, G. Y. (2017). Epidemiological Trends in Atrial Fibrillation in Europe: The EURObservational Research Programme in Atrial Fibrillation Pilot and Long-Term Registries and Euro Heart Survey on Atrial Fibrillation. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (Journal article)
Gorenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J., Fogel, R. I., . . . Abreu, A. (2017). European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 24(1), 4-40. doi:10.1177/2047487316676037DOI: 10.1177/2047487316676037
Evaluation of ABC-stroke and CHA2DS2-VASc ischemic scores in real-world atrial fibrillation patients receiving oral anticoagulation treatment (Conference Paper)
Rivera-Caravaca, J. M., Roldan, V., Esteve Pastor, M. A., Valdes, M., Vicente, V., Lip, G. Y. H., & Marin, F. (2017). Evaluation of ABC-stroke and CHA2DS2-VASc ischemic scores in real-world atrial fibrillation patients receiving oral anticoagulation treatment. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1233). Retrieved from https://www.webofscience.com/
Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc (Conference Paper)
Nielsen, P. B., Skjoeth, F., Overvad, T. F., Larsen, T. B., & Lip, G. Y. H. (2017). Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1220). Retrieved from https://www.webofscience.com/
Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS (Journal article)
Agewall, S., Camm, J., Barón Esquivias, G., Budts, W., Carerj, S., Casselman, F., . . . Vardas, P. (2017). Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS. Revista Española de Cardiología, 70(1), 50.e1-50.e84. doi:10.1016/j.recesp.2016.11.014DOI: 10.1016/j.recesp.2016.11.014
HEALTH CARE COST IN PATIENTS UNDERGOING ELECTRICAL CARDIOVERSION: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY (Conference Paper)
Barrrios, R. J., Goette, A., Kwong, J., Ezekowitz, M. D., Banach, M. S., Hjortshen, S. P., . . . Lip, G. (2017). HEALTH CARE COST IN PATIENTS UNDERGOING ELECTRICAL CARDIOVERSION: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY. In VALUE IN HEALTH Vol. 20 (pp. A608). Retrieved from https://www.webofscience.com/
Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial (Conference Paper)
Goette, A., de Groot, J. R., Le Heuzey, J. -Y., Banach, M., Huber, K., Jin, J., . . . Lip, G. (2017). Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Impact of atrial fibrillation on quality of life and clinical outcomes: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry (Conference Paper)
Proietti, M., Lane, D. A., Laroche, C., Maggioni, A. P., Boriani, G., & Lip, G. Y. H. (2017). Impact of atrial fibrillation on quality of life and clinical outcomes: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1233). Retrieved from https://www.webofscience.com/
Increased evidence of left ventricular myocardial fibrosis in patients with paroxysmal atrial fibrillation and sinus node dysfunction (Conference Paper)
Dzeshka, M. S., Appadoo, K., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2017). Increased evidence of left ventricular myocardial fibrosis in patients with paroxysmal atrial fibrillation and sinus node dysfunction. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 379). Retrieved from https://www.webofscience.com/
LONG-TERM PREDICTION OF THE RISK OF ICTUS IN PATIENTS WITH ATRIAL FIBRILLATION: COMPARISON OF THE ABC-STROKE AND CHA2DS2-VASC SCALES (Conference Paper)
Rivera Caravaca, J. M., Esteve Pastor, M. A., Valdes, M., Vicente, V., Lip, G. Y. H., Marin, F., & Roldan, V. (2017). LONG-TERM PREDICTION OF THE RISK OF ICTUS IN PATIENTS WITH ATRIAL FIBRILLATION: COMPARISON OF THE ABC-STROKE AND CHA2DS2-VASC SCALES. In HAEMATOLOGICA Vol. 102 (pp. 2-3). Retrieved from https://www.webofscience.com/
Lifetime risks, projected numbers and adverse outcomes in asian patients with atrial fibrillation (Conference Paper)
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2017). Lifetime risks, projected numbers and adverse outcomes in asian patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 980). Retrieved from https://www.webofscience.com/
Lower Risk in Young Patients Aged <50 With Atrial Fibrillation and Low CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Score (Conference Paper)
Fauchier, L., Bisson, A., Clementy, N., Angoulvant, D., Babuty, D., Lip, G. Y., & Freedman, B. (2017). Lower Risk in Young Patients Aged <50 With Atrial Fibrillation and Low CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Score. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Medication burden and perception of anticoagulation treatments in atrial fibrillation patients: results from an international survey (Conference Paper)
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2017). Medication burden and perception of anticoagulation treatments in atrial fibrillation patients: results from an international survey. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 777). Retrieved from https://www.webofscience.com/
Monocyte counts predict major bleeding events in patients with atrial fibrillation (Conference Paper)
Shahid, F., Lip, G. Y. H., Montoro-Garcia, S., Rahmat, A., & Shantsila, E. (2017). Monocyte counts predict major bleeding events in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 779-780). Retrieved from https://www.webofscience.com/
Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios (Conference Paper)
Bonde, A. N., Staerk, L., Gislason, G., Torp-Pedersen, C., Lip, G. Y. H., & Olesen, J. B. (2017). Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 838-839). Retrieved from https://www.webofscience.com/
Periprocedural anticoagulation is associated with the risk of thromboembolism after elective cardioversion of atrial fibrillation (Conference Paper)
Hellman, T. A., Kiviniemi, T., Nuotio, I., Vasankari, T., Hartikainen, J., Lip, G. Y. H., & Airaksinen, K. E. (2017). Periprocedural anticoagulation is associated with the risk of thromboembolism after elective cardioversion of atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 839). Retrieved from https://www.webofscience.com/
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE (Journal article)
Mont, L., Pelliccia, A., Sharma, S., Biffi, A., Borjesson, M., Brugada Terradellas, J., . . . Piepoli, M. (2017). Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. EUROPACE, 19(1), 139-163. doi:10.1093/europace/euw243DOI: 10.1093/europace/euw243
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE (Journal article)
Mont, L., Pelliccia, A., Sharma, S., Biffi, A., Borjesson, M., Brugada Terradellas, J., . . . Piepoli, M. (2017). Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 24(1), 41-69. doi:10.1177/2047487316676042DOI: 10.1177/2047487316676042
Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs) (Conference Paper)
Nielsen, P. B., Skjoeth, F., Larsen, T. B., Kjaeldgaard, J. N., & Lip, G. Y. H. (2017). Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs). In EUROPEAN HEART JOURNAL Vol. 38 (pp. 964). Retrieved from https://www.webofscience.com/
Predictors of warfarin discontinuation or switching among non-valvular atrial fibrillation patients (Conference Paper)
Lip, G. Y. H., Keshishian, A., Li, X., Lee, T. C., Mardekian, J., Posner, N., & Luo, X. (2017). Predictors of warfarin discontinuation or switching among non-valvular atrial fibrillation patients. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 774-775). Retrieved from https://www.webofscience.com/
Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry (Conference Paper)
Lip, G. Y. H., Teusch, C., Huisman, M. V., Diener, H. C., Dubner, S. J., Ma, C. S., . . . Halperin, J. L. (2017). Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 975). Retrieved from https://www.webofscience.com/
Previous thromboembolic disease and risk of death in atrial fibrillation: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry (Conference Paper)
Proietti, M., Laroche, C., Maggioni, A. P., Boriani, G., & Lip, G. Y. H. (2017). Previous thromboembolic disease and risk of death in atrial fibrillation: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 83). Retrieved from https://www.webofscience.com/
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry (Journal article)
Mazurek, M., Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. -C., . . . Lip, G. Y. H. (2017). Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry. THROMBOSIS AND HAEMOSTASIS, 117(12), 2376-2388. doi:10.1160/TH17-08-0555DOI: 10.1160/TH17-08-0555
Relation of congestive heart failure history to efficacy and safety of edoxaban for cardioversion of atrial fibrillation: subanalysis from the ENSURE-AF study (Conference Paper)
Dan, A., Dan, G. A., Merino, J. L., Merkely, B., Jin, J., Melino, M., . . . Goette, A. (2017). Relation of congestive heart failure history to efficacy and safety of edoxaban for cardioversion of atrial fibrillation: subanalysis from the ENSURE-AF study. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1368-1369). Retrieved from https://www.webofscience.com/
Relation of renal dysfunction to quality of anticoagulation control in patients with atrial fibrillation: The FANTASIIA registry (Conference Paper)
Esteve Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Roldan Rabadan, I., Muniz, J., Cequier, A., . . . Marin, F. (2017). Relation of renal dysfunction to quality of anticoagulation control in patients with atrial fibrillation: The FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1321). Retrieved from https://www.webofscience.com/
Relationship between renal function and circulating microparticles, soluble P-selectin and E- selectin levels in atrial fibrillation (Journal article)
Lau, Y. C., Xiong, Q., Blann, A. D., & Lip, G. Y. H. (2017). Relationship between renal function and circulating microparticles, soluble P-selectin and E- selectin levels in atrial fibrillation. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 43(1), 18-23. doi:10.1007/s11239-016-1427-3DOI: 10.1007/s11239-016-1427-3
Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries (Journal article)
Bonde, A. N., Lip, G. Y. H., Kamper, A. -L., Staerk, L., Torp-Pedersen, C., Gislason, G., & Olesen, J. B. (2017). Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries. THROMBOSIS AND HAEMOSTASIS, 117(12), 2291-2299. doi:10.1160/TH17-03-0198DOI: 10.1160/TH17-03-0198
Restarting Oral Anticoagulant Therapy After Major Bleeding Events in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Real-World Studies (Conference Paper)
Proietti, M., Romiti, G. F., Romanazzi, I., Farcomeni, A., Staerk, L., Nielsen, P. B., & Lip, G. Y. (2017). Restarting Oral Anticoagulant Therapy After Major Bleeding Events in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Real-World Studies. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Rivaroxaban strategies improve the number of days patients remain out of the hospital and event free: A PIONEER substudy (Conference Paper)
Gibson, C. M., Arbetter, D. F., Jain, P., Mehran, R., Bode, C., Halperin, J., . . . Fox, K. A. A. (2017). Rivaroxaban strategies improve the number of days patients remain out of the hospital and event free: A PIONEER substudy. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 768). Retrieved from https://www.webofscience.com/
Rivaroxaban treatment strategies reduce costs associated with rehospitalizations due to bleeding and cardiovascular events: results from the PIONEER AF-PCI trial (Conference Paper)
Pinto, D. S., Tamez, H., Korjian, S., Daaboul, Y., Mehran, R., Bode, C., . . . Gibson, C. M. (2017). Rivaroxaban treatment strategies reduce costs associated with rehospitalizations due to bleeding and cardiovascular events: results from the PIONEER AF-PCI trial. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 965). Retrieved from https://www.webofscience.com/
Rivaroxaban treatment strategies reduce not only the first bleeding event, but all (including multiple) bleeding events: A PIONEER Substudy (Conference Paper)
Yee, M. K., Chi, G., Jain, P., Mehran, R., Bode, C., Halperin, J., . . . Gibson, C. M. (2017). Rivaroxaban treatment strategies reduce not only the first bleeding event, but all (including multiple) bleeding events: A PIONEER Substudy. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 963-964). Retrieved from https://www.webofscience.com/
Spontaneous Cardioversion in Nonvalvular Atrial Fibrillation in Patients Planned for Electrical Cardioversion: A Subanalysis of the ENSURE-AF Trial (Conference Paper)
Cohen, A. A., Heidbuchel, H., Le Heuzey, J. -Y., De Caterina, R., Merino, J. L., Jin, J., . . . Lip, G. Y. (2017). Spontaneous Cardioversion in Nonvalvular Atrial Fibrillation in Patients Planned for Electrical Cardioversion: A Subanalysis of the ENSURE-AF Trial. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Stroke prevention in Atrial Fibrillation (Journal article)
Lip, G. Y. H. (2017). Stroke prevention in Atrial Fibrillation. EUROPEAN HEART JOURNAL, 38(1), 4-5. doi:10.1093/eurheartj/ehw584DOI: 10.1093/eurheartj/ehw584
Stroke prevention in atrial fibrillation (Journal article)
Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2017). Stroke prevention in atrial fibrillation. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 47(1), 13-23. doi:10.4997/JRCPE.2017.105DOI: 10.4997/JRCPE.2017.105
Stroke-Prophylaxis and 30-Day Clinical Outcomes After United States Emergency Department Diagnosis and Discharge for Atrial Fibrillation (Conference Paper)
Kea, B., Lin, A., Olshansky, B., Raitt, M., Lip, G. Y., Fu, R., & Sun, B. (2017). Stroke-Prophylaxis and 30-Day Clinical Outcomes After United States Emergency Department Diagnosis and Discharge for Atrial Fibrillation. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
Subgroup Analysis From the RE-DUAL PCI Trial: Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (Conference Paper)
Oldgren, J., Steg, P. -G., Hohnloser, S. H., Lip, G. Y., Ellis, S. G., Kimura, T., . . . Kleine, E. (2017). Subgroup Analysis From the RE-DUAL PCI Trial: Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. In CIRCULATION Vol. 136 (pp. E457). Retrieved from https://www.webofscience.com/
Synergic effects of blood pressure control and quality of anticoagulation control on outcomes in patients with atrial fibrillation: the SPORTIF III and V trials (Conference Paper)
Proietti, M., & Lip, G. Y. H. (2017). Synergic effects of blood pressure control and quality of anticoagulation control on outcomes in patients with atrial fibrillation: the SPORTIF III and V trials. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 770). Retrieved from https://www.webofscience.com/
The 2MACE score predicts cardiovascular events in real-world patients with atrial fibrillation: The FANTASIIA registry (Conference Paper)
Esteve Pastor, M. A., Perez-Copete, J., Rivera-Caravaca, J. M., Roldan, V., Roldan Rabadan, I., Muniz, J., . . . Marin, F. (2017). The 2MACE score predicts cardiovascular events in real-world patients with atrial fibrillation: The FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1126-1127). Retrieved from https://www.webofscience.com/
The Effect of Anticoagulation Rates on Time-Trends in Stroke Rates for Atrial Fibrillation: A Nationwide Study Using the Korean National Health Insurance Data (Conference Paper)
Kim, T. -H., Yang, P. -S., Yu, H. T., Uhm, J. -S., Kim, J. -Y., Pak, H. -N., . . . Lip, G. Y. (2017). The Effect of Anticoagulation Rates on Time-Trends in Stroke Rates for Atrial Fibrillation: A Nationwide Study Using the Korean National Health Insurance Data. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
The Effect of Utilization of Non-vitamin K Antagonist Oral Anticoagulants on Time-Trends In Mortality and Hospitalization Rates for Atrial Fibrillation: A Nationwide Study Using the Korean National Health Insurance Data (Conference Paper)
Yu, H. T., Yang, P. -S., Hwang, J., Ryu, S., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. (2017). The Effect of Utilization of Non-vitamin K Antagonist Oral Anticoagulants on Time-Trends In Mortality and Hospitalization Rates for Atrial Fibrillation: A Nationwide Study Using the Korean National Health Insurance Data. In CIRCULATION Vol. 136. Retrieved from https://www.webofscience.com/
The comparison of the lipid profile in the population of Poland between 2004, 2006 and 2015 based on the results of the LIPIDOGRAM cohort studies (Conference Paper)
Banach, M., Wojtowicz, E., Tomaszewski, M., Catapano, A. L., Toth, P. P., Sattar, N., . . . Jozwiak, J. (2017). The comparison of the lipid profile in the population of Poland between 2004, 2006 and 2015 based on the results of the LIPIDOGRAM cohort studies. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1116). Retrieved from https://www.webofscience.com/
The relationship of renal function to outcome: a post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) study (Conference Paper)
Lip, G. Y. H., Al-Saady, N., Ezekowitz, M. D., Banach, M., & Goette, A. (2017). The relationship of renal function to outcome: a post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) study. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1369). Retrieved from https://www.webofscience.com/
Thrombosis and Haemostasis: Past, present and future (Journal article)
Lip, G. Y. H., & Weber, C. (2017). Thrombosis and Haemostasis: Past, present and future. THROMBOSIS AND HAEMOSTASIS, 117(7), 1217-1218. doi:10.1160/TH17-05-0350DOI: 10.1160/TH17-05-0350
Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA<sub>2</sub>DS<sub>2</sub>-VASc score (Journal article)
Overvad, T. F., Nielsen, P. B., & Lip, G. Y. H. (2017). Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA<sub>2</sub>DS<sub>2</sub>-VASc score. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 3(1), 37-41. doi:10.1093/ehjcvp/pvw022DOI: 10.1093/ehjcvp/pvw022
Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events (Conference Paper)
Roldan, V., Esteve Pastor, M. A., Rivera-Caravaca, J. M., Shantsila, A., Garcia Fernandez, A., Valdes, M., . . . Lip, G. Y. H. (2017). Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1232). Retrieved from https://www.webofscience.com/
Use of statins and adverse outcomes in patients with atrial fibrillation: the EURObservational research programme atrial fibrillation (EORP-AF) general pilot registry (Conference Paper)
Proietti, M., Laroche, C., Nyvad, O., Haberka, M., Vassilikos, V. P., Maggioni, A. P., . . . Lip, G. Y. H. (2017). Use of statins and adverse outcomes in patients with atrial fibrillation: the EURObservational research programme atrial fibrillation (EORP-AF) general pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 12). Retrieved from https://www.webofscience.com/
VLSI for space applications: Single event effect investigation and optical analysis on an integrated laser platform (Conference Paper)
Chef, S., Chua, C. T., Siah, Y. W., Perdu, P., Gan, C. L., Tan, S. H., & Koh, L. S. (2017). VLSI for space applications: Single event effect investigation and optical analysis on an integrated laser platform. In Conference Proceedings from the International Symposium for Testing and Failure Analysis Vol. 2017-November (pp. 621-630).
2016
Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease (vol 68, pg 1452, 2016) (Journal article)
Lau, Y. C., Proietti, M., Guiducci, E., Blann, A. D., & Lip, G. Y. H. (2016). Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease (vol 68, pg 1452, 2016). JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 68(25), 2921. doi:10.1016/j.jacc.2016.09.923DOI: 10.1016/j.jacc.2016.09.923
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI (Journal article)
Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., . . . Fox, K. A. (2016). Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. NEW ENGLAND JOURNAL OF MEDICINE, 375(25), 2423-2434. doi:10.1056/NEJMoa1611594DOI: 10.1056/NEJMoa1611594
What do the guidelines suggest for non-vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation? (Journal article)
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). What do the guidelines suggest for non-vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation?. EUROPEAN HEART JOURNAL SUPPLEMENTS, 18(I), 18-24. doi:10.1093/eurheartj/suw049DOI: 10.1093/eurheartj/suw049
Persistence with Dabigatran Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Gloria-AF Registry (Conference Paper)
Teutsch, C., Huisman, M. V., Lip, G. Y. H., Diener, H. -C., Dubner, S. J., Changsheng, M., . . . Halperin, J. (2016). Persistence with Dabigatran Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Gloria-AF Registry. In BLOOD Vol. 128. doi:10.1182/blood.V128.22.2616.2616DOI: 10.1182/blood.V128.22.2616.2616
A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme (Journal article)
Proietti, M., Mairesse, G. H., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Lip, G. Y. H. (2016). A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme. EUROPACE, 18(12), 1779-1786. doi:10.1093/europace/euw069DOI: 10.1093/europace/euw069
Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients? (Journal article)
Shahid, F., & Lip, G. Y. H. (2016). Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients?. Arrhythmia & electrophysiology review, 5(3), 162-163. doi:10.15420/aer.2016.5.3.ed3DOI: 10.15420/aer.2016.5.3.ed3
Causes of Death and Influencing Factors in Patients with Atrial Fibrillation (Journal article)
Fauchier, L., Villejoubert, O., Clementy, N., Bernard, A., Pierre, B., Angoulvant, D., . . . Lip, G. Y. H. (2016). Causes of Death and Influencing Factors in Patients with Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 129(12). doi:10.1016/j.amjmed.2016.06.045DOI: 10.1016/j.amjmed.2016.06.045
Chronic Osteomyelitis and Atrial Fibrillation: Revisiting the Link Between Inflammation Burden and Arrhythmia (Journal article)
Shahid, F., Lip, G. Y. H., & Shantsila, E. (2016). Chronic Osteomyelitis and Atrial Fibrillation: Revisiting the Link Between Inflammation Burden and Arrhythmia. CANADIAN JOURNAL OF CARDIOLOGY, 32(12), 1366-1368. doi:10.1016/j.cjca.2016.05.002DOI: 10.1016/j.cjca.2016.05.002
Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT) (Journal article)
Lip, G. Y. H., Waldo, A. L., Ip, J., Martin, D. T., Bersohn, M. M., Choucair, W. K., . . . Halperin, J. L. (2016). Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT). AMERICAN JOURNAL OF CARDIOLOGY, 118(11), 1680-1684. doi:10.1016/j.amjcard.2016.08.047DOI: 10.1016/j.amjcard.2016.08.047
Drug-drug interactions of non-vitamin K oral anticoagulants (Journal article)
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016). Drug-drug interactions of non-vitamin K oral anticoagulants. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 12(12), 1445-1461. doi:10.1080/17425255.2016.1225037DOI: 10.1080/17425255.2016.1225037
Embolic Stroke of Undetermined Source and Detection of Atrial Fibrillation on Follow-Up: How Much Causality Is There? (Journal article)
Ntaios, G., Papavasileiou, V., Lip, G. Y. H., Milionis, H., Makaritsis, K., Vemmou, A., . . . Vemmos, K. (2016). Embolic Stroke of Undetermined Source and Detection of Atrial Fibrillation on Follow-Up: How Much Causality Is There?. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 25(12), 2975-2980. doi:10.1016/j.jstrokecerebrovasdis.2016.08.015DOI: 10.1016/j.jstrokecerebrovasdis.2016.08.015
Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias (Journal article)
Katritsis, D. G., Boriani, G., Cosio, F. G., Jais, P., Hindricks, G., Josephson, M. E., . . . Lundqvist, C. B. (2016). Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias. ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 5(3), 210-224. doi:10.15420/aer.2016.5.3.GL1DOI: 10.15420/aer.2016.5.3.GL1
Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (Journal article)
Ponikowski, A. M. D. G. D. T. P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., . . . Zamorano, J. L. (2016). Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Revista Española de Cardiología, 69(12), 1167.e1-1167.e85. doi:10.1016/j.recesp.2016.10.014DOI: 10.1016/j.recesp.2016.10.014
How to REVISIT the increasing "real world" evidence for stroke prevention in non-valvular atrial fibrillation? (Journal article)
Lip, G. Y. H. (2016). How to REVISIT the increasing "real world" evidence for stroke prevention in non-valvular atrial fibrillation?. CURRENT MEDICAL RESEARCH AND OPINION, 32(12), 2055-2057. doi:10.1080/03007995.2016.1254604DOI: 10.1080/03007995.2016.1254604
Stroke Prevention in Atrial Fibrillation: Focus on Latin America (Journal article)
Massaro, A. R., & Lip, G. Y. H. (2016). Stroke Prevention in Atrial Fibrillation: Focus on Latin America. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 107(6), 576-588. doi:10.5935/abc.20160116DOI: 10.5935/abc.20160116
Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom (Journal article)
Senoo, K., An, Y., Ogawa, H., Lane, D. A., Wolff, A., Shantsila, E., . . . Lip, G. Y. H. (2016). Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom. HEART, 102(23), 1878-1882. doi:10.1136/heartjnl-2016-309741DOI: 10.1136/heartjnl-2016-309741
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (Journal article)
Luis Zamorano, J., Lancellotti, P., Rodriguez Munoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., . . . Suter, T. M. (2016). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. KARDIOLOGIA POLSKA, 74(11), 1193-1233. doi:10.5603/KP.2016.0156DOI: 10.5603/KP.2016.0156
Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease (Conference Paper)
Pastori, D., Pignatelli, P., Perticone, F., Sciacqua, A., Carnevale, R., Farcomeni, A., . . . Violi, F. (2016). Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease. In INTERNATIONAL JOURNAL OF CARDIOLOGY Vol. 223 (pp. 619-624). doi:10.1016/j.ijcard.2016.08.224DOI: 10.1016/j.ijcard.2016.08.224
Dabigatran in clinical practice: Contemporary overview of the evidence (vol 220, pg 417, 2016) (Journal article)
Ageno, W., Eikelboom, J., & Lip, G. Y. H. (2016). Dabigatran in clinical practice: Contemporary overview of the evidence (vol 220, pg 417, 2016). INTERNATIONAL JOURNAL OF CARDIOLOGY, 223, 1074-1076. doi:10.1016/j.ijcard.2016.08.332DOI: 10.1016/j.ijcard.2016.08.332
Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention (Journal article)
Kowalewski, M., Suwalski, P., Raffa, G. M., Slomka, A., Kowalkowska, M. E., Szwed, K. A., . . . Lip, G. Y. H. (2016). Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention. INTERNATIONAL JOURNAL OF CARDIOLOGY, 223, 186-194. doi:10.1016/j.ijcard.2016.08.089DOI: 10.1016/j.ijcard.2016.08.089
Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial (Conference Paper)
Lip, G. Y., Al-Saady, N., Jin, J., Sun, M., Melino, M., Winters, S. M., . . . Zamoryakhin, D. (2016). Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial. In CIRCULATION Vol. 134. Retrieved from http://gateway.webofknowledge.com/
Perumal, A., Shendre, S., Li, M., Tay, Y. K. E., Sharma, V. K., Chen, S., . . . Demir, H. V. (2016). High brightness formamidinium lead bromide perovskite nanocrystal light emitting devices.. Scientific reports, 6, 36733. doi:10.1038/srep36733DOI: 10.1038/srep36733
International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives (Journal article)
Hsu, J. C., Akao, M., Abe, M., Anderson, K. L., Avezum, A., Glusenkamp, N., . . . Maddox, T. M. (2016). International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 5(11). doi:10.1161/JAHA.116.004037DOI: 10.1161/JAHA.116.004037
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (Journal article)
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., . . . Zeppenfeld, K. (2016). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. EUROPACE, 18(11). doi:10.1093/europace/euw295DOI: 10.1093/europace/euw295
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (Journal article)
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., . . . Zeppenfeld, K. (2016). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 50(5), e1-e88. doi:10.1093/ejcts/ezw313DOI: 10.1093/ejcts/ezw313
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study (Journal article)
Proietti, M., Nobili, A., Raparelli, V., Napoleone, L., Mannucci, P. M., & Lip, G. Y. H. (2016). Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study. CLINICAL RESEARCH IN CARDIOLOGY, 105(11), 912-920. doi:10.1007/s00392-016-0999-4DOI: 10.1007/s00392-016-0999-4
Atrial fibrillation and risk of stroke: a nationwide cohort study (Journal article)
Christiansen, C. B., Gerds, T. A., Olesen, J. B., Kristensen, S. L., Lamberts, M., Lip, G. Y. H., . . . Torp-Pedersen, C. (2016). Atrial fibrillation and risk of stroke: a nationwide cohort study. EUROPACE, 18(11), 1689-1697. doi:10.1093/europace/euv401DOI: 10.1093/europace/euv401
COMPARISON OF ORAL ANTI-COAGULANTS FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: TWO MULTI-CRITERIA DECISION ANALYSES (Conference Paper)
Tervonen, T., Ustyugova, A. V., Lip, G., Verdecchia, P., Bhashyam, S. S., Heinrich-Nols, J., . . . Marsh, K. (2016). COMPARISON OF ORAL ANTI-COAGULANTS FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: TWO MULTI-CRITERIA DECISION ANALYSES. In VALUE IN HEALTH Vol. 19 (pp. A349). doi:10.1016/j.jval.2016.09.014DOI: 10.1016/j.jval.2016.09.014
Effects of Aspirin on Endothelial Function and Hypertension (Journal article)
Dzeshka, M. S., Shantsila, A., & Lip, G. Y. H. (2016). Effects of Aspirin on Endothelial Function and Hypertension. CURRENT HYPERTENSION REPORTS, 18(11). doi:10.1007/s11906-016-0688-8DOI: 10.1007/s11906-016-0688-8
Lau, Y. C., Xiong, Q., Shantsila, E., Lip, G. Y. H., & Blann, A. D. (2016). Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 42(4), 535-544. doi:10.1007/s11239-016-1399-3DOI: 10.1007/s11239-016-1399-3
Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry (Journal article)
Proietti, M., Laroche, C., Drozd, M., Vijgen, J., Cozma, D. C., Drozdz, J., . . . Lip, G. Y. H. (2016). Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. AMERICAN HEART JOURNAL, 181, 83-91. doi:10.1016/j.ahj.2016.08.011DOI: 10.1016/j.ahj.2016.08.011
Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low-moderate risk of stroke? (Journal article)
Fauchier, L., Ruiz-Nodar, J. M., Valdes, M., Angoulvant, D., Lip, G. Y. H., & Marin, F. (2016). Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low-moderate risk of stroke?. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 35, E9-E10. doi:10.1016/j.ejim.2016.08.022DOI: 10.1016/j.ejim.2016.08.022
Optimizing stroke prevention in elderly patients with atrial fibrillation (Journal article)
Lip, G. Y. H. (2016). Optimizing stroke prevention in elderly patients with atrial fibrillation. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 14(11), 2121-2123. doi:10.1111/jth.13480DOI: 10.1111/jth.13480
Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation An Observational Cohort Study (Journal article)
Bonde, A. N., Lip, G. Y. H., Kamper, A. -L., Fosbol, E. L., Staerk, L., Carlson, N., . . . Olesen, J. B. (2016). Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation An Observational Cohort Study. STROKE, 47(11), 2707-2713. doi:10.1161/STROKEAHA.116.014422DOI: 10.1161/STROKEAHA.116.014422
Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA<sub>2</sub>DS<sub>2</sub>-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" (Journal article)
Nielsen, P. B., & Lip, G. Y. H. (2016). Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA<sub>2</sub>DS<sub>2</sub>-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke". CIRCULATION, 134(18), E389-E390. doi:10.1161/CIRCULATIONAHA.116.024013DOI: 10.1161/CIRCULATIONAHA.116.024013
Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care (Journal article)
Gorst-Rasmussen, A., Lip, G. Y. H., & Larsen, T. B. (2016). Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25(11), 1236-1244. doi:10.1002/pds.4034DOI: 10.1002/pds.4034
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin A propensity score matched analysis (Journal article)
Lip, G. Y. H., Keshishian, A., Kamble, S., Pan, X., Mardekian, J., Horblyuk, R., & Hamilton, M. (2016). Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin A propensity score matched analysis. THROMBOSIS AND HAEMOSTASIS, 116(5), 975-986. doi:10.1160/TH16-05-0403DOI: 10.1160/TH16-05-0403
Shantsila, E., Shantsila, A., Gill, P. S., & Lip, G. Y. H. (2016). Premature Cardiac Aging in South Asian Compared to Afro-Caribbean Subjects in a Community-Based Screening Study. Journal of the American Heart Association, 5(11). doi:10.1161/JAHA.116.004110DOI: 10.1161/JAHA.116.004110
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial (Journal article)
Goette, A., Merino, J. L., Ezekowitz, M. D., Zamoryakhin, D., Melino, M., Jin, J., . . . Investigators, E. N. S. U. R. E. -A. F. (2016). Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial. The Lancet, 388(10055), 1995-2003. doi:10.1016/S0140-6736(16)31474-XDOI: 10.1016/S0140-6736(16)31474-X
In patients with type 2 diabetes and high CV risk, liraglutide reduced a composite CV outcome at a median 3.8 years (Journal article)
Mazurek, M., & Lip, G. Y. H. (2016). In patients with type 2 diabetes and high CV risk, liraglutide reduced a composite CV outcome at a median 3.8 years. ANNALS OF INTERNAL MEDICINE, 165(8), JC38. doi:10.7326/ACPJC-2016-165-8-038DOI: 10.7326/ACPJC-2016-165-8-038
Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial (Journal article)
Senoo, K., & Lip, G. Y. H. (2016). Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 221, 379-382. doi:10.1016/j.ijcard.2016.07.100DOI: 10.1016/j.ijcard.2016.07.100
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. (Journal article)
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., . . . ESC Scientific Document Group. (2016). 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.. European heart journal, 37(39), 2999-3058. doi:10.1093/eurheartj/ehw272DOI: 10.1093/eurheartj/ehw272
Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease (Journal article)
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016). Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease. EXPERT OPINION ON PHARMACOTHERAPY, 17(15), 2033-2047. doi:10.1080/14656566.2016.1232393DOI: 10.1080/14656566.2016.1232393
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (Journal article)
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., . . . ESC Scientific Document Group. (2016). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.. European heart journal, 37(38), 2893-2962. doi:10.1093/eurheartj/ehw210DOI: 10.1093/eurheartj/ehw210
IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial (Journal article)
Shantsila, E., Haynes, R., Calvert, M., Fisher, J., Kirchhof, P., Gill, P. S., & Lip, G. Y. H. (2016). IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial. BMJ OPEN, 6(10). doi:10.1136/bmjopen-2016-012241DOI: 10.1136/bmjopen-2016-012241
Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 1 (Men) or 2 (Women)? (Journal article)
Hung, Y., Chao, T. -F., Liu, C. -J., Tuan, T. -C., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2016). Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 1 (Men) or 2 (Women)?. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 5(10). doi:10.1161/JAHA.116.003839DOI: 10.1161/JAHA.116.003839
2016 European Guidelines on cardiovascular disease prevention in clinical practice. (Journal article)
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., . . . Monique Verschuren, W. M. (2016). 2016 European Guidelines on cardiovascular disease prevention in clinical practice.. Revista espanola de cardiologia (English ed.), 69(10), 939. doi:10.1016/j.rec.2016.09.009DOI: 10.1016/j.rec.2016.09.009
Assessment of atrial fibrosis for the rhythm control of atrial fibrillation (Journal article)
Begg, G. A., Holden, A. V., Lip, G. Y. H., Plein, S., & Tayebjee, M. H. (2016). Assessment of atrial fibrosis for the rhythm control of atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 220, 155-161. doi:10.1016/j.ijcard.2016.06.144DOI: 10.1016/j.ijcard.2016.06.144
CHA<sub>2</sub>DS<sub>2</sub>-VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm (Journal article)
Ye, S., Qian, M., Zhao, B., Buchsbaum, R., Sacco, R. L., Levin, B., . . . Homma, S. (2016). CHA<sub>2</sub>DS<sub>2</sub>-VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm. EUROPEAN JOURNAL OF HEART FAILURE, 18(10), 1261-1266. doi:10.1002/ejhf.613DOI: 10.1002/ejhf.613
Dabigatran in clinical practice: Contemporary overview of the evidence (Journal article)
Ageno, W., Eikelboom, J., & Lip, G. Y. H. (2016). Dabigatran in clinical practice: Contemporary overview of the evidence. INTERNATIONAL JOURNAL OF CARDIOLOGY, 220, 417-428. doi:10.1016/j.ijcard.2016.06.078DOI: 10.1016/j.ijcard.2016.06.078
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting (Journal article)
Cannon, C. P., Gropper, S., Bhatt, D. L., Ellis, S. G., Kimura, T., Lip, G. Y. H., . . . Hohnloser, S. H. (2016). Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting. CLINICAL CARDIOLOGY, 39(10), 555-564. doi:10.1002/clc.22572DOI: 10.1002/clc.22572
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication (Journal article)
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Angel Cabrera, J., Chen, S. A., . . . Nattel, S. (2016). EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. EUROPACE, 18(10), 1455-1490. doi:10.1093/europace/euw161DOI: 10.1093/europace/euw161
Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms (Journal article)
Chrusciel, P., Sahebkar, A., Rembek-Wieliczko, M., Serban, M. -C., Ursoniu, S., Mikhailidis, D. P., . . . Banach, M. (2016). Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms. ATHEROSCLEROSIS, 253, 194-208. doi:10.1016/j.atherosclerosis.2016.07.897DOI: 10.1016/j.atherosclerosis.2016.07.897
Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials (Journal article)
Proietti, M., & Lip, G. Y. H. (2016). Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials. AMERICAN JOURNAL OF MEDICINE, 129(10), 1110-1116. doi:10.1016/j.amjmed.2016.03.024DOI: 10.1016/j.amjmed.2016.03.024
Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives (Journal article)
Blann, A. D., Boriani, G., & Lip, G. Y. H. (2016). Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives. EUROPACE, 18(10), 1507-1513. doi:10.1093/europace/euw211DOI: 10.1093/europace/euw211
Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA<sub>2</sub>DS<sub>2</sub>-VASc and Time in Therapeutic Range (Journal article)
Chan, P. -H., Huang, D., Lau, C. -P., Chan, E. W., Wong, I. C. K., Lip, G. Y. H., . . . Siu, C. -W. (2016). Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA<sub>2</sub>DS<sub>2</sub>-VASc and Time in Therapeutic Range. CANADIAN JOURNAL OF CARDIOLOGY, 32(10). doi:10.1016/j.cjca.2016.01.016DOI: 10.1016/j.cjca.2016.01.016
Response by Fauchier et al to Letter Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Factor Be Anticoagulated?" (Journal article)
Fauchier, L., Bisson, A., & Lip, G. Y. H. (2016). Response by Fauchier et al to Letter Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Factor Be Anticoagulated?". STROKE, 47(10), E239. doi:10.1161/STROKEAHA.116.014619DOI: 10.1161/STROKEAHA.116.014619
Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey (Journal article)
Potpara, T. S., Lip, G. Y. H., Larsen, T. B., Madrid, A., Dobreanu, D., Jedrzejczyk-Patej, E., & Dagres, N. (2016). Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey. EUROPACE, 18(10), 1593-1598. doi:10.1093/europace/euw302DOI: 10.1093/europace/euw302
The Yin-Yang of Atrial Fibrillation and Pulmonary Embolism (Conference Paper)
Abou Ziki, M., Bikdeli, B., & Lip, G. (2016). The Yin-Yang of Atrial Fibrillation and Pulmonary Embolism. In CHEST Vol. 150 (pp. 1189A). doi:10.1016/j.chest.2016.08.1298DOI: 10.1016/j.chest.2016.08.1298
Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial Fibrillation (Journal article)
Chan, P. -H., Li, W. -H., Hai, J. -J., Chan, E. W., Wong, I. C. K., Tse, H. -F., . . . Siu, C. -W. (2016). Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial Fibrillation. CANADIAN JOURNAL OF CARDIOLOGY, 32(10). doi:10.1016/j.cjca.2015.10.029DOI: 10.1016/j.cjca.2015.10.029
Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study (Journal article)
Xia, S. -J., Du, X., Li, C., Wu, J. -H., Tang, R. -B., Chang, S. -S., . . . Ma, C. -S. (2016). Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 220, 284-289. doi:10.1016/j.ijcard.2016.06.113DOI: 10.1016/j.ijcard.2016.06.113
Validation of a Modified CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study (Journal article)
Chao, T. -F., Lip, G. Y. H., Liu, C. -J., Tuan, T. -C., Chen, S. -J., Wang, K. -L., . . . Chen, S. -A. (2016). Validation of a Modified CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study. STROKE, 47(10), 2462-2469. doi:10.1161/STROKEAHA.116.013880DOI: 10.1161/STROKEAHA.116.013880
"Unreal world" or "real world" data in oral anticoagulant treatment of atrial fibrillation (Journal article)
Freedman, B., & Lip, G. Y. H. (2016). "Unreal world" or "real world" data in oral anticoagulant treatment of atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 116(4), 587-589. doi:10.1160/TH16-08-0658DOI: 10.1160/TH16-08-0658
Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease (Journal article)
Lau, Y. C., Proietti, M., Guiducci, E., Blann, A. D., & Lip, G. Y. H. (2016). Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 68(13), 1452-1464. doi:10.1016/j.jacc.2016.06.057DOI: 10.1016/j.jacc.2016.06.057
Role and analysis of monocyte subsets in cardiovascular disease Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis" (Journal article)
Weber, C., Shantsila, E., Hristov, M., Caligiuri, G., Guzik, T., Heine, G. H., . . . Lip, G. Y. H. (2016). Role and analysis of monocyte subsets in cardiovascular disease Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis". THROMBOSIS AND HAEMOSTASIS, 116(4), 626-637. doi:10.1160/TH16-02-0091DOI: 10.1160/TH16-02-0091
Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients? (Journal article)
Asuncion Esteve-Pastor, M., Garcia-Fernandez, A., Macias, M., Sogorb, F., Valdes, M., Roldan, V., . . . Marin, F. (2016). Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?. CIRCULATION JOURNAL, 80(10), 2102-2108. doi:10.1253/circj.CJ-16-0471DOI: 10.1253/circj.CJ-16-0471
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (Journal article)
Zamorano, J. L., Lancellotti, P., Munoz, D. R., Aboyans, V., Asteggiano, R., Galderisi, M., . . . Windecker, S. (2016). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. EUROPEAN HEART JOURNAL, 37(36), 2768-2801. doi:10.1093/eurheartj/ehw211DOI: 10.1093/eurheartj/ehw211
Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm (Journal article)
Shantsila, E., & Lip, G. Y. H. (2016). Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (9). doi:10.1002/14651858.CD003333.pub3DOI: 10.1002/14651858.CD003333.pub3
Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage" (Journal article)
Chao, T. -F., Liu, C. -J., Liao, J. -N., Wang, K. -L., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2016). Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage". CIRCULATION, 134(11), E230-E231. doi:10.1161/CIRCULATIONAHA.116.024174DOI: 10.1161/CIRCULATIONAHA.116.024174
A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients (Journal article)
Banach, M., Dinca, M., Ursoniu, S., Serban, M. -C., Howard, G., Mikhailidis, D. P., . . . Sahebkar, A. (2016). A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients. PHARMACOLOGICAL RESEARCH, 111, 343-356. doi:10.1016/j.phrs.2016.06.005DOI: 10.1016/j.phrs.2016.06.005
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort (Journal article)
Huisman, M. V., Ma, C. S., Diener, H. -C., Dubner, S. J., Halperin, J. L., Rothman, K. J., . . . Lip, G. Y. H. (2016). Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort. EUROPACE, 18(9), 1308-1318. doi:10.1093/europace/euw073DOI: 10.1093/europace/euw073
Atrial Fibrillation in Patients With Hypertension Trajectories of Risk Factors in Yet Another Manifestation of Hypertensive Target Organ Damage (Journal article)
Lip, G. Y. H. (2016). Atrial Fibrillation in Patients With Hypertension Trajectories of Risk Factors in Yet Another Manifestation of Hypertensive Target Organ Damage. HYPERTENSION, 68(3), 544-545. doi:10.1161/HYPERTENSIONAHA.116.07901DOI: 10.1161/HYPERTENSIONAHA.116.07901
Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores (Journal article)
Lip, G. Y. H., & Lane, D. A. (2016). Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 14(9), 1711-1714. doi:10.1111/jth.13386DOI: 10.1111/jth.13386
Crystal orientation dependence of the stress-induced martensitic transformation in zirconia-based shape memory ceramics (Journal article)
Zeng, X. M., Lai, A., Gan, C. L., & Schuh, C. A. (2016). Crystal orientation dependence of the stress-induced martensitic transformation in zirconia-based shape memory ceramics. Acta Materialia, 116, 124-135. doi:10.1016/j.actamat.2016.06.030DOI: 10.1016/j.actamat.2016.06.030
Determinants and Time Trends for Ischaemic and Haemorrhagic Stroke in a Large Chinese Population (Journal article)
Guo, Y., Wang, H., Tao, T., Tian, Y., Wang, Y., Chen, Y., & Lip, G. Y. H. (2016). Determinants and Time Trends for Ischaemic and Haemorrhagic Stroke in a Large Chinese Population. PLOS ONE, 11(9). doi:10.1371/journal.pone.0163171DOI: 10.1371/journal.pone.0163171
Echocardiographic Structure and Function in Hypertensive Disorders of Pregnancy: A Systematic Review (Journal article)
Castleman, J. S., Ganapathy, R., Taki, F., Lip, G. Y. H., Steeds, R. P., & Kotecha, D. (2016). Echocardiographic Structure and Function in Hypertensive Disorders of Pregnancy: A Systematic Review. CIRCULATION-CARDIOVASCULAR IMAGING, 9(9). doi:10.1161/CIRCIMAGING.116.004888DOI: 10.1161/CIRCIMAGING.116.004888
Effects of voltage stress on the single event upset (SEU) response of 65 nm flip flop (Journal article)
Chua, C. T., Ong, H. G., Sanchez, K., Perdu, P., & Gan, C. L. (2016). Effects of voltage stress on the single event upset (SEU) response of 65 nm flip flop. Microelectronics Reliability, 64, 199-203. doi:10.1016/j.microrel.2016.07.107DOI: 10.1016/j.microrel.2016.07.107
Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting (Journal article)
Fauchier, L., Lecoq, C., Ancedy, Y., Stamboul, K., Saint Etienne, C., Ivanes, F., . . . Lip, G. Y. H. (2016). Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting. AMERICAN JOURNAL OF CARDIOLOGY, 118(5), 700-707. doi:10.1016/j.amjcard.2016.06.018DOI: 10.1016/j.amjcard.2016.06.018
Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States (Journal article)
Lip, G. Y. H., Pan, X., Kamble, S., Kawabata, H., Mardekian, J., Masseria, C., . . . Phatak, H. (2016). Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 70(9), 752-763. doi:10.1111/ijcp.12863DOI: 10.1111/ijcp.12863
Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation <i>A Meta</i>-<i>Analysis of Randomized Controlled Trials</i> (Journal article)
Kumar, S., Danik, S. B., Altman, R. K., Barrett, C. D., Lip, G. Y. H., Chatterjee, S., . . . Danik, J. S. (2016). Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation <i>A Meta</i>-<i>Analysis of Randomized Controlled Trials</i>. CARDIOLOGY IN REVIEW, 24(5), 218-223. doi:10.1097/CRD.0000000000000088DOI: 10.1097/CRD.0000000000000088
Pulmonary Embolism As a Consequence of Ultrasonographic Examination of Extremities for Suspected Venous Thrombosis: A Systematic Review (Journal article)
Mehdipoor, G., Shabestari, A. A., Lip, G. Y. H., & Bikdeli, B. (2016). Pulmonary Embolism As a Consequence of Ultrasonographic Examination of Extremities for Suspected Venous Thrombosis: A Systematic Review. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 42(6), 636-641. doi:10.1055/s-0036-1571336DOI: 10.1055/s-0036-1571336
Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source (Journal article)
Ntaios, G., Vemmos, K., Lip, G. Y. H., Koroboki, E., Manios, E., Vemmou, A., . . . Papavasileiou, V. (2016). Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source. STROKE, 47(9), 2278-2285. doi:10.1161/STROKEAHA.116.013713DOI: 10.1161/STROKEAHA.116.013713
Role of two-dimensional electron gas (2DEG) in AlGaN/GaN high electron mobility transistor (HEMT) ON-state degradation (Journal article)
Syaranamual, G. J., Sasangka, W. A., Made, R. I., Arulkumaran, S., Ng, G. I., Foo, S. C., . . . Thompson, C. V. (2016). Role of two-dimensional electron gas (2DEG) in AlGaN/GaN high electron mobility transistor (HEMT) ON-state degradation. Microelectronics Reliability, 64, 589-593. doi:10.1016/j.microrel.2016.07.012DOI: 10.1016/j.microrel.2016.07.012
Stroke prevention in atrial fibrillation: can we do better? (Journal article)
Lane, D. A., & Lip, G. Y. H. (2016). Stroke prevention in atrial fibrillation: can we do better?. NATURE REVIEWS CARDIOLOGY, 13(9), 511-512. doi:10.1038/nrcardio.2016.117DOI: 10.1038/nrcardio.2016.117
Threading dislocation movement in AlGaN/GaN-on-Si high electron mobility transistors under high temperature reverse bias stressing (Journal article)
Sasangka, W. A., Syaranamual, G. J., Made, R. I., Thompson, C. V., & Gan, C. L. (2016). Threading dislocation movement in AlGaN/GaN-on-Si high electron mobility transistors under high temperature reverse bias stressing. AIP Advances, 6(9). doi:10.1063/1.4962544DOI: 10.1063/1.4962544
Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice? (Journal article)
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice?. EUROPEAN JOURNAL OF HEART FAILURE, 18(9), 1172-1174. doi:10.1002/ejhf.552DOI: 10.1002/ejhf.552
Altered fibrin clot structure in patients with atrial fibrillation and worsening renal function (Journal article)
Lau, Y. C., Hardy, L. J., Philippou, H., Blann, A. D., & Lip, G. Y. H. (2016). Altered fibrin clot structure in patients with atrial fibrillation and worsening renal function. THROMBOSIS AND HAEMOSTASIS, 116(3), 408-409. doi:10.1160/TH16-05-0361DOI: 10.1160/TH16-05-0361
An investigation into different nickel and nickel–phosphorus stacked thin coatings for the corrosion protection of electrical contacts (Journal article)
Murugan, V. K., Jia, Z., Syaranamual, G. J., Gan, C. L., Huang, Y., & Chen, Z. (2016). An investigation into different nickel and nickel–phosphorus stacked thin coatings for the corrosion protection of electrical contacts. Surface and Coatings Technology, 300, 95-103. doi:10.1016/j.surfcoat.2016.05.013DOI: 10.1016/j.surfcoat.2016.05.013
Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project (Journal article)
Guo, Y. -T., Zhang, Y., Shi, X. -M., Shan, Z. -L., Wang, C. -J., Wang, Y. -T., . . . Lip, G. Y. H. (2016). Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project. SCIENTIFIC REPORTS, 6. doi:10.1038/srep31755DOI: 10.1038/srep31755
Temporal Trends in Stroke Severity and Prior Antithrombotic Use Among Acute Ischemic Stroke Patients in Japan (Journal article)
Nezu, T., Hosomi, N., Lip, G. Y. H., Aoki, S., Shimomura, R., Maruyama, H., . . . Kobayashi, S. (2016). Temporal Trends in Stroke Severity and Prior Antithrombotic Use Among Acute Ischemic Stroke Patients in Japan. CIRCULATION JOURNAL, 80(9), 2033-2036. doi:10.1253/circj.CJ-16-0374DOI: 10.1253/circj.CJ-16-0374
Stroke prevention in atrial fibrillation (Journal article)
Freedman, B., Potpara, T. S., & Lip, G. Y. H. (2016). Stroke prevention in atrial fibrillation. LANCET, 388(10046), 806-817. doi:10.1016/S0140-6736(16)31257-0DOI: 10.1016/S0140-6736(16)31257-0
Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles (Journal article)
Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2016). Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles. ANNALS OF MEDICINE, 48(6), 444-455. doi:10.1080/07853890.2016.1190861DOI: 10.1080/07853890.2016.1190861
The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion (Journal article)
Garcia-Fernandez, A., Marin, F., Roldan, V., Galcera-Jornet, E., Gabriel Martinez-Martinez, J., Valdes, M., . . . Lip, G. Y. H. (2016). The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion. INTERNATIONAL JOURNAL OF CARDIOLOGY, 217, 42-48. doi:10.1016/j.ijcard.2016.04.167DOI: 10.1016/j.ijcard.2016.04.167
Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark (Journal article)
Staerk, L., Fosbol, E. L., Gadsboll, K., Sindet-Pedersen, C., Pallisgaard, J. L., Lamberts, M., . . . Olesen, J. B. (2016). Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark. SCIENTIFIC REPORTS, 6. doi:10.1038/srep31477DOI: 10.1038/srep31477
Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation (Journal article)
Hamatani, Y., Ogawa, H., Takabayashi, K., Yamashita, Y., Takagi, D., Esato, M., . . . Akao, M. (2016). Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation. SCIENTIFIC REPORTS, 6. doi:10.1038/srep31042DOI: 10.1038/srep31042
Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring" (Journal article)
Lip, G. Y. H. (2016). Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring". CIRCULATION, 134(5), E33-E34. doi:10.1161/CIRCULATIONAHA.116.023663DOI: 10.1161/CIRCULATIONAHA.116.023663
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. (Journal article)
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., . . . Document Reviewers. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.. European journal of heart failure, 18(8), 891-975. doi:10.1002/ejhf.592DOI: 10.1002/ejhf.592
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). (Journal article)
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., . . . ESC Scientific Document Group. (2016). 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).. European heart journal, 37(29), 2315-2381. doi:10.1093/eurheartj/ehw106DOI: 10.1093/eurheartj/ehw106
Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review (Journal article)
Woo, S. C. Y., Lip, G. Y. H., & Lip, P. L. (2016). Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review. EYE, 30(8), 1031-1038. doi:10.1038/eye.2016.111DOI: 10.1038/eye.2016.111
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Cabrera, J. A., Chen, S. A., . . . Review coordinator: Alena Shantsila (UK). (2016). EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.. Journal of arrhythmia, 32(4), 247-278. doi:10.1016/j.joa.2016.05.002DOI: 10.1016/j.joa.2016.05.002
Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study (Journal article)
Chan, E. W., Lau, W. C. Y., Siu, C. W., Lip, G. Y. H., Leung, W. K., Anand, S., . . . Wong, I. C. K. (2016). Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study. HEART RHYTHM, 13(8), 1581-1588. doi:10.1016/j.hrthm.2016.03.049DOI: 10.1016/j.hrthm.2016.03.049
From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency (Journal article)
Cremer, A., Amraoui, F., Lip, G. Y. H., Morales, E., Rubin, S., Segura, J., . . . Gosse, P. (2016). From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency. JOURNAL OF HUMAN HYPERTENSION, 30(8), 463-466. doi:10.1038/jhh.2015.112DOI: 10.1038/jhh.2015.112
Interfacial evolution and bond reliability in thermosonic Pd coated Cu wire bonding on aluminum metallization: Effect of palladium distribution (Journal article)
Lim, A. B. Y., Boothroyd, C. B., Yauw, O., Chylak, B., Gan, C. L., & Chen, Z. (2016). Interfacial evolution and bond reliability in thermosonic Pd coated Cu wire bonding on aluminum metallization: Effect of palladium distribution. Microelectronics Reliability, 63, 214-223. doi:10.1016/j.microrel.2016.04.003DOI: 10.1016/j.microrel.2016.04.003
Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis (Journal article)
Lau, Y. C., Xiong, Q., Ranjit, P., Lip, G. Y. H., & Blann, A. D. (2016). Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 42(2), 233-244. doi:10.1007/s11239-016-1344-5DOI: 10.1007/s11239-016-1344-5
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial (Journal article)
Di Tullio, M. R., Qian, M., Thompson, J. L. P., Labovitz, A. J., Mann, D. L., Sacco, R. L., . . . Homma, S. (2016). Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial. STROKE, 47(8), 2031-2037. doi:10.1161/STROKEAHA.116.013679DOI: 10.1161/STROKEAHA.116.013679
Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF) (Journal article)
Lip, G. Y. H., Hammerstingl, C., Marin, F., Cappato, R., Meng, I. L., Kirsch, B., . . . Cohen, A. (2016). Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). AMERICAN HEART JOURNAL, 178, 126-134. doi:10.1016/j.ahj.2016.05.007DOI: 10.1016/j.ahj.2016.05.007
Relation of the SAMe-TT<sub>2</sub>R<sub>2</sub> score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials (Journal article)
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Relation of the SAMe-TT<sub>2</sub>R<sub>2</sub> score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 216, 168-172. doi:10.1016/j.ijcard.2016.04.131DOI: 10.1016/j.ijcard.2016.04.131
The first prognostic model for stroke and death in patients with systolic heart failure (Journal article)
Freudenberger, R. S., Cheng, B., Mann, D. L., Thompson, J. L. P., Sacco, R. L., Buchsbaum, R., . . . Homma, S. (2016). The first prognostic model for stroke and death in patients with systolic heart failure. JOURNAL OF CARDIOLOGY, 68(1-2), 100-103. doi:10.1016/j.jjcc.2015.09.014DOI: 10.1016/j.jjcc.2015.09.014
Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (Journal article)
Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Petrescu, L., . . . Lip, G. Y. H. (2016). Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes. SCIENTIFIC REPORTS, 6. doi:10.1038/srep30271DOI: 10.1038/srep30271
Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis (Journal article)
Rysz-Gorzynska, M., Gluba-Brzozka, A., Sahebkar, A., Serban, M. -C., Mikhailidis, D. P., Ursoniu, S., . . . Banach, M. (2016). Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. SCIENTIFIC REPORTS, 6. doi:10.1038/srep30060DOI: 10.1038/srep30060
Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy (Journal article)
Potpara, T. S., Jokic, V., Dagres, N., Marin, F., Prostran, M. S., Blomstrom-Lundqvist, C., & Lip, G. Y. H. (2016). Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy. CURRENT MEDICINAL CHEMISTRY, 23(19), 2070-2083. doi:10.2174/0929867323666160309114246DOI: 10.2174/0929867323666160309114246
Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease (Journal article)
Potpara, T. S., Jokic, V., Dagres, N., Larsen, T. B., Lane, D. A., Hindricks, G., & Lip, G. Y. H. (2016). Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease. CURRENT MEDICINAL CHEMISTRY, 23(19), 2055-2069. doi:10.2174/0929867323666160210130109DOI: 10.2174/0929867323666160210130109
Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (Journal article)
Serban, M. -C., Sahebkar, A., Zanchetti, A., Mikhailidis, D. P., Howard, G., Antal, D., . . . Banach, M. (2016). Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 5(7). doi:10.1161/JAHA.115.002713DOI: 10.1161/JAHA.115.002713
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) (Journal article)
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., . . . Zamorano, J. L. (2016). 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 23(11), NP1-NP96. doi:10.1177/2047487316653709DOI: 10.1177/2047487316653709
Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants (Journal article)
Enriquez, A., Lip, G. Y. H., & Baranchuk, A. (2016). Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants. EUROPACE, 18(7), 955-964. doi:10.1093/europace/euv030DOI: 10.1093/europace/euv030
Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation The Chinese Atrial Fibrillation Registry Study (Journal article)
Chang, S. -S., Dong, J. -Z., Ma, C. -S., Du, X., Wu, J. -H., Tang, R. -B., . . . Lip, G. Y. H. (2016). Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation The Chinese Atrial Fibrillation Registry Study. STROKE, 47(7), 1803-1810. doi:10.1161/STROKEAHA.116.012988DOI: 10.1161/STROKEAHA.116.012988
Evaluation of the Efficacy and Safety of Dual Antiplatelet Therapy with or Without Warfarin in Patients with a Clinical Indication for DAPT and Chronic Anticoagulation: A Meta-Analysis of Observational Studies (Journal article)
Bavishi, C., Koulova, A., Bangalore, S., Sawant, A., Chatterjee, S., Ather, S., . . . Tamis-Holland, J. E. (2016). Evaluation of the Efficacy and Safety of Dual Antiplatelet Therapy with or Without Warfarin in Patients with a Clinical Indication for DAPT and Chronic Anticoagulation: A Meta-Analysis of Observational Studies. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 88(1), E12-E22. doi:10.1002/ccd.26234DOI: 10.1002/ccd.26234
Letter by Nielsen et al Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 1: Systematic Review and Meta-Analysis" (Journal article)
Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2016). Letter by Nielsen et al Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA<sub>2</sub>DS<sub>2</sub>-VASc Score of 1: Systematic Review and Meta-Analysis". STROKE, 47(7), e193. doi:10.1161/STROKEAHA.116.013672DOI: 10.1161/STROKEAHA.116.013672
Relation of Nonvalvular Atrial Fibrillati to Body Mass Index (from the SPORTIF Trials) (Conference Paper)
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Relation of Nonvalvular Atrial Fibrillati to Body Mass Index (from the SPORTIF Trials). In AMERICAN JOURNAL OF CARDIOLOGY Vol. 118 (pp. 72-78). doi:10.1016/j.amjcard.2016.04.013DOI: 10.1016/j.amjcard.2016.04.013
Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Factor Be Anticoagulated? (Journal article)
Fauchier, L., Clementy, N., Bisson, A., Ivanes, F., Angoulvant, D., Babuty, D., & Lip, G. Y. H. (2016). Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Factor Be Anticoagulated?. STROKE, 47(7), 1831-1836. doi:10.1161/STROKEAHA.116.013253DOI: 10.1161/STROKEAHA.116.013253
Enhanced copper micro/nano-particle mixed paste sintered at low temperature for 3D interconnects (Journal article)
Dai, Y. Y., Ng, M. Z., Anantha, P., Lin, Y. D., Li, Z. G., Gan, C. L., & Tan, C. S. (2016). Enhanced copper micro/nano-particle mixed paste sintered at low temperature for 3D interconnects. Applied Physics Letters, 108(26). doi:10.1063/1.4954966DOI: 10.1063/1.4954966
HAS-BLED Versus ATRIA Risk Scores for Intracranial Hemorrhage in Patients Receiving Thrombolytics for Pulmonary Embolism (Journal article)
Chatterjee, S., Lip, G. Y. H., & Giri, J. (2016). HAS-BLED Versus ATRIA Risk Scores for Intracranial Hemorrhage in Patients Receiving Thrombolytics for Pulmonary Embolism. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 67(24), 2904-2905. doi:10.1016/j.jacc.2016.03.577DOI: 10.1016/j.jacc.2016.03.577
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study (Journal article)
Larsen, T. B., Skjoth, F., Nielsen, P. B., Kjaeldgaard, J. N., & Lip, G. Y. H. (2016). Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ: British Medical Journal, 353. doi:10.1136/bmj.i3189DOI: 10.1136/bmj.i3189
Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism (Journal article)
Blann, A. D., & Lip, G. Y. H. (2016). Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism. HEART, 102(12), 975-983. doi:10.1136/heartjnl-2014-307019DOI: 10.1136/heartjnl-2014-307019
Rationale and design of the Chinese Atrial Fibrillation Registry Study (Journal article)
Du, X., Ma, C., Wu, J., Li, S., Ning, M., Tang, R., . . . Lip, G. Y. H. (2016). Rationale and design of the Chinese Atrial Fibrillation Registry Study. BMC CARDIOVASCULAR DISORDERS, 16. doi:10.1186/s12872-016-0308-1DOI: 10.1186/s12872-016-0308-1
Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study (Journal article)
Nielsen, P. B., Larsen, T. B., Skjoth, F., Overvad, T. F., & Lip, G. Y. H. (2016). Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study. SCIENTIFIC REPORTS, 6. doi:10.1038/srep27410DOI: 10.1038/srep27410
The SAME-TT<sub>2</sub>R<sub>2</sub> score predicts the quality of anticoagulation control in patients with acute VIE A real-life inception cohort study (Journal article)
Palareti, G., Antonucci, E., Lip, G. Y. H., Testa, S., Guazzaloca, G., Falanga, A., . . . Poli, D. (2016). The SAME-TT<sub>2</sub>R<sub>2</sub> score predicts the quality of anticoagulation control in patients with acute VIE A real-life inception cohort study. THROMBOSIS AND HAEMOSTASIS, 115(6), 1101-1108. doi:10.1160/TH15-10-0830DOI: 10.1160/TH15-10-0830
Carotid Atherosclerosis and Stroke in Atrial Fibrillation The Atherosclerosis Risk in Communities Study (Journal article)
Bekwelem, W., Jensen, P. N., Norby, F. L., Soliman, E. Z., Agarwal, S. K., Lip, G. Y. H., . . . Chen, L. Y. (2016). Carotid Atherosclerosis and Stroke in Atrial Fibrillation The Atherosclerosis Risk in Communities Study. STROKE, 47(6), 1643-U565. doi:10.1161/STROKEAHA.116.013133DOI: 10.1161/STROKEAHA.116.013133
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials. EBIOMEDICINE, 8, 309-316. doi:10.1016/j.ebiom.2016.04.013DOI: 10.1016/j.ebiom.2016.04.013
Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses (Journal article)
Li, X., Tse, V. C., Lau, W. C. Y., Cheung, B. M. Y., Lip, G. Y. H., Wong, I. C. K., & Chan, E. W. (2016). Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses. PLOS ONE, 11(6). doi:10.1371/journal.pone.0157129DOI: 10.1371/journal.pone.0157129
Deep vs Lobar Intracerebral Hemorrhage on HAS-BLED Scoring System Response (Journal article)
Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2016). Deep vs Lobar Intracerebral Hemorrhage on HAS-BLED Scoring System Response. CHEST, 149(6), 1590-1591. doi:10.1016/j.chest.2016.03.057DOI: 10.1016/j.chest.2016.03.057
Evaluation of a 'color coding' system for the assessment of patients undergoing primary percutaneous coronary intervention (Journal article)
Ruiz-Nodar, J. M., Gomez-Sansano, J. M., Galcera, E., Mainar, V., Valencia, J., Pineda, J., . . . Lip, G. Y. H. (2016). Evaluation of a 'color coding' system for the assessment of patients undergoing primary percutaneous coronary intervention. INTERNATIONAL JOURNAL OF CARDIOLOGY, 212, 371-376. doi:10.1016/j.ijcard.2016.03.077DOI: 10.1016/j.ijcard.2016.03.077
Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin (Journal article)
Senoo, K., Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin. AMERICAN JOURNAL OF MEDICINE, 129(6), 600-607. doi:10.1016/j.amjmed.2015.10.001DOI: 10.1016/j.amjmed.2015.10.001
Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin (Journal article)
Senoo, K., & Lip, G. Y. H. (2016). Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin. STROKE, 47(6), 1665-U623. doi:10.1161/STROKEAHA.116.013173DOI: 10.1161/STROKEAHA.116.013173
Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation (Journal article)
Eckman, M. H., Lip, G. Y. H., Wise, R. E., Speer, B., Sullivan, M., Walker, N., . . . Kues, J. (2016). Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation. AMERICAN HEART JOURNAL, 176, 17-27. doi:10.1016/j.ahj.2016.02.009DOI: 10.1016/j.ahj.2016.02.009
Multiple Silent Lacunes Are Associated with Recurrent Ischemic Stroke (Journal article)
Andersen, S. D., Skjoth, F., Yavarian, Y., Bach, F. W., Lip, G. Y. H., & Larsen, T. B. (2016). Multiple Silent Lacunes Are Associated with Recurrent Ischemic Stroke. CEREBROVASCULAR DISEASES, 42(1-2), 73-80. doi:10.1159/000445196DOI: 10.1159/000445196
Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry (Journal article)
Watanabe, E., Yamamoto, M., Kodama, I., Inoue, H., Atarashi, H., Okumura, K., . . . Origasa, H. (2016). Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 212, 311-317. doi:10.1016/j.ijcard.2016.03.008DOI: 10.1016/j.ijcard.2016.03.008
Thermal reliability of a bilayer of Ni(P)/Cu as a diffusion barrier for Cu/Sn/Cu bonding (Journal article)
Lee, B., Jeon, H., Gan, C. L., & Lee, H. -J. (2016). Thermal reliability of a bilayer of Ni(P)/Cu as a diffusion barrier for Cu/Sn/Cu bonding. Japanese Journal of Applied Physics, 55(6S3), 06JF03. doi:10.7567/jjap.55.06jf03DOI: 10.7567/jjap.55.06jf03
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry (Journal article)
Boriani, G., Laroche, C., Diemberger, I., Fantecchi, E., Popescu, M. I., Rasmussen, L. H., . . . Lip, G. Y. H. (2016). 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry. EUROPACE, 18(5), 648-657. doi:10.1093/europace/euv390DOI: 10.1093/europace/euv390
Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis (Journal article)
Chan, P. -H., Huang, D., Yip, P. -S., Hai, J., Tse, H. -F., Chan, T. -M., . . . Siu, C. -W. (2016). Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis. EUROPACE, 18(5), 665-671. doi:10.1093/europace/euv289DOI: 10.1093/europace/euv289
Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin (Journal article)
Lau, Y. C., Xiong, Q., Lip, G. Y. H., & Blann, A. D. (2016). Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin. ANNALS OF MEDICINE, 48(4), 275-281. doi:10.3109/07853890.2016.1166516DOI: 10.3109/07853890.2016.1166516
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm (Withdrawn Paper. 2016, art. no. CD003333) (Journal article)
Lip, G. Y. H., Wrigley, B. J., & Pisters, R. (2016). Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm (Withdrawn Paper. 2016, art. no. CD003333). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD003333.pub2DOI: 10.1002/14651858.CD003333.pub2
Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis The Loire Valley Atrial Fibrillation Project (Journal article)
Philippart, R., Brunet-Bernard, A., Clementy, N., Bourguignon, T., Mirza, A., Angoulvant, D., . . . Fauchier, L. (2016). Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis The Loire Valley Atrial Fibrillation Project. THROMBOSIS AND HAEMOSTASIS, 115(5), 1056-1063. doi:10.1160/TH16-01-0007DOI: 10.1160/TH16-01-0007
A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation (Journal article)
Lip, G. Y. H., Potpara, T., Boriani, G., & Blomstrom-Lundqvist, C. (2016). A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation. JOURNAL OF INTERNAL MEDICINE, 279(5), 467-476. doi:10.1111/joim.12468DOI: 10.1111/joim.12468
Atmospheric corrosion resistance of electroplated Ni/Ni–P/Au electronic contacts (Journal article)
Murugan, V. K., Jia, Z., Syaranamual, G. J., Gan, C. L., Huang, Y., & Chen, Z. (2016). Atmospheric corrosion resistance of electroplated Ni/Ni–P/Au electronic contacts. Microelectronics Reliability, 60, 84-92. doi:10.1016/j.microrel.2016.02.014DOI: 10.1016/j.microrel.2016.02.014
Atrial Fibrillation and Stroke Making Sense of Recent Observations on Anticoagulation (Journal article)
Proietti, M., & Lip, G. Y. H. (2016). Atrial Fibrillation and Stroke Making Sense of Recent Observations on Anticoagulation. CARDIOLOGY CLINICS, 34(2), 317-+. doi:10.1016/j.ccl.2015.12.006DOI: 10.1016/j.ccl.2015.12.006
Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study (Journal article)
Chao, T. -F., Liu, C. -J., Tuan, T. -C., Wang, K. -L., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2016). Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study. MAYO CLINIC PROCEEDINGS, 91(5), 567-574. doi:10.1016/j.mayocp.2016.03.007DOI: 10.1016/j.mayocp.2016.03.007
Misconceptions on Interpretation of Risk Prediction Tools in Atrial Fibrillation (Journal article)
Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2016). Misconceptions on Interpretation of Risk Prediction Tools in Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 129(5), E31. doi:10.1016/j.amjmed.2015.11.038DOI: 10.1016/j.amjmed.2015.11.038
Outcomes in a Warfarin-Treated Population With Atrial Fibrillation (Journal article)
Bjorck, F., Renlund, H., Lip, G. Y. H., Wester, P., Svensson, P. J., & Sjalander, A. (2016). Outcomes in a Warfarin-Treated Population With Atrial Fibrillation. JAMA CARDIOLOGY, 1(2), 172-180. doi:10.1001/jamacardio.2016.0199DOI: 10.1001/jamacardio.2016.0199
Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial (Journal article)
Proietti, M., Raparelli, V., Olshansky, B., & Lip, G. Y. H. (2016). Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial. CLINICAL RESEARCH IN CARDIOLOGY, 105(5), 412-420. doi:10.1007/s00392-015-0936-yDOI: 10.1007/s00392-015-0936-y
Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age (Journal article)
Eckman, M. H., Lip, G. Y. H., Wise, R. E., Speer, B., Sullivan, M., Walker, N., . . . Kues, J. (2016). Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 64(5), 1054-1060. doi:10.1111/jgs.14099DOI: 10.1111/jgs.14099
miRNA-197 and miRNA-223 and cardiovascular death in coronary artery disease patients (Journal article)
Orenes-Pinero, E., Marin, F., & Lip, G. Y. H. (2016). miRNA-197 and miRNA-223 and cardiovascular death in coronary artery disease patients. ANNALS OF TRANSLATIONAL MEDICINE, 4(10). doi:10.21037/atm.2016.05.27DOI: 10.21037/atm.2016.05.27
Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis (Journal article)
Kotecha, D., Manzano, L., Krum, H., Rosano, G., Holmes, J., Altman, D. G., . . . Flather, M. D. (2016). Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. BMJ-BRITISH MEDICAL JOURNAL, 353. doi:10.1136/bmj.i1855DOI: 10.1136/bmj.i1855
Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage (Journal article)
Chao, T. -F., Liu, C. -J., Liao, J. -N., Wang, K. -L., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2016). Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage. CIRCULATION, 133(16), 1540-1547. doi:10.1161/CIRCULATIONAHA.115.019794DOI: 10.1161/CIRCULATIONAHA.115.019794
Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation (Journal article)
Melgaard, L., Gorst-Rasmussen, A., Sogaard, P., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2016). Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 209, 1-6. doi:10.1016/j.ijcard.2016.02.004DOI: 10.1016/j.ijcard.2016.02.004
Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores (Journal article)
Proietti, M., Senoo, K., Lane, D. A., & Lip, G. Y. H. (2016). Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores. SCIENTIFIC REPORTS, 6. doi:10.1038/srep24376DOI: 10.1038/srep24376
Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA<sub>2</sub>DS<sub>2</sub>-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? <i>Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke</i> (Journal article)
Lip, G. Y. H., & Nielsen, P. B. (2016). Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA<sub>2</sub>DS<sub>2</sub>-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? <i>Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke</i>. CIRCULATION, 133(15), 1498-1503. doi:10.1161/CIRCULATIONAHA.115.016713DOI: 10.1161/CIRCULATIONAHA.115.016713
PHYSICAL ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A REPORT FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME PILOT SURVEY ON ATRIAL FIBRILLATION (EORP-AF) GENERAL REGISTRY (Conference Paper)
Proietti, M., Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., . . . Lip, G. (2016). PHYSICAL ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A REPORT FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME PILOT SURVEY ON ATRIAL FIBRILLATION (EORP-AF) GENERAL REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 688). doi:10.1016/S0735-1097(16)30689-1DOI: 10.1016/S0735-1097(16)30689-1
Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study (Journal article)
Violi, F., Davi, G., Proietti, M., Pastori, D., Hiatt, W. R., Corazza, G. R., . . . Basili, S. (2016). Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study. THROMBOSIS AND HAEMOSTASIS, 115(4), 856-863. doi:10.1160/TH15-07-0612DOI: 10.1160/TH15-07-0612
Anticoagulant therapy after venous thromboembolism and 10-year mortality (Journal article)
Larsen, T. B., Lip, G. Y. H., & Gorst-Rasmussen, A. (2016). Anticoagulant therapy after venous thromboembolism and 10-year mortality. INTERNATIONAL JOURNAL OF CARDIOLOGY, 208, 72-78. doi:10.1016/j.ijcard.2016.01.190DOI: 10.1016/j.ijcard.2016.01.190
Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation (Journal article)
Dzeshka, M. S., & Lip, G. Y. H. (2016). Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation. HEART FAILURE CLINICS, 12(2), 257-+. doi:10.1016/j.hfc.2015.08.021DOI: 10.1016/j.hfc.2015.08.021
Atrial fibrillation and its complications: a focus on identifying risk factors and risk stratification (Journal article)
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Atrial fibrillation and its complications: a focus on identifying risk factors and risk stratification. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2(2), 88-+. doi:10.1093/ehjcvp/pvv057DOI: 10.1093/ehjcvp/pvv057
CHA2DS2-VASC SCORE AND ADVERSE EVENTS IN PATIENTS WITH HEART FAILURE AND SINUS RHYTHM (Conference Paper)
Ye, S., Qian, M., Zhao, B., Lip, G., Buchsbaum, R., Sacco, R., . . . Homma, S. (2016). CHA2DS2-VASC SCORE AND ADVERSE EVENTS IN PATIENTS WITH HEART FAILURE AND SINUS RHYTHM. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 1335). doi:10.1016/S0735-1097(16)31336-5DOI: 10.1016/S0735-1097(16)31336-5
Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke (Journal article)
Diamantopoulos, A., Sawyer, L. M., Lip, G. Y. H., Witte, K. K., Reynolds, M. R., Fauchier, L., . . . Diener, H. -C. (2016). Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke. INTERNATIONAL JOURNAL OF STROKE, 11(3), 302-312. doi:10.1177/1747493015620803DOI: 10.1177/1747493015620803
EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation (Journal article)
Donal, E., Lip, G. Y. H., Galderisi, M., Goette, A., Shah, D., Marwan, M., . . . Habib, G. (2016). EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 17(4), 355-383. doi:10.1093/ehjci/jev354DOI: 10.1093/ehjci/jev354
IMPACT OF L-CARNITINE ON PLASMA LIPOPROTEIN(A) CONCENTRATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (Conference Paper)
Serban, M. C., Mikhailidis, D. P., Toth, P., Jones, S., Muntner, P., Blaha, M., . . . Banach, M. (2016). IMPACT OF L-CARNITINE ON PLASMA LIPOPROTEIN(A) CONCENTRATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 2032). doi:10.1016/S0735-1097(16)32033-2DOI: 10.1016/S0735-1097(16)32033-2
Microstructure, crystallization and shape memory behavior of titania and yttria co-doped zirconia (Journal article)
Zeng, X. M., Du, Z., Schuh, C. A., Tamura, N., & Gan, C. L. (2016). Microstructure, crystallization and shape memory behavior of titania and yttria co-doped zirconia. Journal of the European Ceramic Society, 36(5), 1277-1283. doi:10.1016/j.jeurceramsoc.2015.11.042DOI: 10.1016/j.jeurceramsoc.2015.11.042
Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor The Loire Valley Atrial Fibrillation Project (Journal article)
Fauchier, L., Lecoq, C., Clementy, N., Bernard, A., Angoulvant, D., Ivanes, F., . . . Lip, G. Y. H. (2016). Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor The Loire Valley Atrial Fibrillation Project. CHEST, 149(4), 960-968. doi:10.1378/chest.15-1622DOI: 10.1378/chest.15-1622
Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease (Journal article)
De Caterina, R., Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., . . . Weitz, J. I. (2016). Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease. THROMBOSIS AND HAEMOSTASIS, 115(4), 685-711. doi:10.1160/TH15-09-0703DOI: 10.1160/TH15-09-0703
REAL WORLD COMPARISON OF MAJOR BLEEDING RISK AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON APIXABAN, WARFARIN, DABIGATRAN OR RIVAROXABAN: A 1:1 PROPENSITY-SCORE MATCHED ANALYSIS (Conference Paper)
Lip, G., Keshishian, A., Kamble, S., Pan, X., Burns, L., Mardekian, J., . . . Phatak, H. (2016). REAL WORLD COMPARISON OF MAJOR BLEEDING RISK AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON APIXABAN, WARFARIN, DABIGATRAN OR RIVAROXABAN: A 1:1 PROPENSITY-SCORE MATCHED ANALYSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 882). doi:10.1016/S0735-1097(16)30883-XDOI: 10.1016/S0735-1097(16)30883-X
REAL-WORLD COMPARISON OF INPATIENT BLEEDING RISK, BLEEDING-RELATED HOSPITALIZATION RATES AND COSTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS ON APIXABAN, DABIGATRAN, RIVAROXABAN: COHORTS COMPRISING NEW INITIATORS AND/OR SWITCHERS FROM WARFARIN (Conference Paper)
Tepper, P., Mardekian, J., Masseria, C., Horblyuk, R., Kamble, S., Hamilton, M., . . . Lip, G. Y. H. (2016). REAL-WORLD COMPARISON OF INPATIENT BLEEDING RISK, BLEEDING-RELATED HOSPITALIZATION RATES AND COSTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS ON APIXABAN, DABIGATRAN, RIVAROXABAN: COHORTS COMPRISING NEW INITIATORS AND/OR SWITCHERS FROM WARFARIN. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 662). doi:10.1016/S0735-1097(16)30663-5DOI: 10.1016/S0735-1097(16)30663-5
SEX DIFFERENCES IN ANTITHROMBOTIC THERAPY: OBSERVATIONS FROM THE GLORIA-AF REGISTRY PROGRAM (Conference Paper)
Teutsch, C., Lip, G. Y. H., Diener, H. -C., Dubner, S., Halperin, J., Ma, C., . . . Huisman, M. (2016). SEX DIFFERENCES IN ANTITHROMBOTIC THERAPY: OBSERVATIONS FROM THE GLORIA-AF REGISTRY PROGRAM. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 794). doi:10.1016/S0735-1097(16)30795-1DOI: 10.1016/S0735-1097(16)30795-1
STROKE AND BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION WITH RESUMPTION OF ORAL ANTICOAGULATION FOLLOWING TRAUMATIC INJURY: A DANISH NATIONWIDE COHORT STUDY (Conference Paper)
Staerk, L., Gislason, G., Lip, G., Fosbol, E., Sindet-Pedersen, C., Gadsboll, K., . . . Olesen, J. (2016). STROKE AND BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION WITH RESUMPTION OF ORAL ANTICOAGULATION FOLLOWING TRAUMATIC INJURY: A DANISH NATIONWIDE COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 892). doi:10.1016/S0735-1097(16)30893-2DOI: 10.1016/S0735-1097(16)30893-2
Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease Is Stroke Prevention Worth the Risk? (Journal article)
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease Is Stroke Prevention Worth the Risk?. CHEST, 149(4), 891-892. doi:10.1016/j.chest.2015.09.026DOI: 10.1016/j.chest.2015.09.026
WHAT DO REAL WORLD DATA SAY ABOUT SAFETY AND RESOURCE USE OF ORAL ANTAGONISTS? EARLY ANALYSIS OF NEWLY ANTICOAGULATED NON-VALVULAR ATRIAL FIBRILLATION PATIENTS USING EITHER APIXABAN, DABIGATRAN, RIVAROXABAN OR WARFARIN (Conference Paper)
Pan, X., Kamble, S., Burns, L., Kawabata, H., Mardekian, J., Masseria, C., . . . Lip, G. Y. H. (2016). WHAT DO REAL WORLD DATA SAY ABOUT SAFETY AND RESOURCE USE OF ORAL ANTAGONISTS? EARLY ANALYSIS OF NEWLY ANTICOAGULATED NON-VALVULAR ATRIAL FIBRILLATION PATIENTS USING EITHER APIXABAN, DABIGATRAN, RIVAROXABAN OR WARFARIN. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 894). doi:10.1016/S0735-1097(16)30895-6DOI: 10.1016/S0735-1097(16)30895-6
[2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)]. (Journal article)
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J. -P., Del Zotti, F., . . . Task Force per il Trattamento dell'Endocardite Infettiva della Società Europea di Cardiologia (ESC). (2016). [2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)].. Giornale italiano di cardiologia (2006), 17(4), 277-319. doi:10.1714/2214.23904DOI: 10.1714/2214.23904
Atrial fibrillation (Journal article)
Lip, G. Y. H., Fauchier, L., Freedman, S. B., Van Gelder, I., Natale, A., Gianni, C., . . . Lane, D. A. (2016). Atrial fibrillation. NATURE REVIEWS DISEASE PRIMERS, 2. doi:10.1038/nrdp.2016.16DOI: 10.1038/nrdp.2016.16
Atrial fibrillation. (Journal article)
Atrial fibrillation. (2016). Nature reviews. Disease primers, 2, 16017. doi:10.1038/nrdp.2016.17DOI: 10.1038/nrdp.2016.17
Endotoxemia as a trigger of thrombosis in cirrhosis (Journal article)
Violi, F., Lip, G. Y. H., & Cangemi, R. (2016). Endotoxemia as a trigger of thrombosis in cirrhosis. HAEMATOLOGICA, 101(4). doi:10.3324/haematol.2015.139972DOI: 10.3324/haematol.2015.139972
How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring (Journal article)
Lip, G. Y. H. (2016). How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring. CIRCULATION, 133(13), 1290-1295. doi:10.1161/CIRCULATIONAHA.115.016797DOI: 10.1161/CIRCULATIONAHA.115.016797
Polish and European management strategies in patients with atrial fibrillation Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot) (Journal article)
Lenarczyk, R., Mitrega, K., Mazurek, M., Janion, M., Opolski, G., Drozdz, J., . . . Kalarus, Z. (2016). Polish and European management strategies in patients with atrial fibrillation Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot). POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 126(3), 138-148. doi:10.20452/pamw.3322DOI: 10.20452/pamw.3322
Interfacial strength and deformation mechanism of SiC–Al composite micro-pillars (Journal article)
Guo, X., Guo, Q., Li, Z., Fan, G., Xiong, D. -B., Su, Y., . . . Zhang, D. (2016). Interfacial strength and deformation mechanism of SiC–Al composite micro-pillars. Scripta Materialia, 114, 56-59. doi:10.1016/j.scriptamat.2015.11.018DOI: 10.1016/j.scriptamat.2015.11.018
Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: The AFFIRM Trial (Journal article)
Proietti, M., Raparelli, V., Basili, S., Olshansky, B., & Lip, G. Y. H. (2016). Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: The AFFIRM Trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 207, 258-263. doi:10.1016/j.ijcard.2016.01.169DOI: 10.1016/j.ijcard.2016.01.169
Pokorney, S. D., Piccini, J. P., Stevens, S. R., Patel, M. R., Pieper, K. S., Halperin, J. L., . . . ROCKET AF Steering Committee Investigators. (2016). Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.. Journal of the American Heart Association, 5(3), e002197. doi:10.1161/jaha.115.002197DOI: 10.1161/jaha.115.002197
Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True? <i>A Systematic Review</i> (Journal article)
Violi, F., Lip, G. Y. H., Pignatelli, P., & Pastori, D. (2016). Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True? <i>A Systematic Review</i>. MEDICINE, 95(10). doi:10.1097/MD.0000000000002895DOI: 10.1097/MD.0000000000002895
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (Journal article)
Roffi, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., . . . Patrono, C. (2016). 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Russian Journal of Cardiology, 131(3), 9-63. doi:10.15829/1560-4071-2016-3-9-63DOI: 10.15829/1560-4071-2016-3-9-63
Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score (Journal article)
Pastori, D., Farcomeni, A., Poli, D., Antonucci, E., Angelico, F., Del Ben, M., . . . Violi, F. (2016). Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score. INTERNAL AND EMERGENCY MEDICINE, 11(2), 199-204. doi:10.1007/s11739-015-1326-1DOI: 10.1007/s11739-015-1326-1
Symptom-to-door times in patients presenting with ST elevation myocardial infarction-do ethnic or gender differences exist? (Journal article)
Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2016). Symptom-to-door times in patients presenting with ST elevation myocardial infarction-do ethnic or gender differences exist?. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 109(3), 175-180. doi:10.1093/qjmed/hcv112DOI: 10.1093/qjmed/hcv112
Use of the SAMe-TT<sub>2</sub>R<sub>2</sub> Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence (Journal article)
Chan, P. H., Hai, J. J., Chan, E. W., Li, W. H., Tse, H. F., Wong, I. C. K., . . . Siu, C. W. (2016). Use of the SAMe-TT<sub>2</sub>R<sub>2</sub> Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence. PLOS ONE, 11(3). doi:10.1371/journal.pone.0150674DOI: 10.1371/journal.pone.0150674
Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study (Journal article)
Melgaard, L., Gorst-Rasmussen, A., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2016). Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study. PLOS ONE, 11(3). doi:10.1371/journal.pone.0152269DOI: 10.1371/journal.pone.0152269
Edoxaban in venous thromboembolism and stroke prevention: an appraisal (Journal article)
Proietti, M., & Lip, G. Y. H. (2016). Edoxaban in venous thromboembolism and stroke prevention: an appraisal. VASCULAR HEALTH AND RISK MANAGEMENT, 12, 45-51. doi:10.2147/VHRM.S81569DOI: 10.2147/VHRM.S81569
Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial - (Journal article)
Kato, T. S., Di Tullio, M. R., Qian, M., Wu, M., Thompson, J. L. P., Mann, D. L., . . . Homma, S. (2016). Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial -. CIRCULATION JOURNAL, 80(3), 619-+. doi:10.1253/circj.CJ-15-1054DOI: 10.1253/circj.CJ-15-1054
Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion (Journal article)
Garcia-Fernandez, A., Marin, F., Roldan, V., Gomez-Sansano, J. M., Hernandez-Romero, D., Valdes, M., . . . Lip, G. Y. H. (2016). Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion. CIRCULATION JOURNAL, 80(3), 605-612. doi:10.1253/circj.CJ-15-0992DOI: 10.1253/circj.CJ-15-0992
Application of copper nanoparticles as die attachment for high power LED (Conference Paper)
Lee, B. H., Ng, M. Z., Zinn, A. A., & Gan, C. L. (2015). Application of copper nanoparticles as die attachment for high power LED. In 2015 IEEE 17th Electronics Packaging and Technology Conference (EPTC). IEEE. doi:10.1109/eptc.2015.7412383DOI: 10.1109/eptc.2015.7412383
Evaluation of the corrosion performance of Cu-Al intermetallic compounds and the effect of Pd addition (Conference Paper)
Lim, A. B. Y., Neo, W. J., Yauw, O., Chylak, B., Gan, C. L., & Chen, Z. (2015). Evaluation of the corrosion performance of Cu-Al intermetallic compounds and the effect of Pd addition. In 2015 IEEE 17th Electronics Packaging and Technology Conference (EPTC). IEEE. doi:10.1109/eptc.2015.7412261DOI: 10.1109/eptc.2015.7412261
Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey (Journal article)
Potpara, T. S., Dan, G. -A., Trendafilova, E., Goda, A., Kusljugic, Z., Manola, S., . . . Lip, G. Y. H. (2016). Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey. SCIENTIFIC REPORTS, 6. doi:10.1038/srep20432DOI: 10.1038/srep20432
Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation The AMADEUS Trial (Journal article)
Senoo, K., & Lip, G. Y. H. (2016). Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation The AMADEUS Trial. STROKE, 47(2), 523-526. doi:10.1161/STROKEAHA.115.011876DOI: 10.1161/STROKEAHA.115.011876
Clinical Characteristics and Outcomes in Extreme Elderly (Age ≥ 85 Years) Japanese Patients With Atrial Fibrillation The Fushimi AF Registry (Journal article)
Yamashita, Y., Hamatani, Y., Esato, M., Chun, Y. -H., Tsuji, H., Wada, H., . . . Akao, M. (2016). Clinical Characteristics and Outcomes in Extreme Elderly (Age ≥ 85 Years) Japanese Patients With Atrial Fibrillation The Fushimi AF Registry. CHEST, 149(2), 401-412. doi:10.1378/chest.15-1095DOI: 10.1378/chest.15-1095
Emerging Tools for Stroke Prevention in Atrial Fibrillation (Journal article)
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016). Emerging Tools for Stroke Prevention in Atrial Fibrillation. EBIOMEDICINE, 4, 26-39. doi:10.1016/j.ebiom.2016.01.017DOI: 10.1016/j.ebiom.2016.01.017
Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction? (Journal article)
Shantsila, E., & Lip, G. Y. H. (2016). Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?. EBIOMEDICINE, 4, 5-6. doi:10.1016/j.ebiom.2016.01.025DOI: 10.1016/j.ebiom.2016.01.025
Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca (Journal article)
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Zannad, F. (2016). Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca. Revista Española de Cardiología, 69(2), 176.e1-176.e77. doi:10.1016/j.recesp.2016.01.001DOI: 10.1016/j.recesp.2016.01.001
Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar (Journal article)
Galiè, N., Humbert, M., Vachiery, J. -L., Gibbs, S., Lang, I., Torbicki, A., . . . Zamorano, J. L. (2016). Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar. Revista Española de Cardiología, 69(2), 177.e1-177.e62. doi:10.1016/j.recesp.2016.01.002DOI: 10.1016/j.recesp.2016.01.002
Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure (Journal article)
Andreu-Cayuelas, J. M., Pastor-Perez, F. J., Puche, C. M., Mateo-Martinez, A., Garcia-Alberola, A., Flores-Blanco, P. J., . . . Manzano-Fernandez, S. (2016). Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure. REVISTA ESPANOLA DE CARDIOLOGIA, 69(2), 134-140. doi:10.1016/j.rec.2015.06.021DOI: 10.1016/j.rec.2015.06.021
Impact of deposition conditions on the crystallization kinetics of amorphous GeTe films (Journal article)
Khoo, C. Y., Liu, H., Sasangka, W. A., Made, R. I., Tamura, N., Kunz, M., . . . Thompson, C. V. (2016). Impact of deposition conditions on the crystallization kinetics of amorphous GeTe films. Journal of Materials Science, 51(4), 1864-1872. doi:10.1007/s10853-015-9493-zDOI: 10.1007/s10853-015-9493-z
Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European Population. (Journal article)
Blann, A. D., Pisters, R., & Lip, G. Y. H. (2016). Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European Population.. JACC. Clinical electrophysiology, 2(1), 47-54. doi:10.1016/j.jacep.2015.09.015DOI: 10.1016/j.jacep.2015.09.015
Recalibration of the HAS- BLED Score Should Hemorrhagic Stroke Account for One or Two Points? (Journal article)
Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2016). Recalibration of the HAS- BLED Score Should Hemorrhagic Stroke Account for One or Two Points?. CHEST, 149(2), 311-314. doi:10.1378/chest.15-1509DOI: 10.1378/chest.15-1509
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups (Journal article)
Lip, G. Y. H., Mitchell, S. A., Liu, X., Liu, L. Z., Phatak, H., Kachroo, S., & Batson, S. (2016). Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups. INTERNATIONAL JOURNAL OF CARDIOLOGY, 204, 88-94. doi:10.1016/j.ijcard.2015.11.084DOI: 10.1016/j.ijcard.2015.11.084
Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project (Journal article)
Xiong, Q., Shantsila, A., Li, J., Hong, K., & Lip, G. Y. H. (2016). Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project. ARCHIVES OF MEDICAL SCIENCE, 12(1), 216-218. doi:10.5114/aoms.2016.57598DOI: 10.5114/aoms.2016.57598
The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation. (Journal article)
Esteve-Pastor, M. A., Roldán, V., Valdés, M., Lip, G. Y. H., & Marín, F. (2016). The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation.. Expert review of cardiovascular therapy, 14(2), 177-187. doi:10.1586/14779072.2016.1116941DOI: 10.1586/14779072.2016.1116941
Usefulness of the SAME-TT<sub>2</sub>R<sub>2</sub> score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea (Journal article)
Szymanski, F. M., Lip, G. Y. H., Filipiak, K. J., Platek, A. E., & Karpinski, G. (2016). Usefulness of the SAME-TT<sub>2</sub>R<sub>2</sub> score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea. INTERNATIONAL JOURNAL OF CARDIOLOGY, 204, 200-205. doi:10.1016/j.ijcard.2015.11.158DOI: 10.1016/j.ijcard.2015.11.158
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology]. (Journal article)
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Task Force per il Trattamento dei Pazienti con Aritmie Ventricolari e la Prevenzione della Morte Cardiaca Improvvisa della Società Europea di Cardiologia. (2016). [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology].. Giornale italiano di cardiologia (2006), 17(2), 108-170. doi:10.1714/2174.23496DOI: 10.1714/2174.23496
β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure Association With Mortality in a Nationwide Cohort Study (Journal article)
Nielsen, P. B., Larsen, T. B., Gorst-Rasmussen, A., Skjoth, F., & Lip, G. Y. H. (2016). β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure Association With Mortality in a Nationwide Cohort Study. CIRCULATION-HEART FAILURE, 9(2), 1-9. doi:10.1161/CIRCHEARTFAILURE.115.002597DOI: 10.1161/CIRCHEARTFAILURE.115.002597
CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis (Journal article)
Philippart, R., Brunet-Bernard, A., Clementy, N., Bourguignon, T., Mirza, A., Angoulvant, D., . . . Fauchier, L. (2016). CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 67(3), 343-344. doi:10.1016/j.jacc.2015.10.061DOI: 10.1016/j.jacc.2015.10.061
Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type (Journal article)
Wilson, D., Charidimou, A., Shakeshaft, C., Ambler, G., White, M., Cohen, H., . . . Werring, D. J. (2016). Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type. NEUROLOGY, 86(4), 360-366. doi:10.1212/WNL.0000000000002310DOI: 10.1212/WNL.0000000000002310
RISKS OF ANTITHROMBOTIC TREATMENT AFTER GASTROINTESTINAL BLEEDING IN ATRIAL FIBRILLATION Reply (Journal article)
Staerk, L., & Lip, G. Y. H. (2016). RISKS OF ANTITHROMBOTIC TREATMENT AFTER GASTROINTESTINAL BLEEDING IN ATRIAL FIBRILLATION Reply. BMJ-BRITISH MEDICAL JOURNAL, 352. doi:10.1136/bmj.i266DOI: 10.1136/bmj.i266
The 5-factor ORBIT bleeding score predicted major bleeding at 2 years in patients with atrial fibrillation (Journal article)
Lip, G. Y. H., & Lane, D. A. (2016). The 5-factor ORBIT bleeding score predicted major bleeding at 2 years in patients with atrial fibrillation. ANNALS OF INTERNAL MEDICINE, 164(2), JC11. doi:10.7326/ACPJC-2016-164-2-011DOI: 10.7326/ACPJC-2016-164-2-011
A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation (Journal article)
Marcucci, M., Skjoth, F., Lip, G. Y. H., Iorio, A., & Larsen, T. B. (2016). A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 203, 785-790. doi:10.1016/j.ijcard.2015.11.035DOI: 10.1016/j.ijcard.2015.11.035
Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence? (Journal article)
Ancedy, Y., Lecoq, C., Saint Etienne, C., Ivanes, F., Angoulvant, D., Babuty, D., . . . Fauchier, L. (2016). Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence?. INTERNATIONAL JOURNAL OF CARDIOLOGY, 203, 987-994. doi:10.1016/j.ijcard.2015.11.090DOI: 10.1016/j.ijcard.2015.11.090
Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation (Journal article)
Nedios, S., Seewoester, T., Lip, G. H. Y., Husser, D., Hindricks, G., Bollmann, A., & Kornej, J. (2016). Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 203, 621-623. doi:10.1016/j.ijcard.2015.11.022DOI: 10.1016/j.ijcard.2015.11.022
Atrial fibrillation and heart failure due to reduced <i>versus</i> preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes (Journal article)
Kotecha, D., Chudasama, R., Lane, D. A., Kirchhof, P., & Lip, G. Y. H. (2016). Atrial fibrillation and heart failure due to reduced <i>versus</i> preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes. INTERNATIONAL JOURNAL OF CARDIOLOGY, 203, 660-666. doi:10.1016/j.ijcard.2015.10.220DOI: 10.1016/j.ijcard.2015.10.220
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) (Journal article)
Roffi, M., Patrono, C., Collet, J. -P., Mueller, C., Valgimigli, M., Andreotti, F., . . . Zamorano, J. L. (2016). 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). EUROPEAN HEART JOURNAL, 37(3), 267-+. doi:10.1093/eurheartj/ehv320DOI: 10.1093/eurheartj/ehv320
Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS) (Journal article)
Kwon, Y., Norby, F. L., Jensen, P. N., Agarwal, S. K., Soliman, E. Z., Lip, G. Y. H., . . . Chen, L. Y. (2016). Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS). PLOS ONE, 11(1). doi:10.1371/journal.pone.0147065DOI: 10.1371/journal.pone.0147065
Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials (Journal article)
Serban, M. -C., Sahebkar, A., Mikhailidis, D. P., Toth, P. P., Jones, S. R., Muntner, P., . . . Banach, M. (2016). Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials. SCIENTIFIC REPORTS, 6. doi:10.1038/srep19188DOI: 10.1038/srep19188
Low volume-high intensity interval exercise elicits antioxidant and anti-inflammatory effects in humans (Journal article)
Wadley, A. J., Chen, Y. -W., Lip, G. Y. H., Fisher, J. P., & Aldred, S. (2016). Low volume-high intensity interval exercise elicits antioxidant and anti-inflammatory effects in humans. JOURNAL OF SPORTS SCIENCES, 34(1), 1-9. doi:10.1080/02640414.2015.1035666DOI: 10.1080/02640414.2015.1035666
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). (Journal article)
Galiè, N., Humbert, M., Humbert, M., Vachiery, J. -L., Gibbs, S., Lang, I., . . . ESC Scientific Document Group . (2016). 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).. European heart journal, 37(1), 67-119. doi:10.1093/eurheartj/ehv317DOI: 10.1093/eurheartj/ehv317
Adherence to ESC antithrombotic guidelines improves mortality among Italian elderly AF patients: insights from the REPOSI study (Conference Paper)
Proietti, M., Nobili, A., Raparelli, V., Cangemi, R., Napoleone, L., Basili, S., . . . Lip, G. Y. H. (2016). Adherence to ESC antithrombotic guidelines improves mortality among Italian elderly AF patients: insights from the REPOSI study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 845). Retrieved from https://www.webofscience.com/
Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the eurobservational research programme pilot survey on atrial fibrillation (Conference Paper)
Proietti, M., Raparelli, V., Laroche, C., Dan, G. A., Janion, M., Popescu, R., . . . Lip, G. Y. H. (2016). Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the eurobservational research programme pilot survey on atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 289). Retrieved from https://www.webofscience.com/
An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention PIONEER AF-PCI (Conference Paper)
Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., . . . Fox, K. (2016). An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention PIONEER AF-PCI. In CIRCULATION Vol. 134 (pp. E705). Retrieved from https://www.webofscience.com/
Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial (Conference Paper)
Lip, G. Y., Al-Saady, N., Jin, J., Sun, M., Melino, M., Winters, S. M., . . . Zamoryakhin, D. (2016). Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials (Conference Paper)
Brie, D., Sahebkar, A., Dinca, M., Ursoniu, S., Penson, P., Serban, M. C., . . . Banach, M. (2016). Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 339). Retrieved from https://www.webofscience.com/
Atrial fibrillation and diabetes mellitus: evidence of a risky, synergistic, interaction. The results of the EURObservational Research Programme - Atrial Fibrillation (EORP-AF) General Pilot Registry (Conference Paper)
Fumagalli, S., Said, S., Laroche, C., Gabbai, D., Boni, S., Marchionni, N., . . . Lip, G. (2016). Atrial fibrillation and diabetes mellitus: evidence of a risky, synergistic, interaction. The results of the EURObservational Research Programme - Atrial Fibrillation (EORP-AF) General Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 285-286). Retrieved from https://www.webofscience.com/
Beta-blockers in heart failure patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (Conference Paper)
Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Sinagra, G., . . . Lip, G. Y. H. (2016). Beta-blockers in heart failure patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 205). Retrieved from https://www.webofscience.com/
Bleeding risk for non-valvular AF patients prescribed warfarin, or standard doses of apixaban 5mg BID, dabigatran 150mg BID or rivaroxaban 20mg QD in real-world practice: Findings from EHR (Conference Paper)
Lin, I., Masseria, C., Mardekian, J., Park, S., Horblyuk, R., Kamble, S., . . . Lip, G. Y. H. (2016). Bleeding risk for non-valvular AF patients prescribed warfarin, or standard doses of apixaban 5mg BID, dabigatran 150mg BID or rivaroxaban 20mg QD in real-world practice: Findings from EHR. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 402). Retrieved from https://www.webofscience.com/
Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients (Conference Paper)
Rivera-Caravaca, J. M., Esteve-Pastor, M. A., Vicente, V., Valdes, M., Lip, G. Y., Marin, F., & Roldan-Schilling, V. (2016). Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1347-1348). Retrieved from https://www.webofscience.com/
Characteristics and outcomes in elderly Japanese and British patients with atrial fibrillation: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries (Conference Paper)
Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2016). Characteristics and outcomes in elderly Japanese and British patients with atrial fibrillation: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1345). Retrieved from https://www.webofscience.com/
Combining oral anticoagulants with antiplatelet therapy in patients with non-valvular atrial fibrillation: findings from the GLORIA-AF registry program (Conference Paper)
Teutsch, C., Halperin, J., Diener, H. -C., Dubner, S., Ma, C., Rothman, K., . . . Lip, G. Y. H. (2016). Combining oral anticoagulants with antiplatelet therapy in patients with non-valvular atrial fibrillation: findings from the GLORIA-AF registry program. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1192-1193). Retrieved from https://www.webofscience.com/
Comparison of oral anti-coagulants for stroke prevention in non-valvular atrial fibrillation: a multi-criteria decision analysis (Conference Paper)
Lip, G. Y. H., Verdecchia, P., Tervonen, T., Ustyugova, A., Heinrich-Nols, J., Gropper, S., . . . Marsh, K. (2016). Comparison of oral anti-coagulants for stroke prevention in non-valvular atrial fibrillation: a multi-criteria decision analysis. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 41). Retrieved from https://www.webofscience.com/
Comprehensive Laser Sensitivity Profiling and Data Register Bit-Flips for Cryptographic Fault Attacks in 65 Nm FPGA (Conference Paper)
He, W., Breier, J., Bhasin, S., Jap, D., Ong, H. G., & Gan, C. L. (2016). Comprehensive Laser Sensitivity Profiling and Data Register Bit-Flips for Cryptographic Fault Attacks in 65 Nm FPGA. In Unknown Conference (pp. 47-65). Springer International Publishing. doi:10.1007/978-3-319-49445-6_3DOI: 10.1007/978-3-319-49445-6_3
Contemporary results from EHR study of real-world bleeding risk among elderly and overall non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, rivaroxaban and warfarin (Conference Paper)
Lin, I., Masseria, C., Mardekian, J., Park, S., Horblyuk, R., Kamble, S., . . . Lip, G. Y. H. (2016). Contemporary results from EHR study of real-world bleeding risk among elderly and overall non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, rivaroxaban and warfarin. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 235-236). Retrieved from https://www.webofscience.com/
Coronary artery disease and use of dual or triple antithrombotic therapy in patients with atrial fibrillation: the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (Conference Paper)
Proietti, M., Raparelli, V., Tavazzi, L., Maggioni, A. P., Laroche, C., Boriani, G., & Lip, G. Y. H. (2016). Coronary artery disease and use of dual or triple antithrombotic therapy in patients with atrial fibrillation: the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1397). Retrieved from https://www.webofscience.com/
Country differences in patient perceptions of atrial fibrillation, stroke risk, and oral anticoagulation treatment (Conference Paper)
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2016). Country differences in patient perceptions of atrial fibrillation, stroke risk, and oral anticoagulation treatment. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 506). Retrieved from https://www.webofscience.com/
Deprivation and prediction of heart failure in minority ethnic patients: the Ethnic - Echocardiographic Heart of England Screening Study (E-ECHOES) (Conference Paper)
Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2016). Deprivation and prediction of heart failure in minority ethnic patients: the Ethnic - Echocardiographic Heart of England Screening Study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1108). Retrieved from https://www.webofscience.com/
Difficult situations in anticoagulation after stroke: between Scylla and Charybdis (Journal article)
Ntaios, G., & Lip, G. Y. H. (2016). Difficult situations in anticoagulation after stroke: between Scylla and Charybdis. CURRENT OPINION IN NEUROLOGY, 29(1), 42-48. doi:10.1097/WCO.0000000000000283DOI: 10.1097/WCO.0000000000000283
Does renal impairment affect the predictive value of the CHA2DS2VASc score for stroke risk assessment in patients with atrial fibrillation? (Conference Paper)
Fauchier, L., Halimi, J. M., Angoulvant, D., Vourc'h, P., Andres, C., Bisson, A., . . . Lip, G. Y. H. (2016). Does renal impairment affect the predictive value of the CHA2DS2VASc score for stroke risk assessment in patients with atrial fibrillation?. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 245). Retrieved from https://www.webofscience.com/
Editors' Choice 2015 papers in Thrombosis and Haemostasis (Journal article)
Weber, C., & Lip, G. Y. H. (2016). Editors' Choice 2015 papers in Thrombosis and Haemostasis. THROMBOSIS AND HAEMOSTASIS, 115(1), 230-232. doi:10.1160/TH15-11-0911DOI: 10.1160/TH15-11-0911
Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation A Registry Study (Journal article)
Vestergaard, A. S., Skjoth, F., Lip, G. Y. H., & Larsen, T. B. (2016). Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation A Registry Study. STROKE, 47(4), 979-985. doi:10.1161/STROKEAHA.115.012338DOI: 10.1161/STROKEAHA.115.012338
Effect of beta-blocker use on mortality in patients with atrial fibrillation. A cohort study (Conference Paper)
Fauchier, L., Clementy, N., Bisson, A., Angoulvant, D., Angoulvant, T. B., Bernard, A., . . . Lip, G. Y. H. (2016). Effect of beta-blocker use on mortality in patients with atrial fibrillation. A cohort study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 290). Retrieved from https://www.webofscience.com/
Brie, D., Sahebkar, A., Penson, P. E., Dinca, M., Ursoniu, S., Serban, M. -C., . . . Banach, M. (2016). Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials. JOURNAL OF HYPERTENSION, 34(12), 2318-2329. doi:10.1097/HJH.0000000000001086DOI: 10.1097/HJH.0000000000001086
Ethnic disparities between Japanese and British atrial fibrillation patients with previous stroke: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries (Conference Paper)
Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2016). Ethnic disparities between Japanese and British atrial fibrillation patients with previous stroke: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1137-1138). Retrieved from https://www.webofscience.com/
Evaluation of the corrosion performance of Cu–Al intermetallic compounds and the effect of Pd addition (Journal article)
Lim, A. B. Y., Neo, W. J., Yauw, O., Chylak, B., Gan, C. L., & Chen, Z. (2016). Evaluation of the corrosion performance of Cu–Al intermetallic compounds and the effect of Pd addition. Microelectronics Reliability, 56, 155-161. doi:10.1016/j.microrel.2015.10.012DOI: 10.1016/j.microrel.2015.10.012
Factors associated with quality of anticoagulation control in patients with atrial fibrillation and risk of stroke and bleeding (Conference Paper)
Bonde, A. N., Lip, G. Y. H., Kamper, A. L., Staerk, L., Gislason, G., Torp-Pedersen, C., & Olesen, J. B. (2016). Factors associated with quality of anticoagulation control in patients with atrial fibrillation and risk of stroke and bleeding. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 402). Retrieved from https://www.webofscience.com/
From clinical trials to real-world clinical practice: observations on the direct oral anticoagulants (Journal article)
Lip, G. Y. H. (2016). From clinical trials to real-world clinical practice: observations on the direct oral anticoagulants. LANCET HAEMATOLOGY, 3(1), E2-E3. doi:10.1016/S2352-3026(15)00282-3DOI: 10.1016/S2352-3026(15)00282-3
Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry (Conference Paper)
Mazurek, M., Shantsila, E., Lane, D., Wolff, A., Proietti, M., & Lip, G. Y. (2016). Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1348). Retrieved from https://www.webofscience.com/
Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa (Journal article)
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J. -P., Zotti, F. D., . . . Walker, D. M. (2016). Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa. Revista Española de Cardiología, 69(1), 69.e1-69.e49. doi:10.1016/j.recesp.2015.11.015DOI: 10.1016/j.recesp.2015.11.015
Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis (Journal article)
Tang, L., Wu, Y. -Y., Lip, G. Y. H., Yin, P., & Hu, Y. (2016). Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis. LANCET HAEMATOLOGY, 3(1), E30-E44. doi:10.1016/S2352-3026(15)00228-8DOI: 10.1016/S2352-3026(15)00228-8
Hypertension in patients with Atrial Fibrillation: the EURObservational research programme on atrial fibrillation (EORP-AF) pilot registry (Conference Paper)
Dan, G. A., Badila, E., Weiss, E., Laroche, C., Boriani, G., Dan, A., . . . Lip, G. Y. H. (2016). Hypertension in patients with Atrial Fibrillation: the EURObservational research programme on atrial fibrillation (EORP-AF) pilot registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 617). Retrieved from https://www.webofscience.com/
IMPACT OF AN ATRIAL FIBRILLATION DECISION SUPPORT TOOL (AFDST) ON THROMBOPROPHYLAXIS FOR ATRIAL FIBRILLATION (Conference Paper)
Eckman, M. H., Lip, G. Y., Wise, R. E., Speer, B., Sullivan, M. D., Walker, N., . . . Kues, J. (2016). IMPACT OF AN ATRIAL FIBRILLATION DECISION SUPPORT TOOL (AFDST) ON THROMBOPROPHYLAXIS FOR ATRIAL FIBRILLATION. In JOURNAL OF GENERAL INTERNAL MEDICINE Vol. 31 (pp. S258-S259). Retrieved from https://www.webofscience.com/
Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms (Conference Paper)
Chrusciel, P., Sahebkar, A., Rembek, M., Serban, M. C., Ursoniu, S., Mikhailidis, D. P., . . . Banach, M. (2016). Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 736). Retrieved from https://www.webofscience.com/
Inflammation and myocardial stiffness in hypertension: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES) (Conference Paper)
Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2016). Inflammation and myocardial stiffness in hypertension: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). In JOURNAL OF HUMAN HYPERTENSION Vol. 30 (pp. 648). Retrieved from https://www.webofscience.com/
Is major bleeding risk for oral anticoagulants similar between non-valvular atrial fibrillation patients newly initiated on warfarin and propensity-score matched NOAC initiators? A real world study (Conference Paper)
Lip, G. Y. H., Keshishian, A., Kamble, S., Pan, X., Burns, L., Mardekian, J., . . . Hamilton, M. (2016). Is major bleeding risk for oral anticoagulants similar between non-valvular atrial fibrillation patients newly initiated on warfarin and propensity-score matched NOAC initiators? A real world study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 493). Retrieved from https://www.webofscience.com/
Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF) (Conference Paper)
Lip, G. Y. H., Hammerstingl, C., Marin, F., Cappato, R., Meng, I. L., Kirsch, B., . . . Cohen, A. (2016). Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). In EUROPEAN HEART JOURNAL Vol. 37 (pp. 501). Retrieved from https://www.webofscience.com/
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) biomarker substudy (Conference Paper)
Marin, F., Hammerstingl, C., Cappato, R., Kramer, F., Meng, I. L., Cohen, A., . . . Lip, G. Y. H. (2016). Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) biomarker substudy. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 503). Retrieved from https://www.webofscience.com/
Major bleeding risk in patients 75 years of age or older with non-valvular atrial fibrillation initiating oral anticoagulants: a real-world comparison of warfarin, apixaban, dabigatran, or rivaroxaban (Conference Paper)
Lip, G. Y. H., Keshishian, A., Kamble, S., Pan, X., Burns, L., Mardekian, J., . . . Hamilton, M. (2016). Major bleeding risk in patients 75 years of age or older with non-valvular atrial fibrillation initiating oral anticoagulants: a real-world comparison of warfarin, apixaban, dabigatran, or rivaroxaban. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 500-501). Retrieved from https://www.webofscience.com/
Major cardiovascular outcomes in anticoagulated atrial fibrillation patients with one stroke risk factor (CHA2DS2-VASc 1 in males, 2 in females): impact of time in therapeutic range (Conference Paper)
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Major cardiovascular outcomes in anticoagulated atrial fibrillation patients with one stroke risk factor (CHA2DS2-VASc 1 in males, 2 in females): impact of time in therapeutic range. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1348). Retrieved from https://www.webofscience.com/
Major cardiovascular risk factors in an unselected "real world" screening cohort: insights from the Belgian heart rhythm week programme (Conference Paper)
Proietti, M., Mairesse, G. H., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Lip, G. Y. H. (2016). Major cardiovascular risk factors in an unselected "real world" screening cohort: insights from the Belgian heart rhythm week programme. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 347-348). Retrieved from https://www.webofscience.com/
Management of atrial fibrillation in specific patient populations (Journal article)
Szymanski, F. M., Lip, G. Y. H., & Filipiak, K. J. (2016). Management of atrial fibrillation in specific patient populations. KARDIOLOGIA POLSKA, 74(1), 1-8. doi:10.5603/KP.a2015.0223DOI: 10.5603/KP.a2015.0223
May your New Year be happy and prosperous with "Thrombosis and Haemostasis" (Journal article)
Lip, G. Y. H., & Weber, C. (2016). May your New Year be happy and prosperous with "Thrombosis and Haemostasis". THROMBOSIS AND HAEMOSTASIS, 115(1), 1-2. doi:10.1160/TH15-11-0912DOI: 10.1160/TH15-11-0912
Monocyte-platelet aggregates associated with CD14++CD16+monocytes predict diffuse coronary artery disease: relationship to microvascular function (Conference Paper)
Brown, R. A., Lip, G. Y. H., Varma, C., & Shantsila, E. (2016). Monocyte-platelet aggregates associated with CD14++CD16+monocytes predict diffuse coronary artery disease: relationship to microvascular function. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 812). Retrieved from https://www.webofscience.com/
Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation An analysis of 425,600 Chinese individuals without prior stroke (Journal article)
Guo, Y., Wang, H., Tian, Y., Wang, Y., & Lip, G. Y. H. (2016). Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation An analysis of 425,600 Chinese individuals without prior stroke. THROMBOSIS AND HAEMOSTASIS, 115(1), 184-192. doi:10.1160/TH15-07-0577DOI: 10.1160/TH15-07-0577
Non-vitamin K antagonist oral anticoagulation usage in elderly patients with atrial fibrillation: Danish nationwide data with temporal trends from 2011 to 2015 (Conference Paper)
Staerk, L., Fosbol, E. L. F., Gadsboll, K. G., Sindet-Pedersen, C. S. P., Pallisgaard, J. L. P., Lamberts, M. L., . . . Olesen, J. B. O. (2016). Non-vitamin K antagonist oral anticoagulation usage in elderly patients with atrial fibrillation: Danish nationwide data with temporal trends from 2011 to 2015. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 501). Retrieved from https://www.webofscience.com/
Overweight and obesity in female and male patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (Conference Paper)
Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Sinagra, G., . . . Lip, G. Y. H. (2016). Overweight and obesity in female and male patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 929). Retrieved from https://www.webofscience.com/
Poor anticoagulation control in warfarin treated atrial fibrillation patients with reduced renal function (Conference Paper)
Bonde, A. N., Lip, G. Y. H., Kamper, A. L., Staerk, L., Torp-Pedersen, C., Gislason, G., & Olesen, J. B. (2016). Poor anticoagulation control in warfarin treated atrial fibrillation patients with reduced renal function. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 499-500). Retrieved from https://www.webofscience.com/
Predicting the Risk of Failure and Recurrence After Electrical Cardioversion for Acute Atrial Fibrillation: Derivation and Validation of the AF-CVS Score (Conference Paper)
Jaakkola, S., Lip, G. Y., Nuotio, I., Biancari, F., Hartikainen, J. E., & Airaksinen, J. K. (2016). Predicting the Risk of Failure and Recurrence After Electrical Cardioversion for Acute Atrial Fibrillation: Derivation and Validation of the AF-CVS Score. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Predicting the Risk of Failure and Recurrence After Electrical Cardioversion for Acute Atrial Fibrillation: Derivation and Validation of the AF-CVS Score (Conference Paper)
Jaakkola, S., Lip, G. Y., Nuotio, I., Biancari, F., Hartikainen, J. E., & Airaksinen, J. K. (2016). Predicting the Risk of Failure and Recurrence After Electrical Cardioversion for Acute Atrial Fibrillation: Derivation and Validation of the AF-CVS Score. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Preexisting cardiovascular comorbidities underlie newly diagnosed atrial fibrillation after acute ischemic stroke (Conference Paper)
Fauchier, L., Bisson, A., Clementy, N., Angoulvant, D., Babuty, D., & Lip, G. Y. H. (2016). Preexisting cardiovascular comorbidities underlie newly diagnosed atrial fibrillation after acute ischemic stroke. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 615). Retrieved from https://www.webofscience.com/
Premature cardiac ageing in South Asians: the ethnic-echocardiographic heart of England screening study (E-ECHOES) (Conference Paper)
Shantsila, E., Shantsila, A., Gill, P. S., & Lip, G. Y. H. (2016). Premature cardiac ageing in South Asians: the ethnic-echocardiographic heart of England screening study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 37 (pp. 931). Retrieved from https://www.webofscience.com/
Preventing Thrombosis to Improve Outcomes in Heart Failure Patients (Journal article)
Shantsila, E., & Lip, G. Y. H. (2016). Preventing Thrombosis to Improve Outcomes in Heart Failure Patients. PROGRESS IN CARDIOVASCULAR DISEASES, 58(4), 386-392. doi:10.1016/j.pcad.2015.09.005DOI: 10.1016/j.pcad.2015.09.005
Real World Bleeding Risks in Non-valvular Atrial Fibrillation Patients With Heart Failure: Contemporary EHR Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban and Warfarin (Conference Paper)
Lin, I., Horblyuk, R., Mardekian, J., Park, S. H., Kamble, S., Hamilton, M., . . . Lip, G. Y. (2016). Real World Bleeding Risks in Non-valvular Atrial Fibrillation Patients With Heart Failure: Contemporary EHR Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban and Warfarin. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Real world comparison of major bleeding risk among nonvalvular atrial fibrillation patients newly initiated on apixaban, warfarin, dabigatran or rivaroxaban: a 1:1 propensity-score matched analysis (Conference Paper)
Lip, G., Keshishian, A., Kamble, S., Pan, X., Burns, L., Mardekian, J., . . . Phatak, H. (2016). Real world comparison of major bleeding risk among nonvalvular atrial fibrillation patients newly initiated on apixaban, warfarin, dabigatran or rivaroxaban: a 1:1 propensity-score matched analysis. In PHARMACOTHERAPY Vol. 36 (pp. E213). Retrieved from https://www.webofscience.com/
Real-world comparisons of major bleeding risk and major bleeding-related hospitalization costs among elderly non-valvular atrial fibrillation patients newly initiated on apixaban or warfarin (Conference Paper)
Kamble, S., Keshishian, A., Pan, X., Mardekian, J., Horbkyuk, R., Hamilton, M., & Lip, G. Y. H. (2016). Real-world comparisons of major bleeding risk and major bleeding-related hospitalization costs among elderly non-valvular atrial fibrillation patients newly initiated on apixaban or warfarin. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 496). Retrieved from https://www.webofscience.com/
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention.. F1000Research, 5, 2887. doi:10.12688/f1000research.10176.1DOI: 10.12688/f1000research.10176.1
Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: the SPORTIF trials (Conference Paper)
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: the SPORTIF trials. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1348). Retrieved from https://www.webofscience.com/
Relationship between COPD and all-cause death in patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (Conference Paper)
Proietti, M., Laroche, C., Tavazzi, L., Maggioni, A. P., Boriani, G., & Lip, G. Y. H. (2016). Relationship between COPD and all-cause death in patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 292). Retrieved from https://www.webofscience.com/
Relationship of left ventricular hypertrophy to vascular events in patients with non-valvular atrial fibrillation: the ARAPACIS study (Conference Paper)
Proietti, M., Marra, A. M., Tassone, E. J., Corrao, S., Vestri, A. R., Perticone, F., . . . Raparelli, V. (2016). Relationship of left ventricular hypertrophy to vascular events in patients with non-valvular atrial fibrillation: the ARAPACIS study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 848-849). Retrieved from https://www.webofscience.com/
Relationship of rate and rhythm control strategies to adverse outcomes in patients with atrial fibrillation: the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry (Conference Paper)
Purmah, Y., Proietti, M., Laroche, C., Tavazzi, L., Maggioni, A. P., Boriani, G., . . . Lip, G. Y. H. (2016). Relationship of rate and rhythm control strategies to adverse outcomes in patients with atrial fibrillation: the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 601-602). Retrieved from https://www.webofscience.com/
Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke" (Journal article)
Pastori, D., Pignatelli, P., Saliola, M., Carnevale, R., Vicario, T., Cangemi, R., . . . Violi, F. (2016). Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke". INTERNATIONAL JOURNAL OF CARDIOLOGY, 202, 934-935. doi:10.1016/j.ijcard.2015.10.122DOI: 10.1016/j.ijcard.2015.10.122
Secondary versus primary stroke prevention in atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry (Conference Paper)
Mazurek, M., Shantsila, E., Lane, D., Wolff, A., Proietti, M., & Lip, G. Y. (2016). Secondary versus primary stroke prevention in atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 845). Retrieved from https://www.webofscience.com/
Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists (Journal article)
Tran, R. T., Rankin, A. J., Abdul-Rahim, A. H., Lip, G. Y. H., Rankin, A. C., & Lees, K. R. (2016). Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 46(2), 87-92. doi:10.4997/JRCPE.2016.204DOI: 10.4997/JRCPE.2016.204
Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation (Conference Paper)
Fauchier, L., Philippart, R., Bernard, A., Clementy, N., Bourguignon, T., Angoulvant, D., . . . Lip, G. (2016). Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Stroke and all cause mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in atrial fibrillation: a nationwide study (Conference Paper)
Staerk, L., Fosbol, E. L. F., Bonde, A. N. B., Lip, G. Y. H. L., Torp-Pedersen, C. T. P., & Gislason, G. H. G. (2016). Stroke and all cause mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in atrial fibrillation: a nationwide study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 393). Retrieved from https://www.webofscience.com/
Stroke prevention in atrial fibrillation: changing concepts (vol 1, pg 76, 2015) (Journal article)
Lip, G. Y. H. (2016). Stroke prevention in atrial fibrillation: changing concepts (vol 1, pg 76, 2015). EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2(4), 217. Retrieved from https://www.webofscience.com/
The Obesity Paradox in patients with non-valvular atrial fibrillation: observations from the SPORTIF trials (Conference Paper)
Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). The Obesity Paradox in patients with non-valvular atrial fibrillation: observations from the SPORTIF trials. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 828). Retrieved from https://www.webofscience.com/
The impact of atrial fibrillation on risk of recurrence and mortality among patients with venous thromboembolism (Conference Paper)
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2016). The impact of atrial fibrillation on risk of recurrence and mortality among patients with venous thromboembolism. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 615). Retrieved from https://www.webofscience.com/
The impact of statin therapy on plasma levels of von Willebrand factor antigen Systematic review and meta-analysis of randomised placebo-controlled trials (Journal article)
Sahebkar, A., Serban, C., Ursoniu, S., Mikhailidis, D. P., Undas, A., Lip, G. Y. H., . . . Banach, M. (2016). The impact of statin therapy on plasma levels of von Willebrand factor antigen Systematic review and meta-analysis of randomised placebo-controlled trials. THROMBOSIS AND HAEMOSTASIS, 115(3), 520-532. doi:10.1160/TH15-08-0620DOI: 10.1160/TH15-08-0620
Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry (Conference Paper)
Proietti, M., Airaksinen, K. E. J., Rubboli, A., Schlitt, A., Kiviniemi, T., Karjalainen, P. P., & Lip, G. Y. (2016). Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry (Conference Paper)
Proietti, M., Airaksinen, K. E. J., Rubboli, A., Schlitt, A., Kiviniemi, T., Karjalainen, P. P., & Lip, G. Y. (2016). Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation (Conference Paper)
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2016). Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1006). Retrieved from https://www.webofscience.com/
Von Willebrand factor predicts adverse events in real world anticoagulated atrial fibrillation patients (Conference Paper)
Roldan-Schilling, V., Rivera-Caravaca, J. M., Hernandez-Romero, D., Esteve-Pastor, M. A., Vicente, V., Valdes, M., . . . Marin, F. (2016). Von Willebrand factor predicts adverse events in real world anticoagulated atrial fibrillation patients. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1200). Retrieved from https://www.webofscience.com/
When should we start thromboprophylaxis? The stroke risk threshold discrepancy between European and US guidelines for atrial fibrillation (Conference Paper)
Nielsen, P. B., Larsen, T. B., Skjoeth, F., Overvad, T. F., & Lip, G. Y. H. (2016). When should we start thromboprophylaxis? The stroke risk threshold discrepancy between European and US guidelines for atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 235). Retrieved from https://www.webofscience.com/
Which Oral Anti-Coagulant Do Patients Prefer for Stroke Prevention in Non-Valvular Atrial Fibrillation? (Conference Paper)
Lip, G. Y., Verdecchia, P., Tervonen, T., Ustyugova, A., Heinrich-Nols, J., Gropper, S., . . . Marsh, K. (2016). Which Oral Anti-Coagulant Do Patients Prefer for Stroke Prevention in Non-Valvular Atrial Fibrillation?. In CIRCULATION Vol. 134. Retrieved from https://www.webofscience.com/
2015
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference (Journal article)
Kirchhof, P., Breithardt, G., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., Boriani, G., . . . Camm, A. J. (2016). A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. EUROPACE, 18(1), 37-50. doi:10.1093/europace/euv304DOI: 10.1093/europace/euv304
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society (Journal article)
Lip, G. Y. H., Heinzel, F. R., Gaita, F., Gonzalez Juanatey, J. R., Le Heuzey, J. Y., Potpara, T., . . . Pieske, B. (2016). European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. EUROPACE, 18(1), 12-36. doi:10.1093/europace/euv191DOI: 10.1093/europace/euv191
Patients with atrial fibrillation undergoing percutaneous coronary intervention (Journal article)
Dzeshka, M. S., Brown, R. A., & Lip, G. Y. H. (2015). Patients with atrial fibrillation undergoing percutaneous coronary intervention. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 125(1-2), 73-+. doi:10.20452/pamw.2650DOI: 10.20452/pamw.2650
Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation (Journal article)
Pastori, D., Pignatelli, P., Saliola, M., Carnevale, R., Vicario, T., Del Ben, M., . . . Violi, F. (2015). Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 201, 513-516. doi:10.1016/j.ijcard.2015.08.054DOI: 10.1016/j.ijcard.2015.08.054
Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study (Journal article)
Blann, A. D., Banerjee, A., Lane, D. A., Torp-Pedersen, C., & Lip, G. Y. H. (2015). Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 201, 693-698. doi:10.1016/j.ijcard.2015.08.074DOI: 10.1016/j.ijcard.2015.08.074
Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project (Journal article)
Xiong, Q., Shantsila, A., Lane, D. A., Zhou, Q., Liu, Y., Shen, Y., . . . Lip, G. Y. H. (2015). Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 201, 195-199. doi:10.1016/j.ijcard.2015.08.076DOI: 10.1016/j.ijcard.2015.08.076
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis (Journal article)
Andreotti, F., Rocca, B., Husted, S., Ajjan, R. A., ten Berg, J., Cattaneo, M., . . . Storey, R. F. (2015). Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. EUROPEAN HEART JOURNAL, 36(46), 3238-+. doi:10.1093/eurheartj/ehv304DOI: 10.1093/eurheartj/ehv304
Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors (Journal article)
Lip, G. Y. H., & Lane, D. A. (2015). Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors. EUROPEAN HEART JOURNAL, 36(46), 3265-3267. doi:10.1093/eurheartj/ehv415DOI: 10.1093/eurheartj/ehv415
Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II (Conference Paper)
Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. C., Dubner, S. J., . . . Lip, G. Y. H. (2015). Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II. In AMERICAN JOURNAL OF MEDICINE Vol. 128 (pp. 1306-+). doi:10.1016/j.amjmed.2015.07.013DOI: 10.1016/j.amjmed.2015.07.013
Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study (Journal article)
Lip, G. Y. H., Skjoth, F., Overvad, K., Rasmussen, L. H., & Larsen, T. B. (2015). Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. CLINICAL RESEARCH IN CARDIOLOGY, 104(12), 1088-1096. doi:10.1007/s00392-015-0878-4DOI: 10.1007/s00392-015-0878-4
CD4<SUP>+</SUP> T cell surface alpha enolase is lower in older adults (Journal article)
Bennett, S. J., Augustyniak, E. M., Dunston, C. R., Brown, R. A., Shantsila, E., Lip, G. Y. H., . . . Griffiths, H. R. (2015). CD4<SUP>+</SUP> T cell surface alpha enolase is lower in older adults. MECHANISMS OF AGEING AND DEVELOPMENT, 152, 56-62. doi:10.1016/j.mad.2015.09.005DOI: 10.1016/j.mad.2015.09.005
Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) (Journal article)
Lane, D. A., Aguinaga, L., Blomstrom-Lundqvist, C., Boriani, G., Dan, G. -A., Hills, M. T., . . . Potpara, T. S. (2015). Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). EUROPACE, 17(12), 1747-1769. doi:10.1093/europace/euv233DOI: 10.1093/europace/euv233
Exposure-response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation (Journal article)
Lip, G. Y. H., Rasmussen, L. H., Olsson, S. B., Jensen, E., Hamren, B., Eriksson, U. G., & Wahlander, K. (2015). Exposure-response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 80(6), 1362-1373. doi:10.1111/bcp.12719DOI: 10.1111/bcp.12719
Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST (Journal article)
Roffi, M., Patrono, C., Collet, J. -P., Mueller, C., Valgimigli, M., Andreotti, F., . . . Zamorano, J. L. (2015). Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST. Revista Española de Cardiología, 68(12), 1125.e1-1125.e64. doi:10.1016/j.recesp.2015.10.012DOI: 10.1016/j.recesp.2015.10.012
Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation The Fushimi Atrial Fibrillation Registry (Journal article)
Takabayashi, K., Hamatani, Y., Yamashita, Y., Takagi, D., Unoki, T., Ishii, M., . . . Akao, M. (2015). Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation The Fushimi Atrial Fibrillation Registry. STROKE, 46(12), 3354-3361. doi:10.1161/STROKEAHA.115.010947DOI: 10.1161/STROKEAHA.115.010947
LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention (Journal article)
Dias, H. K. I., Brown, C. L. R., Polidori, M. C., Lip, G. Y. H., & Griffiths, H. R. (2015). LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention. CLINICAL SCIENCE, 129(12), 1195-1206. doi:10.1042/CS20150351DOI: 10.1042/CS20150351
Matching the NOAC to the Patient Remember the Modifiable Bleeding Risk Factors (Journal article)
Lip, G. Y. H., & Lane, D. A. (2015). Matching the NOAC to the Patient Remember the Modifiable Bleeding Risk Factors. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(21), 2282-2284. doi:10.1016/j.jacc.2015.07.086DOI: 10.1016/j.jacc.2015.07.086
Response to Letter Regarding Article, " Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation : Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure ( CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca- Heart Failure ( GISSI- HF) Trials." (Journal article)
Abdul-Rahim, A. H., Perez, A. -C., Fulton, R. L., Jhund, P. S., Latini, R., Tognoni, G., . . . McMurray, J. J. V. (2015). Response to Letter Regarding Article, " Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation : Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure ( CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca- Heart Failure ( GISSI- HF) Trials.". CIRCULATION, 132(22), E358. doi:10.1161/CIRCULATIONAHA.115.018395DOI: 10.1161/CIRCULATIONAHA.115.018395
Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation (Journal article)
Lerario, M. P., Gialdini, G., Lapidus, D. M., Shaw, M. M., Navi, B. B., Merkler, A. E., . . . Kamel, H. (2015). Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation. PLOS ONE, 10(12). doi:10.1371/journal.pone.0145579DOI: 10.1371/journal.pone.0145579
Stroke Risk,Factors Beyond the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score: Can We Improve Our Identification of "High. Stroke Risk" Patients With Atrial Fibrillation? (Journal article)
Szymanski, F. M., Lip, G. Y. H., Filipiak, K. J., Platek, A. E., Hrynkiewicz-Szymanska, A., & Opolski, G. (2015). Stroke Risk,Factors Beyond the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score: Can We Improve Our Identification of "High. Stroke Risk" Patients With Atrial Fibrillation?. AMERICAN JOURNAL OF CARDIOLOGY, 116(11), 1781-1788. doi:10.1016/j.amjcard.2015.08.049DOI: 10.1016/j.amjcard.2015.08.049
Stroke prevention in atrial fibrillation: Where are we now? (Journal article)
Lip, G. Y. H. (2015). Stroke prevention in atrial fibrillation: Where are we now?. Indian heart journal, 67 Suppl 2, S1-S3. doi:10.1016/j.ihj.2015.11.002DOI: 10.1016/j.ihj.2015.11.002
Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (Journal article)
Dzeshka, M. S., & Lip, G. Y. H. (2015). Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. EXPERT OPINION ON PHARMACOTHERAPY, 16(17), 2661-2678. doi:10.1517/14656566.2015.1104301DOI: 10.1517/14656566.2015.1104301
2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). (Journal article)
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J. -P., Del Zotti, F., . . . ESC Scientific Document Group . (2015). 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).. European heart journal, 36(44), 3075-3128. doi:10.1093/eurheartj/ehv319DOI: 10.1093/eurheartj/ehv319
Copper micro and nano particles mixture for 3D interconnections application (Conference Paper)
Yuan Yuan Dai., Mei Zhen Ng., Anantha, P., Chee Lip Gan., & Chuan Seng Tan. (2015). Copper micro and nano particles mixture for 3D interconnections application. In 2015 International 3D Systems Integration Conference (3DIC). IEEE. doi:10.1109/3dic.2015.7334614DOI: 10.1109/3dic.2015.7334614
Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study (Conference Paper)
Staerk, L., Lip, G. Y. H., Olesen, J. B., Fosbol, E. L., Pallisgaard, J. L., Bonde, A. N., . . . Gislason, G. H. (2015). Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. In BMJ-BRITISH MEDICAL JOURNAL Vol. 351. doi:10.1136/bmj.h5876DOI: 10.1136/bmj.h5876
Predictive accuracy of CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy (Journal article)
Capodanno, D., Rossini, R., Musumeci, G., Lettieri, C., Senni, M., Valsecchi, O., . . . Lip, G. Y. H. (2015). Predictive accuracy of CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy. INTERNATIONAL JOURNAL OF CARDIOLOGY, 199, 319-325. doi:10.1016/j.ijcard.2015.07.064DOI: 10.1016/j.ijcard.2015.07.064
Risk and prediction of dementia in patients with atrial fibrillation - A nationwide population-based cohort study (Journal article)
Liao, J. -N., Chao, T. -F., Liu, C. -J., Wang, K. -L., Chen, S. -J., Tuan, T. -C., . . . Chen, S. -A. (2015). Risk and prediction of dementia in patients with atrial fibrillation - A nationwide population-based cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 199, 25-30. doi:10.1016/j.ijcard.2015.06.170DOI: 10.1016/j.ijcard.2015.06.170
Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry (Journal article)
Lip, G. Y. H., Laroche, C., Popescu, M. I., Rasmussen, L. H., Vitali-Serdoz, L., Dan, G. -A., . . . Boriani, G. (2015). Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. EUROPACE, 17(12), 1777-1786. doi:10.1093/europace/euv269DOI: 10.1093/europace/euv269
2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). (Journal article)
Adler, Y., Charron, P., Imazio, M., Badano, L., Barón-Esquivias, G., Bogaert, J., . . . ESC Scientific Document Group . (2015). 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).. European heart journal, 36(42), 2921-2964. doi:10.1093/eurheartj/ehv318DOI: 10.1093/eurheartj/ehv318
Withdrawn as Duplicate: The CHA₂DS₂-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history. (Journal article)
Lip, G. Y. H. (2015). Withdrawn as Duplicate: The CHA₂DS₂-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history.. European heart journal, 36(42), 2880-2885. doi:10.1093/eurheartj/ehv431DOI: 10.1093/eurheartj/ehv431
Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry (Conference Paper)
Hamatani, Y., Yamashita, Y., Esato, M., Chun, Y. -H., Tsuji, H., Wada, H., . . . Akao, M. (2015). Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry. In PLOS ONE Vol. 10. doi:10.1371/journal.pone.0142394DOI: 10.1371/journal.pone.0142394
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). (Journal article)
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . ESC Scientific Document Group . (2015). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).. European heart journal, 36(41), 2793-2867. doi:10.1093/eurheartj/ehv316DOI: 10.1093/eurheartj/ehv316
Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation (Journal article)
Lip, G. Y. H., Lanitis, T., Kongnakorn, T., Phatak, H., Chalkiadaki, C., Liu, X., . . . Dorian, P. (2015). Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation. CLINICAL THERAPEUTICS, 37(11), 2476-2488. doi:10.1016/j.clinthera.2015.09.005DOI: 10.1016/j.clinthera.2015.09.005
Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic (Journal article)
Hajhosseiny, R., Matthews, G. K., & Lip, G. Y. H. (2015). Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic. HEART RHYTHM, 12(11), 2332-2343. doi:10.1016/j.hrthm.2015.06.038DOI: 10.1016/j.hrthm.2015.06.038
Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials (Journal article)
Xiong, Q., Lau, Y. C., Senoo, K., Lane, D. A., Hong, K., & Lip, G. Y. H. (2015). Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials. EUROPEAN JOURNAL OF HEART FAILURE, 17(11), 1192-1200. doi:10.1002/ejhf.343DOI: 10.1002/ejhf.343
Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: comment (Journal article)
Husted, S., Lip, G. Y. H., & De Caterina, R. (2015). Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: comment. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(11), 2130-2132. doi:10.1111/jth.13124DOI: 10.1111/jth.13124
Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation AMADEUS Trial (Journal article)
Senoo, K., & Lip, G. Y. H. (2015). Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation AMADEUS Trial. STROKE, 46(11), 3202-3207. doi:10.1161/STROKEAHA.115.010614DOI: 10.1161/STROKEAHA.115.010614
Safety and efficacy of abciximab in older adults undergoing percutaneous coronary intervention (Journal article)
Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2015). Safety and efficacy of abciximab in older adults undergoing percutaneous coronary intervention. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(11), 1334-1340. doi:10.1111/ijcp.12702DOI: 10.1111/ijcp.12702
Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure (Journal article)
Montoro-Garcia, S., Shantsila, E., Wrigley, B. J., Tapp, L. D., Abellan Aleman, J., & Lip, G. Y. H. (2015). Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure. REVISTA ESPANOLA DE CARDIOLOGIA, 68(11), 951-958. doi:10.1016/j.rec.2014.11.016DOI: 10.1016/j.rec.2014.11.016
Stroke in atrial fibrillation and improving the identification of 'high-risk' patients: the crossroads of immunity and thrombosis (Journal article)
Shantsila, E., & Lip, G. Y. H. (2015). Stroke in atrial fibrillation and improving the identification of 'high-risk' patients: the crossroads of immunity and thrombosis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(11), 1968-1970. doi:10.1111/jth.13121DOI: 10.1111/jth.13121
The SAMe-TT<sub>2</sub>R<sub>2</sub> Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study (Journal article)
Roldan, V., Cancio, S., Galvez, J., Valdes, M., Vicente, V., Marin, F., & Lip, G. Y. H. (2015). The SAMe-TT<sub>2</sub>R<sub>2</sub> Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study. AMERICAN JOURNAL OF MEDICINE, 128(11), 1237-1243. doi:10.1016/j.amjmed.2015.05.036DOI: 10.1016/j.amjmed.2015.05.036
Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic (Journal article)
Lee, S. I., Sayers, M., Lip, G. Y. H., & Lane, D. A. (2015). Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(11), 1341-1348. doi:10.1111/ijcp.12712DOI: 10.1111/ijcp.12712
Intracerebral haemorrhage, atrial fibrillation, and anticoagulation (Journal article)
Wilson, D., Salman, R. A. -S., Klijn, C. J. M., Lip, G. Y. H., & Werring, D. J. (2015). Intracerebral haemorrhage, atrial fibrillation, and anticoagulation. LANCET, 386(10005), 1736-1737. doi:10.1016/S0140-6736(15)00695-9DOI: 10.1016/S0140-6736(15)00695-9
Composite end point analyses of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation (Journal article)
Madzak, A., Larsen, T. B., Lane, D. A., Lip, G. Y. H., & Nielsen, P. B. (2015). Composite end point analyses of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 13(10), 1155-1163. doi:10.1586/14779072.2015.1086643DOI: 10.1586/14779072.2015.1086643
An update on atrial fibrillation: focus on stroke risk reduction strategies (Journal article)
Potpara, T. S., Jokic, V., Medic, B., Prostran, M., & Lip, G. Y. H. (2015). An update on atrial fibrillation: focus on stroke risk reduction strategies. MINERVA MEDICA, 106(5), 259-273. Retrieved from https://www.webofscience.com/
Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control. (Journal article)
Chan, P. -H., Li, W. -H., Hai, J. -J., Chan, K. -H., Tse, H. -F., Cheung, B. M. -Y., . . . Siu, C. -W. (2015). Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control.. European heart journal. Cardiovascular pharmacotherapy, 1(4), 265-272. doi:10.1093/ehjcvp/pvv032DOI: 10.1093/ehjcvp/pvv032
Gender differences in clinical characteristics and inpatient outcomes amongst 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Registry (Conference Paper)
Xiong, Q., Shantsila, A., Zhou, Q., Liu, Y., Shen, Y., Lane, D., . . . Lip, G. Y. H. (2015). Gender differences in clinical characteristics and inpatient outcomes amongst 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Registry. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 66 (pp. C184). doi:10.1016/j.jacc.2015.06.703DOI: 10.1016/j.jacc.2015.06.703
Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by Italian internists. A survey from the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study (Journal article)
Pignatelli, P., Pastori, D., Perticone, F., Corazza, G. R., & Violi, F. (2015). Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by Italian internists. A survey from the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 26(8), E31-E33. doi:10.1016/j.ejim.2015.06.007DOI: 10.1016/j.ejim.2015.06.007
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint (Journal article)
Rubboli, A., Agewall, S., Huber, K., & Lip, G. Y. H. (2015). New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint. INTERNATIONAL JOURNAL OF CARDIOLOGY, 196, 133-138. doi:10.1016/j.ijcard.2015.06.006DOI: 10.1016/j.ijcard.2015.06.006
Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients with Atrial Fibrillation and Heart Failure: A Systemic Review and Meta-analysis of randomized trials (Conference Paper)
Xiong, Q., Lau, Y., Senoo, K., Hong, K., & Lip, G. Y. H. (2015). Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients with Atrial Fibrillation and Heart Failure: A Systemic Review and Meta-analysis of randomized trials. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 66 (pp. C269-C270). doi:10.1016/j.jacc.2015.06.1049DOI: 10.1016/j.jacc.2015.06.1049
Optimizing Atrial Fibrillation Management From ICU and Beyond (Journal article)
Walkey, A. J., Hogarth, K., & Lip, G. Y. H. (2015). Optimizing Atrial Fibrillation Management From ICU and Beyond. CHEST, 148(4), 859-864. doi:10.1378/chest.15-0358DOI: 10.1378/chest.15-0358
Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study (Journal article)
Chao, T. -F., Liu, C. -J., Chen, S. -J., Wang, K. -L., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2015). Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 196, 91-97. doi:10.1016/j.ijcard.2015.05.159DOI: 10.1016/j.ijcard.2015.05.159
The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods (Journal article)
Charidimou, A., Wilson, D., Shakeshaft, C., Ambler, G., White, M., Cohen, H., . . . Werring, D. J. (2015). The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods. INTERNATIONAL JOURNAL OF STROKE, 10, 155-161. doi:10.1111/ijs.12569DOI: 10.1111/ijs.12569
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) (Journal article)
Priori, S. G., Blomstrom-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Zannad, F. (2015). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). EUROPEAN HEART JOURNAL, 36(41), 2793-+. doi:10.1093/eurheartj/ehv316DOI: 10.1093/eurheartj/ehv316
Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation Meta-Analysis (Journal article)
Wang, K. -L., Lip, G. Y. H., Lin, S. -J., & Chiang, C. -E. (2015). Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation Meta-Analysis. STROKE, 46(9), 2555-2561. doi:10.1161/STROKEAHA.115.009947DOI: 10.1161/STROKEAHA.115.009947
Patients With Ischemic Stroke and Incident Atrial Fibrillation A Nationwide Cohort Study (Journal article)
Fauchier, L., Clementy, N., Pelade, C., Collignon, C., Nicolle, E., & Lip, G. Y. H. (2015). Patients With Ischemic Stroke and Incident Atrial Fibrillation A Nationwide Cohort Study. STROKE, 46(9), 2432-2437. doi:10.1161/STROKEAHA.115.010270DOI: 10.1161/STROKEAHA.115.010270
Recurrent Stroke The Value of the CHA<sub>2</sub>DS<sub>2</sub> VASc Score and the Essen Stroke Risk Score in a Nationwide Stroke Cohort (Journal article)
Andersen, S. D., Gorst-Rasmussen, A., Lip, G. Y. H., Bach, F. W., & Larsen, T. B. (2015). Recurrent Stroke The Value of the CHA<sub>2</sub>DS<sub>2</sub> VASc Score and the Essen Stroke Risk Score in a Nationwide Stroke Cohort. STROKE, 46(9), 2491-2497. doi:10.1161/STROKEAHA.115.009912DOI: 10.1161/STROKEAHA.115.009912
Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation AMADEUS Trial (Journal article)
Senoo, K., Lip, G. Y. H., Lane, D. A., Bueller, H. R., & Kotecha, D. (2015). Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation AMADEUS Trial. STROKE, 46(9), 2523-2528. doi:10.1161/STROKEAHA.115.009487DOI: 10.1161/STROKEAHA.115.009487
Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation A Nationwide Cohort Study From Taiwan (Journal article)
Chao, T. -F., Wang, K. -L., Liu, C. -J., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2015). Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation A Nationwide Cohort Study From Taiwan. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(12), 1339-1347. doi:10.1016/j.jacc.2015.07.026DOI: 10.1016/j.jacc.2015.07.026
Atrial flutter and thromboembolic risk: a systematic review (Journal article)
Vadmann, H., Nielsen, P. B., Hjortshoj, S. P., Riahi, S., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2015). Atrial flutter and thromboembolic risk: a systematic review. HEART, 101(18), 1446-1455. doi:10.1136/heartjnl-2015-307550DOI: 10.1136/heartjnl-2015-307550
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin (Journal article)
Ye, S., Cheng, B., Lip, G. Y. H., Buchsbaum, R., Sacco, R. L., Levin, B., . . . Homma, S. (2015). Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin. AMERICAN JOURNAL OF CARDIOLOGY, 116(6), 904-912. doi:10.1016/j.amjcard.2015.06.016DOI: 10.1016/j.amjcard.2015.06.016
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation (Journal article)
Proietti, M., Marra, A. M., Tassone, E. J., De Vuono, S., Corrao, S., Gobbi, P., . . . Raparelli, V. (2015). Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 116(6), 877-882. doi:10.1016/j.amjcard.2015.05.060DOI: 10.1016/j.amjcard.2015.05.060
The CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis (Journal article)
Xiong, Q., Chen, S., Senoo, K., Proietti, M., Hong, K., & Lip, G. Y. H. (2015). The CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 195, 237-242. doi:10.1016/j.ijcard.2015.05.115DOI: 10.1016/j.ijcard.2015.05.115
Assessment of the CHA(2)DS(2)-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation (Journal article)
Melgaard, L., Gorst-Rasmussen, A., Lane, D. A., Rasmussen, L. H., Larsen, T. B., & Lip, G. Y. H. (2015). Assessment of the CHA(2)DS(2)-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(10), 1030-1038. doi:10.1001/jama.2015.10725DOI: 10.1001/jama.2015.10725
Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation. (Journal article)
Lip, G. Y. (2015). Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation.. Expert review of cardiovascular therapy, 13(9), 963-965. doi:10.1586/14779072.2015.1071665DOI: 10.1586/14779072.2015.1071665
Assessing Bleeding Risk With the HAS-BLED Score: Balancing Simplicity, Practicality, and Predictive Value in Bleeding-Risk Assessment (Journal article)
Lip, G. Y. H. (2015). Assessing Bleeding Risk With the HAS-BLED Score: Balancing Simplicity, Practicality, and Predictive Value in Bleeding-Risk Assessment. CLINICAL CARDIOLOGY, 38(9), 562-564. doi:10.1002/clc.22436DOI: 10.1002/clc.22436
Assessing Eligibility for Anticoagulation After Diagnosis of Atrial Fibrillation Reply (Journal article)
Lip, G. Y. H., & Lane, D. A. (2015). Assessing Eligibility for Anticoagulation After Diagnosis of Atrial Fibrillation Reply. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(9), 949-950. doi:10.1001/jama.2015.8995DOI: 10.1001/jama.2015.8995
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society (Journal article)
Lip, G. Y. H., Heinzel, F. R., Gaita, F., Gonzalez Juanatey, J. R., Le Heuzey, J. Y., Potpara, T., . . . Pieske, B. (2015). European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. EUROPEAN JOURNAL OF HEART FAILURE, 17(9), 848-874. doi:10.1002/ejhf.338DOI: 10.1002/ejhf.338
Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice (Journal article)
Wolff, A., Shantsila, E., Lip, G. Y. H., & Lane, D. A. (2015). Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice. AGE AND AGEING, 44(5), 874-878. doi:10.1093/ageing/afv071DOI: 10.1093/ageing/afv071
Shantsila, A., McIntyre, D. B., Lip, G. Y. H., Fadel, P. J., Paton, J. F. R., Pickering, A. E., & Fisher, J. P. (2015). Influence of age on respiratory modulation of muscle sympathetic nerve activity, blood pressure and baroreflex function in humans. EXPERIMENTAL PHYSIOLOGY, 100(9), 1039-1051. doi:10.1113/EP085071DOI: 10.1113/EP085071
Monitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants. (Journal article)
Rahmat, N. A., & Lip, G. Y. H. (2015). Monitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants.. Arrhythmia & electrophysiology review, 4(2), 90-95. doi:10.15420/aer.2015.04.02.90DOI: 10.15420/aer.2015.04.02.90
Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2015). Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk. PROGRESS IN CARDIOVASCULAR DISEASES, 58(2), 177-194. doi:10.1016/j.pcad.2015.07.003DOI: 10.1016/j.pcad.2015.07.003
Urinary 11-dehydro-thromboxane B<sub>2</sub> is associated with cardiovascular events and mortality in patients with atrial fibrillation (Journal article)
Pastori, D., Pignatelli, P., Farcomeni, A., Cangemi, R., Hiatt, W. R., Bartimoccia, S., . . . Violi, F. (2015). Urinary 11-dehydro-thromboxane B<sub>2</sub> is associated with cardiovascular events and mortality in patients with atrial fibrillation. AMERICAN HEART JOURNAL, 170(3), 490-+. doi:10.1016/j.ahj.2015.05.011DOI: 10.1016/j.ahj.2015.05.011
sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation (Journal article)
Vilchez, J. A., Perez-Cuellar, M., Marin, F., Gallego, P., Manzano-Fernandez, S., Valdes, M., . . . Roldan, V. (2015). sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 45(9), 899-905. doi:10.1111/eci.12482DOI: 10.1111/eci.12482
Association between statin use and plasma D-dimer levels (Journal article)
Sahebkar, A., Serban, C., Mikhailidis, D. P., Undas, A., Lip, G. Y. H., Muntner, P., . . . Banach, M. (2015). Association between statin use and plasma D-dimer levels. THROMBOSIS AND HAEMOSTASIS, 114(3), 546-557. doi:10.1160/TH14-11-0937DOI: 10.1160/TH14-11-0937
Erectile dysfunction in atrial fibrillation: A risk factor for stroke or a reflection of stroke risk factors? (Journal article)
Brown, R. A., & Lip, G. Y. H. (2015). Erectile dysfunction in atrial fibrillation: A risk factor for stroke or a reflection of stroke risk factors?. CARDIOLOGY JOURNAL, 22(4), 359-361. doi:10.5603/CJ.2015.0049DOI: 10.5603/CJ.2015.0049
Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data (Journal article)
Ziff, O. J., Lane, D. A., Samra, M., Griffith, M., Kirchhof, P., Lip, G. Y. H., . . . Kotecha, D. (2015). Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ: British Medical Journal, 351. doi:10.1136/bmj.h4451DOI: 10.1136/bmj.h4451
Cardiac Fibrosis in Patients With Atrial Fibrillation Mechanisms and Clinical Implications (Journal article)
Dzeshka, M. S., Lip, G. Y. H., Snezhitskiy, V., & Shantsila, E. (2015). Cardiac Fibrosis in Patients With Atrial Fibrillation Mechanisms and Clinical Implications. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(8), 943-959. doi:10.1016/j.jacc.2015.06.1313DOI: 10.1016/j.jacc.2015.06.1313
Decapsulation of 3D multi-die stacked package (Conference Paper)
Kor, H. B., Liu, Q., Siah, Y. W., & Gan, C. L. (2015). Decapsulation of 3D multi-die stacked package. In 2015 IEEE 22nd International Symposium on the Physical and Failure Analysis of Integrated Circuits. IEEE. doi:10.1109/ipfa.2015.7224433DOI: 10.1109/ipfa.2015.7224433
Erratum: Stroke prevention in atrial fibrillation: A systematic review (JAMA - Journal of the American Medical Association (2015) 313:19 (1950-1962)) (Journal article)
Lip, G. Y. H., & Lane, D. A. (2015). Erratum: Stroke prevention in atrial fibrillation: A systematic review (JAMA - Journal of the American Medical Association (2015) 313:19 (1950-1962)). JAMA - Journal of the American Medical Association, 314(8), 837.
Evaluation of copper nanoparticles for low temperature bonded interconnections (Conference Paper)
Byung Hoon Lee., Mei Zhen Ng., Zinn, A. A., & Chee Lip Gan. (2015). Evaluation of copper nanoparticles for low temperature bonded interconnections. In 2015 IEEE 22nd International Symposium on the Physical and Failure Analysis of Integrated Circuits. IEEE. doi:10.1109/ipfa.2015.7224343DOI: 10.1109/ipfa.2015.7224343
Stroke Prevention in Atrial Fibrillation: A Systematic Review (vol 313, pg 1950, 2015) (Journal article)
Lip, G. Y. H., & Lane, D. A. (2015). Stroke Prevention in Atrial Fibrillation: A Systematic Review (vol 313, pg 1950, 2015). JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(8), 837. doi:10.1001/jama.2015.9181DOI: 10.1001/jama.2015.9181
Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemics (Journal article)
Albertsen, I. E., Overvad, T. F., Lip, G. Y. H., & Larsen, T. B. (2015). Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemics. CURRENT OPINION IN CARDIOLOGY, 30(5), 512-517. doi:10.1097/HCO.0000000000000205DOI: 10.1097/HCO.0000000000000205
Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding A Nationwide Cohort Study (Journal article)
Nielsen, P. B., Larsen, T. B., Skjoth, F., Gorst-Rasmussen, A., Rasmussen, L. H., & Lip, G. Y. H. (2015). Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding A Nationwide Cohort Study. CIRCULATION, 132(6), 517-525. doi:10.1161/CIRCULATIONAHA.115.015735DOI: 10.1161/CIRCULATIONAHA.115.015735
Patterns in atrial fibrillation management and 'real-world' adherence to guidelines in the Balkan Region: an overview of the Balkan-atrial fibrillation survey (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2015). Patterns in atrial fibrillation management and 'real-world' adherence to guidelines in the Balkan Region: an overview of the Balkan-atrial fibrillation survey. EUROPEAN HEART JOURNAL, 36(30), 1943-1944. Retrieved from https://www.webofscience.com/
A Phase II, double-blind, randomized, parallel group, dose-finding study of the safety and tolerability of darexaban compared with warfarin in patients with non-valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL-2) (Journal article)
Lip, G. Y. H., Halperin, J. L., Petersen, P., Rodgers, G. M., Pall, D., & Renfurm, R. W. (2015). A Phase II, double-blind, randomized, parallel group, dose-finding study of the safety and tolerability of darexaban compared with warfarin in patients with non-valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL-2). JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(8), 1405-1413. doi:10.1111/jth.13025DOI: 10.1111/jth.13025
Age-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: The EORP-AF General Pilot Registry (EURObservational Research Programme-Atrial Fibrillation). (Journal article)
Fumagalli, S., Said, S. A. M., Laroche, C., Gabbai, D., Marchionni, N., Boriani, G., . . . EORP-AF Investigators. (2015). Age-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: The EORP-AF General Pilot Registry (EURObservational Research Programme-Atrial Fibrillation).. JACC. Clinical electrophysiology, 1(4), 326-334. doi:10.1016/j.jacep.2015.02.019DOI: 10.1016/j.jacep.2015.02.019
Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESCWorking Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS) (Journal article)
Sticherling, C., Marin, F., Birnie, D., Boriani, G., Calkins, H., Dan, G. -A., . . . Lip, G. Y. H. (2015). Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESCWorking Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). EUROPACE, 17(8), 1197-1214. doi:10.1093/europace/euv190DOI: 10.1093/europace/euv190
Apixaban versus edoxaban for stroke prevention in nonvalvular atrial fibrillation (Journal article)
Xiong, Q., Lau, Y. C., & Lip, G. Y. H. (2015). Apixaban versus edoxaban for stroke prevention in nonvalvular atrial fibrillation. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 4(4), 367-376. doi:10.2217/CER.15.15DOI: 10.2217/CER.15.15
Benefit of Anticoagulation Therapy in Hyperthyroidism-Related Atrial Fibrillation (Journal article)
Chan, P. -H., Hai, J., Yeung, C. -Y., Lip, G. Y. H., Lam, K. S. -L., Tse, H. -F., & Siu, C. -W. (2015). Benefit of Anticoagulation Therapy in Hyperthyroidism-Related Atrial Fibrillation. CLINICAL CARDIOLOGY, 38(8), 476-482. doi:10.1002/clc.22427DOI: 10.1002/clc.22427
Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making - a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society (Journal article)
Boriani, G., Savelieva, I., Dan, G. -A., Deharo, J. C., Ferro, C., Israel, C. W., . . . Lip, G. Y. H. (2015). Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making - a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace, 17(8), 1169-1196. doi:10.1093/europace/euv202DOI: 10.1093/europace/euv202
Development and validation of a new assay for assessing clot integrity (Journal article)
Ranjit, P., Lau, Y., Lip, G. Y. H., & Blann, A. D. (2015). Development and validation of a new assay for assessing clot integrity. VASCULAR PHARMACOLOGY, 71, 102-107. doi:10.1016/j.vph.2015.02.013DOI: 10.1016/j.vph.2015.02.013
Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation Nationwide Cohort Study (Journal article)
Overvad, T. F., Skjoth, F., Lip, G. Y. H., Lane, D. A., Albertsen, I. E., Rasmussen, L. H., & Larsen, T. B. (2015). Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation Nationwide Cohort Study. STROKE, 46(8), 2168-2174. doi:10.1161/STROKEAHA.115.009371DOI: 10.1161/STROKEAHA.115.009371
Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project (Journal article)
Angoulvant, D., Villejoubert, O., Bejan-Angoulvant, T., Ivanes, F., Saint Etienne, C., Lip, G. Y. H., & Fauchier, L. (2015). Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. CHEST, 148(2), 491-498. doi:10.1378/chest.14-3006DOI: 10.1378/chest.14-3006
Ethnic differences in the diurnal variation of symptom onset time for acute ST elevation myocardial infarction - An observational cohort study (Journal article)
Brown, R. A., Lip, G. Y. H., Varma, C., & Shantsila, E. (2015). Ethnic differences in the diurnal variation of symptom onset time for acute ST elevation myocardial infarction - An observational cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 187, 414-416. doi:10.1016/j.ijcard.2015.03.371DOI: 10.1016/j.ijcard.2015.03.371
Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool (Journal article)
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2015). Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(8), 840-845. doi:10.1111/ijcp.12625DOI: 10.1111/ijcp.12625
Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials (Journal article)
Sahebkar, A., Kotani, K., Serban, C., Ursoniu, S., Mikhailidis, D. P., Jones, S. R., . . . Banach, M. (2015). Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials. ATHEROSCLEROSIS, 241(2), 433-442. doi:10.1016/j.atherosclerosis.2015.05.022DOI: 10.1016/j.atherosclerosis.2015.05.022
Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study (Journal article)
Wolsk, E., Lamberts, M., Hansen, M. L., Blanche, P., Kober, L., Torp-Pedersen, C., . . . Gislason, G. (2015). Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study. EUROPEAN JOURNAL OF HEART FAILURE, 17(8), 828-836. doi:10.1002/ejhf.309DOI: 10.1002/ejhf.309
Unsupervised learning for signal mapping in dynamic photon emission (Journal article)
Chef, S., Jacquir, S., Sanchez, K., Perdu, P., Binczak, S., & Gan, C. L. (2015). Unsupervised learning for signal mapping in dynamic photon emission. Microelectronics Reliability, 55(9-10), 1564-1568. doi:10.1016/j.microrel.2015.06.043DOI: 10.1016/j.microrel.2015.06.043
Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice (Journal article)
Boriani, G., Lane, D. A., Windecker, S., Huber, K., Kirchhof, P., & Lip, G. Y. H. (2015). Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice. EUROPACE, 17(9), 1319-1322. doi:10.1093/europace/euu303DOI: 10.1093/europace/euu303
Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis (Journal article)
Caldeira, D., Costa, J., Ferreira, J. J., Lip, G. Y. H., & Pinto, F. J. (2015). Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis. CLINICAL RESEARCH IN CARDIOLOGY, 104(7), 582-590. doi:10.1007/s00392-015-0821-8DOI: 10.1007/s00392-015-0821-8
Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry (Journal article)
Kornej, J., Kosiuk, J., Hindricks, G., Arya, A., Sommer, P., Rolf, S., . . . Bollmann, A. (2015). Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry. CLINICAL RESEARCH IN CARDIOLOGY, 104(7), 603-610. doi:10.1007/s00392-015-0823-6DOI: 10.1007/s00392-015-0823-6
Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score (Beyond Sex) (Journal article)
Lip, G. Y. H., Skjoth, F., Rasmussen, L. H., Nielsen, P. B., & Larsen, T. B. (2015). Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score (Beyond Sex). JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(4), 488-490. doi:10.1016/j.jacc.2015.05.044DOI: 10.1016/j.jacc.2015.05.044
Statin therapy and plasma coenzyme Q10 concentrations-A systematic review and meta-analysis of placebo-controlled trials (Journal article)
Banach, M., Serban, C., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., . . . Sahebkar, A. (2015). Statin therapy and plasma coenzyme Q10 concentrations-A systematic review and meta-analysis of placebo-controlled trials. PHARMACOLOGICAL RESEARCH, 99, 329-336. doi:10.1016/j.phrs.2015.07.008DOI: 10.1016/j.phrs.2015.07.008
Antidotes to non-vitamin K oral anticoagulants: necessary or not? (Journal article)
Proietti, M., & Lip, G. Y. H. (2015). Antidotes to non-vitamin K oral anticoagulants: necessary or not?. EXPERT OPINION ON PHARMACOTHERAPY, 16(11), 1573-1576. doi:10.1517/14656566.2015.1057119DOI: 10.1517/14656566.2015.1057119
Prognostic value of CHA<sub>2</sub>DS<sub>2</sub>-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project (Journal article)
Philippart, R., Brunet-Bernard, A., Clementy, N., Bourguignon, T., Mirza, A., Babuty, D., . . . Fauchier, L. (2015). Prognostic value of CHA<sub>2</sub>DS<sub>2</sub>-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project. EUROPEAN HEART JOURNAL, 36(28), 1822-1830. doi:10.1093/eurheartj/ehv163DOI: 10.1093/eurheartj/ehv163
Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes (Journal article)
Xiong, Q., Proietti, M., Senoo, K., & Lip, G. Y. H. (2015). Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes. INTERNATIONAL JOURNAL OF CARDIOLOGY, 191, 172-177. doi:10.1016/j.ijcard.2015.05.011DOI: 10.1016/j.ijcard.2015.05.011
CD36 expression and lipid metabolism following an oral glucose challenge in South Asians (Journal article)
Patel, J. V., Banerjee, A., Montoro-Garcia, S., Shantsila, E., Alam, M., Flinders, P., . . . Gill, P. S. (2015). CD36 expression and lipid metabolism following an oral glucose challenge in South Asians. WORLD JOURNAL OF DIABETES, 6(7), 983-989. doi:10.4239/wjd.v6.i7.983DOI: 10.4239/wjd.v6.i7.983
Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices (Journal article)
Martin, D. T., Bersohn, M. M., Waldo, A. L., Wathen, M. S., Choucair, W. K., Lip, G. Y. H., . . . Halperin, J. L. (2015). Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. EUROPEAN HEART JOURNAL, 36(26), 1660-1668. doi:10.1093/eurheartj/ehv115DOI: 10.1093/eurheartj/ehv115
A comprehensive insight of novel antioxidant therapies for atrial fibrillation management (Journal article)
Orenes-Pinero, E., Valdes, M., Lip, G. Y. H., & Marin, F. (2015). A comprehensive insight of novel antioxidant therapies for atrial fibrillation management. DRUG METABOLISM REVIEWS, 47(3), 388-400. doi:10.3109/03602532.2015.1077858DOI: 10.3109/03602532.2015.1077858
Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation (Journal article)
Shields, A. M., & Lip, G. Y. H. (2015). Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation. JOURNAL OF INTERNAL MEDICINE, 278(1), 1-18. doi:10.1111/joim.12360DOI: 10.1111/joim.12360
Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT<sub>2</sub>R<sub>2</sub> score (Journal article)
Proietti, M., & Lip, G. Y. H. (2015). Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT<sub>2</sub>R<sub>2</sub> score. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 1(3), 150-152. doi:10.1093/ehjcvp/pvv012DOI: 10.1093/ehjcvp/pvv012
THE IMPACT OF DIFFERENT GLYCAEMIC INDEX CARBOHYDRATE STAPLE FOODS ON SOUTH ASIAN DIABETIC AND CARDIOVASCULAR INDICES OF HEALTH: A RCT (Conference Paper)
Patel, J., Flinders, P., Gill, P., Lip, G., & Hughes, E. (2015). THE IMPACT OF DIFFERENT GLYCAEMIC INDEX CARBOHYDRATE STAPLE FOODS ON SOUTH ASIAN DIABETIC AND CARDIOVASCULAR INDICES OF HEALTH: A RCT. In ATHEROSCLEROSIS Vol. 241 (pp. E191-E192). doi:10.1016/j.atherosclerosis.2015.04.936DOI: 10.1016/j.atherosclerosis.2015.04.936
Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation (Journal article)
Guo, Y., Wang, H., Tian, Y., Wang, Y., & Lip, G. Y. H. (2015). Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation. CHEST, 148(1), 62-72. doi:10.1378/chest.14-2018DOI: 10.1378/chest.14-2018
Recent scientific documents from the European Heart Rhythm Association (EHRA) (Journal article)
Gorenek, B., & Lip, G. Y. H. (2015). Recent scientific documents from the European Heart Rhythm Association (EHRA). EUROPACE, 17(8), 1161-1163. doi:10.1093/europace/euv193DOI: 10.1093/europace/euv193
Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists (Journal article)
Pignatelli, P., Pastori, D., Vicario, T., Bucci, T., Del Ben, M., Russo, R., . . . Violi, F. (2015). Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists. EUROPACE, 17(8), 1223-1228. doi:10.1093/europace/euv127DOI: 10.1093/europace/euv127
Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study (Journal article)
Staerk, L., Gislason, G. H., Lip, G. Y. H., Fosbol, E. L., Hansen, M. L., Lamberts, M., . . . Olesen, J. B. (2015). Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study. EUROPACE, 17(8), 1215-1222. doi:10.1093/europace/euv119DOI: 10.1093/europace/euv119
Significant enhancement of UV emission in ZnO nanorods subject to Ga+ ion beam irradiation (Journal article)
Yadian, B., Chen, R., Liu, H., Sun, H., Liu, Q., Gan, C. L., . . . Huang, Y. (2015). Significant enhancement of UV emission in ZnO nanorods subject to Ga+ ion beam irradiation. Nano Research, 8(6), 1857-1864. doi:10.1007/s12274-014-0693-7DOI: 10.1007/s12274-014-0693-7
Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors - Results from a systematic review and meta-analysis of randomized controlled trials (Journal article)
Sahebkar, A., Serban, C., Ursoniu, S., Wong, N. D., Muntner, P., Graham, I. M., . . . Banach, M. (2015). Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors - Results from a systematic review and meta-analysis of randomized controlled trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 189, 47-55. doi:10.1016/j.ijcard.2015.04.008DOI: 10.1016/j.ijcard.2015.04.008
Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillation (Journal article)
Xiong, Q., Lau, Y. C., & Lip, G. Y. H. (2015). Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillation. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 11(6), 937-948. doi:10.1517/17425255.2015.1027683DOI: 10.1517/17425255.2015.1027683
Can venous thromboembolism navigate the prevention of cardiovascular complications? (Journal article)
Shantsila, A., & Lip, G. Y. H. (2015). Can venous thromboembolism navigate the prevention of cardiovascular complications?. ANNALS OF TRANSLATIONAL MEDICINE, 3(9). doi:10.3978/j.issn.2305-5839.2015.04.10DOI: 10.3978/j.issn.2305-5839.2015.04.10
Comparison of Estimated Glomerular Filtration Rate Equations for Dosing New Oral Anticoagulants in Patients With Atrial Fibrillation (Journal article)
Manzano-Fernandez, S., Andreu-Cayuelas, J. M., Marin, F., Orenes-Pinero, E., Gallego, P., Valdes, M., . . . Roldan, V. (2015). Comparison of Estimated Glomerular Filtration Rate Equations for Dosing New Oral Anticoagulants in Patients With Atrial Fibrillation. REVISTA ESPANOLA DE CARDIOLOGIA, 68(6), 497-504. doi:10.1016/j.rec.2014.06.026DOI: 10.1016/j.rec.2014.06.026
DIGOXIN - FRIEND OR FOE? A COMPREHENSIVE REVIEW OF DIGOXIN USE AND MORTALITY (Conference Paper)
Ziff, O., Kotecha, D., Samra, M., Kirchhof, P., Steeds, R., Griffith, M., . . . Lip, G. Y. H. (2015). DIGOXIN - FRIEND OR FOE? A COMPREHENSIVE REVIEW OF DIGOXIN USE AND MORTALITY. In HEART Vol. 101 (pp. A14-A15). doi:10.1136/heartjnl-2015-308066.26DOI: 10.1136/heartjnl-2015-308066.26
Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study. (Journal article)
Echocardiographic Normal Ranges Meta-Analysis of the Left Heart Collaboration. (2015). Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study.. JACC. Cardiovascular imaging, 8(6), 656-665. doi:10.1016/j.jcmg.2015.02.014DOI: 10.1016/j.jcmg.2015.02.014
FROM MALIGNANT HYPERTENSION TO HYPERTENSION-MOD: MA MODERN DEFINITION FOR AN OLD BUT STILL DANGEROUS EMERGENCY (Conference Paper)
Gosse, P., Cremer, A., Amraoui, F., Lip, G., Morales, E., Rubin, S., . . . Van den Born, B. (2015). FROM MALIGNANT HYPERTENSION TO HYPERTENSION-MOD: MA MODERN DEFINITION FOR AN OLD BUT STILL DANGEROUS EMERGENCY. In JOURNAL OF HYPERTENSION Vol. 33 (pp. E397). doi:10.1097/01.hjh.0000468619.68444.40DOI: 10.1097/01.hjh.0000468619.68444.40
Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation (Journal article)
Lip, G. Y. H., Laroche, C., Popescu, M. I., Rasmussen, L. H., Vitali-Serdoz, L., Dan, G. -A., . . . Boriani, G. (2015). Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation. EUROPEAN JOURNAL OF HEART FAILURE, 17(6), 570-582. doi:10.1002/ejhf.254DOI: 10.1002/ejhf.254
Incidence of Myocardial Infarction and Vascular Death in Elderly Patients With Atrial Fibrillation Taking Anticoagulants Relation to Atherosclerotic Risk Factors (Journal article)
Pastori, D., Pignatelli, P., Angelico, F., Farcomeni, A., Del Ben, M., Vicario, T., . . . Violi, F. (2015). Incidence of Myocardial Infarction and Vascular Death in Elderly Patients With Atrial Fibrillation Taking Anticoagulants Relation to Atherosclerotic Risk Factors. CHEST, 147(6), 1644-1650. doi:10.1378/chest.14-2414DOI: 10.1378/chest.14-2414
Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation A Nationwide Cohort Study (Journal article)
Nielsen, P. B., Larsen, T. B., Gorst-Rasmussen, A., Skjoth, F., Rasmussen, L. H., & Lip, G. Y. H. (2015). Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation A Nationwide Cohort Study. CHEST, 147(6), 1651-1658. doi:10.1378/chest.14-2099DOI: 10.1378/chest.14-2099
Not all thromboembolism comes from the left atrial appendage in atrial fibrillation (Journal article)
Senoo, K., & Lip, G. Y. H. (2015). Not all thromboembolism comes from the left atrial appendage in atrial fibrillation. HEART, 101(11), 830-831. doi:10.1136/heartjnl-2015-307451DOI: 10.1136/heartjnl-2015-307451
Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial (Journal article)
Lahtela, H. M., Kiviniemi, T. O., Puurunen, M. K., Schlitt, A., Rubboli, A., Ylitalo, A., . . . Airaksinen, K. E. J. (2015). Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial. PLOS ONE, 10(6). doi:10.1371/journal.pone.0128492DOI: 10.1371/journal.pone.0128492
SOUTH ASIAN ETHNICITY IS INDEPENDENTLY RELATED TO DIASTOLIC FUNCTION IN HYPERTENSION (Conference Paper)
Shantsila, A., Gill, P. S., Shantsila, E., & Lip, G. Y. H. (2015). SOUTH ASIAN ETHNICITY IS INDEPENDENTLY RELATED TO DIASTOLIC FUNCTION IN HYPERTENSION. In HEART Vol. 101 (pp. A71). doi:10.1136/heartjnl-2015-308066.124DOI: 10.1136/heartjnl-2015-308066.124
Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Stroke Prevention in Atrial Fibrillation: A Focus on Vascular Disease, Women, and Simple Practical Application (Journal article)
Nielsen, P. B., Skjoth, F., Rasmussen, L. H., Larsen, T. B., & Lip, G. Y. H. (2015). Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Stroke Prevention in Atrial Fibrillation: A Focus on Vascular Disease, Women, and Simple Practical Application. CANADIAN JOURNAL OF CARDIOLOGY, 31(6). doi:10.1016/j.cjca.2015.01.034DOI: 10.1016/j.cjca.2015.01.034
Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State (Journal article)
Orenes-Pinero, E., Pineda, J., Roldan, V., Hernandez-Romero, D., Marco, P., Tello-Montoliu, A., . . . Marin, F. (2015). Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 22(6), 610-617. doi:10.5551/jat.26161DOI: 10.5551/jat.26161
Origin of physical degradation in AlGaN/GaN on Si high electron mobility transistors under reverse bias stressing (Conference Paper)
Sasangka, W. A., Syaranamual, G. J., Gan, C. L., & Thompson, C. V. (2015). Origin of physical degradation in AlGaN/GaN on Si high electron mobility transistors under reverse bias stressing. In 2015 IEEE International Reliability Physics Symposium. IEEE. doi:10.1109/irps.2015.7112768DOI: 10.1109/irps.2015.7112768
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentr cohort study (Journal article)
Violi, F., Pastori, D., Perticone, F., Hiatt, W. R., Sciacqua, A., Basili, S., . . . Pignatelli, P. (2015). Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentr cohort study. BMJ OPEN, 5(5). doi:10.1136/bmjopen-2015-008026DOI: 10.1136/bmjopen-2015-008026
Atrial fibrillation (chronic). (Journal article)
Lane, D. A., Boos, C. J., & Lip, G. Y. H. (2015). Atrial fibrillation (chronic).. BMJ clinical evidence, 2015, 0217.
Stroke Prevention in Atrial Fibrillation: A Systematic Review (Journal article)
Lip, G. Y. H., & Lane, D. A. (2015). Stroke Prevention in Atrial Fibrillation: A Systematic Review. JAMA: Journal of the American Medical Association, 313(19), 1950-1962. doi:10.1001/jama.2015.4369DOI: 10.1001/jama.2015.4369
A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations (Conference Paper)
Serban, C., Sahebkar, A., Ursoniu, S., Mikhailidis, D. P., Rizzo, M., Lip, G. Y. H., . . . Banach, M. (2015). A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. In SCIENTIFIC REPORTS Vol. 5. doi:10.1038/srep09902DOI: 10.1038/srep09902
Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism (Journal article)
Guo, Y., Lip, G. Y. H., & Apostolakis, S. (2015). Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism. CURRENT VASCULAR PHARMACOLOGY, 13(2), 192-201. doi:10.2174/15701611113116660165DOI: 10.2174/15701611113116660165
Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction Trial Substudy (Journal article)
Homma, S., Thompson, J. L. P., Qian, M., Ye, S., Di Tullio, M. R., Lip, G. Y. H., . . . Anker, S. D. (2015). Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction Trial Substudy. CIRCULATION-HEART FAILURE, 8(3), 504-509. doi:10.1161/CIRCHEARTFAILURE.114.001725DOI: 10.1161/CIRCHEARTFAILURE.114.001725
Synthesis of ultrathin face-centered-cubic au@pt and au@pd core-shell nanoplates from hexagonal-close-packed au square sheets. (Journal article)
Fan, Z., Zhu, Y., Huang, X., Han, Y., Wang, Q., Liu, Q., . . . Zhang, H. (2015). Synthesis of ultrathin face-centered-cubic au@pt and au@pd core-shell nanoplates from hexagonal-close-packed au square sheets.. Angewandte Chemie (International ed. in English), 54(19), 5672-5676. doi:10.1002/anie.201500993DOI: 10.1002/anie.201500993
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study (Journal article)
Lip, G. Y. H., Merino, J., Ezekowitz, M., Ellenbogen, K., Zamoryakhin, D., Lanz, H., . . . Goette, A. (2015). A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. AMERICAN HEART JOURNAL, 169(5), 597-U28. doi:10.1016/j.ahj.2015.02.009DOI: 10.1016/j.ahj.2015.02.009
Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry (Journal article)
Boriani, G., Laroche, C., Diemberger, I., Fantecchi, E., Popescu, M. I., Rasmussen, L. H., . . . Lip, G. Y. H. (2015). Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry. AMERICAN JOURNAL OF MEDICINE, 128(5), 509-U212. doi:10.1016/j.amjmed.2014.11.026DOI: 10.1016/j.amjmed.2014.11.026
ESTIMATING THE LIFETIME CLINICAL RISK/BENEFITS OF APIXABAN VERSUS EDOXABAN IN NON-VALVULAR ATRIAL FIBRILLATION (Conference Paper)
Phatak, H., Dorian, P., Kongnakorn, T., Lanitis, T., Liu, X., Mardekian, J., . . . Lip, G. (2015). ESTIMATING THE LIFETIME CLINICAL RISK/BENEFITS OF APIXABAN VERSUS EDOXABAN IN NON-VALVULAR ATRIAL FIBRILLATION. In VALUE IN HEALTH Vol. 18 (pp. A131). doi:10.1016/j.jval.2015.03.762DOI: 10.1016/j.jval.2015.03.762
Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now? (Journal article)
Dzeshka, M. S., & Lip, G. Y. H. (2015). Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?. TRENDS IN CARDIOVASCULAR MEDICINE, 25(4), 315-336. doi:10.1016/j.tcm.2014.10.017DOI: 10.1016/j.tcm.2014.10.017
Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis (Journal article)
Nielsen, P. B., Lane, D. A., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2015). Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis. CLINICAL RESEARCH IN CARDIOLOGY, 104(5), 418-429. doi:10.1007/s00392-014-0797-9DOI: 10.1007/s00392-014-0797-9
Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduces out-of-hours door-to-balloon time but not mortality (Journal article)
Brown, R. A., Varma, C., Connolly, D. L., Ahmad, R., Shantsila, E., & Lip, G. Y. H. (2015). Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduces out-of-hours door-to-balloon time but not mortality. INTERNATIONAL JOURNAL OF CARDIOLOGY, 186, 226-230. doi:10.1016/j.ijcard.2015.03.172DOI: 10.1016/j.ijcard.2015.03.172
Size effects and shape memory properties in ZrO2 ceramic micro- and nano-pillars (Journal article)
Du, Z., Zeng, X. M., Liu, Q., Lai, A., Amini, S., Miserez, A., . . . Gan, C. L. (2015). Size effects and shape memory properties in ZrO2 ceramic micro- and nano-pillars. Scripta Materialia, 101, 40-43. doi:10.1016/j.scriptamat.2015.01.013DOI: 10.1016/j.scriptamat.2015.01.013
The SAMe-TT<sub>2</sub>R<sub>2</sub> score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists (Journal article)
Fauchier, L., Angoulvant, D., & Lip, G. Y. H. (2015). The SAMe-TT<sub>2</sub>R<sub>2</sub> score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists. EUROPACE, 17(5), 671-673. doi:10.1093/europace/euv088DOI: 10.1093/europace/euv088
Meet the Editorial Board (Journal article)
Lip, G. (2015). Meet the Editorial Board. Current Pharmaceutical Design, 21(17), 2167. doi:10.2174/138161282117150430124606DOI: 10.2174/138161282117150430124606
Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study (Journal article)
Chen, P. -C., Lip, G. Y. H., Yeh, G., Lin, H. -J., & Chien, K. -L. (2015). Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study. PLOS ONE, 10(4). doi:10.1371/journal.pone.0125257DOI: 10.1371/journal.pone.0125257
Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials (Journal article)
Abdul-Rahim, A. H., Perez, A. -C., Fulton, R. L., Jhund, P. S., Latini, R., Tognoni, G., . . . McMurray, J. J. V. (2015). Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials. CIRCULATION, 131(17), 1486-1494. doi:10.1161/CIRCULATIONAHA.114.013760DOI: 10.1161/CIRCULATIONAHA.114.013760
The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment (Journal article)
Kooiman, J., van Hagen, N., del Sol, A. I., Planken, E. V., Lip, G. Y. H., van der Meer, F. J. M., . . . Huisman, M. V. (2015). The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment. PLOS ONE, 10(4). doi:10.1371/journal.pone.0122520DOI: 10.1371/journal.pone.0122520
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials (Journal article)
Navarese, E. P., Andreotti, F., Schulze, V., Kolodziejczak, M., Buffon, A., Brouwer, M., . . . Valgimigli, M. (2015). Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials. BMJ-BRITISH MEDICAL JOURNAL, 350. doi:10.1136/bmj.h1618DOI: 10.1136/bmj.h1618
Effect of palladium on the mechanical properties of Cu–Al intermetallic compounds (Journal article)
Lim, A. B. Y., Long, X., Shen, L., Chen, X., Ramanujan, R. V., Gan, C. L., & Chen, Z. (2015). Effect of palladium on the mechanical properties of Cu–Al intermetallic compounds. Journal of Alloys and Compounds, 628, 107-112. doi:10.1016/j.jallcom.2014.12.119DOI: 10.1016/j.jallcom.2014.12.119
Free Light Chains in patients with acute coronary syndromes: Relationships to inflammation and renal function (Journal article)
Shantsila, E., Tapp, L. D., & Lip, G. Y. H. (2015). Free Light Chains in patients with acute coronary syndromes: Relationships to inflammation and renal function. INTERNATIONAL JOURNAL OF CARDIOLOGY, 185, 322-327. doi:10.1016/j.ijcard.2015.03.105DOI: 10.1016/j.ijcard.2015.03.105
Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score (Journal article)
Lip, G. Y. H., Skjoth, F., Rasmussen, L. H., & Larsen, T. B. (2015). Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 65(14), 1385-1394. doi:10.1016/j.jacc.2015.01.044DOI: 10.1016/j.jacc.2015.01.044
Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making (Journal article)
Eckman, M. H., Wise, R. E., Naylor, K., Arduser, L., Lip, G. Y. H., Kissela, B., . . . Costea, A. (2015). Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making. CURRENT MEDICAL RESEARCH AND OPINION, 31(4), 603-614. doi:10.1185/03007995.2015.1019608DOI: 10.1185/03007995.2015.1019608
Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study (Journal article)
Gorst-Rasmussen, A., Skjoth, F., Larsen, T. B., Rasmussen, L. H., Lip, G. Y. H., & Lane, D. A. (2015). Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(4), 495-504. doi:10.1111/jth.12845DOI: 10.1111/jth.12845
Female gender and atrial fibrillation: An association with worse prognosis and outcomes (Journal article)
Kornej, J., Bollmann, A., Hindricks, G., & Lip, G. Y. H. (2015). Female gender and atrial fibrillation: An association with worse prognosis and outcomes. INTERNATIONAL JOURNAL OF CARDIOLOGY, 184, 321-322. doi:10.1016/j.ijcard.2015.02.062DOI: 10.1016/j.ijcard.2015.02.062
Non-steroidal anti-inflammatory drugs and incident atrial fibrillation (Journal article)
Proietti, M., & Lip, G. Y. H. (2015). Non-steroidal anti-inflammatory drugs and incident atrial fibrillation. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 1(2), 115-116. doi:10.1093/ehjcvp/pvv007DOI: 10.1093/ehjcvp/pvv007
Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes (Journal article)
Potpara, T. S., Lane, D. A., & Lip, G. Y. H. (2015). Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes. EUROPACE, 17(4), 507-508. doi:10.1093/europace/euv041DOI: 10.1093/europace/euv041
Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF) (Journal article)
Lip, G. Y. H., Hammerstingl, C., Marin, F., Cappato, R., Meng, I. L., Kirsch, B., . . . Cohen, A. (2015). Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF). AMERICAN HEART JOURNAL, 169(4), 464-+. doi:10.1016/j.ahj.2014.12.020DOI: 10.1016/j.ahj.2014.12.020
Stroke prevention in atrial fibrillation: changing concepts. (Journal article)
Lip, G. Y. H. (2015). Stroke prevention in atrial fibrillation: changing concepts.. European heart journal. Cardiovascular pharmacotherapy, 1(2), 76-79. doi:10.1093/ehjcvp/pvu003DOI: 10.1093/ehjcvp/pvu003
The Impact of Associated Diabetic Retinopathy on Stroke and Severe Bleeding Risk in Diabetic Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project (Journal article)
Lip, G. Y. H., Clementy, N., Pierre, B., Boyer, M., & Fauchier, L. (2015). The Impact of Associated Diabetic Retinopathy on Stroke and Severe Bleeding Risk in Diabetic Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. CHEST, 147(4), 1103-1110. doi:10.1378/chest.14-2096DOI: 10.1378/chest.14-2096
Use of psychotropic drugs following venous thromboembolism in youth. A nationwide cohort study (Journal article)
Hojen, A. A., Gorst-Rasmussen, A., Lip, G. Y. H., Lane, D. A., Rasmussen, L. H., Sorensen, E. E., & Larsen, T. B. (2015). Use of psychotropic drugs following venous thromboembolism in youth. A nationwide cohort study. THROMBOSIS RESEARCH, 135(4), 643-647. doi:10.1016/j.thromres.2015.01.024DOI: 10.1016/j.thromres.2015.01.024
open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI) (Journal article)
Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F., Wildgoose, P., . . . Fox, K. (2015). open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI). AMERICAN HEART JOURNAL, 169(4), 472-+. doi:10.1016/j.ahj.2014.12.006DOI: 10.1016/j.ahj.2014.12.006
Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation (Journal article)
Ntaios, G., Lip, G. Y. H., Lambrou, D., Papavasileiou, V., Manios, E., Milionis, H., . . . Vemmos, K. (2015). Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation. NEUROLOGY, 84(12), 1213-1219. doi:10.1212/WNL.0000000000001402DOI: 10.1212/WNL.0000000000001402
Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: The AFCAS study (Journal article)
Kiviniemi, T., Airaksinen, K. E. J., Rubboli, A., Biancari, F., Valencia, J., Lip, G. Y. H., . . . Schlitt, A. (2015). Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: The AFCAS study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 183, 105-110. doi:10.1016/j.ijcard.2015.01.056DOI: 10.1016/j.ijcard.2015.01.056
Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation (Journal article)
Ben Freedman, S., Gersh, B. J., & Lip, G. Y. H. (2015). Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation. EUROPEAN HEART JOURNAL, 36(11), 653-656. doi:10.1093/eurheartj/ehu494DOI: 10.1093/eurheartj/ehu494
Monitoring changes in thioredoxin and over-oxidised peroxiredoxin in response to exercise in humans (Journal article)
Wadley, A. J., Chen, Y. W., Bennett, S. J., Lip, G. Y. H., Turner, J. E., Fisher, J. P., & Aldred, S. (2015). Monitoring changes in thioredoxin and over-oxidised peroxiredoxin in response to exercise in humans. FREE RADICAL RESEARCH, 49(3), 290-298. doi:10.3109/10715762.2014.1000890DOI: 10.3109/10715762.2014.1000890
ANTITHROMBOTIC TREATMENT IN RELATION TO AGE IN PATIENTS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION IN NORTH AMERICA (GLORIA-AF PHASE II) (Conference Paper)
Halperin, J. L., Huisman, M., Diener, H. -C., Dubner, S., Ma, C., Rothman, K., . . . Lip, G. (2015). ANTITHROMBOTIC TREATMENT IN RELATION TO AGE IN PATIENTS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION IN NORTH AMERICA (GLORIA-AF PHASE II). In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 65 (pp. A1518). doi:10.1016/S0735-1097(15)61518-2DOI: 10.1016/S0735-1097(15)61518-2
Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation? The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (Journal article)
Lip, G. Y. H., Rushton-Smith, S. K., Goldhaber, S. Z., Fitzmaurice, D. A., Mantovani, L. G., Goto, S., . . . Worthy, V. (2015). Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation? The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 8(2), S12-S20. doi:10.1161/CIRCOUTCOMES.114.001556DOI: 10.1161/CIRCOUTCOMES.114.001556
ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS ASPIRIN IN THE LOW RISK NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN THE US: HOW MAY RESULTS FROM AVERROES HELP IMPROVE PATIENT CARE? (Conference Paper)
Lip, G. Y. H., Lanitis, T., Mardekian, J., Kongnakorn, T., Phatak, H., & Dorian, P. (2015). ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS ASPIRIN IN THE LOW RISK NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN THE US: HOW MAY RESULTS FROM AVERROES HELP IMPROVE PATIENT CARE?. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 65 (pp. A347). doi:10.1016/S0735-1097(15)60347-3DOI: 10.1016/S0735-1097(15)60347-3
Female sex is associated with a lower risk of stroke in patients with heart failure (Journal article)
Melgaard, L., Gorst-Rasmussen, A., Lip, G. Y. H., Rasmussen, L. H., & Larsen, T. B. (2015). Female sex is associated with a lower risk of stroke in patients with heart failure. AMERICAN HEART JOURNAL, 169(3), 396-403. doi:10.1016/j.ahj.2014.12.004DOI: 10.1016/j.ahj.2014.12.004
Increased Stroke Risk in Atrial Fibrillation Patients With Heart Failure Does Ejection Fraction Matter? (Journal article)
Kotecha, D., Banerjee, A., & Lip, G. Y. H. (2015). Increased Stroke Risk in Atrial Fibrillation Patients With Heart Failure Does Ejection Fraction Matter?. STROKE, 46(3), 608-609. doi:10.1161/STROKEAHA.114.008421DOI: 10.1161/STROKEAHA.114.008421
Optimising stroke prevention in patients with atrial fibrillation (Journal article)
Lane, D. A., Wolff, A., Shantsila, E., & Lip, G. Y. H. (2015). Optimising stroke prevention in patients with atrial fibrillation. BRITISH JOURNAL OF GENERAL PRACTICE, 65(632), 117. doi:10.3399/bjgp15X683905DOI: 10.3399/bjgp15X683905
PATTERNS OF NEWLY DETECTED ATRIAL FIBRILLATION AND ANTITHROMBOTIC TREATMENT IN NORTH AMERICA (GLORIA-AF PHASE II) (Conference Paper)
Halperin, J. L., Huisman, M., Diener, H. -C., Dubner, S. J., Ma, C., Rothman, K., . . . Lip, G. (2015). PATTERNS OF NEWLY DETECTED ATRIAL FIBRILLATION AND ANTITHROMBOTIC TREATMENT IN NORTH AMERICA (GLORIA-AF PHASE II). In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 65 (pp. A1520). doi:10.1016/S0735-1097(15)61520-0DOI: 10.1016/S0735-1097(15)61520-0
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score (Beyond Sex) Receive Oral Anticoagulation? (Journal article)
Chao, T. -F., Liu, C. -J., Wang, K. -L., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2015). Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score (Beyond Sex) Receive Oral Anticoagulation?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 65(7), 635-642. doi:10.1016/j.jacc.2014.11.046DOI: 10.1016/j.jacc.2014.11.046
Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome (Journal article)
Ramcharan, K. S., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2015). Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 30(3), 315-321. doi:10.1007/s00384-014-2116-3DOI: 10.1007/s00384-014-2116-3
Stroke risk reduction with oral anticoagulation using CHA<sub>2</sub>DS<sub>2</sub>-VASc in a Japanese AF population: A modeling analysis (Journal article)
Senoo, K., Lane, D. A., & Lip, G. Y. H. (2015). Stroke risk reduction with oral anticoagulation using CHA<sub>2</sub>DS<sub>2</sub>-VASc in a Japanese AF population: A modeling analysis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 181, 247-254. doi:10.1016/j.ijcard.2014.11.196DOI: 10.1016/j.ijcard.2014.11.196
What we have learned from the ESC position paper on arrhythmias in acute coronary syndromes (Journal article)
Gorenek, B., Kudaiberdieva, G., & Lip, G. (2015). What we have learned from the ESC position paper on arrhythmias in acute coronary syndromes. ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 15(2), 94-96. doi:10.5152/akd.2015.6206DOI: 10.5152/akd.2015.6206
Triple Therapy for Atrial Fibrillation and ACS With or Without PCI (Journal article)
Capodanno, D., & Lip, G. Y. H. (2015). Triple Therapy for Atrial Fibrillation and ACS With or Without PCI. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 65(5), 515-516. doi:10.1016/j.jacc.2014.10.063DOI: 10.1016/j.jacc.2014.10.063
Adverse cardiovascular outcomes in relation to suboptimal antithrombotic therapy use in patients undergoing peripheral artery disease angioplasty: lost opportunities? (Journal article)
Bodansky, D. M. S., Allon, I. R., Apostolakis, S., & Lip, G. Y. H. (2015). Adverse cardiovascular outcomes in relation to suboptimal antithrombotic therapy use in patients undergoing peripheral artery disease angioplasty: lost opportunities?. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(2), 162-168. doi:10.1111/ijcp.12470DOI: 10.1111/ijcp.12470
Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study (Journal article)
Friberg, L., Benson, L., & Lip, G. Y. H. (2015). Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study. EUROPEAN HEART JOURNAL, 36(5), 297-306. doi:10.1093/eurheartj/ehu139DOI: 10.1093/eurheartj/ehu139
Dabigatran and Myocardial Infarction (Journal article)
Hohnloser, S. H., & Lip, G. Y. H. (2015). Dabigatran and Myocardial Infarction. CHEST, 147(2), E70-E71. doi:10.1378/chest.14-2534DOI: 10.1378/chest.14-2534
Fondaparinux in atrial fibrillation - old dog, new tricks? (Journal article)
Lau, Y. C., Brown, R. A., & Lip, G. Y. H. (2015). Fondaparinux in atrial fibrillation - old dog, new tricks?. ARCHIVES OF CARDIOVASCULAR DISEASES, 108(2), 85-87. doi:10.1016/j.acvd.2014.12.001DOI: 10.1016/j.acvd.2014.12.001
Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal (Journal article)
Lip, G. Y. H., Wang, K. -L., & Chiang, C. -E. (2015). Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal. INTERNATIONAL JOURNAL OF CARDIOLOGY, 180, 246-254. doi:10.1016/j.ijcard.2014.11.182DOI: 10.1016/j.ijcard.2014.11.182
Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry (Journal article)
Lip, G. Y. H., Laroche, C., Boriani, G., Dan, G. -A., Santini, M., Kalarus, Z., . . . Tavazzi, L. (2015). Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. EUROPACE, 17(2), 194-206. doi:10.1093/europace/euu201DOI: 10.1093/europace/euu201
Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial Fibrillation (Journal article)
Xiong, Q., & Lip, G. Y. H. (2015). Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial Fibrillation. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 17(2). doi:10.1007/s11940-014-0331-4DOI: 10.1007/s11940-014-0331-4
Risk of major bleeding in different indications for new oral anticoagulants: Insights from a meta-analysis of approved dosages from 50 randomized trials (Journal article)
Sardar, P., Chatterjee, S., Lavie, C. J., Giri, J. S., Ghosh, J., Mukherjee, D., & Lip, G. Y. H. (2015). Risk of major bleeding in different indications for new oral anticoagulants: Insights from a meta-analysis of approved dosages from 50 randomized trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 179, 279-287. doi:10.1016/j.ijcard.2014.11.101DOI: 10.1016/j.ijcard.2014.11.101
Catheter Ablation of Atrial Fibrillation and Thromboembolic Risk (Journal article)
Kornej, J., Hindricks, G., Lip, G. Y. H., & Bollmann, A. (2015). Catheter Ablation of Atrial Fibrillation and Thromboembolic Risk. CIRCULATION JOURNAL, 79(2), 444. doi:10.1253/circj.CJ-14-1006DOI: 10.1253/circj.CJ-14-1006
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation - Meta-Analysis - (Journal article)
Senoo, K., Lau, Y. C., Dzeshka, M., Lane, D., Okumura, K., & Lip, G. Y. H. (2015). Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation - Meta-Analysis -. CIRCULATION JOURNAL, 79(2), 339-345. doi:10.1253/circj.CJ-14-1042DOI: 10.1253/circj.CJ-14-1042
Analysis of vitamin D levels in patients with and without statin-associated myalgia - A systematic review and meta-analysis of 7 studies with 2420 patients (Journal article)
Michalska-Kasiczak, M., Sahebkar, A., Mikhailidis, D. P., Rysz, J., Muntner, P., Toth, P. P., . . . Banach, M. (2015). Analysis of vitamin D levels in patients with and without statin-associated myalgia - A systematic review and meta-analysis of 7 studies with 2420 patients. INTERNATIONAL JOURNAL OF CARDIOLOGY, 178, 111-116. doi:10.1016/j.ijcard.2014.10.118DOI: 10.1016/j.ijcard.2014.10.118
Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores and arrhythmia recurrences (Journal article)
Kornej, J., Hindricks, G., Banerjee, A., Arya, A., Sommer, P., Rolf, S., . . . Bollmann, A. (2015). Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores and arrhythmia recurrences. HEART, 101(2), 126-131. doi:10.1136/heartjnl-2014-306013DOI: 10.1136/heartjnl-2014-306013
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach (Journal article)
Verdecchia, P., Angeli, F., Bartolini, C., De Filippo, V., Aita, A., Di Giacomo, L., . . . Reboldi, G. (2015). Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach. EXPERT OPINION ON DRUG SAFETY, 14(1), 7-20. doi:10.1517/14740338.2014.971009DOI: 10.1517/14740338.2014.971009
Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation (Journal article)
Dzeshka, M. S., & Lip, G. Y. H. (2015). Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation. EXPERT OPINION ON DRUG SAFETY, 14(1), 45-62. doi:10.1517/14740338.2015.973847DOI: 10.1517/14740338.2015.973847
A Happy New Year from Thrombosis and Haemostasis. A 5 year reflection from the Editorial team (Journal article)
Lip, G. Y. H., & Weber, C. (2015). A Happy New Year from Thrombosis and Haemostasis. A 5 year reflection from the Editorial team. THROMBOSIS AND HAEMOSTASIS, 113(1), 1-2. Retrieved from https://www.webofscience.com/
Ability of bleeding risk scores for stratification of bleeding events in elderly patients with atrial fibrillation (Conference Paper)
Fauchier, L., Banerjee, A., Lagrenade, I., Clementy, N., Bernard, A., Angoulvant, D., . . . Lip, G. Y. H. (2015). Ability of bleeding risk scores for stratification of bleeding events in elderly patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1081-1082). Retrieved from https://www.webofscience.com/
Antithrombotic management in patients with atrial fibrillation undergoing stent implantation: what is the impact of the ESC guidelines adherence? (Conference Paper)
Fauchier, L., Ancedy, Y., Lecoq, C., Saint Etienne, C., Ivanes, F., Babuty, D., . . . Lip, G. Y. H. (2015). Antithrombotic management in patients with atrial fibrillation undergoing stent implantation: what is the impact of the ESC guidelines adherence?. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1084). Retrieved from https://www.webofscience.com/
Assessment of a stroke risk stratification scheme in a heart failure population in sinus rhythm (Conference Paper)
Melgaard, L., Gorst-Rasmussen, A., Rasmussen, L. H., Lip, G. Y., & Larsen, T. B. (2015). Assessment of a stroke risk stratification scheme in a heart failure population in sinus rhythm. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 327). Retrieved from https://www.webofscience.com/
Atrial Fibrillation Patients Categorized as "Not for Anticoagulation" According to the 2014 Canadian Cardiovascular Society Algorithm Are Not "Low Risk" (Journal article)
Lip, G. Y. H., Nielsen, P. B., Skjoth, F., Rasmussen, L. H., & Larsen, T. B. (2015). Atrial Fibrillation Patients Categorized as "Not for Anticoagulation" According to the 2014 Canadian Cardiovascular Society Algorithm Are Not "Low Risk". CANADIAN JOURNAL OF CARDIOLOGY, 31(1), 24-28. doi:10.1016/j.cjca.2014.10.018DOI: 10.1016/j.cjca.2014.10.018
CD14<SUP>+</SUP>+CD16<SUP>+</SUP>CCR2+MONOCYTES ARE INCREASED IN DIFFUSE CORONARY ARTERY DISEASE (Conference Paper)
Brown, R., Lip, G., Varma, C., & Shantsila, E. (2015). CD14<SUP>+</SUP>+CD16<SUP>+</SUP>CCR2+MONOCYTES ARE INCREASED IN DIFFUSE CORONARY ARTERY DISEASE. In HEART Vol. 101 (pp. A90). Retrieved from https://www.webofscience.com/
Cardiovascular risk prediction: balancing complexity against simple practicality (Journal article)
Dzeshka, M. S., Gill, P. S., & Lip, G. Y. H. (2015). Cardiovascular risk prediction: balancing complexity against simple practicality. BRITISH JOURNAL OF GENERAL PRACTICE, 65(630), 4-5. doi:10.3399/bjgp15X683005DOI: 10.3399/bjgp15X683005
Cerebral Microcirculation: An Introduction (Chapter)
Dalkara, T. (2015). Cerebral Microcirculation: An Introduction. In PanVascular Medicine (pp. 655-680). Springer Berlin Heidelberg. doi:10.1007/978-3-642-37078-6_29DOI: 10.1007/978-3-642-37078-6_29
Characteristics of patients initiating oral anticoagulant therapy for management of non-valvular atrial fibrillation (NVAF) (Conference Paper)
Masseria, C., Lin, I., Mardekian, J., Frean, M., Phatak, H., Kamble, S., . . . Lip, G. Y. H. (2015). Characteristics of patients initiating oral anticoagulant therapy for management of non-valvular atrial fibrillation (NVAF). In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1084). Retrieved from https://www.webofscience.com/
Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients (Journal article)
Lip, G. Y. H., Lanitis, T., Mardekian, J., Kongnakorn, T., Phatak, H., & Dorian, P. (2015). Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients. STROKE, 46(10), 2830-2837. doi:10.1161/STROKEAHA.115.009995DOI: 10.1161/STROKEAHA.115.009995
Clinical and demographic characteristics according to dosage among non-valvular atrial fibrillation patients newly initiated on novel oral anticoagulants (Conference Paper)
Masseria, C., Lin, I., Mardekian, J., Frean, M., Phatak, H., Kamble, S., . . . Lip, G. Y. H. (2015). Clinical and demographic characteristics according to dosage among non-valvular atrial fibrillation patients newly initiated on novel oral anticoagulants. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1079). Retrieved from https://www.webofscience.com/
Comparative Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation (Journal article)
Senoo, K., & Lip, G. Y. H. (2015). Comparative Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 41(2), 146-153. doi:10.1055/s-0035-1544156DOI: 10.1055/s-0035-1544156
Comparative cost-effectiveness of oral anticoagulants for stroke prevention in non-valvular atrial fibrillation patients in the UK (Conference Paper)
Lip, G. Y. H., Lanitis, T., Kongnakorn, T., Phatak, H., Liu, L., Lawrence, J., & Dorian, P. (2015). Comparative cost-effectiveness of oral anticoagulants for stroke prevention in non-valvular atrial fibrillation patients in the UK. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 864). Retrieved from https://www.webofscience.com/
Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes Comprehensive network meta-analysis of 42 randomised trials involving 117,353 patients (Journal article)
Navarese, E. P., Andreotti, F., Kolodziejczak, M., Schulze, V., Wolff, G., Dias, S., . . . Kelm, M. (2015). Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes Comprehensive network meta-analysis of 42 randomised trials involving 117,353 patients. THROMBOSIS AND HAEMOSTASIS, 114(5), 933-944. doi:10.1160/TH14-12-1066DOI: 10.1160/TH14-12-1066
Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany (Journal article)
Krejczy, M., Harenberg, J., Wehling, M., Obermann, K., & Lip, G. Y. H. (2015). Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany. BIOMED RESEARCH INTERNATIONAL, 2015. doi:10.1155/2015/876923DOI: 10.1155/2015/876923
Cryptogenic Strokes and Second Ischemic Stroke Rates in Relation to the CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Scores (Conference Paper)
Hunter, T. D., Lip, G. Y., Quiroz, M. E., MolIenkopf, S. A., & Turakhia, M. P. (2015). Cryptogenic Strokes and Second Ischemic Stroke Rates in Relation to the CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Scores. In STROKE Vol. 46. Retrieved from https://www.webofscience.com/
D-Dimer elevation and adverse outcomes (Journal article)
Halaby, R., Popma, C. J., Cohen, A., Chi, G., Zacarkim, M. R., Romero, G., . . . Gibson, C. M. (2015). D-Dimer elevation and adverse outcomes. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 39(1), 55-59. doi:10.1007/s11239-014-1101-6DOI: 10.1007/s11239-014-1101-6
DOES HOME-BASED, SLOW DEEP BREATHING TRAINING REDUCE CENTRAL SYMPATHETIC OUTFLOW AND ENHANCE BAROREFLEX SENSIVITIY IN PRIMARY HYPERTENSION? (Conference Paper)
Shantsila, A., Adlan, A. M., Lip, G. Y. H., Pickering, A. E., Paton, J. F. R., & Fisher, J. P. (2015). DOES HOME-BASED, SLOW DEEP BREATHING TRAINING REDUCE CENTRAL SYMPATHETIC OUTFLOW AND ENHANCE BAROREFLEX SENSIVITIY IN PRIMARY HYPERTENSION?. In HEART Vol. 101 (pp. A83). Retrieved from https://www.webofscience.com/
Development of Recommendations to Continue Anticoagulation with One of the Two Types of Oral Anticoagulants Based on the Identification of Patients' Preference (Journal article)
Zolfaghari, S., Harenberg, J., Froelich, L., Weiss, C., Wehling, M., Wild, P., . . . Lip, G. Y. H. (2015). Development of Recommendations to Continue Anticoagulation with One of the Two Types of Oral Anticoagulants Based on the Identification of Patients' Preference. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 41(2), 166-177. doi:10.1055/s-0035-1546467DOI: 10.1055/s-0035-1546467
Diabetes as a risk factor of stroke and death in heart failure patients in sinus rhythm - a nationwide cohort study (Conference Paper)
Melgaard, L. L., Gorst-Rasmussen, A., Lip, G., & Larsen, T. B. (2015). Diabetes as a risk factor of stroke and death in heart failure patients in sinus rhythm - a nationwide cohort study. In EUROPEAN JOURNAL OF HEART FAILURE Vol. 17 (pp. 70). Retrieved from https://www.webofscience.com/
Do all AF patients with a CHA2DS2-VASc score of 2 (males) or 3 (females) have the same risk of ischemic stroke? A nationwide population-based cohort study (Conference Paper)
Liao, J. -N., Chao, T. F., Lip, G. Y., & Chen, S. A. (2015). Do all AF patients with a CHA2DS2-VASc score of 2 (males) or 3 (females) have the same risk of ischemic stroke? A nationwide population-based cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 901). Retrieved from https://www.webofscience.com/
Duration of diabetes mellitus and thromboembolic events in atrial fibrillation: a nationwide cohort study (Conference Paper)
Overvad, T. F., Skjoeth, F., Lip, G. Y. H., Lane, D. A., Albertsen, I. E., Rasmussen, L. H., & Larsen, T. B. (2015). Duration of diabetes mellitus and thromboembolic events in atrial fibrillation: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 910). Retrieved from https://www.webofscience.com/
Editors' Choice papers in Thrombosis and Haemostasis (Journal article)
Weber, C., & Lip, G. Y. H. (2015). Editors' Choice papers in Thrombosis and Haemostasis. THROMBOSIS AND HAEMOSTASIS, 113(1), 217-220. Retrieved from https://www.webofscience.com/
Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation An indirect comparison analysis (Journal article)
Blann, A. D., Skjoth, F., Rasmussen, L. H., Larsen, T. B., & Lip, G. Y. H. (2015). Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation An indirect comparison analysis. THROMBOSIS AND HAEMOSTASIS, 114(2), 403-409. doi:10.1160/TH15-05-0383DOI: 10.1160/TH15-05-0383
Effect of alcohol intake on diastolic function: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES) (Conference Paper)
Shantsila, E., Shantsila, A., Gill, P. S., & Lip, G. Y. H. (2015). Effect of alcohol intake on diastolic function: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 36 (pp. 314-315). Retrieved from https://www.webofscience.com/
Effect of digoxin on all-cause mortality in patients with atrial fibrillation: a population-based cohort study (Conference Paper)
Fauchier, L., Laborie, G., Clementy, N., Bernard, A., Angoulvant, D., Lip, G. Y. H., & Babuty, D. (2015). Effect of digoxin on all-cause mortality in patients with atrial fibrillation: a population-based cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 899). Retrieved from https://www.webofscience.com/
Effect of rivaroxaban and warfarin on fibrin clot structure (Conference Paper)
Lau, Y. C., Xiong, Q., Blann, A., & Lip, G. Y. H. (2015). Effect of rivaroxaban and warfarin on fibrin clot structure. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 744). Retrieved from https://www.webofscience.com/
Effects of Coenzyme Q10 on Statin-Induced Myopathy: A Meta-analysis of Randomized Controlled Trials (Journal article)
Banach, M., Serban, C., Sahebkar, A., Ursoniu, S., Rysz, J., Muntner, P., . . . Mikhailidis, D. P. (2015). Effects of Coenzyme Q10 on Statin-Induced Myopathy: A Meta-analysis of Randomized Controlled Trials. MAYO CLINIC PROCEEDINGS, 90(1), 24-34. doi:10.1016/j.mayocp.2014.08.021DOI: 10.1016/j.mayocp.2014.08.021
Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. (Journal article)
Banach, M., Serban, C., Sahebkar, A., Ursoniu, S., Rysz, J., Muntner, P., . . . Lipid and Blood Pressure Meta-analysis Collaboration Group. (2015). Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials.. Mayo Clinic proceedings, 90(1), 24-34. doi:10.1016/j.mayocp.2014.08.021DOI: 10.1016/j.mayocp.2014.08.021
Futility of supplementation with Coenzyme Q10 for statin-induced myopathy: an updated (2015) meta-analysis of randomized controlled trials (Conference Paper)
Banach, M., Serban, C., Sahebkar, A., Rysz, J., Muntner, P., Toth, P. P., . . . Mikhailidis, D. P. (2015). Futility of supplementation with Coenzyme Q10 for statin-induced myopathy: an updated (2015) meta-analysis of randomized controlled trials. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1047). Retrieved from https://www.webofscience.com/
Guideline adherence for stroke prevention and risk of mortality in patients with atrial fibrillation (Conference Paper)
Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2015). Guideline adherence for stroke prevention and risk of mortality in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 907-908). Retrieved from https://www.webofscience.com/
Is Major Bleeding Risk for Oral Anticoagulants Similar Among Newly Initiated Non Valvular Atrial Fibrillation Patients? (Conference Paper)
Lip, G. Y., Pan, X., Kamble, S., Kawabata, H., Mardekian, J., Masseria, C., . . . Hemant, P. (2015). Is Major Bleeding Risk for Oral Anticoagulants Similar Among Newly Initiated Non Valvular Atrial Fibrillation Patients?. In CIRCULATION Vol. 132. Retrieved from https://www.webofscience.com/
Ischemic Stroke and Intracranial Hemorrhage With Aspirin, Dabigatran, and Warfarin Impact of Quality of Anticoagulation Control (Journal article)
Ho, C. -W., Ho, M. -H., Chan, P. -H., Hai, J. -J., Cheung, E., Yeung, C. -Y., . . . Siu, C. -W. (2015). Ischemic Stroke and Intracranial Hemorrhage With Aspirin, Dabigatran, and Warfarin Impact of Quality of Anticoagulation Control. STROKE, 46(1), 23-30. doi:10.1161/STROKEAHA.114.006476DOI: 10.1161/STROKEAHA.114.006476
Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation (Conference Paper)
Ntaios, G., Lip, G. Y. H., Lambrou, D., Papavasileiou, V., Manios, E., Milionis, H., . . . Vemmos, K. (2015). Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 49-50). Retrieved from https://www.webofscience.com/
Mental health prognosis of young venous thromboembolism patients. A nationwide cohort study on psychotropic drug purchases (Conference Paper)
Hojen, A., Gorst-Rasmussen, A., Lip, G. Y. H., Lane, D. A., Rasmussen, L. H., Sorensen, E. E., & Larsen, T. B. (2015). Mental health prognosis of young venous thromboembolism patients. A nationwide cohort study on psychotropic drug purchases. In EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING Vol. 14 (pp. S7). Retrieved from https://www.webofscience.com/
Missed opportunities to prevent ischaemic stroke? Frequency of non-anticoagulation in a prospective multicentre cohort study of AF-associated ischaemic stroke and TIA (Conference Paper)
Wilson, D., Shakeshaft, C., Charidimou, A., Ambler, G., White, M., Cohen, H., . . . Werring, D. (2015). Missed opportunities to prevent ischaemic stroke? Frequency of non-anticoagulation in a prospective multicentre cohort study of AF-associated ischaemic stroke and TIA. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 6). Retrieved from https://www.webofscience.com/
Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score (Journal article)
Lip, G. Y. H., Skjoth, F., Nielsen, P. B., & Larsen, T. B. (2015). Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score. THROMBOSIS AND HAEMOSTASIS, 114(4), 826-834. doi:10.1160/TH15-07-0565DOI: 10.1160/TH15-07-0565
Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort (Journal article)
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2015). Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort. BRITISH JOURNAL OF GENERAL PRACTICE, 65(630), E16-E23. doi:10.3399/bjgp15X683113DOI: 10.3399/bjgp15X683113
Paroxysmal versus non-paroxysmal atrial fibrillation in Europe: the EORP-AF General Pilot Registry (Conference Paper)
Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Dan, G. A., . . . Lip, G. Y. H. (2015). Paroxysmal versus non-paroxysmal atrial fibrillation in Europe: the EORP-AF General Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 803). Retrieved from https://www.webofscience.com/
Patterns of Newly Detected Atrial Fibrillation and Antithrombotic Treatment in GLORIA-AF Phase II (Conference Paper)
Halperin, J. L., Huisman, M. V., Diener, H. -C., Dubner, S. J., Ma, C., Rothman, K. J., . . . Lip, G. H. (2015). Patterns of Newly Detected Atrial Fibrillation and Antithrombotic Treatment in GLORIA-AF Phase II. In CIRCULATION Vol. 132. Retrieved from https://www.webofscience.com/
Plasma cell-free DNA levels are elevated in patients with acute ischemic heart failure partially due to neutrophil extracellular trap formation (Conference Paper)
Brill, A., Shantsila, E., Ponomaryov, T., Dinsdale, R., Harrison, P., & Lip, G. (2015). Plasma cell-free DNA levels are elevated in patients with acute ischemic heart failure partially due to neutrophil extracellular trap formation. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 13 (pp. 379-380). Retrieved from https://www.webofscience.com/
Predicting intracranial bleeding risk in patients with atrial fibrillation using several bleeding risk scores (Conference Paper)
Fauchier, L., Banerjee, A., Lagrenade, I., Clementy, N., Angoulvant, D., Bernard, A., . . . Lip, G. Y. H. (2015). Predicting intracranial bleeding risk in patients with atrial fibrillation using several bleeding risk scores. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 338). Retrieved from https://www.webofscience.com/
Predictive Value of the SAMe-TTR2R2 to predict quality of oral anticoagulation in atrial fibrillation: a prospective validation in the multicentre Spanish observational registry fantasiia (Conference Paper)
Marin, F., Roldan-Schilling, V., Bertomeu-Gonzalez, V., Cequier, A., Muniz, J., Roldan, I., . . . Anguita, M. (2015). Predictive Value of the SAMe-TTR2R2 to predict quality of oral anticoagulation in atrial fibrillation: a prospective validation in the multicentre Spanish observational registry fantasiia. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1064-1065). Retrieved from https://www.webofscience.com/
Prevalence and associations of small vessel disease markers in an ischaemic stroke and TIA cohort with atrial fibrillation: Baseline characteristics of patients in the CROMIS-2 study (Conference Paper)
Wilson, D., Shakeshaft, C., Charidimou, A., Ambler, G., White, M., Cohen, H., . . . Werring, D. (2015). Prevalence and associations of small vessel disease markers in an ischaemic stroke and TIA cohort with atrial fibrillation: Baseline characteristics of patients in the CROMIS-2 study. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 11-12). Retrieved from https://www.webofscience.com/
Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China New Insights Into the Global Burden of Atrial Fibrillation (Journal article)
Guo, Y., Tian, Y., Wang, H., Si, Q., Wang, Y., & Lip, G. Y. H. (2015). Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China New Insights Into the Global Burden of Atrial Fibrillation. CHEST, 147(1), 109-119. doi:10.1378/chest.14-0321DOI: 10.1378/chest.14-0321
Prognosis in patients with atrial fibrillation and CHA2DS2-VASc score=1 in a community based cohort study (Conference Paper)
Fauchier, L., Lecoq, C., Clementy, N., Angoulvant, D., Babuty, D., & Lip, G. Y. H. (2015). Prognosis in patients with atrial fibrillation and CHA2DS2-VASc score=1 in a community based cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 863). Retrieved from https://www.webofscience.com/
Prognosis in patients with atrial fibrillation with a presumed temporary cause in a community based cohort study (Conference Paper)
Fauchier, L., Clementy, N., Angoulvant, D., Babuty, D., Bernard, A., & Lip, G. Y. H. (2015). Prognosis in patients with atrial fibrillation with a presumed temporary cause in a community based cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 164). Retrieved from https://www.webofscience.com/
Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on theTreatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013 (Conference Paper)
Van Wagoner, D. R., Piccini, J. P., Albert, C. M., Anderson, M. E., Benjamin, E. J., Brundel, B., . . . Wehrens, X. H. T. (2015). Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on theTreatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013. In HEART RHYTHM Vol. 12 (pp. E5-U37). doi:10.1016/j.hrthm.2014.11.011DOI: 10.1016/j.hrthm.2014.11.011
Psychosocial consequences of venous thromboembolism in youth. Results from a mixed methods study (Conference Paper)
Hojen, A. A., Gorst-Rasmussen, A., Lip, G. Y. H., Lane, D. A., Rasmussen, L. H., Sorensen, E. E., . . . Larsen, T. B. (2015). Psychosocial consequences of venous thromboembolism in youth. Results from a mixed methods study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 283). Retrieved from https://www.webofscience.com/
Real-world bleeding risk among non-valvular atrial fibrillation (NVAF) patients prescribed apixaban, dabigatran, rivaroxaban and warfarin: analysis of electronic health records (Conference Paper)
Lin, I., Masseria, C., Mardekian, J., Frean, M., Phatak, H., Kamble, S., . . . Lip, G. Y. H. (2015). Real-world bleeding risk among non-valvular atrial fibrillation (NVAF) patients prescribed apixaban, dabigatran, rivaroxaban and warfarin: analysis of electronic health records. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1084). Retrieved from https://www.webofscience.com/
Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients on apixaban, dabigatran, rivaroxaban: cohorts comprising new initiators and/or switchers from warfarin (Conference Paper)
Tepper, P., Mardekian, J., Masseria, C., Phatak, H., Kamble, S., Abdulsattar, Y., . . . Lip, G. Y. H. (2015). Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients on apixaban, dabigatran, rivaroxaban: cohorts comprising new initiators and/or switchers from warfarin. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 339). Retrieved from https://www.webofscience.com/
Relation of prior cerebral microbleeds to clinical characteristics of patients presenting with acute intracerebral hemorrhage (Conference Paper)
Nakamura, A., Yasaka, M., Lip, G. Y., Wakugawa, Y., Kuwashiro, T., Tsurusaki, Y., . . . Okada, Y. (2015). Relation of prior cerebral microbleeds to clinical characteristics of patients presenting with acute intracerebral hemorrhage. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 293). Retrieved from https://www.webofscience.com/
Relationship of renal impairment and diastolic dysfunction to hypertension in minority ethnic groups: ethnic-echocardiographic heart of England screening study (E-ECHOES) (Conference Paper)
Shantsila, A., Gill, P. S., Shantsila, E., & Lip, G. Y. H. (2015). Relationship of renal impairment and diastolic dysfunction to hypertension in minority ethnic groups: ethnic-echocardiographic heart of England screening study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 36 (pp. 25). Retrieved from https://www.webofscience.com/
Renal, endothelial function, warfarin management, and the CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>VASc and HAS-BLED scores in predicting MACE in AF (Journal article)
Blann, A. D., & Lip, G. Y. H. (2015). Renal, endothelial function, warfarin management, and the CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>VASc and HAS-BLED scores in predicting MACE in AF. THROMBOSIS AND HAEMOSTASIS, 113(5), 1155-1157. doi:10.1160/TH14-11-0932DOI: 10.1160/TH14-11-0932
Safety and efficacy of well managed warfarin A report from the Swedish quality register Auricula (Journal article)
Sjogren, V., Grzymala-Lubanski, B., Renlund, H., Friberg, L., Lip, G. Y. H., Svensson, P. J., & Sjalander, A. (2015). Safety and efficacy of well managed warfarin A report from the Swedish quality register Auricula. THROMBOSIS AND HAEMOSTASIS, 113(6), 1370-1377. doi:10.1160/TH14-10-0859DOI: 10.1160/TH14-10-0859
Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation (Journal article)
Pignatelli, P., Pastori, D., Carnevale, R., Farcomeni, A., Cangemi, R., Nocella, C., . . . Violi, F. (2015). Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 113(3), 617-624. doi:10.1160/TH14-07-0571DOI: 10.1160/TH14-07-0571
Sex-related differences in epidemiologic and clinical presentation of atrial fibrillation in the Balkan countries - insights from the BALKAN AF Snap Shot Survey (Conference Paper)
Polovina, M., Goshev, E., Kusljugic, Z., Music, L. J., Gjergo, H., Dan, G. A., . . . Lip, G. Y. H. (2015). Sex-related differences in epidemiologic and clinical presentation of atrial fibrillation in the Balkan countries - insights from the BALKAN AF Snap Shot Survey. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 900-901). Retrieved from https://www.webofscience.com/
Statin therapy reduces von Willebrand factor antigen levels: A systematic review and meta-analysis of randomized placebo-controlled trials (Conference Paper)
Sahebkar, A., Serban, C., Ursoniu, S., Mihaescu, R., Mikhailidis, D. P., Muntner, P., . . . Banach, M. (2015). Statin therapy reduces von Willebrand factor antigen levels: A systematic review and meta-analysis of randomized placebo-controlled trials. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 224). Retrieved from https://www.webofscience.com/
Statin treatment is associated with improved prognosis in patients with af-related stroke (Conference Paper)
Ntaios, G., Papavasileiou, V., Makaritsis, K., Milionis, H., Manios, E., Michel, P., . . . Vemmos, K. (2015). Statin treatment is associated with improved prognosis in patients with af-related stroke. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 275-276). Retrieved from https://www.webofscience.com/
Stroke and Major Bleeding Risk in Elderly Patients Aged ≥75 Years With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project (Journal article)
Lip, G. Y. H., Clementy, N., Pericart, L., Banerjee, A., & Fauchier, L. (2015). Stroke and Major Bleeding Risk in Elderly Patients Aged ≥75 Years With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. STROKE, 46(1), 143-150. doi:10.1161/STROKEAHA.114.007199DOI: 10.1161/STROKEAHA.114.007199
Stroke and bleeding risk-associated use of antithrombotic therapies for stroke prevention in atrial fibrillation in routine clinical practice: the BALKAN-AF Survey (Conference Paper)
Potpara, T. S., Dan, G. A., Trendafilova, E., Paparisto, V., Kusljugic, Z., Polovina, M. M., . . . Lip, G. Y. H. (2015). Stroke and bleeding risk-associated use of antithrombotic therapies for stroke prevention in atrial fibrillation in routine clinical practice: the BALKAN-AF Survey. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1082-1083). Retrieved from https://www.webofscience.com/
Suboptimal oral anticoagulation use among Chinese nonvalvular Atrial Fibrillation Patients: the Nanchang Atrial Fibrillation project (Conference Paper)
Xiong, Q., Shantsila, A., Cheng, X., Hong, K., & Lip, G. Y. H. (2015). Suboptimal oral anticoagulation use among Chinese nonvalvular Atrial Fibrillation Patients: the Nanchang Atrial Fibrillation project. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 66 (pp. C271-C272). Retrieved from https://www.webofscience.com/
Switching from a vitamin K antagonist to a NOAC (Journal article)
Senoo, K., & Lip, G. Y. H. (2015). Switching from a vitamin K antagonist to a NOAC. LANCET HAEMATOLOGY, 2(4), E132-E133. doi:10.1016/S2352-3026(15)00041-1DOI: 10.1016/S2352-3026(15)00041-1
Sympathetic nerve activity and arterial baroreflex function in rheumatoid arthritis (Conference Paper)
Adlan, A. M., Paton, J. F. R., Lip, G. Y. H., Kitas, G. D., & Fisher, J. P. (2015). Sympathetic nerve activity and arterial baroreflex function in rheumatoid arthritis. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 728). Retrieved from https://www.webofscience.com/
The CHA<sub>2</sub>DS<sub>2</sub>-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history (Journal article)
Lip, G. Y. H. (2015). The CHA<sub>2</sub>DS<sub>2</sub>-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history. EUROPEAN HEART JOURNAL, 36(42), 2880-2885. Retrieved from https://www.webofscience.com/
The CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for predicting ischemic stroke amongst Asian patients with atrial fibrillation: A systemic review and meta-analysis (Conference Paper)
Xiong, Q., Chen, S., Senoo, K., Proietti, M., Hong, K., & Lip, G. Y. H. (2015). The CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores for predicting ischemic stroke amongst Asian patients with atrial fibrillation: A systemic review and meta-analysis. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 66 (pp. C271). Retrieved from https://www.webofscience.com/
Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement (Journal article)
Capodanno, D., Lip, G. Y. H., Windecker, S., Huber, K., Kirchhof, P., Boriani, G., . . . Byrne, R. A. (2015). Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement. EUROINTERVENTION, 10(9), 1015-1021. doi:10.4244/EIJV10I9A174DOI: 10.4244/EIJV10I9A174
Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients (Conference Paper)
Pignatelli, P., Pastori, D., Hiatt, W. R., Lip, G., & Violi, F. (2015). Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 13 (pp. 519). Retrieved from https://www.webofscience.com/
Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients (Conference Paper)
Pastori, D., Pignatelli, P. P., Cangemi, R. C., Hiatt, W. R. H., Farcomeni, A. F., Vicario, T. V., . . . Violi, F. V. (2015). Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 903). Retrieved from https://www.webofscience.com/
Use of an Insertable Cardiac Monitor to Detect Atrial Fibrillation is Cost Effective in Patients with Cryptogenic Stroke (Conference Paper)
Diamantopoulos, A., Sawyer, L., Sungher, D., Lip, G., Witte, K., Reynolds, M. R., . . . Diener, H. -C. (2015). Use of an Insertable Cardiac Monitor to Detect Atrial Fibrillation is Cost Effective in Patients with Cryptogenic Stroke. In STROKE Vol. 46. Retrieved from https://www.webofscience.com/
Use of antithrombotic therapy in patients with atrial fibrillation and prior stroke: insights from the global GLORIA-AF registry (Conference Paper)
Lip, G. Y. H., Halperin, J. L., Diener, H. C., Dubner, S. J., Ma, C. S., Rothman, K. J., . . . Huisman, M. V. (2015). Use of antithrombotic therapy in patients with atrial fibrillation and prior stroke: insights from the global GLORIA-AF registry. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 243). Retrieved from https://www.webofscience.com/
Use of oral anticoagulants in combination with antiplatelet therapy: insights from the GLORIA-AF registry (Conference Paper)
Lip, G. Y. H., Halperin, J., Diener, H. C., Dubner, S. J., Ma, C. S., Rothman, K. J., . . . Huisman, M. V. (2015). Use of oral anticoagulants in combination with antiplatelet therapy: insights from the GLORIA-AF registry. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 235). Retrieved from https://www.webofscience.com/
Validation of SAME-TT2R2 score for predicting poor anticoagulation in a prospective real world cohort of atrial fibrillation patients initiating Vitamin K antagonists (Conference Paper)
Roldan-Schilling, V., Marin, F., Cancio, S., Galvez, J., Valdes, M., Vicente, V., & Lip, G. Y. H. (2015). Validation of SAME-TT2R2 score for predicting poor anticoagulation in a prospective real world cohort of atrial fibrillation patients initiating Vitamin K antagonists. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 803-804). Retrieved from https://www.webofscience.com/
Vascular disease as a risk factor of stroke or death in heart failure patients in sinus rhythm: a nationwide cohort study (Conference Paper)
Melgaard, L., Gorst-Rasmussen, A., Larsen, T. B., & Lip, G. (2015). Vascular disease as a risk factor of stroke or death in heart failure patients in sinus rhythm: a nationwide cohort study. In EUROPEAN JOURNAL OF HEART FAILURE Vol. 17 (pp. 249). Retrieved from https://www.webofscience.com/
Vascular disease as a risk factor of stroke or death in heart failure patients in sinus rhythm: a nationwide cohort study (Conference Paper)
Melgaard, L., Gorst-Rasmussen, A., Lip, G., & Larsen, T. B. (2015). Vascular disease as a risk factor of stroke or death in heart failure patients in sinus rhythm: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 28-29). Retrieved from https://www.webofscience.com/
Volume and functional outcome of intracerebral haemorrhage associated with non-vitamin K oral anticoagulants compared to warfarin: Prospective, multicentre cross sectional study (Conference Paper)
Wilson, D., Charidimou, A., Shakeshaft, C., Ambler, G., White, M., Cohen, H., . . . Werring, D. (2015). Volume and functional outcome of intracerebral haemorrhage associated with non-vitamin K oral anticoagulants compared to warfarin: Prospective, multicentre cross sectional study. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 62). Retrieved from https://www.webofscience.com/
Volume and functional outcome of intracerebral hemorrhage associated with non-vitamin K oral anticoagulants compared to warfarin: Multicenter cross sectional observational study (Conference Paper)
Wilson, D., Charidimou, A., Shakeshaft, C., Ambler, G., White, M. J., Cohen, H., . . . Werring, D. J. (2015). Volume and functional outcome of intracerebral hemorrhage associated with non-vitamin K oral anticoagulants compared to warfarin: Multicenter cross sectional observational study. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 59-60). Retrieved from https://www.webofscience.com/
Warfarin and major adverse cardiovascular events in the "Real World" of patients with atrial fibrillation (Conference Paper)
Pignatelli, P., Pastori, D., Lip, G., & Violi, F. (2015). Warfarin and major adverse cardiovascular events in the "Real World" of patients with atrial fibrillation. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 13 (pp. 392). Retrieved from https://www.webofscience.com/
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. (Journal article)
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Van Veldhuisen, D. J. (2015). [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death].. Kardiologia polska, 73(10), 795-900. doi:10.5603/kp.2015.0190DOI: 10.5603/kp.2015.0190
2014
Patients with atrial fibrillation undergoing percutaneous coronary intervention Current concepts and concerns: part II (Journal article)
Dzeshka, M. S., Brown, R. A., & Lip, G. Y. H. (2015). Patients with atrial fibrillation undergoing percutaneous coronary intervention Current concepts and concerns: part II. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 125(3), 172-180. Retrieved from https://www.webofscience.com/
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis (Journal article)
Kotecha, D., Holmes, J., Krum, H., Altman, D. G., Manzano, L., Cleland, J. G. F., . . . Flather, M. D. (2014). Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. LANCET, 384(9961), 2235-2243. doi:10.1016/S0140-6736(14)61373-8DOI: 10.1016/S0140-6736(14)61373-8
Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease A Nationwide Observational Cohort Study (Journal article)
Bonde, A. N., Lip, G. Y. H., Kamper, A. -L., Hansen, P. R., Lamberts, M., Hommel, K., . . . Olesen, J. B. (2014). Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease A Nationwide Observational Cohort Study. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 64(23), 2471-2482. doi:10.1016/j.jacc.2014.09.051DOI: 10.1016/j.jacc.2014.09.051
'Lone' atrial fibrillation: no longer lone or even alone. (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2015). 'Lone' atrial fibrillation: no longer lone or even alone.. Current pharmaceutical design, 21(5), 531-532. doi:10.2174/1381612820666140826124522DOI: 10.2174/1381612820666140826124522
A Brief History of 'Lone' Atrial Fibrillation: From 'A Peculiar Pulse Irregularity' to a Modern Public Health Concern (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2015). A Brief History of 'Lone' Atrial Fibrillation: From 'A Peculiar Pulse Irregularity' to a Modern Public Health Concern. CURRENT PHARMACEUTICAL DESIGN, 21(5), 679-696. doi:10.2174/1381612820666140929100209DOI: 10.2174/1381612820666140929100209
Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial (Journal article)
Shaffer, J. A., Thompson, J. L. P., Cheng, B., Ye, S., Lip, G. Y. H., Mann, D. L., . . . Homma, S. (2014). Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 177(2), 715-717. doi:10.1016/j.ijcard.2014.10.012DOI: 10.1016/j.ijcard.2014.10.012
Best Practice for Atrial Fibrillation Patient Education (Journal article)
Lane, D. A., Barker, R. V., & Lip, G. Y. H. (2015). Best Practice for Atrial Fibrillation Patient Education. CURRENT PHARMACEUTICAL DESIGN, 21(5), 533-543. Retrieved from https://www.webofscience.com/
Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation: The Catanzaro atrial fibrillation project (Journal article)
Perticone, F., Sciacqua, A., Perticone, M., Tassone, E. J., Sesti, G., Violi, F., & Lip, G. Y. H. (2014). Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation: The Catanzaro atrial fibrillation project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 177(2), 666-668. doi:10.1016/j.ijcard.2014.09.169DOI: 10.1016/j.ijcard.2014.09.169
Endothelial (Dys) Function in Lone Atrial Fibrillation (Journal article)
Polovina, M. M., Lip, G. Y. H., & Potpara, T. S. (2015). Endothelial (Dys) Function in Lone Atrial Fibrillation. CURRENT PHARMACEUTICAL DESIGN, 21(5), 622-645. Retrieved from https://www.webofscience.com/
Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry) (Journal article)
Lip, G. Y. H., Laroche, C., Ioachim, P. M., Rasmussen, L. H., Vitali-Serdoz, L., Petrescu, L., . . . Boriani, G. (2014). Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry). EUROPEAN HEART JOURNAL, 35(47), 3365-3376. doi:10.1093/eurheartj/ehu374DOI: 10.1093/eurheartj/ehu374
Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes (Journal article)
Larsen, T. B., Nielsen, P. B., Skjoth, F., Rasmussen, L. H., & Lip, G. Y. H. (2014). Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes. PLOS ONE, 9(12). doi:10.1371/journal.pone.0114445DOI: 10.1371/journal.pone.0114445
Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions? (Journal article)
Clemens, A., Strack, A., Noack, H., Konstantinides, S., Brueckmann, M., & Lip, G. Y. H. (2014). Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions?. ANNALS OF MEDICINE, 46(8), 672-678. doi:10.3109/07853890.2014.952327DOI: 10.3109/07853890.2014.952327
Autonomic function and rheumatoid arthritis-A systematic review (Journal article)
Adlan, A. M., Lip, G. Y. H., Paton, J. F. R., Kitas, G. D., & Fisher, J. P. (2014). Autonomic function and rheumatoid arthritis-A systematic review. SEMINARS IN ARTHRITIS AND RHEUMATISM, 44(3), 283-304. doi:10.1016/j.semarthrit.2014.06.003DOI: 10.1016/j.semarthrit.2014.06.003
Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults (Journal article)
Lamberts, M., Nielsen, O. W., Lip, G. Y. H., Ruwald, M. H., Christiansen, C. B., Kristensen, S. L., . . . Gislason, G. H. (2014). Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults. JOURNAL OF INTERNAL MEDICINE, 276(6), 659-666. doi:10.1111/joim.12302DOI: 10.1111/joim.12302
Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study (Journal article)
Larsen, T. B., Rasmussen, L. H., Gorst-Rasmussen, A., Skjoth, F., Lane, D. A., & Lip, G. Y. H. (2014). Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study. AMERICAN JOURNAL OF MEDICINE, 127(12), 1172-1178. doi:10.1016/j.amjmed.2014.07.023DOI: 10.1016/j.amjmed.2014.07.023
Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis (Journal article)
Wagstaff, A. J., Overvad, T. F., Lip, G. Y. H., & Lane, D. A. (2014). Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 107(12), 955-967. doi:10.1093/qjmed/hcu054DOI: 10.1093/qjmed/hcu054
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS) (Journal article)
Lip, G. Y. H., Windecker, S., Huber, K., Kirchhof, P., Marin, F., Ten Berg, J. M., . . . Lane, D. (2014). Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). EUROPEAN HEART JOURNAL, 35(45), 3155-3179. doi:10.1093/eurheartj/ehu298DOI: 10.1093/eurheartj/ehu298
The atrial fibrillation epidemic: a validated diagnosis, or not? (Journal article)
Olesen, J. B., Lip, G. Y. H., & Fauchier, L. (2014). The atrial fibrillation epidemic: a validated diagnosis, or not?. EUROPACE, 16(12), 1701-+. doi:10.1093/europace/euu173DOI: 10.1093/europace/euu173
Atrial fibrillation (acute onset). (Journal article)
Lip, G. Y. H., & Apostolakis, S. (2014). Atrial fibrillation (acute onset).. BMJ clinical evidence, 2014, 0210.
Plasma CX<sub>3</sub>CL1 Levels and Long Term Outcomes of Patients with Atrial Fibrillation: The West Birmingham Atrial Fibrillation Project (Journal article)
Guo, Y., Apostalakis, S., Blann, A. D., & Lip, G. Y. H. (2014). Plasma CX<sub>3</sub>CL1 Levels and Long Term Outcomes of Patients with Atrial Fibrillation: The West Birmingham Atrial Fibrillation Project. CEREBROVASCULAR DISEASES, 38(3), 204-211. doi:10.1159/000365841DOI: 10.1159/000365841
Recurrent Stroke in the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial (Journal article)
Pullicino, P. M., Qian, M., Sacco, R. L., Freudenberger, R., Graham, S., Teerlink, J. R., . . . Homma, S. (2014). Recurrent Stroke in the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial. CEREBROVASCULAR DISEASES, 38(3), 176-181. doi:10.1159/000365502DOI: 10.1159/000365502
Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial (Journal article)
Graham, S., Ye, S., Qian, M., Sanford, A. R., Di Tullio, M. R., Sacco, R. L., . . . Homma, S. (2014). Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial. PLOS ONE, 9(11). doi:10.1371/journal.pone.0113447DOI: 10.1371/journal.pone.0113447
Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation (Journal article)
Lip, G. Y. H., Laroche, C., Boriani, G., Cimaglia, P., Dan, G. -A., Santinis, M., . . . Maggioni, A. P. (2015). Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. EUROPACE, 17(1), 24-31. doi:10.1093/europace/euu155DOI: 10.1093/europace/euu155
New Biomarkers and Risk Stratification in Atrial Fibrillation Simplicity and Practicality Matter (Journal article)
Griffiths, H. R., & Lip, G. Y. H. (2014). New Biomarkers and Risk Stratification in Atrial Fibrillation Simplicity and Practicality Matter. CIRCULATION, 130(21), 1837-1839. doi:10.1161/CIRCULATIONAHA.114.012870DOI: 10.1161/CIRCULATIONAHA.114.012870
Nonsteroidal Anti-inflammatory Drugs and Serious Bleeding and Thromboembolism in Patients With Atrial Fibrillation (Journal article)
Lamberts, M., Lip, G. Y. H., Hansen, M. L., Lindhardsen, J., Olesen, J. B., Raunso, J., . . . Gislason, G. H. (2014). Nonsteroidal Anti-inflammatory Drugs and Serious Bleeding and Thromboembolism in Patients With Atrial Fibrillation. ANNALS OF INTERNAL MEDICINE, 161(10). doi:10.7326/P14-9039DOI: 10.7326/P14-9039
Relation of Nonsteroidal Anti-inflammatory Drugs to Serious Bleeding and Thromboembolism Risk in Patients With Atrial Fibrillation Receiving Antithrombotic Therapy A Nationwide Cohort Study (Journal article)
Lamberts, M., Lip, G. Y. H., Hansen, M. L., Lindhardsen, J., Olesen, J. B., Raunso, J., . . . Gislason, G. H. (2014). Relation of Nonsteroidal Anti-inflammatory Drugs to Serious Bleeding and Thromboembolism Risk in Patients With Atrial Fibrillation Receiving Antithrombotic Therapy A Nationwide Cohort Study. ANNALS OF INTERNAL MEDICINE, 161(10), 690-U136. doi:10.7326/M13-1581DOI: 10.7326/M13-1581
Statin treatment is associated with improved prognosis in patients with AF-related stroke (Journal article)
Ntaios, G., Papavasileiou, V., Makaritsis, K., Milionis, H., Manios, E., Michel, P., . . . Vemmos, K. (2014). Statin treatment is associated with improved prognosis in patients with AF-related stroke. INTERNATIONAL JOURNAL OF CARDIOLOGY, 177(1), 129-133. doi:10.1016/j.ijcard.2014.09.031DOI: 10.1016/j.ijcard.2014.09.031
Effects of Radiofrequency Catheter Ablation of Atrial Fibrillation on Soluble P-Selectin, Von Willebrand Factor and IL-6 in the Peripheral and Cardiac Circulation (Journal article)
Kornej, J., Dinov, B., Blann, A. D., Rolf, S., Arya, A., Schmidl, J., . . . Lip, G. Y. H. (2014). Effects of Radiofrequency Catheter Ablation of Atrial Fibrillation on Soluble P-Selectin, Von Willebrand Factor and IL-6 in the Peripheral and Cardiac Circulation. PLOS ONE, 9(11). doi:10.1371/journal.pone.0111760DOI: 10.1371/journal.pone.0111760
Acute myocardial infarction in patients with atrial fibrillation with a CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 0 or 1: A nationwide cohort study (Journal article)
Chao, T. -F., Huang, Y. -C., Liu, C. -J., Chen, S. -J., Wang, K. -L., Lin, Y. -J., . . . Chen, S. -A. (2014). Acute myocardial infarction in patients with atrial fibrillation with a CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 0 or 1: A nationwide cohort study. HEART RHYTHM, 11(11), 1941-1947. doi:10.1016/j.hrthm.2014.08.003DOI: 10.1016/j.hrthm.2014.08.003
Atrial Fibrillation During Sepsis A Determinant of Long-term Outcomes? (Journal article)
Lau, Y. C., & Lip, G. Y. H. (2014). Atrial Fibrillation During Sepsis A Determinant of Long-term Outcomes?. CHEST, 146(5), 1138-1140. doi:10.1378/chest.14-0986DOI: 10.1378/chest.14-0986
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. (Journal article)
Gorenek, B., Blomström Lundqvist, C., Brugada Terradellas, J., Camm, A. J., Hindricks, G., Huber, K., . . . Savelieva, I. (2014). Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 16(11), 1655-1673. doi:10.1093/europace/euu208DOI: 10.1093/europace/euu208
Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: Incidence, characteristics, and risk factors (Journal article)
Kosiuk, J., Kornej, J., Bollmann, A., Piorkowski, C., Myrda, K., Arya, A., . . . Hindricks, G. (2014). Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: Incidence, characteristics, and risk factors. HEART RHYTHM, 11(11), 1934-1940. doi:10.1016/j.hrthm.2014.07.039DOI: 10.1016/j.hrthm.2014.07.039
Exercise-induced changes in inflammatory processes: Implications for thrombogenesis in cardiovascular disease (Journal article)
Chen, Y. -W., Apostolakis, S., & Lip, G. Y. H. (2014). Exercise-induced changes in inflammatory processes: Implications for thrombogenesis in cardiovascular disease. ANNALS OF MEDICINE, 46(7), 439-455. doi:10.3109/07853890.2014.927713DOI: 10.3109/07853890.2014.927713
Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis (Journal article)
Jaipersad, A. S., Shantsila, A., Lip, G. Y. H., & Shantsila, E. (2014). Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis. ANNALS OF MEDICINE, 46(7), 530-538. doi:10.3109/07853890.2014.931101DOI: 10.3109/07853890.2014.931101
SAMe-TT<sub>2</sub>R<sub>2</sub> Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation (Journal article)
Gallego, P., Roldan, V., Marin, F., Galvez, J., Valdes, M., Vicente, V., & Lip, G. Y. H. (2014). SAMe-TT<sub>2</sub>R<sub>2</sub> Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 127(11), 1083-1088. doi:10.1016/j.amjmed.2014.05.023DOI: 10.1016/j.amjmed.2014.05.023
Stroke Prevention in Atrial Fibrillation - Outcomes and Future Directions. (Journal article)
Mountfort, K., Reviewed for accuracy by:., Camm, J., Lip, G., Goette, A., & Le Heuzey, J. -Y. (2014). Stroke Prevention in Atrial Fibrillation - Outcomes and Future Directions.. Arrhythmia & electrophysiology review, 3(3), 194-200. doi:10.15420/aer.2014.3.3.194DOI: 10.15420/aer.2014.3.3.194
The Value of the European Society of Cardiology Guidelines for Refining Stroke Risk Stratification in Patients With Atrial Fibrillation Categorized as Low Risk Using the Anticoagulation and Risk Factors in Atrial Fibrillation Stroke Score A Nationwide Cohort Study (Journal article)
Lip, G. Y. H., Nielsen, P. B., Skjoth, F., Lane, D. A., Rasmussen, L. H., & Larsen, T. B. (2014). The Value of the European Society of Cardiology Guidelines for Refining Stroke Risk Stratification in Patients With Atrial Fibrillation Categorized as Low Risk Using the Anticoagulation and Risk Factors in Atrial Fibrillation Stroke Score A Nationwide Cohort Study. CHEST, 146(5), 1337-1346. doi:10.1378/chest.14-0533DOI: 10.1378/chest.14-0533
Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer (Journal article)
Ramcharan, K. S., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2014). Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer. BRITISH JOURNAL OF CANCER, 111(9), 1742-1749. doi:10.1038/bjc.2014.491DOI: 10.1038/bjc.2014.491
Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Refining Stroke Risk Stratification in 'Low-Risk' Asian Patients With Atrial Fibrillation (Journal article)
Chao, T. -F., Liu, C. -J., Wang, K. -L., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2014). Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Refining Stroke Risk Stratification in 'Low-Risk' Asian Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 64(16), 1658-1665. doi:10.1016/j.jacc.2014.06.1203DOI: 10.1016/j.jacc.2014.06.1203
Free Light Chains in Patients With Acute Heart Failure Secondary to Atherosclerotic Coronary Artery Disease (Journal article)
Shantsila, E., Wrigley, B., & Lip, G. Y. H. (2014). Free Light Chains in Patients With Acute Heart Failure Secondary to Atherosclerotic Coronary Artery Disease. AMERICAN JOURNAL OF CARDIOLOGY, 114(8), 1243-1248. doi:10.1016/j.amjcard.2014.07.049DOI: 10.1016/j.amjcard.2014.07.049
Hormone Replacement Therapy and Adverse Outcomes in Women With Atrial Fibrillation An Analysis From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management Trial (Journal article)
Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2014). Hormone Replacement Therapy and Adverse Outcomes in Women With Atrial Fibrillation An Analysis From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management Trial. STROKE, 45(10), 3076-+. doi:10.1161/STROKEAHA.114.006668DOI: 10.1161/STROKEAHA.114.006668
Benefits valuation of potable water quality improvement in Malaysia: the case of Kajang Municipality (Journal article)
Othman, J., Lip, G. H., & Jafari, Y. (2014). Benefits valuation of potable water quality improvement in Malaysia: the case of Kajang Municipality. International Journal of Water Resources Development, 30(4), 621-634. doi:10.1080/07900627.2013.876851DOI: 10.1080/07900627.2013.876851
Atrial fibrillation (Journal article)
Lau, Y. C., & Lip, G. Y. H. (2014). Atrial fibrillation. Medicine, 42(10), 598-603. doi:10.1016/j.mpmed.2014.07.013DOI: 10.1016/j.mpmed.2014.07.013
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias (Journal article)
Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della‐Bella, P., Dickfeld, T., . . . Savelieva, I. (2014). EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Journal of Arrhythmia, 30(5), 327-349. doi:10.1016/j.joa.2014.08.001DOI: 10.1016/j.joa.2014.08.001
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. (Journal article)
Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., . . . EP-Europace,UK. (2014). EHRA/HRS/APHRS expert consensus on ventricular arrhythmias.. Heart rhythm, 11(10), e166-e196. doi:10.1016/j.hrthm.2014.07.024DOI: 10.1016/j.hrthm.2014.07.024
Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis. (Journal article)
Chao, T. -F., Liu, C. -J., Wang, K. -L., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2014). Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.. Heart rhythm, 11(10), 1752-1759. doi:10.1016/j.hrthm.2014.06.021DOI: 10.1016/j.hrthm.2014.06.021
New advances in the treatment of atrial fibrillation: focus on stroke prevention (Journal article)
Lau, Y. C., & Lip, G. Y. H. (2014). New advances in the treatment of atrial fibrillation: focus on stroke prevention. EXPERT OPINION ON PHARMACOTHERAPY, 15(15), 2193-2204. doi:10.1517/14656566.2014.948418DOI: 10.1517/14656566.2014.948418
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation and venous thromboembolism: where are we now? (Journal article)
Hajhosseiny, R., Sabir, I., & Lip, G. Y. H. (2014). Non-vitamin K antagonist oral anticoagulants in atrial fibrillation and venous thromboembolism: where are we now?. Hospital practice (1995), 42(4), 153-162. doi:10.3810/hp.2014.10.1152DOI: 10.3810/hp.2014.10.1152
Oxidised LDL lipids, statins and a blood-brain barrier (Conference Paper)
Helen, G., Dias, I., Lip, G. Y. H., Corinne, S., & Cristina, P. (2014). Oxidised LDL lipids, statins and a blood-brain barrier. In FREE RADICAL BIOLOGY AND MEDICINE Vol. 75 (pp. S15-S16). doi:10.1016/j.freeradbiomed.2014.10.591DOI: 10.1016/j.freeradbiomed.2014.10.591
Pocket Ready to Eat at Home in Primary Care Reply (Journal article)
Prasad, V., Kim, J., & Rho, J. (2014). Pocket Ready to Eat at Home in Primary Care Reply. AMERICAN JOURNAL OF MEDICINE, 127(3), E21. doi:10.1016/j.amjmed.2013.11.005DOI: 10.1016/j.amjmed.2013.11.005
Prediction of stroke in patients without atrial fibrillation using the CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores: a justification for more widespread thromboprophylaxis? (Journal article)
Senoo, K., & Lip, G. Y. H. (2014). Prediction of stroke in patients without atrial fibrillation using the CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores: a justification for more widespread thromboprophylaxis?. HEART, 100(19), 1485-1486. doi:10.1136/heartjnl-2014-306161DOI: 10.1136/heartjnl-2014-306161
Prior History of Falls and Risk of Outcomes in Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project (Journal article)
Banerjee, A., Clementy, N., Haguenoer, K., Fauchier, L., & Lip, G. Y. H. (2014). Prior History of Falls and Risk of Outcomes in Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project. AMERICAN JOURNAL OF MEDICINE, 127(10), 972-978. doi:10.1016/j.amjmed.2014.05.035DOI: 10.1016/j.amjmed.2014.05.035
Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey (Journal article)
Marcucci, M., Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Crijns, H. J. G. M., & Iorio, A. (2014). Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey. AMERICAN JOURNAL OF MEDICINE, 127(10), 979-U199. doi:10.1016/j.amjmed.2014.05.003DOI: 10.1016/j.amjmed.2014.05.003
Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk-Score Acronyms (CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>-VASc, R<sub>2</sub>CHADS<sub>2</sub>, HAS-BLED, ATRIA, and More) (Journal article)
Dzeshka, M. S., Lane, D. A., & Lip, G. Y. H. (2014). Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk-Score Acronyms (CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>-VASc, R<sub>2</sub>CHADS<sub>2</sub>, HAS-BLED, ATRIA, and More). CLINICAL CARDIOLOGY, 37(10), 634-644. doi:10.1002/clc.22294DOI: 10.1002/clc.22294
Stroke/Thromboembolism and Intracranial Hemorrhage in a Real-world Atrial Fibrillation Population The Complications of Atrial Fibrillation in the Bologna Area (CAFBO) Study (Journal article)
Palareti, G., Salomone, L., Cavazza, M., Guidi, M., Muscari, A., Boriani, G., . . . Lip, G. Y. H. (2014). Stroke/Thromboembolism and Intracranial Hemorrhage in a Real-world Atrial Fibrillation Population The Complications of Atrial Fibrillation in the Bologna Area (CAFBO) Study. CHEST, 146(4), 1073-1080. doi:10.1378/chest.13-2443DOI: 10.1378/chest.13-2443
Correction: Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria (Journal article)
Correction: Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria (n.d.). PLoS ONE, 9(9), e109437. doi:10.1371/journal.pone.0109437DOI: 10.1371/journal.pone.0109437
Laboratory Monitoring of the Non-Vitamin K Oral Anticoagulants (Journal article)
Blann, A. D., & Lip, G. Y. H. (2014). Laboratory Monitoring of the Non-Vitamin K Oral Anticoagulants. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 64(11), 1140-1142. doi:10.1016/j.jacc.2014.07.010DOI: 10.1016/j.jacc.2014.07.010
Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study. (Journal article)
Montalescot, G., Pitt, B., Lopez de Sa, E., Hamm, C. W., Flather, M., Verheugt, F., . . . REMINDER Investigators. (2014). Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study.. European heart journal, 35(34), 2295-2302. doi:10.1093/eurheartj/ehu164DOI: 10.1093/eurheartj/ehu164
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias (Journal article)
Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., . . . Savelieva, I. (2014). EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. EUROPACE, 16(9), 1257-1283. doi:10.1093/europace/euu194DOI: 10.1093/europace/euu194
Integrating Real-Time Clinical Information to Provide Estimates of Net Clinical Benefit of Antithrombotic Therapy for Patients With Atrial Fibrillation (Journal article)
Eckman, M. H., Wise, R. E., Speer, B., Sullivan, M., Walker, N., Lip, G. Y. H., . . . Costea, A. (2014). Integrating Real-Time Clinical Information to Provide Estimates of Net Clinical Benefit of Antithrombotic Therapy for Patients With Atrial Fibrillation. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 7(5), 680-686. doi:10.1161/CIRCOUTCOMES.114.001163DOI: 10.1161/CIRCOUTCOMES.114.001163
Relationship of the SAMe-TT<sub>2</sub>R<sub>2</sub> Score to Poor-Quality Anticoagulation, Stroke, Clinically Relevant Bleeding, and Mortality in Patients With Atrial Fibrillation (Journal article)
Lip, G. Y. H., Haguenoer, K., Saint-Etienne, C., & Fauchier, L. (2014). Relationship of the SAMe-TT<sub>2</sub>R<sub>2</sub> Score to Poor-Quality Anticoagulation, Stroke, Clinically Relevant Bleeding, and Mortality in Patients With Atrial Fibrillation. CHEST, 146(3), 719-726. doi:10.1378/chest.13-2976DOI: 10.1378/chest.13-2976
Response to Letter Regarding Article, "Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation: Randomized Controlled Trial (Birmingham Atrial Fibrillation Treatment of the Aged Study)" (Journal article)
Mavaddat, N., Roalfe, A., Fletcher, K., Lip, G. Y. H., Hobbs, F. D. R., Fitzmaurice, D., & Mant, J. (2014). Response to Letter Regarding Article, "Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation: Randomized Controlled Trial (Birmingham Atrial Fibrillation Treatment of the Aged Study)". STROKE, 45(9), E192. doi:10.1161/STROKEAHA.114.006301DOI: 10.1161/STROKEAHA.114.006301
Stroke and Bleeding Risk in Atrial Fibrillation (Journal article)
Senoo, K., Lane, D., & Lip, G. Y. H. (2014). Stroke and Bleeding Risk in Atrial Fibrillation. KOREAN CIRCULATION JOURNAL, 44(5), 281-290. doi:10.4070/kcj.2014.44.5.281DOI: 10.4070/kcj.2014.44.5.281
The Impact of Heart Failure and Left Ventricular Dysfunction in Predicting Stroke, Thromboembolism, and Mortality in Atrial Fibrillation Patients: A Systematic Review (Journal article)
Agarwal, M., Apostolakis, S., Lane, D. A., & Lip, G. Y. H. (2014). The Impact of Heart Failure and Left Ventricular Dysfunction in Predicting Stroke, Thromboembolism, and Mortality in Atrial Fibrillation Patients: A Systematic Review. CLINICAL THERAPEUTICS, 36(9), 1135-1144. doi:10.1016/j.clinthera.2014.07.015DOI: 10.1016/j.clinthera.2014.07.015
Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches? (Journal article)
Lip, G. Y. H., Al-Khatib, S. M., Cosio, F. G., Banerjee, A., Savelieva, I., Ruskin, J., . . . Camm, A. J. (2014). Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches?. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 3(4). doi:10.1161/JAHA.114.001179DOI: 10.1161/JAHA.114.001179
MY APPROACH to the use of NOACs for stroke prevention in patients with atrial fibrillation (Journal article)
Lip, G. Y. H. (2014). MY APPROACH to the use of NOACs for stroke prevention in patients with atrial fibrillation. TRENDS IN CARDIOVASCULAR MEDICINE, 24(6), 265-266. doi:10.1016/j.tcm.2014.05.012DOI: 10.1016/j.tcm.2014.05.012
Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy (Journal article)
Orenes-Pinero, E., Hernandez-Romero, D., Romero-Aniorte, A. I., Martinez, M., Garcia-Honrubia, A., Caballero, L., . . . Marin, F. (2014). Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 107(8), 613-621. doi:10.1093/qjmed/hcu046DOI: 10.1093/qjmed/hcu046
Thrombotic Complications in Heart Failure An Underappreciated Challenge (Journal article)
Shantsila, E., & Lip, G. Y. H. (2014). Thrombotic Complications in Heart Failure An Underappreciated Challenge. CIRCULATION, 130(5), 387-389. doi:10.1161/CIRCULATIONAHA.114.011353DOI: 10.1161/CIRCULATIONAHA.114.011353
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation (Journal article)
Dorian, P., Kongnakorn, T., Phatak, H., Rublee, D. A., Kuznik, A., Lanitis, T., . . . Lip, G. Y. H. (2014). Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation. EUROPEAN HEART JOURNAL, 35(28), 1897-1906. doi:10.1093/eurheartj/ehu006DOI: 10.1093/eurheartj/ehu006
Edoxaban: a focused review of its clinical pharmacology (Journal article)
Lip, G. Y. H., & Agnelli, G. (2014). Edoxaban: a focused review of its clinical pharmacology. EUROPEAN HEART JOURNAL, 35(28), 1844-1855. doi:10.1093/eurheartj/ehu181DOI: 10.1093/eurheartj/ehu181
A Persisting Dilemma for Triple Antithrombotic Therapy Are We Close to Finding the Correct Answer? Reply (Journal article)
Lamberts, M., Gislason, G. H., Olesen, J. B., Kristensen, S. L., Olsen, A. -M. S., Mikkelsen, A., . . . Hansen, M. L. (2014). A Persisting Dilemma for Triple Antithrombotic Therapy Are We Close to Finding the Correct Answer? Reply. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 64(2), 231-232. doi:10.1016/j.jacc.2013.11.049DOI: 10.1016/j.jacc.2013.11.049
An "unlikely" Wells rule score (≤ 1) plus a negative D-dimer result excluded DVT in noncancer patients (Journal article)
Brown, R. A., & Lip, G. Y. H. (2014). An "unlikely" Wells rule score (≤ 1) plus a negative D-dimer result excluded DVT in noncancer patients. ANNALS OF INTERNAL MEDICINE, 161(2). doi:10.7326/0003-4819-161-2-201407150-02009DOI: 10.7326/0003-4819-161-2-201407150-02009
Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin (Conference Paper)
Montoro-Garcia, S., Shantsila, E., Hernandez-Romero, D., Jover, E., Valdes, M., Marin, F., & Lip, G. Y. H. (2014). Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin. In CARDIOVASCULAR RESEARCH Vol. 103. doi:10.1093/cvr/cvu094.1DOI: 10.1093/cvr/cvu094.1
Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease A Nationwide Cohort Study (Journal article)
Lamberts, M., Lip, G. Y. H., Ruwald, M. H., Hansen, M. L., Ozcan, C., Kristensen, S. L., . . . Gislason, G. H. (2014). Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease A Nationwide Cohort Study. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 63(24), 2689-2698. doi:10.1016/j.jacc.2014.03.039DOI: 10.1016/j.jacc.2014.03.039
Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons (Journal article)
Verdecchia, P., Angeli, F., Lip, G. Y. H., & Reboldi, G. (2014). Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons. PLOS ONE, 9(6). doi:10.1371/journal.pone.0100478DOI: 10.1371/journal.pone.0100478
Performance of Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (Journal article)
Kiviniemi, T., Puurunen, M., Schlitt, A., Rubboli, A., Karjalainen, P., Vikman, S., . . . Airaksinen, K. E. J. (2014). Performance of Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. AMERICAN JOURNAL OF CARDIOLOGY, 113(12), 1995-2001. doi:10.1016/j.amjcard.2014.03.038DOI: 10.1016/j.amjcard.2014.03.038
Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria (Journal article)
Clemens, A., Noack, H., Brueckmann, M., & Lip, G. Y. H. (2014). Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria. PLOS ONE, 9(6). doi:10.1371/journal.pone.0099276DOI: 10.1371/journal.pone.0099276
Aspirin still overprescribed for stroke prevention in atrial fibrillation. (Journal article)
Taylor, J. (2014). Aspirin still overprescribed for stroke prevention in atrial fibrillation.. European heart journal, 35(22), 1422.
Early management of atrial fibrillation to prevent cardiovascular complications (Journal article)
Nattel, S., Guasch, E., Savelieva, I., Cosio, F. G., Valverde, I., Halperin, J. L., . . . Camm, A. J. (2014). Early management of atrial fibrillation to prevent cardiovascular complications. EUROPEAN HEART JOURNAL, 35(22), 1448-1U32. doi:10.1093/eurheartj/ehu028DOI: 10.1093/eurheartj/ehu028
ETHNIC AND GENDER DIFFERENCES IN SYMPTOM-TO-DOOR TIMES IN PATIENTS PRESENTING WITH ST ELEVATION MYOCARDIAL INFARCTION (Conference Paper)
Brown, R., Shantsila, E., Varma, C., & Lip, G. (2014). ETHNIC AND GENDER DIFFERENCES IN SYMPTOM-TO-DOOR TIMES IN PATIENTS PRESENTING WITH ST ELEVATION MYOCARDIAL INFARCTION. In HEART Vol. 100 (pp. A18-A19). doi:10.1136/heartjnl-2014-306118.34DOI: 10.1136/heartjnl-2014-306118.34
MONOCYTE SUBPOPULATIONS COUNTS AND ASSOCIATIONS WITH GLOBAL LONGITUDINAL STRAIN IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH NORMAL EJECTION FRACTION (Conference Paper)
Ghattas, A., Shantsila, E., Griffiths, H., & Lip, G. (2014). MONOCYTE SUBPOPULATIONS COUNTS AND ASSOCIATIONS WITH GLOBAL LONGITUDINAL STRAIN IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH NORMAL EJECTION FRACTION. In HEART Vol. 100 (pp. A19-A20). doi:10.1136/heartjnl-2014-306118.36DOI: 10.1136/heartjnl-2014-306118.36
Primary Prevention of Ischaemic Stroke in Atrial Fibrillation: New Oral Anticoagulant Drugs for all? (Journal article)
Foley, J., Kirchhof, P., & Lip, G. Y. H. (2014). Primary Prevention of Ischaemic Stroke in Atrial Fibrillation: New Oral Anticoagulant Drugs for all?. CURRENT VASCULAR PHARMACOLOGY, 12(3), 373-383. doi:10.2174/157016111203140518153503DOI: 10.2174/157016111203140518153503
ACP Journal Club. In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS2 and CHA2DS2-VASc. (Journal article)
Marcucci, M. (2014). ACP Journal Club. In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS2 and CHA2DS2-VASc.. Annals of internal medicine, 160(10), JC13. doi:10.7326/0003-4819-160-10-201405200-02013DOI: 10.7326/0003-4819-160-10-201405200-02013
Ablation reduced recurrent atrial tachyarrhythmia more than antiarrhythmic drugs in paroxysmal AF (Journal article)
Lau, Y. C., & Lip, G. Y. H. (2014). Ablation reduced recurrent atrial tachyarrhythmia more than antiarrhythmic drugs in paroxysmal AF. ANNALS OF INTERNAL MEDICINE, 160(10). doi:10.7326/0003-4819-160-10-201405200-02005DOI: 10.7326/0003-4819-160-10-201405200-02005
Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry (Journal article)
Puurunen, M., Kiviniemi, T., Nammas, W., Schlitt, A., Rubboli, A., Nyman, K., . . . Airaksinen, J. K. E. (2014). Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry. BMJ OPEN, 4(5). doi:10.1136/bmjopen-2013-004700DOI: 10.1136/bmjopen-2013-004700
Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease (Journal article)
Kooiman, J., van Rein, N., Spaans, B., van Beers, K. A. J., Bank, J. R., de Peppel, W. R. V., . . . Huisman, M. V. (2014). Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease. PLOS ONE, 9(5). doi:10.1371/journal.pone.0094420DOI: 10.1371/journal.pone.0094420
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation (Journal article)
Skjoth, F., Larsen, T. B., Rasmussen, L. H., & Lip, G. Y. H. (2014). Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 111(5), 981-988. doi:10.1160/TH14-02-0118DOI: 10.1160/TH14-02-0118
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel (Journal article)
Husted, S., de Caterina, R., Andreotti, F., Arnesen, H., Bachmann, F., Huber, K., . . . Weitz, J. I. (2014). Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel. THROMBOSIS AND HAEMOSTASIS, 111(5), 781-782. doi:10.1160/TH14-03-0228DOI: 10.1160/TH14-03-0228
Patient outcomes using the European label for dabigatran A post-hoc analysis from the RE-LY database (Journal article)
Lip, G. Y. H., Clemens, A., Noack, H., Ferreira, J., Connolly, S. J., & Yusuf, S. (2014). Patient outcomes using the European label for dabigatran A post-hoc analysis from the RE-LY database. THROMBOSIS AND HAEMOSTASIS, 111(5), 933-942. doi:10.1160/TH13-09-0734DOI: 10.1160/TH13-09-0734
Stroke prevention in atrial fibrillation: An Asian perspective (Journal article)
Chiang, C. -E., Wang, K. -L., & Lip, G. Y. H. (2014). Stroke prevention in atrial fibrillation: An Asian perspective. THROMBOSIS AND HAEMOSTASIS, 111(5), 789-797. doi:10.1160/TH13-11-0948DOI: 10.1160/TH13-11-0948
Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end? (Journal article)
Lau, Y. C., & Lip, G. Y. H. (2014). Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end?. EUROPACE, 16(5), 619-620. doi:10.1093/europace/eut356DOI: 10.1093/europace/eut356
NT-PROBNP PROVIDED COMPLEMENTARY PROGNOSTIC INFORMATION TO AN ESTABLISHED CLINICAL RISK SCORE (CHA2DS2-VASC) FOR THE PREDICTION OF STROKE/SYSTEMIC EMBOLISM (Conference Paper)
Roldan, V., Antonio Vilchez, J., Manzano-Fernandez, S., Jover, E., Gallego, P., Puche, C. M., . . . Marin, F. (2014). NT-PROBNP PROVIDED COMPLEMENTARY PROGNOSTIC INFORMATION TO AN ESTABLISHED CLINICAL RISK SCORE (CHA2DS2-VASC) FOR THE PREDICTION OF STROKE/SYSTEMIC EMBOLISM. In THROMBOSIS RESEARCH Vol. 133 (pp. S18). doi:10.1016/S0049-3848(14)50079-5DOI: 10.1016/S0049-3848(14)50079-5
RELATIONSHIP OF THE SAME-TT2R2 SCORE TO POOR QUALITY ANTICOAGULATION, STROKE, CLINICALLY RELEVANT BLEEDING AND MORTALITY IN PATIENTS WITH ATRIAL FIBRILLATION (Conference Paper)
Lip, G. Y. H., Haguenoer, K., Saint-Etienne, C., & Fauchier, L. (2014). RELATIONSHIP OF THE SAME-TT2R2 SCORE TO POOR QUALITY ANTICOAGULATION, STROKE, CLINICALLY RELEVANT BLEEDING AND MORTALITY IN PATIENTS WITH ATRIAL FIBRILLATION. In THROMBOSIS RESEARCH Vol. 133 (pp. S19). doi:10.1016/S0049-3848(14)50081-3DOI: 10.1016/S0049-3848(14)50081-3
THE PREDICTIVE VALUE OF THE SAME-TT2R2 SCORE FOR ANTICOAGULATION CONTROL AND ADVERSE OUTCOMES IN ANTICOAGULATED PATIENTS WITH ATRIAL FIBRILLATION (Conference Paper)
Gallego, P., Roldan, V., Marin, F., Galvez, J., Valdes, M., Vicente, V., & Lip, G. H. Y. (2014). THE PREDICTIVE VALUE OF THE SAME-TT2R2 SCORE FOR ANTICOAGULATION CONTROL AND ADVERSE OUTCOMES IN ANTICOAGULATED PATIENTS WITH ATRIAL FIBRILLATION. In THROMBOSIS RESEARCH Vol. 133 (pp. S89). doi:10.1016/S0049-3848(14)50288-5DOI: 10.1016/S0049-3848(14)50288-5
VALIDATION OF THE APIXABAN COST-EFFECTIVENESS MODEL IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (Conference Paper)
Kachroo, S., Phatak, H., Dorian, P., Kongnakorn, T., Lanitis, T., Kuznik, A., . . . Lip, G. Y. (2014). VALIDATION OF THE APIXABAN COST-EFFECTIVENESS MODEL IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION. In VALUE IN HEALTH Vol. 17 (pp. A113). doi:10.1016/j.jval.2014.03.661DOI: 10.1016/j.jval.2014.03.661
The Potential Role of Edoxaban in Stroke Prevention Guidelines. (Journal article)
Plunkett, O., & Lip, G. Y. H. (2014). The Potential Role of Edoxaban in Stroke Prevention Guidelines.. Arrhythmia & electrophysiology review, 3(1), 40-43. doi:10.15420/aer.2011.3.1.40DOI: 10.15420/aer.2011.3.1.40
Ankle-Brachial Index in Patients With Nonvalvular Atrial Fibrillation Reply (Journal article)
Violi, F., Davi, G., Hiatt, W., Lip, G. Y. H., Corazza, G. R., Perticone, F., . . . Basili, S. (2014). Ankle-Brachial Index in Patients With Nonvalvular Atrial Fibrillation Reply. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 63(14), 1457-1458. doi:10.1016/j.jacc.2013.11.011DOI: 10.1016/j.jacc.2013.11.011
Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant A Nationwide Cohort Study (Journal article)
Lamberts, M., Gislason, G. H., Lip, G. Y. H., Lassen, J. F., Olesen, J. B., Mikkelsen, A. P., . . . Hansen, M. L. (2014). Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant A Nationwide Cohort Study. CIRCULATION, 129(15), 1577-1585. doi:10.1161/CIRCULATIONAHA.113.004834DOI: 10.1161/CIRCULATIONAHA.113.004834
Atrial Fibrillation and Heart Failure: A Bad Combination (Journal article)
Lau, Y. C., Lane, D. A., & Lip, G. Y. H. (2014). Atrial Fibrillation and Heart Failure: A Bad Combination. AMERICAN JOURNAL OF CARDIOLOGY, 113(7), 1196-1197. doi:10.1016/j.amjcard.2014.01.002DOI: 10.1016/j.amjcard.2014.01.002
CLINICAL OUTCOME OF PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH BARE-METAL VERSUS DRUG-ELUTING STENTS: INSIGHTS FROM THE AFCAS REGISTRY (Conference Paper)
Puurunen, M. K., Kiviniemi, T., Schlitt, A., Rubboli, A., Karjalainen, P., Biancari, F., . . . Airaksinen, J. (2014). CLINICAL OUTCOME OF PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH BARE-METAL VERSUS DRUG-ELUTING STENTS: INSIGHTS FROM THE AFCAS REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A1681). doi:10.1016/S0735-1097(14)61684-3DOI: 10.1016/S0735-1097(14)61684-3
COGNITIVE FUNCTION IN AMBULATORY PATIENTS WITH SYSTOLIC HEART FAILURE: INSIGHTS FROM THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL (Conference Paper)
Ye, S., Graham, S., Qian, M., Sanford, L. R., Di Tullio, M., Sacco, R., . . . Homma, S. (2014). COGNITIVE FUNCTION IN AMBULATORY PATIENTS WITH SYSTOLIC HEART FAILURE: INSIGHTS FROM THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A946). doi:10.1016/S0735-1097(14)60946-3DOI: 10.1016/S0735-1097(14)60946-3
Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study (Journal article)
Crijns, H. J. G. M., Weijs, B., Fairley, A. -M., Lewalter, T., Maggioni, A. P., Martin, A., . . . Le Heuzey, J. -Y. (2014). Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 172(3), 588-594. doi:10.1016/j.ijcard.2014.01.099DOI: 10.1016/j.ijcard.2014.01.099
ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS CURRENT STANDARD OF CARE REGIMEN IN A UNITED STATES NON-VALVULAR ATRIAL FIBRILLATION POPULATION SIMILAR TO THAT ENROLLED IN ARISTOTLE AND AVERROES (Conference Paper)
Phatak, H., Dorian, P., Kongnakorn, T., Lanitis, T., Kuznik, A., Mardekian, J., . . . Lip, G. (2014). ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS CURRENT STANDARD OF CARE REGIMEN IN A UNITED STATES NON-VALVULAR ATRIAL FIBRILLATION POPULATION SIMILAR TO THAT ENROLLED IN ARISTOTLE AND AVERROES. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A422). doi:10.1016/S0735-1097(14)60422-8DOI: 10.1016/S0735-1097(14)60422-8
High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery (Journal article)
Hernandez-Romero, D., Antonio Vilchez, J., Lahoz, A., Romero-Aniorte, A. I., Orenes-Pinero, E., Caballero, L., . . . Marin, F. (2014). High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 45(4), 733-738. doi:10.1093/ejcts/ezt488DOI: 10.1093/ejcts/ezt488
IMPACT OF ANEMIA ON CLINICAL OUTCOME IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AFCAS REGISTRY (Conference Paper)
Puurunen, M. K., Kiviniemi, T., Nammas, W., Schlitt, A., Rubboli, A., Nyman, K., . . . Airaksinen, J. (2014). IMPACT OF ANEMIA ON CLINICAL OUTCOME IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AFCAS REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A1857). doi:10.1016/S0735-1097(14)61860-XDOI: 10.1016/S0735-1097(14)61860-X
Management of Atrial Fibrillation in Patients With Kidney Disease. (Journal article)
Lau, Y. C., & Lip, G. Y. H. (2014). Management of Atrial Fibrillation in Patients With Kidney Disease.. Journal of atrial fibrillation, 6(6), 989. doi:10.4022/jafib.989DOI: 10.4022/jafib.989
PREDICTING MAJOR BLEEDING IN PATIENTS WITH SYSTOLIC HEART FAILURE TREATED WITH WARFARIN OR ASPIRIN (Conference Paper)
Ye, S., Cheng, B., Buchsbaum, R., Lip, G., Sacco, R., Di Tullio, M., . . . Homma, S. (2014). PREDICTING MAJOR BLEEDING IN PATIENTS WITH SYSTOLIC HEART FAILURE TREATED WITH WARFARIN OR ASPIRIN. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A749). doi:10.1016/S0735-1097(14)60749-XDOI: 10.1016/S0735-1097(14)60749-X
Stroke And Bleeding Risk Assessment: Where Are We Now? (Journal article)
Dzeshka, M. S., & Lip, G. Y. H. (2014). Stroke And Bleeding Risk Assessment: Where Are We Now?. Journal of atrial fibrillation, 6(6), 1042. doi:10.4022/jafib.1042DOI: 10.4022/jafib.1042
THE GLOBAL REGISTRY PROGRAM ON LONG-TERM ORAL ANTI-THROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION (GLORIA-AF): FIRST ASSESSMENT OF BASELINE CHARACTERISTICS OF DABIGATRAN AND VKA COHORTS IN NORTH AMERICA (Conference Paper)
Rothman, K., Huisman, M. V., Lip, G., Diener, H. -C., Dubner, S. J., Ma, C. -S., . . . Halperin, J. (2014). THE GLOBAL REGISTRY PROGRAM ON LONG-TERM ORAL ANTI-THROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION (GLORIA-AF): FIRST ASSESSMENT OF BASELINE CHARACTERISTICS OF DABIGATRAN AND VKA COHORTS IN NORTH AMERICA. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A417). doi:10.1016/S0735-1097(14)60417-4DOI: 10.1016/S0735-1097(14)60417-4
URINARY ISOPROSTANES PREDICT VASCULAR EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A PROSPECTIVE STUDY (Conference Paper)
Pignatelli, P., Pastori, D., Falcomeri, A., Cangemi, R., Lip, G., & Violi, F. (2014). URINARY ISOPROSTANES PREDICT VASCULAR EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A PROSPECTIVE STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A468). doi:10.1016/S0735-1097(14)60468-XDOI: 10.1016/S0735-1097(14)60468-X
Anticoagulation versus placebo for heart failure in sinus rhythm (Journal article)
Lip, G. Y. H., & Shantsila, E. (2014). Anticoagulation versus placebo for heart failure in sinus rhythm. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD003336.pub3DOI: 10.1002/14651858.CD003336.pub3
Warfarin or novel oral anticoagulants for atrial fibrillation? (Journal article)
Larsen, T. B., & Lip, G. Y. H. (2014). Warfarin or novel oral anticoagulants for atrial fibrillation?. LANCET, 383(9921), 931-933. doi:10.1016/S0140-6736(13)62376-4DOI: 10.1016/S0140-6736(13)62376-4
Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation The Loire Valley Atrial Fibrillation Project (Journal article)
Banerjee, A., Fauchier, L., Bernard-Brunet, A., Clementy, N., & Lip, G. Y. H. (2014). Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation The Loire Valley Atrial Fibrillation Project. THROMBOSIS AND HAEMOSTASIS, 111(3), 549-556. doi:10.1160/TH13-12-1033DOI: 10.1160/TH13-12-1033
Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation (Journal article)
Lane, D. A., & Lip, G. Y. H. (2014). Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation. THROMBOSIS AND HAEMOSTASIS, 111(3), 381-383. doi:10.1160/TH14-01-0063DOI: 10.1160/TH14-01-0063
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry (Journal article)
Lip, G. Y. H., Laroche, C., Dan, G. -A., Santini, M., Kalarus, Z., Rasmussen, L. H., . . . Maggioni, A. P. (2014). A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. EUROPACE, 16(3), 308-319. doi:10.1093/europace/eut373DOI: 10.1093/europace/eut373
Common Questions in Anticoagulation Management in Atrial Fibrillation. (Journal article)
Gallego, P., Roldán, V., & Lip, G. Y. H. (2014). Common Questions in Anticoagulation Management in Atrial Fibrillation.. Cardiac electrophysiology clinics, 6(1), 79-86. doi:10.1016/j.ccep.2013.10.005DOI: 10.1016/j.ccep.2013.10.005
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation (Journal article)
Huisman, M. V., Lip, G. Y. H., Diener, H. C., Dubner, S. J., Halperin, J. L., Ma, C. S., . . . Bartels, D. B. (2014). Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation. AMERICAN HEART JOURNAL, 167(3), 329-334. doi:10.1016/j.ahj.2013.12.006DOI: 10.1016/j.ahj.2013.12.006
The Impact of Smoking on Thromboembolism and Mortality in Patients With Incident Atrial Fibrillation (Journal article)
Albertsen, I. E., Rasmussen, L. H., Lane, D. A., Overvad, T. F., Skjoth, F., Overvad, K., . . . Larsen, T. B. (2014). The Impact of Smoking on Thromboembolism and Mortality in Patients With Incident Atrial Fibrillation. CHEST, 145(3), 559-566. doi:10.1378/chest.13-1740DOI: 10.1378/chest.13-1740
The membrane expression of P-selectin, but not monocyte-platelet aggregates, is influenced by variability in response to aspirin in patients with coronary artery disease (Journal article)
Kuzniatsova, N., Shantsila, E., Lip, G. Y. H., & Blann, A. D. (2014). The membrane expression of P-selectin, but not monocyte-platelet aggregates, is influenced by variability in response to aspirin in patients with coronary artery disease. PLATELETS, 25(2), 142-143. doi:10.3109/09537104.2012.739720DOI: 10.3109/09537104.2012.739720
Circulating microparticles: challenges and perspectives of flow cytometric assessment (Journal article)
Shantsila, E., Montoro-Garcia, S., Gallego, P., & Lip, G. Y. H. (2014). Circulating microparticles: challenges and perspectives of flow cytometric assessment. THROMBOSIS AND HAEMOSTASIS, 111(6), 1009-1014. doi:10.1160/TH13-11-0937DOI: 10.1160/TH13-11-0937
Comparison of Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation (Journal article)
Aakre, C. A., McLeod, C. J., Cha, S. S., Tsang, T. S. M., Lip, G. Y. H., & Gersh, B. J. (2014). Comparison of Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation. STROKE, 45(2), 426-431. doi:10.1161/STROKEAHA.113.002585DOI: 10.1161/STROKEAHA.113.002585
Coronary artery diseases in Japanese patients with nonvalvular atrial fibrillation (Journal article)
Senoo, K., Suzuki, S., Sagara, K., Otsuka, T., Matsuno, S., Uejima, T., . . . Yamashita, T. (2014). Coronary artery diseases in Japanese patients with nonvalvular atrial fibrillation. JOURNAL OF CARDIOLOGY, 63(1-2), 123-127. doi:10.1016/j.jjcc.2013.08.007DOI: 10.1016/j.jjcc.2013.08.007
Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation (Journal article)
Lip, G. Y. H., Kongnakorn, T., Phatak, H., Kuznik, A., Lanitiss, T., Liu, L. Z., . . . Dorian, P. (2014). Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation. CLINICAL THERAPEUTICS, 36(2), 192-210. doi:10.1016/j.clinthera.2013.12.011DOI: 10.1016/j.clinthera.2013.12.011
Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey (Journal article)
Potpara, T. S., Lip, G. Y. H., Dagres, N., Estner, H. L., Larsen, T. B., & Blomstrom-Lundqvist, C. (2014). Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey. EUROPACE, 16(2), 293-298. doi:10.1093/europace/euu008DOI: 10.1093/europace/euu008
Overtreatment and Undertreatment With Anticoagulation in Relation to Cardioversion of Atrial Fibrillation (the RHYTHM-AF Study) (Journal article)
Lip, G. Y. H., Gitt, A. K., Le Heuzey, J. -Y., Bash, L. D., Morabito, C. J., Bernhardt, A. A., . . . Crijns, H. J. (2014). Overtreatment and Undertreatment With Anticoagulation in Relation to Cardioversion of Atrial Fibrillation (the RHYTHM-AF Study). AMERICAN JOURNAL OF CARDIOLOGY, 113(3), 480-484. doi:10.1016/j.amjcard.2013.10.036DOI: 10.1016/j.amjcard.2013.10.036
Use of novel oral anticoagulants in patients with heart failure. (Journal article)
Shantsila, E., & Lip, G. Y. H. (2014). Use of novel oral anticoagulants in patients with heart failure.. Current treatment options in cardiovascular medicine, 16(2), 285. doi:10.1007/s11936-013-0285-yDOI: 10.1007/s11936-013-0285-y
Development of ruggedized timer and temperature sensor packaging for 300&#x00B0;C/30kpsi downhole environment (Conference Paper)
Yuan, H. H., Kuruveettil, H., Ching, E. W. L., Rong, E. P. J., Lip, G. C., & Woo, D. R. M. (2014). Development of ruggedized timer and temperature sensor packaging for 300&#x00B0;C/30kpsi downhole environment. In 2014 IEEE 16th Electronics Packaging Technology Conference (EPTC). IEEE. doi:10.1109/eptc.2014.7028366DOI: 10.1109/eptc.2014.7028366
The Role of Monocytes in Angiogenesis and Atherosclerosis (Journal article)
Jaipersad, A. S., Lip, G. Y. H., Silverman, S., & Shantsila, E. (2014). The Role of Monocytes in Angiogenesis and Atherosclerosis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 63(1), 1-11. doi:10.1016/j.jacc.2013.09.019DOI: 10.1016/j.jacc.2013.09.019
"Finding atrial fibrillation in acute stroke patients: just keep looking, just keep looking (with prolonged ECG monitoring)" (Conference Paper)
Weerathunga, J., Kausar, S., Blann, A., & Lip, G. (2014). "Finding atrial fibrillation in acute stroke patients: just keep looking, just keep looking (with prolonged ECG monitoring)". In CEREBROVASCULAR DISEASES Vol. 37 (pp. 224). Retrieved from https://www.webofscience.com/
'Real-World' Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey (Journal article)
Lip, G. Y. H., Laroche, C., Dan, G. -A., Santini, M., Kalarus, Z., Rasmussen, L. H., . . . Maggioni, A. P. (2014). 'Real-World' Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey. AMERICAN JOURNAL OF MEDICINE, 127(6), 519-+. doi:10.1016/j.amjmed.2013.12.022DOI: 10.1016/j.amjmed.2013.12.022
A Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients With Atrial Fibrillation (Journal article)
Banerjee, A., Fauchier, L., Vourc'h, P., Andres, C. R., Taillandier, S., Halimi, J. M., & Lip, G. Y. H. (2014). A Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients With Atrial Fibrillation. CHEST, 145(6), 1370-1382. doi:10.1378/chest.13-2103DOI: 10.1378/chest.13-2103
A multi-biomarker strategy for predicting stroke in stable anticoagulated patients with atrial fibrillation (Conference Paper)
Roldan-Schilling, V., Gallego, P., Vilchez, J. A., Jover, E., Puche, C., Manzano-Fernandez, S., . . . Marin, F. (2014). A multi-biomarker strategy for predicting stroke in stable anticoagulated patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 179). Retrieved from https://www.webofscience.com/
A prospective validation of the SAME-TT<sub>2</sub>R<sub>2</sub> score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin (Journal article)
Poli, D., Antonucci, E., Testa, S., & Lip, G. Y. H. (2014). A prospective validation of the SAME-TT<sub>2</sub>R<sub>2</sub> score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin. INTERNAL AND EMERGENCY MEDICINE, 9(4), 443-447. doi:10.1007/s11739-014-1065-8DOI: 10.1007/s11739-014-1065-8
A very happy new year 2014 from <i>Thrombosis and Haemostasis</i>! (Journal article)
Lip, G. Y. H., & Weber, C. (2014). A very happy new year 2014 from <i>Thrombosis and Haemostasis</i>!. THROMBOSIS AND HAEMOSTASIS, 111(1), 1-2. Retrieved from https://www.webofscience.com/
Abnormal fibrin clot structure in chronic heart failure (Conference Paper)
Ranjit, P., Lau, Y. C., Blann, A., & Lip, G. Y. H. (2014). Abnormal fibrin clot structure in chronic heart failure. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 507). Retrieved from https://www.webofscience.com/
Addition of Smoking Status Improves Risk Prediction of Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study (Conference Paper)
Kwon, Y., Lopez, F. L., Agarwal, S. K., Soliman, E. Z., Lip, G. Y., Alonso, A., & Chen, L. Y. (2014). Addition of Smoking Status Improves Risk Prediction of Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study. In CIRCULATION Vol. 130. Retrieved from https://www.webofscience.com/
Age Dependence of Risk Factors for Stroke and Death in Young Patients With Atrial Fibrillation A Nationwide Study (Journal article)
Melgaard, L., Rasmussen, L. H., Skjoth, F., Lip, G. Y. H., & Larsen, T. B. (2014). Age Dependence of Risk Factors for Stroke and Death in Young Patients With Atrial Fibrillation A Nationwide Study. STROKE, 45(5), 1331-1337. doi:10.1161/STROKEAHA.114.004903DOI: 10.1161/STROKEAHA.114.004903
Analysis of Vitamin D Levels in Patients With and Without Statin-induced Myalgia - A Systematic Review and Meta-analysis of 7 Studies with 2416 Patients (Conference Paper)
Michalska-Kasiczak, M., Sahebkar, A., Mikhailidis, D. P., Rysz, J., Muntner, P., Toth, P. P., . . . Banach, M. (2014). Analysis of Vitamin D Levels in Patients With and Without Statin-induced Myalgia - A Systematic Review and Meta-analysis of 7 Studies with 2416 Patients. In CIRCULATION Vol. 130. Retrieved from https://www.webofscience.com/
Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation (Journal article)
Dzeshka, M. S., & Lip, G. Y. H. (2014). Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation. CARDIOLOGY CLINICS, 32(4), 585-+. doi:10.1016/j.ccl.2014.07.009DOI: 10.1016/j.ccl.2014.07.009
Antithrombotic treatment of atrial fibrillation in general practice: application of the GRASP-AF audit tool (Conference Paper)
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2014). Antithrombotic treatment of atrial fibrillation in general practice: application of the GRASP-AF audit tool. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1104). Retrieved from https://www.webofscience.com/
Antithrombotic treatment pattern and baseline characteristics of dabigatran and vitamin K antagonist cohorts in North America - The GLORIA-AF registry program (Conference Paper)
Huisman, M. V., Lip, G. Y. H., Diener, H. C., Dubner, S. J., Ma, C. S., Rothman, K. J., . . . Halperin, J. L. (2014). Antithrombotic treatment pattern and baseline characteristics of dabigatran and vitamin K antagonist cohorts in North America - The GLORIA-AF registry program. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 777). Retrieved from https://www.webofscience.com/
Assess bleeding risk with HAS-BLED and assess stroke risk with CHA<sub>2</sub>DS<sub>2</sub>-VASc in patients with atrial fibrillation (Journal article)
Lau, Y. C., Lip, G. Y. H., & Gallego, P. (2014). Assess bleeding risk with HAS-BLED and assess stroke risk with CHA<sub>2</sub>DS<sub>2</sub>-VASc in patients with atrial fibrillation. HYPERTENSION RESEARCH, 37(7), 699-700. doi:10.1038/hr.2014.63DOI: 10.1038/hr.2014.63
Atrial Fibrillation in Cryptogenic Stroke Look Harder, Look Longer, But Just Keep Looking (Journal article)
Lau, Y. C., Lane, D. A., & Lip, G. Y. H. (2014). Atrial Fibrillation in Cryptogenic Stroke Look Harder, Look Longer, But Just Keep Looking. STROKE, 45(11), 3184-3185. doi:10.1161/STROKEAHA.114.006862DOI: 10.1161/STROKEAHA.114.006862
Atrial fibrillation ... more than simply being irregularly irregular (Journal article)
Lip, G. Y. H. (2014). Atrial fibrillation ... more than simply being irregularly irregular. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 68(4), 408-409. doi:10.1111/ijcp.12416DOI: 10.1111/ijcp.12416
Atrial fibrillation and heart failure: meta-analysis of clinical outcomes in reduced versus preserved ejection fraction (Conference Paper)
Kotecha, D., Chudasama, R., Lane, D. A., Kirchhof, P., & Lip, G. Y. H. (2014). Atrial fibrillation and heart failure: meta-analysis of clinical outcomes in reduced versus preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1029). Retrieved from https://www.webofscience.com/
Atrial fibrillation and retinal vein or artery occlusion: looking beyond the eye (Journal article)
Plunkett, O., Lip, P. L., & Lip, G. Y. H. (2014). Atrial fibrillation and retinal vein or artery occlusion: looking beyond the eye. BRITISH JOURNAL OF OPHTHALMOLOGY, 98(9), 1141-1143. doi:10.1136/bjophthalmol-2013-304646DOI: 10.1136/bjophthalmol-2013-304646
Atrial fibrillation and stroke prevention: brief observations on the last decade. (Journal article)
Lip, G. Y. (2014). Atrial fibrillation and stroke prevention: brief observations on the last decade.. Expert review of cardiovascular therapy, 12(4), 403-406. doi:10.1586/14779072.2014.896196DOI: 10.1586/14779072.2014.896196
Au-In-based Hermetic Sealing for MEMS Packaging for Down-Hole Application (Journal article)
Chidambaram, V., Chen, B., Lip, G. C., & Woo, D. R. M. (2014). Au-In-based Hermetic Sealing for MEMS Packaging for Down-Hole Application. JOURNAL OF ELECTRONIC MATERIALS, 43(7), 2498-2509. doi:10.1007/s11664-014-3131-4DOI: 10.1007/s11664-014-3131-4
Bare-Metal vs. Drug-Eluting Stents in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - Insights From the AFCAS Registry (Journal article)
Kiviniemi, T., Puurunen, M., Schlitt, A., Rubboli, A., Karjalainen, P., Nammas, W., . . . Airaksinen, K. E. J. (2014). Bare-Metal vs. Drug-Eluting Stents in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - Insights From the AFCAS Registry. CIRCULATION JOURNAL, 78(11), 2674-2681. doi:10.1253/circj.CJ-14-0792DOI: 10.1253/circj.CJ-14-0792
Biomarkers in atrial fibrillation: an overview (Journal article)
Vilchez, J. A., Roldan, V., Hernandez-Romero, D., Valdes, M., Lip, G. Y. H., & Marin, F. (2014). Biomarkers in atrial fibrillation: an overview. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 68(4), 434-443. doi:10.1111/ijcp.12304DOI: 10.1111/ijcp.12304
Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy (Journal article)
Kiviniemi, T., Karjalainen, P., Niemela, M., Rubboli, A., Lip, G. Y. H., Schlitt, A., . . . Airaksinen, K. E. J. (2014). Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy. THROMBOSIS RESEARCH, 133(4), 695-696. doi:10.1016/j.thromres.2014.01.038DOI: 10.1016/j.thromres.2014.01.038
Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial Fibrillation (Journal article)
Larsen, T. B., Gorst-Rasmussen, A., Rasmussen, L. H., Skjoth, F., Rosenzweig, M., & Lip, G. Y. H. (2014). Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 127(7), 650-+. doi:10.1016/j.amjmed.2014.01.031DOI: 10.1016/j.amjmed.2014.01.031
CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention (Journal article)
Puurunen, M. K., Kiviniemi, T., Schlitt, A., Rubboli, A., Dietrich, B., Karjalainen, P., . . . Airaksinen, K. E. J. (2014). CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. THROMBOSIS RESEARCH, 133(4), 560-566. doi:10.1016/j.thromres.2014.01.007DOI: 10.1016/j.thromres.2014.01.007
Cardiopulmonary resuscitation with a different slant: the importance of perimortem caesarean delivery (Conference Paper)
Castleman, J. S., Miti, C., Ajibona, O. O., Lip, G. Y. H., & Ganapathy, R. (2014). Cardiopulmonary resuscitation with a different slant: the importance of perimortem caesarean delivery. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1208-1209). Retrieved from https://www.webofscience.com/
Cardiovascular risk in patients with sleep apnea with or without continuous positive airway pressure therapy among 4.5 million Danes (Conference Paper)
Lamberts, M., Nielsen, O. W., Lip, G. Y. H., Ruwald, M. H., Christiansen, C. B., Kristensen, S. L., . . . Gislason, G. H. (2014). Cardiovascular risk in patients with sleep apnea with or without continuous positive airway pressure therapy among 4.5 million Danes. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 345-346). Retrieved from https://www.webofscience.com/
Comparing the 'New' R<sub>2</sub>CHADS<sub>2</sub> With the 'Old' CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores for Predicting Thromboembolism in Patients Undergoing Atrial Fibrillation Ablation: New Does Not Mean Better (Journal article)
Kornej, J., & Lip, G. Y. H. (2014). Comparing the 'New' R<sub>2</sub>CHADS<sub>2</sub> With the 'Old' CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores for Predicting Thromboembolism in Patients Undergoing Atrial Fibrillation Ablation: New Does Not Mean Better. CANADIAN JOURNAL OF CARDIOLOGY, 30(4), 385-387. doi:10.1016/j.cjca.2013.12.015DOI: 10.1016/j.cjca.2013.12.015
Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation (Conference Paper)
Andreu Cayuelas, J. M., Manzano-Fernandez, S., Sanchez-Martinez, M., Marin, F., Orenes-Pinero, E., Gallego, P., . . . Roldan, V. (2014). Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 383). Retrieved from https://www.webofscience.com/
Cost-effectiveness of Apixaban Against Dabigatran and Rivaroxaban for Stroke Prevention in Non-valvular Atrial Fibrillation Patients (Conference Paper)
Lip, G. Y., Lanitis, T., Kongnakorn, T., Phatak, H., Liu, L. Z., Lawrence, J., & Dorian, P. (2014). Cost-effectiveness of Apixaban Against Dabigatran and Rivaroxaban for Stroke Prevention in Non-valvular Atrial Fibrillation Patients. In CIRCULATION Vol. 130. Retrieved from https://www.webofscience.com/
Cost-effectiveness of apixaban compared to edoxaban for stroke prevention in non-valvular atrial fibrillation (Conference Paper)
Lip, G. Y. H., Kongnakorn, T., Lanitis, T., Phatak, H., Liu, J. X. C., Kuznik, A., . . . Dorian, P. (2014). Cost-effectiveness of apixaban compared to edoxaban for stroke prevention in non-valvular atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1108-1109). Retrieved from https://www.webofscience.com/
Cost-effectiveness of non-Vitamin-K oral anticoagulants compared to warfarin in patients with non-valvular atrial fibrillation (Conference Paper)
Harenberg, J., Krejczy, M., Wehling, M., Obermann, K., & Lip, G. Y. H. (2014). Cost-effectiveness of non-Vitamin-K oral anticoagulants compared to warfarin in patients with non-valvular atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1107). Retrieved from https://www.webofscience.com/
Dabigatran etexilate for venous thromboembolism: a safety evaluation (Journal article)
Brown, R., Lip, G. Y. H., & Gallego, P. (2014). Dabigatran etexilate for venous thromboembolism: a safety evaluation. EXPERT OPINION ON DRUG SAFETY, 13(5), 639-647. doi:10.1517/14740338.2014.895321DOI: 10.1517/14740338.2014.895321
Device-guided slow deep breathing in essential hypertension: is cardiac or sympathetic baroreflex sensitivity altered? (Conference Paper)
Shantsila, A., Adlan, A., Lip, G., Pickering, A., Paton, J., & Fisher, J. (2014). Device-guided slow deep breathing in essential hypertension: is cardiac or sympathetic baroreflex sensitivity altered?. In FASEB JOURNAL Vol. 28. Retrieved from https://www.webofscience.com/
Effect of device guided slow deep breathing on central sympathetic outflow and arterial baroreflex sensitivity in young healthy individuals (Conference Paper)
Shantsila, A., Adlan, A. M., Lip, G., Pickering, A., Paton, J., & Fisher, J. (2014). Effect of device guided slow deep breathing on central sympathetic outflow and arterial baroreflex sensitivity in young healthy individuals. In FASEB JOURNAL Vol. 28. Retrieved from https://www.webofscience.com/
Efficacy and safety of apixaban vs edoxaban for stroke prevention in non-valvular atrial fibrillation: an indirect treatment analysis (Conference Paper)
Lip, G. Y. H., Mitchell, S. A., Liu, X. C., Phatak, H., & Batson, S. (2014). Efficacy and safety of apixaban vs edoxaban for stroke prevention in non-valvular atrial fibrillation: an indirect treatment analysis. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 895-896). Retrieved from https://www.webofscience.com/
Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation (Journal article)
Overvad, T. F., Rasmussen, L. H., Skjoth, F., Overvad, K., Albertsen, I. E., Lane, D. A., . . . Larsen, T. B. (2014). Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 112(4), 789-795. doi:10.1160/TH14-06-0545DOI: 10.1160/TH14-06-0545
Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation (Journal article)
Yasaka, M., & Lip, G. Y. H. (2014). Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation. CIRCULATION JOURNAL, 78(10), 2367-2372. doi:10.1253/circj.CJ-14-0720DOI: 10.1253/circj.CJ-14-0720
Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis (Journal article)
Chao, T. -F., Liu, C. -J., Wang, K. -L., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2014). Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis. HEART RHYTHM, 11(10), 1752-1759. doi:10.1016/j.hrthm.20l4.06.021DOI: 10.1016/j.hrthm.20l4.06.021
Increased Carotid Intima-Media Thickness and Presence of Carotid Plaque are Associated With Increased Stroke Incidence in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study (Conference Paper)
Bekwelem, W., Lopez, F. L., Soliman, E. Z., Agarwal, S., Lip, G. Y., Pan, W., . . . Chen, L. Y. (2014). Increased Carotid Intima-Media Thickness and Presence of Carotid Plaque are Associated With Increased Stroke Incidence in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study. In CIRCULATION Vol. 130. Retrieved from https://www.webofscience.com/
Is oral anticoagulation needed in patients with atrial fibrillation, stent implantation and low-moderate risk of stroke? (Conference Paper)
Marin, F., Fauchier, L., Ruiz-Nodar, J. M., Saint Etienne, C., Manzano-Fernandez, S., Ivanes, F., . . . Lip, G. (2014). Is oral anticoagulation needed in patients with atrial fibrillation, stent implantation and low-moderate risk of stroke?. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1112). Retrieved from https://www.webofscience.com/
Left ventricular geometry and outcomes in patients with atrial fibrillation: The AFFIRM Trial (Journal article)
Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2014). Left ventricular geometry and outcomes in patients with atrial fibrillation: The AFFIRM Trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 170(3), 303-308. doi:10.1016/j.ijcard.2013.11.002DOI: 10.1016/j.ijcard.2013.11.002
Lone atrial fibrillation - an overview (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2014). Lone atrial fibrillation - an overview. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 68(4), 418-433. doi:10.1111/ijcp.12281DOI: 10.1111/ijcp.12281
Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry (Journal article)
Ruff, C. T., Bhatt, D. L., Steg, P. G., Gersh, B. J., Alberts, M. J., Hoffman, E. B., . . . Goto, S. (2014). Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 170(3), 413-418. doi:10.1016/j.ijcard.2013.11.030DOI: 10.1016/j.ijcard.2013.11.030
Long-term predictors of death and incident myocardial infarction in cardiology patients assessed for coronary artery disease (Conference Paper)
Kotecha, D., Jenkins, E., Flather, M. D., Krum, H., Eccleston, D., Collins, P., . . . New, G. (2014). Long-term predictors of death and incident myocardial infarction in cardiology patients assessed for coronary artery disease. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 819). Retrieved from https://www.webofscience.com/
Management of atrial fibrillation in patients with kidney disease (Journal article)
Lau, Y. C., & Lip, G. Y. H. (2014). Management of atrial fibrillation in patients with kidney disease. Journal of Atrial Fibrillation, 6(6), 83-90.
Measurement of rivaroxaban and apixaban in serum samples of patients (Journal article)
Harenberg, J., Kraemer, S., Du, S., Zolfaghari, S., Schulze, A., Kraemer, R., . . . Lip, G. Y. H. (2014). Measurement of rivaroxaban and apixaban in serum samples of patients. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 44(8), 743-752. doi:10.1111/eci.12291DOI: 10.1111/eci.12291
Modern Management of Atrial Fibrillation Requires Initial Identification of "Low-Risk" Patients Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score, and Not Focusing on "High-Risk" Prediction (Journal article)
Lip, G. Y. H., & Lane, D. A. (2014). Modern Management of Atrial Fibrillation Requires Initial Identification of "Low-Risk" Patients Using the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score, and Not Focusing on "High-Risk" Prediction. CIRCULATION JOURNAL, 78(8), 1843-1845. doi:10.1253/circj.CJ-14-0584DOI: 10.1253/circj.CJ-14-0584
Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation A Secondary Analysis of the AVERROES Study (Journal article)
Lip, G. Y. H., Eikelboom, J., Yusuf, S., Shestakovska, O., Hart, R. G., & Connolly, S. (2014). Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation A Secondary Analysis of the AVERROES Study. STROKE, 45(7), 2127-2130. doi:10.1161/STROKEAHA.114.005746DOI: 10.1161/STROKEAHA.114.005746
Monocyte subpopulation counts and function are associated with global longitudinal strain in patients with normal ejection fraction after ST elevation mycardial infarction (Conference Paper)
Ghattas, A., Shantsila, E., Griffiths, H., & Lip, G. (2014). Monocyte subpopulation counts and function are associated with global longitudinal strain in patients with normal ejection fraction after ST elevation mycardial infarction. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 488). Retrieved from https://www.webofscience.com/
Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis (Journal article)
Shantsila, E., Tapp, L. D., Wrigley, B. J., Pamukcu, B., Apostolakis, S., Montoro-Garcia, S., & Lip, G. Y. H. (2014). Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis. ATHEROSCLEROSIS, 234(1), 4-10. doi:10.1016/j.atherosclerosis.2014.02.009DOI: 10.1016/j.atherosclerosis.2014.02.009
Monocytes circulate in constant reversible interaction with platelets in a [Ca2+]-dependent manner (Journal article)
Shantsila, E., Montoro-Garcia, S., & Lip, G. Y. H. (2014). Monocytes circulate in constant reversible interaction with platelets in a [Ca2+]-dependent manner. PLATELETS, 25(3), 197-201. doi:10.3109/09537104.2013.784248DOI: 10.3109/09537104.2013.784248
Myocardial Ischemic Events in 'Real World' Patients with Atrial Fibrillation Treated with Dabigatran or Warfarin (Journal article)
Larsen, T. B., Rasmussen, L. H., Gorst-Rasmussen, A., Skjoth, F., Rosenzweig, M., Lane, D. A., & Lip, G. Y. H. (2014). Myocardial Ischemic Events in 'Real World' Patients with Atrial Fibrillation Treated with Dabigatran or Warfarin. AMERICAN JOURNAL OF MEDICINE, 127(4), 329-+. doi:10.1016/j.amjmed.2013.12.005DOI: 10.1016/j.amjmed.2013.12.005
New Oral Anticoagulants in Elderly Adults: Evidence from a Meta-Analysis of Randomized Trials (Journal article)
Sardar, P., Chatterjee, S., Chaudhari, S., & Lip, G. Y. H. (2014). New Oral Anticoagulants in Elderly Adults: Evidence from a Meta-Analysis of Randomized Trials. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 62(5), 857-864. doi:10.1111/jgs.12799DOI: 10.1111/jgs.12799
Non-Vitamin K Antagonist Oral Anticoagulants An Appeal for Consensus on Terminology (Journal article)
Lip, G. Y. H., Camm, A. J., Hylek, E. M., Halperin, J. L., & Weitz, J. I. (2014). Non-Vitamin K Antagonist Oral Anticoagulants An Appeal for Consensus on Terminology. CHEST, 145(5), 1177-1178. doi:10.1378/chest.13-2951DOI: 10.1378/chest.13-2951
Novel Oral Anticoagulants in Cardiovascular Disease (Journal article)
Gallego, P., Roldan, V., & Lip, G. Y. H. (2014). Novel Oral Anticoagulants in Cardiovascular Disease. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 19(1), 34-44. doi:10.1177/1074248413501392DOI: 10.1177/1074248413501392
One year re-infarction rates in non-culprit vessels following index ST elevation myocardial infarction in patients with multivessel coronary artery disease (Conference Paper)
Brown, R. A., Shantsila, E., Khan, J., Lee, H. L., Connolly, D. L., Ahmad, R., . . . Varma, C. (2014). One year re-infarction rates in non-culprit vessels following index ST elevation myocardial infarction in patients with multivessel coronary artery disease. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 479-480). Retrieved from https://www.webofscience.com/
One-Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry (Journal article)
Rubboli, A., Schlitt, A., Kiviniemi, T., Biancari, F., Karjalainen, P. P., Valencia, J., . . . Airaksinen, K. E. J. (2014). One-Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry. CLINICAL CARDIOLOGY, 37(6), 357-364. doi:10.1002/clc.22254DOI: 10.1002/clc.22254
Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation (Journal article)
Senoo, K., Lane, D. A., & Lip, G. Y. H. (2014). Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation. CURRENT PROBLEMS IN CARDIOLOGY, 39(9), 319-344. doi:10.1016/j.cpcardiol.2014.07.001DOI: 10.1016/j.cpcardiol.2014.07.001
Oxidized LDL lipids increase β-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation (Journal article)
Dias, I. H. K., Mistry, J., Fell, S., Reis, A., Spickett, C. M., Polidori, M. C., . . . Griffiths, H. R. (2014). Oxidized LDL lipids increase β-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation. FREE RADICAL BIOLOGY AND MEDICINE, 75, 48-59. doi:10.1016/j.freeradbiomed.2014.07.012DOI: 10.1016/j.freeradbiomed.2014.07.012
Patent Foramen Ovale and Migraine Attacks: A Systematic Review (Journal article)
Lip, P. Z. Y., & Lip, G. Y. H. (2014). Patent Foramen Ovale and Migraine Attacks: A Systematic Review. AMERICAN JOURNAL OF MEDICINE, 127(5), 411-420. doi:10.1016/j.amjmed.2013.12.006DOI: 10.1016/j.amjmed.2013.12.006
Post myocardial infarction and atrial fibrillation: Thromboprophylaxis and risk stratification using the CHA<sub>2</sub>DS<sub>2</sub>-VASc score (Journal article)
Lau, Y. C., & Lip, G. Y. H. (2014). Post myocardial infarction and atrial fibrillation: Thromboprophylaxis and risk stratification using the CHA<sub>2</sub>DS<sub>2</sub>-VASc score. CARDIOLOGY JOURNAL, 21(5), 451-453. doi:10.5603/CJ.2014.0075DOI: 10.5603/CJ.2014.0075
Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease (Journal article)
Montoro-Garcia, S., Shantsila, E., & Lip, G. Y. H. (2014). Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease. EXPERT OPINION ON THERAPEUTIC TARGETS, 18(1), 43-53. doi:10.1517/14728222.2013.840585DOI: 10.1517/14728222.2013.840585
Predictive role of ST2 for mortality in anticoagulated patients with atrial fibrillation (Conference Paper)
Marin, F., Vilchez, J. A., Perez, M., Gallego, P., Manzano-Fernandez, S., Valdes, M., . . . Roldan-Schilling, V. (2014). Predictive role of ST2 for mortality in anticoagulated patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 221). Retrieved from https://www.webofscience.com/
Predictive value of atrial high-rate episodes for arterial stiffness and endothelial dysfunction in dual-chamber pacemaker patients (Journal article)
Krishnamoorthy, S., Khoo, C. W., Lim, H. S., & Lip, G. Y. H. (2014). Predictive value of atrial high-rate episodes for arterial stiffness and endothelial dysfunction in dual-chamber pacemaker patients. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 44(1), 13-21. doi:10.1111/eci.12182DOI: 10.1111/eci.12182
Remote monitoring of cardiac implantable electronic devices in Europe: results of the European Heart Rhythm Association survey (Journal article)
Hernandez-Madrid, A., Lewalter, T., Proclemer, A., Pison, L., Lip, G. Y. H., & Blomstrom-Lundqvist, C. (2014). Remote monitoring of cardiac implantable electronic devices in Europe: results of the European Heart Rhythm Association survey. EUROPACE, 16(1), 129-132. doi:10.1093/europace/eut414DOI: 10.1093/europace/eut414
Response to Ansell et al "Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel" (Journal article)
Husted, S., & Lip, G. Y. H. (2014). Response to Ansell et al "Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel". THROMBOSIS AND HAEMOSTASIS, 112(4), 842. doi:10.1160/TH14-06-0564DOI: 10.1160/TH14-06-0564
Rheumatoid arthritis and autonomic function (Conference Paper)
Adlan, A., Shantsila, A., Kitas, G., Paton, J., Lip, G., & Fisher, J. (2014). Rheumatoid arthritis and autonomic function. In FASEB JOURNAL Vol. 28. Retrieved from https://www.webofscience.com/
Rhythm outcomes after catheter ablation of atrial fibrillation Clinical implication of biomarkers (Journal article)
Kornej, J., Husser, D., Bollmann, A., & Lip, G. Y. H. (2014). Rhythm outcomes after catheter ablation of atrial fibrillation Clinical implication of biomarkers. HAMOSTASEOLOGIE, 34(1), 9-+. doi:10.5482/HAMO-13-09-0051DOI: 10.5482/HAMO-13-09-0051
Risk of acute myocardial infarction in patients with atrial fibrillation having a CHA2DS2-VASc score of 0 or 1 (Conference Paper)
Chao, T. F., Huang, Y. C., Liu, C. J., Chen, T. J., Lip, G. Y. H., & Chen, S. A. (2014). Risk of acute myocardial infarction in patients with atrial fibrillation having a CHA2DS2-VASc score of 0 or 1. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 441). Retrieved from https://www.webofscience.com/
Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong (Journal article)
Siu, C. -W., Lip, G. Y. H., Lam, K. -F., & Tse, H. -F. (2014). Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong. HEART RHYTHM, 11(8), 1401-1408. doi:10.1016/j.hrthm.2014.04.021DOI: 10.1016/j.hrthm.2014.04.021
SAMeTT<sub>2</sub>R<sub>2</sub> Does Not Predict Time in Therapeutic Range of the International Normalized Ratio in Patients Attending a High-Quality Anticoagulation Clinic <i>Response</i> (Journal article)
Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2014). SAMeTT<sub>2</sub>R<sub>2</sub> Does Not Predict Time in Therapeutic Range of the International Normalized Ratio in Patients Attending a High-Quality Anticoagulation Clinic <i>Response</i>. CHEST, 145(1), 188-189. doi:10.1378/chest.13-2641DOI: 10.1378/chest.13-2641
SAMeTT2R2 Scores Predict Stroke Risk After Initiation of Vitamin K Antagonist Therapy for Atrial Fibrillation: a Real-world Practice Study (Conference Paper)
Martinez, C., Katholing, A., Reitbrock, S., Lip, G. Y., & Freedman, B. (2014). SAMeTT2R2 Scores Predict Stroke Risk After Initiation of Vitamin K Antagonist Therapy for Atrial Fibrillation: a Real-world Practice Study. In CIRCULATION Vol. 130. Retrieved from https://www.webofscience.com/
Safety of new oral anticoagulant drugs: a perspective. (Journal article)
Vílchez, J. A., Gallego, P., & Lip, G. Y. H. (2014). Safety of new oral anticoagulant drugs: a perspective.. Therapeutic advances in drug safety, 5(1), 8-20. doi:10.1177/2042098613507945DOI: 10.1177/2042098613507945
Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduced out-of-hours door-to-balloon time but did not improve mortality (Conference Paper)
Brown, R. A., Lip, G. Y. H., Shantsila, E., Connolly, D. L., Davis, R., Badri, M., . . . Varma, C. (2014). Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduced out-of-hours door-to-balloon time but did not improve mortality. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1173). Retrieved from https://www.webofscience.com/
Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin (Journal article)
Montoro-Garcia, S., Shantsila, E., Hernandez-Romero, D., Jover, E., Valdes, M., Marin, F., & Lip, G. Y. H. (2014). Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin. BRITISH JOURNAL OF HAEMATOLOGY, 166(4), 571-580. doi:10.1111/bjh.12913DOI: 10.1111/bjh.12913
Specific risk scores for specific purposes: Use CHA<sub>2</sub>DS<sub>2</sub>-VASc for assessing stroke risk, and use HAS-BLED for assessing bleeding risk in atrial fibrillation (Journal article)
Dzeshka, M. S., & Lip, G. Y. H. (2014). Specific risk scores for specific purposes: Use CHA<sub>2</sub>DS<sub>2</sub>-VASc for assessing stroke risk, and use HAS-BLED for assessing bleeding risk in atrial fibrillation. THROMBOSIS RESEARCH, 134(2), 217-218. doi:10.1016/j.thromres.2014.06.003DOI: 10.1016/j.thromres.2014.06.003
Stroke Prevention in Asian Patients With Atrial Fibrillation (Journal article)
Yasaka, M., & Lip, G. Y. H. (2014). Stroke Prevention in Asian Patients With Atrial Fibrillation. STROKE, 45(6), 1608-1609. doi:10.1161/STROKEAHA.114.005339DOI: 10.1161/STROKEAHA.114.005339
Stroke and bleeding risk assessment: Where are we now? (Journal article)
Dzeshka, M. S., & Lip, G. Y. H. (2014). Stroke and bleeding risk assessment: Where are we now?. Journal of Atrial Fibrillation, 6(6), 49-57.
The Association of CHA<sub>2</sub>DS<sub>2</sub>-VASc Score and Blood Biomarkers with Ischemic Stroke Outcomes: The Belgrade Stroke Study (Journal article)
Potpara, T. S., Polovina, M. M., Djikic, D., Marinkovic, J. M., Kocev, N., & Lip, G. Y. H. (2014). The Association of CHA<sub>2</sub>DS<sub>2</sub>-VASc Score and Blood Biomarkers with Ischemic Stroke Outcomes: The Belgrade Stroke Study. PLOS ONE, 9(9). doi:10.1371/journal.pone.0106439DOI: 10.1371/journal.pone.0106439
The CHADS2 and CHA2DS2-VASC scores as predictors of thromboembolism in patients with non-valvular atrial fibrillation undergoing direct-current cardioversion (Conference Paper)
Garcia Fernandez, A., Marin Ortuno, F., Roldan Schilling, V., Ibanez Criado, A., Ibanez Criado, J. L., Valdes Chavarri, M., . . . Lip, G. Y. H. (2014). The CHADS2 and CHA2DS2-VASC scores as predictors of thromboembolism in patients with non-valvular atrial fibrillation undergoing direct-current cardioversion. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 291-292). Retrieved from https://www.webofscience.com/
The SAMe-TT<sub>2</sub>R<sub>2</sub> Score Far From Clinical Application <i>Response</i> (Journal article)
Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2014). The SAMe-TT<sub>2</sub>R<sub>2</sub> Score Far From Clinical Application <i>Response</i>. CHEST, 145(2), 419-420. doi:10.1378/chest.13-2775DOI: 10.1378/chest.13-2775
The experiences of consultations on oral anticoagulation for AF: the importance of qualitative research in cardiovascular sciences (Conference Paper)
Xuereb, C. B., Shaw, R. L., Lip, G. Y. H., & Lane, D. A. (2014). The experiences of consultations on oral anticoagulation for AF: the importance of qualitative research in cardiovascular sciences. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 12 (pp. 11). Retrieved from https://www.webofscience.com/
The management of patients with atrial fibrillation undergoing percutaneous intervention with stent implantation (AFCAS): triple therapy with lmwh bridging is associated with higher risk (Conference Paper)
Kiviniemi, T. K., Airaksinen, K. E. J., Rubboli, A., Valencia, J., Lip, G. Y. H., Karjalainen, P. P., . . . Schlitt, A. (2014). The management of patients with atrial fibrillation undergoing percutaneous intervention with stent implantation (AFCAS): triple therapy with lmwh bridging is associated with higher risk. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 990-991). Retrieved from https://www.webofscience.com/
The optimal management of patients on oral anticoagulation undergoing coronary artery stenting The 10th Anniversary Overview (Journal article)
Rubboli, A., Faxon, D. P., Airaksinen, K. E. J., Schlitt, A., Marin, F., Bhatt, D. L., & Lip, G. Y. H. (2014). The optimal management of patients on oral anticoagulation undergoing coronary artery stenting The 10th Anniversary Overview. THROMBOSIS AND HAEMOSTASIS, 112(6), 1080-1087. doi:10.1160/TH14-08-0681DOI: 10.1160/TH14-08-0681
The predictive value of the SAME-TT2R2 score for anticoagulation control and adverse outcomes in anticoagulated patients with atrial fibrillation (Conference Paper)
Roldan-Schilling, V., Gallego, P., Marin, F., Galvez, J., Valdes, M., Vicente, V., & Lip, G. Y. (2014). The predictive value of the SAME-TT2R2 score for anticoagulation control and adverse outcomes in anticoagulated patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 382). Retrieved from https://www.webofscience.com/
Time-dependent rate of events after coronary stent implantation in patients with atrial fibrillation (Conference Paper)
Fauchier, L., Ruiz-Nodar, J. M., Saint Etienne, C., Manzano-Fernandez, S., Ivanes, F., Valdes, M., . . . Marin, F. (2014). Time-dependent rate of events after coronary stent implantation in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 867-868). Retrieved from https://www.webofscience.com/
Updated NICE guideline: management of atrial fibrillation (2014). (Journal article)
Senoo, K., Lau, Y. C., & Lip, G. Y. (2014). Updated NICE guideline: management of atrial fibrillation (2014).. Expert review of cardiovascular therapy, 12(9), 1037-1040. doi:10.1586/14779072.2014.943189DOI: 10.1586/14779072.2014.943189
Urinary 11-Dehydro-Thromboxane B2 is Associated With Vascular and Non-Vascular Events in Atrial Fibrillation Patients (Conference Paper)
Pastori, D., Pignatelli, P., Cangemi, R., Hiatt, W., Farcomeni, A., Bartimoccia, S., . . . Violi, F. (2014). Urinary 11-Dehydro-Thromboxane B2 is Associated With Vascular and Non-Vascular Events in Atrial Fibrillation Patients. In CIRCULATION Vol. 130. Retrieved from https://www.webofscience.com/
Use of Propensity Score Methodology to Assess Comparability of Treatment Groups in a Registry Program (Conference Paper)
Rothman, K. J., Huisman, M. V., Lip, G. Y. H., Diener, H. -C., Dubner, S. J., Ma, C. -S., . . . Halperin, J. (2014). Use of Propensity Score Methodology to Assess Comparability of Treatment Groups in a Registry Program. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 23 (pp. 13). Retrieved from https://www.webofscience.com/
Use of the HAS-BLED bleeding score in real-life settings (Journal article)
Lane, D. A., & Lip, G. Y. H. (2014). Use of the HAS-BLED bleeding score in real-life settings. THROMBOSIS RESEARCH, 134(1), 202. doi:10.1016/j.thromres.2014.03.027DOI: 10.1016/j.thromres.2014.03.027
Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation (Journal article)
Roldan, V., Antonio Vilchez, J., Manzano-Fernandez, S., Jover, E., Galvez, J., Puche, C. M., . . . Marin, F. (2014). Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation. STROKE, 45(3), 696-701. doi:10.1161/STROKEAHA.113.003338DOI: 10.1161/STROKEAHA.113.003338
Using the CHA2DS2-VASc score for refining stroke risk stratification in low-risk Asian patients (ATRIA score 0-5) with atrial fibrillation (Conference Paper)
Chao, T. F., Liu, C. J., Chen, T. J., Lip, G. Y. H., & Chen, S. A. (2014). Using the CHA2DS2-VASc score for refining stroke risk stratification in low-risk Asian patients (ATRIA score 0-5) with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1033). Retrieved from https://www.webofscience.com/
Utility of HAS-BLED score in evaluating the risk of major bleeding and death in patients with non-valvular atrial fibrillation undergoing direct-current cardioversion (Conference Paper)
Garcia Fernandez, A., Marin Ortuno, F., Roldan Schilling, V., Ibanez Criado, A., Ibanez Criado, J. L., Valdes Chavarri, M., . . . Lip, G. Y. H. (2014). Utility of HAS-BLED score in evaluating the risk of major bleeding and death in patients with non-valvular atrial fibrillation undergoing direct-current cardioversion. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1101). Retrieved from https://www.webofscience.com/
Shantsila, A., Shantsila, E., Butt, M., Khair, O. A., Dwivedi, G., & Lip, G. Y. H. (2014). Ventricular-arterial coupling in obstructive sleep apnea. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 8(9), 624-629. doi:10.1016/j.jash.2014.05.013DOI: 10.1016/j.jash.2014.05.013
Vernakalant hydrochloride to treat atrial fibrillation (Journal article)
Brown, R. A., Lau, Y. C., & Lip, G. Y. H. (2014). Vernakalant hydrochloride to treat atrial fibrillation. EXPERT OPINION ON PHARMACOTHERAPY, 15(6), 865-872. doi:10.1517/14656566.2014.898751DOI: 10.1517/14656566.2014.898751
Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation (Journal article)
Mavaddat, N., Roalfe, A., Fletcher, K., Lip, G. Y. H., Hobbs, F. D. R., Fitzmaurice, D., & Mant, J. (2014). Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation. STROKE, 45(5), 1381-1386. doi:10.1161/STROKEAHA.113.004009DOI: 10.1161/STROKEAHA.113.004009
Warfarin is associated with a net clinical benefit in patients with atrial fibrillation and chronic kidney disease (Conference Paper)
Bonde, A. N., Lip, G. Y. H., Hansen, P. R., Lamberts, M., Hommel, K., Kamper, A. L., . . . Olesen, J. B. (2014). Warfarin is associated with a net clinical benefit in patients with atrial fibrillation and chronic kidney disease. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 344). Retrieved from https://www.webofscience.com/
Which drug should we use for stroke prevention in atrial fibrillation? (Journal article)
Lau, Y. C., & Lip, G. Y. H. (2014). Which drug should we use for stroke prevention in atrial fibrillation?. CURRENT OPINION IN CARDIOLOGY, 29(4), 293-300. doi:10.1097/HCO.0000000000000065DOI: 10.1097/HCO.0000000000000065
2013
ACP Journal Club. PCI in noninfarction arteries reduced cardiac events in acute STEMI with multivessel coronary disease. (Journal article)
Brown, R., & Lip, G. Y. H. (2013). ACP Journal Club. PCI in noninfarction arteries reduced cardiac events in acute STEMI with multivessel coronary disease.. Annals of internal medicine, 159(12), JC3. doi:10.7326/0003-4819-159-12-201312170-02003DOI: 10.7326/0003-4819-159-12-201312170-02003
Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation Implications for Risk and Therapy (Journal article)
Violi, F., Davi, G., Hiatt, W., Lip, G. Y. H., Corazza, G. R., Perticone, F., . . . Basili, S. (2013). Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation Implications for Risk and Therapy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 62(23), 2255-2256. doi:10.1016/j.jacc.2013.07.035DOI: 10.1016/j.jacc.2013.07.035
Treatment of hypertension in peripheral arterial disease (Journal article)
Lane, D. A., & Lip, G. Y. H. (2013). Treatment of hypertension in peripheral arterial disease. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (12). doi:10.1002/14651858.CD003075.pub3DOI: 10.1002/14651858.CD003075.pub3
Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial (Journal article)
Apostolakis, S., Guo, Y., Lane, D. A., Buller, H., & Lip, G. Y. H. (2013). Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial. EUROPEAN HEART JOURNAL, 34(46), 3572-3579. doi:10.1093/eurheartj/eht328DOI: 10.1093/eurheartj/eht328
Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard? (Journal article)
Rubboli, A., Oldgren, J., Marìn, F., & Lip, G. (2013). Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?. Internal and emergency medicine, 8(8), 673-680. doi:10.1007/s11739-013-1008-9DOI: 10.1007/s11739-013-1008-9
The effect of statin therapy withdrawal on monocyte subsets (Journal article)
Jaipersad, A. S., Shantsila, E., Blann, A., & Lip, G. Y. H. (2013). The effect of statin therapy withdrawal on monocyte subsets. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 43(12), 1307-1313. doi:10.1111/eci.12183DOI: 10.1111/eci.12183
The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study. (Journal article)
Schlitt, A., Rubboli, A., Lip, G. Y. H., Lahtela, H., Valencia, J., Karjalainen, P. P., . . . AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting Study Group). (2013). The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 82(7), E864-E870. doi:10.1002/ccd.25064DOI: 10.1002/ccd.25064
Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation. (Journal article)
Overvad, T. F., Larsen, T. B., Albertsen, I. E., Rasmussen, L. H., & Lip, G. Y. H. (2013). Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.. Expert review of cardiovascular therapy, 11(12), 1619-1629. doi:10.1586/14779072.2013.839214DOI: 10.1586/14779072.2013.839214
Comparison of the CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub> -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial (Journal article)
Apostolakis, S., Lane, D. A., Buller, H., & Lip, G. Y. H. (2013). Comparison of the CHADS<sub>2</sub>, CHA<sub>2</sub>DS<sub>2</sub> -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial. THROMBOSIS AND HAEMOSTASIS, 110(5), 1074-1079. doi:10.1160/TH13-07-0552DOI: 10.1160/TH13-07-0552
Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants. (Journal article)
Kasmeridis, C., Apostolakis, S., Ehlers, L., Rasmussen, L. H., Boriani, G., & Lip, G. Y. H. (2013). Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants.. PharmacoEconomics, 31(11), 971-980. doi:10.1007/s40273-013-0090-1DOI: 10.1007/s40273-013-0090-1
Finding atrial fibrillation: just keep looking, just keep looking … (but remember stroke prevention). (Journal article)
Lip, G. Y. H. (2013). Finding atrial fibrillation: just keep looking, just keep looking … (but remember stroke prevention).. Journal of internal medicine, 274(5), 457-460. doi:10.1111/joim.12118DOI: 10.1111/joim.12118
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference (Conference Paper)
Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., . . . Camm, A. J. (2013). Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. In EUROPACE Vol. 15 (pp. 1540-1556). doi:10.1093/europace/eut232DOI: 10.1093/europace/eut232
The immunological axis in heart failure: importance of the leukocyte differential (Journal article)
Vaduganathan, M., Greene, S. J., Butler, J., Sabbah, H. N., Shantsila, E., Lip, G. Y. H., & Gheorghiade, M. (2013). The immunological axis in heart failure: importance of the leukocyte differential. HEART FAILURE REVIEWS, 18(6), 835-845. doi:10.1007/s10741-012-9352-9DOI: 10.1007/s10741-012-9352-9
Using the CHADS2 and CHA2DS2-VASc scores for stroke risk prediction as well as the identification of stroke outcomes and cardiac complications in patients with and without atrial fibrillation. (Journal article)
Lip, G. Y. H. (2013). Using the CHADS2 and CHA2DS2-VASc scores for stroke risk prediction as well as the identification of stroke outcomes and cardiac complications in patients with and without atrial fibrillation.. Cerebrovascular diseases (Basel, Switzerland), 36(4), 281-282. doi:10.1159/000355981DOI: 10.1159/000355981
Psychological interventions for depression in adolescent and adult congenital heart disease (Journal article)
Lane, D. A., Millane, T. A., & Lip, G. Y. H. (2013). Psychological interventions for depression in adolescent and adult congenital heart disease. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (10). doi:10.1002/14651858.CD004372.pub2DOI: 10.1002/14651858.CD004372.pub2
Monocytes in Coronary Artery Disease and Atherosclerosis Where Are We Now? (Journal article)
Ghattas, A., Griffiths, H. R., Devitt, A., Lip, G. Y. H., & Shantsila, E. (2013). Monocytes in Coronary Artery Disease and Atherosclerosis Where Are We Now?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 62(17), 1541-1551. doi:10.1016/j.jacc.2013.07.043DOI: 10.1016/j.jacc.2013.07.043
Subclinical thyroid dysfunction and cardiac function amongst minority ethnic groups in the UK: a cross sectional study. (Journal article)
Gill, P. S., Patel, J. V., Chackathayil, J., Webster, C., Davis, R. C., Hughes, E., & Lip, G. Y. H. (2013). Subclinical thyroid dysfunction and cardiac function amongst minority ethnic groups in the UK: a cross sectional study.. International journal of cardiology, 168(6), 5218-5220. doi:10.1016/j.ijcard.2013.08.030DOI: 10.1016/j.ijcard.2013.08.030
A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. (Journal article)
Potpara, T. S., Polovina, M. M., Marinkovic, J. M., & Lip, G. Y. H. (2013). A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.. International journal of cardiology, 168(5), 4744-4749. doi:10.1016/j.ijcard.2013.07.234DOI: 10.1016/j.ijcard.2013.07.234
Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation. (Journal article)
Guo, Y., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., . . . Lip, G. Y. H. (2013). Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.. International journal of cardiology, 168(5), 4678-4684. doi:10.1016/j.ijcard.2013.07.179DOI: 10.1016/j.ijcard.2013.07.179
Anticoagulation management in nonvalvular atrial fibrillation: current and future directions. (Journal article)
Kornej, J., Potpara, T., & Lip, G. Y. H. (2013). Anticoagulation management in nonvalvular atrial fibrillation: current and future directions.. Polskie Archiwum Medycyny Wewnetrznej, 123(11), 623-634. doi:10.20452/pamw.1978DOI: 10.20452/pamw.1978
Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation (Journal article)
Cangemi, R., Pignatelli, P., Carnevale, R., Corazza, G. R., Pastori, D., Farcomeni, A., . . . Violi, F. (2013). Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 168(4), 3241-3247. doi:10.1016/j.ijcard.2013.04.142DOI: 10.1016/j.ijcard.2013.04.142
Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial. (Journal article)
Apostolakis, S., Haeusler, K. G., Oeff, M., Treszl, A., Andresen, D., Borggrefe, M., . . . Kirchhof, P. (2013). Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial.. International journal of cardiology, 168(4), 3977-3981. doi:10.1016/j.ijcard.2013.06.090DOI: 10.1016/j.ijcard.2013.06.090
Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy. (Journal article)
Marín, F., Huber, K., & Lip, G. Y. H. (2013). Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy.. Thrombosis and haemostasis, 110(4), 623-625. doi:10.1160/th13-08-0677DOI: 10.1160/th13-08-0677
Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. (Journal article)
Gallego, P., Roldan, V., Marín, F., Romera, M., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013). Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation.. Thrombosis and haemostasis, 110(6), 1189-1198. doi:10.1160/th13-07-0556DOI: 10.1160/th13-07-0556
Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study. (Journal article)
Lip, G. Y. H., Lin, H. -J., Hsu, H. -C., Su, T. -C., Chen, M. -F., Lee, Y. -T., & Chien, K. -L. (2013). Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study.. International journal of cardiology, 168(3), 1832-1836. doi:10.1016/j.ijcard.2012.12.076DOI: 10.1016/j.ijcard.2012.12.076
Ambulatory blood pressure in atrial fibrillation: an irregular conundrum of rate and rhythm. (Journal article)
Kotecha, D., & Lip, G. Y. H. (2013). Ambulatory blood pressure in atrial fibrillation: an irregular conundrum of rate and rhythm.. Hypertension research : official journal of the Japanese Society of Hypertension, 36(10), 854-855. doi:10.1038/hr.2013.59DOI: 10.1038/hr.2013.59
Hospital delay in South Asian patients with acute ST-elevation myocardial infarction in the UK. (Journal article)
Kendall, H., Marley, A., Patel, J. V., Khan, J. M., Blann, A. D., Lip, G. Y. H., & Dwivedi, G. (2013). Hospital delay in South Asian patients with acute ST-elevation myocardial infarction in the UK.. European journal of preventive cardiology, 20(5), 737-742. doi:10.1177/2047487312447844DOI: 10.1177/2047487312447844
Inflammation does not influence arterial stiffness and pulse-wave velocity in patients with coronary artery disease. (Journal article)
Blann, A. D., Kuzniatsova, N., & Lip, G. Y. H. (2013). Inflammation does not influence arterial stiffness and pulse-wave velocity in patients with coronary artery disease.. Journal of human hypertension, 27(10), 629-634. doi:10.1038/jhh.2013.17DOI: 10.1038/jhh.2013.17
Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey. (Journal article)
Lip, G. Y. H., Bongiorni, M. G., Dobreanu, D., Lewalter, T., Hastrup Svendsen, J., Blomström-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2013). Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(10), 1526-1532. doi:10.1093/europace/eut292DOI: 10.1093/europace/eut292
Pharmacokinetic considerations for antithrombotic therapies in stroke (Journal article)
Apostolakis, S., Lip, G. Y. H., & Shantsila, E. (2013). Pharmacokinetic considerations for antithrombotic therapies in stroke. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 9(10), 1335-1347. doi:10.1517/17425255.2013.808331DOI: 10.1517/17425255.2013.808331
Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. (Journal article)
Kornej, J., Hindricks, G., Kosiuk, J., Arya, A., Sommer, P., Husser, D., . . . Bollmann, A. (2013). Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.. Circulation. Arrhythmia and electrophysiology, 6(5), 868-874. doi:10.1161/circep.113.000869DOI: 10.1161/circep.113.000869
Stroke Prevention in Atrial Fibrillation in Heart Failure (Journal article)
Shantsila, E., & Lip, G. Y. H. (2013). Stroke Prevention in Atrial Fibrillation in Heart Failure. HEART FAILURE CLINICS, 9(4), 427-+. doi:10.1016/j.hfc.2013.07.008DOI: 10.1016/j.hfc.2013.07.008
The emerging role of biomarkers in atrial fibrillation. (Journal article)
Kornej, J., Apostolakis, S., Bollmann, A., & Lip, G. Y. H. (2013). The emerging role of biomarkers in atrial fibrillation.. The Canadian journal of cardiology, 29(10), 1181-1193. doi:10.1016/j.cjca.2013.04.016DOI: 10.1016/j.cjca.2013.04.016
Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: The Gulf SAFE registry (Journal article)
Apostolakis, S., Zubaid, M., Rashed, W. A., Alsheikh-Ali, A. A., Almahmeed, W., Shehab, A., . . . Lip, G. Y. H. (2013). Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: The Gulf SAFE registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 168(2), 1644-1646. doi:10.1016/j.ijcard.2013.02.003DOI: 10.1016/j.ijcard.2013.02.003
Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation. (Journal article)
Guo, Y., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., . . . Lip, G. Y. H. (2013). Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation.. International journal of cardiology, 168(2), 1502-1508. doi:10.1016/j.ijcard.2012.12.099DOI: 10.1016/j.ijcard.2012.12.099
Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation. (Journal article)
Guo, Y., Apostolakis, S., Blann, A. D., Wang, H., Zhao, X., Zhang, Y., . . . Lip, G. Y. H. (2013). Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation.. International journal of cardiology, 168(2), 904-909. doi:10.1016/j.ijcard.2012.10.052DOI: 10.1016/j.ijcard.2012.10.052
Comparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study. (Journal article)
Lip, G. Y. H., Lin, H. -J., Chien, K. -L., Hsu, H. -C., Su, T. -C., Chen, M. -F., & Lee, Y. -T. (2013). Comparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study.. International journal of cardiology, 168(1), 414-419. doi:10.1016/j.ijcard.2012.09.148DOI: 10.1016/j.ijcard.2012.09.148
Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact? (Journal article)
Guo, Y., Pisters, R., Apostolakis, S., Blann, A. D., Wang, H., Zhao, X., . . . Lip, G. Y. H. (2013). Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact?. International journal of cardiology, 168(1), 515-522. doi:10.1016/j.ijcard.2012.09.187DOI: 10.1016/j.ijcard.2012.09.187
Anticoagulant treatment is effective in atrial fibrillation. (Journal article)
Robson, J. P., & Lip, G. Y. H. (2013). Anticoagulant treatment is effective in atrial fibrillation.. BMJ (Clinical research ed.), 347, f5429. doi:10.1136/bmj.f5429DOI: 10.1136/bmj.f5429
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. (Journal article)
Lamberts, M., Gislason, G. H., Olesen, J. B., Kristensen, S. L., Schjerning Olsen, A. -M., Mikkelsen, A., . . . Hansen, M. L. (2013). Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.. Journal of the American College of Cardiology, 62(11), 981-989. doi:10.1016/j.jacc.2013.05.029DOI: 10.1016/j.jacc.2013.05.029
Pattern of atrial fibrillation and risk of outcomes: The Loire Valley Atrial Fibrillation Project (Journal article)
Banerjee, A., Taillandier, S., Olesen, J. B., Lane, D. A., Lallemand, B., Lip, G. Y. H., & Fauchier, L. (2013). Pattern of atrial fibrillation and risk of outcomes: The Loire Valley Atrial Fibrillation Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 167(6), 2682-2687. doi:10.1016/j.ijcard.2012.06.118DOI: 10.1016/j.ijcard.2012.06.118
Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial (Journal article)
Clarkesmith, D. E., Pattison, H. M., Lip, G. Y. H., & Lane, D. A. (2013). Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial. PLOS ONE, 8(9). doi:10.1371/journal.pone.0074037DOI: 10.1371/journal.pone.0074037
Reply: Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials. (Journal article)
Larsen, T. B., Rasmussen, L. H., Skjøth, F., Due, K. M., Callréus, T., Rosenzweig, M., & Lip, G. Y. H. (2013). Reply: Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials.. Journal of the American College of Cardiology, 62(10), 946-947. doi:10.1016/j.jacc.2013.05.067DOI: 10.1016/j.jacc.2013.05.067
Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review (Journal article)
Udompanich, S., Lip, G. Y. H., Apostolakis, S., & Lane, D. A. (2013). Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 106(9), 795-802. doi:10.1093/qjmed/hct129DOI: 10.1093/qjmed/hct129
Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation. (Journal article)
Ng, K. P., Edwards, N. C., Lip, G. Y. H., Townend, J. N., & Ferro, C. J. (2013). Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation.. American journal of kidney diseases : the official journal of the National Kidney Foundation, 62(3), 615-632. doi:10.1053/j.ajkd.2013.02.381DOI: 10.1053/j.ajkd.2013.02.381
New oral anticoagulants in heart failure. (Journal article)
Van Gelder, I. C., Van Veldhuisen, D. J., & Lip, G. Y. H. (2013). New oral anticoagulants in heart failure.. European journal of heart failure, 15(9), 966-973. doi:10.1093/eurjhf/hft135DOI: 10.1093/eurjhf/hft135
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. (Journal article)
Krijthe, B. P., Kunst, A., Benjamin, E. J., Lip, G. Y. H., Franco, O. H., Hofman, A., . . . Heeringa, J. (2013). Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.. European heart journal, 34(35), 2746-2751. doi:10.1093/eurheartj/eht280DOI: 10.1093/eurheartj/eht280
Role of microRNAs in cardiac remodelling: new insights and future perspectives. (Journal article)
Orenes-Piñero, E., Montoro-García, S., Patel, J. V., Valdés, M., Marín, F., & Lip, G. Y. H. (2013). Role of microRNAs in cardiac remodelling: new insights and future perspectives.. International journal of cardiology, 167(5), 1651-1659. doi:10.1016/j.ijcard.2012.09.120DOI: 10.1016/j.ijcard.2012.09.120
Vitamin D deficiency amongst minority ethnic groups in the UK: a cross sectional study. (Journal article)
Patel, J. V., Chackathayil, J., Hughes, E. A., Webster, C., Lip, G. Y. H., & Gill, P. S. (2013). Vitamin D deficiency amongst minority ethnic groups in the UK: a cross sectional study.. International journal of cardiology, 167(5), 2172-2176. doi:10.1016/j.ijcard.2012.05.081DOI: 10.1016/j.ijcard.2012.05.081
Potpara, T. S., Polovina, M. M., Mujovic, N. M., Kocijancic, A. M., & Lip, G. Y. (2013). Patient preferences at ten years following initial diagnosis of atrial fibrillation: the Belgrade Atrial Fibrillation Study.. Patient preference and adherence, 7, 835-842. doi:10.2147/ppa.s50990DOI: 10.2147/ppa.s50990
Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation (Journal article)
Krishnamoorthy, S., Khoo, C. W., Lim, H. S., Lane, D. A., Pignatelli, P., Basili, S., . . . Lip, G. Y. H. (2013). Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 43(10), 1032-1038. doi:10.1111/eci.12140DOI: 10.1111/eci.12140
Ethnic/racial differences in circulating markers of angiogenesis and their association with cardiovascular risk factors and cardiovascular disease. (Journal article)
Bennett, P. C., Gill, P. S., Silverman, S., Blann, A. D., Balakrishnan, B., & Lip, G. Y. H. (2013). Ethnic/racial differences in circulating markers of angiogenesis and their association with cardiovascular risk factors and cardiovascular disease.. International journal of cardiology, 167(4), 1247-1250. doi:10.1016/j.ijcard.2012.03.158DOI: 10.1016/j.ijcard.2012.03.158
Conventional and new oral anticoagulants in the treatment of chest disease and its complications. (Journal article)
Gallego, P., Roldan, V., & Lip, G. Y. H. (2013). Conventional and new oral anticoagulants in the treatment of chest disease and its complications.. American journal of respiratory and critical care medicine, 188(4), 413-421. doi:10.1164/rccm.201301-0141ppDOI: 10.1164/rccm.201301-0141pp
Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention. (Journal article)
Kiviniemi, T., Karjalainen, P., Rubboli, A., Schlitt, A., Tuomainen, P., Niemelä, M., . . . Airaksinen, K. E. J. (2013). Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention.. The American journal of cardiology, 112(4), 493-498. doi:10.1016/j.amjcard.2013.04.007DOI: 10.1016/j.amjcard.2013.04.007
Receptors to interleukin-6 and adhesion molecules on circulating monocyte subsets in acute myocardial infarction (Journal article)
Shantsila, E., Tapp, L. D., Wrigley, B. J., Montoro-Garcia, S., & Lip, G. Y. H. (2013). Receptors to interleukin-6 and adhesion molecules on circulating monocyte subsets in acute myocardial infarction. THROMBOSIS AND HAEMOSTASIS, 110(2), 340-348. doi:10.1160/TH13-02-0085DOI: 10.1160/TH13-02-0085
Alcohol intake and prognosis of atrial fibrillation (Journal article)
Overvad, T. F., Rasmussen, L. H., Skjoth, F., Overvad, K., Albertsen, I. E., Lane, D. A., . . . Larsen, T. B. (2013). Alcohol intake and prognosis of atrial fibrillation. HEART, 99(15), 1093-1099. doi:10.1136/heartjnl-2013-304036DOI: 10.1136/heartjnl-2013-304036
Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancer. (Journal article)
Ramcharan, S. K., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2013). Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancer.. European journal of clinical investigation, 43(8), 801-808. doi:10.1111/eci.12108DOI: 10.1111/eci.12108
Bridging therapy: a challenging area in the management of patients with atrial fibrillation. (Journal article)
Guo, Y., Lip, G. Y. H., & Apostolakis, S. (2013). Bridging therapy: a challenging area in the management of patients with atrial fibrillation.. American journal of cardiovascular drugs : drugs, devices, and other interventions, 13(4), 259-261. doi:10.1007/s40256-013-0032-5DOI: 10.1007/s40256-013-0032-5
Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey. (Journal article)
Dobreanu, D., Svendsen, J. H., Lewalter, T., Hernández-Madrid, A., Lip, G. Y. H., Blomström-Lundqvist, C., & Scientific Initiatives Committee, European Heart Rhythm Association. (2013). Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(8), 1223-1225. doi:10.1093/europace/eut227DOI: 10.1093/europace/eut227
Evaluation of Carotid Plaque Neovascularization Using Contrast Ultrasound (Journal article)
Jaipersad, A. S., Shantsila, A., Silverman, S., Lip, G. Y. H., & Shantsila, E. (2013). Evaluation of Carotid Plaque Neovascularization Using Contrast Ultrasound. ANGIOLOGY, 64(6), 447-450. doi:10.1177/0003319712457013DOI: 10.1177/0003319712457013
Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation. (Journal article)
Myat, A., Ahmad, Y., Haldar, S., Tantry, U. S., Redwood, S. R., Gurbel, P. A., & Lip, G. Y. (2013). Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation.. Expert review of cardiovascular therapy, 11(8), 1029-1049. doi:10.1586/14779072.2013.815423DOI: 10.1586/14779072.2013.815423
Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation. (Journal article)
Christiansen, C. B., Lip, G. Y. H., Lamberts, M., Gislason, G., Torp-Pedersen, C., & Olesen, J. B. (2013). Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation.. Journal of thrombosis and haemostasis : JTH, 11(8), 1485-1492. doi:10.1111/jth.12297DOI: 10.1111/jth.12297
A comprehensive assessment of cardiac structure and function in patients with treated malignant phase hypertension: The West Birmingham Malignant Hypertension project (Journal article)
Shantsila, A., Dwivedi, G., Shantsila, E., Butt, M., Beevers, D. G., & Lip, G. Y. H. (2013). A comprehensive assessment of cardiac structure and function in patients with treated malignant phase hypertension: The West Birmingham Malignant Hypertension project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 167(1), 67-72. doi:10.1016/j.ijcard.2011.11.077DOI: 10.1016/j.ijcard.2011.11.077
Differences between ACC/AHA and ESC Guidelines on antiplatelet therapy in patients with acute coronary syndromes. (Journal article)
Huber, K., & Lip, G. Y. H. (2013). Differences between ACC/AHA and ESC Guidelines on antiplatelet therapy in patients with acute coronary syndromes.. Thrombosis and haemostasis, 110(1), 11-13. doi:10.1160/th13-06-0453DOI: 10.1160/th13-06-0453
Increased expression of cell adhesion molecule receptors on monocyte subsets in ischaemic heart failure (Journal article)
Wrigley, B. J., Shantsila, E., Tapp, L. D., & Lip, G. Y. H. (2013). Increased expression of cell adhesion molecule receptors on monocyte subsets in ischaemic heart failure. THROMBOSIS AND HAEMOSTASIS, 110(1), 92-100. doi:10.1160/TH13-02-0088DOI: 10.1160/TH13-02-0088
Antiplatelet therapy and anticoagulants. (Journal article)
Schlitt, A., Rubboli, A., Airaksinen, K. E. J., & Lip, G. Y. H. (2013). Antiplatelet therapy and anticoagulants.. Lancet (London, England), 382(9886), 24-25. doi:10.1016/s0140-6736(13)61521-4DOI: 10.1016/s0140-6736(13)61521-4
Body mass index and adverse events in patients with incident atrial fibrillation. (Journal article)
Overvad, T. F., Rasmussen, L. H., Skjøth, F., Overvad, K., Lip, G. Y. H., & Larsen, T. B. (2013). Body mass index and adverse events in patients with incident atrial fibrillation.. The American journal of medicine, 126(7), 640.e9-640.17. doi:10.1016/j.amjmed.2012.11.024DOI: 10.1016/j.amjmed.2012.11.024
Warfarin for stroke prevention in atrial fibrillation: time to switch? (Journal article)
Ahmad, Y., & Lip, G. Y. H. (2013). Warfarin for stroke prevention in atrial fibrillation: time to switch?. International journal of clinical practice, 67(7), 603-605. doi:10.1111/ijcp.12157DOI: 10.1111/ijcp.12157
Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study. (Journal article)
Larsen, T. B., Rasmussen, L. H., Skjøth, F., Due, K. M., Callréus, T., Rosenzweig, M., & Lip, G. Y. H. (2013). Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.. Journal of the American College of Cardiology, 61(22), 2264-2273. doi:10.1016/j.jacc.2013.03.020DOI: 10.1016/j.jacc.2013.03.020
Age as a risk factor for stroke in atrial fibrillation patients: Implications in thromboprophylaxis in the era of novel oral anticoagulants (Journal article)
Mitrousi, K., Lip, G. Y. H., & Apostolakis, S. (2013). Age as a risk factor for stroke in atrial fibrillation patients: Implications in thromboprophylaxis in the era of novel oral anticoagulants. Journal of Atrial Fibrillation, 6(1), 104-109.
Bleeding risk during oral anticoagulation therapy for atrial fibrillation (Journal article)
Gallego, P., Lip, G. Y. H., & Lane, D. A. (2013). Bleeding risk during oral anticoagulation therapy for atrial fibrillation. EUROPACE, 15(6), 773-774. doi:10.1093/europace/eut061DOI: 10.1093/europace/eut061
Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey. (Journal article)
Hernández-Madrid, A., Svendsen, J. H., Lip, G. Y. H., Van Gelder, I. C., Dobreanu, D., Blomstrom-Lundqvist, C., & Scientific Initiatives Committee, European Heart Rhythm Association (EHRA). (2013). Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(6), 915-918. doi:10.1093/europace/eut143DOI: 10.1093/europace/eut143
Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project (Journal article)
Shantsila, A., Lane, D. A., Beevers, D. G., & Lip, G. Y. H. (2013). Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project. HYPERTENSION RESEARCH, 36(6), 546-549. doi:10.1038/hr.2012.222DOI: 10.1038/hr.2012.222
Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin. (Journal article)
Wieloch, M., Jönsson, K. M., Själander, A., Lip, G. Y. H., Eriksson, N., & Svensson, P. J. (2013). Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin.. Thrombosis research, 131(6), 481-486. doi:10.1016/j.thromres.2013.01.006DOI: 10.1016/j.thromres.2013.01.006
Novel oral anticoagulants in non-valvular atrial fibrillation. (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2013). Novel oral anticoagulants in non-valvular atrial fibrillation.. Best practice & research. Clinical haematology, 26(2), 115-129. doi:10.1016/j.beha.2013.07.008DOI: 10.1016/j.beha.2013.07.008
The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke. (Journal article)
Zuo, M. -L., Liu, S., Chan, K. -H., Lau, K. -K., Chong, B. -H., Lam, K. -F., . . . Siu, C. -W. (2013). The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke.. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 37(1), 47-54. doi:10.1007/s10840-012-9776-0DOI: 10.1007/s10840-012-9776-0
The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure. (Journal article)
Guo, Y., Lip, G. Y. H., & Apostolakis, S. (2013). The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.. Journal of cardiovascular translational research, 6(3), 388-397. doi:10.1007/s12265-012-9427-yDOI: 10.1007/s12265-012-9427-y
Stroke Prevention With Oral Anticoagulation Therapy in Patients With Atrial Fibrillation -Focus on the Elderly- (Journal article)
Lip, G. Y. H., & Lane, D. A. (2013). Stroke Prevention With Oral Anticoagulation Therapy in Patients With Atrial Fibrillation -Focus on the Elderly-. CIRCULATION JOURNAL, 77(6), 1380-1388. doi:10.1253/circj.CJ-13-0465DOI: 10.1253/circj.CJ-13-0465
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation. (Chapter)
Ahmad, Y., & Lip, G. Y. H. (2013). Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.. In Unknown Book (Vol. 179, pp. 81-91). doi:10.1159/000346726DOI: 10.1159/000346726
Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. (Journal article)
Banerjee, A., Fauchier, L., Vourc'h, P., Andres, C. R., Taillandier, S., Halimi, J. M., & Lip, G. Y. H. (2013). Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.. Journal of the American College of Cardiology, 61(20), 2079-2087. doi:10.1016/j.jacc.2013.02.035DOI: 10.1016/j.jacc.2013.02.035
Kakkar, A. K., Mueller, I., Bassand, J. -P., Fitzmaurice, D. A., Goldhaber, S. Z., Goto, S., . . . GARFIELD Registry Investigators. (2013). Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.. PloS one, 8(5), e63479. doi:10.1371/journal.pone.0063479DOI: 10.1371/journal.pone.0063479
Response to letter regarding article, "Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation". (Journal article)
Gallego, P., Apostolakis, S., & Lip, G. Y. H. (2013). Response to letter regarding article, "Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation".. Circulation, 127(19), e617. doi:10.1161/circulationaha.113.001659DOI: 10.1161/circulationaha.113.001659
Sympathetic nerve activity during non-sustained ventricular tachycardia in chronic heart failure. (Journal article)
Adlan, A. M., Lip, G. Y. H., Fadel, P. J., & Fisher, J. P. (2013). Sympathetic nerve activity during non-sustained ventricular tachycardia in chronic heart failure.. International journal of cardiology, 165(2), e15-e17. doi:10.1016/j.ijcard.2012.10.088DOI: 10.1016/j.ijcard.2012.10.088
Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? (Journal article)
Roldán, V., Marín, F., Manzano-Fernandez, S., Fernández, H., Gallego, P., Valdés, M., . . . Lip, G. Y. H. (2013). Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?. Thrombosis and haemostasis, 109(5), 956-960. doi:10.1160/th13-01-0054DOI: 10.1160/th13-01-0054
Sørensen, R., Gislason, G., Torp-Pedersen, C., Olesen, J. B., Fosbøl, E. L., Hvidtfeldt, M. W., . . . Hansen, M. L. (2013). Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study.. BMJ open, 3(5), e002758. doi:10.1136/bmjopen-2013-002758DOI: 10.1136/bmjopen-2013-002758
ATRIAL FIBRILLATION Anticoagulation for AF: can we GRASP-AF patients? (Journal article)
Lane, D. A., & Lip, G. Y. H. (2013). ATRIAL FIBRILLATION Anticoagulation for AF: can we GRASP-AF patients?. NATURE REVIEWS CARDIOLOGY, 10(5), 241-242. doi:10.1038/nrcardio.2013.47DOI: 10.1038/nrcardio.2013.47
Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease. (Journal article)
Jover, E., Marín, F., Roldán, V., Montoro-García, S., Valdés, M., & Lip, G. Y. H. (2013). Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.. Annals of medicine, 45(3), 274-290. doi:10.3109/07853890.2012.732702DOI: 10.3109/07853890.2012.732702
Awareness and treatment of atrial fibrillation in older adults: the present and the future. (Journal article)
Lip, G. Y. H. (2013). Awareness and treatment of atrial fibrillation in older adults: the present and the future.. QJM : monthly journal of the Association of Physicians, 106(5), 393-394. doi:10.1093/qjmed/hct074DOI: 10.1093/qjmed/hct074
Guo, Y., Lip, G. Y. H., & Banerjee, A. (2013). Heart failure in East Asia.. Current cardiology reviews, 9(2), 112-122. doi:10.2174/1573403x11309020004DOI: 10.2174/1573403x11309020004
Reduction of stroke and mortality in patients with atrial fibrillation by catheter ablation? Finally, tackling the hard endpoints. (Journal article)
Kornej, J., Lip, G. Y. H., & Bollmann, A. (2013). Reduction of stroke and mortality in patients with atrial fibrillation by catheter ablation? Finally, tackling the hard endpoints.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(5), 620-622. doi:10.1093/europace/eus389DOI: 10.1093/europace/eus389
Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis. (Journal article)
Albertsen, I. E., Rasmussen, L. H., Overvad, T. F., Graungaard, T., Larsen, T. B., & Lip, G. Y. H. (2013). Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis.. Stroke, 44(5), 1329-1336. doi:10.1161/strokeaha.113.000883DOI: 10.1161/strokeaha.113.000883
The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review (Journal article)
Anandasundaram, B., Lane, D. A., Apostolakis, S., & Lip, G. Y. H. (2013). The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 11(5), 975-987. doi:10.1111/jth.12177DOI: 10.1111/jth.12177
Upper limb arterial thromboembolism: a systematic review on incidence, risk factors, and prognosis, including a meta-analysis of risk-modifying drugs. (Journal article)
Andersen, L. V., Lip, G. Y. H., Lindholt, J. S., & Frost, L. (2013). Upper limb arterial thromboembolism: a systematic review on incidence, risk factors, and prognosis, including a meta-analysis of risk-modifying drugs.. Journal of thrombosis and haemostasis : JTH, 11(5), 836-844. doi:10.1111/jth.12181DOI: 10.1111/jth.12181
Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). (Journal article)
Roldán, V., Marín, F., Fernández, H., Manzano-Fernández, S., Gallego, P., Valdés, M., . . . Lip, G. Y. H. (2013). Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).. The American journal of cardiology, 111(8), 1159-1164. doi:10.1016/j.amjcard.2012.12.045DOI: 10.1016/j.amjcard.2012.12.045
Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why? (Journal article)
Lip, G. Y. H. (2013). Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?. European heart journal, 34(14), 1041-1049. doi:10.1093/eurheartj/ehs435DOI: 10.1093/eurheartj/ehs435
Metabolic syndrome and renal disease. (Journal article)
Gluba, A., Mikhailidis, D. P., Lip, G. Y. H., Hannam, S., Rysz, J., & Banach, M. (2013). Metabolic syndrome and renal disease.. International journal of cardiology, 164(2), 141-150. doi:10.1016/j.ijcard.2012.01.013DOI: 10.1016/j.ijcard.2012.01.013
Aspirin and aspirin resistance in coronary artery disease. (Journal article)
Kasmeridis, C., Apostolakis, S., & Lip, G. Y. H. (2013). Aspirin and aspirin resistance in coronary artery disease.. Current opinion in pharmacology, 13(2), 242-250. doi:10.1016/j.coph.2012.12.004DOI: 10.1016/j.coph.2012.12.004
Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey. (Journal article)
Dagres, N., Lewalter, T., Lip, G. Y. H., Pison, L., Proclemer, A., Blomström-Lundqvist, C., & Scientific Initiatives Committee, European Heart Rhythm Association. (2013). Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(4), 478-481. doi:10.1093/europace/eut063DOI: 10.1093/europace/eut063
Left Ventricular Fibrosis in Atrial Fibrillation (Journal article)
Shantsila, E., Shantsila, A., Blann, A. D., & Lip, G. Y. H. (2013). Left Ventricular Fibrosis in Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 111(7), 996-1001. doi:10.1016/j.amjcard.2012.12.005DOI: 10.1016/j.amjcard.2012.12.005
Localized retinal nerve fiber layer defects and arterial hypertension: insights into pathophysiology and perhaps an eye for detail? (Journal article)
Kalitzeos, A. A., Heitmar, R., & Lip, G. Y. H. (2013). Localized retinal nerve fiber layer defects and arterial hypertension: insights into pathophysiology and perhaps an eye for detail?. American journal of hypertension, 26(4), 454-455. doi:10.1093/ajh/hpt013DOI: 10.1093/ajh/hpt013
Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary. (Journal article)
Lip, G. Y. H. (2013). Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary.. Journal of thrombosis and haemostasis : JTH, 11(4), 615-626. doi:10.1111/jth.12140DOI: 10.1111/jth.12140
Small-size circulating microparticles in acute coronary syndromes: Relevance to fibrinolytic status, reparative markers and outcomes (Journal article)
Montoro-Garcia, S., Shantsila, E., Tapp, L. D., Lopez-Cuenca, A., Isabel Romero, A., Hernandez-Romero, D., . . . Lip, G. Y. H. (2013). Small-size circulating microparticles in acute coronary syndromes: Relevance to fibrinolytic status, reparative markers and outcomes. ATHEROSCLEROSIS, 227(2), 313-322. doi:10.1016/j.atherosclerosis.2013.01.028DOI: 10.1016/j.atherosclerosis.2013.01.028
Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker? (Journal article)
Riva, N., & Lip, G. Y. H. (2013). Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker?. Current pharmaceutical design, 19(21), 3753-3765. doi:10.2174/13816128113199990299DOI: 10.2174/13816128113199990299
Chackathayil, J., Patel, J. V., Gill, P. S., Potluri, R., Natalwala, A., Uppal, H., . . . Lip, G. Y. H. (2013). Cardiovascular Risk Profiles amongst Women in a Multiethnic Population in Inner City Britain: A Potential Impact of Anaemia.. International journal of endocrinology, 2013, 303859. doi:10.1155/2013/303859DOI: 10.1155/2013/303859
CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation. (Journal article)
Ntaios, G., Lip, G. Y. H., Makaritsis, K., Papavasileiou, V., Vemmou, A., Koroboki, E., . . . Vemmos, K. (2013). CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.. Neurology, 80(11), 1009-1017. doi:10.1212/wnl.0b013e318287281bDOI: 10.1212/wnl.0b013e318287281b
CXCR4 positive and angiogenic monocytes in myocardial infarction (Journal article)
Shantsila, E., Tapp, L. D., Wrigley, B. J., Montoro-Garcia, S., & Lip, G. Y. H. (2013). CXCR4 positive and angiogenic monocytes in myocardial infarction. THROMBOSIS AND HAEMOSTASIS, 109(2), 255-262. doi:10.1160/TH12-06-0395DOI: 10.1160/TH12-06-0395
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation A modelling analysis from the Euro Heart Survey (Journal article)
Pisters, R., Nieuwlaat, R., Lane, D. A., Crijns, H. J. G. M., & Lip, G. Y. H. (2013). Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation A modelling analysis from the Euro Heart Survey. THROMBOSIS AND HAEMOSTASIS, 109(2), 328-336. doi:10.1160/TH12-08-0539DOI: 10.1160/TH12-08-0539
EUR Observational research programme: atrial fibrillation general registry pilot phase. (Journal article)
Lip, G. Y. H. (2013). EUR Observational research programme: atrial fibrillation general registry pilot phase.. European heart journal, 34(11), 794.
Interleukin-6 and high-sensitivity C-reactive protein for the prediction of outcomes in non-ST-segment elevation acute coronary syndromes. (Journal article)
López-Cuenca, Á., Manzano-Fernández, S., Lip, G. Y. H., Casas, T., Sánchez-Martínez, M., Mateo-Martínez, A., . . . Marín, F. (2013). Interleukin-6 and high-sensitivity C-reactive protein for the prediction of outcomes in non-ST-segment elevation acute coronary syndromes.. Revista espanola de cardiologia (English ed.), 66(3), 185-192. doi:10.1016/j.rec.2012.07.019DOI: 10.1016/j.rec.2012.07.019
Safety and efficacy of new anticoagulants in patients with heart failure. (Journal article)
Pisters, R., & Lip, G. Y. H. (2013). Safety and efficacy of new anticoagulants in patients with heart failure.. Current heart failure reports, 10(1), 18-25. doi:10.1007/s11897-012-0125-5DOI: 10.1007/s11897-012-0125-5
TLR4 expression on monocyte subsets in myocardial infarction (Journal article)
Tapp, L. D., Shantsila, E., Wrigley, B. J., Montoro-Garcia, S., & Lip, G. Y. H. (2013). TLR4 expression on monocyte subsets in myocardial infarction. JOURNAL OF INTERNAL MEDICINE, 273(3), 294-305. doi:10.1111/joim.12011DOI: 10.1111/joim.12011
Using the CHA(2)DS(2)-VASc score for stroke risk stratification in atrial fibrillation: a clinical perspective. (Journal article)
Lip, G. Y. H. (2013). Using the CHA(2)DS(2)-VASc score for stroke risk stratification in atrial fibrillation: a clinical perspective.. Expert review of cardiovascular therapy, 11(3), 259-262. doi:10.1586/erc.13.13DOI: 10.1586/erc.13.13
General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease. (Journal article)
De Caterina, R., Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., . . . European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease. (2013). General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.. Thrombosis and haemostasis, 109(4), 569-579. doi:10.1160/th12-10-0772DOI: 10.1160/th12-10-0772
Atrial fibrillation and thrombosis: the missing molecular links. (Journal article)
Blann, A. D., & Lip, G. Y. H. (2013). Atrial fibrillation and thrombosis: the missing molecular links.. Journal of the American College of Cardiology, 61(8), 861-862. doi:10.1016/j.jacc.2012.11.047DOI: 10.1016/j.jacc.2012.11.047
Reply: To PMID 22575324. (Journal article)
Lip, G. Y. H., Larsen, T. B., Skjøth, F., & Rasmussen, L. H. (2013). Reply: To PMID 22575324.. Journal of the American College of Cardiology, 61(5), 596. doi:10.1016/j.jacc.2012.10.034DOI: 10.1016/j.jacc.2012.10.034
Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation. (Journal article)
Adlan, A. M. A., & Lip, G. Y. H. (2013). Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation.. Drug safety, 36(2), 93-110. doi:10.1007/s40264-012-0012-8DOI: 10.1007/s40264-012-0012-8
CD14++CD16+ monocytes in patients with acute ischaemic heart failure (Journal article)
Wrigley, B. J., Shantsila, E., Tapp, L. D., & Lip, G. Y. H. (2013). CD14++CD16+ monocytes in patients with acute ischaemic heart failure. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 43(2), 121-130. doi:10.1111/eci.12023DOI: 10.1111/eci.12023
Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey. (Journal article)
Proclemer, A., Dagres, N., Marinskis, G., Pison, L., Lip, G. Y. H., Blomstrom-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2013). Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(2), 167-169. doi:10.1093/europace/eus436DOI: 10.1093/europace/eus436
Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications (Journal article)
Karthikeyan, V. J., Lane, D. A., Beevers, D. G., Lip, G. Y. H., & Blann, A. D. (2013). Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications. JOURNAL OF HUMAN HYPERTENSION, 27(2), 72-78. doi:10.1038/jhh.2012.8DOI: 10.1038/jhh.2012.8
Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study. (Journal article)
Lip, G. Y. H., Connolly, S., Yusuf, S., Shestakovska, O., Flaker, G., Hart, R., . . . ERROES Investigators. (2013). Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.. Circulation. Arrhythmia and electrophysiology, 6(1), 31-38. doi:10.1161/circep.112.975847DOI: 10.1161/circep.112.975847
Periprocedural antithrombotic management of patients undergoing ablation for atrial fibrillation: what we currently do...and what should we do? (Journal article)
Pisters, R., & Lip, G. Y. H. (2013). Periprocedural antithrombotic management of patients undergoing ablation for atrial fibrillation: what we currently do...and what should we do?. The Canadian journal of cardiology, 29(2), 139-141. doi:10.1016/j.cjca.2012.05.016DOI: 10.1016/j.cjca.2012.05.016
Prior aspirin therapy and cardiovascular implantable electronic device infections. (Journal article)
Gallego, P., Marin, F., & Lip, G. Y. H. (2013). Prior aspirin therapy and cardiovascular implantable electronic device infections.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(2), 163-164. doi:10.1093/europace/eus346DOI: 10.1093/europace/eus346
The prognostic role of the adiponectin levels in atrial fibrillation. (Journal article)
Hernández-Romero, D., Jover, E., Marín, F., Vilchez, J. A., Manzano-Fernandez, S., Romera, M., . . . Roldán, V. (2013). The prognostic role of the adiponectin levels in atrial fibrillation.. European journal of clinical investigation, 43(2), 168-173. doi:10.1111/eci.12028DOI: 10.1111/eci.12028
The Analysis of Bleeding Risk-Prediction Scores Should Include All Major Bleeds Reply (Journal article)
Apostolakis, S., Lane, D. A., Guo, Y., Buller, H., & Lip, G. Y. H. (2013). The Analysis of Bleeding Risk-Prediction Scores Should Include All Major Bleeds Reply. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 61(4), 482-483. doi:10.1016/j.jacc.2012.10.033DOI: 10.1016/j.jacc.2012.10.033
Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double-blind conditions? (Journal article)
O'Neil, W. M., Welner, S. A., & Lip, G. Y. H. (2013). Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double-blind conditions?. Thrombosis and haemostasis, 109(3), 497-503. doi:10.1160/th12-10-0715DOI: 10.1160/th12-10-0715
Performance of the HEMORR<sub>2</sub>HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Nonwarfarin Anticoagulated Atrial Fibrillation Patients (Journal article)
Apostolakis, S., Lane, D. A., Guo, Y., Buller, H., & Lip, G. Y. H. (2013). Performance of the HEMORR<sub>2</sub>HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Nonwarfarin Anticoagulated Atrial Fibrillation Patients. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 61(3), 386-387. doi:10.1016/j.jacc.2012.10.010DOI: 10.1016/j.jacc.2012.10.010
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. (Journal article)
Coppens, M., Eikelboom, J. W., Hart, R. G., Yusuf, S., Lip, G. Y. H., Dorian, P., . . . Connolly, S. J. (2013). The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.. European heart journal, 34(3), 170-176. doi:10.1093/eurheartj/ehs314DOI: 10.1093/eurheartj/ehs314
A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice. (Other)
Kasmeridis, C., Lip, G. Y., & Apostolakis, S. (2013). A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.. In Hospital practice (1995) (Vol. 41, Iss. 1, pp. 61-70). [Print]. doi:10.3810/hp.2013.02.1011DOI: 10.3810/hp.2013.02.1011
A very happy new year 2014 from Thrombosis and Haemostasis! Reflections on the past, the present and the future. (Journal article)
Lip, G. Y. H., & Weber, C. (2014). A very happy new year 2014 from Thrombosis and Haemostasis! Reflections on the past, the present and the future.. Thrombosis and haemostasis, 111(1), 1-2. doi:10.1055/s-0037-1608911DOI: 10.1055/s-0037-1608911
Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention. (Journal article)
Ruiz-Nodar, J. M., Marín, F., & Lip, G. Y. H. (2013). Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention.. Revista espanola de cardiologia (English ed.), 66(1), 12-16. doi:10.1016/j.recesp.2012.07.018DOI: 10.1016/j.recesp.2012.07.018
Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants. (Other)
Guo, Y., Lip, G. Y., & Apostolakis, S. (2013). Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.. In Hospital practice (1995) (Vol. 41, Iss. 1, pp. 71-78). [Print]. doi:10.3810/hp.2013.02.1012DOI: 10.3810/hp.2013.02.1012
Common Clinical Indications for Anticoagulation (Chapter)
Krishnamoorthy, S., Khoo, C. W., Shantsila, E., & Lip, G. Y. H. (2013). Common Clinical Indications for Anticoagulation. In Handbook of Oral Anticoagulation (pp. 7-31). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_2DOI: 10.1007/978-1-908517-96-8_2
Development of a Novel Composite Stroke and Bleeding Risk Score in Patients With Atrial Fibrillation The AMADEUS Study (Journal article)
Lip, G. Y. H., Lane, D. A., Buller, H., & Apostolakis, S. (2013). Development of a Novel Composite Stroke and Bleeding Risk Score in Patients With Atrial Fibrillation The AMADEUS Study. CHEST, 144(6), 1839-1847. doi:10.1378/chest.13-1635DOI: 10.1378/chest.13-1635
Differences between indirect comparison studies of the oral anticoagulants for stroke prevention in atrial fibrillation: where do we go next? (Journal article)
Harenberg, J., & Lip, G. Y. H. (2013). Differences between indirect comparison studies of the oral anticoagulants for stroke prevention in atrial fibrillation: where do we go next?. QJM : monthly journal of the Association of Physicians, 106(1), 95-96. doi:10.1093/qjmed/hcs224DOI: 10.1093/qjmed/hcs224
Editors' Choice papers in <i>Thrombosis and Haemostasis</i> (Journal article)
Weber, C., & Lip, G. Y. H. (2014). Editors' Choice papers in <i>Thrombosis and Haemostasis</i>. THROMBOSIS AND HAEMOSTASIS, 111(1), 183-188. Retrieved from https://www.webofscience.com/
Editors’ Choice papers in Thrombosis and Haemostasis (Journal article)
Weber, C., & Lip, G. Y. H. (2013). Editors’ Choice papers in Thrombosis and Haemostasis. Thrombosis and Haemostasis, 109(01), 170-173. doi:10.1055/s-0037-1609008DOI: 10.1055/s-0037-1609008
Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score. (Journal article)
Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2013). Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.. Chest, 144(5), 1555-1563. doi:10.1378/chest.13-0054DOI: 10.1378/chest.13-0054
Future Directions (Chapter)
Shantsila, E., & Lip, G. Y. H. (2013). Future Directions. In Handbook of Oral Anticoagulation (pp. 87-88). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_6DOI: 10.1007/978-1-908517-96-8_6
Handbook of Oral Anticoagulation (Book)
Lip, G. Y. H., & Shantsila, E. (Eds.) (2013). Handbook of Oral Anticoagulation. Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8DOI: 10.1007/978-1-908517-96-8
Hemorrhage Risks, Patient Perspectives, and Quality-of-Life Issues (Chapter)
Tay, K. -H., Apostolakis, S., Lane, D. A., & Lip, G. Y. H. (2013). Hemorrhage Risks, Patient Perspectives, and Quality-of-Life Issues. In Handbook of Oral Anticoagulation (pp. 41-51). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_4DOI: 10.1007/978-1-908517-96-8_4
Increased Formation of Monocyte-Platelet Aggregates in Ischemic Heart Failure (Journal article)
Wrigley, B. J., Shantsila, E., Tapp, L. D., & Lip, G. Y. H. (2013). Increased Formation of Monocyte-Platelet Aggregates in Ischemic Heart Failure. CIRCULATION-HEART FAILURE, 6(1), 127-+. doi:10.1161/CIRCHEARTFAILURE.112.968073DOI: 10.1161/CIRCHEARTFAILURE.112.968073
Is the higher risk of cardiovascular disease amongst South Asian populations linked to abnormalities of haemoglobin? A preliminary case control study. (Journal article)
Patel, J. V., Chackathayil, J., Gammon, B., Tracey, I., Lovick, A., Gill, P. S., . . . Hughes, E. A. (2013). Is the higher risk of cardiovascular disease amongst South Asian populations linked to abnormalities of haemoglobin? A preliminary case control study.. Atherosclerosis, 226(1), 198-200. doi:10.1016/j.atherosclerosis.2012.09.017DOI: 10.1016/j.atherosclerosis.2012.09.017
Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey. (Journal article)
Lip, G. Y. H., Dagres, N., Proclemer, A., Svendsen, J. H., Pison, L., Blomstrom-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2013). Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(1), 141-143. doi:10.1093/europace/eus413DOI: 10.1093/europace/eus413
New Oral Anticoagulants (Chapter)
Shantsila, E., Apostolakis, S., & Lip, G. Y. H. (2013). New Oral Anticoagulants. In Handbook of Oral Anticoagulation (pp. 53-86). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_5DOI: 10.1007/978-1-908517-96-8_5
Oral anticoagulation for heart failure in sinus rhythm: from evidence to clinical recommendations, or not? (Journal article)
Marín, F., & Lip, G. Y. H. (2013). Oral anticoagulation for heart failure in sinus rhythm: from evidence to clinical recommendations, or not?. European journal of heart failure, 15(1), 3-4. doi:10.1093/eurjhf/hfs198DOI: 10.1093/eurjhf/hfs198
Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting. (Journal article)
Caballero, L., Ruiz-Nodar, J. M., Marín, F., Roldán, V., Hurtado, J. A., Valencia, J., . . . Lip, G. Y. H. (2013). Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting.. Age and ageing, 42(1), 70-75. doi:10.1093/ageing/afs121DOI: 10.1093/ageing/afs121
Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy. (Journal article)
Roldán, V., Marín, F., Fernández, H., Manzano-Fernandez, S., Gallego, P., Valdés, M., . . . Lip, G. Y. H. (2013). Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.. Chest, 143(1), 179-184. doi:10.1378/chest.12-0608DOI: 10.1378/chest.12-0608
Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study. (Journal article)
Potpara, T. S., Polovina, M. M., Licina, M. M., Marinkovic, J. M., & Lip, G. Y. H. (2013). Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.. European journal of heart failure, 15(4), 415-424. doi:10.1093/eurjhf/hft004DOI: 10.1093/eurjhf/hft004
Recent Developments in Understanding Epidemiology and Risk Determinants of Atrial Fibrillation as a Cause of Stroke (Journal article)
Ahmad, Y., Lip, G. Y. H., & Lane, D. A. (2013). Recent Developments in Understanding Epidemiology and Risk Determinants of Atrial Fibrillation as a Cause of Stroke. CANADIAN JOURNAL OF CARDIOLOGY, 29(7), S4-S13. doi:10.1016/j.cjca.2013.03.009DOI: 10.1016/j.cjca.2013.03.009
Recent advances in management of atrial fibrillation in patients with heart failure (Journal article)
Shantsila, E., & Lip, G. Y. H. (2013). Recent advances in management of atrial fibrillation in patients with heart failure. CURRENT OPINION IN CARDIOLOGY, 28(2), 197-208. doi:10.1097/HCO.0b013e32835bd465DOI: 10.1097/HCO.0b013e32835bd465
Retinal vessel tortuosity measures and their applications. (Journal article)
Kalitzeos, A. A., Lip, G. Y. H., & Heitmar, R. (2013). Retinal vessel tortuosity measures and their applications.. Experimental eye research, 106, 40-46. doi:10.1016/j.exer.2012.10.015DOI: 10.1016/j.exer.2012.10.015
Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study (Journal article)
Alings, M., Smit, M. D., Moes, M. L., Crijns, H. J. G. M., Tijssen, J. G. P., Brugemann, J., . . . Van Gelder, I. C. (2013). Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study. NETHERLANDS HEART JOURNAL, 21(7-8), 354-363. doi:10.1007/s12471-013-0428-5DOI: 10.1007/s12471-013-0428-5
Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future perspectives. (Journal article)
Durrant, J., Lip, G. Y. H., & Lane, D. A. (2013). Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future perspectives.. Expert review of cardiovascular therapy, 11(1), 77-90. doi:10.1586/erc.12.161DOI: 10.1586/erc.12.161
The Coagulation Pathway and Approaches to Anticoagulation (Chapter)
Tay, K. H., Shantsila, E., & Lip, G. Y. H. (2013). The Coagulation Pathway and Approaches to Anticoagulation. In Handbook of Oral Anticoagulation (pp. 1-5). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_1DOI: 10.1007/978-1-908517-96-8_1
Vascular and platelet responses to aspirin in patients with coronary artery disease. (Journal article)
Blann, A. D., Kuzniatsova, N., & Lip, G. Y. H. (2013). Vascular and platelet responses to aspirin in patients with coronary artery disease.. European journal of clinical investigation, 43(1), 91-99. doi:10.1111/eci.12021DOI: 10.1111/eci.12021
Vitamin K Antagonists and Their Limitations (Chapter)
Khoo, C. W., Shantsila, E., & Lip, G. Y. H. (2013). Vitamin K Antagonists and Their Limitations. In Handbook of Oral Anticoagulation (pp. 33-40). Springer Healthcare Ltd.. doi:10.1007/978-1-908517-96-8_3DOI: 10.1007/978-1-908517-96-8_3
β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment. (Journal article)
Vílchez, J. A., Roldán, V., Manzano-Fernández, S., Fernández, H., Avilés-Plaza, F., Martínez-Hernández, P., . . . Lip, G. Y. H. (2013). β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment.. Chest, 144(5), 1564-1570. doi:10.1378/chest.13-0922DOI: 10.1378/chest.13-0922
2012
Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm An Executive Summary<SUP>#</SUP> of a joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis (Journal article)
Lip, G. Y. H., Ponikowski, P., Andreotti, F., Anker, S. D., Filippatos, G., Homma, S., . . . Lane, D. A. (2012). Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm An Executive Summary<SUP>#</SUP> of a joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. THROMBOSIS AND HAEMOSTASIS, 108(6), 1009-1022. doi:10.1160/TH12-08-0578DOI: 10.1160/TH12-08-0578
Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM). (Journal article)
Sullivan, R. M., Zhang, J., Zamba, G., Lip, G. Y. H., & Olshansky, B. (2012). Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM).. The American journal of cardiology, 110(12), 1799-1802. doi:10.1016/j.amjcard.2012.08.014DOI: 10.1016/j.amjcard.2012.08.014
Inflammation in atrial fibrillation. (Journal article)
Guo, Y., Lip, G. Y. H., & Apostolakis, S. (2012). Inflammation in atrial fibrillation.. Journal of the American College of Cardiology, 60(22), 2263-2270. doi:10.1016/j.jacc.2012.04.063DOI: 10.1016/j.jacc.2012.04.063
A contemporary viewpoint on 'aspirin resistance' (Journal article)
Kuzniatsova, N., Shantsila, E., Blann, A., & Lip, G. Y. H. (2012). A contemporary viewpoint on 'aspirin resistance'. ANNALS OF MEDICINE, 44(8), 773-783. doi:10.3109/07853890.2011.605388DOI: 10.3109/07853890.2011.605388
Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation. (Journal article)
Gallego, P., Roldán, V., Marín, F., Jover, E., Manzano-Fernández, S., Valdés, M., . . . Lip, G. Y. H. (2012). Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation.. European journal of clinical investigation, 42(12), 1302-1308. doi:10.1111/eci.12004DOI: 10.1111/eci.12004
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial. (Journal article)
Flaker, G. C., Eikelboom, J. W., Shestakovska, O., Connolly, S. J., Kaatz, S., Budaj, A., . . . Hart, R. G. (2012). Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.. Stroke, 43(12), 3291-3297. doi:10.1161/strokeaha.112.664144DOI: 10.1161/strokeaha.112.664144
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation. (Journal article)
Ahmad, Y., Lip, G. Y. H., & Apostolakis, S. (2012). New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation.. Expert review of cardiovascular therapy, 10(12), 1471-1480. doi:10.1586/erc.12.148DOI: 10.1586/erc.12.148
Lee, S., Monz, B. U., Clemens, A., Brueckmann, M., & Lip, G. Y. H. (2012). Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database.. BMJ open, 2(6), e001768. doi:10.1136/bmjopen-2012-001768DOI: 10.1136/bmjopen-2012-001768
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature. (Journal article)
Dentali, F., Riva, N., Crowther, M., Turpie, A. G. G., Lip, G. Y. H., & Ageno, W. (2012). Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.. Circulation, 126(20), 2381-2391. doi:10.1161/circulationaha.112.115410DOI: 10.1161/circulationaha.112.115410
Response to Letter Regarding Article, “Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study” (Journal article)
Friberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012). Response to Letter Regarding Article, “Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study”. Circulation, 126(20). doi:10.1161/circulationaha.112.134841DOI: 10.1161/circulationaha.112.134841
Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis. (Journal article)
Rasmussen, L. H., Larsen, T. B., Graungaard, T., Skjøth, F., & Lip, G. Y. H. (2012). Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis.. BMJ (Clinical research ed.), 345, e7097. doi:10.1136/bmj.e7097DOI: 10.1136/bmj.e7097
Atrial Fibrillation (Chapter)
Khoo, C. W., & Lip, G. Y. H. (2012). Atrial Fibrillation. In Unknown Book (pp. 143-173). Wiley. doi:10.1002/9781118399378.ch6DOI: 10.1002/9781118399378.ch6
Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study. (Journal article)
Potpara, T. S., Marinkovic, J. M., Polovina, M. M., Stankovic, G. R., Seferovic, P. M., Ostojic, M. C., & Lip, G. Y. H. (2012). Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study.. International journal of cardiology, 161(1), 39-44. doi:10.1016/j.ijcard.2011.04.022DOI: 10.1016/j.ijcard.2011.04.022
High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: a reply to a rebuttal (Journal article)
ROLDÁN, V., MARÍN, F., GALLEGO, P., VICENTE, V., & LIP, G. Y. H. (2012). High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: a reply to a rebuttal. Journal of Thrombosis and Haemostasis, 10(11), 2414-2415. doi:10.1111/j.1538-7836.2012.04918.xDOI: 10.1111/j.1538-7836.2012.04918.x
How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey. (Journal article)
Bongiorni, M. G., Marinskis, G., Lip, G. Y. H., Svendsen, J. H., Dobreanu, D., Blomström-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2012). How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(11), 1666-1669. doi:10.1093/europace/eus350DOI: 10.1093/europace/eus350
No effect of clopidogrel activity or cessation on vascular function or markers of inflammation. (Journal article)
Kuzniatsova, N., Balakrishnan, B., Lip, G. Y. H., & Blann, A. D. (2012). No effect of clopidogrel activity or cessation on vascular function or markers of inflammation.. The International journal of angiology : official publication of the International College of Angiology, Inc, 21(4), 195-200. doi:10.1055/s-0032-1328777DOI: 10.1055/s-0032-1328777
Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study. (Journal article)
Davis, R. C., Hobbs, F. D. R., Kenkre, J. E., Roalfe, A. K., Iles, R., Lip, G. Y. H., & Davies, M. K. (2012). Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(11), 1553-1559. doi:10.1093/europace/eus087DOI: 10.1093/europace/eus087
Ahmad, Y., & Lip, G. Y. H. (2012). Stroke prevention in atrial fibrillation: concepts and controversies.. Current cardiology reviews, 8(4), 290-301. doi:10.2174/157340312803760820DOI: 10.2174/157340312803760820
ACP Journal Club. Various risk stratification schemes predict ischemic stroke and bleeding in atrial fibrillation. (Journal article)
Gage, B. F., & Andrade, A. (2012). ACP Journal Club. Various risk stratification schemes predict ischemic stroke and bleeding in atrial fibrillation.. Annals of internal medicine, 157(8), JC4-J13. doi:10.7326/0003-4819-157-8-201210160-02013DOI: 10.7326/0003-4819-157-8-201210160-02013
Chronic Atrial Fibrillation (Journal article)
Lane, D. A., Apostolakis, S., Boos, C. J., & Lip, G. Y. H. (2012). Chronic Atrial Fibrillation. AMERICAN FAMILY PHYSICIAN, 86(8), 757-758. Retrieved from https://www.webofscience.com/
Crijns, H. J. G. M., Bash, L. D., Chazelle, F., Le Heuzey, J. -Y., Lewalter, T., Lip, G. Y. H., . . . Gitt, A. K. (2012). RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers.. BMC cardiovascular disorders, 12, 85. doi:10.1186/1471-2261-12-85DOI: 10.1186/1471-2261-12-85
A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study. (Journal article)
Roalfe, A. K., Bryant, T. L., Davies, M. H., Hackett, T. G., Saba, S., Fletcher, K., . . . BAFTA investigators. (2012). A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(10), 1420-1427. doi:10.1093/europace/eus102DOI: 10.1093/europace/eus102
Assessing the Risk of Bleeding in Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project (Journal article)
Lip, G. Y. H., Banerjee, A., Lagrenade, I., Lane, D. A., Taillandier, S., & Fauchier, L. (2012). Assessing the Risk of Bleeding in Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 5(5), 941-948. doi:10.1161/CIRCEP.112.972869DOI: 10.1161/CIRCEP.112.972869
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance. (Journal article)
Ahmad, Y., & Lip, G. Y. H. (2012). Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance.. Heart (British Cardiac Society), 98(19), 1404-1406. doi:10.1136/heartjnl-2012-302101DOI: 10.1136/heartjnl-2012-302101
Eosinophil count predicts mortality following percutaneous coronary intervention. (Journal article)
Toor, I. S., Jaumdally, R., Lip, G. Y. H., Millane, T., & Varma, C. (2012). Eosinophil count predicts mortality following percutaneous coronary intervention.. Thrombosis research, 130(4), 607-611. doi:10.1016/j.thromres.2012.05.033DOI: 10.1016/j.thromres.2012.05.033
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). (Journal article)
Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Barón-Esquivias, G., Baumgartner, H., . . . European Association for Cardio-Thoracic Surgery (EACTS). (2012). Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 42(4), S1-44. doi:10.1093/ejcts/ezs455DOI: 10.1093/ejcts/ezs455
Pre and post-operative treatments for prevention of atrial fibrillation after cardiac surgery. (Journal article)
Orenes-Piñero, E., Montoro-García, S., Banerjee, A., Valdés, M., Lip, G. Y. H., & Marín, F. (2012). Pre and post-operative treatments for prevention of atrial fibrillation after cardiac surgery.. Mini reviews in medicinal chemistry, 12(13), 1419-1431. doi:10.2174/13895575112091419DOI: 10.2174/13895575112091419
Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey. (Journal article)
Holt, T. A., Hunter, T. D., Gunnarsson, C., Khan, N., Cload, P., & Lip, G. Y. H. (2012). Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey.. The British journal of general practice : the journal of the Royal College of General Practitioners, 62(603), e710-e717. doi:10.3399/bjgp12x656856DOI: 10.3399/bjgp12x656856
Stroke risk assessment in atrial fibrillation (Chapter)
Apostolakis, S., & Lip, G. Y. H. (2012). Stroke risk assessment in atrial fibrillation. In Unknown Book (pp. 10-29). Future Medicine Ltd. doi:10.2217/ebo.12.47DOI: 10.2217/ebo.12.47
Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients. (Journal article)
Hernández-Romero, D., Marín, F., Roldán, V., & Lip, G. Y. H. (2012). Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients.. Journal of internal medicine, 272(4), 409. doi:10.1111/j.1365-2796.2012.02565.xDOI: 10.1111/j.1365-2796.2012.02565.x
[ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012]. (Journal article)
McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., . . . Heart Failure Association. (2012). [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012].. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 40 Suppl 3, 77-137.
Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation. (Journal article)
Gallego, P., Apostolakis, S., & Lip, G. Y. H. (2012). Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation.. Circulation, 126(13), 1573-1576. doi:10.1161/circulationaha.112.135681DOI: 10.1161/circulationaha.112.135681
New anticoagulant treatments to protect against stroke in atrial fibrillation. (Journal article)
Potpara, T. S., Lip, G. Y. H., & Apostolakis, S. (2012). New anticoagulant treatments to protect against stroke in atrial fibrillation.. Heart (British Cardiac Society), 98(18), 1341-1347. doi:10.1136/heartjnl-2012-301841DOI: 10.1136/heartjnl-2012-301841
Christensen, A. L., Rasmussen, L. H., Baker, M. G., Lip, G. Y. H., Dethlefsen, C., & Larsen, T. B. (2012). Seasonality, incidence and prognosis in atrial fibrillation and stroke in Denmark and New Zealand.. BMJ open, 2(4), e001210. doi:10.1136/bmjopen-2012-001210DOI: 10.1136/bmjopen-2012-001210
Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysis. (Journal article)
Albertsen, I. E., Larsen, T. B., Rasmussen, L. H., Overvad, T. F., & Lip, G. Y. H. (2012). Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysis.. Drugs, 72(13), 1755-1764. doi:10.2165/11635630-000000000-00000DOI: 10.2165/11635630-000000000-00000
Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study. (Journal article)
Mikkelsen, A. P., Lindhardsen, J., Lip, G. Y. H., Gislason, G. H., Torp-Pedersen, C., & Olesen, J. B. (2012). Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study.. Journal of thrombosis and haemostasis : JTH, 10(9), 1745-1751. doi:10.1111/j.1538-7836.2012.04853.xDOI: 10.1111/j.1538-7836.2012.04853.x
Renal function and aspirin resistance in patients with coronary artery disease. (Journal article)
Blann, A. D., Kuzniatsova, N., Velu, S., & Lip, G. Y. H. (2012). Renal function and aspirin resistance in patients with coronary artery disease.. Thrombosis research, 130(3), e103-e106. doi:10.1016/j.thromres.2012.06.026DOI: 10.1016/j.thromres.2012.06.026
Performance of the HEMORR<sub>2</sub>HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation (Journal article)
Apostolakis, S., Lane, D. A., Guo, Y., Buller, H., & Lip, G. Y. H. (2012). Performance of the HEMORR<sub>2</sub>HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 60(9), 861-867. doi:10.1016/j.jacc.2012.06.019DOI: 10.1016/j.jacc.2012.06.019
Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. (Journal article)
Lip, G. Y. H., Larsen, T. B., Skjøth, F., & Rasmussen, L. H. (2012). Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.. Journal of the American College of Cardiology, 60(8), 738-746. doi:10.1016/j.jacc.2012.03.019DOI: 10.1016/j.jacc.2012.03.019
Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease (Journal article)
Olesen, J. B., Lip, G. Y. H., Kamper, A. -L., Hommel, K., Kober, L., Lane, D. A., . . . Torp-Pedersen, C. (2012). Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease. NEW ENGLAND JOURNAL OF MEDICINE, 367(7), 625-635. doi:10.1056/NEJMoa1105594DOI: 10.1056/NEJMoa1105594
Use of the CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation (Journal article)
Lane, D. A., & Lip, G. Y. H. (2012). Use of the CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation. CIRCULATION, 126(7), 860-865. doi:10.1161/CIRCULATIONAHA.111.060061DOI: 10.1161/CIRCULATIONAHA.111.060061
Edoxaban in Japanese patients with nonvalvular atrial fibrillation: not the same dose for everybody. (Journal article)
Roldán, V., Marín, F., & Lip, G. Y. H. (2012). Edoxaban in Japanese patients with nonvalvular atrial fibrillation: not the same dose for everybody.. Circulation journal : official journal of the Japanese Circulation Society, 76(8), 1826-1827. doi:10.1253/circj.cj-12-0765DOI: 10.1253/circj.cj-12-0765
A contemporary view on endothelial function in heart failure (Journal article)
Shantsila, E., Wrigley, B. J., Blann, A. D., Gill, P. S., & Lip, G. Y. H. (2012). A contemporary view on endothelial function in heart failure. EUROPEAN JOURNAL OF HEART FAILURE, 14(8), 873-881. doi:10.1093/eurjhf/hfs066DOI: 10.1093/eurjhf/hfs066
An innovative flow cytometric approach for small-size platelet microparticles: Influence of calcium (Journal article)
Montoro-Garcia, S., Shantsila, E., Orenes-Pinero, E., Luisa Lozano, M., & Lip, G. Y. H. (2012). An innovative flow cytometric approach for small-size platelet microparticles: Influence of calcium. THROMBOSIS AND HAEMOSTASIS, 108(2), 373-383. doi:10.1160/TH12-02-0120DOI: 10.1160/TH12-02-0120
Antiplatelet therapy in stroke prevention. (Journal article)
Apostolakis, S., Marín, F., & Lip, G. Y. H. (2012). Antiplatelet therapy in stroke prevention.. Advances in cardiology, 47, 141-154. doi:10.1159/000338050DOI: 10.1159/000338050
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. (Journal article)
Harenberg, J., Marx, S., Diener, H. -C., Lip, G. Y. H., Marder, V. J., Wehling, M., & Weiss, C. (2012). Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.. International angiology : a journal of the International Union of Angiology, 31(4), 330-339.
Current practice in out-of-hospital cardiac arrest management: a European heart rhythm association EP network survey. (Journal article)
Proclemer, A., Dobreanu, D., Pison, L., Lip, G. Y. H., Svendsen, J. H., Lundqvist, C. B., & Scientific Initiative Committee-European Heart Rhythm Association. (2012). Current practice in out-of-hospital cardiac arrest management: a European heart rhythm association EP network survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(8), 1195-1198. doi:10.1093/europace/eus232DOI: 10.1093/europace/eus232
High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation. (Journal article)
Roldán, V., Marín, F., Díaz, J., Gallego, P., Jover, E., Romera, M., . . . Lip, G. Y. H. (2012). High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation.. Journal of thrombosis and haemostasis : JTH, 10(8), 1500-1507. doi:10.1111/j.1538-7836.2012.04812.xDOI: 10.1111/j.1538-7836.2012.04812.x
Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? (Journal article)
Ruiz-Nodar, J. M., Marín, F., Roldán, V., Valencia, J., Manzano-Fernández, S., Caballero, L., . . . Lip, G. Y. H. (2012). Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?. Circulation. Cardiovascular interventions, 5(4), 459-466. doi:10.1161/circinterventions.112.968792DOI: 10.1161/circinterventions.112.968792
The effects of exercise and diurnal variation on monocyte subsets and monocyte-platelet aggregates (Journal article)
Shantsila, E., Tapp, L. D., Wrigley, B. J., Montoro-Garcia, S., Ghattas, A., Jaipersad, A., & Lip, G. Y. H. (2012). The effects of exercise and diurnal variation on monocyte subsets and monocyte-platelet aggregates. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 42(8), 832-839. doi:10.1111/j.1365-2362.2012.02656.xDOI: 10.1111/j.1365-2362.2012.02656.x
Vascular Disease and Stroke Risk in Atrial Fibrillation: A Nationwide Cohort Study (Journal article)
Olesen, J. B., Lip, G. Y. H., Lane, D. A., Kober, L., Hansen, M. L., Karasoy, D., . . . Torp-Pedersen, C. (2012). Vascular Disease and Stroke Risk in Atrial Fibrillation: A Nationwide Cohort Study. AMERICAN JOURNAL OF MEDICINE, 125(8). doi:10.1016/j.amjmed.2011.11.024DOI: 10.1016/j.amjmed.2011.11.024
Lip, G. Y. H., Rasmussen, L. H., Skjøth, F., Overvad, K., & Larsen, T. B. (2012). Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study.. BMJ open, 2(4), e000975. doi:10.1136/bmjopen-2012-000975DOI: 10.1136/bmjopen-2012-000975
Comparison of frequency of major adverse events in patients with atrial fibrillation receiving bare-metal versus drug-eluting stents in their coronary arteries. (Journal article)
Fauchier, L., Pellegrin, C., Bernard, A., Clementy, N., Angoulvant, D., Lip, G. Y. H., & Babuty, D. (2012). Comparison of frequency of major adverse events in patients with atrial fibrillation receiving bare-metal versus drug-eluting stents in their coronary arteries.. The American journal of cardiology, 110(1), 7-12. doi:10.1016/j.amjcard.2012.02.042DOI: 10.1016/j.amjcard.2012.02.042
Fibrinolytic status hi acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathways (Journal article)
Shantsila, E., Montoro-Garcia, S., Tapp, L. D., Apostolakis, S., Wrigley, B. J., & Lip, G. Y. H. (2012). Fibrinolytic status hi acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathways. THROMBOSIS AND HAEMOSTASIS, 108(1), 32-40. doi:10.1160/TH12-01-0011DOI: 10.1160/TH12-01-0011
Monocyte-derived and CD34+/KDR+ endothelial progenitor cells in heart failure (Journal article)
Shantsila, E., Wrigley, B. J., Shantsila, A., Tapp, L. D., Gill, P. S., & Lip, G. Y. H. (2012). Monocyte-derived and CD34+/KDR+ endothelial progenitor cells in heart failure. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 10(7), 1252-1261. doi:10.1111/j.1538-7836.2012.04753.xDOI: 10.1111/j.1538-7836.2012.04753.x
Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban. (Journal article)
Apostolakis, S., & Lip, G. Y. H. (2012). Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban.. Expert opinion on investigational drugs, 21(7), 1057-1064. doi:10.1517/13543784.2012.689286DOI: 10.1517/13543784.2012.689286
Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation. (Journal article)
Jover, E., Roldán, V., Gallego, P., Hernández-Romero, D., Valdés, M., Vicente, V., . . . Marín, F. (2012). Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.. Revista espanola de cardiologia (English ed.), 65(7), 627-633. doi:10.1016/j.recesp.2012.02.017DOI: 10.1016/j.recesp.2012.02.017
Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study. (Journal article)
Taillandier, S., Olesen, J. B., Clémenty, N., Lagrenade, I., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2012). Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.. Journal of cardiovascular electrophysiology, 23(7), 708-713. doi:10.1111/j.1540-8167.2011.02257.xDOI: 10.1111/j.1540-8167.2011.02257.x
Resource utilization and outcomes in patients with atrial fibrillation: a case control study. (Journal article)
Boggon, R., Lip, G. Y. H., Gallagher, A. M., & van Staa, T. P. (2012). Resource utilization and outcomes in patients with atrial fibrillation: a case control study.. Applied health economics and health policy, 10(4), 249-259. doi:10.2165/11599940-000000000-00000DOI: 10.2165/11599940-000000000-00000
The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction (Journal article)
Tapp, L. D., Shantsila, E., Wrigley, B. J., Pamukcu, B., & Lip, G. Y. H. (2012). The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 10(7), 1231-1241. doi:10.1111/j.1538-7836.2011.04603.xDOI: 10.1111/j.1538-7836.2011.04603.x
The unmet need of stroke prevention in atrial fibrillation in the Far East and South East Asia (Journal article)
Guo, Y., Lip, G. Y. H., & ApostolaLAkis, S. (2012). The unmet need of stroke prevention in atrial fibrillation in the Far East and South East Asia. Malaysian Journal of Medical Sciences, 19(3), 1-7.
Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis (Journal article)
Lip, G. Y. H., Ponikowski, P., Andreotti, F., Anker, S. D., Filippatos, G., Homma, S., . . . Lane, D. A. (2012). Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. EUROPEAN JOURNAL OF HEART FAILURE, 14(7), 681-695. doi:10.1093/eurjhf/hfs073DOI: 10.1093/eurjhf/hfs073
Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project (Journal article)
Shantsila, A., Dwivedi, G., Shantsila, E., Steeds, R. P., Beevers, G., & Lip, G. Y. H. (2012). Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project. HYPERTENSION RESEARCH, 35(7), 725-728. doi:10.1038/hr.2012.18DOI: 10.1038/hr.2012.18
Atrial fibrillation, arrhythmia burden and thrombogenesis. (Journal article)
Khoo, C. W., Krishnamoorthy, S., Lim, H. S., & Lip, G. Y. H. (2012). Atrial fibrillation, arrhythmia burden and thrombogenesis.. International journal of cardiology, 157(3), 318-323. doi:10.1016/j.ijcard.2011.06.088DOI: 10.1016/j.ijcard.2011.06.088
Anticoagulation versus placebo for heart failure in sinus rhythm. (Journal article)
Lip, G. Y., Wrigley, B. J., & Pisters, R. (2012). Anticoagulation versus placebo for heart failure in sinus rhythm.. The Cochrane database of systematic reviews, (6), CD003336. doi:10.1002/14651858.cd003336.pub2DOI: 10.1002/14651858.cd003336.pub2
An audience with... Gregory Lip. Interview by Asher Mullard. (Journal article)
Lip, G. (2012). An audience with... Gregory Lip. Interview by Asher Mullard.. Nature reviews. Drug discovery, 11(6), 434. doi:10.1038/nrd3752DOI: 10.1038/nrd3752
Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about? (Journal article)
Tchaikovski, V., & Lip, G. Y. H. (2012). Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?. Current hypertension reports, 14(3), 183-192. doi:10.1007/s11906-012-0263-xDOI: 10.1007/s11906-012-0263-x
Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable? (Journal article)
Marín, F., Roldán, V., & Lip, G. Y. H. (2012). Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable?. Expert opinion on pharmacotherapy, 13(8), 1087-1090. doi:10.1517/14656566.2012.688954DOI: 10.1517/14656566.2012.688954
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. (Journal article)
Friberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012). Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.. European heart journal, 33(12), 1500-1510. doi:10.1093/eurheartj/ehr488DOI: 10.1093/eurheartj/ehr488
Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry. (Journal article)
Lahtela, H., Rubboli, A., Schlitt, A., Karjalainen, P. P., Niemelä, M., Vikman, S., . . . AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting) study group. (2012). Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry.. Circulation journal : official journal of the Japanese Circulation Society, 76(6), 1363-1368. doi:10.1253/circj.cj-11-1206DOI: 10.1253/circj.cj-11-1206
Insights from the RCPE UK Consensus Conference on approaching the comprehensive management of atrial fibrillation. (Conference Paper)
Lip, G. Y. H., & Ramsay, S. G. (2012). Insights from the RCPE UK Consensus Conference on approaching the comprehensive management of atrial fibrillation.. In Expert review of cardiovascular therapy Vol. 10 (pp. 697-700). doi:10.1586/erc.12.48DOI: 10.1586/erc.12.48
Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. (Journal article)
Potpara, T. S., Polovina, M. M., Licina, M. M., Stojanovic, R. M., Prostran, M. S., & Lip, G. Y. H. (2012). Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.. Advances in therapy, 29(6), 491-507. doi:10.1007/s12325-012-0026-8DOI: 10.1007/s12325-012-0026-8
Peripheral artery disease and atrial fibrillation: a potentially dangerous combination. (Journal article)
Violi, F., Lip, G. Y. H., & Basili, S. (2012). Peripheral artery disease and atrial fibrillation: a potentially dangerous combination.. Internal and emergency medicine, 7(3), 213-218. doi:10.1007/s11739-011-0637-0DOI: 10.1007/s11739-011-0637-0
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. (Journal article)
Olesen, J. B., Torp-Pedersen, C., Hansen, M. L., & Lip, G. Y. H. (2012). The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.. Thrombosis and haemostasis, 107(6), 1172-1179. doi:10.1160/th12-03-0175DOI: 10.1160/th12-03-0175
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. (Journal article)
Friberg, L., Benson, L., Rosenqvist, M., & Lip, G. Y. H. (2012). Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study.. BMJ (Clinical research ed.), 344, e3522. doi:10.1136/bmj.e3522DOI: 10.1136/bmj.e3522
Bleeding risk assessment and management in atrial fibrillation patients. Key messages for clinical practice from the European Heart Rhythm Association position statement. (Journal article)
Guo, Y., Lip, G. Y. H., & Apostolakis, S. (2012). Bleeding risk assessment and management in atrial fibrillation patients. Key messages for clinical practice from the European Heart Rhythm Association position statement.. Polskie Archiwum Medycyny Wewnetrznej, 122(5), 235-242.
Warfarin and aspirin in patients with heart failure and sinus rhythm. (Journal article)
Homma, S., Thompson, J. L. P., Pullicino, P. M., Levin, B., Freudenberger, R. S., Teerlink, J. R., . . . WARCEF Investigators. (2012). Warfarin and aspirin in patients with heart failure and sinus rhythm.. The New England journal of medicine, 366(20), 1859-1869. doi:10.1056/nejmoa1202299DOI: 10.1056/nejmoa1202299
Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. (Journal article)
Friberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012). Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.. Circulation, 125(19), 2298-2307. doi:10.1161/circulationaha.111.055079DOI: 10.1161/circulationaha.111.055079
Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study. (Journal article)
Larsen, T. B., Lip, G. Y. H., Skjøth, F., Due, K. M., Overvad, K., & Hvilsted Rasmussen, L. (2012). Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study.. Circulation. Cardiovascular quality and outcomes, 5(3), 335-342. doi:10.1161/circoutcomes.111.964023DOI: 10.1161/circoutcomes.111.964023
An observational study of endothelial function in early arthritis. (Journal article)
Foster, W., Lip, G. Y. H., Raza, K., Carruthers, D., & Blann, A. D. (2012). An observational study of endothelial function in early arthritis.. European journal of clinical investigation, 42(5), 510-516. doi:10.1111/j.1365-2362.2011.02607.xDOI: 10.1111/j.1365-2362.2011.02607.x
Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice. (Journal article)
Huisman, M. V., Lip, G. Y. H., Diener, H. -C., Brueckmann, M., van Ryn, J., & Clemens, A. (2012). Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice.. Thrombosis and haemostasis, 107(5), 838-847. doi:10.1160/th11-10-0718DOI: 10.1160/th11-10-0718
Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants? (Journal article)
Foley, J., & Lip, G. Y. H. (2012). Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants?. International journal of clinical practice, 66(5), 422-424. doi:10.1111/j.1742-1241.2011.02815.xDOI: 10.1111/j.1742-1241.2011.02815.x
How early is early enough to prevent stroke in atrial fibrillation? (Journal article)
Guo, Y., Lip, G. Y., & Apostolakis, S. (2012). How early is early enough to prevent stroke in atrial fibrillation?. Expert review of cardiovascular therapy, 10(5), 585-588. doi:10.1586/erc.12.36DOI: 10.1586/erc.12.36
Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation. (Journal article)
Lip, G. Y. H., Proclemer, A., Dagres, N., Bongiorni, M. G., Lewalter, T., Blomström-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2012). Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(5), 741-744. doi:10.1093/europace/eus105DOI: 10.1093/europace/eus105
Calvert, M., Duffy, H., Freemantle, N., Davis, R., Lip, G. Y. H., & Gill, P. (2012). Population health status of South Asian and African-Caribbean communities in the United Kingdom.. BMC health services research, 12, 101. doi:10.1186/1472-6963-12-101DOI: 10.1186/1472-6963-12-101
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. (Conference Paper)
Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S. -A., . . . Wilber, D. (2012). 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.. In Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology Vol. 14 (pp. 528-606). doi:10.1093/europace/eus027DOI: 10.1093/europace/eus027
Angiogenin and Hemoxygenase in Pregnancy: Influence of Hypertension (Journal article)
Karthikeyan, V. J., Lip, G. Y. H., Baghdadi, S., Lane, D. A., Beevers, D. G., & Blann, A. D. (2012). Angiogenin and Hemoxygenase in Pregnancy: Influence of Hypertension. ANGIOLOGY, 63(3), 194-198. doi:10.1177/0003319711410308DOI: 10.1177/0003319711410308
Anthropometric discriminators of the risk of high blood pressure amongst public schoolchildren in Gujarat, India. (Journal article)
Patel, J. V., Lip, G. Y., Prabharkaran, D., Reddy, K. S., Gill, P. S., & Hughes, E. A. (2012). Anthropometric discriminators of the risk of high blood pressure amongst public schoolchildren in Gujarat, India.. International journal of clinical practice, 66(4), 418-420. doi:10.1111/j.1742-1241.2011.02875.xDOI: 10.1111/j.1742-1241.2011.02875.x
Comments on the Spanish Society of Cardiology critical review of the ESC 2010 clinical practice guidelines on atrial fibrillation. (Journal article)
Lip, G. Y. H., & Camm, A. J. (2012). Comments on the Spanish Society of Cardiology critical review of the ESC 2010 clinical practice guidelines on atrial fibrillation.. Revista espanola de cardiologia (English ed.), 65(4), 390-391. doi:10.1016/j.recesp.2011.12.007DOI: 10.1016/j.recesp.2011.12.007
Monitoring in the management of atrial fibrillation. (Journal article)
Lewalter, T., Morgan, J., Halimi, F., Lip, G., Dagres, N., Blomström-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2012). Monitoring in the management of atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(4), 591-592. doi:10.1093/europace/eus073DOI: 10.1093/europace/eus073
Preventative measures of stroke in patients with atrial fibrillation (Journal article)
Adlan, A., & Lip, G. Y. H. (2012). Preventative measures of stroke in patients with atrial fibrillation. Journal of Atrial Fibrillation, 2(10).
Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. (Journal article)
Gallego, P., Roldán, V., Torregrosa, J. M., Gálvez, J., Valdés, M., Vicente, V., . . . Lip, G. Y. H. (2012). Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.. Circulation. Arrhythmia and electrophysiology, 5(2), 312-318. doi:10.1161/circep.111.967000DOI: 10.1161/circep.111.967000
Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study. (Journal article)
Potpara, T. S., Polovina, M. M., Licina, M. M., Marinkovic, J. M., Prostran, M. S., & Lip, G. Y. H. (2012). Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.. Circulation. Arrhythmia and electrophysiology, 5(2), 319-326. doi:10.1161/circep.111.966713DOI: 10.1161/circep.111.966713
The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries. (Journal article)
Rubboli, A., Dewilde, W., Huber, K., Eeckhout, E., Herzfeld, I., Valencia, J., . . . Lip, G. Y. H. (2012). The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries.. Journal of interventional cardiology, 25(2), 163-169. doi:10.1111/j.1540-8183.2011.00683.xDOI: 10.1111/j.1540-8183.2011.00683.x
Blood leukocytes in heart failure with preserved ejection fraction: Impact on prognosis (Journal article)
Shantsila, E., Bialiuk, N., Navitski, D., Pyrochkin, A., Gill, P. S., Pyrochkin, V., . . . Lip, G. Y. H. (2012). Blood leukocytes in heart failure with preserved ejection fraction: Impact on prognosis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 155(2), 337-338. doi:10.1016/j.ijcard.2011.12.048DOI: 10.1016/j.ijcard.2011.12.048
Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project (Journal article)
Banerjee, A., Taillandier, S., Olesen, J. B., Lane, D. A., Lallemand, B., Lip, G. Y. H., & Fauchier, L. (2012). Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project. EUROPEAN JOURNAL OF HEART FAILURE, 14(3), 295-301. doi:10.1093/eurjhf/hfs005DOI: 10.1093/eurjhf/hfs005
Highlights of the American Heart Association Scientific Sessions 2011: a focus on ATLAS-TIMI 51, TRACER and PALLAS. (Conference Paper)
Shantsila, A., & Lip, G. Y. H. (2012). Highlights of the American Heart Association Scientific Sessions 2011: a focus on ATLAS-TIMI 51, TRACER and PALLAS.. In Expert review of cardiovascular therapy Vol. 10 (pp. 305-307). doi:10.1586/erc.11.192DOI: 10.1586/erc.11.192
Left Ventricular Systolic and Diastolic Function in Obstructive Sleep Apnea Impact of Continuous Positive Airway Pressure Therapy (Journal article)
Butt, M., Dwivedi, G., Shantsila, A., Khair, O. A., & Lip, G. Y. H. (2012). Left Ventricular Systolic and Diastolic Function in Obstructive Sleep Apnea Impact of Continuous Positive Airway Pressure Therapy. CIRCULATION-HEART FAILURE, 5(2), 226-233. doi:10.1161/CIRCHEARTFAILURE.111.964106DOI: 10.1161/CIRCHEARTFAILURE.111.964106
Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey. (Journal article)
Marinskis, G., van Erven, L., Bongiorni, M. G., Lip, G. Y. H., Pison, L., Blomström-Lundqvist, C., & Scientific Initiative Committee, European Heart Rhythm Association. (2012). Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(3), 423-425. doi:10.1093/europace/eus020DOI: 10.1093/europace/eus020
Atrial fibrillation (Conference Paper)
Lip, G. Y. H., Tse, H. F., & Lane, D. A. (2012). Atrial fibrillation. In LANCET Vol. 379 (pp. 648-661). doi:10.1016/S0140-6736(11)61514-6DOI: 10.1016/S0140-6736(11)61514-6
A new era for anticoagulation in atrial fibrillation. Which anticoagulant should we choose for long‑term prevention of thromboembolic complications in patients with atrial fibrillation? (Journal article)
Riva, N., & Lip, G. Y. H. (2012). A new era for anticoagulation in atrial fibrillation. Which anticoagulant should we choose for long‑term prevention of thromboembolic complications in patients with atrial fibrillation?. Polskie Archiwum Medycyny Wewnetrznej, 122(1-2), 45-53.
Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents. (Journal article)
Pamukcu, B., Huber, K., & Lip, G. Y. H. (2012). Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.. Current pharmaceutical design, 18(6), 850-860. doi:10.2174/138161212799277716DOI: 10.2174/138161212799277716
Dronedarone: an overview. (Journal article)
Kozlowski, D., Budrejko, S., Lip, G. Y. H., Mikhailidis, D. P., Rysz, J., Raczak, G., & Banach, M. (2012). Dronedarone: an overview.. Annals of medicine, 44(1), 60-72. doi:10.3109/07853890.2011.594808DOI: 10.3109/07853890.2011.594808
Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort. (Journal article)
Weijs, B., Pisters, R., Nieuwlaat, R., Breithardt, G., Le Heuzey, J. -Y., Vardas, P. E., . . . Crijns, H. J. G. M. (2012). Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(2), 184-190. doi:10.1093/europace/eur379DOI: 10.1093/europace/eur379
Improving the diagnosis and prognosis of atrial fibrillation in stroke: quo vadis? (Journal article)
Banerjee, A., & Lip, G. Y. H. (2012). Improving the diagnosis and prognosis of atrial fibrillation in stroke: quo vadis?. European journal of neurology, 19(2), 187-188. doi:10.1111/j.1468-1331.2011.03516.xDOI: 10.1111/j.1468-1331.2011.03516.x
Pharmacological Modulation of Microparticle Release: New Strategies for the Management of Atherothrombotic Vascular Disorders (Journal article)
Montoro-Garcia, S., Orenes-Pinero, E., Marin, F., Mariano, V., Lip, G. Y. H., & Shantsila, E. (2012). Pharmacological Modulation of Microparticle Release: New Strategies for the Management of Atherothrombotic Vascular Disorders. CURRENT PHARMACEUTICAL DESIGN, 18(6), 840-849. doi:10.2174/138161212799277789DOI: 10.2174/138161212799277789
Silent cerebral embolism after catheter ablation of atrial fibrillation (Journal article)
Shantsila, A., & Lip, G. Y. H. (2012). Silent cerebral embolism after catheter ablation of atrial fibrillation. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 66(2), 118-120. doi:10.1111/j.1742-1241.2011.02820.xDOI: 10.1111/j.1742-1241.2011.02820.x
Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10-year follow-up study. (Journal article)
Vemmos, K., Ntaios, G., Savvari, P., Vemmou, A. M., Koroboki, E., Manios, E., . . . Lip, G. Y. H. (2012). Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10-year follow-up study.. European journal of heart failure, 14(2), 211-218. doi:10.1093/eurjhf/hfr172DOI: 10.1093/eurjhf/hfr172
Stroke prevention in atrial fibrillation: do we still need warfarin? (Journal article)
Diener, H. -C., Weber, R., Lip, G. Y. H., & Hohnloser, S. H. (2012). Stroke prevention in atrial fibrillation: do we still need warfarin?. Current opinion in neurology, 25(1), 27-35. doi:10.1097/wco.0b013e32834e604aDOI: 10.1097/wco.0b013e32834e604a
<i>Clinical Practice</i>: a new direction (Journal article)
<i>Clinical Practice</i>: a new direction (2012). Clinical Practice, 9(1), 1-3. doi:10.2217/cpr.11.130DOI: 10.2217/cpr.11.130
A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study. (Journal article)
Potpara, T. S., Stankovic, G. R., Beleslin, B. D., Polovina, M. M., Marinkovic, J. M., Ostojic, M. C., & Lip, G. Y. H. (2012). A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study.. Chest, 141(2), 339-347. doi:10.1378/chest.11-0340DOI: 10.1378/chest.11-0340
A proposal for new clinical concepts in the management of atrial fibrillation. (Journal article)
Camm, A. J., Al-Khatib, S. M., Calkins, H., Halperin, J. L., Kirchhof, P., Lip, G. Y. H., . . . Williams, E. S. (2012). A proposal for new clinical concepts in the management of atrial fibrillation.. American heart journal, 164(3), 292-302.e1. doi:10.1016/j.ahj.2012.05.017DOI: 10.1016/j.ahj.2012.05.017
Antithrombotic Therapy for Atrial Fibrillation Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (Journal article)
You, J. J., Singer, D. E., Howard, P. A., Lane, D. A., Eckman, M. H., Fang, M. C., . . . Lip, G. Y. H. (2012). Antithrombotic Therapy for Atrial Fibrillation Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST, 141(2), E531S-E575S. doi:10.1378/chest.11-2304DOI: 10.1378/chest.11-2304
Atrial fibrillation and vascular disease--a bad combination. (Journal article)
Olesen, J. B., Gislason, G. H., Torp-Pedersen, C., & Lip, G. Y. H. (2012). Atrial fibrillation and vascular disease--a bad combination.. Clinical cardiology, 35 Suppl 1, 15-20. doi:10.1002/clc.20955DOI: 10.1002/clc.20955
Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies. (Journal article)
Biancari, F., Airaksinen, K. E. J., & Lip, G. Y. H. (2012). Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies.. The Journal of thoracic and cardiovascular surgery, 143(3), 665-675.e4. doi:10.1016/j.jtcvs.2011.01.069DOI: 10.1016/j.jtcvs.2011.01.069
Can we predict stroke in atrial fibrillation? (Journal article)
Lip, G. Y. H. (2012). Can we predict stroke in atrial fibrillation?. Clinical cardiology, 35 Suppl 1, 21-27. doi:10.1002/clc.20969DOI: 10.1002/clc.20969
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference (Conference Paper)
Kirchhof, P., Lip, G. Y. H., Van Gelder, I. C., Bax, J., Hylek, E., Kaab, S., . . . Camm, A. J. (2012). Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. In EUROPACE Vol. 14 (pp. 8-27). doi:10.1093/europace/eur241DOI: 10.1093/europace/eur241
Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs. (Journal article)
Ahrens, I., Peter, K., Lip, G. Y. H., & Bode, C. (2012). Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs.. Discovery medicine, 13(73), 433-443.
Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation. (Journal article)
Ahrens, I., Peter, K., Lip, G. Y. H., & Bode, C. (2012). Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation.. Discovery medicine, 13(73), 445-450.
Highlights and hot topics from 2011 in Thrombosis and Haemostasis (Journal article)
Weber, C., & Lip, G. Y. H. (2012). Highlights and hot topics from 2011 in Thrombosis and Haemostasis. Thrombosis and Haemostasis, 107(01), 196-199. doi:10.1055/s-0037-1608981DOI: 10.1055/s-0037-1608981
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension. (Journal article)
Manolis, A. J., Rosei, E. A., Coca, A., Cifkova, R., Erdine, S. E., Kjeldsen, S., . . . Mancia, G. (2012). Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension.. Journal of hypertension, 30(2), 239-252. doi:10.1097/hjh.0b013e32834f03bfDOI: 10.1097/hjh.0b013e32834f03bf
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). (Journal article)
Kakkar, A. K., Mueller, I., Bassand, J. -P., Fitzmaurice, D. A., Goldhaber, S. Z., Goto, S., . . . Turpie, A. G. G. (2012). International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).. American heart journal, 163(1), 13-19.e1. doi:10.1016/j.ahj.2011.09.011DOI: 10.1016/j.ahj.2011.09.011
Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study (Journal article)
Shantsila, A., Lane, D. A., Beevers, D. G., & Lip, G. Y. H. (2012). Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study. JOURNAL OF HYPERTENSION, 30(5), 974-979. doi:10.1097/HJH.0b013e3283526e47DOI: 10.1097/HJH.0b013e3283526e47
Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study (Journal article)
Banerjee, A., Lane, D. A., Torp-Pedersen, C., & Lip, G. Y. H. (2012). Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study. THROMBOSIS AND HAEMOSTASIS, 107(3), 584-589. doi:10.1160/TH11-11-0784DOI: 10.1160/TH11-11-0784
Oral antithrombotic therapy and gastrointestinal bleeding: the good, the bad and the ugly. (Journal article)
Riva, N., Apostolakis, S., & Lip, G. Y. H. (2012). Oral antithrombotic therapy and gastrointestinal bleeding: the good, the bad and the ugly.. International journal of clinical practice, 66(1), 2-4. doi:10.1111/j.1742-1241.2011.02828.xDOI: 10.1111/j.1742-1241.2011.02828.x
Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis. (Journal article)
Marchesi, C., Dentali, F., Nicolini, E., Maresca, A. M., Tayebjee, M. H., Franz, M., . . . Grandi, A. M. (2012). Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis.. Journal of hypertension, 30(1), 3-16. doi:10.1097/hjh.0b013e32834d249aDOI: 10.1097/hjh.0b013e32834d249a
Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project (Journal article)
Olesen, J. B., Fauchier, L., Lane, D. A., Taillandier, S., & Lip, G. Y. H. (2012). Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. CHEST, 141(1), 147-153. doi:10.1378/chest.11-0862DOI: 10.1378/chest.11-0862
Role of the CHADS2 score in acute coronary syndromes: with or without atrial fibrillation. (Journal article)
Adlan, A. M. A., & Lip, G. Y. H. (2012). Role of the CHADS2 score in acute coronary syndromes: with or without atrial fibrillation.. Chest, 141(6), 1375-1376. doi:10.1378/chest.11-2780DOI: 10.1378/chest.11-2780
Soluble Fas and Fas Ligand in Pregnancy: Influence of Hypertension (Journal article)
Karthikeyan, V. J., Lip, G. Y. H., Baghdadi, S., Lane, D. A., Beevers, D. G., & Blann, A. D. (2012). Soluble Fas and Fas Ligand in Pregnancy: Influence of Hypertension. ANGIOLOGY, 63(1), 35-38. doi:10.1177/0003319711406901DOI: 10.1177/0003319711406901
Ahmad, Y., & Lip, G. Y. H. (2012). Stroke Prevention in Atrial Fibrillation: Where are We Now?. Clinical Medicine Insights. Cardiology, 6, 65-78. doi:10.4137/cmc.s8976DOI: 10.4137/cmc.s8976
Stroke and Thromboembolism in Atrial Fibrillation - Systematic Review of Stroke Risk Factors and Risk Stratification Schema - (Journal article)
Pisters, R., Lane, D. A., Marin, F., Camm, A. J., & Lip, G. Y. H. (2012). Stroke and Thromboembolism in Atrial Fibrillation - Systematic Review of Stroke Risk Factors and Risk Stratification Schema -. CIRCULATION JOURNAL, 76(10), 2289-2304. doi:10.1253/circj.CJ-12-1036DOI: 10.1253/circj.CJ-12-1036
The Global Burden of Atrial Fibrillation and Stroke A Systematic Review of the Epidemiology of Atrial Fibrillation in Regions Outside North America and Europe (Journal article)
Lip, G. Y. H., Brechin, C. M., & Lane, D. A. (2012). The Global Burden of Atrial Fibrillation and Stroke A Systematic Review of the Epidemiology of Atrial Fibrillation in Regions Outside North America and Europe. CHEST, 142(6), 1489-1498. doi:10.1378/chest.11-2888DOI: 10.1378/chest.11-2888
The role of echocardiography in stroke risk assessment in patients with atrial fibrillation: is it additive or does it simply echo clinical risk factors? (Journal article)
Pisters, R., Olesen, J. B., & Lip, G. Y. H. (2012). The role of echocardiography in stroke risk assessment in patients with atrial fibrillation: is it additive or does it simply echo clinical risk factors?. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 14(1), 1-2. doi:10.1093/europace/eur310DOI: 10.1093/europace/eur310
Translating regulatory advice into practice: use of dronedarone and older anti-arrhythmics in AF management (Journal article)
Camm. (2012). Translating regulatory advice into practice: use of dronedarone and older anti-arrhythmics in AF management. British Journal of Cardiology. doi:10.5837/bjc.2012.020DOI: 10.5837/bjc.2012.020
Treatment pathways for atrial fibrillation: simplifying the approach to thromboprophylaxis. (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2012). Treatment pathways for atrial fibrillation: simplifying the approach to thromboprophylaxis.. International journal of clinical practice, 66(1), 4-6. doi:10.1111/j.1742-1241.2011.02816.xDOI: 10.1111/j.1742-1241.2011.02816.x
Welcome to a new year in Thrombosis and Haemostasis….. (Journal article)
Lip, G. Y. H., & Weber, C. (2012). Welcome to a new year in Thrombosis and Haemostasis…... Thrombosis and Haemostasis, 107(01), 1-2. doi:10.1055/s-0037-1608982DOI: 10.1055/s-0037-1608982
What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation? (Journal article)
Lip, G. Y. H. (2012). What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?. The journal of the Royal College of Physicians of Edinburgh, 42 Suppl 18, 35-44. doi:10.4997/jrcpe.2012.s04DOI: 10.4997/jrcpe.2012.s04
Wytyczne ESC dotycza̧ce rozpoznania oraz leczenia ostrej i przewlekłej niewydolności serca na 2012 rok (Journal article)
McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Boḧm, M., Dickstein, K., . . . Bax, J. J. (2012). Wytyczne ESC dotycza̧ce rozpoznania oraz leczenia ostrej i przewlekłej niewydolności serca na 2012 rok. Kardiologia Polska, 70(SUPPL. 2), 101-175.
2011
Atrial fibrillation in 2011: Stroke prevention in AF. (Journal article)
Lip, G. Y. H. (2011). Atrial fibrillation in 2011: Stroke prevention in AF.. Nature reviews. Cardiology, 9(2), 71-73. doi:10.1038/nrcardio.2011.203DOI: 10.1038/nrcardio.2011.203
Antiplatelet agents and anticoagulants for hypertension. (Journal article)
Lip, G. Y., Felmeden, D. C., & Dwivedi, G. (2011). Antiplatelet agents and anticoagulants for hypertension.. The Cochrane database of systematic reviews, (12), CD003186. doi:10.1002/14651858.cd003186.pub3DOI: 10.1002/14651858.cd003186.pub3
Bleeding risk assessment and management in atrial fibrillation patients Executive Summary* of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis (Journal article)
Lip, G. Y. H., Andreotti, F., Fauchier, L., Huber, K., Hylek, E., Knight, E., . . . Kirchhof, P. (2011). Bleeding risk assessment and management in atrial fibrillation patients Executive Summary* of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. THROMBOSIS AND HAEMOSTASIS, 106(6), 997-1011. doi:10.1160/TH11-10-0690DOI: 10.1160/TH11-10-0690
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference (Journal article)
Kirchhof, P., Lip, G. Y. H., Van Gelder, I. C., Bax, J., Hylek, E., Kaeaeb, S., . . . Camm, A. J. (2011). Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference. THROMBOSIS AND HAEMOSTASIS, 106(6), 1012-1019. doi:10.1160/TH11-07-0517DOI: 10.1160/TH11-07-0517
Patel, J. V., Hughes, E. A., Lip, G. Y. H., & Gill, P. S. (2011). Diabetes Health, Residence & Metabolism in Asians: the DHRMA study, research into foods from the Indian subcontinent - a blinded, randomised, placebo controlled trial.. BMC cardiovascular disorders, 11, 70. doi:10.1186/1471-2261-11-70DOI: 10.1186/1471-2261-11-70
Atrial Fibrillation: Non Surgical Management (Chapter)
Khoo, C. W., & Lip, G. Y. H. (2010). Atrial Fibrillation: Non Surgical Management. In Mitral Valve Surgery (pp. 133-143). Springer London. doi:10.1007/978-1-84996-426-5_13DOI: 10.1007/978-1-84996-426-5_13
Differences between South Asians and White Europeans in five year outcome following percutaneous coronary intervention. (Journal article)
Toor, I. S., Jaumdally, R., Lip, G. Y. H., Pagano, D., Dimitri, W., Millane, T., & Varma, C. (2011). Differences between South Asians and White Europeans in five year outcome following percutaneous coronary intervention.. International journal of clinical practice, 65(12), 1259-1266. doi:10.1111/j.1742-1241.2011.02776.xDOI: 10.1111/j.1742-1241.2011.02776.x
Dronedarone A New Hope for Stroke Prevention in Atrial Fibrillation? (Journal article)
Shantsila, A., & Lip, G. Y. H. (2011). Dronedarone A New Hope for Stroke Prevention in Atrial Fibrillation?. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 11(6), 355-356. doi:10.2165/11595330-000000000-00000DOI: 10.2165/11595330-000000000-00000
Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy. (Journal article)
Orenes-Piñero, E., Hernández-Romero, D., Jover, E., Valdés, M., Lip, G. Y. H., & Marín, F. (2011). Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.. Journal of the renin-angiotensin-aldosterone system : JRAAS, 12(4), 521-530. doi:10.1177/1470320311405247DOI: 10.1177/1470320311405247
Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation. (Journal article)
Kaireviciute, D., Lip, G. Y. H., Balakrishnan, B., Uzdavinys, G., Norkunas, G., Kalinauskas, G., . . . Blann, A. D. (2011). Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation.. Journal of thrombosis and haemostasis : JTH, 9(12), 2345-2352. doi:10.1111/j.1538-7836.2011.04523.xDOI: 10.1111/j.1538-7836.2011.04523.x
Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage? (Journal article)
Montoro-García, S., Marín, F., Roldán, V., & Lip, G. Y. H. (2011). Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?. Thrombosis research, 128(6), 601-602. doi:10.1016/j.thromres.2011.07.005DOI: 10.1016/j.thromres.2011.07.005
Nebivolol for the treatment of heart failure. (Journal article)
Riva, N., & Lip, G. Y. H. (2011). Nebivolol for the treatment of heart failure.. Expert opinion on investigational drugs, 20(12), 1733-1746. doi:10.1517/13543784.2011.625011DOI: 10.1517/13543784.2011.625011
Peripheral Artery Disease and Angiogenesis: A Link Between Angiogenesis and Atherothrombosis (Chapter)
Bennett, P. C., Silverman, S., Gill, P., & Lip, G. Y. H. (2010). Peripheral Artery Disease and Angiogenesis: A Link Between Angiogenesis and Atherothrombosis. In Therapeutic Angiogenesis for Vascular Diseases (pp. 339-359). Springer Netherlands. doi:10.1007/978-90-481-9495-7_15DOI: 10.1007/978-90-481-9495-7_15
Systolic heart failure in South Asians (Journal article)
Shantsila, E., Lip, G. Y. H., & Gill, P. S. (2011). Systolic heart failure in South Asians. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 65(12), 1274-1282. doi:10.1111/j.1742-1241.2011.02796.xDOI: 10.1111/j.1742-1241.2011.02796.x
The Quest for New Anticoagulants: From Clinical Development to Clinical Practice (Journal article)
Apostolakis, S., Lip, G. Y. H., Lane, D. A., & Shantsila, E. (2011). The Quest for New Anticoagulants: From Clinical Development to Clinical Practice. CARDIOVASCULAR THERAPEUTICS, 29(6), E12-E22. doi:10.1111/j.1755-5922.2010.00160.xDOI: 10.1111/j.1755-5922.2010.00160.x
Gill, P. S., Calvert, M., Davis, R., Davies, M. K., Freemantle, N., & Lip, G. Y. H. (2011). Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES).. PloS one, 6(11), e26710. doi:10.1371/journal.pone.0026710DOI: 10.1371/journal.pone.0026710
Atrial fibrillation (chronic). (Journal article)
Lane, D. A., Apostolakis, S., Boos, C. J., & Lip, G. Y. H. (2011). Atrial fibrillation (chronic).. BMJ clinical evidence, 2011, 0217.
A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices. (Journal article)
Banerjee, A., Marín, F., & Lip, G. Y. H. (2011). A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices.. Stroke, 42(11), 3316-3322. doi:10.1161/strokeaha.111.617886DOI: 10.1161/strokeaha.111.617886
Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation (Journal article)
Riva, N., Smith, D. E., Lip, G. Y. H., & Lane, D. A. (2011). Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation. AGE AND AGEING, 40(6), 653-655. doi:10.1093/ageing/afr128DOI: 10.1093/ageing/afr128
Circulating microparticles: new insights into the biochemical basis of microparticle release and activity (Journal article)
Montoro-Garcia, S., Shantsila, E., Marin, F., Blann, A., & Lip, G. Y. H. (2011). Circulating microparticles: new insights into the biochemical basis of microparticle release and activity. BASIC RESEARCH IN CARDIOLOGY, 106(6), 911-923. doi:10.1007/s00395-011-0198-4DOI: 10.1007/s00395-011-0198-4
Dronedarone (Multaq<sup>®</sup>) for the treatment of atrial fibrillation (Journal article)
Kuzniatsova, N., Pamukcu, B., & Lip, G. Y. H. (2011). Dronedarone (Multaq<sup>®</sup>) for the treatment of atrial fibrillation. Therapy, 8(6), 681-689. doi:10.2217/thy.11.67DOI: 10.2217/thy.11.67
Ethnic Differences in Macrovascular and Microvascular Function in Systolic Heart Failure (Journal article)
Shantsila, E., Wrigley, B., Shantsila, A., Tapp, L. D., Blann, A. D., Gill, P. S., & Lip, G. Y. H. (2011). Ethnic Differences in Macrovascular and Microvascular Function in Systolic Heart Failure. CIRCULATION-HEART FAILURE, 4(6), 754-762. doi:10.1161/CIRCHEARTFAILURE.111.962365DOI: 10.1161/CIRCHEARTFAILURE.111.962365
Ischemic stroke and atrial fibrillation--a deadly serious combination. (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2011). Ischemic stroke and atrial fibrillation--a deadly serious combination.. Cerebrovascular diseases (Basel, Switzerland), 32(5), 461-462. doi:10.1159/000332030DOI: 10.1159/000332030
Safety of coronary artery bypass surgery during therapeutic oral anticoagulation. (Journal article)
Airaksinen, K. E. J., Biancari, F., Karjalainen, P., Mikkola, R., Kuttila, K., Porela, P., . . . Lip, G. Y. H. (2011). Safety of coronary artery bypass surgery during therapeutic oral anticoagulation.. Thrombosis research, 128(5), 435-439. doi:10.1016/j.thromres.2011.05.021DOI: 10.1016/j.thromres.2011.05.021
Stroke prevention in non-valvular atrial fibrillation: can warfarin do better? (Journal article)
Apostolakis, S., & Lip, G. Y. H. (2011). Stroke prevention in non-valvular atrial fibrillation: can warfarin do better?. Thrombosis and haemostasis, 106(5), 753-754. doi:10.1160/th11-08-0580DOI: 10.1160/th11-08-0580
The impact of dilated left atrium on rhythm control in patients with newly diagnosed persistent atrial fibrillation: the Belgrade atrial fibrillation project. (Journal article)
Potpara, T. S., Polovina, M. M., Licina, M. M., Mujovic, N. M., Marinkovic, J. M., Petrovic, M., . . . Lip, G. Y. H. (2011). The impact of dilated left atrium on rhythm control in patients with newly diagnosed persistent atrial fibrillation: the Belgrade atrial fibrillation project.. International journal of clinical practice, 65(11), 1202-1203. doi:10.1111/j.1742-1241.2011.02772.xDOI: 10.1111/j.1742-1241.2011.02772.x
The role of monocytes and inflammation in the pathophysiology of heart failure (Journal article)
Wrigley, B. J., Lip, G. Y. H., & Shantsila, E. (2011). The role of monocytes and inflammation in the pathophysiology of heart failure. EUROPEAN JOURNAL OF HEART FAILURE, 13(11), 1161-1171. doi:10.1093/eurjhf/hfr122DOI: 10.1093/eurjhf/hfr122
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe. (Journal article)
Huber, K., Airaksinen, K. J., Cuisset, T., Marín, F., Rubboli, A., & Lip, G. Y. H. (2011). Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe.. Thrombosis and haemostasis, 106(4), 569-571. doi:10.1160/th11-08-0602DOI: 10.1160/th11-08-0602
Erratum to “Angiogenin, a marker of Angiogenesis increases with coronary heart disease severity” [Antheroscler. Suppl. 9 (May (1)) (2008) 247–248] (Journal article)
Chackathayil, J., Abraheem, A., Panja, N., Patel, J., Gunarathne, A., Dotsenko, O., . . . Lip, G. (2011). Erratum to “Angiogenin, a marker of Angiogenesis increases with coronary heart disease severity” [Antheroscler. Suppl. 9 (May (1)) (2008) 247–248]. Atherosclerosis, 218(2), 552. doi:10.1016/j.atherosclerosis.2011.07.018DOI: 10.1016/j.atherosclerosis.2011.07.018
Erratum to “Circulating adiponectin reflects severity of coronary atherosclerosis but not cardiac function abnormalities” [Atheroscler. Suppl. 9 (May (1)) (2008) 78] (Journal article)
Dotsenko, O., Abraheem, O., Chackathayil, J., Patel, J. V., Gunarathne, A., Panjal, N., . . . Lip, G. Y. (2011). Erratum to “Circulating adiponectin reflects severity of coronary atherosclerosis but not cardiac function abnormalities” [Atheroscler. Suppl. 9 (May (1)) (2008) 78]. Atherosclerosis, 218(2), 553. doi:10.1016/j.atherosclerosis.2011.07.017DOI: 10.1016/j.atherosclerosis.2011.07.017
Impact of high-dose atorvastatin on endothelial, platelet, and angiogenic indices: effect of ethnicity, cardiovascular disease, and diabetes. (Journal article)
Jaumdally, R. J., Lip, G. Y. H., Varma, C., & Blann, A. D. (2011). Impact of high-dose atorvastatin on endothelial, platelet, and angiogenic indices: effect of ethnicity, cardiovascular disease, and diabetes.. Angiology, 62(7), 571-578. doi:10.1177/0003319711401904DOI: 10.1177/0003319711401904
Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study. (Journal article)
Marín, F., Roldán, V., Martínez, J. G., Hernández-Madrid, A., Hernández-Romero, D., Ortego, M., . . . Moro, C. (2011). Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study.. Thrombosis research, 128(4), 391-394. doi:10.1016/j.thromres.2011.05.022DOI: 10.1016/j.thromres.2011.05.022
Looking through the PRISM: new insights for young patients with atrial fibrillation and stroke. (Journal article)
Banerjee, A., & Lip, G. Y. H. (2011). Looking through the PRISM: new insights for young patients with atrial fibrillation and stroke.. Cerebrovascular diseases (Basel, Switzerland), 32(4), 383-384. doi:10.1159/000331464DOI: 10.1159/000331464
New anticoagulation drugs for atrial fibrillation. (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2011). New anticoagulation drugs for atrial fibrillation.. Clinical pharmacology and therapeutics, 90(4), 502-506. doi:10.1038/clpt.2011.180DOI: 10.1038/clpt.2011.180
Steg, P. G., Mehta, S. R., Jukema, J. W., Lip, G. Y. H., Gibson, C. M., Kovar, F., . . . RUBY-1 Investigators. (2011). RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.. European heart journal, 32(20), 2541-2554. doi:10.1093/eurheartj/ehr334DOI: 10.1093/eurheartj/ehr334
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study (Journal article)
Olesen, J. B., Lip, G. Y. H., Lindhardsen, J., Lane, D. A., Ahlehoff, O., Hansen, M. L., . . . Torp-Pedersen, C. (2011). Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study. THROMBOSIS AND HAEMOSTASIS, 106(4), 739-749. doi:10.1160/TH11-05-0364DOI: 10.1160/TH11-05-0364
Comparative Analysis of the HAS-BLED Score With Other Bleeding Risk Scores, Using Estimates of Net Reclassification Improvement and Integrated Discrimination Improvement (Journal article)
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. (2011). Comparative Analysis of the HAS-BLED Score With Other Bleeding Risk Scores, Using Estimates of Net Reclassification Improvement and Integrated Discrimination Improvement. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 58(13), 1398-1399. doi:10.1016/j.jacc.2011.03.065DOI: 10.1016/j.jacc.2011.03.065
Periprocedural and Long‐Term Anticoagulation (Chapter)
Connolly, S. J., Callans, D., Hocini, M., Lip, G. Y. H., Michaud, G. F., Waldo, A. L., & Themistoclakis, S. (2011). Periprocedural and Long‐Term Anticoagulation. In Unknown Book (pp. 77-84). Wiley. doi:10.1002/9781119963868.ch6DOI: 10.1002/9781119963868.ch6
Atrial fibrillation and upper limb thromboembolectomy: a national cohort study. (Journal article)
Andersen, L. V., Mortensen, L. S., Lip, G. Y. H., Lindholt, J. S., Faergeman, O., Henneberg, E. W., & Frost, L. (2011). Atrial fibrillation and upper limb thromboembolectomy: a national cohort study.. Journal of thrombosis and haemostasis : JTH, 9(9), 1738-1743. doi:10.1111/j.1538-7836.2011.04435.xDOI: 10.1111/j.1538-7836.2011.04435.x
Intracerebral hemorrhage and warfarin: perceived versus actual risk. (Journal article)
Banerjee, A., & Lip, G. Y. H. (2011). Intracerebral hemorrhage and warfarin: perceived versus actual risk.. Stroke, 42(9), 2383-2384. doi:10.1161/strokeaha.111.626739DOI: 10.1161/strokeaha.111.626739
Myocardial Perfusion by Myocardial Contrast Echocardiography and Endothelial Dysfunction in Obstructive Sleep Apnea (Journal article)
Butt, M., Khair, O. A., Dwivedi, G., Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2011). Myocardial Perfusion by Myocardial Contrast Echocardiography and Endothelial Dysfunction in Obstructive Sleep Apnea. HYPERTENSION, 58(3), 417-U177. doi:10.1161/HYPERTENSIONAHA.111.170910DOI: 10.1161/HYPERTENSIONAHA.111.170910
Atorvastatin and its collateral effects on microparticles (Journal article)
Montoro-Garcia, S., Lip, G. Y. H., & Shantsila, E. (2011). Atorvastatin and its collateral effects on microparticles. THROMBOSIS AND HAEMOSTASIS, 106(2), 185-186. doi:10.1160/TH11-05-0335DOI: 10.1160/TH11-05-0335
Altered blood vessel responses in the eye and finger in coronary artery disease. (Journal article)
Heitmar, R., Cubbidge, R. P., Lip, G. Y. H., Gherghel, D., & Blann, A. D. (2011). Altered blood vessel responses in the eye and finger in coronary artery disease.. Investigative ophthalmology & visual science, 52(9), 6199-6205. doi:10.1167/iovs.10-6628DOI: 10.1167/iovs.10-6628
An epidemic of atrial fibrillation? (Journal article)
Olesen, J. B., Lip, G. Y. H., & Lane, D. A. (2011). An epidemic of atrial fibrillation?. EUROPACE, 13(8), 1059-1060. doi:10.1093/europace/eur141DOI: 10.1093/europace/eur141
Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort. (Journal article)
Olesen, J. B., Lip, G. Y. H., Hansen, P. R., Lindhardsen, J., Ahlehoff, O., Andersson, C., . . . Torp-Pedersen, C. (2011). Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort.. Journal of thrombosis and haemostasis : JTH, 9(8), 1460-1467. doi:10.1111/j.1538-7836.2011.04378.xDOI: 10.1111/j.1538-7836.2011.04378.x
Response to Magnesium and Vascular Dysfunction in Malignant Hypertension (Journal article)
Shantsila, A., Dwivedi, G., & Lip, G. Y. H. (2011). Response to Magnesium and Vascular Dysfunction in Malignant Hypertension. HYPERTENSION, 58(2), E8. doi:10.1161/HYPERTENSIONAHA.111.176107DOI: 10.1161/HYPERTENSIONAHA.111.176107
Strategies to Improve Oral Anticoagulation Management (Journal article)
Smith, D. E., Lip, G. Y. H., & Lane, D. A. (2011). Strategies to Improve Oral Anticoagulation Management. CHEST, 140(2), 281-282. doi:10.1378/chest.11-0418DOI: 10.1378/chest.11-0418
The CD40-CD40L system in cardiovascular disease (Journal article)
Pamukcu, B., Lip, G. Y. H., Snezhitskiy, V., & Shantsila, E. (2011). The CD40-CD40L system in cardiovascular disease. ANNALS OF MEDICINE, 43(5), 331-340. doi:10.3109/07853890.2010.546362DOI: 10.3109/07853890.2010.546362
The nuclear factor - kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease (Journal article)
Pamukcu, B., Lip, G. Y. H., & Shantsila, E. (2011). The nuclear factor - kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease. THROMBOSIS RESEARCH, 128(2), 117-123. doi:10.1016/j.thromres.2011.03.025DOI: 10.1016/j.thromres.2011.03.025
The role of aspirin for stroke prevention in atrial fibrillation. (Journal article)
Lip, G. Y. H. (2011). The role of aspirin for stroke prevention in atrial fibrillation.. Nature reviews. Cardiology, 8(10), 602-606. doi:10.1038/nrcardio.2011.112DOI: 10.1038/nrcardio.2011.112
Angiogenin and apoptosis in hypertension in pregnancy (Journal article)
Karthikeyan, V. J., Lip, G. Y. H., Lane, D. A., & Blann, A. D. (2011). Angiogenin and apoptosis in hypertension in pregnancy. PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 1(3-4), 191-196. doi:10.1016/j.preghy.2011.07.002DOI: 10.1016/j.preghy.2011.07.002
Bleeding Risk in Patients With Atrial Fibrillation The AMADEUS Study (Journal article)
Lane, D. A., Kamphuisen, P. W., Minini, P., Buller, H. R., & Lip, G. Y. H. (2011). Bleeding Risk in Patients With Atrial Fibrillation The AMADEUS Study. CHEST, 140(1), 146-155. doi:10.1378/chest.10-3270DOI: 10.1378/chest.10-3270
Bleeding risk with oral anticoagulation - new frontiers and new questions (Journal article)
Banerjee, A., Lane, D. A., & Lip, G. Y. H. (2011). Bleeding risk with oral anticoagulation - new frontiers and new questions. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 65(7), 719-721. doi:10.1111/j.1742-1241.2011.02716.xDOI: 10.1111/j.1742-1241.2011.02716.x
Characterization of the proportion of untreated and antiplatelet therapy treated patients with atrial fibrillation. (Journal article)
Ogilvie, I. M., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2011). Characterization of the proportion of untreated and antiplatelet therapy treated patients with atrial fibrillation.. The American journal of cardiology, 108(1), 151-161. doi:10.1016/j.amjcard.2011.02.353DOI: 10.1016/j.amjcard.2011.02.353
Endothelial Progenitor Cells and Circulating Endothelial Cells in Early Prostate Cancer: A Comparison With Plasma Vascular Markers (Journal article)
Blann, A. D., Balakrishnan, B., Shantsila, E., Ryan, P., & Lip, G. Y. H. (2011). Endothelial Progenitor Cells and Circulating Endothelial Cells in Early Prostate Cancer: A Comparison With Plasma Vascular Markers. PROSTATE, 71(10), 1047-1053. doi:10.1002/pros.21319DOI: 10.1002/pros.21319
Guidelines for the management of atrial fibrillation (Journal article)
Guidelines for the management of atrial fibrillation (2011). EP Europace, 13(7), 1058. doi:10.1093/europace/eur134DOI: 10.1093/europace/eur134
Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study. (Journal article)
Rasmussen, L. H., Larsen, T. B., Due, K. M., Tjønneland, A., Overvad, K., & Lip, G. Y. H. (2011). Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study.. Journal of thrombosis and haemostasis : JTH, 9(7), 1301-1307. doi:10.1111/j.1538-7836.2011.04308.xDOI: 10.1111/j.1538-7836.2011.04308.x
Ischaemic stroke and bleeding rates in 'real-world' atrial fibrillation patients. (Journal article)
Ogilvie, I. M., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2011). Ischaemic stroke and bleeding rates in 'real-world' atrial fibrillation patients.. Thrombosis and haemostasis, 106(1), 34-44. doi:10.1160/th10-10-0674DOI: 10.1160/th10-10-0674
Stroke in atrial fibrillation: epidemiology and thromboprophylaxis. (Journal article)
Lip, G. Y. H. (2011). Stroke in atrial fibrillation: epidemiology and thromboprophylaxis.. Journal of thrombosis and haemostasis : JTH, 9 Suppl 1, 344-351. doi:10.1111/j.1538-7836.2011.04302.xDOI: 10.1111/j.1538-7836.2011.04302.x
The Reply (Journal article)
Ogilvie, I. M., Newton, N., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2011). The Reply. The American Journal of Medicine, 124(7), e13. doi:10.1016/j.amjmed.2011.03.004DOI: 10.1016/j.amjmed.2011.03.004
The angiome: a new concept in cancer biology. (Journal article)
Blann, A. D., Ramcharan, K. S., Stonelake, P. S., Luesley, D., & Lip, G. Y. H. (2011). The angiome: a new concept in cancer biology.. Journal of clinical pathology, 64(7), 637-643. doi:10.1136/jcp.2011.088948DOI: 10.1136/jcp.2011.088948
The endotheliome: a new concept in vascular biology. (Journal article)
Ramcharan, K. S., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2011). The endotheliome: a new concept in vascular biology.. Thrombosis research, 128(1), 1-7. doi:10.1016/j.thromres.2010.11.019DOI: 10.1016/j.thromres.2010.11.019
Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial. (Journal article)
Hobbs, F. D. R., Roalfe, A. K., Lip, G. Y. H., Fletcher, K., Fitzmaurice, D. A., Mant, J., & Birmingham Atrial Fibrillation in the Aged Investigators and Midland Research Practices Consortium Network. (2011). Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.. BMJ (Clinical research ed.), 342, d3653. doi:10.1136/bmj.d3653DOI: 10.1136/bmj.d3653
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. (Journal article)
Roldán, V., Marín, F., Muiña, B., Torregrosa, J. M., Hernández-Romero, D., Valdés, M., . . . Lip, G. Y. H. (2011). Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.. Journal of the American College of Cardiology, 57(25), 2496-2504. doi:10.1016/j.jacc.2010.12.033DOI: 10.1016/j.jacc.2010.12.033
Bennett, P. C., Lip, G. Y. H., Silverman, S., Blann, A. D., & Gill, P. S. (2011). Validation of the Edinburgh Claudication Questionnaire in 1st generation Black African-Caribbean and South Asian UK migrants: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.. BMC medical research methodology, 11, 85. doi:10.1186/1471-2288-11-85DOI: 10.1186/1471-2288-11-85
An evaluation of the CHADS₂ stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization. (Journal article)
Ruiz-Nodar, J. M., Marín, F., Manzano-Fernández, S., Valencia-Martín, J., Hurtado, J. A., Roldán, V., . . . Lip, G. Y. H. (2011). An evaluation of the CHADS₂ stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization.. Chest, 139(6), 1402-1409. doi:10.1378/chest.10-1408DOI: 10.1378/chest.10-1408
Endothelial damage/dysfunction and hypertension in pregnancy. (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2011). Endothelial damage/dysfunction and hypertension in pregnancy.. Frontiers in bioscience (Elite edition), 3(3), 1100-1108. doi:10.2741/314DOI: 10.2741/314
Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor (Journal article)
Karthikeyan, V. J., Blann, A. D., Baghdadi, S., Lane, D. A., Beevers, D. G., & Lip, G. Y. H. (2011). Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor. CLINICAL RESEARCH IN CARDIOLOGY, 100(6), 531-537. doi:10.1007/s00392-010-0277-9DOI: 10.1007/s00392-010-0277-9
Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. (Journal article)
Boriani, G., Botto, G. L., Padeletti, L., Santini, M., Capucci, A., Gulizia, M., . . . Italian AT-500 Registry Investigators. (2011). Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring.. Stroke, 42(6), 1768-1770. doi:10.1161/strokeaha.110.609297DOI: 10.1161/strokeaha.110.609297
Increased levels of plasma haemoxygenase-1 in prostate cancer. (Journal article)
Blann, A. D., Balakrishnan, B., Ryan, P., & Lip, G. Y. H. (2011). Increased levels of plasma haemoxygenase-1 in prostate cancer.. Prostate cancer and prostatic diseases, 14(2), 114-117. doi:10.1038/pcan.2010.56DOI: 10.1038/pcan.2010.56
Interactions between clopidogrel and proton pump inhibitors: a review of evidence. (Journal article)
Muñoz-Esparza, C., Jover, E., Hernández-Romero, D., Saura, D., Valdés, M., Lip, G. Y. H., & Marín, F. (2011). Interactions between clopidogrel and proton pump inhibitors: a review of evidence.. Current medicinal chemistry, 18(16), 2386-2400. doi:10.2174/092986711795843245DOI: 10.2174/092986711795843245
Soluble vascular endothelial growth factor receptor (VEGFR)-2 in macular oedema--a mechanism for regulating angiogenesis? (Journal article)
Montoro-García, S., Lip, P. -L., Chan, C. -C., & Lip, G. Y. H. (2011). Soluble vascular endothelial growth factor receptor (VEGFR)-2 in macular oedema--a mechanism for regulating angiogenesis?. The British journal of ophthalmology, 95(6), 757-758. doi:10.1136/bjo.2010.198002DOI: 10.1136/bjo.2010.198002
Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. (Journal article)
Damman, K., Ng Kam Chuen, M. J., MacFadyen, R. J., Lip, G. Y. H., Gaze, D., Collinson, P. O., . . . van Veldhuisen, D. J. (2011). Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.. Journal of the American College of Cardiology, 57(22), 2233-2241. doi:10.1016/j.jacc.2010.10.065DOI: 10.1016/j.jacc.2010.10.065
Aortic coarctation and twin pregnancy. (Journal article)
Beevers, D. G., & Lip, G. Y. (2011). Aortic coarctation and twin pregnancy.. Journal of paediatrics and child health, 47(5), 316. doi:10.1111/j.1440-1754.2011.02092.xDOI: 10.1111/j.1440-1754.2011.02092.x
Assessing the Performance of the HAS-BLED Score Is the C Statistic Sufficient? <i>Response</i> (Journal article)
Pisters, R., Lane, D. A., Nieuwlaat, R., Crijns, H. J. G. M., & Lip, G. Y. H. (2011). Assessing the Performance of the HAS-BLED Score Is the C Statistic Sufficient? <i>Response</i>. CHEST, 139(5), 1248. doi:10.1378/chest.11-0184DOI: 10.1378/chest.11-0184
Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis (Journal article)
Lip, G. Y. H., Andreotti, F., Fauchier, L., Huber, K., Hylek, E., Knight, E., . . . Camm, J. (2011). Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. EUROPACE, 13(5), 723-746. doi:10.1093/europace/eur126DOI: 10.1093/europace/eur126
Coronary stent implantation in patients committed to long-term oral anticoagulation therapy: successfully navigating the treatment options. (Journal article)
Rubboli, A., Kovacic, J. C., Mehran, R., & Lip, G. Y. H. (2011). Coronary stent implantation in patients committed to long-term oral anticoagulation therapy: successfully navigating the treatment options.. Chest, 139(5), 981-987. doi:10.1378/chest.10-2719DOI: 10.1378/chest.10-2719
Endothelium-dependent and endothelium-independent vasodilatation of the cutaneous circulation in sickle cell disease. (Journal article)
Mohan, J. S., Lip, G. Y. H., Blann, A. D., Bareford, D., & Marshall, J. M. (2011). Endothelium-dependent and endothelium-independent vasodilatation of the cutaneous circulation in sickle cell disease.. European journal of clinical investigation, 41(5), 546-551. doi:10.1111/j.1365-2362.2010.02444.xDOI: 10.1111/j.1365-2362.2010.02444.x
Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology (Journal article)
Shantsila, E., Wrigley, B., Tapp, L., Apostolakis, S., Montoro-Garcia, S., Drayson, M. T., & Lip, G. Y. H. (2011). Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 9(5), 1056-1066. doi:10.1111/j.1538-7836.2011.04244.xDOI: 10.1111/j.1538-7836.2011.04244.x
Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension. (Journal article)
Ho, L. Y., Siu, C. W., Yue, W. S., Lau, C. P., Lip, G. Y., & Tse, H. F. (2011). Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension.. Journal of human hypertension, 25(5), 304-310. doi:10.1038/jhh.2010.57DOI: 10.1038/jhh.2010.57
The HAS-BLED Score and Renal Failure <i>Response</i> (Journal article)
Pisters, R., Nieuwlaat, R., Lane, D. A., Crijns, H. J. G. M., & Lip, G. Y. H. (2011). The HAS-BLED Score and Renal Failure <i>Response</i>. CHEST, 139(5), 1249-1250. doi:10.1378/chest.10-3237DOI: 10.1378/chest.10-3237
Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study. (Journal article)
de Peuter, O. R., Lip, G. Y. H., Souverein, P. C., Klungel, O. H., de Boer, A., Büller, H. R., & Kamphuisen, P. W. (2011). Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.. European journal of heart failure, 13(5), 489-495. doi:10.1093/eurjhf/hfq228DOI: 10.1093/eurjhf/hfq228
What are the costs of atrial fibrillation? (Journal article)
Blomstrom Lundqvist, C., Lip, G. Y. H., & Kirchhof, P. (2011). What are the costs of atrial fibrillation?. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 13 Suppl 2, ii9-i12. doi:10.1093/europace/eur087DOI: 10.1093/europace/eur087
Recent progress in antithrombotic therapy for atrial fibrillation. (Journal article)
Velu, S., & Lip, G. Y. H. (2011). Recent progress in antithrombotic therapy for atrial fibrillation.. Journal of atherosclerosis and thrombosis, 18(4), 257-273. doi:10.5551/jat.7153DOI: 10.5551/jat.7153
Patel, J. V., Gill, P. S., Chackathayil, J., Ojukwu, H., Stemman, P., Sheldon, L., . . . Hughes, E. A. (2011). Short-term effects of screening for cardiovascular risk in the deaf community: a pilot study.. Cardiology research and practice, 2011, 493546. doi:10.4061/2011/493546DOI: 10.4061/2011/493546
Combined antiplatelet therapy and oral anticoagulation: is a balance between thromboembolism and bleeding possible? (Journal article)
Kuzniatsova, N., & Lip, G. Y. H. (2011). Combined antiplatelet therapy and oral anticoagulation: is a balance between thromboembolism and bleeding possible?. International journal of cardiology, 148(1), 1-3. doi:10.1016/j.ijcard.2010.12.098DOI: 10.1016/j.ijcard.2010.12.098
Hemostatic cardiovascular risk factors, common carotid-intima medial thickness and peripheral arterial disease in South Asians and African Caribbeans: a substudy to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study. (Journal article)
Bennett, P. C., Gill, P. S., Silverman, S., Blann, A. D., Chackathayil, J., & Lip, G. Y. H. (2011). Hemostatic cardiovascular risk factors, common carotid-intima medial thickness and peripheral arterial disease in South Asians and African Caribbeans: a substudy to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.. Journal of thrombosis and haemostasis : JTH, 9(4), 645-652. doi:10.1111/j.1538-7836.2011.04190.xDOI: 10.1111/j.1538-7836.2011.04190.x
Lone atrial fibrillation: what is known and what is to come. (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2011). Lone atrial fibrillation: what is known and what is to come.. International journal of clinical practice, 65(4), 446-457. doi:10.1111/j.1742-1241.2010.02618.xDOI: 10.1111/j.1742-1241.2010.02618.x
Review article: proton pump inhibitors with clopidogrel--evidence for and against a clinically-important interaction. (Journal article)
Disney, B. R., Watson, R. D. S., Blann, A. D., Lip, G. Y. H., & Anderson, M. R. (2011). Review article: proton pump inhibitors with clopidogrel--evidence for and against a clinically-important interaction.. Alimentary pharmacology & therapeutics, 33(7), 758-767. doi:10.1111/j.1365-2036.2011.04585.xDOI: 10.1111/j.1365-2036.2011.04585.x
What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation? (Journal article)
Ahrens, I., Lip, G. Y. H., & Peter, K. (2011). What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?. Thrombosis and haemostasis, 105(4), 574-578. doi:10.1160/th10-12-0808DOI: 10.1160/th10-12-0808
Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation Implications for Thromboprophylaxis and Bleeding Risk (Journal article)
Marinigh, R., Lane, D. A., & Lip, G. Y. H. (2011). Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation Implications for Thromboprophylaxis and Bleeding Risk. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 57(12), 1339-1348. doi:10.1016/j.jacc.2010.12.013DOI: 10.1016/j.jacc.2010.12.013
Apixaban in patients with atrial fibrillation. (Journal article)
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H. -C., Hart, R., Golitsyn, S., . . . AVERROES Steering Committee and Investigators. (2011). Apixaban in patients with atrial fibrillation.. The New England journal of medicine, 364(9), 806-817. doi:10.1056/nejmoa1007432DOI: 10.1056/nejmoa1007432
Ethnic differences in common carotid intima-media thickness, and the relationship to cardiovascular risk factors and peripheral arterial disease: the Ethnic-Echocardiographic Heart of England Screening Study. (Journal article)
Bennett, P. C., Gill, P. S., Silverman, S., Blann, A. D., & Lip, G. Y. H. (2011). Ethnic differences in common carotid intima-media thickness, and the relationship to cardiovascular risk factors and peripheral arterial disease: the Ethnic-Echocardiographic Heart of England Screening Study.. QJM : monthly journal of the Association of Physicians, 104(3), 245-254. doi:10.1093/qjmed/hcq187DOI: 10.1093/qjmed/hcq187
Monocytes: Possible mediators of benefits and harms from physical activity? (Journal article)
Shantsila, E., & Lip, G. Y. H. (2011). Monocytes: Possible mediators of benefits and harms from physical activity?. THROMBOSIS AND HAEMOSTASIS, 105(3), 387-389. doi:10.1160/TH11-01-0009DOI: 10.1160/TH11-01-0009
Peri-operative management of ophthalmic patients taking antithrombotic therapy. (Journal article)
Lip, G. Y. H., Durrani, O. M., Roldan, V., Lip, P. L., Marin, F., & Reuser, T. Q. (2011). Peri-operative management of ophthalmic patients taking antithrombotic therapy.. International journal of clinical practice, 65(3), 361-371. doi:10.1111/j.1742-1241.2010.02538.xDOI: 10.1111/j.1742-1241.2010.02538.x
Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension (Journal article)
Shantsila, A., Dwivedi, G., Shantsila, E., Butt, M., Beevers, D. G., & Lip, G. Y. H. (2011). Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension. HYPERTENSION, 57(3), 490-496. doi:10.1161/HYPERTENSIONAHA.110.166314DOI: 10.1161/HYPERTENSIONAHA.110.166314
Atrial fibrillation (acute onset). (Journal article)
Lip, G. Y. H., & Apostolakis, S. (2011). Atrial fibrillation (acute onset).. BMJ clinical evidence, 2011, 0210.
The Risk of Thromboembolism in Heart Failure: Does It Merit Anticoagulation Therapy? (Journal article)
Shantsila, E., & Lip, G. Y. H. (2011). The Risk of Thromboembolism in Heart Failure: Does It Merit Anticoagulation Therapy?. AMERICAN JOURNAL OF CARDIOLOGY, 107(4), 558-560. doi:10.1016/j.amjcard.2010.10.029DOI: 10.1016/j.amjcard.2010.10.029
Assessment of left atrial volume: a focus on echocardiographic methods and clinical implications. (Journal article)
Khoo, C. W., Krishnamoorthy, S., Lim, H. S., & Lip, G. Y. H. (2011). Assessment of left atrial volume: a focus on echocardiographic methods and clinical implications.. Clinical research in cardiology : official journal of the German Cardiac Society, 100(2), 97-105. doi:10.1007/s00392-010-0222-yDOI: 10.1007/s00392-010-0222-y
Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk. (Journal article)
Lip, G. Y. H. (2011). Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 13(2), 145-148. doi:10.1093/europace/euq427DOI: 10.1093/europace/euq427
Optimal Antithrombotic Therapy in Patients Receiving Long-term Oral Anticoagulation Requiring Percutaneous Coronary Intervention "Triple Therapy" or "Triple Threat" (Journal article)
Tapp, L. D., Lip, G. Y. H., & Lane, D. A. (2011). Optimal Antithrombotic Therapy in Patients Receiving Long-term Oral Anticoagulation Requiring Percutaneous Coronary Intervention "Triple Therapy" or "Triple Threat". CHEST, 139(2), 240-243. doi:10.1378/chest.10-1102DOI: 10.1378/chest.10-1102
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy. (Journal article)
Lip, G. Y. H., Rasmussen, L. H., Olsson, S. B., Zetterstrand, S., Stahre, C., Bylock, A., . . . Steering Committee. (2011). Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy.. Thrombosis research, 127(2), 91-99. doi:10.1016/j.thromres.2010.11.012DOI: 10.1016/j.thromres.2010.11.012
Platelet reactivity in prolonged stress disorders-A link with cardiovascular disease? (Journal article)
Montoro-Garcia, S., Shantsila, E., & Lip, G. Y. H. (2011). Platelet reactivity in prolonged stress disorders-A link with cardiovascular disease?. PSYCHONEUROENDOCRINOLOGY, 36(2), 159-160. doi:10.1016/j.psyneuen.2010.08.010DOI: 10.1016/j.psyneuen.2010.08.010
Renin-angiotensin blockade in diabetic retinopathy. (Journal article)
Ghattas, A., Lip, P. -L., & Lip, G. Y. H. (2011). Renin-angiotensin blockade in diabetic retinopathy.. International journal of clinical practice, 65(2), 113-116. doi:10.1111/j.1742-1241.2010.02592.xDOI: 10.1111/j.1742-1241.2010.02592.x
Author Response: Can Vascular Function Be Assessed by the Interpretation of Retinal Vascular Diameter Changes? (Journal article)
Heitmar, R., Blann, A., Cubbidge, R. P., Lip, G., & Gherghel, D. (2011). Author Response: Can Vascular Function Be Assessed by the Interpretation of Retinal Vascular Diameter Changes?. Investigative Opthalmology & Visual Science, 52(1), 636. doi:10.1167/iovs.10-6690DOI: 10.1167/iovs.10-6690
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. (Journal article)
Olesen, J. B., Lip, G. Y. H., Hansen, M. L., Hansen, P. R., Tolstrup, J. S., Lindhardsen, J., . . . Torp-Pedersen, C. (2011). Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.. BMJ (Clinical research ed.), 342, d124. doi:10.1136/bmj.d124DOI: 10.1136/bmj.d124
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score (Journal article)
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2011). Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 57(2), 173-180. doi:10.1016/j.jacc.2010.09.024DOI: 10.1016/j.jacc.2010.09.024
A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice (Journal article)
van Staa, T. P., Setakis, E., di Tanna, G. L., Lane, D. A., & Lip, G. Y. H. (2011). A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 9(1), 39-48. doi:10.1111/j.1538-7836.2010.04085.xDOI: 10.1111/j.1538-7836.2010.04085.x
Antithrombotic therapy after percutaneous coronary intervention in anticoagulated patients: a fine balance between thrombosis and bleeding. (Journal article)
Ghattas, A., Shantsila, E., & Lip, G. Y. H. (2011). Antithrombotic therapy after percutaneous coronary intervention in anticoagulated patients: a fine balance between thrombosis and bleeding.. Therapeutic advances in cardiovascular disease, 5(1), 5-9. doi:10.1177/1753944710397225DOI: 10.1177/1753944710397225
Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies (Journal article)
Karthikeyan, V. J., Ferner, R. E., Baghdadi, S., Lane, D. A., Lip, G. Y. H., & Beevers, D. G. (2011). Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies. JOURNAL OF HYPERTENSION, 29(2), 396-399. doi:10.1097/HJH.0b013e328341885dDOI: 10.1097/HJH.0b013e328341885d
Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation. (Journal article)
Poli, D., Testa, S., Antonucci, E., Grifoni, E., Paoletti, O., & Lip, G. Y. H. (2011). Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation.. Chest, 140(4), 918-924. doi:10.1378/chest.10-3024DOI: 10.1378/chest.10-3024
Can We IMPROVE Bleeding Risk Assessment for Acutely III, Hospitalized Medical Patients? (Journal article)
Tay, K. H., Lip, G. Y. H., & Lane, D. A. (2011). Can We IMPROVE Bleeding Risk Assessment for Acutely III, Hospitalized Medical Patients?. CHEST, 139(1), 10-13. doi:10.1378/chest.10-1127DOI: 10.1378/chest.10-1127
Clinical and basic science articles from Thrombosis and Haemostasis. (Journal article)
Lip, G. Y. H., & Weber, C. (2011). Clinical and basic science articles from Thrombosis and Haemostasis.. Thrombosis and haemostasis, 105(1), 202-205. doi:10.1055/s-0037-1609004DOI: 10.1055/s-0037-1609004
Commencing 2011 with Thrombosis and Haemostasis – and looking to the future (Journal article)
Weber, C., & Lip, G. (2011). Commencing 2011 with Thrombosis and Haemostasis – and looking to the future. Thrombosis and Haemostasis, 105(01), 1-2. doi:10.1055/s-0037-1609003DOI: 10.1055/s-0037-1609003
Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice. (Journal article)
Pamukcu, B., & Lip, G. Y. H. (2011). Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.. Expert opinion on pharmacotherapy, 12(1), 131-140. doi:10.1517/14656566.2011.540800DOI: 10.1517/14656566.2011.540800
Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation. (Journal article)
Lip, G. Y. H. (2011). Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.. The American journal of medicine, 124(2), 111-114. doi:10.1016/j.amjmed.2010.05.007DOI: 10.1016/j.amjmed.2010.05.007
Lone atrial fibrillation: where are we now? (Journal article)
Potpara, T. S., & Lip, G. Y. (2011). Lone atrial fibrillation: where are we now?. Hospital practice (1995), 39(4), 17-31. doi:10.3810/hp.2011.10.919DOI: 10.3810/hp.2011.10.919
Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study. (Journal article)
Potpara, T. S., Vasiljevic, Z. M., Vujisic-Tesic, B. D., Marinkovic, J. M., Polovina, M. M., Stepanovic, J. M., . . . Lip, G. Y. H. (2011). Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study.. Chest, 140(4), 902-910. doi:10.1378/chest.10-2963DOI: 10.1378/chest.10-2963
New Oral Anti-Coagulants for Atrial Fibrillation: Will We Say Good Bye to Warfarin? (Journal article)
YH Lip, G. (2011). New Oral Anti-Coagulants for Atrial Fibrillation: Will We Say Good Bye to Warfarin?. Journal of Arrhythmia, 27(Supplement), SY06_4. doi:10.4020/jhrs.27.sy06_4DOI: 10.4020/jhrs.27.sy06_4
Prevention of Thromboembolism in Atrial Fibrillation Patients (Journal article)
Kuzniatsova, N., & Lip, G. Y. H. (2011). Prevention of Thromboembolism in Atrial Fibrillation Patients. European Cardiology Review, 7(1), 37. doi:10.15420/ecr.2011.7.1.37DOI: 10.15420/ecr.2011.7.1.37
Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project. (Journal article)
Gorin, L., Fauchier, L., Nonin, E., Charbonnier, B., Babuty, D., & Lip, G. Y. H. (2011). Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project.. Chest, 140(4), 911-917. doi:10.1378/chest.10-2436DOI: 10.1378/chest.10-2436
Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA<sub>2</sub>DS<sub>2</sub>-VASc risk stratification scores (vol 39, pg 533, 2010) (Journal article)
Pamukcu, B., Lip, G. Y. H., & Lane, D. A. (2011). Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA<sub>2</sub>DS<sub>2</sub>-VASc risk stratification scores (vol 39, pg 533, 2010). AGE AND AGEING, 40(1), 141. doi:10.1093/ageing/afq128DOI: 10.1093/ageing/afq128
Stroke Risk Stratification in a "Real-World" Elderly Anticoagulated Atrial Fibrillation Population (Journal article)
Poli, D., Lip, G. Y., Antonucci, E., Grifoni, E., & Lane, D. (2011). Stroke Risk Stratification in a "Real-World" Elderly Anticoagulated Atrial Fibrillation Population. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 22(1), 25-30. doi:10.1111/j.1540-8167.2010.01858.xDOI: 10.1111/j.1540-8167.2010.01858.x
The 2010 European Society of Cardiology Guidelines on the management of atrial fibrillation: an evolution or revolution? (Journal article)
Lip, G. Y. H., Halperin, J. L., & Tse, H. -F. (2011). The 2010 European Society of Cardiology Guidelines on the management of atrial fibrillation: an evolution or revolution?. Chest, 139(4), 738-741. doi:10.1378/chest.10-2763DOI: 10.1378/chest.10-2763
The improved but unfinished business of stroke risk stratification in atrial fibrillation. (Journal article)
Banerjee, A., Marín, F., & Lip, G. Y. H. (2011). The improved but unfinished business of stroke risk stratification in atrial fibrillation.. Revista espanola de cardiologia, 64(8), 639-641. doi:10.1016/j.recesp.2011.04.005DOI: 10.1016/j.recesp.2011.04.005
Thrombogenesis in lone atrial fibrillation: a role for soluble P-selectin? (Journal article)
Montoro-García, S., Marín, F., & Lip, G. Y. H. (2011). Thrombogenesis in lone atrial fibrillation: a role for soluble P-selectin?. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 13(1), 3-4. doi:10.1093/europace/euq376DOI: 10.1093/europace/euq376
What is the role of the cardiologist in future management of stroke prevention in atrial fibrillation? (Journal article)
Velu, S., & Lip, G. Y. H. (2011). What is the role of the cardiologist in future management of stroke prevention in atrial fibrillation?. Advances in therapy, 28(1), 1-12. doi:10.1007/s12325-010-0091-9DOI: 10.1007/s12325-010-0091-9
2010
Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments. (Journal article)
Schirmer, S. H., Baumhäkel, M., Neuberger, H. -R., Hohnloser, S. H., van Gelder, I. C., Lip, G. Y. H., & Böhm, M. (2010). Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments.. Journal of the American College of Cardiology, 56(25), 2067-2076. doi:10.1016/j.jacc.2010.09.017DOI: 10.1016/j.jacc.2010.09.017
Plasma indices of angiogenesis in rheumatoid disease: relationship to cardiovascular risk factors and cardiac function. (Journal article)
Bhatia, G. S., Sosin, M. D., Patel, J. V., Grindulis, K. A., Khattak, F. H., Davis, R. C., & Lip, G. Y. H. (2010). Plasma indices of angiogenesis in rheumatoid disease: relationship to cardiovascular risk factors and cardiac function.. International journal of cardiology, 145(3), e105-e108. doi:10.1016/j.ijcard.2008.12.168DOI: 10.1016/j.ijcard.2008.12.168
Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk (Journal article)
Lane, D. A., & Lip, G. Y. H. (2010). Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk. LANCET NEUROLOGY, 9(12), 1140-1142. doi:10.1016/S1474-4422(10)70275-1DOI: 10.1016/S1474-4422(10)70275-1
Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study. (Journal article)
Pamukcu, B., & Lip, G. Y. (2010). Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.. Expert opinion on pharmacotherapy, 11(17), 2775-2778. doi:10.1517/14656566.2010.517196DOI: 10.1517/14656566.2010.517196
Editors choice: recent highlights from the journal of human hypertension (Journal article)
Stowasser, M., & Lip, G. Y. H. (2010). Editors choice: recent highlights from the journal of human hypertension. Journal of Human Hypertension, 24(12), 775-778. doi:10.1038/jhh.2010.90DOI: 10.1038/jhh.2010.90
Identifying Patients at High Risk for Stroke Despite Anticoagulation A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort (Journal article)
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2010). Identifying Patients at High Risk for Stroke Despite Anticoagulation A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort. STROKE, 41(12), 2731-2738. doi:10.1161/STROKEAHA.110.590257DOI: 10.1161/STROKEAHA.110.590257
New concepts and approaches to stroke prevention in the new European Society of Cardiology guidelines for the management of atrial fibrillation. (Journal article)
Kuzniatsova, N., & Lip, G. Y. H. (2010). New concepts and approaches to stroke prevention in the new European Society of Cardiology guidelines for the management of atrial fibrillation.. Expert review of cardiovascular therapy, 8(12), 1643-1647. doi:10.1586/erc.10.150DOI: 10.1586/erc.10.150
The assessment of stroke and bleeding risk in atrial fibrillation: where are we now? (Journal article)
Pamukcu, B., Lane, D. A., & Lip, G. Y. H. (2010). The assessment of stroke and bleeding risk in atrial fibrillation: where are we now?. Expert review of cardiovascular therapy, 8(12), 1703-1710. doi:10.1586/erc.10.153DOI: 10.1586/erc.10.153
Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate. (Journal article)
Roskell, N. S., Lip, G. Y. H., Noack, H., Clemens, A., & Plumb, J. M. (2010). Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.. Thrombosis and haemostasis, 104(6), 1106-1115. doi:10.1160/th10-10-0642DOI: 10.1160/th10-10-0642
Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation. (Journal article)
Ezekowitz, M. D., Wallentin, L., Connolly, S. J., Parekh, A., Chernick, M. R., Pogue, J., . . . RE-LY Steering Committee and Investigators. (2010). Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.. Circulation, 122(22), 2246-2253. doi:10.1161/circulationaha.110.973735DOI: 10.1161/circulationaha.110.973735
How do we get better at identifying patients with atrial fibrillation who are at 'truly low risk' or 'truly high risk' of stroke? (Journal article)
Kuzniatsova, N., & Lip, G. Y. H. (2010). How do we get better at identifying patients with atrial fibrillation who are at 'truly low risk' or 'truly high risk' of stroke?. Journal of the neurological sciences, 298(1-2), 21-22. doi:10.1016/j.jns.2010.08.015DOI: 10.1016/j.jns.2010.08.015
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey (Journal article)
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010). A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey. CHEST, 138(5), 1093-1100. doi:10.1378/chest.10-0134DOI: 10.1378/chest.10-0134
Anger rumination, social support, and cardiac symptoms in patients undergoing angiography. (Journal article)
Closa León, T., Nouwen, A., Sheffield, D., Jaumdally, R., & Lip, G. Y. H. (2010). Anger rumination, social support, and cardiac symptoms in patients undergoing angiography.. British journal of health psychology, 15(Pt 4), 841-857. doi:10.1348/135910710x491360DOI: 10.1348/135910710x491360
Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis (Journal article)
Shantsila, E., Kamphuisen, P. W., & Lip, G. Y. H. (2010). Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 8(11), 2358-2368. doi:10.1111/j.1538-7836.2010.04007.xDOI: 10.1111/j.1538-7836.2010.04007.x
Continuous retinal vessel diameter measurements: the future in retinal vessel assessment? (Journal article)
Heitmar, R., Blann, A. D., Cubbidge, R. P., Lip, G. Y. H., & Gherghel, D. (2010). Continuous retinal vessel diameter measurements: the future in retinal vessel assessment?. Investigative ophthalmology & visual science, 51(11), 5833-5839. doi:10.1167/iovs.09-5136DOI: 10.1167/iovs.09-5136
Insights from the new European Society of Cardiology guidelines for the medical management of atrial fibrillation. (Journal article)
Pamukcu, B., & Lip, G. Y. H. (2010). Insights from the new European Society of Cardiology guidelines for the medical management of atrial fibrillation.. International journal of clinical practice, 64(12), 1587-1590. doi:10.1111/j.1742-1241.2010.02522.xDOI: 10.1111/j.1742-1241.2010.02522.x
Malignant Hypertension: A Rare Problem or is it Underdiagnosed? (Journal article)
Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2010). Malignant Hypertension: A Rare Problem or is it Underdiagnosed?. CURRENT VASCULAR PHARMACOLOGY, 8(6), 775-779. doi:10.2174/157016110793563834DOI: 10.2174/157016110793563834
Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor. (Journal article)
Idriss, N. K., Lip, G. Y. H., Balakrishnan, B., Jaumdally, R., Boos, C. J., & Blann, A. D. (2010). Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.. Thrombosis and haemostasis, 104(5), 1029-1037. doi:10.1160/th09-11-0802DOI: 10.1160/th09-11-0802
Response to Dr Kula: Asymptomatic hypoxia in a young pregnant lady--unusual presentation of atrial septal defect. (Journal article)
Krishnamoorthy, S., & Lip, G. Y. H. (2010). Response to Dr Kula: Asymptomatic hypoxia in a young pregnant lady--unusual presentation of atrial septal defect.. International journal of cardiology, 144(3), 428. doi:10.1016/j.ijcard.2009.03.047DOI: 10.1016/j.ijcard.2009.03.047
Soluble Fms-Like Tyrosine Kinase-1-A Novel Marker for Atherosclerotic Progression? - (Journal article)
Pamukcu, B., Shantsila, E., & Lip, G. Y. H. (2010). Soluble Fms-Like Tyrosine Kinase-1-A Novel Marker for Atherosclerotic Progression? -. CIRCULATION JOURNAL, 74(10), 2064-2065. doi:10.1253/circj.CJ-10-0621DOI: 10.1253/circj.CJ-10-0621
CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Scheme Not Ready for Clinical Use Response (Journal article)
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010). CHA<sub>2</sub>DS<sub>2</sub>-VASc Risk Scheme Not Ready for Clinical Use Response. CHEST, 138(4), 1020-1021. doi:10.1378/chest.10-0938DOI: 10.1378/chest.10-0938
Complement activation, endothelial dysfunction, insulin resistance and chronic heart failure. (Journal article)
Bjerre, M., Kistorp, C., Hansen, T. K., Faber, J., Lip, G. Y. H., Hildebrandt, P., & Flyvbjerg, A. (2010). Complement activation, endothelial dysfunction, insulin resistance and chronic heart failure.. Scandinavian cardiovascular journal : SCJ, 44(5), 260-266. doi:10.3109/14017431.2010.484506DOI: 10.3109/14017431.2010.484506
Current therapeutic strategies and future perspectives for the prevention of arterial thromboembolism: focus on atrial fibrillation. (Journal article)
Potpara, T. S., & Lip, G. Y. H. (2010). Current therapeutic strategies and future perspectives for the prevention of arterial thromboembolism: focus on atrial fibrillation.. Current pharmaceutical design, 16(31), 3455-3471. doi:10.2174/138161210793563400DOI: 10.2174/138161210793563400
Endothelial dysfunction: methods of assessment & implications for cardiovascular diseases. (Journal article)
Butt, M., Dwivedi, G., Blann, A., Khair, O., & Lip, G. Y. H. (2010). Endothelial dysfunction: methods of assessment & implications for cardiovascular diseases.. Current pharmaceutical design, 16(31), 3442-3454. doi:10.2174/138161210793563383DOI: 10.2174/138161210793563383
Omega-3 polyunsaturated acids and cardiovascular disease: notable ethnic differences or unfulfilled promise? (Journal article)
Patel, J. V., Tracey, I., Hughes, E. A., & Lip, G. Y. (2010). Omega-3 polyunsaturated acids and cardiovascular disease: notable ethnic differences or unfulfilled promise?. Journal of thrombosis and haemostasis : JTH, 8(10), 2095-2104. doi:10.1111/j.1538-7836.2010.03956.xDOI: 10.1111/j.1538-7836.2010.03956.x
Percutaneous Coronary Intervention in Anticoagulated Patients and Balancing the Risk of Stroke and Bleeding To Interrupt or Not To Interrupt? (Journal article)
Wrigley, B. J., Shantsila, E., & Lip, G. Y. H. (2010). Percutaneous Coronary Intervention in Anticoagulated Patients and Balancing the Risk of Stroke and Bleeding To Interrupt or Not To Interrupt?. CHEST, 138(4), 771-774. doi:10.1378/chest.10-0789DOI: 10.1378/chest.10-0789
Stroke prevention in atrial fibrillation patients (Journal article)
Marinigh, R., Lip, G. Y. H., & Lane, D. A. (2010). Stroke prevention in atrial fibrillation patients. EXPERT OPINION ON PHARMACOTHERAPY, 11(14), 2331-2350. doi:10.1517/14656566.2010.498819DOI: 10.1517/14656566.2010.498819
Review: direct thrombin inhibitors are similar to LMWH and vitamin K antagonists for preventing VTE after hip or knee replacement. (Journal article)
Salazar, C. A. (2010). Review: direct thrombin inhibitors are similar to LMWH and vitamin K antagonists for preventing VTE after hip or knee replacement.. Annals of internal medicine, 153(6), JC3-JC8. doi:10.7326/0003-4819-153-6-201009210-02008DOI: 10.7326/0003-4819-153-6-201009210-02008
Quality of anticoagulation control in atrial fibrillation (Journal article)
Lane, D. A., & Lip, G. Y. H. (2010). Quality of anticoagulation control in atrial fibrillation. LANCET, 376(9745), 935-937. doi:10.1016/S0140-6736(10)61305-0DOI: 10.1016/S0140-6736(10)61305-0
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients Implications for Thromboprophylaxis (Journal article)
Marinigh, R., Lip, G. Y. H., Fiotti, N., Giansante, C., & Lane, D. A. (2010). Age as a Risk Factor for Stroke in Atrial Fibrillation Patients Implications for Thromboprophylaxis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 56(11), 827-837. doi:10.1016/j.jacc.2010.05.028DOI: 10.1016/j.jacc.2010.05.028
The prognostic value of biomarkers after a premature myocardial infarction. (Journal article)
Pineda, J., Marín, F., Marco, P., Roldán, V., Valencia, J., Ruiz-Nodar, J. M., . . . Lip, G. Y. H. (2010). The prognostic value of biomarkers after a premature myocardial infarction.. International journal of cardiology, 143(3), 249-254. doi:10.1016/j.ijcard.2009.02.019DOI: 10.1016/j.ijcard.2009.02.019
Atrial fibrillation and mortality: the impact of antithrombotic therapy (Journal article)
Lane, D. A., & Lip, G. Y. H. (2010). Atrial fibrillation and mortality: the impact of antithrombotic therapy. EUROPEAN HEART JOURNAL, 31(17), 2075-2076. doi:10.1093/eurheartj/ehp486DOI: 10.1093/eurheartj/ehp486
Does Warfarin for Stroke Thromboprophylaxis Protect Against MI in Atrial Fibrillation Patients? (Journal article)
Lip, G. Y. H., & Lane, D. A. (2010). Does Warfarin for Stroke Thromboprophylaxis Protect Against MI in Atrial Fibrillation Patients?. AMERICAN JOURNAL OF MEDICINE, 123(9), 785-789. doi:10.1016/j.amjmed.2010.01.031DOI: 10.1016/j.amjmed.2010.01.031
Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding (Journal article)
Fauchier, L., & Lip, G. Y. H. (2010). Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding. Europace, 12(9), 1349. doi:10.1093/europace/euq311DOI: 10.1093/europace/euq311
Rhythm control agents and adverse events in patients with atrial fibrillation. (Journal article)
Marín, F., & Lip, G. Y. H. (2010). Rhythm control agents and adverse events in patients with atrial fibrillation.. International journal of clinical practice, 64(10), 1329-1331. doi:10.1111/j.1742-1241.2010.02473.xDOI: 10.1111/j.1742-1241.2010.02473.x
Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA<sub>2</sub>DS<sub>2</sub>-VASc risk stratification scores (Journal article)
Pamukcu, B., Lip, G. Y. H., & Lane, D. A. (2010). Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA<sub>2</sub>DS<sub>2</sub>-VASc risk stratification scores. AGE AND AGEING, 39(5), 533-535. doi:10.1093/ageing/afq059DOI: 10.1093/ageing/afq059
Statins and prophylaxis of venous thrombosis - a further link between arterial and venous thrombosis (Journal article)
Shantsila, A., & Lip, G. Y. H. (2010). Statins and prophylaxis of venous thrombosis - a further link between arterial and venous thrombosis. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 64(10), 1327-1328. doi:10.1111/j.1742-1241.2010.02461.xDOI: 10.1111/j.1742-1241.2010.02461.x
Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction. (Journal article)
Hernández-Romero, D., Marín, F., Lee, K. W., Roldán, V., Caturla, J., Corral, J., . . . González-Conejero, R. (2010). Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction.. Thrombosis and haemostasis, 104(3), 650-652. doi:10.1160/th10-01-0022DOI: 10.1160/th10-01-0022
The contribution of cardiovascular risk factors to peripheral arterial disease in South Asians and Blacks: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study. (Journal article)
Bennett, P. C., Lip, G. Y. H., Silverman, S., Blann, A. D., & Gill, P. S. (2010). The contribution of cardiovascular risk factors to peripheral arterial disease in South Asians and Blacks: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.. QJM : monthly journal of the Association of Physicians, 103(9), 661-669. doi:10.1093/qjmed/hcq102DOI: 10.1093/qjmed/hcq102
The role of monocytes in atherosclerotic coronary artery disease (Journal article)
Pamukcu, B., Lip, G. Y. H., Devitt, A., Griffiths, H., & Shantsila, E. (2010). The role of monocytes in atherosclerotic coronary artery disease. ANNALS OF MEDICINE, 42(6), 394-403. doi:10.3109/07853890.2010.497767DOI: 10.3109/07853890.2010.497767
Asymptomatic hypoxia in a young pregnant lady--unusual presentation of atrial septal defect. (Journal article)
Krishnamoorthy, S., Butt, M., & Lip, G. Y. H. (2010). Asymptomatic hypoxia in a young pregnant lady--unusual presentation of atrial septal defect.. International journal of cardiology, 143(2), e34-e36. doi:10.1016/j.ijcard.2008.12.039DOI: 10.1016/j.ijcard.2008.12.039
Circulating monocytes and atherogenesis: From animal experiments to human studies (Journal article)
Shantsila, E., Devitt, A., & Lip, G. Y. H. (2010). Circulating monocytes and atherogenesis: From animal experiments to human studies. THROMBOSIS AND HAEMOSTASIS, 104(2), 191-193. doi:10.1160/TH10-03-0176DOI: 10.1160/TH10-03-0176
Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis (Journal article)
Watson, T., Shantsila, E., Blann, A., & Lip, G. Y. H. (2010). Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis. THROMBOSIS AND HAEMOSTASIS, 104(2), 327-334. doi:10.1160/TH10-01-0024DOI: 10.1160/TH10-01-0024
The impact of new and emerging clinical data on treatment strategies for atrial fibrillation. (Journal article)
Prystowsky, E. N., Camm, J., Lip, G. Y. H., Allessie, M., Bergmann, J. -F., Breithardt, G., . . . Tamargo, J. (2010). The impact of new and emerging clinical data on treatment strategies for atrial fibrillation.. Journal of cardiovascular electrophysiology, 21(8), 946-958. doi:10.1111/j.1540-8167.2010.01770.xDOI: 10.1111/j.1540-8167.2010.01770.x
Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting (Journal article)
Wrigley, B. J., Tapp, L. D., Shantsila, E., & Lip, G. Y. H. (2010). Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 120(7-8), 290-293. doi:10.20452/pamw.949DOI: 10.20452/pamw.949
Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients (Journal article)
Kaireviciute, D., Blann, A. D., Balakrishnan, B., Lane, D. A., Patel, J. V., Uzdavinys, G., . . . Lip, G. Y. H. (2010). Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients. THROMBOSIS AND HAEMOSTASIS, 104(1), 122-127. doi:10.1160/TH09-12-0837DOI: 10.1160/TH09-12-0837
Levosimendan - a calcium sensitising agent with potential anti-arrhythmic properties. (Journal article)
Kowalczyk, M., Banach, M., Lip, G. Y. H., Kozłowski, D., Mikhailidis, D. P., & Rysz, J. (2010). Levosimendan - a calcium sensitising agent with potential anti-arrhythmic properties.. International journal of clinical practice, 64(8), 1148-1154. doi:10.1111/j.1742-1241.2010.02396.xDOI: 10.1111/j.1742-1241.2010.02396.x
New oral anticoagulant drugs in cardiovascular disease. (Journal article)
Ahrens, I., Lip, G. Y. H., & Peter, K. (2010). New oral anticoagulant drugs in cardiovascular disease.. Thrombosis and haemostasis, 104(1), 49-60. doi:10.1160/th09-05-0327DOI: 10.1160/th09-05-0327
Obstructive Sleep Apnea Is a Risk Factor for Stroke and Atrial Fibrillation <i>Response</i> (Journal article)
Pisters, R., Nieuwlaat, R., Lane, D. A., Crijns, H. J. G. M., & Lip, G. Y. H. (2010). Obstructive Sleep Apnea Is a Risk Factor for Stroke and Atrial Fibrillation <i>Response</i>. CHEST, 138(1), 239-240. doi:10.1378/chest.10-0545DOI: 10.1378/chest.10-0545
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (Journal article)
Lip, G. Y. H., Huber, K., Andreotti, F., Arnesen, H., Airaksinen, J. K., Cuisset, T., . . . Consensus Document of European Society of Cardiology Working Group on Thrombosis. (2010). Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).. European heart journal, 31(11), 1311-1318. doi:10.1093/eurheartj/ehq117DOI: 10.1093/eurheartj/ehq117
Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding. (Journal article)
Fauchier, L., & Lip, G. Y. H. (2010). Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 12(6), 761-763. doi:10.1093/europace/euq102DOI: 10.1093/europace/euq102
Improving stroke risk stratification in atrial fibrillation. (Journal article)
Lip, G. Y. H., & Halperin, J. L. (2010). Improving stroke risk stratification in atrial fibrillation.. The American journal of medicine, 123(6), 484-488. doi:10.1016/j.amjmed.2009.12.013DOI: 10.1016/j.amjmed.2009.12.013
Novel oral anticoagulants: the potential relegation of vitamin K antagonists in clinical practice (Journal article)
Wrigley, B. J., Lip, G. Y. H., & Shantsila, E. (2010). Novel oral anticoagulants: the potential relegation of vitamin K antagonists in clinical practice. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 64(7), 835-838. doi:10.1111/j.1742-1241.2010.02351.xDOI: 10.1111/j.1742-1241.2010.02351.x
Peripheral artery disease: appreciating the asymptomatic - yet lethal - epidemic. (Journal article)
Jaipersad, A. S., Silverman, S. H., & Lip, G. Y. H. (2010). Peripheral artery disease: appreciating the asymptomatic - yet lethal - epidemic.. International journal of clinical practice, 64(7), 832-835. doi:10.1111/j.1742-1241.2010.02393.xDOI: 10.1111/j.1742-1241.2010.02393.x
TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT) (Journal article)
Smith, D. E., Xuereb, C. B., Pattison, H. M., Lip, G. Y. H., & Lane, D. A. (2010). TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT). BMC CARDIOVASCULAR DISORDERS, 10. doi:10.1186/1471-2261-10-21DOI: 10.1186/1471-2261-10-21
Aliot, E., Breithardt, G., Brugada, J., Camm, J., Lip, G. Y. H., Vardas, P. E., . . . World Heart Federation. (2010). An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 12(5), 626-633. doi:10.1093/europace/euq109DOI: 10.1093/europace/euq109
Anticoagulation for Atrial Fibrillation Patients with CHADS<sub>2</sub> Score of 1 (Journal article)
Lane, D. A., & Lip, G. Y. H. (2010). Anticoagulation for Atrial Fibrillation Patients with CHADS<sub>2</sub> Score of 1. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 21(5), 508-510. doi:10.1111/j.1540-8167.2009.01687.xDOI: 10.1111/j.1540-8167.2009.01687.x
Impact of symptom control on health-related quality of life in atrial fibrillation patients: the psychologist's viewpoint (Journal article)
Smith, D., Lip, G. Y. H., & Lane, D. A. (2010). Impact of symptom control on health-related quality of life in atrial fibrillation patients: the psychologist's viewpoint. EUROPACE, 12(5), 608-610. doi:10.1093/europace/euq083DOI: 10.1093/europace/euq083
Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment. (Journal article)
Foster, W., Carruthers, D., Lip, G. Y. H., & Blann, A. D. (2010). Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment.. Journal of thrombosis and thrombolysis, 29(4), 437-442. doi:10.1007/s11239-009-0370-yDOI: 10.1007/s11239-009-0370-y
Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. (Journal article)
Barbalic, M., Dupuis, J., Dehghan, A., Bis, J. C., Hoogeveen, R. C., Schnabel, R. B., . . . Benjamin, E. J. (2010). Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels.. Human molecular genetics, 19(9), 1863-1872. doi:10.1093/hmg/ddq061DOI: 10.1093/hmg/ddq061
Anti-platelet therapy: is it all over in peripheral artery disease? (Journal article)
Jaipersad, A. S., Silverman, S. H., & Lip, G. Y. H. (2010). Anti-platelet therapy: is it all over in peripheral artery disease?. Thrombosis and haemostasis, 103(4), 689-691. doi:10.1160/th10-01-0053DOI: 10.1160/th10-01-0053
Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice. (Journal article)
Lip, G. Y. H. (2010). Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.. Thrombosis and haemostasis, 103(4), 683-685. doi:10.1160/th10-01-0038DOI: 10.1160/th10-01-0038
Assessment of endothelial dysfunction. (Journal article)
Freestone, B., Krishnamoorthy, S., & Lip, G. Y. H. (2010). Assessment of endothelial dysfunction.. Expert review of cardiovascular therapy, 8(4), 557-571. doi:10.1586/erc.09.184DOI: 10.1586/erc.09.184
Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus. (Journal article)
Jaumdally, R. J., Goon, P. K. Y., Varma, C., Blann, A. D., & Lip, G. Y. H. (2010). Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus.. Journal of internal medicine, 267(4), 385-393. doi:10.1111/j.1365-2796.2009.02151.xDOI: 10.1111/j.1365-2796.2009.02151.x
Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment. (Journal article)
Foster, W., Carruthers, D., Lip, G. Y. H., & Blann, A. D. (2010). Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.. The Journal of rheumatology, 37(4), 711-716. doi:10.3899/jrheum.090699DOI: 10.3899/jrheum.090699
Lone atrial fibrillation: what do we know? (Journal article)
Kozlowski, D., Budrejko, S., Lip, G. Y. H., Rysz, J., Mikhailidis, D. P., Raczak, G., & Banach, M. (2010). Lone atrial fibrillation: what do we know?. Heart (British Cardiac Society), 96(7), 498-503. doi:10.1136/hrt.2009.176321DOI: 10.1136/hrt.2009.176321
Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm. (Journal article)
Siu, C. -W., Watson, T., Lai, W. -H., Lee, Y. -K., Chan, Y. -H., Ng, K. -M., . . . Tse, H. -F. (2010). Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 12(4), 517-521. doi:10.1093/europace/eup382DOI: 10.1093/europace/eup382
Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation. (Journal article)
Watson, T., Arya, A., Sulke, N., & Lip, G. Y. H. (2010). Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation.. Chest, 137(4), 869-876. doi:10.1378/chest.09-1426DOI: 10.1378/chest.09-1426
Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations. (Journal article)
Patel, J. V., Caslake, M. J., Vyas, A., Cruickshank, J. K., Prabhakaran, D., Bhatnagar, D., . . . Durrington, P. N. (2010). Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations.. Atherosclerosis, 209(2), 579-584. doi:10.1016/j.atherosclerosis.2009.10.010DOI: 10.1016/j.atherosclerosis.2009.10.010
Plasma YKL-40 levels are elevated in patients with chronic heart failure. (Journal article)
Rathcke, C. N., Kistorp, C., Raymond, I., Hildebrandt, P., Gustafsson, F., Lip, G. Y. H., . . . Vestergaard, H. (2010). Plasma YKL-40 levels are elevated in patients with chronic heart failure.. Scandinavian cardiovascular journal : SCJ, 44(2), 92-99. doi:10.3109/14017430903402218DOI: 10.3109/14017430903402218
Role of Ticagrelor in Clopidogrel Nonresponders: Resistance Is Futile? (Journal article)
Tapp, L., Shantsila, E., & Lip, G. Y. H. (2010). Role of Ticagrelor in Clopidogrel Nonresponders: Resistance Is Futile?. CIRCULATION, 121(10), 1169-1171. doi:10.1161/CIR.0b013e3181d8d929DOI: 10.1161/CIR.0b013e3181d8d929
Advances in therapy for atrial fibrillation (Journal article)
Lane, D. A., & Lip, G. Y. H. (2010). Advances in therapy for atrial fibrillation. Therapy, 7(2), 103-105. doi:10.2217/thy.10.15DOI: 10.2217/thy.10.15
Apolipoproteins in the discrimination of atherosclerotic burden and cardiac function in patients with stable coronary artery disease. (Journal article)
Patel, J. V., Abraheem, A., Creamer, J., Gunning, M., Hughes, E. A., & Lip, G. Y. H. (2010). Apolipoproteins in the discrimination of atherosclerotic burden and cardiac function in patients with stable coronary artery disease.. European journal of heart failure, 12(3), 254-259. doi:10.1093/eurjhf/hfp202DOI: 10.1093/eurjhf/hfp202
Changing the scope of preventative and therapeutic approaches in atherothrombosis. (Journal article)
Peter, K., & Lip, G. Y. H. (2010). Changing the scope of preventative and therapeutic approaches in atherothrombosis.. Thrombosis and haemostasis, 103(3), 487-488. doi:10.1160/th10-01-0063DOI: 10.1160/th10-01-0063
Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials. (Journal article)
Gray, J., Edwards, S. J., & Lip, G. Y. H. (2010). Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials.. Current medical research and opinion, 26(3), 537-547. doi:10.1185/03007990903513980DOI: 10.1185/03007990903513980
Coronary Atherosclerosis in Rheumatoid Arthritis: Could Endothelial Progenitor Cells Be the Missing Link? (Journal article)
Wrigley, B. J., Lip, G. Y. H., & Shantsila, E. (2010). Coronary Atherosclerosis in Rheumatoid Arthritis: Could Endothelial Progenitor Cells Be the Missing Link?. JOURNAL OF RHEUMATOLOGY, 37(3), 479-481. doi:10.3899/jrheum.091341DOI: 10.3899/jrheum.091341
Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial. (Journal article)
Khoo, C. W., & Lip, G. Y. H. (2010). Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial.. Expert opinion on pharmacotherapy, 11(4), 685-687. doi:10.1517/14656560903530691DOI: 10.1517/14656560903530691
Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? (Journal article)
Apostolakis, S., Lip, G. Y. H., & Shantsila, E. (2010). Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?. CARDIOVASCULAR RESEARCH, 85(4), 649-660. doi:10.1093/cvr/cvp327DOI: 10.1093/cvr/cvp327
Siddique, A., Shantsila, E., Lip, G. Y., & Varma, C. (2010). Endothelial progenitor cells: what use for the cardiologist?. Journal of angiogenesis research, 2, 6. doi:10.1186/2040-2384-2-6DOI: 10.1186/2040-2384-2-6
Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease. (Journal article)
López-Cuenca, A., Marín, F., Roldán, V., Climent, V. E., Valdés, M., & Lip, G. Y. H. (2010). Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease.. International journal of cardiology, 139(1), 95-97. doi:10.1016/j.ijcard.2008.06.076DOI: 10.1016/j.ijcard.2008.06.076
Obstructive sleep apnea and cardiovascular disease. (Journal article)
Butt, M., Dwivedi, G., Khair, O., & Lip, G. Y. H. (2010). Obstructive sleep apnea and cardiovascular disease.. International journal of cardiology, 139(1), 7-16. doi:10.1016/j.ijcard.2009.05.021DOI: 10.1016/j.ijcard.2009.05.021
Aspirin-A Drug Whose Time Has Gone? (Journal article)
Tapp, L., Shantsila, E., & Lip, G. Y. H. (2010). Aspirin-A Drug Whose Time Has Gone?. AMERICAN JOURNAL OF CARDIOLOGY, 105(4), 577-578. doi:10.1016/j.amjcard.2009.10.026DOI: 10.1016/j.amjcard.2009.10.026
Anticoagulation intensity for elderly atrial fibrillation patients: Should we use a conventional INR target (2.0 to 3.0) or a lower range? (Journal article)
Lane, D. A., & Lip, G. Y. H. (2010). Anticoagulation intensity for elderly atrial fibrillation patients: Should we use a conventional INR target (2.0 to 3.0) or a lower range?. THROMBOSIS AND HAEMOSTASIS, 103(2), 254-256. doi:10.1160/TH09-12-0843DOI: 10.1160/TH09-12-0843
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation (Journal article)
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010). Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation. CHEST, 137(2), 263-272. doi:10.1378/chest.09-1584DOI: 10.1378/chest.09-1584
The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage? (Journal article)
Tello-Montoliu, A., Marín, F., Roldán, V., & Lip, G. Y. H. (2010). The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?. Heart (British Cardiac Society), 96(3), 227-228. doi:10.1136/hrt.2009.182105DOI: 10.1136/hrt.2009.182105
The effects of exercise stress testing, diurnal variation and temporal decline on circulating progenitor cells (Journal article)
Watson, T., Shantsila, E., Karthikeyan, V. J., Jessani, S., Goon, P. K., & Lip, G. Y. H. (2010). The effects of exercise stress testing, diurnal variation and temporal decline on circulating progenitor cells. THROMBOSIS AND HAEMOSTASIS, 103(2), 419-425. doi:10.1160/TH09-06-0386DOI: 10.1160/TH09-06-0386
Peripheral Blood Monocyte Subset Assessment in Non-ST-Segment Elevation Myocardial Infarction Is Required Reply (Journal article)
Shantsila, E., & Lip, G. Y. H. (2010). Peripheral Blood Monocyte Subset Assessment in Non-ST-Segment Elevation Myocardial Infarction Is Required Reply. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 55(2), 170-171. doi:10.1016/j.jacc.2009.08.044DOI: 10.1016/j.jacc.2009.08.044
ATRIAL FIBRILLATION Blockade of the renin-angiotensin system in atrial fibrillation (Journal article)
Kuzniatsova, N., Shantsila, E., & Lip, G. Y. H. (2010). ATRIAL FIBRILLATION Blockade of the renin-angiotensin system in atrial fibrillation. NATURE REVIEWS CARDIOLOGY, 7(8), 428-430. doi:10.1038/nrcardio.2010.103DOI: 10.1038/nrcardio.2010.103
Bleeding after coronary stenting in patients on oral anticoagulation: who is guilty? (Journal article)
Rubboli, A., Schlitt, A., Airaksinen, J., & Lip, G. Y. H. (2010). Bleeding after coronary stenting in patients on oral anticoagulation: who is guilty?. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 5(6), 649-650. doi:10.4244/5i6a105DOI: 10.4244/5i6a105
Dronedarone: NICE enough? (Journal article)
Khoo, C. W., Lim, H. S., & Lip, G. Y. H. (2010). Dronedarone: NICE enough?. Expert review of cardiovascular therapy, 8(8), 1049-1051. doi:10.1586/erc.10.83DOI: 10.1586/erc.10.83
Editor´s choice articles 2008–2009 (Journal article)
Lip, G., Preissner, K., & Weber, C. (2010). Editor´s choice articles 2008–2009. Thrombosis and Haemostasis, 103(01), 3-6. doi:10.1055/s-0037-1608916DOI: 10.1055/s-0037-1608916
Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk. (Journal article)
López-Cuenca, A., Marín, F., Roldán, V., González-Conejero, R., Hernández-Romero, D., Valdés, M., & Lip, G. Y. H. (2010). Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk.. Annals of medicine, 42(8), 562-575. doi:10.3109/07853890.2010.507601DOI: 10.3109/07853890.2010.507601
How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"? (Journal article)
Airaksinen, K. E. J., Schlitt, A., Rubboli, A., Karjalainen, P., & Lip, G. Y. H. (2010). How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"?. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 6(4), 520-526. doi:10.4244/eij30v6i4a86DOI: 10.4244/eij30v6i4a86
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting. (Conference Paper)
Lip, G. Y. H., Huber, K., Andreotti, F., Arnesen, H., Airaksinen, K. J., Cuisset, T., . . . European Society of Cardiology Working Group on Thrombosis. (2010). Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.. In Thrombosis and haemostasis Vol. 103 (pp. 13-28). doi:10.1160/th09-08-0580DOI: 10.1160/th09-08-0580
Moving forward with a new editorial team for Thrombosis and Haemostasis. (Journal article)
Weber, C., & Lip, G. Y. H. (2010). Moving forward with a new editorial team for Thrombosis and Haemostasis.. Thrombosis and haemostasis, 103(1), 1-2. doi:10.1160/th10-04-0256DOI: 10.1160/th10-04-0256
Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy. (Journal article)
Peter, K., & Lip, G. Y. H. (2010). Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy.. Thrombosis and haemostasis, 103(5), 875-876. doi:10.1160/th10-03-0205DOI: 10.1160/th10-03-0205
Towards (cost)effective cardiovascular risk management: using new drugs vs. the better use of available ones (Journal article)
Shantsila, A., & Lip, G. Y. H. (2010). Towards (cost)effective cardiovascular risk management: using new drugs vs. the better use of available ones. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 64(2), 138-140. doi:10.1111/j.1742-1241.2009.02233.xDOI: 10.1111/j.1742-1241.2009.02233.x
Underuse of oral anticoagulants in atrial fibrillation: a systematic review. (Journal article)
Ogilvie, I. M., Newton, N., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2010). Underuse of oral anticoagulants in atrial fibrillation: a systematic review.. The American journal of medicine, 123(7), 638-645.e4. doi:10.1016/j.amjmed.2009.11.025DOI: 10.1016/j.amjmed.2009.11.025
2009
A prospective survey of acute hospital admissions with atrial fibrillation in Karachi, Pakistan (Journal article)
Haq, U., & Lip, G. Y. H. (2009). A prospective survey of acute hospital admissions with atrial fibrillation in Karachi, Pakistan. Journal of the Royal College of Physicians of Edinburgh, 39(3), 200-203.
Antithrombotic therapy for heart failure in sinus rhythm (Journal article)
Subramaniam, V., Davis, R. C., Shantsila, E., & Lip, G. Y. H. (2009). Antithrombotic therapy for heart failure in sinus rhythm. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 23(6), 705-717. doi:10.1111/j.1472-8206.2009.00776.xDOI: 10.1111/j.1472-8206.2009.00776.x
Assessment of endothelial (dys)function in atrial fibrillation. (Journal article)
Krishnamoorthy, S., Lim, S. H., & Lip, G. Y. H. (2009). Assessment of endothelial (dys)function in atrial fibrillation.. Annals of medicine, 41(8), 576-590. doi:10.1080/07853890903160726DOI: 10.1080/07853890903160726
Atrial fibrillation in primary aldosteronism. (Journal article)
Watson, T., Karthikeyan, V. J., Lip, G. Y. H., & Beevers, D. G. (2009). Atrial fibrillation in primary aldosteronism.. Journal of the renin-angiotensin-aldosterone system : JRAAS, 10(4), 190-194. doi:10.1177/1470320309342734DOI: 10.1177/1470320309342734
Balancing Thromboembolism and Bleeding Risks Insights From Anticoagulation for Prosthetic Heart Valves (Journal article)
Tay, K. -H., Lane, D. A., & Lip, G. Y. H. (2009). Balancing Thromboembolism and Bleeding Risks Insights From Anticoagulation for Prosthetic Heart Valves. CHEST, 136(6), 1451-1452. doi:10.1378/chest.09-1187DOI: 10.1378/chest.09-1187
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. (Journal article)
Kirchhof, P., Bax, J., Blomstrom-Lundquist, C., Calkins, H., Camm, A. J., Cappato, R., . . . Breithardt, G. (2009). Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.. European heart journal, 30(24), 2969-277c. doi:10.1093/eurheartj/ehp235DOI: 10.1093/eurheartj/ehp235
Evidence guided antiplatelet treatment: Time to move from bench to bedside (Journal article)
Apostolakis, S., Shantsila, E., & Lip, G. Y. H. (2009). Evidence guided antiplatelet treatment: Time to move from bench to bedside. THROMBOSIS RESEARCH, 124(6), 649-650. doi:10.1016/j.thromres.2009.04.020DOI: 10.1016/j.thromres.2009.04.020
Heparin-Induced Thrombocytopenia <i>Response</i> (Journal article)
Shantsila, E., & Lip, G. Y. H. (2009). Heparin-Induced Thrombocytopenia <i>Response</i>. CHEST, 136(6), 1704-1705. doi:10.1378/chest.09-1753DOI: 10.1378/chest.09-1753
High-risk myocardial infarction patients appear to derive more mortality benefit from short door-to-balloon time than low-risk patients. (Journal article)
Kong, P. K., Connolly, D., Varma, C., Lip, G., Millane, T., Davis, R., & Ahmad, R. (2009). High-risk myocardial infarction patients appear to derive more mortality benefit from short door-to-balloon time than low-risk patients.. International journal of clinical practice, 63(12), 1693-1701. doi:10.1111/j.1742-1241.2009.02122.xDOI: 10.1111/j.1742-1241.2009.02122.x
Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction (Journal article)
Jessani, S. S., Lane, D. A., Shantsila, E., Watson, T., Millane, T. A., & Lip, G. Y. H. (2009). Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction. ANNALS OF MEDICINE, 41(8), 608-618. doi:10.1080/07853890903159256DOI: 10.1080/07853890903159256
Lip, G. Y. H., Rasmussen, L. H., Olsson, S. B., Jensen, E. C., Persson, A. L., Eriksson, U., . . . Steering Committee. (2009). Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists.. European heart journal, 30(23), 2897-2907. doi:10.1093/eurheartj/ehp318DOI: 10.1093/eurheartj/ehp318
Vernakalant hydrochloride for the treatment of atrial fibrillation. (Journal article)
Kozlowski, D., Budrejko, S., Lip, G. Y. H., Mikhailidis, D. P., Rysz, J., Raczak, G., & Banach, M. (2009). Vernakalant hydrochloride for the treatment of atrial fibrillation.. Expert opinion on investigational drugs, 18(12), 1929-1937. doi:10.1517/13543780903386246DOI: 10.1517/13543780903386246
Circulating levels of adiponectin, leptin, and tumour necrosis factor alpha in hypertension. (Journal article)
Patel, J. V., Lim, H. S., Dubb, K., Hughes, E. A., & Lip, G. Y. H. (2009). Circulating levels of adiponectin, leptin, and tumour necrosis factor alpha in hypertension.. Annals of medicine, 41(4), 291-300. doi:10.1080/07853890802672839DOI: 10.1080/07853890802672839
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation" (Journal article)
Apostolakis, S., Shantsila, E., Lip, G. Y. H., & Lane, D. A. (2009). Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". THROMBOSIS AND HAEMOSTASIS, 102(5), 914-915. doi:10.1160/TH09-08-0563DOI: 10.1160/TH09-08-0563
Improving Survival of Malignant Hypertension Patients Over 40 Years (Journal article)
Lane, D. A., Lip, G. Y. H., & Beevers, D. G. (2009). Improving Survival of Malignant Hypertension Patients Over 40 Years. AMERICAN JOURNAL OF HYPERTENSION, 22(11), 1199-1204. doi:10.1038/ajh.2009.153DOI: 10.1038/ajh.2009.153
Systemic inflammation as a driver of vascular calcification: a proof of concept (Journal article)
Shantsila, E., & Lip, G. Y. H. (2009). Systemic inflammation as a driver of vascular calcification: a proof of concept. JOURNAL OF INTERNAL MEDICINE, 266(5), 453-456. doi:10.1111/j.1365-2796.2009.02138.xDOI: 10.1111/j.1365-2796.2009.02138.x
The role of monocytes in thrombotic disorders Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms (Journal article)
Shantsila, E., & Lip, G. Y. H. (2009). The role of monocytes in thrombotic disorders Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms. THROMBOSIS AND HAEMOSTASIS, 102(5), 916-924. doi:10.1160/TH09-01-0023DOI: 10.1160/TH09-01-0023
New Anticoagulants for the Prevention of Deep Venous Thrombosis Time to Consider Cost Effectiveness? (Journal article)
Apostolakis, S., Shantsila, E., & Lip, G. Y. H. (2009). New Anticoagulants for the Prevention of Deep Venous Thrombosis Time to Consider Cost Effectiveness?. PHARMACOECONOMICS, 27(10), 793-795. doi:10.2165/11313780-000000000-00000DOI: 10.2165/11313780-000000000-00000
Treatment of hypertension in peripheral arterial disease (Journal article)
Lane, D. A., & Lip, G. Y. H. (2009). Treatment of hypertension in peripheral arterial disease. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (4). doi:10.1002/14651858.CD003075.pub2DOI: 10.1002/14651858.CD003075.pub2
Can the WATCHMAN device truly PROTECT from stroke in atrial fibrillation? (Journal article)
Wrigley, B. J., & Lip, G. Y. H. (2009). Can the WATCHMAN device truly PROTECT from stroke in atrial fibrillation?. The Lancet. Neurology, 8(10), 877-878. doi:10.1016/s1474-4422(09)70244-3DOI: 10.1016/s1474-4422(09)70244-3
Monocytes in Acute Coronary Syndromes (Journal article)
Shantsila, E., & Lip, G. Y. H. (2009). Monocytes in Acute Coronary Syndromes. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 29(10), 1433-1U66. doi:10.1161/ATVBAHA.108.180513DOI: 10.1161/ATVBAHA.108.180513
Pathophysiological insights into atrial fibrillation following cardiac surgery: implications for current pharmaceutical design. (Journal article)
Kaireviciute, D., Aidietis, A., & Lip, G. Y. H. (2009). Pathophysiological insights into atrial fibrillation following cardiac surgery: implications for current pharmaceutical design.. Current pharmaceutical design, 15(29), 3367-3383. doi:10.2174/138161209789105063DOI: 10.2174/138161209789105063
Response to Letter by De Silva et al (Journal article)
Gunarathne, A., Patel, J. V., Gammon, B., Gill, P. S., Hughes, E. A., & Lip, G. Y. H. (2009). Response to Letter by De Silva et al. Stroke, 40(10). doi:10.1161/strokeaha.109.560102DOI: 10.1161/strokeaha.109.560102
Review: combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure. (Journal article)
Shantsila, A., & Lip, G. Y. H. (2009). Review: combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure.. Evidence-based medicine, 14(5), 142. doi:10.1136/ebm.14.5.142DOI: 10.1136/ebm.14.5.142
Vascular Imaging as a Cardiovascular Risk Stratification Tool in Systemic Lupus Erythematosus (Journal article)
Apostolakis, S., Shantsila, E., & Lip, G. Y. H. (2009). Vascular Imaging as a Cardiovascular Risk Stratification Tool in Systemic Lupus Erythematosus. JOURNAL OF RHEUMATOLOGY, 36(10), 2141-2143. doi:10.3899/jrheum.090640DOI: 10.3899/jrheum.090640
Vascular damage in impaired glucose tolerance: an unappreciated phenomenon? (Journal article)
Jessani, S., Millane, T., & Lip, G. Y. H. (2009). Vascular damage in impaired glucose tolerance: an unappreciated phenomenon?. Current pharmaceutical design, 15(29), 3417-3432. doi:10.2174/138161209789105072DOI: 10.2174/138161209789105072
Gill, P. S., Davis, R., Davies, M., Freemantle, N., & Lip, G. Y. (2009). Rationale and study design of a cross sectional study documenting the prevalence of Heart Failure amongst the minority ethnic communities in the UK: the E-ECHOES Study (Ethnic--Echocardiographic Heart of England Screening Study).. BMC cardiovascular disorders, 9, 47. doi:10.1186/1471-2261-9-47DOI: 10.1186/1471-2261-9-47
Combination Anticoagulant and Antiplatelet Therapy in Atrial Fibrillation Patients (Journal article)
Lip, G. Y. H., & Lane, D. A. (2009). Combination Anticoagulant and Antiplatelet Therapy in Atrial Fibrillation Patients. REVISTA ESPANOLA DE CARDIOLOGIA, 62(9), 972-975. doi:10.1016/S0300-8932(09)72094-9DOI: 10.1016/S0300-8932(09)72094-9
Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers. (Journal article)
Pineda, J., Marín, F., Marco, P., Roldán, V., Valencia, J., Ruiz-Nodar, J. M., . . . Lip, G. Y. H. (2009). Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers.. International journal of cardiology, 136(2), 222-225. doi:10.1016/j.ijcard.2008.04.020DOI: 10.1016/j.ijcard.2008.04.020
Acute Management of Atrial Fibrillation: Response (Journal article)
Khoo, C. W., & Lip, G. Y. H. (2009). Acute Management of Atrial Fibrillation: Response. Chest, 136(2), 652. doi:10.1378/chest.09-0976DOI: 10.1378/chest.09-0976
Angiopoietins and Preeclampsia: New Perspectives in the Quest for Markers (Journal article)
Apostolakis, S., Shantsila, E., & Lip, G. Y. H. (2009). Angiopoietins and Preeclampsia: New Perspectives in the Quest for Markers. AMERICAN JOURNAL OF HYPERTENSION, 22(8), 820. doi:10.1038/ajh.2009.108DOI: 10.1038/ajh.2009.108
Defibrillation testing in patients with atrial fibrillation. (Journal article)
Lim, H. S., & Lip, G. Y. H. (2009). Defibrillation testing in patients with atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 11(8), 1108-1109. doi:10.1093/europace/eup157DOI: 10.1093/europace/eup157
Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil. (Journal article)
Krishnamoorthy, S., & Lip, G. Y. H. (2009). Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil.. Expert opinion on investigational drugs, 18(8), 1191-1196. doi:10.1517/13543780903114150DOI: 10.1517/13543780903114150
The endothelium and thrombotic risk in heart failure (Journal article)
Shantsila, E., & Lip, G. Y. H. (2009). The endothelium and thrombotic risk in heart failure. THROMBOSIS AND HAEMOSTASIS, 102(2), 185-187. doi:10.1160/TH09-06-0344DOI: 10.1160/TH09-06-0344
Monocyte Diversity in Myocardial Infarction (Journal article)
Shantsila, E., & Lip, G. Y. H. (2009). Monocyte Diversity in Myocardial Infarction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 54(2), 139-142. doi:10.1016/j.jacc.2009.03.047DOI: 10.1016/j.jacc.2009.03.047
Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence. (Journal article)
Marín, F., Kirchhof, P., & Lip, G. Y. H. (2009). Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 11(7), 842-843. doi:10.1093/europace/eup161DOI: 10.1093/europace/eup161
Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation (Journal article)
Tay, K. -H., Lip, G. Y. H., & Lane, D. A. (2009). Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation. BLOOD COAGULATION & FIBRINOLYSIS, 20(5), 392-393. doi:10.1097/MBC.0b013e32832aec47DOI: 10.1097/MBC.0b013e32832aec47
Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'. (Journal article)
Kirchhof, P., Bax, J., Blomstrom-Lundquist, C., Calkins, H., Camm, A. J., Cappato, R., . . . Breithardt, G. (2009). Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 11(7), 860-885. doi:10.1093/europace/eup124DOI: 10.1093/europace/eup124
Glycemic status underlies increased arterial stiffness and impaired endothelial function in migrant South Asian stroke survivors compared to European Caucasians: pathophysiological insights from the West Birmingham Stroke Project. (Journal article)
Gunarathne, A., Patel, J. V., Kausar, S., Gammon, B., Hughes, E. A., & Lip, G. Y. H. (2009). Glycemic status underlies increased arterial stiffness and impaired endothelial function in migrant South Asian stroke survivors compared to European Caucasians: pathophysiological insights from the West Birmingham Stroke Project.. Stroke, 40(7), 2298-2306. doi:10.1161/strokeaha.109.548388DOI: 10.1161/strokeaha.109.548388
How safe is the antiarrhythmic drug therapy in atrial fibrillation? (Journal article)
Krishnamoorthy, S., & Lip, G. Y. H. (2009). How safe is the antiarrhythmic drug therapy in atrial fibrillation?. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 11(7), 837-839. doi:10.1093/europace/eup170DOI: 10.1093/europace/eup170
Drug-eluting stents: a comprehensive appraisal. (Journal article)
Butt, M., Connolly, D., & Lip, G. Y. H. (2009). Drug-eluting stents: a comprehensive appraisal.. Future cardiology, 5(2), 141-157. doi:10.2217/14796678.5.2.141DOI: 10.2217/14796678.5.2.141
Assessment of endothelial function: implications for hypertension and cardiovascular disorders. (Journal article)
Butt, M., Dwivedi, G., Khair, O., & Lip, G. Y. (2009). Assessment of endothelial function: implications for hypertension and cardiovascular disorders.. Expert review of cardiovascular therapy, 7(6), 561-563. doi:10.1586/erc.09.36DOI: 10.1586/erc.09.36
Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus. (Journal article)
Jaumdally, R. J., Lip, G. Y. H., Patel, J. V., MacFadyen, R. J., & Varma, C. (2009). Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.. Journal of internal medicine, 265(6), 689-697. doi:10.1111/j.1365-2796.2009.02072.xDOI: 10.1111/j.1365-2796.2009.02072.x
Fondaparinux: an overview. (Journal article)
Nadar, S. K., Goyal, D., Shantsila, E., Banerjee, P., & Lip, G. Y. H. (2009). Fondaparinux: an overview.. Expert review of cardiovascular therapy, 7(6), 577-585. doi:10.1586/erc.09.19DOI: 10.1586/erc.09.19
Heparin-Induced Thrombocytopenia A Contemporary Clinical Approach to Diagnosis and Management (Journal article)
Shantsila, E., Lip, G. Y. H., & Chong, B. H. (2009). Heparin-Induced Thrombocytopenia A Contemporary Clinical Approach to Diagnosis and Management. CHEST, 135(6), 1651-1664. doi:10.1378/chest.08-2830DOI: 10.1378/chest.08-2830
Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke. (Journal article)
Subramaniam, V., & Lip, G. Y. H. (2009). Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke.. Expert review of cardiovascular therapy, 7(6), 703-713. doi:10.1586/erc.09.43DOI: 10.1586/erc.09.43
Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical features. (Journal article)
Gunarathne, A., Patel, J. V., Gammon, B., Gill, P. S., Hughes, E. A., & Lip, G. Y. H. (2009). Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical features.. Stroke, 40(6), e415-e423. doi:10.1161/strokeaha.108.535724DOI: 10.1161/strokeaha.108.535724
Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment. (Journal article)
Ng Kam Chuen, M. J., Lip, G. Y. H., & Macfadyen, R. J. (2009). Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment.. Cardiovascular therapeutics, 27(2), 89-95. doi:10.1111/j.1755-5922.2009.00080.xDOI: 10.1111/j.1755-5922.2009.00080.x
Quality of life in older people with atrial fibrillation (Journal article)
Lane, D. A., & Lip, G. Y. H. (2009). Quality of life in older people with atrial fibrillation. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 25(1), 37-42. doi:10.1007/s10840-008-9318-yDOI: 10.1007/s10840-008-9318-y
Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone. (Journal article)
Krishnamoorthy, S., & Lip, G. Y. H. (2009). Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.. Expert review of cardiovascular therapy, 7(5), 473-481. doi:10.1586/erc.09.14DOI: 10.1586/erc.09.14
Burden of atrial fibrillation. (Journal article)
Khoo, C. W., & Lip, G. Y. H. (2009). Burden of atrial fibrillation.. Current medical research and opinion, 25(5), 1261-1263. doi:10.1185/03007990902910443DOI: 10.1185/03007990902910443
Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients (Journal article)
Lane, D. A., & Lip, G. Y. H. (2009). Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients. THROMBOSIS AND HAEMOSTASIS, 101(5), 802-805. doi:10.1160/TH09-02-0106DOI: 10.1160/TH09-02-0106
Indications for the use of diagnostic implantable and external ECG loop recorders. (Journal article)
Task Force members., Brignole, M., Vardas, P., Hoffman, E., Huikuri, H., Moya, A., . . . EHRA Scientific Documents Committee. (2009). Indications for the use of diagnostic implantable and external ECG loop recorders.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 11(5), 671-687. doi:10.1093/europace/eup097DOI: 10.1093/europace/eup097
Mitral regurgitation reduces systemic coagulation activity in rheumatic heart disease: using fibrin D-dimer as a biomarker of thrombogenesis. (Journal article)
Tay, K. H., Khoo, C. W., & Lip, G. Y. H. (2009). Mitral regurgitation reduces systemic coagulation activity in rheumatic heart disease: using fibrin D-dimer as a biomarker of thrombogenesis.. The Journal of heart valve disease, 18(3), 276-277.
New antiplatelet drugs: beyond aspirin and clopidogrel (Journal article)
Siddique, A., Butt, M., Shantsila, E., & Lip, G. Y. H. (2009). New antiplatelet drugs: beyond aspirin and clopidogrel. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 63(5), 776-789. doi:10.1111/j.1742-1241.2009.02058.xDOI: 10.1111/j.1742-1241.2009.02058.x
Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity. (Journal article)
Bhatia, G. S., Sosin, M. D., Patel, J. V., Grindulis, K. A., Khattak, F. H., Davis, R. C., & Lip, G. Y. H. (2009). Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity.. International journal of cardiology, 134(1), 97-103. doi:10.1016/j.ijcard.2008.01.038DOI: 10.1016/j.ijcard.2008.01.038
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. (Journal article)
Du, X., Ninomiya, T., de Galan, B., Abadir, E., Chalmers, J., Pillai, A., . . . ADVANCE Collaborative Group. (2009). Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.. European heart journal, 30(9), 1128-1135. doi:10.1093/eurheartj/ehp055DOI: 10.1093/eurheartj/ehp055
AZD6140 and bleeding: towards safer antiplatelet therapy? (Journal article)
Siddique, A., Shantsila, E., & Lip, G. Y. H. (2009). AZD6140 and bleeding: towards safer antiplatelet therapy?. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 63(4), 537-539. doi:10.1111/j.1742-1241.2008.01963.xDOI: 10.1111/j.1742-1241.2008.01963.x
Clinical outcomes of acute stroke patients with atrial fibrillation. (Journal article)
Khoo, C. W., & Lip, G. Y. H. (2009). Clinical outcomes of acute stroke patients with atrial fibrillation.. Expert review of cardiovascular therapy, 7(4), 371-374. doi:10.1586/erc.09.11DOI: 10.1586/erc.09.11
Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting. (Journal article)
Manzano-Fernández, S., Marín, F., Pastor-Pérez, F. J., Caro, C., Cambronero, F., Lacunza, J., . . . Lip, G. Y. H. (2009). Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting.. Chest, 135(4), 983-990. doi:10.1378/chest.08-1425DOI: 10.1378/chest.08-1425
Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability. (Journal article)
Hamaad, A., Sosin, M. D., Blann, A. D., Lip, G. Y. H., & MacFadyen, R. J. (2009). Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability.. Clinical cardiology, 32(4), 204-209. doi:10.1002/clc.20321DOI: 10.1002/clc.20321
Novel oral anticoagulants (Journal article)
Khoo, C. W., Tay, K. -H., Shantsila, E., & Lip, G. Y. H. (2009). Novel oral anticoagulants. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 63(4), 630-641. doi:10.1111/j.1742-1241.2009.02011.xDOI: 10.1111/j.1742-1241.2009.02011.x
Unraveling the paradoxical link between obesity and heart failure: the role of adipocytokines. (Journal article)
Patel, J. V., Tracey, I., Hughes, E. A., & Lip, G. Y. H. (2009). Unraveling the paradoxical link between obesity and heart failure: the role of adipocytokines.. Expert review of cardiovascular therapy, 7(4), 337-340. doi:10.1586/erc.09.12DOI: 10.1586/erc.09.12
Mechanisms of thrombogenesis in atrial fibrillation Reply (Journal article)
Lip, G. Y. H., & Shantsila, E. (2009). Mechanisms of thrombogenesis in atrial fibrillation Reply. LANCET, 373(9668), 1006-1007. doi:10.1016/S0140-6736(09)60605-XDOI: 10.1016/S0140-6736(09)60605-X
Challenges facing anticoagulation among the elderly and frail (Journal article)
Tay, K. H., Lane, D. A., & Lip, G. Y. H. (2009). Challenges facing anticoagulation among the elderly and frail. AGE AND AGEING, 38(2), 140-142. doi:10.1093/ageing/afn295DOI: 10.1093/ageing/afn295
Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction (Journal article)
Foster, W., Shantsila, E., Carruthers, D., Lip, G. Y. H., & Blann, A. D. (2009). Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction. RHEUMATOLOGY, 48(3), 285-288. doi:10.1093/rheumatology/ken486DOI: 10.1093/rheumatology/ken486
Anticoagulation variability: is it the physician, patient or hospital? (Journal article)
Tay, K. H., Lip, G. Y. H., & Lane, D. A. (2009). Anticoagulation variability: is it the physician, patient or hospital?. Journal of internal medicine, 265(3), 303-306. doi:10.1111/j.1365-2796.2008.02069.xDOI: 10.1111/j.1365-2796.2008.02069.x
Atrial fibrillation and stroke risk prevention in real-life clinical practice (Journal article)
Tay, K. H., Lip, G. Y. H., & Lane, D. A. (2009). Atrial fibrillation and stroke risk prevention in real-life clinical practice. THROMBOSIS AND HAEMOSTASIS, 101(3), 415-416. doi:10.1160/TH08-10-0645DOI: 10.1160/TH08-10-0645
Generalized obesity but not that characterized by raised waist-hip ratio is associated with increased perceived breathlessness during treadmill exercise testing. (Journal article)
Goyal, D., Logie, I. -M., Nadar, S. K., Lip, G. Y. H., & Macfadyen, R. J. (2009). Generalized obesity but not that characterized by raised waist-hip ratio is associated with increased perceived breathlessness during treadmill exercise testing.. Cardiovascular therapeutics, 27(1), 10-16. doi:10.1111/j.1755-5922.2008.00067.xDOI: 10.1111/j.1755-5922.2008.00067.x
Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation (Journal article)
Lane, D. A., Langman, C. M., Lip, G. Y. H., & Nouwen, A. (2009). Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation. JOURNAL OF PSYCHOSOMATIC RESEARCH, 66(3), 203-210. doi:10.1016/j.jpsychores.2008.10.007DOI: 10.1016/j.jpsychores.2008.10.007
Rivaroxaban, a new oral factor Xa inhibitor, provides new data on anticoagulation (Journal article)
Siddique, A., Lip, G. Y. H., & Shantsila, E. (2009). Rivaroxaban, a new oral factor Xa inhibitor, provides new data on anticoagulation. Therapy, 6(2), 187-189. doi:10.2217/14750708.6.2.187DOI: 10.2217/14750708.6.2.187
Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure. (Journal article)
Chung, I., Choudhury, A., Patel, J., & Lip, G. Y. H. (2009). Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.. Annals of medicine, 41(1), 45-51. doi:10.1080/07853890802227089DOI: 10.1080/07853890802227089
Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation. (Journal article)
Climent, V., Marín, F., Mainar, L., Roldán, V., García, A., Martínez, J. G., & Lip, G. Y. H. (2009). Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation.. International journal of cardiology, 132(2), 227-232. doi:10.1016/j.ijcard.2007.11.044DOI: 10.1016/j.ijcard.2007.11.044
A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM-CHF) study. (Journal article)
Jolly, K., Taylor, R. S., Lip, G. Y. H., Davies, M., Davis, R., Mant, J., . . . Stevens, A. (2009). A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM-CHF) study.. European journal of heart failure, 11(2), 205-213. doi:10.1093/eurjhf/hfn029DOI: 10.1093/eurjhf/hfn029
Atrial fibrillation following cardiac surgery: clinical features and preventative strategies. (Journal article)
Kaireviciute, D., Aidietis, A., & Lip, G. Y. H. (2009). Atrial fibrillation following cardiac surgery: clinical features and preventative strategies.. European heart journal, 30(4), 410-425. doi:10.1093/eurheartj/ehn609DOI: 10.1093/eurheartj/ehn609
Relationships between endothelial, inflammatory and angiogenesis markers in rheumatoid arthritis: implications for cardiovascular pathophysiology. (Journal article)
Foster, W., Carruthers, D., Lip, G. Y. H., & Blann, A. D. (2009). Relationships between endothelial, inflammatory and angiogenesis markers in rheumatoid arthritis: implications for cardiovascular pathophysiology.. Thrombosis research, 123(4), 659-664. doi:10.1016/j.thromres.2008.06.014DOI: 10.1016/j.thromres.2008.06.014
Response to letter by Haft: Using CHADS2 backwards plus echo criteria to identify stroke patients who have occult intermittent atrial fibrillation (Journal article)
Lip, G. Y. H. (2009). Response to letter by Haft: Using CHADS2 backwards plus echo criteria to identify stroke patients who have occult intermittent atrial fibrillation. American Heart Journal, 157(2), e11. doi:10.1016/j.ahj.2008.10.015DOI: 10.1016/j.ahj.2008.10.015
Response to the letter by Dr Jolobe: “Risk factors and stroke risk stratification for atrial fibrillation: Limitations and new possibilities” (Journal article)
Lip, G. Y. H. (2009). Response to the letter by Dr Jolobe: “Risk factors and stroke risk stratification for atrial fibrillation: Limitations and new possibilities”. American Heart Journal, 157(2), e7. doi:10.1016/j.ahj.2008.10.013DOI: 10.1016/j.ahj.2008.10.013
Variability of response to antiplatelet therapy: what should we do next? (Journal article)
Shantsila, E., & Lip, G. Y. H. (2009). Variability of response to antiplatelet therapy: what should we do next?. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 23(1), 19-22. doi:10.1111/j.1472-8206.2008.00674.xDOI: 10.1111/j.1472-8206.2008.00674.x
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited (Journal article)
Watson, T., Shantsila, E., & Lip, G. Y. H. (2009). Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. LANCET, 373(9658), 155-166. doi:10.1016/S0140-6736(09)60040-4DOI: 10.1016/S0140-6736(09)60040-4
Acute coronary syndromes: oral factor Xa inhibitors in acute coronary syndromes. (Journal article)
Tapp, L., Wrigley, B., & Lip, G. Y. H. (2009). Acute coronary syndromes: oral factor Xa inhibitors in acute coronary syndromes.. Nature reviews. Cardiology, 6(10), 619-620. doi:10.1038/nrcardio.2009.160DOI: 10.1038/nrcardio.2009.160
Acute management of atrial fibrillation. (Journal article)
Khoo, C. W., & Lip, G. Y. H. (2009). Acute management of atrial fibrillation.. Chest, 135(3), 849-859. doi:10.1378/chest.08-2183DOI: 10.1378/chest.08-2183
Alcohol and Illicit Drug Use as Precipitants of Atrial Fibrillation in Young Adults: A Case Series and Literature Review (Journal article)
Krishnamoorthy, S., Lip, G. Y. H., & Lane, D. A. (2009). Alcohol and Illicit Drug Use as Precipitants of Atrial Fibrillation in Young Adults: A Case Series and Literature Review. AMERICAN JOURNAL OF MEDICINE, 122(9), 851-U83. doi:10.1016/j.amjmed.2009.02.012DOI: 10.1016/j.amjmed.2009.02.012
Angiopoietins in arterial hypertension: a mechanism of adaptation or a target for treatment? (Journal article)
Shantsila, E., & Lip, G. Y. H. (2009). Angiopoietins in arterial hypertension: a mechanism of adaptation or a target for treatment?. JOURNAL OF HYPERTENSION, 27(8), 1524-1526. doi:10.1097/HJH.0b013e32832dd5c4DOI: 10.1097/HJH.0b013e32832dd5c4
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis. (Journal article)
Cambronero, F., Marín, F., Roldán, V., Hernández-Romero, D., Valdés, M., & Lip, G. Y. H. (2009). Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.. European heart journal, 30(2), 139-151. doi:10.1093/eurheartj/ehn538DOI: 10.1093/eurheartj/ehn538
Can the NICE guidelines on the management of atrial fibrillation improve its management? (Journal article)
Khoo, C. W., & Lip, G. Y. H. (2009). Can the NICE guidelines on the management of atrial fibrillation improve its management?. Clinical medicine (London, England), 9(3), 207-209. doi:10.7861/clinmedicine.9-3-207DOI: 10.7861/clinmedicine.9-3-207
Circulating biomarkers of angiogenesis as indicators of left ventricular systolic dysfunction amongst patients with coronary artery disease. (Journal article)
Patel, J. V., Abraheem, A., Chackathayil, J., Gunning, M., Creamer, J., Hughes, E. A., & Lip, G. Y. H. (2009). Circulating biomarkers of angiogenesis as indicators of left ventricular systolic dysfunction amongst patients with coronary artery disease.. Journal of internal medicine, 265(5), 562-567. doi:10.1111/j.1365-2796.2008.02057.xDOI: 10.1111/j.1365-2796.2008.02057.x
Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index. (Journal article)
Goon, P. K. Y., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2009). Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.. Neoplasia (New York, N.Y.), 11(8), 771-779. doi:10.1593/neo.09490DOI: 10.1593/neo.09490
Endothelial function and endothelial progenitors: possible mediators of the benefits from physical exercise? (Journal article)
Shantsila, E., & Lip, G. Y. H. (2009). Endothelial function and endothelial progenitors: possible mediators of the benefits from physical exercise?. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 16(4), 401-403. doi:10.1097/HJR.0b013e32832d3c76DOI: 10.1097/HJR.0b013e32832d3c76
Ethnicity and peripheral artery disease. (Journal article)
Bennett, P. C., Silverman, S., Gill, P. S., & Lip, G. Y. H. (2009). Ethnicity and peripheral artery disease.. QJM : monthly journal of the Association of Physicians, 102(1), 3-16. doi:10.1093/qjmed/hcn140DOI: 10.1093/qjmed/hcn140
Face to face with basic and clinical research in Thrombosis and Haemostasis. (Journal article)
Preissner, K. T., & Lip, G. Y. H. (2009). Face to face with basic and clinical research in Thrombosis and Haemostasis.. Thrombosis and haemostasis, 101(1), 1. doi:10.1160/th08-12-0791DOI: 10.1160/th08-12-0791
Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling. (Journal article)
Saura, D., Marín, F., Climent, V., González, J., Roldán, V., Hernández-Romero, D., . . . Valdés, M. (2009). Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling.. International journal of clinical practice, 63(10), 1465-1471. doi:10.1111/j.1742-1241.2009.02127.xDOI: 10.1111/j.1742-1241.2009.02127.x
Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study. (Journal article)
Ip, J., Waldo, A. L., Lip, G. Y. H., Rothwell, P. M., Martin, D. T., Bersohn, M. M., . . . IMPACT Investigators. (2009). Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.. American heart journal, 158(3), 364-370.e1. doi:10.1016/j.ahj.2009.07.002DOI: 10.1016/j.ahj.2009.07.002
Patel, J. V., Tracey, I., Hughes, E. A., & Lip, G. Y. H. (2009). Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy.. Vascular health and risk management, 5, 801-810. doi:10.2147/vhrm.s4307DOI: 10.2147/vhrm.s4307
Peripheral arterial disease and Virchow's triad. (Journal article)
Bennett, P. C., Silverman, S. H., Gill, P. S., & Lip, G. Y. H. (2009). Peripheral arterial disease and Virchow's triad.. Thrombosis and haemostasis, 101(6), 1032-1040. doi:10.1160/th08-08-0518DOI: 10.1160/th08-08-0518
Plasma metalloproteinase-9 in age-related macular degeneration. (Journal article)
Blann, A. D., & Lip, G. Y. H. (2009). Plasma metalloproteinase-9 in age-related macular degeneration.. Eye (London, England), 23(2), 494-495. doi:10.1038/eye.2008.71DOI: 10.1038/eye.2008.71
Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation" (Journal article)
Healey, J. S. (2009). Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". THROMBOSIS AND HAEMOSTASIS, 102(5), 912-913. doi:10.1160/TH09-06-0369DOI: 10.1160/TH09-06-0369
Renin-angiotensin-aldosterone system blockade in atrial fibrillation and left atrial remodelling. (Journal article)
Krishnamoorthy, S., & Lip, G. Y. H. (2009). Renin-angiotensin-aldosterone system blockade in atrial fibrillation and left atrial remodelling.. International journal of clinical practice, 63(7), 982-985. doi:10.1111/j.1742-1241.2009.02083.xDOI: 10.1111/j.1742-1241.2009.02083.x
The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation. (Journal article)
Jolly, K., Lip, G. Y. H., Taylor, R. S., Raftery, J., Mant, J., Lane, D., . . . Stevens, A. (2009). The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation.. Heart (British Cardiac Society), 95(1), 36-42. doi:10.1136/hrt.2007.127209DOI: 10.1136/hrt.2007.127209
Thrombosis prophylaxis in patients with ischaemic (cardioembolic) stroke. How long is long enough? (Journal article)
Lip, G. Y. H., & Krishnamoorthy, S. (2009). Thrombosis prophylaxis in patients with ischaemic (cardioembolic) stroke. How long is long enough?. Hamostaseologie, 29(1), 96-101.
2008
Is thrombogenesis related to residual platelet function in ischaemic heart disease? (Journal article)
Pastor-Pérez, F. J., Marín, F., Manzano-Fernández, S., & Lip, G. Y. H. (2008). Is thrombogenesis related to residual platelet function in ischaemic heart disease?. European heart journal, 29(24), 3065. doi:10.1093/eurheartj/ehn472DOI: 10.1093/eurheartj/ehn472
Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: Is clopidogrel any safer than aspirin when combined with warfarin? (Journal article)
Tay, K. H., Lane, D. A., & Lip, G. Y. H. (2008). Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: Is clopidogrel any safer than aspirin when combined with warfarin?. THROMBOSIS AND HAEMOSTASIS, 100(6), 955-957. doi:10.1160/TH08-10-0685DOI: 10.1160/TH08-10-0685
Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function. (Journal article)
Patel, J. V., Abraheem, A., Dotsenko, O., Creamer, J., Gunning, M., Hughes, E. A., & Lip, G. Y. H. (2008). Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function.. Journal of internal medicine, 264(6), 593-598. doi:10.1111/j.1365-2796.2008.02007.xDOI: 10.1111/j.1365-2796.2008.02007.x
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. (Journal article)
Van de Werf, F., Bax, J., Betriu, A., Blomstrom-Lundqvist, C., Crea, F., Falk, V., . . . ESC Committee for Practice Guidelines (CPG). (2008). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.. European heart journal, 29(23), 2909-2945. doi:10.1093/eurheartj/ehn416DOI: 10.1093/eurheartj/ehn416
Predicting thrombotic events: Creating a complex approach for a complex condition (Journal article)
Shantsila, E., & Lip, G. Y. H. (2008). Predicting thrombotic events: Creating a complex approach for a complex condition. THROMBOSIS AND HAEMOSTASIS, 100(6), 962-964. doi:10.1160/TH08-10-0681DOI: 10.1160/TH08-10-0681
Radiofrequency catheter ablation of atrial fibrillation and thromboembolic risk. (Journal article)
Khoo, C. W., & Lip, G. Y. H. (2008). Radiofrequency catheter ablation of atrial fibrillation and thromboembolic risk.. European journal of neurology, 15(12), 1261-1262. doi:10.1111/j.1468-1331.2008.02342.xDOI: 10.1111/j.1468-1331.2008.02342.x
The endothelium, arterial stiffness, and von Willebrand factor levels in hypertensive women: effects of ethnicity. (Journal article)
Butt, M., & Lip, G. Y. H. (2008). The endothelium, arterial stiffness, and von Willebrand factor levels in hypertensive women: effects of ethnicity.. American journal of hypertension, 21(12), 1275-1276. doi:10.1038/ajh.2008.303DOI: 10.1038/ajh.2008.303
The search for new anticoagulants: dabigatran etexilate (Journal article)
Siddique, A., Shantsila, E., & Lip, G. Y. H. (2008). The search for new anticoagulants: dabigatran etexilate. Therapy, 5(6), 793-796. doi:10.2217/14750708.5.6.793DOI: 10.2217/14750708.5.6.793
What "drives" the link between the renin-angiotensin-aldosterone system and the prothrombotic state in hypertension? (Journal article)
Tay, K. -H., & Lip, G. Y. H. (2008). What "drives" the link between the renin-angiotensin-aldosterone system and the prothrombotic state in hypertension?. American journal of hypertension, 21(12), 1278-1279. doi:10.1038/ajh.2008.315DOI: 10.1038/ajh.2008.315
10 steps before you refer for: Atrial fibrillation (Journal article)
Heath, R., & Lip, G. Y. H. (2008). 10 steps before you refer for: Atrial fibrillation. British Journal of Cardiology, 15(6), 302-305.
Gender and the response to blood pressure-lowering treatment. (Journal article)
Lip, G. Y. H., & Butt, M. (2008). Gender and the response to blood pressure-lowering treatment.. European heart journal, 29(21), 2585-2586. doi:10.1093/eurheartj/ehn451DOI: 10.1093/eurheartj/ehn451
Hypertension, stroke and the impact of atrial fibrillation. (Journal article)
Krishnamoorthy, S., & Lip, G. Y. (2008). Hypertension, stroke and the impact of atrial fibrillation.. Expert review of cardiovascular therapy, 6(10), 1287-1289. doi:10.1586/14779072.6.10.1287DOI: 10.1586/14779072.6.10.1287
The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis. (Journal article)
Boos, C. J., Balakrishnan, B., Blann, A. D., & Lip, G. Y. H. (2008). The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis.. Journal of thrombosis and haemostasis : JTH, 6(11), 1841-1850. doi:10.1111/j.1538-7836.2008.03148.xDOI: 10.1111/j.1538-7836.2008.03148.x
Reply (Journal article)
Gasparyan, A. Y., & Lip, G. Y. H. (2008). Reply. Journal of the American College of Cardiology, 52(15), 1277. doi:10.1016/j.jacc.2008.07.014DOI: 10.1016/j.jacc.2008.07.014
Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk. (Journal article)
Roldán, V., Marín, F., González-Conejero, R., García-Honrubia, A., Martí, S., Alfaro, A., . . . Vicente, V. (2008). Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk.. Annals of medicine, 40(7), 553-559. doi:10.1080/07853890802108412DOI: 10.1080/07853890802108412
Arterial stiffness: beyond pulse wave velocity and its measurement. (Journal article)
Lim, H. S., & Lip, G. Y. H. (2008). Arterial stiffness: beyond pulse wave velocity and its measurement.. Journal of human hypertension, 22(10), 656-658. doi:10.1038/jhh.2008.47DOI: 10.1038/jhh.2008.47
Response to letter to editor by Jolobe ‘Stroke risk might be specifically correlated with the burden of paroxysmal atrial fibrillation’ (Journal article)
Lip, G. Y. H. (2008). Response to letter to editor by Jolobe ‘Stroke risk might be specifically correlated with the burden of paroxysmal atrial fibrillation’. Journal of Internal Medicine, 264(4), 402-403. doi:10.1111/j.1365-2796.2008.02009.xDOI: 10.1111/j.1365-2796.2008.02009.x
Initiation and persistence of warfarin or aspirin as thromboprophylaxis in chronic atrial fibrillation in general practice. (Journal article)
Khoo, C. W., & Lip, G. Y. H. (2008). Initiation and persistence of warfarin or aspirin as thromboprophylaxis in chronic atrial fibrillation in general practice.. Journal of thrombosis and haemostasis : JTH, 6(10), 1622-1624. doi:10.1111/j.1538-7836.2008.03115.xDOI: 10.1111/j.1538-7836.2008.03115.x
Effects of white European, African Caribbean and South Asian ethnicity on homocysteine levels in patients with systolic heart failure. (Journal article)
Sosin, M. D., Patel, J. V., Bhatia, G. S., Hughes, E. A., Davis, R. C., & Lip, G. Y. H. (2008). Effects of white European, African Caribbean and South Asian ethnicity on homocysteine levels in patients with systolic heart failure.. International journal of cardiology, 129(1), 69-75. doi:10.1016/j.ijcard.2007.04.112DOI: 10.1016/j.ijcard.2007.04.112
Hemoxygenase-1 in cardiovascular disease. (Journal article)
Idriss, N. K., Blann, A. D., & Lip, G. Y. H. (2008). Hemoxygenase-1 in cardiovascular disease.. Journal of the American College of Cardiology, 52(12), 971-978. doi:10.1016/j.jacc.2008.06.019DOI: 10.1016/j.jacc.2008.06.019
Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary intervention. (Journal article)
Lip, G. Y. H. (2008). Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary intervention.. BMJ (Clinical research ed.), 337, a840. doi:10.1136/bmj.39533.570602.beDOI: 10.1136/bmj.39533.570602.be
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. (Journal article)
Rubboli, A., Halperin, J. L., Airaksinen, K. E. J., Buerke, M., Eeckhout, E., Freedman, S. B., . . . Lip, G. Y. H. (2008). Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.. Annals of medicine, 40(6), 428-436. doi:10.1080/07853890802089786DOI: 10.1080/07853890802089786
Elevated angiogenin levels in chronic heart failure. (Journal article)
Patel, J. V., Sosin, M., Gunarathne, A., Hussain, I., Davis, R. C., Hughes, E. A., & Lip, G. Y. H. (2008). Elevated angiogenin levels in chronic heart failure.. Annals of medicine, 40(6), 474-479. doi:10.1080/07853890802001419DOI: 10.1080/07853890802001419
Stroke prevention. (Journal article)
Lip, G. Y., & Kalra, L. (2008). Stroke prevention.. BMJ clinical evidence, 2008, 0207.
Apixaban, an oral, direct inhibitor of activated Factor Xa (Journal article)
Shantsila, E., & Lip, G. Y. H. (2008). Apixaban, an oral, direct inhibitor of activated Factor Xa. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 9(9), 1020-1033. Retrieved from https://www.webofscience.com/
Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis? (Journal article)
Krishnamoorthy, S., & Lip, G. Y. H. (2008). Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis?. Therapy, 5(4), 487-489. doi:10.2217/14750708.5.4.487DOI: 10.2217/14750708.5.4.487
Asymptomatic atrial fibrillation on device interrogation. (Journal article)
Lim, H. S., & Lip, G. Y. H. (2008). Asymptomatic atrial fibrillation on device interrogation.. Journal of cardiovascular electrophysiology, 19(8), 891-893. doi:10.1111/j.1540-8167.2008.01194.xDOI: 10.1111/j.1540-8167.2008.01194.x
Candidate circulating biomarkers for the cardiovascular disease continuum. (Journal article)
Dotsenko, O., Chackathayil, J., Patel, J. V., Gill, P. S., & Lip, G. Y. H. (2008). Candidate circulating biomarkers for the cardiovascular disease continuum.. Current pharmaceutical design, 14(24), 2445-2461. doi:10.2174/138161208785777388DOI: 10.2174/138161208785777388
Endothelium and fibrinolysis in hypertension: important facets of a prothrombotic state? (Journal article)
Lip, G. Y. H., & Blann, A. D. (2008). Endothelium and fibrinolysis in hypertension: important facets of a prothrombotic state?. Hypertension (Dallas, Tex. : 1979), 52(2), 218-219. doi:10.1161/hypertensionaha.108.114876DOI: 10.1161/hypertensionaha.108.114876
Measurement of stiffness index by digital volume pulse analysis technique: clinical utility in cardiovascular disease risk stratification. (Journal article)
Gunarathne, A., Patel, J. V., Hughes, E. A., & Lip, G. Y. H. (2008). Measurement of stiffness index by digital volume pulse analysis technique: clinical utility in cardiovascular disease risk stratification.. American journal of hypertension, 21(8), 866-872. doi:10.1038/ajh.2008.207DOI: 10.1038/ajh.2008.207
Ventricular optimization of biventricular pacing: a systematic review. (Journal article)
Lim, S. H., Lip, G. Y. H., & Sanderson, J. E. (2008). Ventricular optimization of biventricular pacing: a systematic review.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10(8), 901-906. doi:10.1093/europace/eun177DOI: 10.1093/europace/eun177
Imaging of the unstable plaque. (Journal article)
Tan, K. T., & Lip, G. Y. H. (2008). Imaging of the unstable plaque.. International journal of cardiology, 127(2), 157-165. doi:10.1016/j.ijcard.2007.11.054DOI: 10.1016/j.ijcard.2007.11.054
Vital exhaustion and cardiovascular disease: Are circulating fibrinogen and D-dimer levels a plausible link? (Journal article)
Bennett, P. C., Lane, D. A., & Lip, G. Y. H. (2008). Vital exhaustion and cardiovascular disease: Are circulating fibrinogen and D-dimer levels a plausible link?. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, 11(4), 247-249. doi:10.1080/10253890701833029DOI: 10.1080/10253890701833029
Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease? (Journal article)
Lim, H. S., Tayebjee, M. H., Tan, K. T., Patel, J. V., Macfadyen, R. J., & Lip, G. Y. H. (2008). Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?. Thrombosis research, 122(3), 307-313. doi:10.1016/j.thromres.2007.10.013DOI: 10.1016/j.thromres.2007.10.013
Beyond glucose levels in diabetic patients with coronary artery disease: Platelet activity and non-responsiveness to antiplatelet therapy (Journal article)
Shantsila, E., & Lip, G. Y. H. (2008). Beyond glucose levels in diabetic patients with coronary artery disease: Platelet activity and non-responsiveness to antiplatelet therapy. THROMBOSIS AND HAEMOSTASIS, 100(1), 7-8. doi:10.1160/TH08-06-0342DOI: 10.1160/TH08-06-0342
Interleukin-8 and atrial fibrillation. (Journal article)
Melenovsky, V., & Lip, G. Y. H. (2008). Interleukin-8 and atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10(7), 784-785. doi:10.1093/europace/eun154DOI: 10.1093/europace/eun154
Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis. (Journal article)
Lip, G. Y. H. (2008). Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.. Thrombosis and haemostasis, 100(1), 11-13. doi:10.1160/th08-05-0331DOI: 10.1160/th08-05-0331
Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities. (Journal article)
Lip, G. Y. H. (2008). Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.. American heart journal, 156(1), 1-3. doi:10.1016/j.ahj.2008.02.020DOI: 10.1016/j.ahj.2008.02.020
Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation. (Journal article)
Lip, G. Y. H., Frison, L., Grind, M., & SPORTIF Investigators. (2008). Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation.. Journal of internal medicine, 264(1), 50-61. doi:10.1111/j.1365-2796.2007.01909.xDOI: 10.1111/j.1365-2796.2007.01909.x
Thrombosis and Haemostasis: volume 100 and going strong ... (Journal article)
Preissner, K. T., & Lip, G. Y. H. (2008). Thrombosis and Haemostasis: volume 100 and going strong .... Thrombosis and haemostasis, 100(1), 1-2. doi:10.1160/th08-06-0359DOI: 10.1160/th08-06-0359
Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction. (Journal article)
Blann, A. D., Choudhury, A., Freestone, B., Patel, J., & Lip, G. Y. H. (2008). Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction.. International journal of cardiology, 127(1), 135-137. doi:10.1016/j.ijcard.2007.04.028DOI: 10.1016/j.ijcard.2007.04.028
Identifying AF patients at risk of stroke: can prothrombotic indices improve things? (Journal article)
Watson, T., & Lip, G. Y. H. (2008). Identifying AF patients at risk of stroke: can prothrombotic indices improve things?. International journal of cardiology, 126(3), 299-301. doi:10.1016/j.ijcard.2007.08.092DOI: 10.1016/j.ijcard.2007.08.092
Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation. (Journal article)
Ruiz-Nodar, J. M., Marín, F., & Lip, G. Y. H. (2008). Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation.. JACC. Cardiovascular interventions, 1(3), 329. doi:10.1016/j.jcin.2008.03.016DOI: 10.1016/j.jcin.2008.03.016
Circulating endothelial cells in health and disease: how do we best quantify them? (Journal article)
Shantsila, E., & Lip, G. Y. H. (2008). Circulating endothelial cells in health and disease: how do we best quantify them?. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 6(6), 1021-1024. doi:10.1111/j.1538-7836.2008.02985.xDOI: 10.1111/j.1538-7836.2008.02985.x
Circulating matrix metalloproteinase-9 levels in atherosclerotic vascular disease: a possible measurement of systemic or specific disease pathophysiology? (Journal article)
Lim, H. S., & Lip, G. Y. H. (2008). Circulating matrix metalloproteinase-9 levels in atherosclerotic vascular disease: a possible measurement of systemic or specific disease pathophysiology?. Journal of internal medicine, 263(6), 620-622. doi:10.1111/j.1365-2796.2008.01937.xDOI: 10.1111/j.1365-2796.2008.01937.x
Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension. (Journal article)
Watson, T., Goon, P. K. Y., & Lip, G. Y. H. (2008). Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension.. Antioxidants & redox signaling, 10(6), 1079-1088. doi:10.1089/ars.2007.1998DOI: 10.1089/ars.2007.1998
Obstructive sleep apnoea and metabolic syndrome: two sides of the same coin? (Journal article)
Dwivedi, G., Khair, O., & Lip, G. Y. H. (2008). Obstructive sleep apnoea and metabolic syndrome: two sides of the same coin?. Journal of human hypertension, 22(6), 377-379. doi:10.1038/jhh.2008.14DOI: 10.1038/jhh.2008.14
Platelet adhesion in congestive heart failure. (Journal article)
Chung, I., Choudhury, A., & Lip, G. Y. H. (2008). Platelet adhesion in congestive heart failure.. Thrombosis research, 121(6), 885-888. doi:10.1016/j.thromres.2007.07.011DOI: 10.1016/j.thromres.2007.07.011
Premature coronary artery disease: an inferred cardiovascular variant or a South Asian genetic disorder? (Journal article)
Patel, J. V., Dwivedi, S., Hughes, E. A., & Lip, G. Y. H. (2008). Premature coronary artery disease: an inferred cardiovascular variant or a South Asian genetic disorder?. Thrombosis and haemostasis, 99(6), 991-992. doi:10.1160/th08-05-0286DOI: 10.1160/th08-05-0286
Statins and inflammation: Reciprocal effectors to endothelial progenitors? (Journal article)
Shantsila, E., Watson, T., & Lip, G. Y. H. (2008). Statins and inflammation: Reciprocal effectors to endothelial progenitors?. THROMBOSIS RESEARCH, 123(1), 1-4. doi:10.1016/j.thromres.2008.03.021DOI: 10.1016/j.thromres.2008.03.021
The role of aspirin in cardiovascular prevention: implications of aspirin resistance. (Journal article)
Gasparyan, A. Y., Watson, T., & Lip, G. Y. H. (2008). The role of aspirin in cardiovascular prevention: implications of aspirin resistance.. Journal of the American College of Cardiology, 51(19), 1829-1843. doi:10.1016/j.jacc.2007.11.080DOI: 10.1016/j.jacc.2007.11.080
Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels. (Journal article)
Freestone, B., Chong, A. Y., Nuttall, S., & Lip, G. Y. H. (2008). Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.. Thrombosis research, 122(1), 85-90. doi:10.1016/j.thromres.2007.09.008DOI: 10.1016/j.thromres.2007.09.008
Atrial fibrillation (acute onset). (Journal article)
Lip, G. Y. H., & Watson, T. (2008). Atrial fibrillation (acute onset).. BMJ clinical evidence, 2008, 0210.
Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range. (Journal article)
Taggar, J. S., & Lip, G. Y. H. (2008). Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range.. Current medical research and opinion, 24(5), 1455-1458. doi:10.1185/030079908x301875DOI: 10.1185/030079908x301875
Antithrombotic treatment in atrial fibrillation. (Journal article)
Lip, G. Y. H., & Boos, C. J. (2006). Antithrombotic treatment in atrial fibrillation.. Heart (British Cardiac Society), 92(2), 155-161. doi:10.1136/hrt.2005.066944DOI: 10.1136/hrt.2005.066944
Circulating endothelial cells: from bench to clinical practice (Journal article)
Shantsila, E., Blann, A. D., & Lip, G. Y. H. (2008). Circulating endothelial cells: from bench to clinical practice. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 6(5), 865-868. doi:10.1111/j.1538-7836.2008.02918.xDOI: 10.1111/j.1538-7836.2008.02918.x
Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule. (Journal article)
Lim, H. S., Lip, G. Y. H., & Tse, H. -F. (2008). Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10(5), 536-539. doi:10.1093/europace/eun070DOI: 10.1093/europace/eun070
The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited. (Journal article)
Lip, G. Y. H. (2008). The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited.. Stroke, 39(5), 1406-1408. doi:10.1161/strokeaha.107.506832DOI: 10.1161/strokeaha.107.506832
Atrial fibrillation (chronic). (Journal article)
Boos, C. J., Lane, D. A., & Lip, G. Y. H. (2008). Atrial fibrillation (chronic).. BMJ clinical evidence, 2008, 0217.
Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension. (Journal article)
Patel, J. V., Lim, H. S., Varughese, G. I., Hughes, E. A., & Lip, G. Y. H. (2008). Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.. Annals of medicine, 40(3), 215-222. doi:10.1080/07853890701779586DOI: 10.1080/07853890701779586
Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes. (Journal article)
Kistorp, C., Chong, A. Y., Gustafsson, F., Galatius, S., Raymond, I., Faber, J., . . . Hildebrandt, P. (2008). Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes.. European journal of heart failure, 10(4), 380-387. doi:10.1016/j.ejheart.2008.02.012DOI: 10.1016/j.ejheart.2008.02.012
Left ventricular ejection fraction: are the revised cut-off points for defining systolic dysfunction sufficiently evidence based? (Journal article)
Mahadevan, G., Davis, R. C., Frenneaux, M. P., Hobbs, F. D. R., Lip, G. Y. H., Sanderson, J. E., & Davies, M. K. (2008). Left ventricular ejection fraction: are the revised cut-off points for defining systolic dysfunction sufficiently evidence based?. Heart (British Cardiac Society), 94(4), 426-428. doi:10.1136/hrt.2007.123877DOI: 10.1136/hrt.2007.123877
Mortality in patients with atrial fibrillation: improving or not? (Journal article)
Taggar, J. S., Marín, F., & Lip, G. Y. H. (2008). Mortality in patients with atrial fibrillation: improving or not?. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10(4), 389-390. doi:10.1093/europace/eun054DOI: 10.1093/europace/eun054
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? (Journal article)
Nieuwlaat, R., Dinh, T., Olsson, S. B., Camm, A. J., Capucci, A., Tieleman, R. G., . . . Euro Heart Survey Investigators. (2008). Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?. European heart journal, 29(7), 915-922. doi:10.1093/eurheartj/ehn101DOI: 10.1093/eurheartj/ehn101
Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype. (Journal article)
Blann, A. D., Mohan, J. S., Bareford, D., & Lip, G. Y. H. (2008). Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype.. Journal of thrombosis and thrombolysis, 25(2), 185-189. doi:10.1007/s11239-007-0177-7DOI: 10.1007/s11239-007-0177-7
The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood. (Journal article)
Boos, C. J., Balakrishnan, B., & Lip, G. Y. H. (2008). The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood.. Journal of thrombosis and thrombolysis, 25(2), 135-140. doi:10.1007/s11239-007-0034-8DOI: 10.1007/s11239-007-0034-8
Reproducibility and safety of the incremental shuttle walking test for cardiac rehabilitation. (Journal article)
Jolly, K., Taylor, R. S., Lip, G. Y. H., Singh, S., & BRUM Steering Committee. (2008). Reproducibility and safety of the incremental shuttle walking test for cardiac rehabilitation.. International journal of cardiology, 125(1), 144-145. doi:10.1016/j.ijcard.2007.01.037DOI: 10.1016/j.ijcard.2007.01.037
Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation. (Journal article)
Lip, G. Y. H. (2008). Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation.. BMJ (Clinical research ed.), 336(7644), 614-615. doi:10.1136/bmj.39351.706586.adDOI: 10.1136/bmj.39351.706586.ad
Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity. (Journal article)
Chung, I., Choudhury, A., Patel, J., & Lip, G. Y. H. (2008). Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.. Journal of internal medicine, 263(3), 313-321. doi:10.1111/j.1365-2796.2007.01891.xDOI: 10.1111/j.1365-2796.2007.01891.x
The effects of maximal treadmill graded exercise testing on haemorheological, haemodynamic and flow cytometry platelet markers in patients with systolic or diastolic heart failure. (Journal article)
Chung, I., Goyal, D., Macfadyen, R. J., & Lip, G. Y. H. (2008). The effects of maximal treadmill graded exercise testing on haemorheological, haemodynamic and flow cytometry platelet markers in patients with systolic or diastolic heart failure.. European journal of clinical investigation, 38(3), 150-158. doi:10.1111/j.1365-2362.2008.01909.xDOI: 10.1111/j.1365-2362.2008.01909.x
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. (Journal article)
Ruiz-Nodar, J. M., Marín, F., Hurtado, J. A., Valencia, J., Pinar, E., Pineda, J., . . . Lip, G. Y. H. (2008). Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.. Journal of the American College of Cardiology, 51(8), 818-825. doi:10.1016/j.jacc.2007.11.035DOI: 10.1016/j.jacc.2007.11.035
Letter by Roldán et al regarding article, "Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass". (Journal article)
Roldán, V., Marín, F., & Lip, G. Y. H. (2008). Letter by Roldán et al regarding article, "Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass".. Circulation, 117(8), e169. doi:10.1161/circulationaha.107.746461DOI: 10.1161/circulationaha.107.746461
New insights on endothelial progenitor cell subpopulations and their angiogenic properties (Journal article)
Shantsila, E., Watson, T., Tse, H. -F., & Lip, G. Y. H. (2008). New insights on endothelial progenitor cell subpopulations and their angiogenic properties. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 51(6), 669-671. doi:10.1016/j.jacc.2007.09.057DOI: 10.1016/j.jacc.2007.09.057
Gohar, F., Greenfield, S. M., Beevers, D. G., Lip, G. Y. H., & Jolly, K. (2008). Self-care and adherence to medication: a survey in the hypertension outpatient clinic.. BMC complementary and alternative medicine, 8, 4. doi:10.1186/1472-6882-8-4DOI: 10.1186/1472-6882-8-4
The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction. (Journal article)
Boos, C. J., Balakrishnan, B., & Lip, G. Y. H. (2008). The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.. Annals of medicine, 40(1), 66-73. doi:10.1080/07853890701652833DOI: 10.1080/07853890701652833
Cardioversion and remodelline in atrial, fibrillation: Insights beyond the prothrombotic state (Journal article)
Shantsila, E., Watson, T., & Lip, G. Y. H. (2008). Cardioversion and remodelline in atrial, fibrillation: Insights beyond the prothrombotic state. THROMBOSIS RESEARCH, 121(4), 443-445. doi:10.1016/j.thromres.2007.08.019DOI: 10.1016/j.thromres.2007.08.019
Can patients with atrial fibrillation be optimally risk stratified for stroke and thromboembolism? (Journal article)
Taggar, J. S., Watson, T., & Lip, G. Y. H. (2008). Can patients with atrial fibrillation be optimally risk stratified for stroke and thromboembolism?. Stroke, 39(2), e24-e25. doi:10.1161/strokeaha.107.502369DOI: 10.1161/strokeaha.107.502369
Experiences of living with congestive heart failure: a qualitative study. (Journal article)
Thornhill, K., Lyons, A. C., Nouwen, A., & Lip, G. Y. H. (2008). Experiences of living with congestive heart failure: a qualitative study.. British journal of health psychology, 13(Pt 1), 155-175. doi:10.1348/135910706x170983DOI: 10.1348/135910706x170983
Increased 5-year mortality in the migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: the West Birmingham Stroke Project. (Journal article)
Gunarathne, A., Patel, J. V., Potluri, R., Gammon, B., Jessani, S., Hughes, E. A., & Lip, G. Y. H. (2008). Increased 5-year mortality in the migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: the West Birmingham Stroke Project.. International journal of clinical practice, 62(2), 197-201. doi:10.1111/j.1742-1241.2007.01580.xDOI: 10.1111/j.1742-1241.2007.01580.x
Inflammation and atrial fibrillation: cause or effect? (Journal article)
Boos, C. J., & Lip, G. Y. H. (2008). Inflammation and atrial fibrillation: cause or effect?. Heart (British Cardiac Society), 94(2), 133-134. doi:10.1136/hrt.2007.119651DOI: 10.1136/hrt.2007.119651
New approaches to therapy with omega-3 fatty acids. (Journal article)
Kakar, P., Watson, T., & Lip, G. Y. H. (2008). New approaches to therapy with omega-3 fatty acids.. Current atherosclerosis reports, 10(1), 79-87. doi:10.1007/s11883-008-0012-4DOI: 10.1007/s11883-008-0012-4
Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. (Journal article)
Hughes, M., Lip, G. Y. H., & Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical Excellence. (2008). Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.. Thrombosis and haemostasis, 99(2), 295-304. doi:10.1160/th07-08-0508DOI: 10.1160/th07-08-0508
Erratum to “Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias” [International Journal of Cardiology 107/1 (2006) 134–135] (Journal article)
Marinskis, G., Lip, G. Y. H., Adietis, A., Jurkuvėnas, P., Kairevičiūte, D., Ježov, V., . . . Laucevičius, A. (2008). Erratum to “Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias” [International Journal of Cardiology 107/1 (2006) 134–135]. International Journal of Cardiology, 123(2), 217. doi:10.1016/j.ijcard.2007.10.013DOI: 10.1016/j.ijcard.2007.10.013
Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting. (Journal article)
Manzano-Fernández, S., Marin, F., Martinez, J. A. H., Cambronero, F., Valdés, M., Ruiz-Nodar, J. M., . . . Lip, G. Y. H. (2008). Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting.. QJM : monthly journal of the Association of Physicians, 101(9), 749-751. doi:10.1093/qjmed/hcn082DOI: 10.1093/qjmed/hcn082
Anticoagulation for elderly patients with atrial fibrillation: not to be neglected. (Journal article)
Taggar, J. S., & Lip, G. Y. H. (2008). Anticoagulation for elderly patients with atrial fibrillation: not to be neglected.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10(1), 1-2. doi:10.1093/europace/eum223DOI: 10.1093/europace/eum223
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). (Journal article)
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., . . . Manning, W. J. (2008). Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).. Chest, 133(6 Suppl), 546S-592S. doi:10.1378/chest.08-0678DOI: 10.1378/chest.08-0678
Barriers to anticoagulation in patients with atrial fibrillation - Changing physician-related factors (Journal article)
Lane, D. A., & Lip, G. Y. H. (2008). Barriers to anticoagulation in patients with atrial fibrillation - Changing physician-related factors. STROKE, 39(1), 7-9. doi:10.1161/STROKEAHA.107.496554DOI: 10.1161/STROKEAHA.107.496554
Endothelial progenitor cells: from pathophysiology to clinical practice. (Journal article)
Goon, P. K. Y., Watson, T., Stonelake, P. S., & Lip, G. Y. H. (2008). Endothelial progenitor cells: from pathophysiology to clinical practice.. International journal of clinical practice, 62(1), 4-6. doi:10.1111/j.1742-1241.2007.01555.xDOI: 10.1111/j.1742-1241.2007.01555.x
Ethnic differences in myocardial infarction in patients with hypertension: effects of diabetes mellitus. (Journal article)
Patel, J. V., Lim, H. S., Gunarathne, A., Tracey, I., Durrington, P. N., Hughes, E. A., & Lip, G. Y. H. (2008). Ethnic differences in myocardial infarction in patients with hypertension: effects of diabetes mellitus.. QJM : monthly journal of the Association of Physicians, 101(3), 231-236. doi:10.1093/qjmed/hcm151DOI: 10.1093/qjmed/hcm151
Impact of mean arterial blood pressure on higher arterial stiffness indices in South Asians compared to white Europeans. (Journal article)
Gunarathne, A., Patel, J. V., Gammon, B., Hughes, E. A., & Lip, G. Y. H. (2008). Impact of mean arterial blood pressure on higher arterial stiffness indices in South Asians compared to white Europeans.. Journal of hypertension, 26(7), 1420-1426. doi:10.1097/hjh.0b013e3282ffb42aDOI: 10.1097/hjh.0b013e3282ffb42a
Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. (Journal article)
Manzano-Fernández, S., Pastor, F. J., Marín, F., Cambronero, F., Caro, C., Pascual-Figal, D. A., . . . Lip, G. Y. H. (2008). Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.. Chest, 134(3), 559-567. doi:10.1378/chest.08-0350DOI: 10.1378/chest.08-0350
Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure. (Journal article)
Freestone, B., Gustafsson, F., Chong, A. Y., Corell, P., Kistorp, C., Hildebrandt, P., & Lip, G. Y. H. (2008). Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.. Chest, 133(5), 1203-1208. doi:10.1378/chest.07-2557DOI: 10.1378/chest.07-2557
Measurement of C-reactive protein and natriuretic peptides for cardiovascular risk assessment: the need for age and gender-specific thresholds. (Journal article)
Dotsenko, O., Chackathayil, J., & Lip, G. Y. H. (2008). Measurement of C-reactive protein and natriuretic peptides for cardiovascular risk assessment: the need for age and gender-specific thresholds.. Journal of hypertension, 26(1), 11-13. doi:10.1097/hjh.0b013e3282f3320eDOI: 10.1097/hjh.0b013e3282f3320e
Risk predictors for lone atrial fibrillation. (Journal article)
Taggar, J. S., & Lip, G. Y. H. (2008). Risk predictors for lone atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10(1), 6-8. doi:10.1093/europace/eum274DOI: 10.1093/europace/eum274
Secular trends in the cardiovascular risk profile and mortality of stroke admissions in an inner city, multiethnic population in the United Kingdom (1997-2005). (Journal article)
Gunarathne, A., Patel, J. V., Potluri, R., Gill, P. S., Hughes, E. A., & Lip, G. Y. H. (2008). Secular trends in the cardiovascular risk profile and mortality of stroke admissions in an inner city, multiethnic population in the United Kingdom (1997-2005).. Journal of human hypertension, 22(1), 18-23. doi:10.1038/sj.jhh.1002265DOI: 10.1038/sj.jhh.1002265
Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention. (Journal article)
Choudhury, A., Chung, I., Panja, N., Patel, J., & Lip, G. Y. H. (2008). Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.. Chest, 134(3), 574-581. doi:10.1378/chest.07-2745DOI: 10.1378/chest.07-2745
The endothelium and atrial fibrillation. The prothrombotic state revisited. (Journal article)
Freestone, B., & Lip, G. Y. H. (2008). The endothelium and atrial fibrillation. The prothrombotic state revisited.. Hamostaseologie, 28(4), 207-212. doi:10.1055/s-0037-1617102DOI: 10.1055/s-0037-1617102
The impact of statin use on atrial fibrillation. (Journal article)
Sánchez-Quiñones, J., Marín, F., Roldán, V., & Lip, G. Y. H. (2008). The impact of statin use on atrial fibrillation.. QJM : monthly journal of the Association of Physicians, 101(11), 845-861. doi:10.1093/qjmed/hcn101DOI: 10.1093/qjmed/hcn101
The left atrium and diastolic dysfunction in hypertensive left ventricular hypertrophy: a consideration of size and function? (Journal article)
Dwivedi, G., & Lip, G. Y. H. (2008). The left atrium and diastolic dysfunction in hypertensive left ventricular hypertrophy: a consideration of size and function?. Journal of hypertension, 26(7), 1310-1312. doi:10.1097/hjh.0b013e328302ee20DOI: 10.1097/hjh.0b013e328302ee20
2007
Atrial fibrillation: Rate control and digoxin. (Journal article)
Lip, G. Y. H., Rudolf, M., & Guideline development group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Atrial fibrillation: Rate control and digoxin.. BMJ (Clinical research ed.), 335(7631), 1169-1170. doi:10.1136/bmj.39416.442731.beDOI: 10.1136/bmj.39416.442731.be
Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: differences in central versus peripheral levels. (Journal article)
Jaumdally, R. J., Varma, C., Blann, A. D., Macfadyen, R. J., & Lip, G. Y. H. (2007). Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: differences in central versus peripheral levels.. Annals of medicine, 39(8), 628-633. doi:10.1080/07853890701636265DOI: 10.1080/07853890701636265
A comparison of plasma versus histologic indices of angiogenic markers in breast cancer. (Journal article)
Caine, G. J., Lip, G., Zanetto, U., Maheshwari, M., Stonelake, P. S., & Blann, A. D. (2007). A comparison of plasma versus histologic indices of angiogenic markers in breast cancer.. Applied immunohistochemistry & molecular morphology : AIMM, 15(4), 382-388. doi:10.1097/01.pai.0000213137.01536.caDOI: 10.1097/01.pai.0000213137.01536.ca
Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure. (Journal article)
Hamaad, A., Lip, G. Y. H., Nicholls, D., & MacFadyen, R. J. (2007). Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure.. Cardiovascular drugs and therapy, 21(6), 437-444. doi:10.1007/s10557-007-6055-xDOI: 10.1007/s10557-007-6055-x
Measuring soluble CD40 ligand:interleukin-10 ratio as a prognostic marker in acute myocardial infarction: yet another prognostic biomarker? (Journal article)
Jessani, S., & Lip, G. Y. H. (2007). Measuring soluble CD40 ligand:interleukin-10 ratio as a prognostic marker in acute myocardial infarction: yet another prognostic biomarker?. Thrombosis research, 121(3), 289-291. doi:10.1016/j.thromres.2007.05.011DOI: 10.1016/j.thromres.2007.05.011
Plasma angiogenin levels in acute coronary syndromes: implications for prognosis. (Journal article)
Tello-Montoliu, A., Marín, F., Patel, J., Roldán, V., Mainar, L., Vicente, V., . . . Lip, G. Y. H. (2007). Plasma angiogenin levels in acute coronary syndromes: implications for prognosis.. European heart journal, 28(24), 3006-3011. doi:10.1093/eurheartj/ehm488DOI: 10.1093/eurheartj/ehm488
Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain - the Healthy Hearts Project (Journal article)
Patel, J. V., Gunarathne, A., Lane, D., Lim, H. S., Tracey, I., Panja, N. C., . . . Hughes, E. A. (2007). Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain - the Healthy Hearts Project. BMC HEALTH SERVICES RESEARCH, 7. doi:10.1186/1472-6963-7-192DOI: 10.1186/1472-6963-7-192
Management of atrial fibrillation – Authors' reply (Journal article)
Lip, G. Y. H., & Tse, H. -F. (2007). Management of atrial fibrillation – Authors' reply. The Lancet, 370(9599), 1608. doi:10.1016/s0140-6736(07)61683-3DOI: 10.1016/s0140-6736(07)61683-3
Atrial fibrillation and stroke prevention. (Journal article)
Lip, G. Y. H., & Lim, H. S. (2007). Atrial fibrillation and stroke prevention.. The Lancet. Neurology, 6(11), 981-993. doi:10.1016/s1474-4422(07)70264-8DOI: 10.1016/s1474-4422(07)70264-8
Cardiac biomarkers: myths, facts and future horizons. (Journal article)
Dotsenko, O., Chackathayil, J., & Lip, G. Y. H. (2007). Cardiac biomarkers: myths, facts and future horizons.. Expert review of molecular diagnostics, 7(6), 693-697. doi:10.1586/14737159.7.6.693DOI: 10.1586/14737159.7.6.693
Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke. (Journal article)
Sharobeem, K. M., Patel, J. V., Ritch, A. E. S., Lip, G. Y. H., Gill, P. S., & Hughes, E. A. (2007). Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke.. International journal of clinical practice, 61(11), 1824-1828. doi:10.1111/j.1742-1241.2007.01521.xDOI: 10.1111/j.1742-1241.2007.01521.x
Post-stenting antithrombotic drug therapy in patients with atrial fibrillation. (Journal article)
Lip, G. Y. H. (2007). Post-stenting antithrombotic drug therapy in patients with atrial fibrillation.. The American journal of medicine, 120(11), 920-922. doi:10.1016/j.amjmed.2007.01.036DOI: 10.1016/j.amjmed.2007.01.036
Stroke prevention in atrial fibrillation--things can only get better. (Journal article)
Lip, G. Y. H., & Watson, T. (2007). Stroke prevention in atrial fibrillation--things can only get better.. British journal of clinical pharmacology, 64(5), 575-577. doi:10.1111/j.1365-2125.2007.02953.xDOI: 10.1111/j.1365-2125.2007.02953.x
Raised leptin concentrations among South Asian patients with chronic heart failure. (Journal article)
Patel, J. V., Sosin, M., Lim, H. S., Chung, I., Panja, N., Davis, R. C., . . . Lip, G. Y. H. (2007). Raised leptin concentrations among South Asian patients with chronic heart failure.. International journal of cardiology, 122(1), 34-40. doi:10.1016/j.ijcard.2006.11.013DOI: 10.1016/j.ijcard.2006.11.013
Atherosclerotic renal artery stenosis--do we really know what to do? (Journal article)
Srivastava, S., & Lip, G. Y. H. (2007). Atherosclerotic renal artery stenosis--do we really know what to do?. Blood pressure, 16(5), 288-290. doi:10.1080/08037050701685567DOI: 10.1080/08037050701685567
Erratum: Cardioversion of atrial fibrillation (British Medical Journal (1996) 312, (112-115)) (Journal article)
Lip, G. Y. H. (2007). Erratum: Cardioversion of atrial fibrillation (British Medical Journal (1996) 312, (112-115)). British Medical Journal, 335(7624), 805.
Combining antiplatelet drugs and oral anticoagulant therapy in atrial fibrillation: acute coronary syndromes and/or percutaneous coronary intervention/stenting revisited. (Journal article)
Watson, T., & Lip, G. Y. H. (2007). Combining antiplatelet drugs and oral anticoagulant therapy in atrial fibrillation: acute coronary syndromes and/or percutaneous coronary intervention/stenting revisited.. Stroke, 38(10), e107-e108. doi:10.1161/strokeaha.107.492488DOI: 10.1161/strokeaha.107.492488
Endothelial colony forming units: Are they a reliable marker of endothelial progenitor cell numbers? (Journal article)
Shantsila, E., Watson, T., Tse, H. F., & Lip, G. Y. H. (2007). Endothelial colony forming units: Are they a reliable marker of endothelial progenitor cell numbers?. ANNALS OF MEDICINE, 39(6), 474-479. doi:10.1080/07853890701329283DOI: 10.1080/07853890701329283
Peripheral artery disease and hypertension: the relation between ankle-brachial index and mortality. (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2007). Peripheral artery disease and hypertension: the relation between ankle-brachial index and mortality.. Journal of human hypertension, 21(10), 762-765. doi:10.1038/sj.jhh.1002219DOI: 10.1038/sj.jhh.1002219
Anticoagulation Issues (Chapter)
Prystowsky, E. N., Themistoclakis, S., Brachmann, J., Callans, D., Connolly, S., Lip, G. Y., & Waldo, A. L. (2007). Anticoagulation Issues. In Unknown Book (pp. 41-50). Wiley. doi:10.1002/9780470692646.ch6DOI: 10.1002/9780470692646.ch6
A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes (Journal article)
Thrall, G., Lane, D., Carroll, D., & Lip, G. Y. H. (2007). A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes. THROMBOSIS RESEARCH, 120(6), 819-847. doi:10.1016/j.thromres.2007.01.004DOI: 10.1016/j.thromres.2007.01.004
Endotoxemia, inflammation, and atrial fibrillation. (Journal article)
Boos, C. J., Lip, G. Y. H., & Jilma, B. (2007). Endotoxemia, inflammation, and atrial fibrillation.. The American journal of cardiology, 100(6), 986-988. doi:10.1016/j.amjcard.2007.04.039DOI: 10.1016/j.amjcard.2007.04.039
Circulating Markers of Endothelial Function (Chapter)
Blann, A. D., Foster, W., & Lip, G. Y. H. (2007). Circulating Markers of Endothelial Function. In Endothelial Biomedicine (pp. 1602-1611). Cambridge University Press. doi:10.1017/cbo9780511546198.174DOI: 10.1017/cbo9780511546198.174
Common carotid artery intima-media thickness and intracranial pulsatility index in non-ST-elevation acute coronary syndromes. (Journal article)
Tello-Montoliu, A., Moltó, J. M., López-Hernández, N., García-Medina, A., Roldán, V., Sogorb, F., . . . Marín, F. (2007). Common carotid artery intima-media thickness and intracranial pulsatility index in non-ST-elevation acute coronary syndromes.. Cerebrovascular diseases (Basel, Switzerland), 24(4), 338-342. doi:10.1159/000106979DOI: 10.1159/000106979
Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias (Journal article)
Shantsila, E., Watson, T., & Lip, G. Y. H. (2007). Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias. EUROPACE, 9, 37-44. doi:10.1093/europace/eum169DOI: 10.1093/europace/eum169
Editorial [Hot Topic: The Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)] (Journal article)
Lip, G. (2007). Editorial [Hot Topic: The Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]. Current Pharmaceutical Design, 13(25), 2538. doi:10.2174/138161207781663055DOI: 10.2174/138161207781663055
Endothelial progenitor cells, endothelial cell dysfunction and much more: observations from cardiac syndrome X. (Journal article)
Goon, P. K. Y., & Lip, G. Y. H. (2007). Endothelial progenitor cells, endothelial cell dysfunction and much more: observations from cardiac syndrome X.. Heart (British Cardiac Society), 93(9), 1020-1021. doi:10.1136/hrt.2006.112664DOI: 10.1136/hrt.2006.112664
From diabetes to metabolic syndrome: a viewpoint on an evolving concept. (Journal article)
Lim, H. S., & Lip, G. Y. H. (2007). From diabetes to metabolic syndrome: a viewpoint on an evolving concept.. Current pharmaceutical design, 13(25), 2580-2583. doi:10.2174/138161207781663028DOI: 10.2174/138161207781663028
Hypertension in pregnancy: pathophysiology and management strategies. (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2007). Hypertension in pregnancy: pathophysiology and management strategies.. Current pharmaceutical design, 13(25), 2567-2579. doi:10.2174/138161207781663019DOI: 10.2174/138161207781663019
Hypertension, anti-hypertensive therapy and neoplasia. (Journal article)
Goon, P. K. Y., Stonelake, P. S., & Lip, G. Y. H. (2007). Hypertension, anti-hypertensive therapy and neoplasia.. Current pharmaceutical design, 13(25), 2539-2544. doi:10.2174/138161207781663073DOI: 10.2174/138161207781663073
Management of hypertension in relation to acute coronary syndromes and revascularisation. (Journal article)
Kühl, M., Lip, G. Y. H., & Varma, C. (2007). Management of hypertension in relation to acute coronary syndromes and revascularisation.. Current pharmaceutical design, 13(25), 2556-2566. doi:10.2174/138161207781663046DOI: 10.2174/138161207781663046
Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis. (Journal article)
Jordán, A., Roldán, V., García, M., Monmeneu, J., de Burgos, F. G., Lip, G. Y. H., & Marín, F. (2007). Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.. Journal of internal medicine, 262(3), 385-392. doi:10.1111/j.1365-2796.2007.01823.xDOI: 10.1111/j.1365-2796.2007.01823.x
The quest for circulating endothelial cell standardization: the peril of platelets. (Journal article)
Goon, P. K. Y., Watson, T., Stonelake, P. S., & Lip, G. Y. H. (2007). The quest for circulating endothelial cell standardization: the peril of platelets.. Cytometry. Part B, Clinical cytometry, 72(5), 416. doi:10.1002/cyto.b.20355DOI: 10.1002/cyto.b.20355
Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial. (Journal article)
Mant, J., Fitzmaurice, D. A., Hobbs, F. D. R., Jowett, S., Murray, E. T., Holder, R., . . . Lip, G. Y. H. (2007). Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial.. BMJ (Clinical research ed.), 335(7616), 380. doi:10.1136/bmj.39227.551713.aeDOI: 10.1136/bmj.39227.551713.ae
Platelet activation in acute, decompensated congestive heart failure. (Journal article)
Chung, I., Choudhury, A., & Lip, G. Y. H. (2007). Platelet activation in acute, decompensated congestive heart failure.. Thrombosis research, 120(5), 709-713. doi:10.1016/j.thromres.2007.01.003DOI: 10.1016/j.thromres.2007.01.003
Management of atrial fibrillation. (Journal article)
Lip, G. Y. H., & Tse, H. -F. (2007). Management of atrial fibrillation.. Lancet (London, England), 370(9587), 604-618. doi:10.1016/s0140-6736(07)61300-2DOI: 10.1016/s0140-6736(07)61300-2
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. (Journal article)
Mant, J., Hobbs, F. D. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y. H., . . . Midland Research Practices Network (MidReC). (2007). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.. Lancet (London, England), 370(9586), 493-503. doi:10.1016/s0140-6736(07)61233-1DOI: 10.1016/s0140-6736(07)61233-1
Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation (Journal article)
Watson, T., Shantsila, E., & Lip, G. Y. H. (2007). Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 120(1), 123-124. doi:10.1016/j.ijcard.2006.07.185DOI: 10.1016/j.ijcard.2006.07.185
'DNA' may not mean 'did not participate': a qualitative study of reasons for non-adherence at home- and centre-based cardiac rehabilitation. (Journal article)
Jones, M., Jolly, K., Raftery, J., Lip, G. Y. H., Greenfield, S., & BRUM Steering Committee. (2007). 'DNA' may not mean 'did not participate': a qualitative study of reasons for non-adherence at home- and centre-based cardiac rehabilitation.. Family practice, 24(4), 343-357. doi:10.1093/fampra/cmm021DOI: 10.1093/fampra/cmm021
An analysis of factors that predict patient consent to take part in a randomized controlled trial. (Journal article)
Fletcher, K., Mant, J., Holder, R., Fitzmaurice, D., Lip, G. Y. H., & Hobbs, F. D. R. (2007). An analysis of factors that predict patient consent to take part in a randomized controlled trial.. Family practice, 24(4), 388-394. doi:10.1093/fampra/cmm019DOI: 10.1093/fampra/cmm019
Platelet adhesion in atrial fibrillation. (Journal article)
Choudhury, A., Chung, I., Blann, A., & Lip, G. Y. H. (2007). Platelet adhesion in atrial fibrillation.. Thrombosis research, 120(4), 623-629. doi:10.1016/j.thromres.2006.12.008DOI: 10.1016/j.thromres.2006.12.008
Compliance and the treatment of hypertension: where are we now? (Journal article)
Nadar, S. K., & Lip, G. Y. H. (2007). Compliance and the treatment of hypertension: where are we now?. Therapy, 4(4), 385-386. doi:10.2217/14750708.4.4.385DOI: 10.2217/14750708.4.4.385
Thromboprophylaxis in acute ischaemic stroke: how can we PREVAIL? (Journal article)
Lim, H. S., & Lip, G. Y. H. (2007). Thromboprophylaxis in acute ischaemic stroke: how can we PREVAIL?. The Lancet. Neurology, 6(7), 578-579. doi:10.1016/s1474-4422(07)70159-xDOI: 10.1016/s1474-4422(07)70159-x
New frontiers in cardiovascular disease: circulating endothelial cells and endothelial progenitor cells as cellular biomarkers. (Journal article)
Goon, P. K., Watson, T., & Lip, G. Y. H. (2007). New frontiers in cardiovascular disease: circulating endothelial cells and endothelial progenitor cells as cellular biomarkers.. Clinical laboratory, 53(5-6), 297-299.
Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients. (Journal article)
Caine, G. J., Ryan, P., Lip, G. Y. H., & Blann, A. D. (2007). Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.. Cancer letters, 251(2), 296-301. doi:10.1016/j.canlet.2006.11.026DOI: 10.1016/j.canlet.2006.11.026
Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study. (Journal article)
Chong, A. Y., Freestone, B., Lim, H. S., Kistorp, C., Gustafsson, F., Hildebrandt, P., & Lip, G. Y. H. (2007). Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.. International journal of cardiology, 119(1), 80-82. doi:10.1016/j.ijcard.2006.07.085DOI: 10.1016/j.ijcard.2006.07.085
Circulating endothelial cells in obstructive sleep apnea: an important methodological lesson. (Journal article)
Goon, P. K. Y., Watson, T., & Lip, G. Y. H. (2007). Circulating endothelial cells in obstructive sleep apnea: an important methodological lesson.. American journal of respiratory and critical care medicine, 175(12), 1346. doi:10.1164/ajrccm.175.12.1346DOI: 10.1164/ajrccm.175.12.1346
Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty. (Journal article)
Jaumdally, R. J., Varma, C., Blann, A. D., MacFadyen, R. J., & Lip, G. Y. H. (2007). Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty.. Annals of medicine, 39(4), 298-305. doi:10.1080/07853890701298132DOI: 10.1080/07853890701298132
Kakar, P., Boos, C. J., & Lip, G. Y. H. (2007). Management of atrial fibrillation.. Vascular health and risk management, 3(1), 109-116.
Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation. (Journal article)
Lip, G. Y. H., Frison, L., & Grind, M. (2007). Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.. Journal of internal medicine, 261(6), 577-586. doi:10.1111/j.1365-2796.2007.01780.xDOI: 10.1111/j.1365-2796.2007.01780.x
Cardioversion for atrial fibrillation: does inflammation matter? (Journal article)
Watson, T., Kakar, P., & Lip, G. Y. H. (2007). Cardioversion for atrial fibrillation: does inflammation matter?. The American journal of cardiology, 99(11), 1617-1618. doi:10.1016/j.amjcard.2006.12.089DOI: 10.1016/j.amjcard.2006.12.089
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. (Journal article)
Spencer, C. G. C., Felmeden, D. C., Blann, A. D., & Lip, G. Y. H. (2007). Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.. American journal of hypertension, 20(6), 699-704. doi:10.1016/j.amjhyper.2007.01.004DOI: 10.1016/j.amjhyper.2007.01.004
Statin therapy in South-Asian patients: clinical implications beyond lipid lowering? (Journal article)
Jaumdally, J. R., Varma, C., & Lip, G. Y. H. (2007). Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?. Expert opinion on pharmacotherapy, 8(9), 1235-1243. doi:10.1517/14656566.8.9.1235DOI: 10.1517/14656566.8.9.1235
Statins and intra-plaque angiogenesis in carotid artery disease. (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2007). Statins and intra-plaque angiogenesis in carotid artery disease.. Atherosclerosis, 192(2), 455-456. doi:10.1016/j.atherosclerosis.2007.01.018DOI: 10.1016/j.atherosclerosis.2007.01.018
Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm. (Journal article)
Choudhury, A., Chung, I., Blann, A. D., & Lip, G. Y. H. (2007). Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.. Journal of the American College of Cardiology, 49(19), 1957-1964. doi:10.1016/j.jacc.2007.02.038DOI: 10.1016/j.jacc.2007.02.038
Antioxidant protection: yet another function of endothelial progenitor cells? (Journal article)
Shantsila, E., Watson, T., & Lip, G. Y. H. (2007). Antioxidant protection: yet another function of endothelial progenitor cells?. JOURNAL OF HUMAN HYPERTENSION, 21(5), 343-346. doi:10.1038/sj.jhh.1002166DOI: 10.1038/sj.jhh.1002166
Atrial fibrillation--the growing epidemic. (Journal article)
Lip, G. Y. H., Kakar, P., & Watson, T. (2007). Atrial fibrillation--the growing epidemic.. Heart (British Cardiac Society), 93(5), 542-543. doi:10.1136/hrt.2006.110791DOI: 10.1136/hrt.2006.110791
Cardioversion of atrial fibrillation: from guidelines to contemporary clinical practice. (Journal article)
Lip, G. Y. H. (2007). Cardioversion of atrial fibrillation: from guidelines to contemporary clinical practice.. International journal of clinical practice, 61(5), 714-716. doi:10.1111/j.1742-1241.2007.01306.xDOI: 10.1111/j.1742-1241.2007.01306.x
Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy. (Journal article)
Kakar, P., & Lip, G. Y. H. (2007). Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy.. Expert review of cardiovascular therapy, 5(3), 441-450. doi:10.1586/14779072.5.3.441DOI: 10.1586/14779072.5.3.441
Oral anticoagulation in atrial fibrillation: A pan-European patient survey. (Journal article)
Lip, G. Y. H., Agnelli, G., Thach, A. A., Knight, E., Rost, D., & Tangelder, M. J. D. (2007). Oral anticoagulation in atrial fibrillation: A pan-European patient survey.. European journal of internal medicine, 18(3), 202-208. doi:10.1016/j.ejim.2006.11.005DOI: 10.1016/j.ejim.2006.11.005
Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes. (Journal article)
Boos, C. J., Soor, S. K., Kang, D., & Lip, G. Y. H. (2007). Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes.. European heart journal, 28(9), 1092-1101. doi:10.1093/eurheartj/ehm070DOI: 10.1093/eurheartj/ehm070
A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial. (Journal article)
Hurley, V., Ireson, R., Fletcher, K., Lip, G. Y. H., Hobbs, F. D. R., Mant, J., & BAFTA Investigators. (2007). A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.. International journal of cardiology, 117(2), 152-156. doi:10.1016/j.ijcard.2006.04.061DOI: 10.1016/j.ijcard.2006.04.061
Assessment of mean platelet volume in coronary artery disease - what does it mean? (Journal article)
Boos, C. J., & Lip, G. Y. H. (2007). Assessment of mean platelet volume in coronary artery disease - what does it mean?. Thrombosis research, 120(1), 11-13. doi:10.1016/j.thromres.2006.09.002DOI: 10.1016/j.thromres.2006.09.002
Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer. (Journal article)
Caine, G. J., Stonelake, P. S., Lip, G. Y. H., & Blann, A. D. (2007). Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.. Cancer letters, 248(1), 131-136. doi:10.1016/j.canlet.2006.06.011DOI: 10.1016/j.canlet.2006.06.011
Effects of low osmolar contrast (iomeprol) on haemorheology and platelet activation in patients with coronary artery disease. (Journal article)
Jaumdally, R. J., Varma, C., MacFadyen, R. J., & Lip, G. Y. H. (2007). Effects of low osmolar contrast (iomeprol) on haemorheology and platelet activation in patients with coronary artery disease.. Journal of thrombosis and thrombolysis, 23(3), 189-194. doi:10.1007/s11239-006-9048-xDOI: 10.1007/s11239-006-9048-x
Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment? (Journal article)
Jaumdally, R., Varma, C., Macfadyen, R. J., & Lip, G. Y. H. (2007). Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?. European heart journal, 28(8), 929-940. doi:10.1093/eurheartj/ehm015DOI: 10.1093/eurheartj/ehm015
Stroke prevention in atrial fibrillation: antiplatelet therapy revisited. (Journal article)
Lip, G. Y. H., & Watson, T. (2007). Stroke prevention in atrial fibrillation: antiplatelet therapy revisited.. European heart journal, 28(8), 926-928. doi:10.1093/eurheartj/ehm077DOI: 10.1093/eurheartj/ehm077
Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation. (Journal article)
Varughese, G. I., Patel, J. V., Tomson, J., & Lip, G. Y. H. (2007). Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation.. Heart (British Cardiac Society), 93(4), 495-499. doi:10.1136/hrt.2006.099374DOI: 10.1136/hrt.2006.099374
Ethnic disparities in malignant hypertension: further observations. (Journal article)
Karthikeyan, V. J., Beevers, D. G., & Lip, G. Y. H. (2007). Ethnic disparities in malignant hypertension: further observations.. Journal of hypertension, 25(4), 895. doi:10.1097/hjh.0b013e32802ef31eDOI: 10.1097/hjh.0b013e32802ef31e
High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. (Journal article)
Lip, G. Y. H., Patel, J. V., Hughes, E., & Hart, R. G. (2007). High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis.. Stroke, 38(4), 1229-1237. doi:10.1161/01.str.0000260090.90508.3eDOI: 10.1161/01.str.0000260090.90508.3e
In response [7] (Journal article)
Watson, T., Shantsila, E., & Lip, G. Y. H. (2007). In response [7]. Clinical Medicine, Journal of the Royal College of Physicians of London, 7(2), 199-200.
New insights into complement C3 and inflammation in hypertension. (Journal article)
Nadar, S. K., & Lip, G. Y. H. (2007). New insights into complement C3 and inflammation in hypertension.. Journal of human hypertension, 21(4), 261-263. doi:10.1038/sj.jhh.1002160DOI: 10.1038/sj.jhh.1002160
Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial. (Journal article)
Varughese, G. I., Patel, J. V., Tomson, J., Blann, A. D., Hughes, E. A., & Lip, G. Y. H. (2007). Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.. Journal of internal medicine, 261(4), 384-391. doi:10.1111/j.1365-2796.2007.01770.xDOI: 10.1111/j.1365-2796.2007.01770.x
Should oral glucose tolerance testing be mandatory following acute myocardial infarction? (Journal article)
Jessani, S., Gangopadhyay, K., Patel, J. V., Lip, G. Y. H., & Millane, T. (2007). Should oral glucose tolerance testing be mandatory following acute myocardial infarction?. International journal of clinical practice, 61(4), 680-683. doi:10.1111/j.1742-1241.2007.01301.xDOI: 10.1111/j.1742-1241.2007.01301.x
Standardization of circulating endothelial cell enumeration by the use of human umbilical vein endothelial cells (Journal article)
Goon, P. K. Y., Watson, T., Shantsila, E., Boos, C. J., & Lip, G. Y. H. (2007). Standardization of circulating endothelial cell enumeration by the use of human umbilical vein endothelial cells. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 5(4), 870-872. doi:10.1111/j.1538-7836.2007.02411.xDOI: 10.1111/j.1538-7836.2007.02411.x
Jolly, K., Tayor, R. S., Lip, G. Y. H., Greenfield, S. M., Davies, M. K., Davis, R. C., . . . Stevens, A. J. (2007). Home-based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF): a randomised controlled trial.. BMC cardiovascular disorders, 7, 9. doi:10.1186/1471-2261-7-9DOI: 10.1186/1471-2261-7-9
Circulating endothelial cells and von Willebrand factor as indices of endothelial damage/dysfunction in coronary artery disease: a comparison of central vs. peripheral levels and effects of coronary angioplasty. (Journal article)
Boos, C. J., Jaumdally, R. J., MacFadyen, R. J., Varma, C., & Lip, G. Y. H. (2007). Circulating endothelial cells and von Willebrand factor as indices of endothelial damage/dysfunction in coronary artery disease: a comparison of central vs. peripheral levels and effects of coronary angioplasty.. Journal of thrombosis and haemostasis : JTH, 5(3), 630-632. doi:10.1111/j.1538-7836.2007.02341.xDOI: 10.1111/j.1538-7836.2007.02341.x
Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor X. (Journal article)
Kakar, P., Watson, T., & Lip, G. Y. H. (2007). Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor X.. Current opinion in investigational drugs (London, England : 2000), 8(3), 256-265.
Effect of hypertension on anticoagulated patients with atrial fibrillation. (Journal article)
Lip, G. Y. H., Frison, L., Grind, M., & SPORTIF Invetigators. (2007). Effect of hypertension on anticoagulated patients with atrial fibrillation.. European heart journal, 28(6), 752-759. doi:10.1093/eurheartj/ehl504DOI: 10.1093/eurheartj/ehl504
Is it the post-challenge hyperglycaemic spike or arterial stiffness we should be screening for? (Journal article)
Jessani, S., & Lip, G. Y. H. (2007). Is it the post-challenge hyperglycaemic spike or arterial stiffness we should be screening for?. International journal of clinical practice, 61(3), 356-358. doi:10.1111/j.1742-1241.2006.01209.xDOI: 10.1111/j.1742-1241.2006.01209.x
Rivaroxaban. (Journal article)
Kakar, P., Watson, T., & Lip, G. Y. H. (2007). Rivaroxaban.. Drugs of today (Barcelona, Spain : 1998), 43(3), 129-136. doi:10.1358/dot.2007.43.3.1067345DOI: 10.1358/dot.2007.43.3.1067345
Aspirin resistance: What, why and when? (Journal article)
Shantsita, E., Watson, T., & Lip, G. Y. H. (2007). Aspirin resistance: What, why and when?. THROMBOSIS RESEARCH, 119(5), 551-554. doi:10.1016/j.thromres.2006.08.009DOI: 10.1016/j.thromres.2006.08.009
Subclinical atherosclerosis and risk of atrial fibrillation: the rotterdam study. (Journal article)
Heeringa, J., van der Kuip, D. A. M., Hofman, A., Kors, J. A., van Rooij, F. J. A., Lip, G. Y. H., & Witteman, J. C. M. (2007). Subclinical atherosclerosis and risk of atrial fibrillation: the rotterdam study.. Archives of internal medicine, 167(4), 382-387. doi:10.1001/archinte.167.4.382DOI: 10.1001/archinte.167.4.382
Assessment of platelet activation indices using the ADVIATM 120 amongst 'high-risk' patients with hypertension. (Journal article)
Boos, C. J., Beevers, G. D., & Lip, G. Y. H. (2007). Assessment of platelet activation indices using the ADVIATM 120 amongst 'high-risk' patients with hypertension.. Annals of medicine, 39(1), 72-78. doi:10.1080/07853890601040063DOI: 10.1080/07853890601040063
Endothelial progenitor cells in cardiovascular disorders (Journal article)
Shantsila, E., Watson, T., & Lip, G. Y. H. (2007). Endothelial progenitor cells in cardiovascular disorders. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 49(7), 741-752. doi:10.1016/j.jacc.2006.09.050DOI: 10.1016/j.jacc.2006.09.050
Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response? (Journal article)
Chong, A. -Y., & Lip, G. Y. H. (2007). Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?. European journal of heart failure, 9(2), 124-128. doi:10.1016/j.ejheart.2006.05.009DOI: 10.1016/j.ejheart.2006.05.009
Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction. (Journal article)
Patel, J. V., Lee, K. W., Tomson, J., Dubb, K., Hughes, E. A., & Lip, G. Y. H. (2007). Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction.. International journal of cardiology, 115(1), 42-45. doi:10.1016/j.ijcard.2006.04.004DOI: 10.1016/j.ijcard.2006.04.004
Cross-cultural adaptation into Punjabi of the English version of the Hospital Anxiety and Depression Scale (Journal article)
Lane, D. A., Jajoo, J., Taylor, R. S., Lip, G. Y. H., & Jolly, K. (2007). Cross-cultural adaptation into Punjabi of the English version of the Hospital Anxiety and Depression Scale. BMC PSYCHIATRY, 7. doi:10.1186/1471-244X-7-5DOI: 10.1186/1471-244X-7-5
South Asian or Afro-Caribbean ethnicity is not associated with altered 1 min heart rate recovery estimates in suspected coronary artery disease patients. (Journal article)
Goyal, D., Tayebjee, M., Lip, G. Y. H., & MacFadyen, R. J. (2007). South Asian or Afro-Caribbean ethnicity is not associated with altered 1 min heart rate recovery estimates in suspected coronary artery disease patients.. International journal of cardiology, 114(2), 261-264. doi:10.1016/j.ijcard.2005.11.065DOI: 10.1016/j.ijcard.2005.11.065
A systematic review of the prothrombotic effects of an acute change in posture - A possible mechanism underlying the morning excess in cardiovascular events? (Journal article)
Thrall, G., Lane, D., Carroll, D., & Lip, G. Y. H. (2007). A systematic review of the prothrombotic effects of an acute change in posture - A possible mechanism underlying the morning excess in cardiovascular events?. CHEST, 132(4), 1337-1347. doi:10.1378/chest.06-2978DOI: 10.1378/chest.06-2978
Acute management of atrial fibrillation with acute haemodynamic instability and in the postoperative setting. (Conference Paper)
Mann, C. J., Kendall, S., Lip, G. Y. H., & Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Acute management of atrial fibrillation with acute haemodynamic instability and in the postoperative setting.. In Heart (British Cardiac Society) Vol. 93 (pp. 45-47). doi:10.1136/hrt.2006.099929DOI: 10.1136/hrt.2006.099929
Adiponectin and hypertension: a putative link between adipocyte function and atherosclerotic risk? (Journal article)
Patel, J. V., Lim, H. S., Hughes, E. A., & Lip, G. Y. H. (2007). Adiponectin and hypertension: a putative link between adipocyte function and atherosclerotic risk?. Journal of human hypertension, 21(1), 1-4. doi:10.1038/sj.jhh.1002078DOI: 10.1038/sj.jhh.1002078
Alpha 1-microglobulin: a further insight into inflammation in hypertension? (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2007). Alpha 1-microglobulin: a further insight into inflammation in hypertension?. American journal of hypertension, 20(9), 1022-1023. doi:10.1016/j.amjhyper.2007.03.001DOI: 10.1016/j.amjhyper.2007.03.001
Antihypertensive treatment, adiponectin and cardiovascular risk. (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2007). Antihypertensive treatment, adiponectin and cardiovascular risk.. Journal of human hypertension, 21(1), 8-11. doi:10.1038/sj.jhh.1002113DOI: 10.1038/sj.jhh.1002113
Antithrombotic Therapy in Hypertension (Chapter)
Lip, G. Y. H. (2007). Antithrombotic Therapy in Hypertension. In Comprehensive Hypertension (pp. 1101-1104). Elsevier. doi:10.1016/b978-0-323-03961-1.50092-1DOI: 10.1016/b978-0-323-03961-1.50092-1
Antithrombotic treatment in atrial fibrillation. (Conference Paper)
Kalra, L., Lip, G. Y. H., & Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Antithrombotic treatment in atrial fibrillation.. In Heart (British Cardiac Society) Vol. 93 (pp. 39-44). doi:10.1136/hrt.2006.099911DOI: 10.1136/hrt.2006.099911
Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells. (Journal article)
Boos, C. J., Blann, A. D., & Lip, G. Y. H. (2007). Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells.. Methods in molecular medicine, 139, 211-224. doi:10.1007/978-1-59745-571-8_13DOI: 10.1007/978-1-59745-571-8_13
Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension (Journal article)
Boos, C. J., Lane, D. A., Karpha, M., Beevers, D. G., Haynes, R., & Lip, G. Y. H. (2007). Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension. CHEST, 132(5), 1540-1547. doi:10.1378/chest.07-0428DOI: 10.1378/chest.07-0428
Coronary artery disease and ischemic stroke in atrial fibrillation. (Journal article)
Lip, G. Y. H. (2007). Coronary artery disease and ischemic stroke in atrial fibrillation.. Chest, 132(1), 8-10. doi:10.1378/chest.07-0500DOI: 10.1378/chest.07-0500
Depression, anxiety, and quality of life in patients with atrial fibrillation (Journal article)
Thrall, G., Lip, G. Y. H., Carroll, D., & Lane, D. (2007). Depression, anxiety, and quality of life in patients with atrial fibrillation. CHEST, 132(4), 1259-1264. doi:10.1378/chest.07-0036DOI: 10.1378/chest.07-0036
Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction. (Journal article)
Boos, C. J., Balakrishnan, B., Jessani, S., Blann, A. D., & Lip, G. Y. H. (2007). Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction.. Chest, 132(6), 1920-1926. doi:10.1378/chest.07-1693DOI: 10.1378/chest.07-1693
Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy. (Journal article)
Choudhury, A., Chung, I., Blann, A. D., & Lip, G. Y. H. (2007). Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.. Chest, 131(3), 809-815. doi:10.1378/chest.06-2039DOI: 10.1378/chest.06-2039
Ethnic differences in cancer incidence and mortality: the Birmingham factory screening project (Journal article)
Lane, D. A., Lip, G. Y. H., & Beevers, D. G. (2007). Ethnic differences in cancer incidence and mortality: the Birmingham factory screening project. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 100(7), 423-431. doi:10.1093/qjmed/hcm041DOI: 10.1093/qjmed/hcm041
Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. (Conference Paper)
Spencer, C. G. C., Felmeden, D. C., Blann, A. D., & Lip, G. Y. H. (2007). Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.. In Journal of internal medicine Vol. 261 (pp. 82-90). doi:10.1111/j.1365-2796.2006.01735.xDOI: 10.1111/j.1365-2796.2006.01735.x
Hypertension in the Context of Acute Myocardial Infarction and Percutaneous Coronary Interventions (Chapter)
Jaumdally, R., & Lip, G. Y. H. (2007). Hypertension in the Context of Acute Myocardial Infarction and Percutaneous Coronary Interventions. In Comprehensive Hypertension (pp. 747-751). Elsevier. doi:10.1016/b978-0-323-03961-1.50064-7DOI: 10.1016/b978-0-323-03961-1.50064-7
Identification, diagnosis and assessment of atrial fibrillation. (Conference Paper)
Dewar, R. I., Lip, G. Y. H., & Guidelines Development Group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Identification, diagnosis and assessment of atrial fibrillation.. In Heart (British Cardiac Society) Vol. 93 (pp. 25-28). doi:10.1136/hrt.2006.099861DOI: 10.1136/hrt.2006.099861
Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy. (Journal article)
Goon, P. K. Y., & Lip, G. Y. H. (2007). Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.. Eye (London, England), 21(6), 838-839. doi:10.1038/sj.eye.6702650DOI: 10.1038/sj.eye.6702650
Maintaining therapeutic anticoagulation - The importance of keeping "within range" (Journal article)
Lane, D. A., & Lip, G. Y. H. (2007). Maintaining therapeutic anticoagulation - The importance of keeping "within range". CHEST, 131(5), 1277-1279. doi:10.1378/chest.07-0273DOI: 10.1378/chest.07-0273
Management of atrial fibrillation: An overview of the NICE guidance on AF management (Journal article)
Watson, T., Shanstila, E., & Lip, G. Y. H. (2007). Management of atrial fibrillation: An overview of the NICE guidance on AF management. British Journal of Cardiology, 14(1), 23-28.
Management of atrial fibrillation: the NICE guidelines. (Journal article)
Lip, G. Y. H., Rudolf, M., & Kakar, P. (2007). Management of atrial fibrillation: the NICE guidelines.. International journal of clinical practice, 61(1), 9-11. doi:10.1111/j.1742-1241.2006.01151.xDOI: 10.1111/j.1742-1241.2006.01151.x
Matrix Metalloproteinases and the Extracellular Matrix (Chapter)
Tayebjee, M. H., & Lip, G. Y. H. (2007). Matrix Metalloproteinases and the Extracellular Matrix. In Comprehensive Hypertension (pp. 183-189). Elsevier. doi:10.1016/b978-0-323-03961-1.50020-9DOI: 10.1016/b978-0-323-03961-1.50020-9
Modern management of atrial fibrillation. (Journal article)
Watson, T., Shanstila, E., & Lip, G. Y. H. (2007). Modern management of atrial fibrillation.. Clinical medicine (London, England), 7(1), 28-34. doi:10.7861/clinmedicine.7-1-28DOI: 10.7861/clinmedicine.7-1-28
N-terminal pro-brain natriuretic peptide and coronary artery disease. (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2007). N-terminal pro-brain natriuretic peptide and coronary artery disease.. European journal of clinical investigation, 37(1), 1-7. doi:10.1111/j.1365-2362.2007.01750.xDOI: 10.1111/j.1365-2362.2007.01750.x
Patient care pathway, implementation and audit criteria for patients with atrial fibrillation. (Conference Paper)
Davis, M., Rodgers, S., Rudolf, M., Hughes, M., Lip, G. Y. H., & Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Patient care pathway, implementation and audit criteria for patients with atrial fibrillation.. In Heart (British Cardiac Society) Vol. 93 (pp. 48-52). doi:10.1136/hrt.2006.099937DOI: 10.1136/hrt.2006.099937
Physical fitness and the relationship between hypertension and markers of atherothrombosis. (Journal article)
Jessani, S., & Lip, G. Y. H. (2007). Physical fitness and the relationship between hypertension and markers of atherothrombosis.. American journal of hypertension, 20(6), 676-677. doi:10.1016/j.amjhyper.2007.02.003DOI: 10.1016/j.amjhyper.2007.02.003
Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty. (Journal article)
Jaumdally, R. J., Varma, C., Blann, A. D., MacFadyen, R. J., & Lip, G. Y. H. (2007). Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty.. Chest, 132(5), 1532-1539. doi:10.1378/chest.07-0389DOI: 10.1378/chest.07-0389
Platelet and Coagulation Abnormalities (Chapter)
Varughese, G. I., & Lip, G. Y. H. (2007). Platelet and Coagulation Abnormalities. In Comprehensive Hypertension (pp. 223-227). Elsevier. doi:10.1016/b978-0-323-03961-1.50024-6DOI: 10.1016/b978-0-323-03961-1.50024-6
Rate control in the medical management of atrial fibrillation. (Conference Paper)
Camm, A. J., Savelieva, I., Lip, G. Y. H., & Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Rate control in the medical management of atrial fibrillation.. In Heart (British Cardiac Society) Vol. 93 (pp. 35-38). doi:10.1136/hrt.2006.099903DOI: 10.1136/hrt.2006.099903
Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis? (Journal article)
Choudhury, A., Freestone, B., Patel, J., & Lip, G. Y. H. (2007). Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?. Chest, 132(6), 1913-1919. doi:10.1378/chest.07-1565DOI: 10.1378/chest.07-1565
Rhythm control and cardioversion. (Conference Paper)
Sulke, N., Sayers, F., Lip, G. Y. H., & Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. (2007). Rhythm control and cardioversion.. In Heart (British Cardiac Society) Vol. 93 (pp. 29-34). doi:10.1136/hrt.2006.099879DOI: 10.1136/hrt.2006.099879
Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. (Journal article)
Hughes, M., Lip, G. Y. H., & Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care. (2007). Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review.. QJM : monthly journal of the Association of Physicians, 100(10), 599-607. doi:10.1093/qjmed/hcm076DOI: 10.1093/qjmed/hcm076
Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. (Journal article)
Freestone, B., Chong, A. Y., Nuttall, S., Blann, A. D., & Lip, G. Y. H. (2007). Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.. Chest, 132(4), 1253-1258. doi:10.1378/chest.07-1185DOI: 10.1378/chest.07-1185
Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely. (Journal article)
Watson, T., Kakar, P., & Lip, G. Y. H. (2007). Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely.. International journal of clinical practice, 61(1), 6-9. doi:10.1111/j.1742-1241.2006.01226.xDOI: 10.1111/j.1742-1241.2006.01226.x
The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence (Journal article)
Jolly, K., Taylor, R., Lip, G. Y. H., Greenfield, S., Raftery, J., Mant, J., . . . Stevens, A. (2007). The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence. HEALTH TECHNOLOGY ASSESSMENT, 11(35), 1-+. doi:10.3310/hta11350DOI: 10.3310/hta11350
The JBS-2 guidelines on prevention of cardiovascular disease in clinical practice: an opportunity missed. (Journal article)
Jessani, S., Lip, G. Y. H., Barnett, A., & Millane, T. (2007). The JBS-2 guidelines on prevention of cardiovascular disease in clinical practice: an opportunity missed.. QJM : monthly journal of the Association of Physicians, 100(2), 121-124. doi:10.1093/qjmed/hcm002DOI: 10.1093/qjmed/hcm002
The new NICE guideline on atrial fibrillation management. (Conference Paper)
Lip, G. Y. H., & Rudolf, M. (2007). The new NICE guideline on atrial fibrillation management.. In Heart (British Cardiac Society) Vol. 93 (pp. 23). doi:10.1136/hrt.2006.099952DOI: 10.1136/hrt.2006.099952
2006
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. (Journal article)
Nieuwlaat, R., Capucci, A., Lip, G. Y. H., Olsson, S. B., Prins, M. H., Nieman, F. H., . . . Euro Heart Survey Investigators. (2006). Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.. European heart journal, 27(24), 3018-3026. doi:10.1093/eurheartj/ehl015DOI: 10.1093/eurheartj/ehl015
Management of atrial fibrillation. (Journal article)
Watson, T., & Lip, G. Y. H. (2006). Management of atrial fibrillation.. Herz, 31(9), 849-856. doi:10.1007/s00059-006-2932-5DOI: 10.1007/s00059-006-2932-5
Oxidative stress and hypertension. (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Oxidative stress and hypertension.. International journal of clinical practice, 60(12), 1525-1527. doi:10.1111/j.1742-1241.2006.00963.xDOI: 10.1111/j.1742-1241.2006.00963.x
Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study. (Journal article)
Lee, K. W., Blann, A. D., Jolly, K., Lip, G. Y. H., & BRUM Investigators. (2006). Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study.. Heart (British Cardiac Society), 92(12), 1732-1738. doi:10.1136/hrt.2006.092163DOI: 10.1136/hrt.2006.092163
Platelet activation and cardiovascular outcomes in acute coronary syndromes. (Journal article)
Boos, C. J., & Lip, G. Y. H. (2006). Platelet activation and cardiovascular outcomes in acute coronary syndromes.. Journal of thrombosis and haemostasis : JTH, 4(12), 2542-2543. doi:10.1111/j.1538-7836.2006.02250.xDOI: 10.1111/j.1538-7836.2006.02250.x
Stroke: ethnic differences do exist. (Journal article)
Kakar, P., Gunarathne, A., & Lip, G. Y. H. (2006). Stroke: ethnic differences do exist.. Expert review of neurotherapeutics, 6(12), 1769-1771. doi:10.1586/14737175.6.12.1769DOI: 10.1586/14737175.6.12.1769
Towards improving the clinical assessment and management of human hypertension: An overview from this Journal. (Journal article)
Kakar, P., & Lip, G. Y. H. (2006). Towards improving the clinical assessment and management of human hypertension: An overview from this Journal.. Journal of human hypertension, 20(12), 913-916. doi:10.1038/sj.jhh.1002083DOI: 10.1038/sj.jhh.1002083
Aortic elasticity, left ventricular geometry and diastolic dysfunction in hypertension. (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Aortic elasticity, left ventricular geometry and diastolic dysfunction in hypertension.. International journal of clinical practice, 60(11), 1337-1340. doi:10.1111/j.1742-1241.2006.01030.xDOI: 10.1111/j.1742-1241.2006.01030.x
Are guidelines on cardiovascular risk prevention comprehensive enough? Focus on the 2005 Joint British Societies? Guidelines (Journal article)
Jessani, S., & Lip, G. Y. H. (2006). Are guidelines on cardiovascular risk prevention comprehensive enough? Focus on the 2005 Joint British Societies? Guidelines. Therapy, 3(6), 687-690. doi:10.1586/14750708.3.6.687DOI: 10.1586/14750708.3.6.687
Endotoxemia enhances circulating endothelial cells in humans. (Journal article)
Boos, C. J., Mayr, F. B., Lip, G. Y. H., & Jilma, B. (2006). Endotoxemia enhances circulating endothelial cells in humans.. Journal of thrombosis and haemostasis : JTH, 4(11), 2509-2511. doi:10.1111/j.1538-7836.2006.02172.xDOI: 10.1111/j.1538-7836.2006.02172.x
Platelets and heart failure. (Journal article)
Chung, I., & Lip, G. Y. H. (2006). Platelets and heart failure.. European heart journal, 27(22), 2623-2631. doi:10.1093/eurheartj/ehl305DOI: 10.1093/eurheartj/ehl305
Towards understanding the aetiology and pathophysiology of human hypertension: where are we now? (Journal article)
Kakar, P., & Lip, G. Y. H. (2006). Towards understanding the aetiology and pathophysiology of human hypertension: where are we now?. Journal of human hypertension, 20(11), 833-836. doi:10.1038/sj.jhh.1002082DOI: 10.1038/sj.jhh.1002082
Circulating endothelial cells in cardiovascular disease. (Journal article)
Boos, C. J., Lip, G. Y. H., & Blann, A. D. (2006). Circulating endothelial cells in cardiovascular disease.. Journal of the American College of Cardiology, 48(8), 1538-1547. doi:10.1016/j.jacc.2006.02.078DOI: 10.1016/j.jacc.2006.02.078
Reply (Journal article)
Bhatia, G., Lip, G. Y. H., & Davis, R. C. (2006). Reply. Journal of the American College of Cardiology, 48(8), 1727. doi:10.1016/j.jacc.2006.07.028DOI: 10.1016/j.jacc.2006.07.028
Anticoagulation for stroke prevention - High effectiveness, more cost benefit? (Journal article)
Shantsila, E., Watson, T., & Lip, G. Y. H. (2006). Anticoagulation for stroke prevention - High effectiveness, more cost benefit?. PHARMACOECONOMICS, 24(10), 1035-1038. doi:10.2165/00019053-200624100-00010DOI: 10.2165/00019053-200624100-00010
Atrial fibrillation and stroke prevention. (Journal article)
Kakar, P., & Lip, G. Y. H. (2006). Atrial fibrillation and stroke prevention.. Expert review of neurotherapeutics, 6(10), 1523-1530. doi:10.1586/14737175.6.10.1523DOI: 10.1586/14737175.6.10.1523
C-reactive protein and lone atrial fibrillation: potential confounders. (Journal article)
Boos, C. J., & Lip, G. Y. H. (2006). C-reactive protein and lone atrial fibrillation: potential confounders.. The American journal of cardiology, 98(7), 991-992. doi:10.1016/j.amjcard.2006.05.005DOI: 10.1016/j.amjcard.2006.05.005
Death or heart failure post acute myocardial infarction? The role of cardiac biomarkers. (Journal article)
Jessani, S., & Lip, G. Y. H. (2006). Death or heart failure post acute myocardial infarction? The role of cardiac biomarkers.. Journal of cardiac failure, 12(8), 641-643. doi:10.1016/j.cardfail.2006.07.004DOI: 10.1016/j.cardfail.2006.07.004
Hypertension and breast cancer: an association revisited? (Journal article)
Goon, P. K. Y., Messerli, F. H., & Lip, G. Y. H. (2006). Hypertension and breast cancer: an association revisited?. Journal of human hypertension, 20(10), 722-724. doi:10.1038/sj.jhh.1002053DOI: 10.1038/sj.jhh.1002053
Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients. (Journal article)
Hamaad, A., Kaeng Lee, W., Lip, G. Y. H., & MacFadyen, R. J. (2006). Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients.. Cardiovascular drugs and therapy, 20(5), 359-364. doi:10.1007/s10557-006-0295-zDOI: 10.1007/s10557-006-0295-z
Proteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes. (Journal article)
Goon, P. K. Y., & Lip, G. Y. H. (2006). Proteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes.. Journal of thrombosis and thrombolysis, 22(2), 155-156. doi:10.1007/s11239-006-8983-xDOI: 10.1007/s11239-006-8983-x
Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood (Journal article)
Boos, C. J., Lane, D. A., Kang, D., Goon, P. K. Y., Blann, A. D., & Lip, G. Y. H. (2006). Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 22(2), 125-131. doi:10.1007/s11239-006-8422-zDOI: 10.1007/s11239-006-8422-z
Patel, J. V., Cummings, D. E., Girod, J. P., Mascarenhas, A. V., Hughes, E. A., Gupta, M., . . . Brotman, D. J. (2006). Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment.. Journal of negative results in biomedicine, 5, 14. doi:10.1186/1477-5751-5-14DOI: 10.1186/1477-5751-5-14
The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction. (Journal article)
Freestone, B., Chong, A. Y., Blann, A. D., & Lip, G. Y. H. (2006). The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.. Thrombosis research, 118(4), 479-485. doi:10.1016/j.thromres.2005.10.004DOI: 10.1016/j.thromres.2005.10.004
A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999. (Journal article)
Heeringa, J., Conway, D. S. G., van der Kuip, D. A. M., Hofman, A., Breteler, M. M. B., Lip, G. Y. H., & Witteman, J. C. M. (2006). A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999.. Journal of thrombosis and haemostasis : JTH, 4(9), 1944-1949. doi:10.1111/j.1538-7836.2006.02115.xDOI: 10.1111/j.1538-7836.2006.02115.x
Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation (Journal article)
Lip, G. Y. H., Lane, D., Van Walraven, C., & Hart, R. G. (2006). Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation. STROKE, 37(9), 2294-2300. doi:10.1161/01.STR.0000236840.00467.84DOI: 10.1161/01.STR.0000236840.00467.84
Angiogenin: a review of the pathophysiology and potential clinical applications. (Journal article)
Tello-Montoliu, A., Patel, J. V., & Lip, G. Y. H. (2006). Angiogenin: a review of the pathophysiology and potential clinical applications.. Journal of thrombosis and haemostasis : JTH, 4(9), 1864-1874. doi:10.1111/j.1538-7836.2006.01995.xDOI: 10.1111/j.1538-7836.2006.01995.x
Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not? (Journal article)
Lip, G. Y. H., & Varma, C. (2006). Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not?. Thrombosis research, 118(4), 429-432. doi:10.1016/j.thromres.2005.09.012DOI: 10.1016/j.thromres.2005.09.012
Blood pressure control in the setting of diabetes mellitus: new targets, new hope for improvement? (Journal article)
Varughese, G. I., Patel, J. V., & Lip, G. Y. H. (2006). Blood pressure control in the setting of diabetes mellitus: new targets, new hope for improvement?. Journal of human hypertension, 20(9), 635-637. doi:10.1038/sj.jhh.1002029DOI: 10.1038/sj.jhh.1002029
Blood pressure measurement in atrial fibrillation: goodbye mercury? (Journal article)
Watson, T., & Lip, G. Y. H. (2006). Blood pressure measurement in atrial fibrillation: goodbye mercury?. Journal of human hypertension, 20(9), 638-640. doi:10.1038/sj.jhh.1002031DOI: 10.1038/sj.jhh.1002031
Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients. (Journal article)
Nadar, S., Blann, A. D., & Lip, G. Y. H. (2006). Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.. American journal of hypertension, 19(9), 970-978. doi:10.1016/j.amjhyper.2006.03.001DOI: 10.1016/j.amjhyper.2006.03.001
Prevention of cardiovascular disease in clinical practice: The Joint British Societies' (JBS 2) guidelines. (Journal article)
Jessani, S., Watson, T., Cappuccio, F. P., & Lip, G. Y. H. (2006). Prevention of cardiovascular disease in clinical practice: The Joint British Societies' (JBS 2) guidelines.. Journal of human hypertension, 20(9), 641-645. doi:10.1038/sj.jhh.1002058DOI: 10.1038/sj.jhh.1002058
Home-based cardiac rehabilitation compared with centre-based rehabilitation and usual care: a systematic review and meta-analysis. (Journal article)
Jolly, K., Taylor, R. S., Lip, G. Y. H., & Stevens, A. (2006). Home-based cardiac rehabilitation compared with centre-based rehabilitation and usual care: a systematic review and meta-analysis.. International journal of cardiology, 111(3), 343-351. doi:10.1016/j.ijcard.2005.11.002DOI: 10.1016/j.ijcard.2005.11.002
Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes. (Journal article)
Lee, K. W., Blann, A. D., & Lip, G. Y. H. (2006). Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.. International journal of cardiology, 111(2), 302-308. doi:10.1016/j.ijcard.2005.10.014DOI: 10.1016/j.ijcard.2005.10.014
Anticoagulation for stroke prevention in atrial fibrillation: is gender important? (Journal article)
Lip, G. Y. H., Watson, T., & Shantsila, E. (2006). Anticoagulation for stroke prevention in atrial fibrillation: is gender important?. EUROPEAN HEART JOURNAL, 27(16), 1893-1894. doi:10.1093/eurheartj/ehl140DOI: 10.1093/eurheartj/ehl140
Arterial disease and venous thromboembolism: a modern paradigm? (Journal article)
Goon, P. K. Y., & Lip, G. Y. H. (2006). Arterial disease and venous thromboembolism: a modern paradigm?. Thrombosis and haemostasis, 96(2), 111-112. doi:10.1160/th06-07-0380DOI: 10.1160/th06-07-0380
Atrial fibrillation post-cardiac surgery: changing perspectives (Journal article)
Shantsila, E., Watson, T., & Lip, G. Y. H. (2006). Atrial fibrillation post-cardiac surgery: changing perspectives. CURRENT MEDICAL RESEARCH AND OPINION, 22(8), 1437-1441. doi:10.1185/030079906X115658DOI: 10.1185/030079906X115658
Management of atrial fibrillation. (Journal article)
Lip, G. Y. H., & Tello-Montoliu, A. (2006). Management of atrial fibrillation.. Heart (British Cardiac Society), 92(8), 1177-1182. doi:10.1136/hrt.2005.071555DOI: 10.1136/hrt.2005.071555
The pathophysiology of target organ damage in hypertension. (Journal article)
Karpha, M., & Lip, G. V. H. (2006). The pathophysiology of target organ damage in hypertension.. Minerva cardioangiologica, 54(4), 417-429.
Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction. (Journal article)
Lee, K. W., Blann, A. D., & Lip, G. Y. H. (2006). Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction.. Thrombosis research, 118(3), 305-312. doi:10.1016/j.thromres.2005.07.018DOI: 10.1016/j.thromres.2005.07.018
Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. (Journal article)
Lip, G. Y. H., & Edwards, S. J. (2006). Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.. Thrombosis research, 118(3), 321-333. doi:10.1016/j.thromres.2005.08.007DOI: 10.1016/j.thromres.2005.08.007
Ximelagatran: an eulogy. (Journal article)
Boos, C. J., & Lip, G. Y. H. (2006). Ximelagatran: an eulogy.. Thrombosis research, 118(3), 301-304. doi:10.1016/j.thromres.2006.02.012DOI: 10.1016/j.thromres.2006.02.012
Hypercalcemia and the cardiovascular system (Journal article)
Karthikeyan, V. J., Khan, J. M., & Lip, G. Y. H. (2006). Hypercalcemia and the cardiovascular system. Heart and Metabolism, (30).
Antithrombotic therapy: standard therapy in essential hypertension? (Journal article)
Lip, G. Y. H. (2006). Antithrombotic therapy: standard therapy in essential hypertension?. Progress in cardiovascular diseases, 49(1), 11-15. doi:10.1016/j.pcad.2006.03.004DOI: 10.1016/j.pcad.2006.03.004
Aspirin for prevention of stroke in atrial fibrillation. (Journal article)
Lip, G. Y. H. (2006). Aspirin for prevention of stroke in atrial fibrillation.. Stroke, 37(7), 1640. doi:10.1161/01.str.0000227301.55019.60DOI: 10.1161/01.str.0000227301.55019.60
Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison. (Journal article)
Goon, P. K. Y., Boos, C. J., Stonelake, P. S., Blann, A. D., & Lip, G. Y. H. (2006). Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison.. Thrombosis and haemostasis, 96(1), 45-52. doi:10.1160/th06-04-0185DOI: 10.1160/th06-04-0185
Endothelial progenitor cells in the vascular pathophysiology of hypertension: arterial stiffness, ageing and more. (Journal article)
Boos, C. J., Goon, P. K. Y., & Lip, G. Y. H. (2006). Endothelial progenitor cells in the vascular pathophysiology of hypertension: arterial stiffness, ageing and more.. Journal of human hypertension, 20(7), 475-477. doi:10.1038/sj.jhh.1001991DOI: 10.1038/sj.jhh.1001991
Therapy for atrial fibrillation: new challenges (Journal article)
Shantsila, E., Watson, T., & Lip, G. Y. H. (2006). Therapy for atrial fibrillation: new challenges. Therapy, 3(4), 445-448. doi:10.2217/14750708.3.4.445DOI: 10.2217/14750708.3.4.445
Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: Effects of an educational intervention programme The West Birmingham Atrial Fibrillation Project (Journal article)
Lane, D. A., Ponsford, J., Shelley, A., Sirpal, A., & Lip, G. Y. H. (2006). Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: Effects of an educational intervention programme The West Birmingham Atrial Fibrillation Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 110(3), 354-358. doi:10.1016/j.ijcard.2005.07.031DOI: 10.1016/j.ijcard.2005.07.031
Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation? (Journal article)
Roldán, V., Marín, F., García, A., Tello-Montoliu, A., & Lip, G. Y. H. (2006). Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?. International journal of cardiology, 110(2), 265-266. doi:10.1016/j.ijcard.2005.08.057DOI: 10.1016/j.ijcard.2005.08.057
Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. (Journal article)
Brotman, D. J., Girod, J. P., Posch, A., Jani, J. T., Patel, J. V., Gupta, M., . . . Kickler, T. S. (2006). Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers.. Thrombosis research, 118(2), 247-252. doi:10.1016/j.thromres.2005.06.006DOI: 10.1016/j.thromres.2005.06.006
Failed reperfusion with thrombolysis--the effect of a local environment? (Journal article)
Varma, C., & Lip, G. Y. H. (2006). Failed reperfusion with thrombolysis--the effect of a local environment?. Thrombosis research, 118(2), 185-187. doi:10.1016/j.thromres.2005.07.016DOI: 10.1016/j.thromres.2005.07.016
Pharmacotherapy for atrial fibrillation: is rhythm control achievable? (Journal article)
Watson, T., Shantsila, E., & Lip, G. Y. H. (2006). Pharmacotherapy for atrial fibrillation: is rhythm control achievable?. EXPERT OPINION ON PHARMACOTHERAPY, 7(9), 1105-1107. doi:10.1517/14656566.7.9.1105DOI: 10.1517/14656566.7.9.1105
Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype. (Journal article)
Mohan, J. S., Lip, G. Y. H., Bareford, D., & Blann, A. D. (2006). Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype.. Thrombosis research, 117(6), 623-629. doi:10.1016/j.thromres.2005.05.010DOI: 10.1016/j.thromres.2005.05.010
Editorial [Hot Topic: Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)] (Journal article)
Lip, G. (2006). Editorial [Hot Topic: Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]. Current Pharmaceutical Design, 12(13), 1555. doi:10.2174/138161206776843359DOI: 10.2174/138161206776843359
Is hypertension an inflammatory process? (Journal article)
Boos, C. J., & Lip, G. Y. H. (2006). Is hypertension an inflammatory process?. Current pharmaceutical design, 12(13), 1623-1635. doi:10.2174/138161206776843313DOI: 10.2174/138161206776843313
Novel concepts of statin therapy for cardiovascular risk reduction in hypertension. (Journal article)
Varughese, G. I., Patel, J. V., Lip, G. Y. H., & Varma, C. (2006). Novel concepts of statin therapy for cardiovascular risk reduction in hypertension.. Current pharmaceutical design, 12(13), 1593-1609. doi:10.2174/138161206776843304DOI: 10.2174/138161206776843304
Quality of life in patients with atrial fibrillation: a systematic review. (Journal article)
Thrall, G., Lane, D., Carroll, D., & Lip, G. Y. H. (2006). Quality of life in patients with atrial fibrillation: a systematic review.. The American journal of medicine, 119(5), 448.e1-448.19. doi:10.1016/j.amjmed.2005.10.057DOI: 10.1016/j.amjmed.2005.10.057
Reactive oxygen species production by circulating monocytes: insights from pathophysiology to clinical hypertension. (Journal article)
Lim, H. S., Patel, J. V., & Lip, G. Y. H. (2006). Reactive oxygen species production by circulating monocytes: insights from pathophysiology to clinical hypertension.. Journal of human hypertension, 20(5), 307-309. doi:10.1038/sj.jhh.1001994DOI: 10.1038/sj.jhh.1001994
Target organ damage in hypertension: pathophysiology and implications for drug therapy. (Journal article)
Nadar, S. K., Tayebjee, M. H., Messerli, F., & Lip, G. Y. H. (2006). Target organ damage in hypertension: pathophysiology and implications for drug therapy.. Current pharmaceutical design, 12(13), 1581-1592. doi:10.2174/138161206776843368DOI: 10.2174/138161206776843368
The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management. (Journal article)
Lim, H. S., MacFadyen, R. J., Bakris, G., & Lip, G. Y. H. (2006). The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management.. Current pharmaceutical design, 12(13), 1567-1579. doi:10.2174/138161206776843322DOI: 10.2174/138161206776843322
Traditional risk factors for coronary atherosclerosis in Indo Asians: the need for a reappraisal. (Journal article)
Jaumdally, J. R., Lip, G. Y. H., & Varma, C. (2006). Traditional risk factors for coronary atherosclerosis in Indo Asians: the need for a reappraisal.. Current pharmaceutical design, 12(13), 1611-1621. doi:10.2174/138161206776843331DOI: 10.2174/138161206776843331
White blood cell count and hypertension. (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2006). White blood cell count and hypertension.. Journal of human hypertension, 20(5), 310-312. doi:10.1038/sj.jhh.1001980DOI: 10.1038/sj.jhh.1001980
Do the National Institute of Clinical Excellence guidelines apply to 'real world' use of Abciximab in percutaneous coronary intervention in a teaching hospital setting? (Journal article)
Khan, J. M., Watson, R. D. S., Varma, C., Millane, T., & Lip, G. Y. H. (2006). Do the National Institute of Clinical Excellence guidelines apply to 'real world' use of Abciximab in percutaneous coronary intervention in a teaching hospital setting?. International journal of clinical practice, 60(4), 498-499. doi:10.1111/j.1368-5031.2006.0827c.xDOI: 10.1111/j.1368-5031.2006.0827c.x
Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers? (Journal article)
Tello-Montoliu, A., Roldán, V., Climent, V. E., Sogorb, F., Lip, G. Y. H., & Marín, F. (2006). Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?. Journal of thrombosis and thrombolysis, 21(2), 163-166. doi:10.1007/s11239-006-4384-4DOI: 10.1007/s11239-006-4384-4
Growth hormone therapy and the heart. (Journal article)
Climent, V. E., Picó, A., Sogorb, F., Aznar, S., Lip, G. Y. H., & Marín, F. (2006). Growth hormone therapy and the heart.. The American journal of cardiology, 97(7), 1097-1102. doi:10.1016/j.amjcard.2005.10.054DOI: 10.1016/j.amjcard.2005.10.054
Is atrial fibrillation an inflammatory disorder?: reply (Journal article)
Boos, C. J. (n.d.). Is atrial fibrillation an inflammatory disorder?: reply. European Heart Journal, 27(7), 886. doi:10.1093/eurheartj/ehi781DOI: 10.1093/eurheartj/ehi781
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. (Journal article)
Heeringa, J., van der Kuip, D. A. M., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H. C., . . . Witteman, J. C. M. (2006). Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.. European heart journal, 27(8), 949-953. doi:10.1093/eurheartj/ehi825DOI: 10.1093/eurheartj/ehi825
The role of inflammation in atrial fibrillation: increasing evidence in support of a novel concept (Journal article)
Boos, C. J., & Lip, G. Y. H. (n.d.). The role of inflammation in atrial fibrillation: increasing evidence in support of a novel concept. International Journal of Clinical Practice, 60(4), 497-498. doi:10.1111/j.1368-5031.2006.0827b.xDOI: 10.1111/j.1368-5031.2006.0827b.x
Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden? (Journal article)
Bhatia, G. S., Sosin, M. D., Patel, J. V., Grindulis, K. A., Khattak, F. H., Hughes, E. A., . . . Davis, R. C. (2006). Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden?. Journal of the American College of Cardiology, 47(6), 1169-1174. doi:10.1016/j.jacc.2005.10.059DOI: 10.1016/j.jacc.2005.10.059
Viewpoint. (Journal article)
Lip, G. Y. H. (2006). Viewpoint.. Circulation, 113(9), f33-f34.
Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. (Journal article)
Chong, A. Y., Freestone, B., Patel, J., Lim, H. S., Hughes, E., Blann, A. D., & Lip, G. Y. H. (2006). Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.. The American journal of cardiology, 97(5), 671-675. doi:10.1016/j.amjcard.2005.09.113DOI: 10.1016/j.amjcard.2005.09.113
Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin. (Journal article)
Chong, A. Y., Lip, G. Y. H., Freestone, B., & Blann, A. D. (2006). Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin.. European journal of heart failure, 8(2), 167-172. doi:10.1016/j.ejheart.2005.06.010DOI: 10.1016/j.ejheart.2005.06.010
Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers. (Journal article)
Boos, C. J., & Lip, G. Y. H. (2006). Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.. Journal of the American College of Cardiology, 47(4), 889-890. doi:10.1016/j.jacc.2005.11.033DOI: 10.1016/j.jacc.2005.11.033
Sudden death is less common than might be expected in underprivileged ethnic minorities at high cardiovascular risk. (Journal article)
Hamaad, A., Ghattas, A., Hirani, F., Lip, G. Y. H., & MacFadyen, R. J. (2006). Sudden death is less common than might be expected in underprivileged ethnic minorities at high cardiovascular risk.. International journal of cardiology, 107(2), 235-240. doi:10.1016/j.ijcard.2005.03.020DOI: 10.1016/j.ijcard.2005.03.020
Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias. (Journal article)
Marinskis, G., Lip, G. Y. H., Aidietis, A., Jurkuvenas, P., Kaireviciūte, D., Jezov, V., . . . Laucevicius, A. (2006). Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias.. International journal of cardiology, 107(1), 134-135. doi:10.1016/j.ijcard.2005.01.030DOI: 10.1016/j.ijcard.2005.01.030
Assessment of hemostatic risk factors in predicting arterial thrombotic events. (Journal article)
Boos, C. J., & Lip, G. Y. H. (2006). Assessment of hemostatic risk factors in predicting arterial thrombotic events.. Arteriosclerosis, thrombosis, and vascular biology, 26(2), e18. doi:10.1161/01.atv.0000199298.80771.1fDOI: 10.1161/01.atv.0000199298.80771.1f
Blood pressure control and prevention of stroke. (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Blood pressure control and prevention of stroke.. Expert review of neurotherapeutics, 6(2), 203-212. doi:10.1586/14737175.6.2.203DOI: 10.1586/14737175.6.2.203
Corrigendum to: ‘The adhesion molecule P-selectin and cardiovascular disease’ [Eur Heart J 2003;24:2166–2179] (Journal article)
Blann, A. D., Nadar, S. K., & Lip, G. Y. H. (2006). Corrigendum to: ‘The adhesion molecule P-selectin and cardiovascular disease’ [Eur Heart J 2003;24:2166–2179]. European Heart Journal, 27(4), 501. doi:10.1093/eurheartj/ehi764DOI: 10.1093/eurheartj/ehi764
Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients. (Journal article)
Bacon, S. L., Ring, C., Hee, F. L. S., Lip, G. Y. H., Blann, A. D., Lavoie, K. L., & Carroll, D. (2006). Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients.. Biological psychology, 71(2), 162-170. doi:10.1016/j.biopsycho.2005.03.003DOI: 10.1016/j.biopsycho.2005.03.003
New evidence of anti-inflammatory interventions in atrial fibrillation: reply (Journal article)
Boos, C. J. (n.d.). New evidence of anti-inflammatory interventions in atrial fibrillation: reply. European Heart Journal, 27(4), 501. doi:10.1093/eurheartj/ehi692DOI: 10.1093/eurheartj/ehi692
Pulse pressure and carotid atherosclerosis: an important link revisited? (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Pulse pressure and carotid atherosclerosis: an important link revisited?. International journal of clinical practice, 60(2), 127-130. doi:10.1111/j.1742-1241.2006.00843b.xDOI: 10.1111/j.1742-1241.2006.00843b.x
Review: Angiotensin converting enzyme inhibitors and angiotensin receptor blockers prevent atrial fibrillation. (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Review: Angiotensin converting enzyme inhibitors and angiotensin receptor blockers prevent atrial fibrillation.. Evidence-based medicine, 11(1), 15. doi:10.1136/ebm.11.1.15DOI: 10.1136/ebm.11.1.15
Venous thromboembolism. (Journal article)
Blann, A. D., & Lip, G. Y. H. (2006). Venous thromboembolism.. BMJ (Clinical research ed.), 332(7535), 215-219. doi:10.1136/bmj.332.7535.215DOI: 10.1136/bmj.332.7535.215
Matrix metalloproteinases and hypertension: a link between left ventricular hypertrophy and diastolic dysfunction? (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Matrix metalloproteinases and hypertension: a link between left ventricular hypertrophy and diastolic dysfunction?. The Tohoku journal of experimental medicine, 208(2), 93-97. doi:10.1620/tjem.208.93DOI: 10.1620/tjem.208.93
Abnormal circulating neutrophil linked matrix metalloproteinase -9 in stable coronary artery disease. (Journal article)
Tayebjee, M. H., Lip, G. Y. H., Tan, K. T., & MacFadyen, R. J. (2006). Abnormal circulating neutrophil linked matrix metalloproteinase -9 in stable coronary artery disease.. Thrombosis and haemostasis, 95(1), 202-204. doi:10.1055/s-0037-1612586DOI: 10.1055/s-0037-1612586
Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis. (Journal article)
Patel, J. V., Lim, H. S., Nadar, S., Tayebjee, M., Hughes, E. A., & Lip, G. Y. (2006). Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis.. Journal of hypertension, 24(1), 117-121. doi:10.1097/01.hjh.0000198034.09010.bcDOI: 10.1097/01.hjh.0000198034.09010.bc
Alcohol and hypertension: an old relationship revisited. (Journal article)
Tomson, J., & Lip, G. Y. (2006). Alcohol and hypertension: an old relationship revisited.. Alcohol and alcoholism (Oxford, Oxfordshire), 41(1), 3-4. doi:10.1093/alcalc/agh223DOI: 10.1093/alcalc/agh223
Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline. (Journal article)
Lip, G. Y. H., & Karpha, M. (2006). Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.. Chest, 130(6), 1823-1827. doi:10.1378/chest.130.6.1823DOI: 10.1378/chest.130.6.1823
Anticoagulation control with vitamin K antagonists - How well are we doing? (Journal article)
Lane, D. A., Boos, C. J., & Lip, G. Y. H. (2006). Anticoagulation control with vitamin K antagonists - How well are we doing?. CHEST, 129(5), 1122-1124. doi:10.1378/chest.129.5.1122DOI: 10.1378/chest.129.5.1122
Antithrombotic therapy for congestive heart failure. (Journal article)
Chung, I., & Lip, G. Y. H. (2006). Antithrombotic therapy for congestive heart failure.. International journal of clinical practice, 60(1), 36-47. doi:10.1111/j.1368-5031.2005.00676.xDOI: 10.1111/j.1368-5031.2005.00676.x
Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation - A useful complement to stroke risk stratification schema (Journal article)
Kakar, P., Lane, D., & Lip, G. Y. H. (2006). Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation - A useful complement to stroke risk stratification schema. CHEST, 130(5), 1296-1299. doi:10.1378/chest.130.5.1296DOI: 10.1378/chest.130.5.1296
Blood clotting, inflammation, and thrombosis in cardiovascular events: perspectives. (Journal article)
Boos, C. J., & Lip, G. Y. H. (2006). Blood clotting, inflammation, and thrombosis in cardiovascular events: perspectives.. Frontiers in bioscience : a journal and virtual library, 11, 328-336. doi:10.2741/1800DOI: 10.2741/1800
Cardioversion and the endothelium in atrial fibrillation. (Journal article)
Lip, G. Y. H., & Freestone, B. (2006). Cardioversion and the endothelium in atrial fibrillation.. Thrombosis research, 117(3), 231-233. doi:10.1016/j.thromres.2005.04.028DOI: 10.1016/j.thromres.2005.04.028
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. (Journal article)
Goon, P. K. Y., Lip, G. Y. H., Boos, C. J., Stonelake, P. S., & Blann, A. D. (2006). Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer.. Neoplasia (New York, N.Y.), 8(2), 79-88. doi:10.1593/neo.05592DOI: 10.1593/neo.05592
Differences in the platelet reactivity response to mental stress in cardiac syndrome X patients compared to known coronary artery disease patients: concepts, explanations and methodological weaknesses. (Journal article)
Thrall, G., Lane, D., & Lip, G. Y. H. (2006). Differences in the platelet reactivity response to mental stress in cardiac syndrome X patients compared to known coronary artery disease patients: concepts, explanations and methodological weaknesses.. Thrombosis research, 117(3), 351-352. doi:10.1016/j.thromres.2005.06.018DOI: 10.1016/j.thromres.2005.06.018
Drug development and the importance of ethnicity: Lessons from heart failure management and implications for hypertension (Book)
Sosin, M. D., Bhatia, G. S., Lip, G. Y. H., & Davis, R. C. (2006). Drug development and the importance of ethnicity: Lessons from heart failure management and implications for hypertension (Vol. 3).
Is atrial fibrillation an inflammatory disorder? (Journal article)
Boos, C. J., Anderson, R. A., & Lip, G. Y. H. (2006). Is atrial fibrillation an inflammatory disorder?. European heart journal, 27(2), 136-149. doi:10.1093/eurheartj/ehi645DOI: 10.1093/eurheartj/ehi645
Platelet microparticles and platelet adhesion: therapeutic implications for the prevention and treatment of stroke. (Journal article)
Tan, K. T., & Lip, G. Y. H. (2006). Platelet microparticles and platelet adhesion: therapeutic implications for the prevention and treatment of stroke.. Current treatment options in cardiovascular medicine, 8(3), 251-258. doi:10.1007/s11936-006-0019-5DOI: 10.1007/s11936-006-0019-5
Reduction of Vessel Wall Inflammation in Hypertensive Patients: Is Physical Activity the Answer? (Journal article)
THRALL, G., & LIP, G. (2006). Reduction of Vessel Wall Inflammation in Hypertensive Patients: Is Physical Activity the Answer?. American Journal of Hypertension, 19(7), 676-677. doi:10.1016/j.amjhyper.2005.11.007DOI: 10.1016/j.amjhyper.2005.11.007
Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. (Journal article)
Marín, F., Pascual, D. A., Roldán, V., Arribas, J. M., Ahumada, M., Tornel, P. L., . . . Valdés, M. (2006). Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.. The American journal of cardiology, 97(1), 55-60. doi:10.1016/j.amjcard.2005.07.124DOI: 10.1016/j.amjcard.2005.07.124
The endothelium, inflammation, and coagulation in sepsis. (Journal article)
Boos, C. J., Goon, P. K. Y., & Lip, G. Y. H. (2006). The endothelium, inflammation, and coagulation in sepsis.. Clinical pharmacology and therapeutics, 79(1), 20-22. doi:10.1016/j.clpt.2005.10.004DOI: 10.1016/j.clpt.2005.10.004
Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better? (Journal article)
Watson, T., & Lip, G. Y. H. (2006). Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better?. International journal of clinical practice, 60(3), 252-255. doi:10.1111/j.1368-5031.2006.0884b.xDOI: 10.1111/j.1368-5031.2006.0884b.x
Urotensin and cardiovascular risk among patients with end-stage renal disease: fact or fiction? (Journal article)
Boos, C. J., & Lip, G. Y. H. (2006). Urotensin and cardiovascular risk among patients with end-stage renal disease: fact or fiction?. American journal of hypertension, 19(5), 511-512. doi:10.1016/j.amjhyper.2005.11.013DOI: 10.1016/j.amjhyper.2005.11.013
Vasculoprotective effects of angiotensin receptor blockers: beyond the renin-angiotensin-aldosterone system? (Journal article)
Karthikeyan, V. J., & Lip, G. Y. H. (2006). Vasculoprotective effects of angiotensin receptor blockers: beyond the renin-angiotensin-aldosterone system?. Journal of hypertension, 24(9), 1715-1717. doi:10.1097/01.hjh.0000242394.30344.8fDOI: 10.1097/01.hjh.0000242394.30344.8f
Ximelagatran. (Journal article)
Choudhury, A., Goyal, D., & Lip, G. Y. H. (2006). Ximelagatran.. Drugs of today (Barcelona, Spain : 1998), 42(1), 3-19. doi:10.1358/dot.2006.42.1.893611DOI: 10.1358/dot.2006.42.1.893611
2005
Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links. (Journal article)
Lip, G. Y. H., & Varughese, G. I. (2005). Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links.. International journal of cardiology, 105(3), 319-321. doi:10.1016/j.ijcard.2005.03.003DOI: 10.1016/j.ijcard.2005.03.003
Biomarkers in atrial fibrillation: further observations on biologic plausibility, cause and effect. (Journal article)
Boos, C. J., & Lip, G. Y. H. (2005). Biomarkers in atrial fibrillation: further observations on biologic plausibility, cause and effect.. Journal of thrombosis and thrombolysis, 20(3), 189-190. doi:10.1007/s11239-005-3597-2DOI: 10.1007/s11239-005-3597-2
Circulating endothelial cells in malignant disease. (Journal article)
Goon, P. K. Y., Boos, C. J., Stonelake, P. S., & Lip, G. Y. H. (2005). Circulating endothelial cells in malignant disease.. Future oncology (London, England), 1(6), 813-820. doi:10.2217/14796694.1.6.813DOI: 10.2217/14796694.1.6.813
Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. (Journal article)
Tan, K. T., Tayebjee, M. H., Lim, H. S., & Lip, G. Y. H. (2005). Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.. Diabetic medicine : a journal of the British Diabetic Association, 22(12), 1657-1662. doi:10.1111/j.1464-5491.2005.01707.xDOI: 10.1111/j.1464-5491.2005.01707.x
How far can population epidemiology contribute to defining the relationship between hypertension and left ventricular systolic dysfunction? (Journal article)
MacFadyen, R. J., Goyal, D., & Lip, G. Y. H. (2005). How far can population epidemiology contribute to defining the relationship between hypertension and left ventricular systolic dysfunction?. Journal of human hypertension, 19(12), 919-922. doi:10.1038/sj.jhh.1001927DOI: 10.1038/sj.jhh.1001927
Serum adiponectin in coronary heart disease: ethnic differences and relation to coronary artery disease severity. (Journal article)
Lim, H. S., Tayebjee, M. H., Tan, K. T., Patel, J. V., Macfadyen, R. J., & Lip, G. Y. H. (2005). Serum adiponectin in coronary heart disease: ethnic differences and relation to coronary artery disease severity.. Heart (British Cardiac Society), 91(12), 1605-1606. doi:10.1136/hrt.2004.047803DOI: 10.1136/hrt.2004.047803
The assessment of platelet activation in antiplatelet drug development. (Journal article)
Tan, K. T., & Lip, G. Y. H. (2005). The assessment of platelet activation in antiplatelet drug development.. Current medicinal chemistry, 12(26), 3117-3125. doi:10.2174/092986705774933399DOI: 10.2174/092986705774933399
The prothrombotic risk of diabetes mellitus in atrial fibrillation and heart failure. (Journal article)
Varughese, G. I., Patel, J. V., Tomson, J., & Lip, G. Y. H. (2005). The prothrombotic risk of diabetes mellitus in atrial fibrillation and heart failure.. Journal of thrombosis and haemostasis : JTH, 3(12), 2811-2813. doi:10.1111/j.1538-7836.2005.01694.xDOI: 10.1111/j.1538-7836.2005.01694.x
What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus? (Journal article)
Tayebjee, M. H., Lip, G. Y. H., & MacFadyen, R. J. (2005). What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus?. Diabetic medicine : a journal of the British Diabetic Association, 22(12), 1628-1635. doi:10.1111/j.1464-5491.2005.01675.xDOI: 10.1111/j.1464-5491.2005.01675.x
Circulating endothelial cells: markers of vascular dysfunction. (Journal article)
Goon, P. K. Y., Boos, C. J., & Lip, G. Y. H. (2005). Circulating endothelial cells: markers of vascular dysfunction.. Clinical laboratory, 51(9-10), 531-538.
Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis. (Journal article)
Varughese, G. I., & Lip, G. Y. H. (2005). Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis.. Journal of human hypertension, 19(11), 851-853. doi:10.1038/sj.jhh.1001926DOI: 10.1038/sj.jhh.1001926
Endothelial function and its assessment. (Journal article)
Felmeden, D. C., & Lip, G. Y. H. (2005). Endothelial function and its assessment.. Expert opinion on investigational drugs, 14(11), 1319-1336. doi:10.1517/13543784.14.11.1319DOI: 10.1517/13543784.14.11.1319
Ethnic differences in arterial responses, inflammation, and metabolic profiles: possible insights into ethnic differences in cardiovascular disease and stroke. (Journal article)
Lip, G. Y. H., & Boos, C. J. (2005). Ethnic differences in arterial responses, inflammation, and metabolic profiles: possible insights into ethnic differences in cardiovascular disease and stroke.. Arteriosclerosis, thrombosis, and vascular biology, 25(11), 2240-2242. doi:10.1161/01.atv.0000188507.89134.efDOI: 10.1161/01.atv.0000188507.89134.ef
Incremental shuttle walking is associated with activation of haemostatic and haemorheological markers in patients with coronary artery disease: the Birmingham rehabilitation uptake maximization study (BRUM). (Journal article)
Lee, K. W., Blann, A. D., Ingram, J., Jolly, K., Lip, G. Y. H., & BRUM Investigators. (2005). Incremental shuttle walking is associated with activation of haemostatic and haemorheological markers in patients with coronary artery disease: the Birmingham rehabilitation uptake maximization study (BRUM).. Heart (British Cardiac Society), 91(11), 1413-1417. doi:10.1136/hrt.2004.050005DOI: 10.1136/hrt.2004.050005
Plasma markers of angiogenesis in pregnancy induced hypertension. (Journal article)
Nadar, S. K., Karalis, I., Al Yemeni, E., Blann, A. D., & Lip, G. Y. H. (2005). Plasma markers of angiogenesis in pregnancy induced hypertension.. Thrombosis and haemostasis, 94(5), 1071-1076. doi:10.1160/th05-03-0167DOI: 10.1160/th05-03-0167
Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes. (Journal article)
Lee, K. W., Blann, A. D., & Lip, G. Y. H. (2005). Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes.. Thrombosis and haemostasis, 94(5), 1077-1083. doi:10.1160/th05-03-0179DOI: 10.1160/th05-03-0179
Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials. (Journal article)
Boos, C. J., & Lip, G. Y. H. (2005). Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.. Journal of human hypertension, 19(11), 855-859. doi:10.1038/sj.jhh.1001933DOI: 10.1038/sj.jhh.1001933
Rheumatoid disease and ischaemic heart disease: insights from pathophysiology and vascular biology. (Journal article)
Bhatia, G. S., Sosin, M. D., Khattak, F. H., Davis, R. C., & Lip, G. Y. H. (2005). Rheumatoid disease and ischaemic heart disease: insights from pathophysiology and vascular biology.. International journal of cardiology, 105(1), 1-10. doi:10.1016/j.ijcard.2004.12.064DOI: 10.1016/j.ijcard.2004.12.064
Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis? (Journal article)
Freestone, B., Chong, A. Y., Lim, H. S., Blann, A., & Lip, G. Y. H. (2005). Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?. Annals of medicine, 37(5), 365-372. doi:10.1080/07853890510037392DOI: 10.1080/07853890510037392
Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. (Journal article)
Nadar, S. K., Blann, A., Beevers, D. G., & Lip, G. Y. H. (2005). Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].. Journal of internal medicine, 258(4), 336-343. doi:10.1111/j.1365-2796.2005.01550.xDOI: 10.1111/j.1365-2796.2005.01550.x
Circulating endothelial cells in acute ischaemic stroke. (Journal article)
Nadar, S. K., Lip, G. Y. H., Lee, K. W., & Blann, A. D. (2005). Circulating endothelial cells in acute ischaemic stroke.. Thrombosis and haemostasis, 94(4), 707-712. doi:10.1160/th04-12-0795DOI: 10.1160/th04-12-0795
Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease. (Journal article)
Freestone, B., Lip, G. Y. H., Chong, A. Y., Nadar, S., Lee, K. W., & Blann, A. D. (2005). Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.. Thrombosis and haemostasis, 94(4), 702-706. doi:10.1160/th05-02-0093DOI: 10.1160/th05-02-0093
Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation. (Journal article)
Lee, K. W., Blann, A. D., & Lip, G. Y. H. (2005). Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation.. American heart journal, 150(4), 756-766. doi:10.1016/j.ahj.2004.11.019DOI: 10.1016/j.ahj.2004.11.019
Is there an association between hypertension and the development of coronary collateral flow? (Journal article)
Tayebjee, M. H., Lip, G. Y. H., & Macfadyen, R. J. (2005). Is there an association between hypertension and the development of coronary collateral flow?. Journal of human hypertension, 19(10), 757-759. doi:10.1038/sj.jhh.1001906DOI: 10.1038/sj.jhh.1001906
Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy? (Journal article)
Choudhury, A., Varughese, G. I., & Lip, G. Y. H. (2005). Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?. Expert opinion on pharmacotherapy, 6(13), 2193-2207. doi:10.1517/14656566.6.13.2193DOI: 10.1517/14656566.6.13.2193
Preventing stroke in atrial fibrillation: the SPORTIF programme. (Journal article)
Lip, G. Y. H. (2005). Preventing stroke in atrial fibrillation: the SPORTIF programme.. Pathophysiology of haemostasis and thrombosis, 34 Suppl 1, 25-30. doi:10.1159/000083081DOI: 10.1159/000083081
Aspirin and endothelial function in hypertension. (Journal article)
Felmeden, D., Nadar, S. K., & Lip, G. Y. H. (2005). Aspirin and endothelial function in hypertension.. Journal of human hypertension, 19(9), 663-665. doi:10.1038/sj.jhh.1001880DOI: 10.1038/sj.jhh.1001880
Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation. (Journal article)
Tan, K. T., Tayebjee, M. H., Macfadyen, R. J., Lip, G. Y. H., & Blann, A. D. (2005). Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation.. Platelets, 16(6), 368-371. doi:10.1080/00207230500120401DOI: 10.1080/00207230500120401
Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy. (Journal article)
Jaumdally, R., Lip, G. Y. H., & Varma, C. (2005). Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy.. International journal of clinical practice, 59(9), 1070-1081. doi:10.1111/j.1742-1241.2005.00608.xDOI: 10.1111/j.1742-1241.2005.00608.x
Platelet activation in pregnancy-induced hypertension. (Journal article)
Karalis, I., Nadar, S. K., Al Yemeni, E., Blann, A. D., & Lip, G. Y. H. (2005). Platelet activation in pregnancy-induced hypertension.. Thrombosis research, 116(5), 377-383. doi:10.1016/j.thromres.2005.01.009DOI: 10.1016/j.thromres.2005.01.009
The potential role of platelet microparticles in atherosclerosis. (Journal article)
Tan, K. T., & Lip, G. Y. H. (2005). The potential role of platelet microparticles in atherosclerosis.. Thrombosis and haemostasis, 94(3), 488-492. doi:10.1160/th05-03-0201DOI: 10.1160/th05-03-0201
Blood pressure changes in acute haemorrhagic stroke. (Journal article)
Tomson, J., & Lip, G. Y. H. (2005). Blood pressure changes in acute haemorrhagic stroke.. Blood pressure monitoring, 10(4), 197-199. doi:10.1097/1.mbp.0000172707.59416.3eDOI: 10.1097/1.mbp.0000172707.59416.3e
Exercise and hypertension. (Journal article)
Choudhury, A., & Lip, G. Y. H. (2005). Exercise and hypertension.. Journal of human hypertension, 19(8), 585-587. doi:10.1038/sj.jhh.1001851DOI: 10.1038/sj.jhh.1001851
Interleukin-15 in hypertension: further insights into inflammation and vascular disease. (Journal article)
Lim, H. S., & Lip, G. Y. H. (2005). Interleukin-15 in hypertension: further insights into inflammation and vascular disease.. American journal of hypertension, 18(8), 1017-1018. doi:10.1016/j.amjhyper.2005.03.742DOI: 10.1016/j.amjhyper.2005.03.742
Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. (Journal article)
Tayebjee, M. H., Lip, G. Y. H., Tan, K. T., Patel, J. V., Hughes, E. A., & MacFadyen, R. J. (2005). Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.. The American journal of cardiology, 96(3), 339-345. doi:10.1016/j.amjcard.2005.03.072DOI: 10.1016/j.amjcard.2005.03.072
The role of inflammation in atrial fibrillation. (Journal article)
Boos, C. J., & Lip, G. Y. H. (2005). The role of inflammation in atrial fibrillation.. International journal of clinical practice, 59(8), 870-872. doi:10.1111/j.1368-5031.2005.0599b.xDOI: 10.1111/j.1368-5031.2005.0599b.x
Ximelagatran in the clinic: practical management of patients. (Journal article)
Schulman, S., & Lip, G. Y. H. (2005). Ximelagatran in the clinic: practical management of patients.. Seminars in vascular medicine, 5(3), 301-307. doi:10.1055/s-2005-916170DOI: 10.1055/s-2005-916170
Ximelagatran: a clinical perspective. (Conference Paper)
Boos, C. J., Hinton, A., & Lip, G. Y. H. (2005). Ximelagatran: a clinical perspective.. In European journal of internal medicine Vol. 16 (pp. 267-278). doi:10.1016/j.ejim.2005.02.005DOI: 10.1016/j.ejim.2005.02.005
Antiplatelet and anticoagulant therapy in patients with advanced heart failure. (Journal article)
Lip, G. Y. H., & Chung, I. (2005). Antiplatelet and anticoagulant therapy in patients with advanced heart failure.. Thrombosis research, 116(4), 275-277. doi:10.1016/j.thromres.2004.12.022DOI: 10.1016/j.thromres.2004.12.022
Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation. (Journal article)
Roldán, V., Marín, F., García-Herola, A., & Lip, G. Y. H. (2005). Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.. Thrombosis research, 116(4), 321-325. doi:10.1016/j.thromres.2005.01.005DOI: 10.1016/j.thromres.2005.01.005
Relation of platelet activation to coronary angiographic severity and collateralization. (Journal article)
Tan, K. T., Tayebjee, M. H., Macfadyen, R. J., & Lip, G. Y. H. (2005). Relation of platelet activation to coronary angiographic severity and collateralization.. The American journal of cardiology, 96(2), 208-210. doi:10.1016/j.amjcard.2005.03.045DOI: 10.1016/j.amjcard.2005.03.045
Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension? (Journal article)
Boos, C. J., & Lip, G. Y. H. (2005). Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension?. Journal of human hypertension, 19(7), 511-513. doi:10.1038/sj.jhh.1001858DOI: 10.1038/sj.jhh.1001858
The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment. (Journal article)
Mohan, J. S., Lip, P. L., Blann, A. D., Bareford, D., & Lip, G. Y. H. (2005). The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.. The British journal of ophthalmology, 89(7), 815-819. doi:10.1136/bjo.2004.058164DOI: 10.1136/bjo.2004.058164
Type 2 diabetes mellitus: a cardiovascular perspective. (Journal article)
Varughese, G. I., Tomson, J., & Lip, G. Y. H. (2005). Type 2 diabetes mellitus: a cardiovascular perspective.. International journal of clinical practice, 59(7), 798-816. doi:10.1111/j.1368-5031.2005.00571.xDOI: 10.1111/j.1368-5031.2005.00571.x
Ximelagatran for stroke prevention in atrial fibrillation. (Journal article)
Boos, C. J., & Lip, G. Y. H. (2005). Ximelagatran for stroke prevention in atrial fibrillation.. Expert review of cardiovascular therapy, 3(4), 551-563. doi:10.1586/14779072.3.4.551DOI: 10.1586/14779072.3.4.551
Tomson, J., & Lip, G. Y. H. (2005). Peripheral arterial disease: a high risk - but neglected - disease population.. BMC cardiovascular disorders, 5(1), 15. doi:10.1186/1471-2261-5-15DOI: 10.1186/1471-2261-5-15
Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm. (Journal article)
Chong, A. Y., Chin, B. S. P., Blann, A. D., & Lip, G. Y. H. (2005). Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm.. Thrombosis research, 116(2), 181-183. doi:10.1016/j.thromres.2004.11.023DOI: 10.1016/j.thromres.2004.11.023
Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation. (Journal article)
Lip, G. Y. H., Pearce, L. A., Chin, B. S. P., Conway, D. S. G., & Hart, R. G. (2005). Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.. Heart (British Cardiac Society), 91(6), 759-763. doi:10.1136/hrt.2004.036160DOI: 10.1136/hrt.2004.036160
Effects of short-term glucocorticoids on cardiovascular biomarkers. (Journal article)
Brotman, D. J., Girod, J. P., Garcia, M. J., Patel, J. V., Gupta, M., Posch, A., . . . Reddy, S. (2005). Effects of short-term glucocorticoids on cardiovascular biomarkers.. The Journal of clinical endocrinology and metabolism, 90(6), 3202-3208. doi:10.1210/jc.2004-2379DOI: 10.1210/jc.2004-2379
Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation. (Journal article)
Varughese, G. I., & Lip, G. Y. H. (2005). Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation.. Journal of human hypertension, 19(6), 421-424. doi:10.1038/sj.jhh.1001833DOI: 10.1038/sj.jhh.1001833
Stroke prevention in atrial fibrillation: the case for ximelagatran (Journal article)
Lip, G. Y. H. (2005). Stroke prevention in atrial fibrillation: the case for ximelagatran. European Heart Journal Supplements, 7(suppl_E), E21-E25. doi:10.1093/eurheartj/sui032DOI: 10.1093/eurheartj/sui032
Heterotopic heart transplantation. (Journal article)
Tayebjee, M. H., & Lip, G. Y. H. (2005). Heterotopic heart transplantation.. International journal of cardiology, 101(2), 311-312. doi:10.1016/j.ijcard.2004.01.024DOI: 10.1016/j.ijcard.2004.01.024
Jolly, K., Lip, G. Y., Taylor, R. S., Mant, J. W., Lane, D. A., Lee, K. W., . . . BRUM Steering Committee. (2005). Recruitment of ethnic minority patients to a cardiac rehabilitation trial: the Birmingham Rehabilitation Uptake Maximisation (BRUM) study [ISRCTN72884263].. BMC medical research methodology, 5, 18. doi:10.1186/1471-2288-5-18DOI: 10.1186/1471-2288-5-18
Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension. (Journal article)
Lim, H. S., Lip, G. Y. H., Beevers, D. G., & Blann, A. D. (2005). Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.. European journal of clinical investigation, 35(5), 324-329. doi:10.1111/j.1365-2362.2005.01495.xDOI: 10.1111/j.1365-2362.2005.01495.x
Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure. (Journal article)
Hamaad, A., Sosin, M., Lip, G. Y. H., & MacFadyen, R. J. (2005). Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure.. Cardiovascular drugs and therapy, 19(3), 183-187. doi:10.1007/s10557-005-2219-8DOI: 10.1007/s10557-005-2219-8
Vascular endothelial growth factor and angiogenesis in heart failure. (Journal article)
Lip, G. Y. H., & Chung, I. (2005). Vascular endothelial growth factor and angiogenesis in heart failure.. Journal of cardiac failure, 11(4), 285-287. doi:10.1016/j.cardfail.2005.02.002DOI: 10.1016/j.cardfail.2005.02.002
Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers. (Journal article)
Schmidt-Lucke, C., Belgore, F., Reinhold, D., Ansorge, S., Klein, H. U., Schmidt-Lucke, J. A., & Lip, G. Y. H. (2005). Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers.. International journal of cardiology, 100(2), 207-212. doi:10.1016/j.ijcard.2004.05.046DOI: 10.1016/j.ijcard.2004.05.046
Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension. (Journal article)
Karalis, I., Beevers, G., Beevers, M., & Lip, G. (2005). Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension.. Blood pressure, 14(1), 38-44. doi:10.1080/08037050510008788DOI: 10.1080/08037050510008788
Hormone replacement use and cardiovascular function and structure in postmenopausal women. (Journal article)
Tomson, J., Os, I., & Lip, G. Y. H. (2005). Hormone replacement use and cardiovascular function and structure in postmenopausal women.. Blood pressure, 14(1), 3-5. doi:10.1080/08037050510008841DOI: 10.1080/08037050510008841
Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain. (Journal article)
López, F., Lee, K. W., Marín, F., Roldán, V., Sogorb, F., Caturla, J., & Lip, G. Y. H. (2005). Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain.. International journal of cardiology, 100(1), 151-154. doi:10.1016/j.ijcard.2004.12.002DOI: 10.1016/j.ijcard.2004.12.002
Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects. (Journal article)
Lim, H. S., Patel, J. V., Nadar, S., Hughes, E. A., & Lip, G. Y. H. (2005). Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects.. The American journal of cardiology, 95(7), 905-908. doi:10.1016/j.amjcard.2004.12.024DOI: 10.1016/j.amjcard.2004.12.024
Depression, indirect clinical markers of cardiac disease (Journal article)
Lane, D., Ring, C., Lip, G. Y. H., & Carroll, D. (2005). Depression, indirect clinical markers of cardiac disease. HEART, 91(4), 531-532. doi:10.1136/hrt.2004.036392DOI: 10.1136/hrt.2004.036392
How good is anticoagulation control in non-valvar atrial fibrillation? Observations on the elderly, ethnicity, patient perceptions, and understanding of AF thromboprophylaxis. (Journal article)
Choudhury, A., & Lip, G. Y. H. (2005). How good is anticoagulation control in non-valvar atrial fibrillation? Observations on the elderly, ethnicity, patient perceptions, and understanding of AF thromboprophylaxis.. Heart (British Cardiac Society), 91(4), 425-426. doi:10.1136/hrt.2004.052480DOI: 10.1136/hrt.2004.052480
Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance. (Journal article)
Tayebjee, M. H., Lip, G. Y. H., & MacFadyen, R. J. (2005). Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance.. Current medicinal chemistry, 12(8), 917-925. doi:10.2174/0929867053507270DOI: 10.2174/0929867053507270
Plasma von Willebrand factor levels and surrogates of atherosclerosis. (Journal article)
Lip, G. Y. H., Foster, W., & Blann, A. D. (2005). Plasma von Willebrand factor levels and surrogates of atherosclerosis.. Journal of thrombosis and haemostasis : JTH, 3(4), 659-661. doi:10.1111/j.1538-7836.2005.01284.xDOI: 10.1111/j.1538-7836.2005.01284.x
Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation. (Journal article)
Roldán, V., Marín, F., Martínez, J. G., García-Herola, A., Sogorb, F., & Lip, G. Y. H. (2005). Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation.. The American journal of cardiology, 95(7), 881-882. doi:10.1016/j.amjcard.2004.12.016DOI: 10.1016/j.amjcard.2004.12.016
Statins in women: Is primary prevention beneficial? (Journal article)
Varughese, G. I., & Lip, G. Y. H. (2005). Statins in women: Is primary prevention beneficial?. Evidence-based Healthcare and Public Health, 9(2), 91-92. doi:10.1016/j.ehbc.2005.01.032DOI: 10.1016/j.ehbc.2005.01.032
Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers. (Journal article)
Tan, K. T., Tayebjee, M. H., Lynd, C., Blann, A. D., & Lip, G. Y. H. (2005). Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.. Annals of medicine, 37(1), 61-66. doi:10.1080/07853890410018943DOI: 10.1080/07853890410018943
Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta-analysis. (Journal article)
Nadar, S., Prasad, N., Taylor, R. S., & Lip, G. Y. H. (2005). Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta-analysis.. International journal of cardiology, 99(2), 171-185. doi:10.1016/j.ijcard.2004.03.047DOI: 10.1016/j.ijcard.2004.03.047
Atrial fibrillation, the prothrombotic state, inflammation, and gender. (Journal article)
Conway, D. S. G., & Lip, G. Y. H. (2005). Atrial fibrillation, the prothrombotic state, inflammation, and gender.. The American journal of cardiology, 95(6), 819. doi:10.1016/j.amjcard.2004.11.017DOI: 10.1016/j.amjcard.2004.11.017
Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer. (Journal article)
Caine, G. J., Harris, A. L., Christodoulos, K., Lip, G. Y. H., & Blann, A. D. (2005). Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer.. Cancer letters, 219(2), 163-167. doi:10.1016/j.canlet.2004.09.036DOI: 10.1016/j.canlet.2004.09.036
Ambulatory blood pressure monitoring in heart failure: a systematic review. (Journal article)
Goyal, D., Macfadyen, R. J., Watson, R. D., & Lip, G. Y. H. (2005). Ambulatory blood pressure monitoring in heart failure: a systematic review.. European journal of heart failure, 7(2), 149-156. doi:10.1016/j.ejheart.2004.05.010DOI: 10.1016/j.ejheart.2004.05.010
Antithrombotic therapy in hypertension: a Cochrane Systematic review. (Journal article)
Felmeden, D. C., & Lip, G. Y. H. (2005). Antithrombotic therapy in hypertension: a Cochrane Systematic review.. Journal of human hypertension, 19(3), 185-196. doi:10.1038/sj.jhh.1001807DOI: 10.1038/sj.jhh.1001807
Goodbye mercury? Blood pressure measurement and its future. (Journal article)
Varughese, G. I., & Lip, G. Y. H. (2005). Goodbye mercury? Blood pressure measurement and its future.. Journal of the Royal Society of Medicine, 98(3), 89-90. doi:10.1177/014107680509800301DOI: 10.1177/014107680509800301
Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty. (Journal article)
Blann, A. D., Tan, K. T., Tayebjee, M. H., Davagnanam, I., Moss, M., & Lip, G. Y. H. (2005). Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.. Thrombosis and haemostasis, 93(3), 578-583. doi:10.1160/th04-09-0586DOI: 10.1160/th04-09-0586
The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease. (Journal article)
Lim, H. S., Chong, A. Y., Freestone, B., Blann, A. D., & Lip, G. Y. H. (2005). The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease.. Diabetic medicine : a journal of the British Diabetic Association, 22(3), 249-255. doi:10.1111/j.1464-5491.2004.01388.xDOI: 10.1111/j.1464-5491.2004.01388.x
Exercise and the prothrombotic state: a paradox of cardiovascular prevention or an enhanced prothrombotic state? (Journal article)
Thrall, G., & Lip, G. Y. H. (2005). Exercise and the prothrombotic state: a paradox of cardiovascular prevention or an enhanced prothrombotic state?. Arteriosclerosis, thrombosis, and vascular biology, 25(2), 265-266. doi:10.1161/01.atv.0000154579.11213.daDOI: 10.1161/01.atv.0000154579.11213.da
Fondaparinux. (Journal article)
Tan, K. T., & Lip, G. Y. H. (2005). Fondaparinux.. Current pharmaceutical design, 11(4), 415-419. doi:10.2174/1381612053382089DOI: 10.2174/1381612053382089
Recent developments in atrial fibrillation. (Journal article)
Iqbal, M. B., Taneja, A. K., Lip, G. Y. H., & Flather, M. (2005). Recent developments in atrial fibrillation.. BMJ (Clinical research ed.), 330(7485), 238-243. doi:10.1136/bmj.330.7485.238DOI: 10.1136/bmj.330.7485.238
Psychological interventions for depression in heart failure. (Journal article)
Lane, D. A., Chong, A. Y., & Lip, G. Y. H. (2005). Psychological interventions for depression in heart failure.. The Cochrane database of systematic reviews, (1), CD003329. doi:10.1002/14651858.cd003329.pub2DOI: 10.1002/14651858.cd003329.pub2
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. (Journal article)
Lee, K. W., Lip, G. Y. H., Tayebjee, M., Foster, W., & Blann, A. D. (2005). Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes.. Blood, 105(2), 526-532. doi:10.1182/blood-2004-03-1106DOI: 10.1182/blood-2004-03-1106
Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. (Journal article)
Tayebjee, M. H., Lip, G. Y. H., Blann, A. D., & Macfadyen, R. J. (2005). Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.. Thrombosis research, 115(3), 205-210. doi:10.1016/j.thromres.2004.08.023DOI: 10.1016/j.thromres.2004.08.023
Haemoconcentration and the hypercoagulable state associated with mental stress. (Journal article)
Thrall, G., & Lip, G. Y. H. (2005). Haemoconcentration and the hypercoagulable state associated with mental stress.. Thrombosis research, 115(3), 171-173. doi:10.1016/j.thromres.2004.08.021DOI: 10.1016/j.thromres.2004.08.021
Tomson, J., & Lip, G. Y. H. (2005). Blood pressure demographics: nature or nurture ... ... genes or environment?. BMC medicine, 3, 3. doi:10.1186/1741-7015-3-3DOI: 10.1186/1741-7015-3-3
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction. (Journal article)
Marín, F., González-Conejero, R., Lee, K. W., Corral, J., Roldán, V., López, F., . . . Vicente, V. (2005). A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.. Journal of the American College of Cardiology, 45(1), 25-29. doi:10.1016/j.jacc.2004.09.051DOI: 10.1016/j.jacc.2004.09.051
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. (Journal article)
Hobbs, F. D. R., Fitzmaurice, D. A., Mant, J., Murray, E., Jowett, S., Bryan, S., . . . Lip, G. (2005). A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.. Health technology assessment (Winchester, England), 9(40), iii-74. doi:10.3310/hta9400DOI: 10.3310/hta9400
Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity. (Journal article)
Tayebjee, M. H., Tan, K. T., MacFadyen, R. J., & Lip, G. Y. H. (2005). Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity.. Journal of internal medicine, 257(1), 110-116. doi:10.1111/j.1365-2796.2004.01431.xDOI: 10.1111/j.1365-2796.2004.01431.x
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. (Journal article)
Lim, H. S., Lip, G. Y. H., & Blann, A. D. (2005). Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.. Atherosclerosis, 180(1), 113-118. doi:10.1016/j.atherosclerosis.2004.11.004DOI: 10.1016/j.atherosclerosis.2004.11.004
Angiotensin II-mediated vascular inflammation: the balance between vascular endothelial growth factor and angiopoietins. (Journal article)
Lim, H. S., Felmeden, D., & Lip, G. Y. H. (2005). Angiotensin II-mediated vascular inflammation: the balance between vascular endothelial growth factor and angiopoietins.. Hypertension (Dallas, Tex. : 1979), 45(2), e3. doi:10.1161/01.hyp.0000151886.26341.4bDOI: 10.1161/01.hyp.0000151886.26341.4b
Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment. (Journal article)
Lane, D., & Lip, G. Y. H. (2005). Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.. Age and ageing, 34(1), 1-3. doi:10.1093/ageing/afi008DOI: 10.1093/ageing/afi008
Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratification (Journal article)
Lane, D. A., & Lip, G. Y. H. (2005). Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratification. BLOOD COAGULATION & FIBRINOLYSIS, 16(7), 461-464. doi:10.1097/01.mbc.0000184739.35347.13DOI: 10.1097/01.mbc.0000184739.35347.13
Atrial fibrillation (recent onset). (Journal article)
Lip, G. Y. H. (2005). Atrial fibrillation (recent onset).. Clinical evidence, (14), 71-89.
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension. (Journal article)
Tayebjee, M. H., Karalis, I., Nadar, S. K., Beevers, D. G., MacFadyen, R. J., & Lip, G. Y. H. (2005). Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.. American journal of hypertension, 18(3), 325-329. doi:10.1016/j.amjhyper.2004.09.014DOI: 10.1016/j.amjhyper.2004.09.014
Echocardiographic changes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension Register. (Journal article)
Nadar, S., Beevers, D. G., & Lip, G. Y. H. (2005). Echocardiographic changes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension Register.. Journal of human hypertension, 19(1), 69-75. doi:10.1038/sj.jhh.1001773DOI: 10.1038/sj.jhh.1001773
Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: the Birmingham Factory Screening Project (Journal article)
Lane, D. A., Lip, G. Y. H., & Beevers, D. G. (2005). Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: the Birmingham Factory Screening Project. JOURNAL OF HYPERTENSION, 23(7), 1347-1353. doi:10.1097/01.hjh.0000173516.60610.b5DOI: 10.1097/01.hjh.0000173516.60610.b5
Hibernating myocardium in heart failure. (Journal article)
Bhatia, G., Sosin, M., Leahy, J. F., Connolly, D. L., Davis, R. C., & Lip, G. Y. H. (2005). Hibernating myocardium in heart failure.. Expert review of cardiovascular therapy, 3(1), 111-122. doi:10.1586/14779072.3.1.111DOI: 10.1586/14779072.3.1.111
High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction. (Journal article)
Lee, K. W., Blann, A. D., & Lip, G. Y. H. (2005). High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.. American journal of hypertension, 18(1), 104-115. doi:10.1016/j.amjhyper.2004.09.003DOI: 10.1016/j.amjhyper.2004.09.003
Is hypertension a prothrombotic state? (Journal article)
Varughese, G. I., & Lip, G. Y. H. (2005). Is hypertension a prothrombotic state?. Current hypertension reports, 7(3), 168-173. doi:10.1007/s11906-005-0005-4DOI: 10.1007/s11906-005-0005-4
Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability. (Journal article)
Hamaad, A., Sosin, M., Blann, A. D., Patel, J., Lip, G. Y. H., & MacFadyen, R. J. (2005). Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability.. Clinical cardiology, 28(12), 570-576. doi:10.1002/clc.4960281207DOI: 10.1002/clc.4960281207
Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation. (Journal article)
Mohan, J. S., Lip, G. Y., Wright, J., Bareford, D., & Blann, A. D. (2005). Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation.. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 16(3), 209-214. doi:10.1097/01.mbc.0000164431.98169.8fDOI: 10.1097/01.mbc.0000164431.98169.8f
Platelet adhesion in hypertension: application of a novel assay of platelet adhesion. (Journal article)
Nadar, S. K., Caine, G. J., Blann, A. D., & Lip, G. Y. H. (2005). Platelet adhesion in hypertension: application of a novel assay of platelet adhesion.. Annals of medicine, 37(1), 55-60. doi:10.1080/07853890410018916-1DOI: 10.1080/07853890410018916-1
Rheumatoid disease and the heart: from epidemiology to echocardiography. (Journal article)
Bhatia, G. S., Sosin, M. D., Grindulis, K. A., Davis, R. C., & Lip, G. Y. H. (2005). Rheumatoid disease and the heart: from epidemiology to echocardiography.. Expert opinion on investigational drugs, 14(1), 65-76. doi:10.1517/13543784.14.1.65DOI: 10.1517/13543784.14.1.65
Stroke prevention. (Journal article)
Lip, G. H., Rothwell, P., & Sudlow, C. (2005). Stroke prevention.. Clinical evidence, (14), 173-197.
Thrombotic complications and thromboprophylaxis in breast and gynaecological malignancies. (Journal article)
Goyal, D., Choudhury, A., & Lip, G. Y. H. (2005). Thrombotic complications and thromboprophylaxis in breast and gynaecological malignancies.. Current opinion in obstetrics & gynecology, 17(1), 13-20. doi:10.1097/00001703-200502000-00004DOI: 10.1097/00001703-200502000-00004
Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension. (Journal article)
Tayebjee, M. H., Lim, H. S., Nadar, S., MacFadyen, R. J., & Lip, G. Y. H. (2005). Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension.. European journal of clinical investigation, 35(1), 8-12. doi:10.1111/j.1365-2362.2005.01438.xDOI: 10.1111/j.1365-2362.2005.01438.x
2004
Heart failure--the importance of ethnicity. (Journal article)
Sosin, M. D., Bhatia, G. S., Davis, R. C., & Lip, G. Y. H. (2004). Heart failure--the importance of ethnicity.. European journal of heart failure, 6(7), 831-843. doi:10.1016/j.ejheart.2003.11.019DOI: 10.1016/j.ejheart.2003.11.019
Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention. (Journal article)
Lim, H. S., Blann, A. D., Chong, A. Y., Freestone, B., & Lip, G. Y. H. (2004). Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.. Diabetes care, 27(12), 2918-2924. doi:10.2337/diacare.27.12.2918DOI: 10.2337/diacare.27.12.2918
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. (Journal article)
Lip, P. L., Chatterjee, S., Caine, G. J., Hope-Ross, M., Gibson, J., Blann, A. D., & Lip, G. Y. H. (2004). Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.. The British journal of ophthalmology, 88(12), 1543-1546. doi:10.1136/bjo.2004.048587DOI: 10.1136/bjo.2004.048587
Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project. (Journal article)
Nadar, S. K., Lip, G. Y. H., & Blann, A. D. (2004). Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project.. Thrombosis and haemostasis, 92(6), 1342-1348. doi:10.1160/th04-07-0433DOI: 10.1160/th04-07-0433
Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy. (Journal article)
Nadar, S., Blann, A. D., & Lip, G. Y. H. (2004). Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy.. Annals of medicine, 36(7), 552-557. doi:10.1080/07853890410017386DOI: 10.1080/07853890410017386
Impact of delays to cardiac surgery. (Journal article)
Gubner, R., & Rowe, W. (2004). Impact of delays to cardiac surgery.. Journal of the American College of Cardiology, 44(10), 2094. doi:10.1016/j.jacc.2004.08.022DOI: 10.1016/j.jacc.2004.08.022
Pushing the envelope too far? (Journal article)
Connolly, D. L., Lip, G. Y. H., & Lo, T. S. N. (2004). Pushing the envelope too far?. Journal of the American College of Cardiology, 44(10), 2094-2095. doi:10.1016/j.jacc.2004.08.021DOI: 10.1016/j.jacc.2004.08.021
Antihypertensive therapy and endothelial function. (Journal article)
Nadar, S., Blann, A. D., & Lip, G. Y. H. (2004). Antihypertensive therapy and endothelial function.. Current pharmaceutical design, 10(29), 3607-3614. doi:10.2174/1381612043382800DOI: 10.2174/1381612043382800
Drug development and the importance of ethnicity: lessons from heart failure management and implications for hypertension. (Journal article)
Sosin, M. D., Bhatia, G. S., Lip, G. Y. H., & Davis, R. C. (2004). Drug development and the importance of ethnicity: lessons from heart failure management and implications for hypertension.. Current pharmaceutical design, 10(29), 3569-3577. doi:10.2174/1381612043382783DOI: 10.2174/1381612043382783
Endothelial dysfunction: methods of assessment and application to hypertension. (Journal article)
Nadar, S., Blann, A. D., & Lip, G. Y. H. (2004). Endothelial dysfunction: methods of assessment and application to hypertension.. Current pharmaceutical design, 10(29), 3591-3605. doi:10.2174/1381612043382765DOI: 10.2174/1381612043382765
Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension. (Journal article)
Lim, H. S., Lip, G. Y. H., & Blann, A. D. (2004). Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension.. The Journal of clinical endocrinology and metabolism, 89(11), 5377-5381. doi:10.1210/jc.2004-0616DOI: 10.1210/jc.2004-0616
Preface (Journal article)
Lip, G. Y. H. (2004). Preface. Current Pharmaceutical Design, 10(29).
Ximelagatran: The future in anticoagulation practice? (Multiple letters) [1] (Journal article)
Murin, R. J. A., Hamaad, A., Tayebjee, M. H., & Lip, G. Y. H. (2004). Ximelagatran: The future in anticoagulation practice? (Multiple letters) [1]. British Journal of Cardiology, 11(6), 447-448.
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. (Journal article)
Lee, K. W., Lip, G. Y. H., & Blann, A. D. (2004). Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.. Circulation, 110(16), 2355-2360. doi:10.1161/01.cir.0000138112.90641.7fDOI: 10.1161/01.cir.0000138112.90641.7f
Heart rate variability estimates of autonomic tone: relationship to mapping pathological and procedural stress responses in coronary disease. (Journal article)
Hamaad, A., Lip, G. Y. H., & MacFadyen, R. J. (2004). Heart rate variability estimates of autonomic tone: relationship to mapping pathological and procedural stress responses in coronary disease.. Annals of medicine, 36(6), 448-461. doi:10.1080/07853890410015810DOI: 10.1080/07853890410015810
Acute coronary syndromes presenting solely with heart failure symptoms: are they under recognised? (Journal article)
Hamaad, A., Lip, G. Y. H., & MacFadyen, R. J. (2004). Acute coronary syndromes presenting solely with heart failure symptoms: are they under recognised?. European journal of heart failure, 6(6), 683-686. doi:10.1016/j.ejheart.2004.02.009DOI: 10.1016/j.ejheart.2004.02.009
Genetic polymorphisms and thromoembolic risk in atrial fibrillation. (Journal article)
Marín, F., Roldán, V., Tello, A., & Lip, G. Y. H. (2004). Genetic polymorphisms and thromoembolic risk in atrial fibrillation.. Journal of thrombosis and thrombolysis, 18(2), 151-152. doi:10.1007/s11239-004-0211-yDOI: 10.1007/s11239-004-0211-y
Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation. (Journal article)
Conway, D. S. G., & Lip, G. Y. H. (2004). Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation.. European heart journal, 25(19), 1761. doi:10.1016/j.ehj.2004.08.001DOI: 10.1016/j.ehj.2004.08.001
Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy. (Journal article)
Nadar, S. K., Blann, A. D., & Lip, G. Y. H. (2004). Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy.. Journal of internal medicine, 256(4), 331-337. doi:10.1111/j.1365-2796.2004.01367.xDOI: 10.1111/j.1365-2796.2004.01367.x
Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation. (Journal article)
Marín, F., Roldán, V., Climent, V. E., Ibáñez, A., García, A., Marco, P., . . . Lip, G. Y. H. (2004). Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.. Heart (British Cardiac Society), 90(10), 1162-1166. doi:10.1136/hrt.2003.024521DOI: 10.1136/hrt.2003.024521
Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. (Journal article)
Chong, A. Y., Blann, A. D., Patel, J., Freestone, B., Hughes, E., & Lip, G. Y. H. (2004). Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.. Circulation, 110(13), 1794-1798. doi:10.1161/01.cir.0000143073.60937.50DOI: 10.1161/01.cir.0000143073.60937.50
Which strategies should be used for the primary and secondary prevention of cardiovascular disease? (Journal article)
Tayebjee, M. H., & Lip, G. Y. H. (2004). Which strategies should be used for the primary and secondary prevention of cardiovascular disease?. Dialogues in Cardiovascular Medicine, 9(2), 93-100.
Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart. (Journal article)
Lim, H. S., MacFadyen, R. J., & Lip, G. Y. H. (2004). Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart.. Archives of internal medicine, 164(16), 1737-1748. doi:10.1001/archinte.164.16.1737DOI: 10.1001/archinte.164.16.1737
Compliance with pharmacological therapy in hypertension: can we do better, and how? (Journal article)
Thrall, G., Lip, G. Y. H., & Lane, D. (2004). Compliance with pharmacological therapy in hypertension: can we do better, and how?. Journal of human hypertension, 18(9), 595-597. doi:10.1038/sj.jhh.1001722DOI: 10.1038/sj.jhh.1001722
Ethnic differences in left ventricular size and the prevalence of left ventricular hypertrophy among hypertensive patients vary with electrocardiographic criteria. (Journal article)
Spencer, C. G. C., Beevers, D. G., & Lip, G. Y. H. (2004). Ethnic differences in left ventricular size and the prevalence of left ventricular hypertrophy among hypertensive patients vary with electrocardiographic criteria.. Journal of human hypertension, 18(9), 631-636. doi:10.1038/sj.jhh.1001713DOI: 10.1038/sj.jhh.1001713
Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project. (Journal article)
Lip, G. Y. H., Khan, H., Bhatnagar, A., Brahmabhatt, N., Crook, P., Davies, M. K., & West Birmingham heart failure project. (2004). Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project.. Heart (British Cardiac Society), 90(9), 1016-1019. doi:10.1136/hrt.2003.025742DOI: 10.1136/hrt.2003.025742
Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation. (Journal article)
Marín, F., Corral, J., Roldán, V., González-Conejero, R., del Rey, M. L., Sogorb, F., . . . Vicente, V. (2004). Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.. Journal of molecular and cellular cardiology, 37(3), 699-704. doi:10.1016/j.yjmcc.2004.06.001DOI: 10.1016/j.yjmcc.2004.06.001
Left ventricular systolic dysfunction and atrial fibrillation in older people in the community: the need for identification, as well as appropriate management. (Journal article)
Choudhury, A., & Lip, G. Y. H. (2004). Left ventricular systolic dysfunction and atrial fibrillation in older people in the community: the need for identification, as well as appropriate management.. Age and ageing, 33(5), 434-436. doi:10.1093/ageing/afh185DOI: 10.1093/ageing/afh185
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). (Journal article)
Tayebjee, M. H., Nadar, S., Blann, A. D., Gareth Beevers, D., MacFadyen, R. J., & Lip, G. Y. H. (2004). Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).. American journal of hypertension, 17(9), 764-769. doi:10.1016/j.amjhyper.2004.05.019DOI: 10.1016/j.amjhyper.2004.05.019
New antiarrhythmic agents for atrial fibrillation (Journal article)
Choudhury, A., & Lip, G. Y. H. (2004). New antiarrhythmic agents for atrial fibrillation. Therapy, 1(1), 111-121. doi:10.2217/14750708.1.1.111DOI: 10.2217/14750708.1.1.111
Platelet adhesion in breast cancer: development and application of a novel assay. (Journal article)
Caine, G. J., Nadar, S. K., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2004). Platelet adhesion in breast cancer: development and application of a novel assay.. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 15(6), 513-518. doi:10.1097/00001721-200408000-00012DOI: 10.1097/00001721-200408000-00012
Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. (Journal article)
Conway, D. S. G., Buggins, P., Hughes, E., & Lip, G. Y. H. (2004). Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation.. American heart journal, 148(3), 462-466. doi:10.1016/j.ahj.2004.01.026DOI: 10.1016/j.ahj.2004.01.026
Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. (Journal article)
Conway, D. S. G., Buggins, P., Hughes, E., & Lip, G. Y. H. (2004). Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation.. The American journal of cardiology, 94(4), 508-510. doi:10.1016/j.amjcard.2004.04.070DOI: 10.1016/j.amjcard.2004.04.070
Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension. (Journal article)
Chung, N. A., Beevers, D. G., & Lip, G. (2004). Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension.. Blood pressure, 13(3), 183-189. doi:10.1080/08037050410033312DOI: 10.1080/08037050410033312
An 8-year follow-up study of acute admissions with heart failure in a multiethnic population. (Journal article)
Sosin, M. D., Bhatia, G. S., Zarifis, J., Davis, R. C., & Lip, G. Y. H. (2004). An 8-year follow-up study of acute admissions with heart failure in a multiethnic population.. European journal of heart failure, 6(5), 669-672. doi:10.1016/j.ejheart.2003.11.016DOI: 10.1016/j.ejheart.2003.11.016
Lim, H. S., Hamaad, A., & Lip, G. Y. H. (2004). Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control.. Critical care (London, England), 8(4), 271-279. doi:10.1186/cc2827DOI: 10.1186/cc2827
Diastolic heart failure: recognition, diagnosis and management. (Journal article)
Goyal, D., Choudhary, A., Lip, G. Y. H., & MacFadyen, R. J. (2004). Diastolic heart failure: recognition, diagnosis and management.. Expert opinion on pharmacotherapy, 5(8), 1745-1754. doi:10.1517/14656566.5.8.1745DOI: 10.1517/14656566.5.8.1745
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy. (Journal article)
Tayebjee, M. H., Lim, H. S., MacFadyen, R. J., & Lip, G. Y. H. (2004). Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy.. Diabetes care, 27(8), 2049-2051. doi:10.2337/diacare.27.8.2049DOI: 10.2337/diacare.27.8.2049
Swancutt, D., Hobbs, R., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., . . . Lip, G. (2004). A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732].. BMC cardiovascular disorders, 4, 12. doi:10.1186/1471-2261-4-12DOI: 10.1186/1471-2261-4-12
Is depression a risk factor for coronary heart disease? (Journal article)
Pickering, T. G., Davidson, K., & Shimbo, D. (2004). Is depression a risk factor for coronary heart disease?. Journal of the American College of Cardiology, 44(2), 472-473. doi:10.1016/j.jacc.2004.04.029DOI: 10.1016/j.jacc.2004.04.029
Is depression following acute myocardial infarction an independent risk for mortality? (Journal article)
Lane, D., Lip, G. Y. H., & Carroll, D. (2004). Is depression following acute myocardial infarction an independent risk for mortality?. AMERICAN JOURNAL OF CARDIOLOGY, 93(10), 1333-1334. doi:10.1016/j.amjcard.2004.01.001DOI: 10.1016/j.amjcard.2004.01.001
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (Conference Paper)
Clagett, G. P., Sobel, M., Jackson, M. R., Lip, G. Y. H., Tangelder, M., & Verhaeghe, R. (2004). Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.. In Chest Vol. 126 (pp. 609S-626S). doi:10.1378/chest.126.3_suppl.609sDOI: 10.1378/chest.126.3_suppl.609s
Meta-analysis finds exercise training is safe in people with heart failure and left ventricular dysfunction (Journal article)
Meta-analysis finds exercise training is safe in people with heart failure and left ventricular dysfunction (2004). Evidence-based Cardiovascular Medicine, 8(4), 327-328. doi:10.1016/j.ebcm.2004.09.021DOI: 10.1016/j.ebcm.2004.09.021
Novel therapies for the prevention of stroke. (Journal article)
Boos, C. J., & Lip, G. Y. H. (2004). Novel therapies for the prevention of stroke.. Expert opinion on investigational drugs, 13(12), 1615-1630. doi:10.1517/13543784.13.12.1615DOI: 10.1517/13543784.13.12.1615
Salt intake and Helicobacter pylori infection. (Journal article)
Beevers, D. G., Lip, G. Y. H., & Blann, A. D. (2004). Salt intake and Helicobacter pylori infection.. Journal of hypertension, 22(8), 1475-1477. doi:10.1097/01.hjh.0000133736.77866.77DOI: 10.1097/01.hjh.0000133736.77866.77
Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertensionRelationship to tissue Doppler indices of diastolic relaxation (Journal article)
TAYEBJEE, M., NADAR, S., MACFADYEN, R., & LIP, G. (2004). Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertensionRelationship to tissue Doppler indices of diastolic relaxation. American Journal of Hypertension, 17(9), 770-774. doi:10.1016/s0895-7061(04)00902-1DOI: 10.1016/s0895-7061(04)00902-1
2003
Anxiety, depression, and prognosis after myocardial infarction - Is there a causal association? (Journal article)
Lane, D., Carroll, D., & Lip, G. Y. H. (2003). Anxiety, depression, and prognosis after myocardial infarction - Is there a causal association?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 42(10), 1808-1810. doi:10.1016/j.jacc.2003.08.018DOI: 10.1016/j.jacc.2003.08.018
Heart failure: treatment and ethnic origin. (Journal article)
Sosin, M. D., Bhatia, G. S., Davis, R. C., Connolly, D. L., & Lip, G. Y. H. (2003). Heart failure: treatment and ethnic origin.. Lancet (London, England), 362(9387), 919-920. doi:10.1016/s0140-6736(03)14317-6DOI: 10.1016/s0140-6736(03)14317-6
Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263] (Journal article)
Jolly, K., Lip, G. Y. H., Sandercock, J., Greenfield, S. M., Raftery, J. P., Mant, J., . . . Stevens, A. J. (2003). Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263]. BMC CARDIOVASCULAR DISORDERS, 3. doi:10.1186/1471-2261-3-10DOI: 10.1186/1471-2261-3-10
Psychological interventions for depression in adolescent and adult congenital heart disease. (Journal article)
Lip, G. Y. H., Lane, D. A., Millane, T. A., & Tayebjee, M. H. (2003). Psychological interventions for depression in adolescent and adult congenital heart disease.. The Cochrane database of systematic reviews, (3), CD004394. doi:10.1002/14651858.cd004394DOI: 10.1002/14651858.cd004394
2002
In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction (Journal article)
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2002). In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 31(6), 1179-1182. doi:10.1093/ije/31.6.1179DOI: 10.1093/ije/31.6.1179
Quality of life in adults with congenital heart disease (Journal article)
Lane, D. A., Lip, G. Y. H., & Millane, T. A. (2002). Quality of life in adults with congenital heart disease. HEART, 88(1), 71-75. doi:10.1136/heart.88.1.71DOI: 10.1136/heart.88.1.71
Ethnic differences in blood pressure and the prevalence of hypertension in England (Journal article)
Lane, D., Beevers, D. G., & Lip, G. Y. H. (2002). Ethnic differences in blood pressure and the prevalence of hypertension in England. JOURNAL OF HUMAN HYPERTENSION, 16(4), 267-273. doi:10.1038/sj.jhh.1001371DOI: 10.1038/sj.jhh.1001371
The prevalence and persistence of depression and anxiety following myocardial infarction (Journal article)
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2002). The prevalence and persistence of depression and anxiety following myocardial infarction. BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 7, 11-21. doi:10.1348/135910702169321DOI: 10.1348/135910702169321
Cancer and ethnic minorities. (Journal article)
Caine, G. J., Beevers, D. G., & Lip, G. Y. H. (2002). Cancer and ethnic minorities.. The Lancet. Oncology, 3(1), 9. doi:10.1016/s1470-2045(01)00614-3DOI: 10.1016/s1470-2045(01)00614-3
2001
Blood pressure in different ethnic groups. (Journal article)
Lane, D., & Lip, G. Y. (2001). Blood pressure in different ethnic groups.. The American journal of cardiology, 88(10), 1218-1219. doi:10.1016/s0002-9149(01)01963-4DOI: 10.1016/s0002-9149(01)01963-4
Predictors of attendance at cardiac rehabilitation after myocardial infarction (Journal article)
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2001). Predictors of attendance at cardiac rehabilitation after myocardial infarction. JOURNAL OF PSYCHOSOMATIC RESEARCH, 51(3), 497-501. doi:10.1016/S0022-3999(01)00225-2DOI: 10.1016/S0022-3999(01)00225-2
Ethnic differences in hypertension and blood pressure control in the UK (Journal article)
Lane, D. A., & Lip, G. Y. H. (2001). Ethnic differences in hypertension and blood pressure control in the UK. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 94(7), 391-396. doi:10.1093/qjmed/94.7.391DOI: 10.1093/qjmed/94.7.391
Lone papilloedema (Journal article)
Lip, P. L., Burdon, M. A., Clarke, C. E., Beevers, D. G., & Lip, G. Y. H. (2001). Lone papilloedema. The Lancet, 357(9272), 1924. doi:10.1016/s0140-6736(00)05062-5DOI: 10.1016/s0140-6736(00)05062-5
Cardiovascular and behavioral reactions to stress and cerebrovascular disease (Journal article)
Lane, D. A., Carroll, D., & Lip, G. Y. H. (2001). Cardiovascular and behavioral reactions to stress and cerebrovascular disease. STROKE, 32(8), 1718-1720. Retrieved from https://www.webofscience.com/
Laboratory investigation of platelets (Chapter)
Shantsila, E., Watson, T., & Lip, G. Y. H. (2001). Laboratory investigation of platelets. In Platelets in Hematologic and Cardiovascular Disorders (pp. 124-146). Cambridge University Press. doi:10.1017/cbo9780511545276.010DOI: 10.1017/cbo9780511545276.010
Mortality and quality of life 12 months after myocardial infarction: Effects of depression and anxiety (Journal article)
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2001). Mortality and quality of life 12 months after myocardial infarction: Effects of depression and anxiety. PSYCHOSOMATIC MEDICINE, 63(2), 221-230. doi:10.1097/00006842-200103000-00005DOI: 10.1097/00006842-200103000-00005
2000
Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction (Journal article)
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2000). Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction. JOURNAL OF PSYCHOSOMATIC RESEARCH, 49(4), 229-238. doi:10.1016/S0022-3999(00)00170-7DOI: 10.1016/S0022-3999(00)00170-7
Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction? (Journal article)
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. H. (2000). Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction?. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 93(11), 739-744. doi:10.1093/qjmed/93.11.739DOI: 10.1093/qjmed/93.11.739
1999
Psychology in coronary care (Journal article)
Lane, D., Carroll, D., & Lip, G. Y. H. (1999). Psychology in coronary care. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 92(8), 425-431. doi:10.1093/qjmed/92.8.425DOI: 10.1093/qjmed/92.8.425
1998
Oxidative stress after thrombolysis. (Journal article)
Landray, M. J., Nuttall, S. L., Lydakis, C., Martin, U., Maxwell, S. R., & Lip, G. Y. (1998). Oxidative stress after thrombolysis.. Lancet (London, England), 352(9132), 960. doi:10.1016/s0140-6736(05)61514-0DOI: 10.1016/s0140-6736(05)61514-0